data_2lna_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lna _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -77.01 126.18 30.55 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.92 0.888 . . . . 0.0 108.752 177.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.3 pt -126.55 166.86 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.785 1.234 . . . . 0.0 108.139 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 22' ' ' ASP . 9.8 t -96.4 157.84 15.71 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.541 ' O ' HG23 ' A' ' 24' ' ' VAL . 73.5 t-105 -53.91 -46.0 71.31 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.392 1.077 . . . . 0.0 110.993 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -61.04 -39.64 90.56 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.616 0.766 . . . . 0.0 112.037 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.417 ' H ' HG22 ' A' ' 19' ' ' THR . 24.4 t70 -66.55 -43.35 85.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.532 1.133 . . . . 0.0 110.415 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.434 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 12.5 t80 -52.46 -53.72 41.8 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.802 175.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 20' ' ' TRP . 62.3 t -58.65 -55.45 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 123.805 0.691 . . . . 0.0 111.22 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -71.78 -49.55 37.88 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.085 -0.962 . . . . 0.0 112.147 -169.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -90.07 -13.84 35.03 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.434 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 41.7 m-85 -127.81 -64.72 0.95 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 119.245 0.929 . . . . 0.0 113.131 -175.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.406 HD13 HG21 ' A' ' 89' ' ' VAL . 32.8 tp -58.47 -50.18 74.66 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.566 0.747 . . . . 0.0 112.775 -170.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.7 p -70.45 -18.37 63.0 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.15 0.58 . . . . 0.0 111.623 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -86.41 -7.59 58.32 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.435 0.694 . . . . 0.0 110.893 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.33 13.16 67.3 Favored Glycine 0 C--N 1.356 1.659 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 m -86.8 -0.47 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.435 0.617 . . . . 0.0 111.274 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.6 t -97.87 128.03 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.185 0.994 . . . . 0.0 109.062 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.521 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 23.9 t70 -86.94 -52.42 5.47 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.08 0.952 . . . . 0.0 109.75 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.489 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 17.5 ptp180 -156.48 163.66 39.16 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.512 -174.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.6 mt -118.75 104.4 10.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.825 0.85 . . . . 0.0 108.972 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.438 ' HG2' ' HB ' ' A' ' 92' ' ' VAL . 46.1 mt-10 -97.75 107.77 20.33 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.734 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.522 HG13 ' HA ' ' A' ' 41' ' ' LYS . 26.5 t -82.91 92.42 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -172.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.543 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 61.9 t -83.19 120.44 34.47 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 C-N-CA 122.797 0.439 . . . . 0.0 110.815 -169.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 54.53 21.45 3.35 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.811 1.644 . . . . 0.0 113.016 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.522 ' HA ' HG13 ' A' ' 38' ' ' VAL . 99.5 mttt 55.85 5.43 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.301 1.44 . . . . 0.0 114.472 -175.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -78.41 -41.32 33.37 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.02 0.914 . . . . 0.0 108.87 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -151.49 172.91 15.24 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.021 -172.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.437 HG23 HG23 ' A' ' 38' ' ' VAL . 79.4 t -122.38 131.26 73.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 124.248 1.019 . . . . 0.0 108.53 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -90.43 127.01 36.08 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.8 t -80.97 106.87 12.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 171.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.452 HG21 ' HE2' ' A' ' 59' ' ' TYR . 66.1 m -88.4 123.14 32.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -82.74 147.55 28.38 Favored 'General case' 0 C--O 1.247 0.939 0 O-C-N 123.609 0.568 . . . . 0.0 109.728 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.521 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 43.4 p . . . . . 0 CA--C 1.556 1.174 0 O-C-N 124.327 1.017 . . . . 0.0 109.855 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' HE2' HG21 ' A' ' 47' ' ' THR . 3.7 m-30 . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 121.252 0.549 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.1 m -110.2 164.68 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.343 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -157.35 165.67 35.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.176 0.59 . . . . 0.0 110.027 -173.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -149.2 142.01 24.64 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.467 0.707 . . . . 0.0 109.967 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -75.31 140.05 42.86 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.564 HD12 ' HA ' ' A' ' 67' ' ' VAL . 31.0 pt -115.18 -44.02 3.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.205 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.12 -74.74 0.36 Allowed Glycine 0 C--N 1.352 1.45 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 -171.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -80.33 97.47 7.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.456 1.102 . . . . 0.0 109.3 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.564 ' HA ' HD12 ' A' ' 64' ' ' ILE . 37.4 t -59.28 -37.44 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.821 0.849 . . . . 0.0 111.027 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 21.8 t70 -58.09 -49.87 75.43 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.497 1.119 . . . . 0.0 110.803 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.4 m -58.68 -46.08 88.03 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.917 0.887 . . . . 0.0 111.075 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -49.99 -50.81 45.85 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.16 0.984 . . . . 0.0 111.322 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 42.4 mt-10 -67.97 -45.83 73.09 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 124.251 0.97 . . . . 0.0 111.62 -173.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 68' ' ' ASP . 14.2 mtm180 -58.27 -46.05 86.73 Favored 'General case' 0 C--N 1.364 1.213 0 O-C-N 123.821 0.7 . . . . 0.0 109.845 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -65.48 -42.99 91.59 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.652 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.27 -50.59 69.57 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 123.946 0.778 . . . . 0.0 112.265 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -34.6 76.71 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.808 0.443 . . . . 0.0 111.675 -177.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.435 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 86.8 m -63.66 -52.02 62.57 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.352 0.596 . . . . 0.0 109.512 171.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.457 HD21 HG21 ' A' ' 24' ' ' VAL . 47.1 tp -52.99 -42.65 65.78 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.505 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -64.53 -45.7 86.03 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.915 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 76' ' ' THR . 10.1 pt20 -70.25 -26.84 64.02 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-N 117.763 0.256 . . . . 0.0 110.79 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 76' ' ' THR . 43.8 mt-10 -68.22 -50.23 55.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.013 0.925 . . . . 0.0 110.738 174.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.16 5.03 18.07 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.677 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.86 19.54 72.73 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-O 119.823 -0.432 . . . . 0.0 114.106 172.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.55 117.53 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.842 0.857 . . . . 0.0 109.612 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.65 -179.18 3.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.772 1.229 . . . . 0.0 108.568 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.17 -36.27 1.98 Allowed Glycine 0 N--CA 1.48 1.572 0 N-CA-C 116.246 1.258 . . . . 0.0 116.246 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.6 -37.03 60.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.504 0.722 . . . . 0.0 111.385 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -93.2 -5.63 49.56 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 118.85 -0.595 . . . . 0.0 111.966 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -58.85 124.51 20.06 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 118.046 0.385 . . . . 0.0 110.433 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.406 HG21 HD13 ' A' ' 28' ' ' LEU . 99.6 t -89.7 108.64 26.66 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.452 -172.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.489 ' HG2' ' HB3' ' A' ' 35' ' ' ARG . 19.4 Cg_endo -58.74 129.21 31.17 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.299 2.666 . . . . 0.0 112.591 -174.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.61 109.35 25.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.438 ' HB ' ' HG2' ' A' ' 37' ' ' GLU . 43.4 t -104.07 111.67 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -174.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -78.66 124.97 28.73 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 47.2 mt . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.461 ' HB2' HG11 ' A' ' 60' ' ' VAL . 34.7 mmt180 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 110.715 -0.106 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -79.76 109.62 14.35 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.2 pt -104.85 177.14 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 124.931 1.292 . . . . 0.0 108.9 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.5 p -92.02 163.14 14.09 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.527 ' O ' HG21 ' A' ' 24' ' ' VAL . 69.7 t-105 -58.89 -41.08 86.33 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.007 0.523 . . . . 0.0 109.657 171.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -52.16 -57.34 9.92 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.894 0.878 . . . . 0.0 111.733 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.33 -34.82 79.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.427 0.691 . . . . 0.0 111.157 -175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.402 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 45.2 t80 -54.56 -54.87 35.55 Favored 'General case' 0 C--N 1.344 0.334 0 O-C-N 123.991 0.807 . . . . 0.0 111.302 174.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.544 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 43.7 t -64.88 -50.64 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 O-C-N 123.43 0.456 . . . . 0.0 110.605 -174.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -66.44 -45.22 80.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.211 -172.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -95.71 -24.64 16.44 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -171.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.402 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 80.0 m-85 -122.13 -64.84 1.17 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 118.782 0.719 . . . . 0.0 112.591 -169.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.544 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 48.9 tp -55.54 -48.75 74.23 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.981 0.912 . . . . 0.0 112.045 -173.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 p -64.94 -22.95 67.08 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -89.49 -3.72 58.24 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.902 0.481 . . . . 0.0 110.439 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.37 19.14 61.78 Favored Glycine 0 C--N 1.355 1.599 0 N-CA-C 114.671 0.628 . . . . 0.0 114.671 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.5 m -79.06 0.16 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 117.415 0.608 . . . . 0.0 111.638 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.1 135.09 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.303 1.041 . . . . 0.0 108.941 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -81.64 -53.69 6.03 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.337 1.055 . . . . 0.0 108.887 174.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -168.15 164.19 13.35 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.944 -171.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.6 mt -116.96 105.18 12.05 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.061 0.945 . . . . 0.0 109.377 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -96.33 110.67 22.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.106 -174.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 41' ' ' LYS . 7.6 t -90.65 93.79 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -171.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.7 t -71.14 117.95 15.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 123.738 0.815 . . . . 0.0 110.919 -171.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 54.19 22.71 3.75 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.54 1.536 . . . . 0.0 113.03 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.547 ' HA ' HG11 ' A' ' 38' ' ' VAL . 8.5 mtpm? 53.7 17.15 1.15 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.852 1.261 . . . . 0.0 114.067 -172.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -91.28 -37.18 13.45 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.114 0.566 . . . . 0.0 110.434 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -152.8 163.78 39.07 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.75 0.82 . . . . 0.0 109.26 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.441 HG22 HG23 ' A' ' 38' ' ' VAL . 47.8 t -110.27 130.35 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.404 ' HG2' ' HB3' ' A' ' 61' ' ' TRP . 3.5 tmm_? -116.14 132.46 56.65 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.0 t -88.44 125.83 41.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.178 -170.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.9 m -95.14 129.77 42.12 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 167.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -87.03 144.7 26.78 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.828 0.451 . . . . 0.0 110.716 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 123.005 0.522 . . . . 0.0 110.195 -178.967 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 . . . . . 0 C--O 1.237 0.446 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 16' ' ' ARG . 25.2 m -122.81 170.26 13.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.404 ' HB3' ' HG2' ' A' ' 45' ' ' ARG . 8.9 p-90 -165.43 158.56 16.1 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.622 0.369 . . . . 0.0 110.624 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -145.0 151.03 37.94 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.316 0.579 . . . . 0.0 110.291 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -82.9 151.06 26.13 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.579 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 67' ' ' VAL . 26.0 pt -125.69 144.19 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.521 0.728 . . . . 0.0 110.425 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.99 -52.64 7.75 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m -131.72 135.7 47.05 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.717 0.807 . . . . 0.0 108.972 176.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.429 ' HA ' HD11 ' A' ' 64' ' ' ILE . 5.0 t -67.15 -37.27 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.01 0.924 . . . . 0.0 110.477 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 5.9 m-20 -67.0 -49.41 65.44 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.646 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.8 m -62.7 -36.01 81.57 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 122.576 0.351 . . . . 0.0 110.647 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -54.33 -57.52 10.92 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 123.81 0.844 . . . . 0.0 111.385 174.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -64.33 -33.13 75.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.438 0.462 . . . . 0.0 111.368 -175.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 5.3 mmp_? -60.69 -55.53 32.13 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.099 0.476 . . . . 0.0 110.412 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.401 HD21 ' N ' ' A' ' 73' ' ' ASN . 0.8 OUTLIER -66.6 -42.4 86.97 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.224 -173.057 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.5 tp -58.76 -56.02 27.58 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.111 0.964 . . . . 0.0 112.527 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -59.67 -42.06 92.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 123.447 0.467 . . . . 0.0 111.932 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.42 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 54.9 m -59.79 -53.08 62.11 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.3 tp -53.91 -46.48 71.46 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.813 1.645 . . . . 0.0 113.119 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -62.04 -48.34 80.68 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.998 0.519 . . . . 0.0 110.662 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -68.48 -22.95 64.53 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.42 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 76' ' ' THR . 61.1 mm-40 -71.56 -43.18 66.81 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.919 0.488 . . . . 0.0 110.135 169.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.0 mt -73.86 -15.58 61.15 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.921 0.888 . . . . 0.0 111.214 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.66 -6.79 80.04 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-O 119.601 -0.555 . . . . 0.0 112.923 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.439 HG21 ' HA ' ' A' ' 88' ' ' ARG . 77.8 mt -64.92 101.36 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.537 1.535 . . . . 0.0 110.271 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -144.31 167.84 21.49 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.523 1.129 . . . . 0.0 110.027 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.52 -122.89 23.96 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.506 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.97 -25.4 59.91 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.645 0.778 . . . . 0.0 111.307 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -75.61 -23.35 56.42 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.163 0.585 . . . . 0.0 110.407 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.439 ' HA ' HG21 ' A' ' 83' ' ' ILE . 15.0 ttm180 -57.88 137.48 56.64 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 124.103 0.961 . . . . 0.0 110.677 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.9 t -92.38 101.61 5.21 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.824 1.25 . . . . 0.0 109.723 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 88' ' ' ARG . 19.5 Cg_exo -68.15 153.69 74.17 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.994 2.463 . . . . 0.0 112.351 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.0 t -107.07 118.74 55.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.2 t -106.61 97.86 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -72.92 97.44 2.28 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.1 mt . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.221 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.541 ' HB3' HG12 ' A' ' 60' ' ' VAL . 69.1 ttp85 . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -73.56 109.2 6.89 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 37.9 pt -97.35 173.64 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 166.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.4 p -110.49 169.72 8.56 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 166.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.408 ' O ' HG21 ' A' ' 24' ' ' VAL . 69.9 t-105 -53.33 -37.67 62.51 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.119 0.968 . . . . 0.0 111.695 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -58.07 -46.01 86.16 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 176.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.519 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 39.5 m-20 -66.44 -35.31 79.98 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.128 0.571 . . . . 0.0 111.036 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -59.77 -58.54 8.13 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.583 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.439 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 85.1 t -58.51 -57.11 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.179 0.592 . . . . 0.0 111.713 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -62.12 -56.23 20.94 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.031 0.832 . . . . 0.0 111.981 -173.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -84.49 -34.58 23.34 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.67 -168.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -114.36 -62.25 1.63 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -162.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.439 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 68.4 tp -59.42 -51.12 71.26 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.294 1.038 . . . . 0.0 111.172 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.9 t -59.38 -24.19 63.22 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.001 0.92 . . . . 0.0 113.024 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -98.66 -6.0 30.58 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.547 0.339 . . . . 0.0 111.504 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.06 31.38 58.76 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 114.477 0.551 . . . . 0.0 114.477 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.7 m -81.93 0.65 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.693 0.397 . . . . 0.0 110.882 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 24.9 t -98.65 128.48 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.514 1.126 . . . . 0.0 109.799 -173.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.584 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 31.0 t70 -77.81 -47.08 19.74 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.776 0.83 . . . . 0.0 109.692 177.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.442 ' HD2' HG23 ' A' ' 92' ' ' VAL . 31.7 ptt-85 -162.68 163.93 26.73 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.968 0.793 . . . . 0.0 111.243 -174.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.3 mt -117.8 104.66 11.17 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.583 1.153 . . . . 0.0 109.428 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -87.79 101.96 14.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.844 0.857 . . . . 0.0 109.767 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.459 HG23 HG23 ' A' ' 44' ' ' VAL . 35.6 t -88.32 91.3 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -175.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.9 t -92.91 119.69 41.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.825 -170.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 58.66 18.61 6.02 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.979 1.312 . . . . 0.0 112.56 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 54.84 21.09 3.4 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.87 1.268 . . . . 0.0 113.314 175.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -107.69 -28.51 9.67 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.283 1.033 . . . . 0.0 110.466 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -152.56 159.03 43.3 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.969 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.459 HG23 HG23 ' A' ' 38' ' ' VAL . 57.9 t -124.03 130.67 73.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 -98.14 124.79 42.86 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.492 ' HB ' HG22 ' A' ' 60' ' ' VAL . 55.9 t -82.67 107.72 14.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.1 m -93.62 128.61 39.86 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 57.2 m-85 -85.1 164.56 18.1 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.014 0.821 . . . . 0.0 109.519 176.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.584 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 11.5 t . . . . . 0 CA--C 1.557 1.233 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.8 p90 . . . . . 0 C--O 1.244 0.769 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.541 HG12 ' HB3' ' A' ' 16' ' ' ARG . 27.8 m -129.18 178.75 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.329 0.652 . . . . 0.0 109.724 177.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -157.86 162.05 38.35 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.995 0.518 . . . . 0.0 110.245 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.416 ' HB3' HG13 ' A' ' 18' ' ' ILE . 47.4 p90 -145.73 153.75 41.31 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.326 0.65 . . . . 0.0 109.454 175.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -80.34 152.76 28.77 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.787 0.435 . . . . 0.0 110.748 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.8 pt -126.01 144.45 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.232 0.613 . . . . 0.0 109.445 172.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.05 -61.99 2.56 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.1 m -127.48 133.71 49.86 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.674 0.789 . . . . 0.0 109.024 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.4 t -57.87 -40.47 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.351 1.06 . . . . 0.0 111.506 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.09 -40.41 96.18 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.619 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.2 m -67.88 -45.08 75.5 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -51.04 -52.94 38.11 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.481 1.112 . . . . 0.0 112.495 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -71.32 -35.97 71.41 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.466 0.478 . . . . 0.0 110.838 -174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -66.97 -39.56 87.26 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.573 0.349 . . . . 0.0 110.589 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -66.79 -52.62 41.84 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.088 0.555 . . . . 0.0 110.173 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.4 tp -53.48 -55.08 28.32 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.205 1.002 . . . . 0.0 111.377 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 79' ' ' GLN . 68.6 mm-40 -61.84 -48.92 78.37 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.796 0.685 . . . . 0.0 112.725 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 58.1 m -64.53 -50.11 68.64 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.471 0.482 . . . . 0.0 110.116 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.8 tp -50.26 -46.29 54.89 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.229 1.411 . . . . 0.0 112.471 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -61.65 -46.75 88.45 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.842 0.457 . . . . 0.0 110.641 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 75.0 mt-30 -62.69 -34.76 77.79 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.255 0.622 . . . . 0.0 111.065 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.8 -39.31 57.1 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.81 0.844 . . . . 0.0 111.702 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.57 -21.34 61.16 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.601 0.361 . . . . 0.0 110.951 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.3 -5.65 57.51 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 120.075 -0.292 . . . . 0.0 113.019 -173.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.7 mt -70.08 121.53 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 124.478 1.111 . . . . 0.0 109.984 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -162.42 162.48 27.71 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.077 0.551 . . . . 0.0 111.107 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.97 -111.09 3.64 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.636 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.97 -23.75 58.33 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.902 0.881 . . . . 0.0 110.901 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.75 -26.71 29.46 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 ttm105 -63.32 123.38 18.55 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.5 t -72.69 119.57 75.94 Favored Pre-proline 0 CA--C 1.555 1.155 0 O-C-N 123.808 0.693 . . . . 0.0 110.247 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 31.9 Cg_exo -60.41 141.22 95.05 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.42 2.747 . . . . 0.0 112.523 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.6 t -111.69 114.94 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.442 HG23 ' HD2' ' A' ' 35' ' ' ARG . 60.8 t -109.15 98.33 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.212 1.005 . . . . 0.0 109.043 -173.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -71.7 114.86 10.23 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.939 0.496 . . . . 0.0 110.434 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 58.7 mt . . . . . 0 CA--C 1.543 0.702 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.373 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.49 ' HB3' HG11 ' A' ' 60' ' ' VAL . 34.9 ttm180 . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -75.12 133.23 41.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.1 pt -128.67 168.82 21.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.755 1.222 . . . . 0.0 108.292 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.4 p -85.75 161.01 19.36 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.458 ' O ' HG23 ' A' ' 24' ' ' VAL . 61.2 t-105 -51.03 -48.98 61.36 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.933 0.893 . . . . 0.0 111.146 174.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -75.21 -24.13 57.71 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.515 0.509 . . . . 0.0 111.863 -175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -65.53 -42.81 91.57 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 172.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.419 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 17.7 t80 -56.44 -51.22 69.24 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.877 172.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 20' ' ' TRP . 60.8 t -58.11 -61.88 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.844 0.458 . . . . 0.0 111.035 -177.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.475 HD21 ' N ' ' A' ' 25' ' ' ASN . 0.7 OUTLIER -68.16 -46.17 71.49 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.427 0.691 . . . . 0.0 111.768 -166.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -84.77 -34.13 22.88 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.472 -172.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.504 ' HH ' HG12 ' A' ' 60' ' ' VAL . 88.0 m-85 -112.29 -66.57 1.07 Allowed 'General case' 0 C--O 1.248 0.977 0 O-C-N 121.849 -0.532 . . . . 0.0 111.825 -166.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.521 HD12 HG22 ' A' ' 89' ' ' VAL . 21.2 tp -64.57 -48.3 75.5 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -170.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 m -65.67 -21.2 66.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.627 0.771 . . . . 0.0 112.429 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -98.14 -1.02 43.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.858 0.863 . . . . 0.0 111.62 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.12 23.23 61.59 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 115.364 0.905 . . . . 0.0 115.364 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.413 HG22 ' HA ' ' A' ' 27' ' ' TYR . 17.6 m -88.36 11.62 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 117.476 0.638 . . . . 0.0 110.668 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.43 136.16 31.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 125.193 1.397 . . . . 0.0 108.938 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.514 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 25.8 t70 -87.55 -49.05 7.44 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.918 0.887 . . . . 0.0 109.014 172.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -164.2 172.42 13.67 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.523 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.2 mt -119.95 112.97 19.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.201 1.001 . . . . 0.0 110.222 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -99.6 104.49 16.27 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.913 0.885 . . . . 0.0 110.069 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.521 HG23 HG23 ' A' ' 44' ' ' VAL . 28.2 t -86.83 99.61 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -175.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.3 t -89.54 123.05 41.56 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 C-N-CA 123.942 0.897 . . . . 0.0 110.367 -169.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 54.12 18.45 1.76 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.569 1.548 . . . . 0.0 113.14 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.476 ' HB3' HG22 ' A' ' 67' ' ' VAL . 94.8 mttt 57.09 16.04 2.72 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.584 1.154 . . . . 0.0 113.496 -176.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -91.55 -32.87 15.38 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.334 0.654 . . . . 0.0 110.483 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -156.69 170.61 22.02 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.528 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.521 HG23 HG23 ' A' ' 38' ' ' VAL . 59.2 t -117.31 129.47 73.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.035 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -96.15 122.63 39.2 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.462 1.105 . . . . 0.0 108.08 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.513 ' HB ' HG22 ' A' ' 60' ' ' VAL . 46.3 t -84.72 112.13 21.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.7 m -90.08 132.61 35.32 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.596 ' HE2' ' HA ' ' A' ' 59' ' ' TYR . 53.1 m-85 -84.33 146.82 27.51 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.568 0.747 . . . . 0.0 110.286 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.514 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.7 OUTLIER . . . . . 0 CA--C 1.565 1.533 0 C-N-CA 123.626 0.77 . . . . 0.0 110.154 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.596 ' HA ' ' HE2' ' A' ' 48' ' ' PHE . 35.6 p90 . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 120.59 0.233 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.513 HG22 ' HB ' ' A' ' 46' ' ' VAL . 27.6 m -110.38 153.36 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 169.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 -160.3 166.25 29.83 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.615 0.766 . . . . 0.0 109.777 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -147.78 140.39 24.64 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.35 0.66 . . . . 0.0 109.939 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -84.58 126.92 33.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.323 0.649 . . . . 0.0 109.637 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' A' ' 67' ' ' VAL . 41.3 pt -104.61 -41.13 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 122.508 0.323 . . . . 0.0 111.754 -173.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.78 -80.43 0.12 Allowed Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 -171.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.3 m -71.4 95.45 1.35 Allowed 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.788 0.835 . . . . 0.0 109.901 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.555 ' HA ' HD12 ' A' ' 64' ' ' ILE . 58.5 t -61.49 -40.34 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.522 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 5.8 m-20 -58.57 -44.53 89.78 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.856 0.863 . . . . 0.0 110.478 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.0 m -66.67 -40.31 88.55 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.702 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -55.77 -46.09 77.98 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 123.258 0.623 . . . . 0.0 110.618 173.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 47.4 mt-10 -64.07 -44.95 90.84 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 124.244 0.965 . . . . 0.0 109.973 -176.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 4.5 mmp_? -59.15 -51.22 70.93 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 124.186 0.928 . . . . 0.0 111.262 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -65.6 -40.47 92.71 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.41 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.9 -50.25 72.94 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.672 0.789 . . . . 0.0 112.197 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -32.98 70.29 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -175.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.2 m -64.11 -44.9 90.84 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.189 0.596 . . . . 0.0 109.846 171.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 34.3 tp -63.05 -37.4 87.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.699 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -63.94 -38.43 91.04 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.347 0.659 . . . . 0.0 109.998 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -68.08 -36.73 80.3 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 175.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.07 -46.0 72.28 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.038 0.535 . . . . 0.0 111.383 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.0 mt -82.42 2.22 33.64 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.627 0.771 . . . . 0.0 112.259 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.47 14.6 79.39 Favored Glycine 0 C--N 1.358 1.787 0 O-C-N 123.311 0.382 . . . . 0.0 113.684 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 87.2 mt -82.56 111.66 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.282 1.433 . . . . 0.0 109.603 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.39 168.02 28.64 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.124 0.57 . . . . 0.0 111.605 -175.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.11 -126.41 23.08 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.492 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.81 -14.24 60.67 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.039 0.536 . . . . 0.0 110.487 177.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -79.64 -16.16 56.28 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.855 0.862 . . . . 0.0 111.699 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -51.1 129.89 24.94 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.067 0.947 . . . . 0.0 111.002 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.521 HG22 HD12 ' A' ' 28' ' ' LEU . 49.6 t -63.02 113.1 8.19 Favored Pre-proline 0 N--CA 1.474 0.727 0 O-C-N 124.484 1.115 . . . . 0.0 109.905 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.76 115.59 4.02 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.344 2.029 . . . . 0.0 111.137 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.2 t -108.45 121.05 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.4 t -116.57 119.68 62.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -174.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -90.07 113.66 25.42 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 176.591 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.423 ' HB3' HG12 ' A' ' 60' ' ' VAL . 20.9 tpp180 . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 120.422 0.153 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.63 110.15 13.49 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 27.4 pt -104.73 174.06 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.393 1.477 . . . . 0.0 109.959 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.6 p -91.3 168.74 11.36 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 169.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.544 ' O ' HG23 ' A' ' 24' ' ' VAL . 74.1 t-105 -57.07 -41.68 79.22 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.74 0.65 . . . . 0.0 109.473 168.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -55.66 -50.62 69.75 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.304 1.041 . . . . 0.0 112.409 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.493 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 65.1 m-20 -62.97 -38.95 93.14 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.856 0.462 . . . . 0.0 110.184 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.442 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 34.5 t80 -55.04 -50.51 68.9 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.663 1.227 . . . . 0.0 110.873 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 20' ' ' TRP . 47.1 t -58.12 -62.42 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 123.611 0.569 . . . . 0.0 110.895 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -65.87 -53.76 35.5 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.954 -168.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -84.73 -21.49 30.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.154 0.582 . . . . 0.0 111.86 -167.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.442 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 73.0 m-85 -122.75 -69.35 0.83 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -169.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.54 -56.54 20.79 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.834 0.853 . . . . 0.0 111.467 -173.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.6 m -60.38 -20.33 59.16 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.215 1.006 . . . . 0.0 112.891 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -94.05 -9.13 37.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.667 0.787 . . . . 0.0 111.617 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.27 21.5 68.37 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.723 0.64 . . . . 0.0 114.385 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 27' ' ' TYR . 10.4 m -80.74 -5.39 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 117.143 0.472 . . . . 0.0 110.984 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.8 t -93.75 130.07 43.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 123.321 0.648 . . . . 0.0 109.332 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 30.1 t70 -83.97 -51.96 6.71 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.495 1.118 . . . . 0.0 109.739 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.489 ' HD2' HG23 ' A' ' 92' ' ' VAL . 25.0 ptt180 -158.16 160.47 37.27 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.293 -174.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.8 mt -118.03 103.0 9.48 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.998 0.919 . . . . 0.0 109.027 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 43.4 mt-10 -87.55 108.65 19.15 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.415 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.532 HG13 ' HA ' ' A' ' 41' ' ' LYS . 43.0 t -84.83 92.82 3.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -177.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 96.0 t -81.73 109.81 16.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.101 -167.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 52.25 27.25 4.56 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 125.548 1.539 . . . . 0.0 112.945 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.532 ' HA ' HG13 ' A' ' 38' ' ' VAL . 35.3 mtmm 63.31 -4.44 0.3 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.077 1.351 . . . . 0.0 113.869 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -76.08 -38.88 56.48 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.386 1.074 . . . . 0.0 110.604 -171.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -153.44 179.98 8.29 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.574 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.461 HG23 HG23 ' A' ' 38' ' ' VAL . 98.3 t -127.64 131.44 70.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 123.97 0.908 . . . . 0.0 108.694 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -100.41 123.63 44.88 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -81.86 108.77 15.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.869 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.3 m -86.14 131.4 34.26 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -85.06 149.94 25.21 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 42.1 p . . . . . 0 CA--C 1.548 0.87 0 O-C-N 123.416 0.447 . . . . 0.0 110.391 175.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 121.085 0.469 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.423 HG12 ' HB3' ' A' ' 16' ' ' ARG . 20.0 m -107.23 164.41 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -162.69 162.81 27.07 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.785 0.326 . . . . 0.0 111.119 -172.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -145.06 146.69 31.97 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.727 0.811 . . . . 0.0 109.379 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -81.65 140.07 34.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.19 0.596 . . . . 0.0 109.591 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 65' ' ' GLY . 42.7 pt -117.12 -49.0 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.589 0.356 . . . . 0.0 111.434 -177.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.416 ' N ' HG13 ' A' ' 64' ' ' ILE . . . 67.67 -78.2 0.19 Allowed Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.949 -0.46 . . . . 0.0 111.949 -171.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.5 m -74.27 94.09 2.45 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.595 0.758 . . . . 0.0 109.663 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 64' ' ' ILE . 40.3 t -60.6 -36.66 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.805 1.242 . . . . 0.0 111.172 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -62.66 -39.13 92.95 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.553 0.741 . . . . 0.0 110.331 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.9 m -70.19 -41.44 73.69 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 123.503 0.502 . . . . 0.0 110.666 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -52.85 -53.39 49.51 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.19 0.596 . . . . 0.0 110.735 174.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -60.51 -52.41 65.32 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 124.509 1.13 . . . . 0.0 111.425 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.487 ' HE ' ' HA ' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -59.28 -46.39 88.67 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.508 1.123 . . . . 0.0 111.921 -174.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.407 HD21 ' N ' ' A' ' 73' ' ' ASN . 0.8 OUTLIER -67.47 -41.89 83.86 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.391 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.461 ' HG ' ' NE2' ' A' ' 78' ' ' GLN . 33.4 tp -59.55 -43.41 93.53 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 124.108 0.88 . . . . 0.0 111.465 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -60.27 -56.44 21.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.841 0.857 . . . . 0.0 111.059 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.1 m -63.22 -48.57 77.73 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.43 1.081 . . . . 0.0 110.303 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.418 HD22 HG21 ' A' ' 24' ' ' VAL . 42.9 tp -53.99 -53.06 58.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.77 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.461 ' NE2' ' HG ' ' A' ' 74' ' ' LEU . 45.0 mt-30 -66.8 -30.17 70.3 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.266 0.354 . . . . 0.0 111.266 -178.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -63.86 -38.68 92.0 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.615 0.366 . . . . 0.0 110.076 172.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -70.14 -43.92 69.94 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.221 0.608 . . . . 0.0 110.99 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 76.5 mt -71.22 -18.75 62.44 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.624 0.77 . . . . 0.0 111.578 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.02 8.1 76.29 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.282 0.364 . . . . 0.0 112.982 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.522 HG21 ' HA ' ' A' ' 88' ' ' ARG . 80.1 mt -82.52 97.08 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 125.343 1.457 . . . . 0.0 108.769 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -138.93 155.52 47.99 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.836 -0.54 . . . . 0.0 111.51 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.44 -99.85 0.11 Allowed Glycine 0 C--N 1.354 1.532 0 O-C-N 124.74 1.275 . . . . 0.0 113.893 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -75.59 -29.04 59.15 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.348 1.059 . . . . 0.0 111.427 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -87.82 -23.46 24.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.379 0.672 . . . . 0.0 111.277 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.522 ' HA ' HG21 ' A' ' 83' ' ' ILE . 43.0 ttm180 -61.48 119.54 8.78 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.401 0.68 . . . . 0.0 110.557 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 80.4 t -66.65 118.94 59.16 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.829 0.852 . . . . 0.0 111.225 -175.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 31.5 Cg_exo -60.58 146.87 96.26 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.294 2.662 . . . . 0.0 113.239 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.4 t -104.91 129.84 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.489 HG23 ' HD2' ' A' ' 35' ' ' ARG . 4.5 t -127.78 98.99 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.505 0.722 . . . . 0.0 109.394 -175.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -69.55 106.33 2.97 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 29.9 mm . . . . . 0 C--O 1.22 -0.457 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -175.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.405 ' HB2' HG13 ' A' ' 60' ' ' VAL . 49.7 mtp180 . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 120.342 0.115 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -79.92 110.92 15.76 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 165.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.559 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 34.4 pt -96.13 174.39 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 123.99 0.916 . . . . 0.0 110.61 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.2 p -98.21 168.63 10.12 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 166.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.435 ' O ' HG23 ' A' ' 24' ' ' VAL . 61.7 t-105 -55.41 -37.22 67.34 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.685 0.794 . . . . 0.0 110.781 175.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -56.08 -48.66 75.67 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.518 0.727 . . . . 0.0 111.671 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.559 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 34.4 m-20 -65.53 -42.27 92.18 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.414 0.286 . . . . 0.0 110.791 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -50.35 -48.17 55.65 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.51 1.131 . . . . 0.0 111.116 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.438 HG21 HD23 ' A' ' 77' ' ' LEU . 90.7 t -71.97 -62.07 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 O-C-N 123.421 0.45 . . . . 0.0 110.82 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -69.87 -52.65 23.04 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.03 0.532 . . . . 0.0 111.737 -167.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -80.01 -19.48 47.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.912 0.485 . . . . 0.0 112.049 -171.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -126.12 -69.95 0.75 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -171.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.1 tp -63.79 -43.61 95.81 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -166.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.2 p -73.23 -11.38 60.49 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.904 0.481 . . . . 0.0 111.944 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -92.61 -9.22 41.81 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.252 0.621 . . . . 0.0 110.64 173.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.78 27.83 67.25 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 114.047 0.379 . . . . 0.0 114.047 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.7 m -86.87 6.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 116.972 0.386 . . . . 0.0 110.548 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.26 125.72 51.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.023 0.929 . . . . 0.0 108.964 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 28.5 t70 -77.34 -54.08 6.9 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.315 1.046 . . . . 0.0 108.196 172.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.442 ' HD2' HG23 ' A' ' 92' ' ' VAL . 43.0 ttp180 -154.9 153.19 30.72 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.024 -164.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.9 mt -113.32 119.82 39.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.88 1.272 . . . . 0.0 108.535 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -111.92 106.48 15.19 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.383 0.673 . . . . 0.0 110.312 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.412 HG23 HG23 ' A' ' 44' ' ' VAL . 44.9 t -81.61 98.48 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 54.7 t -94.96 122.41 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 122.862 0.465 . . . . 0.0 110.522 -171.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 60.11 15.24 5.01 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.245 1.418 . . . . 0.0 113.434 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.9 mttm 65.64 -3.02 0.76 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.534 1.533 . . . . 0.0 112.778 -175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -87.62 -32.51 19.24 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.11 0.964 . . . . 0.0 109.982 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -154.2 171.28 19.44 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.488 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.412 HG23 HG23 ' A' ' 38' ' ' VAL . 54.4 t -128.86 133.87 65.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -99.52 130.36 45.77 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.4 t -82.85 106.58 13.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 172.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.4 m -94.11 126.02 39.08 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.401 ' HE1' ' HA ' ' A' ' 59' ' ' TYR . 89.8 m-85 -81.84 152.38 26.92 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.875 0.734 . . . . 0.0 111.24 -175.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.543 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.2 OUTLIER . . . . . 0 CA--C 1.558 1.286 0 CA-C-O 117.802 -1.094 . . . . 0.0 109.061 173.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.401 ' HA ' ' HE1' ' A' ' 48' ' ' PHE . 92.3 m-85 . . . . . 0 C--O 1.238 0.486 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.405 HG13 ' HB2' ' A' ' 16' ' ' ARG . 27.1 m -105.73 156.52 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.333 -172.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -150.91 158.41 44.11 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.848 0.459 . . . . 0.0 111.37 -173.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -140.32 139.24 35.4 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.397 0.679 . . . . 0.0 109.298 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -79.34 131.58 36.17 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.443 0.697 . . . . 0.0 110.323 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.7 pt -110.05 143.08 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.931 0.892 . . . . 0.0 109.298 173.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.11 -43.28 7.17 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.8 t -131.25 140.34 49.81 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.92 0.888 . . . . 0.0 109.282 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.429 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 62.0 t -60.11 -41.74 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 123.679 0.612 . . . . 0.0 110.226 172.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.22 -42.14 80.81 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.323 0.649 . . . . 0.0 111.631 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 m -66.12 -45.77 79.93 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.194 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -55.65 -48.42 75.04 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.836 0.454 . . . . 0.0 111.271 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 39.4 mm-40 -62.43 -52.9 61.69 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.342 0.657 . . . . 0.0 111.292 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -67.41 -38.3 84.42 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.659 0.783 . . . . 0.0 111.396 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -67.09 -35.86 80.72 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 122.658 0.383 . . . . 0.0 110.317 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.99 -32.25 71.68 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.071 0.548 . . . . 0.0 111.503 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 51.5 mm-40 -62.09 -51.78 66.54 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.153 0.501 . . . . 0.0 110.172 173.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.457 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 25.7 m -62.9 -47.95 81.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.242 -1.344 . . . . 0.0 110.395 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.438 HD23 HG21 ' A' ' 24' ' ' VAL . 49.6 tp -57.94 -57.92 10.7 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.405 1.082 . . . . 0.0 112.2 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 45.5 mt-30 -62.12 -39.92 94.17 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 123.715 0.634 . . . . 0.0 111.514 -174.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -66.46 -33.92 76.77 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 76' ' ' THR . 43.3 mm-40 -70.18 -39.98 74.93 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.795 0.438 . . . . 0.0 110.573 176.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.25 -12.43 60.86 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.602 0.761 . . . . 0.0 111.166 176.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.33 -8.09 79.71 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.944 -0.365 . . . . 0.0 112.829 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.415 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 70.7 mt -67.76 105.53 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.254 1.422 . . . . 0.0 109.172 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -151.46 159.59 44.12 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.561 0.344 . . . . 0.0 111.432 -174.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.3 -124.34 33.27 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.926 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -66.3 -22.52 66.29 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.306 1.043 . . . . 0.0 111.752 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -83.54 -5.18 59.09 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.232 0.613 . . . . 0.0 112.362 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -65.56 142.2 58.18 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 120.803 0.335 . . . . 0.0 111.325 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.8 t -82.84 122.99 78.44 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.92 0.888 . . . . 0.0 109.516 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.14 132.76 43.25 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.413 2.742 . . . . 0.0 113.786 -171.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.3 t -108.28 119.84 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.0 0.92 . . . . 0.0 108.877 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.442 HG23 ' HD2' ' A' ' 35' ' ' ARG . 41.7 t -129.37 121.94 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.018 0.927 . . . . 0.0 109.11 -173.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -84.98 116.68 23.52 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.037 0.535 . . . . 0.0 110.24 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 49.8 mm . . . . . 0 N--CA 1.472 0.663 0 C-N-CA 124.104 0.961 . . . . 0.0 108.758 -176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 6.3 ptm180 . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.944 0.402 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.508 ' HG3' ' HA ' ' A' ' 62' ' ' PHE . 32.6 tt0 -85.35 128.1 34.58 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 pt -109.88 179.61 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 125.696 1.598 . . . . 0.0 109.621 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.8 p -89.93 154.15 20.07 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.074 0.95 . . . . 0.0 109.441 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.413 ' O ' HG23 ' A' ' 24' ' ' VAL . 54.4 t-105 -59.93 -43.37 94.96 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.513 0.725 . . . . 0.0 110.282 176.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -53.85 -48.67 69.75 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 123.952 0.783 . . . . 0.0 111.292 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' ' 26' ' ' ASN . 26.3 t70 -70.09 -34.96 73.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.778 0.431 . . . . 0.0 110.224 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.418 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 18.0 t80 -55.78 -46.12 78.01 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.945 0.498 . . . . 0.0 110.627 175.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 20' ' ' TRP . 79.9 t -61.98 -71.38 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 123.602 0.564 . . . . 0.0 110.783 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -73.66 -31.77 63.65 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.923 -161.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' A' ' 22' ' ' ASP . 54.9 t30 -90.99 -23.59 20.35 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.665 0.786 . . . . 0.0 111.902 -176.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.418 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 75.4 m-85 -124.62 -66.42 0.98 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -172.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.64 -49.83 76.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.718 0.807 . . . . 0.0 111.401 -174.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.0 m -64.5 -20.74 66.39 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.555 1.142 . . . . 0.0 112.161 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -97.1 0.14 48.04 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.507 0.723 . . . . 0.0 111.301 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.92 26.61 60.95 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 115.543 0.977 . . . . 0.0 115.543 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.8 m -90.7 3.9 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 122.898 0.479 . . . . 0.0 111.405 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.3 126.06 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.887 0.875 . . . . 0.0 108.926 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.498 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 30.9 t70 -84.1 -51.61 6.94 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.546 1.138 . . . . 0.0 109.967 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -154.07 161.61 41.79 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.583 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.05 101.83 9.37 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.9 0.88 . . . . 0.0 108.67 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -87.0 101.13 13.15 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.102 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.635 HG11 ' HA ' ' A' ' 41' ' ' LYS . 19.8 t -88.54 90.2 3.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -173.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.9 t -81.43 127.76 39.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.6 -173.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 59.95 19.51 8.55 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.8 2.04 . . . . 0.0 111.452 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.635 ' HA ' HG11 ' A' ' 38' ' ' VAL . 19.7 pttm 42.06 18.29 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 126.287 1.835 . . . . 0.0 115.251 -167.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.3 ttp-105 -98.93 -30.49 12.34 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.149 0.98 . . . . 0.0 109.102 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -147.62 152.12 37.36 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.02 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 59.0 t -110.97 128.07 67.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.541 1.137 . . . . 0.0 108.465 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -100.67 124.73 46.68 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.1 t -82.69 105.39 12.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.7 m -92.1 125.91 36.97 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.407 ' H ' ' HE1' ' A' ' 59' ' ' TYR . 67.4 m-85 -84.87 148.98 25.99 Favored 'General case' 0 C--O 1.241 0.607 0 O-C-N 123.723 0.64 . . . . 0.0 111.917 -176.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.498 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 10.0 p . . . . . 0 CA--C 1.55 0.946 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.779 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.407 ' HE1' ' H ' ' A' ' 48' ' ' PHE . 34.6 m-85 . . . . . 0 C--O 1.241 0.654 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 16' ' ' ARG . 33.2 m -106.38 154.96 7.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -157.57 174.94 14.6 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.173 0.589 . . . . 0.0 110.11 -175.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.508 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 33.9 p90 -157.6 147.32 20.26 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.974 0.51 . . . . 0.0 110.253 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -91.09 130.16 37.01 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 67' ' ' VAL . 30.3 pt -102.93 -46.99 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.217 0.607 . . . . 0.0 111.334 -176.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.26 -83.24 0.43 Allowed Glycine 0 C--N 1.345 1.082 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -167.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.8 t -72.45 96.74 1.95 Allowed 'General case' 0 C--O 1.249 1.027 0 CA-C-O 121.778 0.799 . . . . 0.0 109.875 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.562 ' HA ' HD12 ' A' ' 64' ' ' ILE . 11.0 t -56.04 -39.33 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 113.952 -1.477 . . . . 0.0 110.999 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -58.26 -42.37 86.3 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.049 0.843 . . . . 0.0 111.02 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.0 m -64.67 -45.73 85.47 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 123.657 0.598 . . . . 0.0 110.159 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -52.66 -50.83 62.44 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.816 0.698 . . . . 0.0 111.266 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -63.58 -46.19 86.99 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.135 0.897 . . . . 0.0 110.774 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 mtp-105 -59.35 -49.47 77.71 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.765 0.826 . . . . 0.0 111.41 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -66.32 -43.6 85.72 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.435 0.694 . . . . 0.0 110.18 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.3 tp -56.13 -49.6 73.45 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.272 1.029 . . . . 0.0 110.736 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -66.62 -49.17 67.16 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.446 0.698 . . . . 0.0 111.649 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.4 m -60.17 -44.61 94.88 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.46 0.648 . . . . 0.0 109.926 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.9 tp -57.81 -53.38 58.81 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.757 175.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.402 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 22.9 mt-30 -64.89 -45.04 87.62 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.28 0.632 . . . . 0.0 111.018 -173.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.56 -38.2 83.79 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.312 0.645 . . . . 0.0 110.633 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.34 -41.12 90.05 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.2 1.0 . . . . 0.0 110.978 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.1 mt -87.29 0.77 54.9 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.487 0.715 . . . . 0.0 111.458 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.25 -4.32 63.37 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.595 -0.558 . . . . 0.0 113.809 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 68.4 mt -68.08 116.31 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.672 1.189 . . . . 0.0 109.47 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -161.1 148.26 15.16 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.082 0.553 . . . . 0.0 110.497 -173.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.07 -89.84 0.01 OUTLIER Glycine 0 C--N 1.349 1.263 0 O-C-N 124.923 1.389 . . . . 0.0 114.722 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.41 -44.31 83.36 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.29 1.036 . . . . 0.0 110.565 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -98.65 -1.46 40.72 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.445 0.698 . . . . 0.0 111.741 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -70.44 134.41 47.77 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 122.994 0.184 . . . . 0.0 110.939 -178.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.2 t -72.37 112.51 15.09 Favored Pre-proline 0 CA--C 1.561 1.391 0 O-C-N 124.165 0.916 . . . . 0.0 109.49 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.92 142.63 57.67 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.981 2.454 . . . . 0.0 113.117 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.4 t -105.75 118.2 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.461 1.104 . . . . 0.0 109.178 -175.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.7 t -119.93 98.96 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.583 0.753 . . . . 0.0 110.166 -171.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -75.3 109.59 8.95 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.153 0.581 . . . . 0.0 110.585 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.7 mt . . . . . 0 N--CA 1.476 0.853 0 C-N-CA 123.983 0.913 . . . . 0.0 108.54 -178.36 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.595 ' HB3' HG13 ' A' ' 60' ' ' VAL . 20.0 ttt180 . . . . . 0 C--O 1.237 0.396 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.9 109.33 8.27 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.7 pt -106.8 175.38 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.685 1.194 . . . . 0.0 108.762 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.0 p -97.2 167.92 10.75 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.492 ' O ' HG23 ' A' ' 24' ' ' VAL . 69.1 t-105 -57.5 -41.97 81.8 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 123.462 0.476 . . . . 0.0 110.04 169.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.623 ' HZ2' ' HB2' ' A' ' 21' ' ' LYS . 5.0 ttmp? -60.4 -49.39 77.76 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.71 0.404 . . . . 0.0 111.761 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.51 -38.79 90.73 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.298 0.639 . . . . 0.0 110.591 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.44 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 40.3 t80 -52.56 -53.46 46.11 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.968 172.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.558 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 69.1 t -60.33 -47.77 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.11 0.564 . . . . 0.0 110.769 -177.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.28 -55.91 11.96 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.521 -173.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -85.01 -27.88 26.12 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.44 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 87.1 m-85 -117.01 -68.86 0.89 Allowed 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -165.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.558 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 56.6 tp -59.91 -45.28 93.05 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.457 1.103 . . . . 0.0 113.149 -171.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 81.2 p -64.53 -21.29 66.64 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.066 0.546 . . . . 0.0 112.39 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -99.2 -9.05 24.21 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.794 0.837 . . . . 0.0 110.728 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.44 37.72 88.88 Favored Glycine 0 C--N 1.348 1.218 0 O-C-N 123.835 0.709 . . . . 0.0 114.836 -173.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 m -79.76 -3.46 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.407 ' HB ' HG22 ' A' ' 89' ' ' VAL . 16.6 t -99.54 128.08 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.911 0.884 . . . . 0.0 109.308 -175.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -86.72 -48.24 8.43 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.161 1.385 . . . . 0.0 110.312 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.507 ' HD3' HG23 ' A' ' 92' ' ' VAL . 19.2 ptp180 -158.49 149.39 20.48 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.857 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.532 ' HG ' HG12 ' A' ' 89' ' ' VAL . 31.4 mt -108.16 102.0 11.18 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -93.6 105.79 17.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.864 -172.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.517 HG23 HG23 ' A' ' 44' ' ' VAL . 48.3 t -81.06 102.12 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -176.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.3 t -90.23 114.71 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.263 0.625 . . . . 0.0 109.537 -173.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.3 m120 58.94 16.75 4.82 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.434 1.493 . . . . 0.0 113.688 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 90.6 mttt 60.35 8.58 1.65 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.447 1.099 . . . . 0.0 113.335 -171.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 -81.67 -39.51 24.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.924 0.889 . . . . 0.0 109.516 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -155.33 174.82 14.68 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.267 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.517 HG23 HG23 ' A' ' 38' ' ' VAL . 59.4 t -123.81 131.53 72.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -103.29 127.32 50.65 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.439 0.695 . . . . 0.0 109.439 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 80.2 t -84.08 110.16 18.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.621 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.5 m -90.44 141.62 28.56 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 170.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.433 ' HE2' ' HA ' ' A' ' 59' ' ' TYR . 63.3 m-85 -97.38 149.69 21.84 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 176.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 CA--C 1.548 0.87 0 C-N-CA 124.224 1.01 . . . . 0.0 111.419 179.916 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.433 ' HA ' ' HE2' ' A' ' 48' ' ' PHE . 11.6 m-85 . . . . . 0 N--CA 1.469 0.485 0 CA-C-O 121.539 0.685 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.595 HG13 ' HB3' ' A' ' 16' ' ' ARG . 33.8 m -131.39 170.12 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -167.04 160.1 13.76 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.141 0.576 . . . . 0.0 110.091 -174.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -144.1 140.17 29.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.998 0.519 . . . . 0.0 110.351 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -77.08 147.05 36.88 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.406 0.682 . . . . 0.0 110.27 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 67' ' ' VAL . 40.3 pt -131.03 139.4 51.18 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 C-N-CA 123.552 0.741 . . . . 0.0 109.992 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.34 -44.36 17.53 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 172.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.7 t -131.16 129.84 42.28 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.992 0.917 . . . . 0.0 110.285 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.405 ' HA ' HD12 ' A' ' 64' ' ' ILE . 15.6 t -64.41 -37.99 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.796 0.838 . . . . 0.0 110.691 171.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.587 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 31.3 t70 -62.23 -56.53 17.7 Favored 'General case' 0 C--O 1.216 -0.694 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.5 m -55.24 -45.42 76.03 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.943 0.497 . . . . 0.0 111.176 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -47.3 -56.15 7.36 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.411 1.084 . . . . 0.0 112.096 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 12.2 pt-20 -73.27 -28.77 62.31 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.814 -173.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 18.1 mmm-85 -59.98 -45.76 91.66 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 176.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -67.57 -38.37 84.0 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.705 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 tp -57.28 -56.73 18.03 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.697 0.623 . . . . 0.0 111.059 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 79' ' ' GLN . 32.0 mt-10 -59.92 -47.74 84.55 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.023 0.929 . . . . 0.0 112.693 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 51.5 m -61.56 -48.87 79.0 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.504 0.669 . . . . 0.0 110.144 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 35.6 tp -57.56 -38.94 75.63 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.251 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.745 ' HB3' HD12 ' A' ' 83' ' ' ILE . 25.0 mt-30 -63.81 -39.03 93.27 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.522 0.729 . . . . 0.0 110.434 175.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 76.7 mt-30 -67.97 -29.25 68.24 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.932 0.493 . . . . 0.0 110.697 176.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -71.24 -47.78 55.12 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.617 0.767 . . . . 0.0 110.546 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 87.6 mt -68.0 -18.72 64.8 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.183 0.993 . . . . 0.0 111.644 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.76 31.27 79.64 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.713 0.633 . . . . 0.0 112.342 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.745 HD12 ' HB3' ' A' ' 78' ' ' GLN . 1.2 pp -64.81 162.49 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 122.041 0.924 . . . . 0.0 113.186 -176.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -119.53 169.15 10.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 161.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.89 -25.69 1.0 Allowed Glycine 0 N--CA 1.481 1.687 0 N-CA-C 117.311 1.685 . . . . 0.0 117.311 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.02 -46.65 83.51 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.688 0.744 . . . . 0.0 111.522 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -101.34 -11.9 19.06 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.439 0.696 . . . . 0.0 111.225 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -84.0 140.89 31.59 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.213 1.005 . . . . 0.0 109.294 174.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.532 HG12 ' HG ' ' A' ' 36' ' ' LEU . 46.5 t -117.17 120.41 33.65 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 122.781 0.432 . . . . 0.0 111.467 -167.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.83 154.26 48.47 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.976 2.451 . . . . 0.0 112.592 172.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.4 t -106.94 125.38 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.519 0.727 . . . . 0.0 109.768 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.507 HG23 ' HD3' ' A' ' 35' ' ' ARG . 21.8 t -113.13 112.45 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -82.39 109.43 16.63 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.2 mt . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -175.489 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 . . . . . 0 C--O 1.239 0.534 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -77.3 107.25 9.58 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 172.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 pt -95.48 170.2 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 123.737 0.815 . . . . 0.0 109.235 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 22' ' ' ASP . 9.0 t -85.43 149.85 25.12 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 172.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.535 ' O ' HG23 ' A' ' 24' ' ' VAL . 67.1 t-105 -52.09 -42.85 63.56 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.972 0.909 . . . . 0.0 111.192 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -61.3 -36.21 79.46 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 123.372 0.42 . . . . 0.0 111.725 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.428 ' H ' HG22 ' A' ' 19' ' ' THR . 31.7 t70 -70.35 -40.83 73.84 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -56.15 -42.33 76.81 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.673 175.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 20' ' ' TRP . 97.3 t -67.65 -66.3 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.402 0.681 . . . . 0.0 111.025 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -71.13 -44.81 64.82 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.443 0.464 . . . . 0.0 111.664 -166.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -80.13 -29.22 38.89 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.906 0.883 . . . . 0.0 111.786 -171.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -120.34 -66.19 1.08 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -169.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.34 -44.36 95.59 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.972 0.909 . . . . 0.0 111.526 -172.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.528 ' HG ' HD12 ' A' ' 81' ' ' LEU . 40.1 m -73.04 -16.23 61.49 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.351 1.06 . . . . 0.0 112.412 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -96.2 -3.77 43.69 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.136 0.575 . . . . 0.0 110.974 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.22 37.37 91.71 Favored Glycine 0 C--N 1.357 1.738 0 N-CA-C 114.776 0.671 . . . . 0.0 114.776 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.7 m -98.95 0.8 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.06 126.6 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.481 0.712 . . . . 0.0 110.272 -174.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -85.28 -47.21 10.28 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.343 1.057 . . . . 0.0 110.707 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.467 ' HG2' ' HB ' ' A' ' 47' ' ' THR . 10.2 ptp180 -157.07 160.29 38.76 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.873 0.469 . . . . 0.0 110.138 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.4 mt -117.77 103.29 9.85 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.74 0.816 . . . . 0.0 109.303 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -88.9 111.86 22.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.602 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.498 HG23 HG23 ' A' ' 44' ' ' VAL . 31.0 t -84.45 99.86 7.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.9 t -91.25 114.43 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 122.865 0.466 . . . . 0.0 110.033 -171.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 52.52 27.29 4.92 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.408 1.483 . . . . 0.0 112.886 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.411 ' HA ' HG11 ' A' ' 38' ' ' VAL . 98.0 mttt 61.71 -0.7 0.39 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.812 1.645 . . . . 0.0 114.31 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -81.74 -34.16 30.64 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.385 0.674 . . . . 0.0 110.6 -171.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -157.4 179.32 9.36 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.498 HG23 HG23 ' A' ' 38' ' ' VAL . 91.9 t -126.59 129.1 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 124.175 0.99 . . . . 0.0 109.072 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -101.37 128.75 47.41 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.9 t -88.84 109.84 20.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.726 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.467 ' HB ' ' HG2' ' A' ' 35' ' ' ARG . 87.1 m -88.31 134.37 33.83 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 172.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -103.6 154.5 19.43 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.198 0.599 . . . . 0.0 111.379 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 CA--C 1.549 0.917 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.172 -179.392 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -118.67 -179.6 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.626 0.371 . . . . 0.0 110.127 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -159.54 165.82 32.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.966 0.907 . . . . 0.0 109.167 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -152.56 152.16 31.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.624 0.37 . . . . 0.0 111.455 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -78.19 149.59 33.67 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.206 1.002 . . . . 0.0 110.145 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.2 pt -127.06 -26.79 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.063 0.545 . . . . 0.0 111.999 -174.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.52 -78.0 1.52 Allowed Glycine 0 C--N 1.344 0.991 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.2 t -107.4 132.05 53.6 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.181 0.992 . . . . 0.0 108.585 172.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.8 t -62.33 -32.37 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.357 0.663 . . . . 0.0 110.757 173.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.95 -38.2 90.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.689 0.796 . . . . 0.0 110.807 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.6 m -63.39 -51.38 66.08 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 122.905 0.482 . . . . 0.0 110.221 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -53.33 -58.22 7.86 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 124.102 0.876 . . . . 0.0 111.961 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 15.5 pt-20 -62.56 -47.78 82.37 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.962 0.789 . . . . 0.0 111.065 -172.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -64.15 -48.1 77.32 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 122.37 0.268 . . . . 0.0 110.873 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.87 -43.34 88.67 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.814 0.696 . . . . 0.0 110.24 -176.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.436 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 39.9 tp -57.7 -55.92 28.58 Favored 'General case' 0 C--O 1.215 -0.751 0 O-C-N 124.759 1.287 . . . . 0.0 111.651 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.587 ' HG2' ' NH2' ' A' ' 88' ' ' ARG . 44.8 mt-10 -66.43 -35.35 80.09 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.409 0.684 . . . . 0.0 112.156 -172.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.7 m -65.12 -48.04 75.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.188 0.595 . . . . 0.0 109.441 174.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.509 HD22 HG21 ' A' ' 24' ' ' VAL . 44.9 tp -57.17 -41.48 79.35 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.216 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.46 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 60.8 mt-30 -63.65 -46.31 86.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.682 0.793 . . . . 0.0 110.243 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -65.65 -31.04 71.84 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.46 0.704 . . . . 0.0 110.886 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -71.79 -52.64 16.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.559 1.143 . . . . 0.0 110.791 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.528 HD12 ' HG ' ' A' ' 29' ' ' SER . 72.3 mt -79.42 -10.16 59.75 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.403 0.681 . . . . 0.0 111.592 -173.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.88 10.17 59.03 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 114.301 0.48 . . . . 0.0 114.301 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 3.5 mp -80.13 90.32 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 168.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.99 143.14 50.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.656 -0.653 . . . . 0.0 111.925 -171.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.0 -100.3 0.17 Allowed Glycine 0 C--N 1.349 1.297 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.749 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -79.02 -27.88 43.28 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.946 0.899 . . . . 0.0 110.904 -176.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -76.46 -9.53 58.72 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.088 0.555 . . . . 0.0 111.557 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.587 ' NH2' ' HG2' ' A' ' 75' ' ' GLU . 70.2 mtp180 -69.15 151.55 46.23 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-O 121.551 0.691 . . . . 0.0 112.836 -175.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.5 t -91.87 108.77 32.37 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.056 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -57.36 125.57 19.27 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.972 2.448 . . . . 0.0 111.535 -175.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.77 107.79 20.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -176.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 t -105.52 98.03 6.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -71.14 107.77 4.34 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.9 mt . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 123.903 0.881 . . . . 0.0 109.814 -175.254 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.468 ' HB2' HG13 ' A' ' 60' ' ' VAL . 4.1 mmp_? . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 111.45 0.167 . . . . 0.0 111.45 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.07 108.52 7.85 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 36.0 pt -100.62 171.55 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.514 1.126 . . . . 0.0 109.227 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.6 p -100.11 178.43 4.79 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 166.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -59.05 -35.19 72.91 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.445 173.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -60.88 -46.55 90.18 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.388 0.675 . . . . 0.0 112.22 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.593 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 7.0 m-20 -62.23 -44.95 95.4 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.312 0.245 . . . . 0.0 110.368 174.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.432 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 37.3 t80 -55.15 -50.63 68.8 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 124.118 0.886 . . . . 0.0 110.81 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.8 t -64.04 -66.47 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.944 0.897 . . . . 0.0 111.583 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -71.46 -47.15 57.54 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.87 0.468 . . . . 0.0 112.186 -166.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -80.26 -22.37 41.76 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -172.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.432 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 53.7 m-85 -128.22 -61.57 1.09 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -169.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.0 tp -64.13 -44.67 91.51 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.085 0.954 . . . . 0.0 111.317 -168.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.477 ' HA ' HD13 ' A' ' 81' ' ' LEU . 91.0 p -62.91 -20.31 65.04 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.59 0.756 . . . . 0.0 112.791 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -97.4 -10.44 25.5 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.868 0.867 . . . . 0.0 110.747 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.32 31.89 80.89 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 114.652 0.621 . . . . 0.0 114.652 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.2 m -80.5 -0.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 117.125 0.462 . . . . 0.0 110.676 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 t -98.82 133.06 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -176.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.475 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 18.6 t70 -92.38 -55.03 3.56 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.519 1.128 . . . . 0.0 109.621 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -154.46 164.99 37.81 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.386 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.6 mt -120.51 108.84 14.57 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.689 0.795 . . . . 0.0 110.788 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 45' ' ' ARG . 49.3 mt-10 -88.21 102.64 15.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.741 0.816 . . . . 0.0 110.053 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 41' ' ' LYS . 21.8 t -97.3 91.03 2.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.1 t -79.58 118.25 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.079 -174.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 49.73 27.92 2.45 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.688 1.595 . . . . 0.0 113.425 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.547 ' HA ' HG11 ' A' ' 38' ' ' VAL . 10.6 mtmp? 53.74 15.52 0.81 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.116 1.366 . . . . 0.0 114.181 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -85.64 -47.02 10.22 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.964 0.906 . . . . 0.0 110.421 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.409 ' HE2' ' HE ' ' A' ' 45' ' ' ARG . 44.1 p90 -147.56 159.83 43.31 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.177 0.513 . . . . 0.0 109.852 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.479 HG23 HG23 ' A' ' 38' ' ' VAL . 57.4 t -121.53 131.9 71.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.345 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.409 ' HE ' ' HE2' ' A' ' 43' ' ' PHE . 89.3 mtt180 -99.32 124.82 44.74 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HB ' HG22 ' A' ' 60' ' ' VAL . 44.8 t -82.36 108.87 15.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 83.4 m -87.82 129.48 35.18 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -86.03 145.08 27.24 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.79 0.436 . . . . 0.0 110.409 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.4 t . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 123.297 0.639 . . . . 0.0 111.265 179.874 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 121.126 0.489 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 16' ' ' ARG . 33.0 m -109.17 144.16 18.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 173.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -154.73 163.13 40.7 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.83 0.452 . . . . 0.0 110.693 -173.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -150.19 150.76 32.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.708 0.403 . . . . 0.0 110.733 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -93.8 119.12 32.35 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.1 pt -84.31 116.77 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.069 0.548 . . . . 0.0 110.384 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.35 99.42 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.776 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.6 t -132.15 126.59 34.03 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.052 0.941 . . . . 0.0 108.731 172.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 41' ' ' LYS . 17.5 t -61.57 -36.3 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.363 0.665 . . . . 0.0 110.049 172.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -58.01 -43.9 86.92 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.125 0.97 . . . . 0.0 111.094 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.5 m -64.87 -46.53 81.45 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.537 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -51.39 -53.45 36.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.813 0.845 . . . . 0.0 111.834 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 44.7 mt-10 -67.9 -52.95 30.52 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.761 0.824 . . . . 0.0 111.845 -172.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -68.88 -36.06 77.63 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.588 0.555 . . . . 0.0 111.785 -173.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -70.89 -39.7 72.65 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 174.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 46.5 tp -56.51 -45.19 81.2 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.023 0.529 . . . . 0.0 111.34 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.5 -42.18 99.32 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.874 0.734 . . . . 0.0 111.187 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.1 m -60.31 -56.41 21.84 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 123.8 0.688 . . . . 0.0 110.398 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -51.73 -52.16 50.65 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 124.418 1.074 . . . . 0.0 112.067 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -60.17 -43.34 95.91 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 123.627 0.579 . . . . 0.0 111.383 -175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -62.75 -44.86 95.11 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.923 0.889 . . . . 0.0 111.122 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -70.1 -38.36 75.61 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.131 -176.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.477 HD13 ' HA ' ' A' ' 29' ' ' SER . 41.5 mt -77.77 -17.3 57.65 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.66 0.784 . . . . 0.0 110.515 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.7 6.54 88.99 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-O 119.887 -0.396 . . . . 0.0 113.853 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.527 HG23 ' HA ' ' A' ' 88' ' ' ARG . 75.7 mt -70.98 92.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.1 0.96 . . . . 0.0 109.479 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -136.33 152.82 51.07 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 124.133 0.973 . . . . 0.0 110.569 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.0 -93.91 0.07 OUTLIER Glycine 0 C--N 1.343 0.947 0 CA-C-N 114.594 -1.185 . . . . 0.0 115.406 172.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -77.46 -45.72 24.79 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.562 0.696 . . . . 0.0 109.517 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -79.86 -15.7 56.85 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.759 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.527 ' HA ' HG23 ' A' ' 83' ' ' ILE . 58.0 ttt180 -56.53 152.25 12.09 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.112 0.965 . . . . 0.0 111.991 -174.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 68.6 t -100.09 99.74 10.03 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 57.2 Cg_endo -70.48 149.07 61.71 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.919 2.413 . . . . 0.0 112.268 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.8 t -108.63 119.32 57.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.417 -174.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.7 t -104.84 96.27 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -74.64 98.52 3.43 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.3 mt . . . . . 0 C--N 1.324 -0.535 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -178.747 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -74.26 128.98 36.92 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.4 pt -129.69 170.6 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.618 0.767 . . . . 0.0 109.649 -175.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.6 p -91.71 153.59 19.55 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.574 ' O ' HG22 ' A' ' 24' ' ' VAL . 68.9 t-105 -53.58 -46.46 70.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.302 0.641 . . . . 0.0 110.806 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -54.82 -50.73 67.86 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.815 0.846 . . . . 0.0 112.476 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.454 ' HA ' ' ND2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -70.99 -33.83 70.79 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -176.627 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -54.23 -45.47 72.3 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.41 0.444 . . . . 0.0 110.49 172.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 20' ' ' TRP . 89.3 t -58.11 -64.09 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.017 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.454 ' ND2' ' HA ' ' A' ' 22' ' ' ASP . 9.3 p30 -75.21 -33.41 61.39 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.233 0.333 . . . . 0.0 111.815 -166.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -80.66 -41.29 24.04 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.868 0.467 . . . . 0.0 111.606 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -113.51 -65.3 1.2 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -163.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.8 tp -60.89 -45.52 94.26 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.886 0.741 . . . . 0.0 111.53 -174.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.485 ' HA ' HD13 ' A' ' 83' ' ' ILE . 22.7 t -72.39 -14.29 61.67 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.33 1.052 . . . . 0.0 111.863 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -101.83 -2.18 30.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.771 0.428 . . . . 0.0 111.12 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.93 22.41 34.49 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.8 m -77.78 -3.59 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 123.055 0.542 . . . . 0.0 111.468 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.9 t -93.63 129.91 43.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.267 1.027 . . . . 0.0 108.625 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -80.56 -47.32 14.36 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.537 0.735 . . . . 0.0 110.193 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.508 ' HG2' ' HB ' ' A' ' 47' ' ' THR . 6.6 ptp85 -159.4 157.92 31.18 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.092 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.5 mt -114.83 102.14 9.71 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.774 0.829 . . . . 0.0 108.964 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -89.79 108.61 19.8 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.136 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.505 HG23 HG23 ' A' ' 44' ' ' VAL . 40.6 t -88.45 94.59 4.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.9 t -90.94 127.06 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 O-C-N 123.233 0.333 . . . . 0.0 111.44 -169.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.4 m120 53.28 23.23 3.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.653 1.581 . . . . 0.0 113.632 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 61.28 6.6 1.41 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.986 1.314 . . . . 0.0 114.196 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.7 mtp-105 -91.22 -40.81 11.33 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.274 0.488 . . . . 0.0 110.436 -176.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -151.99 174.04 14.13 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.15 -170.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.505 HG23 HG23 ' A' ' 38' ' ' VAL . 71.9 t -119.88 122.89 69.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -100.03 121.9 42.09 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.0 t -90.24 119.74 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.127 0.971 . . . . 0.0 110.327 -168.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.508 ' HB ' ' HG2' ' A' ' 35' ' ' ARG . 58.1 m -93.86 130.05 40.04 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -97.32 170.39 9.11 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.931 0.769 . . . . 0.0 111.079 176.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 CA--C 1.553 1.093 0 C-N-CA 123.301 0.64 . . . . 0.0 110.997 176.369 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 121.001 0.429 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.8 169.87 20.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.078 170.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -158.25 158.42 34.43 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.533 0.733 . . . . 0.0 109.35 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -146.54 141.32 26.88 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.951 0.5 . . . . 0.0 109.722 177.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -83.15 128.57 34.61 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.874 0.47 . . . . 0.0 109.897 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 67' ' ' VAL . 22.5 pt -106.5 -29.29 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.342 0.657 . . . . 0.0 110.658 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.79 -71.85 1.6 Allowed Glycine 0 C--N 1.35 1.314 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.4 t -100.18 121.45 41.45 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.278 1.031 . . . . 0.0 110.127 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.478 ' HA ' HD12 ' A' ' 64' ' ' ILE . 39.5 t -66.56 -34.13 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.091 172.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 24.6 t70 -64.09 -37.11 86.26 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 63.2 m -65.89 -45.39 82.18 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.737 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -52.55 -41.56 63.64 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 123.778 0.674 . . . . 0.0 111.619 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.46 -51.25 53.63 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.488 0.492 . . . . 0.0 110.341 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 68' ' ' ASP . 95.5 mtt180 -55.94 -54.94 38.67 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.211 0.604 . . . . 0.0 111.771 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -71.42 -31.95 67.82 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.521 -175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.44 ' HG ' ' NE2' ' A' ' 78' ' ' GLN . 35.4 tp -62.84 -44.75 95.3 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.345 0.658 . . . . 0.0 111.858 172.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -63.32 -45.17 92.56 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.267 0.627 . . . . 0.0 112.065 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 14.8 m -63.57 -50.18 70.47 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.01 0.819 . . . . 0.0 109.361 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.429 HD22 HG23 ' A' ' 24' ' ' VAL . 45.3 tp -54.16 -51.24 64.95 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.298 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.44 ' NE2' ' HG ' ' A' ' 74' ' ' LEU . 46.0 mt-30 -64.72 -39.61 93.94 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.453 0.47 . . . . 0.0 111.232 -178.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 76' ' ' THR . 1.4 pt20 -68.04 -35.76 78.79 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 120.647 0.26 . . . . 0.0 110.549 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 76' ' ' THR . 30.9 mm-40 -74.24 -43.81 55.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.305 0.642 . . . . 0.0 111.047 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.6 mt -70.92 -8.65 54.51 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.74 0.816 . . . . 0.0 112.193 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.15 2.55 87.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.969 -0.351 . . . . 0.0 113.216 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 29' ' ' SER . 76.8 mt -73.03 101.73 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 124.844 1.258 . . . . 0.0 108.961 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -137.5 155.74 48.93 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.281 0.633 . . . . 0.0 111.257 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.23 -118.43 12.91 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 124.114 0.884 . . . . 0.0 113.719 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -20.75 66.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.385 1.074 . . . . 0.0 111.895 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -79.62 -24.77 41.7 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.666 0.386 . . . . 0.0 111.998 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -69.78 118.67 12.92 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.733 0.242 . . . . 0.0 110.773 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.09 126.42 92.4 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.272 0.629 . . . . 0.0 110.117 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.9 143.2 65.57 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.817 2.345 . . . . 0.0 112.575 -177.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.4 t -109.53 122.04 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.748 0.819 . . . . 0.0 109.322 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.453 HG23 ' HD3' ' A' ' 35' ' ' ARG . 23.0 t -114.31 101.77 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.932 0.893 . . . . 0.0 109.61 -174.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -75.62 104.49 6.19 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.088 0.555 . . . . 0.0 110.648 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 51.4 mm . . . . . 0 N--CA 1.469 0.476 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.505 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.554 ' HB3' HG13 ' A' ' 60' ' ' VAL . 63.7 ttt180 . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -73.53 130.72 40.67 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.9 pt -133.15 175.68 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.509 1.124 . . . . 0.0 109.218 -177.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.9 p -95.92 164.8 12.57 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.72 172.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.504 ' O ' HG23 ' A' ' 24' ' ' VAL . 72.6 t-105 -55.49 -44.42 76.5 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.013 0.925 . . . . 0.0 110.657 174.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -56.07 -47.26 78.3 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.732 0.813 . . . . 0.0 111.129 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.6 -42.02 92.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.05 0.54 . . . . 0.0 110.567 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -51.78 -51.02 59.46 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.665 0.603 . . . . 0.0 111.228 175.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 20' ' ' TRP . 59.9 t -63.75 -61.31 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.238 0.615 . . . . 0.0 111.5 -175.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -71.91 -40.87 68.53 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.034 -168.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -79.82 -43.48 22.32 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.377 0.671 . . . . 0.0 110.915 -175.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -114.08 -65.66 1.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -163.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.4 tp -55.08 -45.14 75.36 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.081 0.952 . . . . 0.0 112.146 -171.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.2 p -71.55 -9.18 57.81 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -95.96 -6.47 38.92 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 118.835 -0.603 . . . . 0.0 112.012 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.42 31.25 80.26 Favored Glycine 0 C--N 1.353 1.482 0 C-N-CA 121.433 -0.413 . . . . 0.0 113.687 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.8 -3.46 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.38 0.672 . . . . 0.0 111.728 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.04 130.78 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.497 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 24.8 t70 -88.26 -51.27 5.85 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.967 1.307 . . . . 0.0 110.124 -175.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -152.71 152.33 31.57 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.676 0.79 . . . . 0.0 110.208 -175.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.1 mt -112.0 101.97 10.23 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.43 1.092 . . . . 0.0 109.054 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 43.1 mt-10 -93.49 101.18 13.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.856 -172.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.56 HG23 HG23 ' A' ' 44' ' ' VAL . 49.0 t -81.08 104.94 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -176.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.5 t -95.24 115.48 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 123.055 0.542 . . . . 0.0 110.538 -174.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 53.31 24.04 3.59 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.157 1.783 . . . . 0.0 113.905 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt 67.49 0.77 2.29 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.447 1.499 . . . . 0.0 112.98 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -76.87 -45.26 28.93 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.109 0.963 . . . . 0.0 110.135 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -152.32 175.02 13.1 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.964 -173.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.56 HG23 HG23 ' A' ' 38' ' ' VAL . 86.8 t -124.58 130.57 73.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 125.109 1.364 . . . . 0.0 107.846 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.615 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 68.4 ttt180 -97.9 116.91 31.07 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.732 1.213 . . . . 0.0 108.48 -177.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.51 ' HB ' HG23 ' A' ' 60' ' ' VAL . 46.7 t -85.11 106.7 15.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.7 m -103.17 135.86 44.03 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -97.0 148.08 23.34 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.88 0.738 . . . . 0.0 111.96 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.497 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 57.7 p . . . . . 0 C--N 1.349 0.557 0 C-N-CA 124.56 1.144 . . . . 0.0 111.26 -176.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 121.034 0.445 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.554 HG13 ' HB3' ' A' ' 16' ' ' ARG . 10.6 m -119.53 170.04 9.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.505 -175.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -156.18 161.52 40.3 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.166 0.586 . . . . 0.0 109.532 176.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -147.26 145.15 29.31 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.92 154.53 31.57 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 67' ' ' VAL . 31.9 pt -128.82 -46.37 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 122.937 0.495 . . . . 0.0 110.441 174.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.45 -72.15 0.47 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -168.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.9 t -78.57 104.51 9.23 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 124.456 1.102 . . . . 0.0 110.638 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.478 ' HA ' HD12 ' A' ' 64' ' ' ILE . 26.4 t -66.95 -31.7 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.068 173.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.45 -42.91 98.63 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.238 0.615 . . . . 0.0 110.597 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 80.4 m -62.86 -48.47 78.87 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -51.73 -52.43 48.57 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 124.475 1.11 . . . . 0.0 112.046 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -66.24 -42.38 88.67 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.306 0.379 . . . . 0.0 111.301 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -66.18 -49.87 65.84 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.829 0.452 . . . . 0.0 112.064 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -71.14 -32.5 69.03 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 119.206 -0.426 . . . . 0.0 110.828 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.1 tp -59.78 -48.16 82.81 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.89 0.876 . . . . 0.0 111.135 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -65.0 -42.89 94.08 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.261 0.624 . . . . 0.0 112.139 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.7 m -59.77 -49.51 77.46 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 122.013 0.911 . . . . 0.0 109.693 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.9 tp -58.96 -42.73 90.58 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 112.914 -1.948 . . . . 0.0 112.614 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -65.77 -37.11 85.44 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.242 0.617 . . . . 0.0 111.051 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -69.85 -35.28 74.58 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.108 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.31 -52.54 22.04 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.565 1.146 . . . . 0.0 110.996 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.5 mt -73.02 -19.77 61.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.183 0.993 . . . . 0.0 111.222 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 7.39 70.38 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-O 119.723 -0.487 . . . . 0.0 113.2 -175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.3 mt -67.77 92.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.157 0.983 . . . . 0.0 109.033 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -137.97 148.12 44.91 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.716 0.807 . . . . 0.0 110.147 -171.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.78 -102.83 0.74 Allowed Glycine 0 C--N 1.351 1.365 0 O-C-N 124.508 1.13 . . . . 0.0 112.992 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.52 -30.42 57.17 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.746 0.818 . . . . 0.0 110.72 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -72.05 -21.09 61.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.082 0.553 . . . . 0.0 111.379 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -62.01 142.6 57.4 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.231 0.613 . . . . 0.0 111.751 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.4 t -107.55 106.37 58.26 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -58.6 143.86 97.99 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 124.047 3.164 . . . . 0.0 113.258 -175.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.7 t -98.87 119.4 46.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 54.2 t -110.95 121.39 63.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -87.51 127.2 35.24 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.8 mm . . . . . 0 N--CA 1.474 0.753 0 C-N-CA 125.289 1.436 . . . . 0.0 107.791 -175.903 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.521 ' HB3' HG13 ' A' ' 60' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.94 107.2 6.02 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 48.2 pt -99.72 176.66 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.943 0.897 . . . . 0.0 109.967 173.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.3 p -104.78 171.6 7.24 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.383 171.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -57.78 -38.88 76.22 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.504 0.722 . . . . 0.0 110.381 171.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -55.45 -48.79 73.94 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.747 0.819 . . . . 0.0 111.211 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.554 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 50.8 m-20 -64.66 -45.15 87.96 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.77 0.428 . . . . 0.0 111.924 176.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -49.39 -57.35 7.09 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.121 0.888 . . . . 0.0 110.228 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.13 -56.41 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 123.89 0.744 . . . . 0.0 111.859 -174.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -76.32 -48.87 18.54 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -168.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -76.49 -39.62 52.62 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.265 0.626 . . . . 0.0 111.528 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -108.91 -65.54 1.13 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -165.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.4 tp -58.07 -44.45 87.51 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.88 0.872 . . . . 0.0 111.86 -173.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.1 t -57.47 -30.23 64.88 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.201 1.0 . . . . 0.0 112.455 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -91.81 0.97 57.46 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.979 0.912 . . . . 0.0 110.887 -176.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.46 25.41 62.93 Favored Glycine 0 C--N 1.351 1.409 0 N-CA-C 114.444 0.537 . . . . 0.0 114.444 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.9 m -85.91 -2.02 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 117.257 0.529 . . . . 0.0 110.617 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.5 t -93.77 122.22 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.908 0.883 . . . . 0.0 109.431 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.502 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 17.8 t70 -82.25 -52.44 6.94 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.208 1.003 . . . . 0.0 109.625 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -155.13 166.19 34.35 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.57 0.748 . . . . 0.0 110.687 -173.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.408 ' HG ' HG13 ' A' ' 89' ' ' VAL . 84.4 mt -119.15 107.25 13.24 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.949 0.9 . . . . 0.0 110.432 175.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -94.27 101.75 13.73 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.335 0.654 . . . . 0.0 110.257 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.477 HG11 ' HA ' ' A' ' 41' ' ' LYS . 23.4 t -82.58 89.91 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.412 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 95.4 t -73.94 116.77 16.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.289 1.035 . . . . 0.0 110.946 -169.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 55.8 21.4 4.73 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.604 1.162 . . . . 0.0 112.397 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.477 ' HA ' HG11 ' A' ' 38' ' ' VAL . 91.7 mttt 61.98 2.18 0.75 Allowed 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.845 1.658 . . . . 0.0 114.143 -173.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -80.06 -39.96 28.67 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.87 0.868 . . . . 0.0 110.766 -173.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -153.56 166.54 32.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.042 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 53.0 t -120.16 130.91 73.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -175.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -91.01 127.93 36.63 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.489 ' HB ' HG22 ' A' ' 60' ' ' VAL . 44.9 t -83.42 105.45 13.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 165.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.9 m -94.59 130.18 41.14 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -87.76 156.88 19.21 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.018 0.824 . . . . 0.0 111.095 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.502 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 64.4 p . . . . . 0 CA--C 1.553 1.088 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.361 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' A' ' 16' ' ' ARG . 35.7 m -110.94 152.69 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -153.64 156.57 38.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.85 0.46 . . . . 0.0 110.678 -174.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -139.8 139.94 36.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.322 0.649 . . . . 0.0 109.294 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -81.3 144.02 31.82 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.417 0.687 . . . . 0.0 110.045 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 67' ' ' VAL . 37.4 pt -120.46 140.18 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.519 0.728 . . . . 0.0 109.516 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.49 -46.13 26.77 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 177.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.8 m -132.09 138.44 48.13 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.694 0.798 . . . . 0.0 109.439 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.49 ' HA ' HD11 ' A' ' 64' ' ' ILE . 34.4 t -63.03 -41.4 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.287 0.635 . . . . 0.0 110.967 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.87 -39.69 92.76 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.939 0.495 . . . . 0.0 111.079 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.6 m -63.03 -45.86 90.31 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.864 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -53.46 -47.69 69.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.789 0.836 . . . . 0.0 111.291 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 52.1 mt-10 -63.35 -47.67 81.17 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.73 0.644 . . . . 0.0 110.901 -178.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.1 mtp-105 -61.24 -44.63 96.95 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.227 0.611 . . . . 0.0 111.082 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -63.65 -46.78 84.05 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.552 0.741 . . . . 0.0 110.741 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.23 -48.93 79.21 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.143 0.977 . . . . 0.0 111.655 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 23.0 mm-40 -61.96 -48.37 80.66 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.117 0.567 . . . . 0.0 110.956 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.446 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 96.1 m -57.24 -55.43 34.88 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.502 0.721 . . . . 0.0 110.35 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.4 tp -44.71 -51.24 9.46 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.18 1.792 . . . . 0.0 112.686 174.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -64.71 -41.59 95.88 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.014 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 13.9 mm100 -64.04 -38.65 91.85 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.485 0.314 . . . . 0.0 110.567 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 76' ' ' THR . 21.1 mm-40 -60.48 -39.81 89.0 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.83 0.852 . . . . 0.0 111.07 175.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.9 mt -84.1 -8.49 59.09 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.721 0.808 . . . . 0.0 112.097 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.45 6.25 89.36 Favored Glycine 0 C--N 1.353 1.474 0 C-N-CA 122.894 0.283 . . . . 0.0 113.392 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.509 HG23 ' HA ' ' A' ' 88' ' ' ARG . 69.5 mt -76.26 108.66 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 124.987 1.315 . . . . 0.0 109.555 177.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.25 177.29 10.38 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.62 0.768 . . . . 0.0 110.658 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.04 -125.15 29.6 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.662 0.601 . . . . 0.0 113.621 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -85.76 -8.12 58.34 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.354 0.662 . . . . 0.0 111.096 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.435 HD21 HG22 ' A' ' 83' ' ' ILE . 7.9 t30 -88.41 -12.94 41.77 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.339 0.655 . . . . 0.0 110.865 -178.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.509 ' HA ' HG23 ' A' ' 83' ' ' ILE . 12.1 ptp85 -63.69 147.52 51.4 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 117.507 0.14 . . . . 0.0 110.681 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.408 HG13 ' HG ' ' A' ' 36' ' ' LEU . 40.2 t -66.39 116.51 34.58 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -175.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 32.3 Cg_exo -59.56 117.34 4.07 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.576 2.851 . . . . 0.0 111.248 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.9 t -102.63 125.45 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.65 95.73 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -76.85 100.45 5.52 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.412 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 56.4 mt . . . . . 0 CA--C 1.546 0.817 0 C-N-CA 123.833 0.853 . . . . 0.0 109.51 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.501 ' HB2' HG13 ' A' ' 60' ' ' VAL . 18.9 mmm180 . . . . . 0 N--CA 1.478 0.945 0 CA-C-O 120.576 0.227 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 42.8 tt0 -89.68 116.54 27.89 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 169.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.3 pt -105.92 -177.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.663 0.785 . . . . 0.0 109.679 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.0 p -97.55 165.71 11.85 Favored 'General case' 0 C--O 1.248 0.999 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 169.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.487 ' O ' HG22 ' A' ' 24' ' ' VAL . 73.6 t-105 -55.84 -40.81 73.36 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.58 0.55 . . . . 0.0 110.388 171.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -53.4 -53.78 46.35 Favored 'General case' 0 C--O 1.256 1.447 0 C-N-CA 124.017 0.927 . . . . 0.0 111.881 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -51.88 -54.42 29.44 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 124.318 1.011 . . . . 0.0 109.195 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -51.89 -45.32 64.11 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 124.983 1.427 . . . . 0.0 111.745 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 20' ' ' TRP . 72.4 t -55.56 -63.16 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 O-C-N 123.551 0.532 . . . . 0.0 111.31 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -67.37 -42.03 84.12 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.923 0.764 . . . . 0.0 112.757 -167.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.62 -21.45 18.8 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -173.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.44 ' HE2' HG22 ' A' ' 60' ' ' VAL . 22.8 m-85 -122.19 -67.47 0.96 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.778 0.717 . . . . 0.0 112.618 -169.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.4 tp -59.46 -48.2 82.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.612 0.765 . . . . 0.0 111.597 -173.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.3 p -64.86 -20.64 66.52 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -102.74 -2.48 28.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.949 0.5 . . . . 0.0 110.995 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.61 33.88 42.17 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 115.424 0.93 . . . . 0.0 115.424 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.7 m -81.87 -3.57 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 122.934 0.493 . . . . 0.0 111.297 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.42 135.76 30.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 123.972 0.909 . . . . 0.0 108.792 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.09 -49.51 7.73 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.801 0.84 . . . . 0.0 110.323 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -153.83 149.17 27.11 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.765 0.826 . . . . 0.0 111.095 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.411 ' HG ' HG11 ' A' ' 89' ' ' VAL . 54.5 mt -118.39 103.22 9.58 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.908 1.283 . . . . 0.0 108.01 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.606 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 37.8 mt-10 -99.15 109.59 22.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.066 -171.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.493 HG23 HG23 ' A' ' 44' ' ' VAL . 57.3 t -83.42 98.6 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.5 t -92.62 120.99 42.87 Favored 'Isoleucine or valine' 0 C--O 1.251 1.176 0 C-N-CA 123.204 0.602 . . . . 0.0 109.779 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 59.47 18.37 6.84 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.084 1.354 . . . . 0.0 113.437 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 60.4 6.69 1.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.686 1.194 . . . . 0.0 112.94 -173.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -87.71 -48.82 7.56 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.609 1.164 . . . . 0.0 110.215 -173.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -146.21 170.14 17.33 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.416 -172.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.493 HG23 HG23 ' A' ' 38' ' ' VAL . 95.6 t -121.26 123.54 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.86 0.864 . . . . 0.0 109.561 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.606 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 7.9 tpm_? -83.37 109.48 17.33 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.312 1.445 . . . . 0.0 107.458 177.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.06 107.44 16.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.4 m -107.79 127.73 53.96 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.475 ' H ' ' HE1' ' A' ' 59' ' ' TYR . 99.7 m-85 -100.61 169.55 8.97 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.269 1.028 . . . . 0.0 111.991 -171.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.1 p . . . . . 0 CA--C 1.552 1.038 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.17 179.581 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.475 ' HE1' ' H ' ' A' ' 48' ' ' PHE . 60.2 m-85 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.501 HG13 ' HB2' ' A' ' 16' ' ' ARG . 28.7 m -111.15 172.48 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.666 -174.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.4 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 42.8 p-90 -160.45 164.87 31.92 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.048 0.939 . . . . 0.0 108.948 178.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -152.53 143.65 23.13 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.551 0.34 . . . . 0.0 110.357 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -89.09 123.67 33.59 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' A' ' 67' ' ' VAL . 32.1 pt -95.44 -40.95 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.777 -171.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.94 -75.31 0.24 Allowed Glycine 0 C--N 1.35 1.307 0 O-C-N 123.424 0.452 . . . . 0.0 112.264 -172.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.1 m -82.06 99.22 9.05 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.484 ' HA ' HD12 ' A' ' 64' ' ' ILE . 60.3 t -54.7 -39.59 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.379 1.072 . . . . 0.0 110.887 171.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 18.9 t70 -54.34 -55.93 23.63 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 123.97 0.908 . . . . 0.0 110.73 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.4 m -59.82 -42.81 94.33 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 124.087 0.867 . . . . 0.0 111.506 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -50.84 -50.09 57.49 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 123.409 0.684 . . . . 0.0 111.488 172.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 47.0 mt-10 -68.58 -47.23 67.32 Favored 'General case' 0 C--O 1.217 -0.639 0 O-C-N 123.97 0.794 . . . . 0.0 111.243 -177.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 24.3 mmm180 -53.55 -48.6 68.98 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.454 0.701 . . . . 0.0 110.458 -178.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.21 -53.42 37.46 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.601 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.13 -53.31 58.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.69 0.796 . . . . 0.0 112.117 -174.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -61.64 -51.19 69.51 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.492 0.717 . . . . 0.0 112.028 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.419 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 94.1 m -63.11 -47.4 82.96 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.781 0.676 . . . . 0.0 110.619 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.457 HD22 HG13 ' A' ' 24' ' ' VAL . 35.4 tp -56.82 -45.61 82.16 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.73 1.212 . . . . 0.0 112.913 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -66.44 -34.83 78.83 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.385 0.428 . . . . 0.0 110.284 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -66.36 -38.35 87.39 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.632 0.373 . . . . 0.0 111.347 173.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 76' ' ' THR . 49.9 mt-10 -69.5 -36.99 76.99 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.909 0.884 . . . . 0.0 111.0 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.78 -19.38 59.03 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.017 0.927 . . . . 0.0 111.641 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.85 6.03 70.34 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.862 -0.41 . . . . 0.0 113.494 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.714 HG23 HD21 ' A' ' 87' ' ' ASN . 68.5 mt -71.27 109.98 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 124.511 1.124 . . . . 0.0 109.403 176.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -124.35 144.09 50.21 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.369 0.668 . . . . 0.0 111.507 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.83 -115.0 5.0 Favored Glycine 0 C--N 1.354 1.549 0 O-C-N 124.897 1.373 . . . . 0.0 114.831 169.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -64.61 -26.43 68.39 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.17 0.988 . . . . 0.0 112.067 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.714 HD21 HG23 ' A' ' 83' ' ' ILE . 6.6 t30 -79.71 -20.3 46.82 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.24 0.216 . . . . 0.0 110.988 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -64.86 139.59 58.78 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 174.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.411 HG11 ' HG ' ' A' ' 36' ' ' LEU . 35.3 t -75.9 114.84 40.87 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 124.03 0.831 . . . . 0.0 109.243 -177.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.87 140.3 94.58 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.465 2.777 . . . . 0.0 113.252 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.8 t -105.97 112.52 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.437 ' HB ' ' HG2' ' A' ' 37' ' ' GLU . 63.0 t -110.78 97.13 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 123.821 0.849 . . . . 0.0 109.656 -171.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -70.61 103.11 2.43 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.551 0.34 . . . . 0.0 110.276 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 63.1 mt . . . . . 0 CA--C 1.537 0.452 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.819 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.34 141.24 35.61 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.7 pt -137.38 -175.44 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.237 1.415 . . . . 0.0 108.14 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.4 p -105.44 165.36 11.18 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.63 0.372 . . . . 0.0 110.209 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.46 ' O ' HG23 ' A' ' 24' ' ' VAL . 70.8 t-105 -56.43 -37.54 70.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.61 0.764 . . . . 0.0 109.879 169.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.18 -46.04 83.18 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 123.799 0.84 . . . . 0.0 112.217 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -61.31 -46.13 91.59 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.684 0.393 . . . . 0.0 110.895 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -54.29 -55.55 27.14 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 124.184 0.927 . . . . 0.0 111.256 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 20' ' ' TRP . 94.2 t -57.19 -62.69 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.299 0.639 . . . . 0.0 111.73 -176.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -67.38 -54.39 20.87 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.573 -170.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -87.64 -14.79 39.06 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.441 0.696 . . . . 0.0 112.649 -165.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -124.8 -67.12 0.93 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 118.397 0.544 . . . . 0.0 112.003 -174.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.4 tp -60.68 -47.98 83.85 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.749 0.819 . . . . 0.0 111.733 -172.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.9 m -68.96 -16.67 63.8 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.615 0.766 . . . . 0.0 112.807 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -93.56 -5.49 48.83 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.011 0.524 . . . . 0.0 111.512 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.18 33.94 82.1 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 123.572 0.545 . . . . 0.0 114.142 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 18.5 m -93.23 1.66 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 122.551 0.34 . . . . 0.0 111.071 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 t -96.67 126.68 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 120.688 0.28 . . . . 0.0 110.278 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.582 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 23.4 t70 -88.45 -50.36 6.36 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.347 1.059 . . . . 0.0 109.43 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -155.01 162.72 41.0 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.794 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.4 mt -117.08 103.32 10.11 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.457 0.703 . . . . 0.0 109.648 174.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -87.39 100.74 12.96 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.511 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.2 t -93.1 92.64 3.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -172.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.408 HG23 ' HB ' ' A' ' 94' ' ' ILE . 60.7 t -83.6 132.23 31.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.566 -175.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 66.19 11.12 7.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.895 1.278 . . . . 0.0 112.392 172.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.464 ' HB3' HG22 ' A' ' 67' ' ' VAL . 62.0 mttm 58.47 6.14 0.53 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.478 1.111 . . . . 0.0 112.55 -168.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -94.52 -38.11 11.06 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.7 1.2 . . . . 0.0 110.234 -168.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -148.4 151.85 35.98 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.237 -176.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.91 126.43 68.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.257 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -101.84 123.22 45.41 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.464 ' HB ' HG22 ' A' ' 60' ' ' VAL . 46.5 t -83.78 111.2 19.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.526 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.0 m -91.91 135.48 33.9 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.544 ' HE1' ' HA ' ' A' ' 59' ' ' TYR . 75.9 m-85 -85.49 148.46 25.96 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.308 0.38 . . . . 0.0 110.159 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.582 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 27.5 p . . . . . 0 CA--C 1.549 0.933 0 C-N-CA 123.13 0.572 . . . . 0.0 111.055 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.544 ' HA ' ' HE1' ' A' ' 48' ' ' PHE . 97.5 m-85 . . . . . 0 C--O 1.238 0.498 0 CA-C-O 121.181 0.515 . . . . 0.0 109.641 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.464 HG22 ' HB ' ' A' ' 46' ' ' VAL . 19.1 m -109.56 159.16 9.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.504 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -159.44 164.5 34.48 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.836 0.855 . . . . 0.0 108.975 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -148.73 141.11 24.19 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -88.35 132.5 34.4 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 67' ' ' VAL . 24.3 pt -104.36 139.8 24.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 123.788 0.835 . . . . 0.0 109.808 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.22 -41.94 44.75 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.824 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.4 t -132.17 132.17 42.93 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.937 0.895 . . . . 0.0 110.393 177.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 41' ' ' LYS . 38.6 t -63.6 -35.49 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.467 0.707 . . . . 0.0 110.745 172.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -57.81 -50.26 73.86 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.767 0.827 . . . . 0.0 110.724 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.1 m -61.69 -45.82 92.34 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 124.167 0.917 . . . . 0.0 111.027 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -54.0 -51.25 64.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.197 0.599 . . . . 0.0 111.023 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -64.77 -51.13 63.91 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.577 0.751 . . . . 0.0 112.451 -174.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -66.74 -36.4 82.37 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.116 0.26 . . . . 0.0 111.054 -175.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -69.25 -42.53 75.49 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.424 ' HG ' ' NE2' ' A' ' 78' ' ' GLN . 29.9 tp -59.76 -53.19 60.88 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 123.593 0.558 . . . . 0.0 111.232 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -62.96 -41.84 99.64 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.046 0.539 . . . . 0.0 111.807 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.6 m -66.97 -54.95 16.85 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.387 0.675 . . . . 0.0 111.05 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.8 tp -52.0 -41.17 61.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.142 1.377 . . . . 0.0 112.651 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.424 ' NE2' ' HG ' ' A' ' 74' ' ' LEU . 44.8 mt-30 -64.01 -42.95 96.97 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.4 0.28 . . . . 0.0 110.487 175.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.495 ' NE2' ' HB3' ' A' ' 84' ' ' GLU . 23.8 mm-40 -63.37 -32.13 73.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.756 0.423 . . . . 0.0 111.782 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -64.42 -38.32 90.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.12 0.568 . . . . 0.0 110.32 173.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.4 mt -78.36 -13.97 59.61 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.518 0.727 . . . . 0.0 111.324 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.35 21.35 58.7 Favored Glycine 0 C--N 1.355 1.606 0 C-N-CA 122.88 0.276 . . . . 0.0 113.126 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.1 mt -94.06 131.62 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 125.467 1.507 . . . . 0.0 110.179 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.495 ' HB3' ' NE2' ' A' ' 79' ' ' GLN . 9.5 pt-20 -166.63 160.83 15.4 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.026 0.93 . . . . 0.0 109.737 175.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.93 -92.65 0.01 OUTLIER Glycine 0 C--N 1.347 1.149 0 O-C-N 123.919 0.762 . . . . 0.0 114.688 173.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -69.8 -46.44 65.7 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.37 1.068 . . . . 0.0 110.638 -172.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -92.48 -4.9 52.91 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.374 -174.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -70.39 128.28 35.66 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.153 0.581 . . . . 0.0 109.87 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.84 113.67 13.03 Favored Pre-proline 0 CA--C 1.55 0.977 0 O-C-N 124.049 0.843 . . . . 0.0 111.081 -170.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 74.9 Cg_exo -54.48 122.67 11.96 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.482 2.788 . . . . 0.0 112.666 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.7 121.43 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.8 t -118.69 97.47 5.34 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -71.61 117.87 13.73 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.408 ' HB ' HG23 ' A' ' 39' ' ' VAL . 54.9 mt . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.594 ' HB2' HG12 ' A' ' 60' ' ' VAL . 51.6 mmm-85 . . . . . 0 C--O 1.236 0.372 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -75.24 108.21 7.85 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 50.0 pt -105.49 -178.13 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 124.936 1.295 . . . . 0.0 108.804 173.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.4 p -98.85 168.6 10.02 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 123.186 0.594 . . . . 0.0 109.506 167.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.476 ' O ' HG23 ' A' ' 24' ' ' VAL . 44.8 t-105 -53.74 -42.74 68.46 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.563 0.745 . . . . 0.0 110.336 171.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -60.33 -43.47 96.37 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.007 0.523 . . . . 0.0 112.34 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.516 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 63.1 m-20 -64.5 -35.12 79.91 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.51 0.324 . . . . 0.0 110.845 177.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 35.8 t80 -57.67 -51.93 67.51 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 123.905 0.753 . . . . 0.0 110.839 174.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 20' ' ' TRP . 90.4 t -54.75 -62.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.047 0.939 . . . . 0.0 112.136 -176.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -73.25 -49.27 28.7 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.06 -18.91 37.99 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -170.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.552 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 60.0 m-85 -128.12 -64.93 0.93 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.075 0.852 . . . . 0.0 112.994 -170.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -60.84 -46.25 91.32 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.312 0.645 . . . . 0.0 111.787 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.1 t -58.56 -27.77 64.9 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.581 1.152 . . . . 0.0 112.929 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -87.51 -17.63 31.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.957 0.503 . . . . 0.0 110.739 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.35 32.59 84.13 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 123.804 0.69 . . . . 0.0 113.897 -172.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.8 m -80.7 -0.88 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.3 t -100.5 132.16 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.694 0.798 . . . . 0.0 110.117 -170.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -83.28 -52.69 6.34 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.206 1.002 . . . . 0.0 109.967 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -154.67 156.81 37.11 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.657 0.783 . . . . 0.0 109.74 -175.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.3 mt -112.28 102.87 11.0 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -92.5 101.88 14.33 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.984 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 38.7 t -83.88 96.23 4.21 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -175.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.23 118.63 25.66 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.639 -173.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 58.74 18.38 5.93 Favored 'General case' 0 CA--C 1.559 1.298 0 O-C-N 124.944 1.402 . . . . 0.0 112.587 172.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm 58.66 2.23 0.22 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.388 1.475 . . . . 0.0 114.33 -171.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -82.05 -33.85 29.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.371 0.668 . . . . 0.0 109.803 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -154.36 163.81 39.58 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.767 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 57.9 t -111.74 129.28 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -103.84 128.07 51.31 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.88 106.98 17.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.397 -1.274 . . . . 0.0 107.656 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.4 m -96.71 125.53 41.23 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -94.44 170.38 9.53 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.027 0.829 . . . . 0.0 110.994 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.6 p . . . . . 0 CA--C 1.552 1.026 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 168.813 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 . . . . . 0 C--O 1.239 0.55 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 16' ' ' ARG . 11.4 m -124.6 166.7 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -165.2 159.86 17.95 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.767 0.427 . . . . 0.0 111.079 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -147.76 142.29 26.48 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.4 0.68 . . . . 0.0 109.914 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -81.49 141.64 33.66 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 67' ' ' VAL . 33.3 pt -117.42 124.09 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.274 0.63 . . . . 0.0 110.361 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -71.6 -40.46 59.1 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.1 t -129.92 120.01 24.18 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.118 0.967 . . . . 0.0 108.73 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.499 ' HA ' HD13 ' A' ' 64' ' ' ILE . 97.5 t -56.04 -38.83 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.49 1.116 . . . . 0.0 110.774 172.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -60.66 -45.62 93.44 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.003 0.921 . . . . 0.0 110.805 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.1 m -59.57 -47.46 85.46 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.353 0.661 . . . . 0.0 110.747 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -53.65 -60.43 3.32 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.772 0.829 . . . . 0.0 111.862 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -42.01 80.19 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.24 0.616 . . . . 0.0 112.032 -169.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -62.9 -47.79 81.77 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.063 0.545 . . . . 0.0 110.851 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -65.92 -38.73 89.45 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.329 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.3 tp -58.04 -56.85 16.67 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.683 0.793 . . . . 0.0 111.974 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -35.17 79.55 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 123.452 0.47 . . . . 0.0 112.182 -174.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.1 m -62.26 -55.03 32.39 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.328 0.651 . . . . 0.0 110.116 172.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.468 HD22 HG13 ' A' ' 24' ' ' VAL . 52.5 tp -50.77 -45.09 58.88 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.644 1.578 . . . . 0.0 113.04 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -63.07 -41.32 99.41 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.046 0.539 . . . . 0.0 110.775 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -65.2 -35.83 82.28 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.129 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -71.33 -44.12 65.7 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.514 0.726 . . . . 0.0 111.458 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.7 mt -74.19 -7.27 52.08 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.753 0.821 . . . . 0.0 111.888 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.27 8.18 87.84 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.506 0.504 . . . . 0.0 112.537 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.9 mt -70.24 108.67 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.868 1.267 . . . . 0.0 108.057 175.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -141.59 162.73 34.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.627 0.771 . . . . 0.0 110.616 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.44 -120.67 23.75 Favored Glycine 0 C--N 1.344 1.009 0 O-C-N 124.577 1.173 . . . . 0.0 112.995 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.36 -39.99 85.03 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.69 1.196 . . . . 0.0 111.362 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -69.5 -19.75 63.73 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.353 0.661 . . . . 0.0 111.596 -168.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -68.35 148.29 50.92 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.911 0.386 . . . . 0.0 111.097 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.92 117.93 56.44 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.744 -173.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.16 150.63 72.07 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 123.215 2.61 . . . . 0.0 112.473 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.3 t -112.88 116.89 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.665 0.786 . . . . 0.0 108.957 -176.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.92 115.6 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.419 1.088 . . . . 0.0 108.56 -171.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -94.69 115.57 27.7 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.176 0.59 . . . . 0.0 110.902 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 175.121 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.595 ' HB2' HG13 ' A' ' 60' ' ' VAL . 18.8 mtm180 . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.67 109.83 6.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.684 0.394 . . . . 0.0 110.095 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 36.6 pt -104.16 170.89 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.023 0.929 . . . . 0.0 109.226 175.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 76.9 p -86.41 168.62 13.64 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 166.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.56 ' O ' HG22 ' A' ' 24' ' ' VAL . 69.2 t-105 -55.1 -40.78 70.81 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.626 0.579 . . . . 0.0 109.849 168.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -56.15 -47.97 77.18 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.552 0.741 . . . . 0.0 111.424 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.555 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 39.7 m-20 -65.11 -39.19 92.77 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.488 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 19.5 t80 -53.8 -48.92 69.37 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 124.208 0.943 . . . . 0.0 110.852 176.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 20' ' ' TRP . 61.2 t -67.4 -65.98 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 123.572 0.545 . . . . 0.0 111.231 -176.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -67.76 -46.67 71.4 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.637 -166.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -85.56 -18.53 33.13 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.964 0.506 . . . . 0.0 112.001 -172.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.488 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 47.8 m-85 -127.55 -67.99 0.8 Allowed 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 119.277 0.944 . . . . 0.0 112.946 -171.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.13 -47.99 83.27 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.736 0.815 . . . . 0.0 111.482 -172.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.4 m -63.79 -23.25 67.29 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.855 0.862 . . . . 0.0 113.13 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -101.99 4.47 39.95 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 119.361 -0.352 . . . . 0.0 111.533 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.63 28.24 56.14 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.1 m -81.31 -5.96 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.115 0.566 . . . . 0.0 111.01 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.83 136.4 26.09 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 C-N-CA 124.014 0.926 . . . . 0.0 108.923 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -86.86 -57.75 2.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.131 0.973 . . . . 0.0 108.978 174.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -153.31 159.93 42.6 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.716 -174.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.4 mt -113.87 102.17 9.96 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -94.8 103.68 15.58 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.446 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 18.4 t -87.79 101.7 11.76 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -174.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.5 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 94.9 t -75.59 116.8 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 37.85 37.17 0.12 Allowed 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 128.348 2.659 . . . . 0.0 115.913 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt 67.27 -1.83 1.4 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.918 1.287 . . . . 0.0 112.793 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -80.76 -37.37 30.5 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.063 0.945 . . . . 0.0 110.42 -175.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -159.07 158.93 33.97 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.11 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 61.8 t -109.38 129.42 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.533 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -94.02 126.01 38.98 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.424 ' HB ' HG21 ' A' ' 60' ' ' VAL . 33.5 t -84.21 105.1 13.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.2 m -103.95 130.98 51.61 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -96.43 163.8 12.9 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.17 0.918 . . . . 0.0 111.956 -170.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.1 p . . . . . 0 CA--C 1.561 1.372 0 C-N-CA 124.084 0.953 . . . . 0.0 112.052 -178.317 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 . . . . . 0 N--CA 1.466 0.333 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.595 HG13 ' HB2' ' A' ' 16' ' ' ARG . 29.5 m -124.67 156.51 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 124.127 0.892 . . . . 0.0 108.595 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -155.23 171.23 20.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.938 0.495 . . . . 0.0 110.556 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -150.54 143.66 24.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.83 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -79.97 134.45 36.25 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.182 0.593 . . . . 0.0 110.454 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.8 pt -120.24 175.66 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.148 0.579 . . . . 0.0 110.334 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.4 -50.69 0.08 OUTLIER Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.2 t -100.72 108.87 20.83 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.771 0.828 . . . . 0.0 109.631 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.0 t -57.88 -37.69 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.124 0.97 . . . . 0.0 110.402 170.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -53.59 -50.23 66.05 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.786 1.234 . . . . 0.0 110.574 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.6 m -66.83 -43.75 82.9 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 124.126 0.891 . . . . 0.0 111.275 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -53.52 -49.56 67.33 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.084 0.554 . . . . 0.0 110.948 172.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -65.61 -51.67 57.88 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.256 1.022 . . . . 0.0 112.847 -172.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.5 ptt85 -68.11 -38.24 82.05 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.57 0.544 . . . . 0.0 111.255 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -72.48 -39.14 67.93 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 40.5 tp -59.92 -54.42 46.3 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.822 0.849 . . . . 0.0 111.931 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.445 ' HB2' HH12 ' A' ' 88' ' ' ARG . 13.6 pt-20 -63.13 -40.03 96.41 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.301 0.64 . . . . 0.0 111.447 -175.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.7 m -66.86 -49.43 65.7 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.617 0.767 . . . . 0.0 109.736 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 43.0 tp -51.11 -48.81 61.62 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.526 1.13 . . . . 0.0 111.998 174.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -62.42 -46.41 88.68 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 123.67 0.606 . . . . 0.0 111.225 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -67.04 -30.15 70.14 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 123.043 0.214 . . . . 0.0 110.871 -177.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.64 -42.65 70.59 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.812 0.845 . . . . 0.0 110.842 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 94.4 mt -71.81 -12.16 61.16 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.645 0.778 . . . . 0.0 111.47 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.03 -0.61 76.24 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 123.288 0.368 . . . . 0.0 112.75 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 66.2 mt -74.46 92.28 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.75 152.2 48.05 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.82 0.448 . . . . 0.0 111.225 -172.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.92 -115.91 8.26 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 124.453 1.096 . . . . 0.0 113.02 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.16 -26.48 68.19 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.248 1.019 . . . . 0.0 111.595 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.45 -24.41 60.22 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.846 0.458 . . . . 0.0 111.881 -176.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.445 HH12 ' HB2' ' A' ' 75' ' ' GLU . 60.8 mtt180 -63.02 135.2 57.14 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 123.427 0.455 . . . . 0.0 110.802 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.56 118.87 74.81 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 123.733 0.813 . . . . 0.0 110.44 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.99 135.27 50.45 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 123.596 2.864 . . . . 0.0 113.262 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.2 116.38 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.531 0.733 . . . . 0.0 109.48 -176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.2 t -105.74 99.08 7.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -174.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -74.92 99.71 3.9 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.5 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 42.3 mm . . . . . 0 C--N 1.323 -0.554 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.626 ' HB2' HG13 ' A' ' 60' ' ' VAL . 31.9 mmt180 . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -78.52 133.21 37.41 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.267 0.556 . . . . 0.0 109.648 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 48.5 pt -132.13 -177.04 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 126.009 1.724 . . . . 0.0 108.27 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.8 p -102.98 169.91 8.28 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 167.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.491 ' O ' HG22 ' A' ' 24' ' ' VAL . 66.4 t-105 -53.18 -40.15 64.17 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.552 0.741 . . . . 0.0 110.486 170.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.6 tttp -56.48 -49.0 75.94 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.749 0.819 . . . . 0.0 111.632 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 30.5 m-20 -61.95 -40.66 96.3 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.625 0.37 . . . . 0.0 110.773 177.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.436 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 33.9 t80 -54.01 -53.0 59.0 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 124.413 1.07 . . . . 0.0 110.96 177.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 20' ' ' TRP . 63.8 t -57.23 -56.77 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 123.732 0.645 . . . . 0.0 111.074 -177.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -67.6 -58.95 3.78 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.739 0.816 . . . . 0.0 112.274 -170.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -85.44 -20.65 29.47 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.555 0.742 . . . . 0.0 112.084 -165.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.436 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 78.1 m-85 -120.66 -68.97 0.87 Allowed 'General case' 0 C--O 1.248 1.003 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -168.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.7 tp -60.21 -48.85 79.98 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.562 0.745 . . . . 0.0 111.894 -173.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.1 m -68.48 -17.05 64.1 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -96.6 1.38 51.18 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.267 0.485 . . . . 0.0 111.358 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.94 22.01 56.82 Favored Glycine 0 C--N 1.35 1.307 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 m -89.95 4.83 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.886 0.474 . . . . 0.0 111.334 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.6 t -96.18 128.58 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.421 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 25.6 t70 -90.35 -50.09 6.16 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.885 0.874 . . . . 0.0 109.951 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -163.94 159.21 20.6 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.291 -177.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 46' ' ' VAL . 96.3 mt -120.72 102.55 8.47 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.987 0.915 . . . . 0.0 110.877 -173.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 49.4 mp0 -83.99 108.67 17.09 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.698 0.799 . . . . 0.0 110.092 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 41' ' ' LYS . 47.8 t -86.15 90.61 3.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.441 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 59.8 t -84.84 119.05 33.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.851 -170.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 56.89 22.38 7.06 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 125.404 1.482 . . . . 0.0 112.992 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.523 ' HA ' HG13 ' A' ' 38' ' ' VAL . 36.2 mtmm 58.58 8.28 0.86 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.526 1.13 . . . . 0.0 113.666 -173.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -88.59 -40.18 13.56 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.447 1.099 . . . . 0.0 110.851 -174.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -150.33 173.78 13.6 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.062 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.505 HG23 HG23 ' A' ' 38' ' ' VAL . 73.8 t -124.05 132.72 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.179 0.992 . . . . 0.0 109.676 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.688 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 40.9 ttm180 -96.39 113.09 24.64 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.521 1.128 . . . . 0.0 108.582 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' A' ' 36' ' ' LEU . 44.6 t -82.66 107.2 14.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.3 m -93.16 144.67 25.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.27 140.48 29.65 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.887 0.475 . . . . 0.0 112.02 177.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 CA--C 1.55 0.978 0 C-N-CA 124.121 0.968 . . . . 0.0 110.96 174.566 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.5 p90 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 121.152 0.501 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.626 HG13 ' HB2' ' A' ' 16' ' ' ARG . 23.3 m -109.19 164.61 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -158.89 158.35 33.23 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 118.385 0.539 . . . . 0.0 111.202 -173.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -146.1 145.68 30.62 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.999 0.52 . . . . 0.0 110.245 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -85.35 121.81 28.62 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.973 0.909 . . . . 0.0 110.487 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 67' ' ' VAL . 36.2 pt -103.77 -51.51 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.283 0.633 . . . . 0.0 111.236 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.435 ' N ' HG13 ' A' ' 64' ' ' ILE . . . 71.03 -70.07 0.78 Allowed Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -165.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.6 m -81.55 96.27 7.39 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.108 0.963 . . . . 0.0 110.895 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.539 ' HA ' HD12 ' A' ' 64' ' ' ILE . 13.0 t -64.72 -34.06 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.626 0.77 . . . . 0.0 111.383 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -58.73 -45.35 89.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.063 0.545 . . . . 0.0 109.819 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.5 m -64.19 -46.23 84.87 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.014 0.926 . . . . 0.0 110.229 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -49.65 -54.53 18.0 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.197 0.999 . . . . 0.0 112.042 174.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -66.59 -43.5 84.72 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.125 0.891 . . . . 0.0 111.83 -174.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -63.98 -40.07 95.57 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.568 0.747 . . . . 0.0 111.041 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -64.17 -46.82 82.32 Favored 'General case' 0 C--O 1.216 -0.698 0 O-C-N 123.704 0.627 . . . . 0.0 109.678 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.7 tp -60.79 -41.81 96.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.935 0.894 . . . . 0.0 111.86 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -65.14 -51.53 60.69 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.211 0.605 . . . . 0.0 111.786 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 m -65.7 -37.28 86.01 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.618 0.767 . . . . 0.0 110.214 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.42 -44.02 95.82 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.494 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -66.25 -29.88 70.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.694 0.397 . . . . 0.0 110.516 176.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -66.88 -49.12 66.64 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.65 0.38 . . . . 0.0 111.397 175.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.46 -36.03 73.66 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.228 0.211 . . . . 0.0 111.239 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.531 ' HB2' HG12 ' A' ' 83' ' ' ILE . 92.0 mt -75.78 -20.06 58.52 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.144 0.578 . . . . 0.0 111.228 175.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.68 30.56 66.11 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 120.121 -0.266 . . . . 0.0 113.131 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 81' ' ' LEU . 17.6 mm -66.45 102.35 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.414 1.085 . . . . 0.0 109.279 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -72.6 166.99 21.64 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.63 -32.85 54.26 Favored Glycine 0 N--CA 1.48 1.613 0 O-C-N 124.179 0.924 . . . . 0.0 114.73 -171.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -67.28 -43.52 81.56 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.966 0.906 . . . . 0.0 110.408 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -81.19 -19.91 42.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.145 0.978 . . . . 0.0 111.593 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.5 mtt-85 -61.47 122.08 14.3 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.904 0.881 . . . . 0.0 110.567 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.5 t -77.91 117.95 69.06 Favored Pre-proline 0 CA--C 1.554 1.103 0 O-C-N 123.983 0.802 . . . . 0.0 110.47 -172.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 71.9 Cg_exo -54.84 136.98 74.19 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.841 3.027 . . . . 0.0 113.261 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.3 t -103.53 113.4 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 37' ' ' GLU . 60.3 t -100.89 149.36 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.927 1.291 . . . . 0.0 108.025 -177.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -114.2 131.5 56.44 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.441 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 38.4 mm . . . . . 0 N--CA 1.473 0.72 0 C-N-CA 123.882 0.873 . . . . 0.0 109.244 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.621 ' HB2' HG11 ' A' ' 60' ' ' VAL . 59.2 mtm180 . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -78.81 129.72 34.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.4 pt -124.42 179.72 2.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 124.914 1.286 . . . . 0.0 108.921 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.8 p -106.32 170.1 8.12 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.66 0.784 . . . . 0.0 109.682 172.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.403 ' O ' HG21 ' A' ' 24' ' ' VAL . 71.1 t-105 -59.62 -39.87 85.71 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.527 0.731 . . . . 0.0 111.174 176.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -55.68 -52.38 64.05 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.585 0.754 . . . . 0.0 112.229 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -70.18 -32.38 70.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.935 0.494 . . . . 0.0 111.51 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.481 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 17.4 t80 -55.84 -56.11 24.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.635 0.774 . . . . 0.0 111.671 172.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.442 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 97.4 t -61.95 -58.33 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 123.595 0.56 . . . . 0.0 110.419 -176.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -65.47 -49.82 67.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.052 -168.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -87.46 -17.08 33.0 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -170.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.481 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 42.7 m-85 -128.6 -68.04 0.77 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -171.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.442 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 7.9 tt -59.06 -52.65 64.83 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.559 0.744 . . . . 0.0 111.903 -169.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 82.3 p -66.61 -22.57 66.12 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.554 0.742 . . . . 0.0 112.152 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -89.76 -5.42 56.98 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.342 0.657 . . . . 0.0 111.664 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.24 32.67 77.34 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.468 0.48 . . . . 0.0 113.991 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 m -101.93 11.44 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 122.855 0.462 . . . . 0.0 110.328 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.67 122.59 51.69 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 C-N-CA 124.207 1.003 . . . . 0.0 109.519 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 25.7 t70 -77.04 -45.89 25.62 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.732 0.813 . . . . 0.0 109.601 176.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -162.59 162.44 27.18 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.747 -167.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.421 ' HG ' HG11 ' A' ' 89' ' ' VAL . 95.4 mt -120.41 137.11 54.49 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.906 1.283 . . . . 0.0 108.375 170.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -120.13 110.49 16.7 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.213 0.605 . . . . 0.0 109.491 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.51 HG23 HG23 ' A' ' 44' ' ' VAL . 24.3 t -90.09 91.14 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -176.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.49 119.11 34.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -172.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 57.99 17.1 4.14 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.629 1.571 . . . . 0.0 113.855 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.1 mttp 61.69 2.81 0.76 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -172.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -80.04 -42.43 23.77 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.658 0.783 . . . . 0.0 109.856 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -151.38 170.41 19.63 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.334 -174.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.51 HG23 HG23 ' A' ' 38' ' ' VAL . 84.6 t -129.21 133.7 65.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -99.57 132.41 44.93 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.15 109.39 16.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 114.59 -1.186 . . . . 0.0 107.819 174.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.7 m -82.13 125.95 31.47 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 172.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.441 ' CE2' ' HA ' ' A' ' 59' ' ' TYR . 22.7 m-85 -84.21 133.42 34.59 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.369 0.668 . . . . 0.0 110.204 177.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.817 0 O-C-N 123.497 0.498 . . . . 0.0 109.95 175.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.441 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 17.8 m-85 . . . . . 0 C--O 1.237 0.425 0 CA-C-O 121.184 0.516 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.621 HG11 ' HB2' ' A' ' 16' ' ' ARG . 34.9 m -107.7 161.33 6.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.506 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 45.5 p-90 -153.3 162.26 41.49 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.601 0.76 . . . . 0.0 109.276 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -147.75 144.38 28.21 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -79.57 136.22 36.8 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.459 HD12 ' HA ' ' A' ' 67' ' ' VAL . 43.1 pt -108.23 -42.22 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 110.658 -0.127 . . . . 0.0 110.658 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.81 -81.53 0.05 OUTLIER Glycine 0 C--N 1.35 1.306 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 -173.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.3 m -74.48 97.49 3.12 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.739 0.816 . . . . 0.0 109.134 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.459 ' HA ' HD12 ' A' ' 64' ' ' ILE . 25.2 t -59.81 -33.67 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.98 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -57.05 -40.77 77.42 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.944 0.898 . . . . 0.0 111.069 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.2 m -67.19 -46.01 75.19 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.129 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -52.64 -52.73 54.32 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.503 0.502 . . . . 0.0 111.213 177.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -59.63 -59.01 6.12 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.3 1.0 . . . . 0.0 112.767 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -67.2 -36.79 82.46 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.534 -171.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.82 -52.63 59.3 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 174.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 47.7 tp -52.78 -52.96 54.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.188 1.395 . . . . 0.0 112.722 -176.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -68.17 -45.55 73.16 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.449 -175.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.406 ' HA ' ' NE2' ' A' ' 79' ' ' GLN . 27.6 m -64.72 -45.14 87.78 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.4 tp -46.45 -48.52 18.93 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.883 1.673 . . . . 0.0 112.382 171.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -62.23 -43.25 99.24 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.3 0.64 . . . . 0.0 111.258 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.406 ' NE2' ' HA ' ' A' ' 76' ' ' THR . 17.7 mt-30 -65.25 -41.69 94.05 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.255 0.622 . . . . 0.0 111.142 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -68.47 -40.26 81.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.741 0.816 . . . . 0.0 111.25 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.58 -15.04 59.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.214 0.605 . . . . 0.0 112.52 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.96 13.57 68.94 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-O 120.269 -0.184 . . . . 0.0 113.41 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.4 mt -71.67 108.11 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.43 1.092 . . . . 0.0 109.2 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -137.98 151.47 47.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.929 0.891 . . . . 0.0 110.568 -172.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.22 -118.91 13.96 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 123.905 0.753 . . . . 0.0 113.65 174.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.69 -29.32 70.56 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.043 0.937 . . . . 0.0 111.734 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.84 -21.66 60.92 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.943 -171.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 37.6 mtp85 -66.55 150.01 49.63 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.175 0.59 . . . . 0.0 110.416 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.421 HG11 ' HG ' ' A' ' 36' ' ' LEU . 20.2 t -91.64 119.55 68.46 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.118 -168.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.4 123.86 13.59 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.066 2.51 . . . . 0.0 111.377 175.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.2 t -116.19 118.34 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.8 t -113.36 105.59 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.106 0.963 . . . . 0.0 109.567 -173.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -75.35 123.46 25.42 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.051 0.54 . . . . 0.0 109.814 175.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.8 mt . . . . . 0 CA--C 1.54 0.573 0 C-N-CA 124.882 1.273 . . . . 0.0 108.084 -178.978 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 20.4 tpp180 . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -77.44 111.32 13.02 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 167.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.457 HD13 HG22 ' A' ' 46' ' ' VAL . 27.5 pt -93.77 166.78 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.555 1.142 . . . . 0.0 109.241 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.9 p -88.57 170.73 10.6 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -56.79 -40.86 76.67 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.097 0.559 . . . . 0.0 110.13 168.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -59.98 -49.17 78.74 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.663 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -66.61 -36.79 83.46 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.193 0.197 . . . . 0.0 111.183 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -54.65 -59.4 4.76 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.654 0.596 . . . . 0.0 110.736 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.424 HG13 HD13 ' A' ' 77' ' ' LEU . 47.5 t -60.17 -50.79 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 123.933 0.771 . . . . 0.0 111.255 -175.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -73.1 -56.97 4.38 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.793 -173.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -90.89 -10.99 40.53 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.9 -64.69 1.0 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 119.158 0.89 . . . . 0.0 111.737 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.9 tp -58.15 -41.81 84.55 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.551 1.14 . . . . 0.0 112.224 -176.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.8 t -66.55 -22.21 66.15 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.576 0.751 . . . . 0.0 112.751 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -87.09 -7.9 57.58 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.326 0.512 . . . . 0.0 110.949 175.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.66 12.95 60.25 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 114.259 0.464 . . . . 0.0 114.259 -175.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.14 -1.01 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 117.317 0.558 . . . . 0.0 111.084 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.55 126.44 45.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 C-N-CA 123.525 0.73 . . . . 0.0 109.155 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.472 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 16.5 t70 -86.03 -51.58 6.25 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.886 0.851 . . . . 0.0 109.095 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.529 ' HD3' HG23 ' A' ' 92' ' ' VAL . 16.2 ptp180 -160.13 164.42 32.99 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.05 -172.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.2 mt -117.17 101.93 8.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.685 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -92.96 107.61 19.36 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.495 0.718 . . . . 0.0 109.944 -171.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.556 HG23 HG23 ' A' ' 44' ' ' VAL . 41.0 t -91.89 91.61 3.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -175.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.675 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 49.1 t -79.08 114.22 19.52 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.666 -172.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 50.66 31.7 6.1 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.496 1.519 . . . . 0.0 113.217 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.449 ' HA ' HG13 ' A' ' 38' ' ' VAL . 61.3 mttm 66.8 -6.87 0.5 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 125.714 1.606 . . . . 0.0 112.801 -177.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.7 mmt-85 -64.94 -50.19 67.42 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 124.865 1.266 . . . . 0.0 110.904 -170.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -148.74 159.83 43.77 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.49 -175.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.556 HG23 HG23 ' A' ' 38' ' ' VAL . 65.5 t -101.14 123.06 53.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 171.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -101.6 129.29 47.68 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.54 ' HB ' HG22 ' A' ' 60' ' ' VAL . 68.8 t -85.13 110.24 19.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.5 m -82.97 134.74 35.04 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -82.99 128.17 34.23 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 171.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.472 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 5.1 t . . . . . 0 CA--C 1.556 1.202 0 C-N-CA 123.109 0.564 . . . . 0.0 110.541 -176.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 121.362 0.601 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.54 HG22 ' HB ' ' A' ' 46' ' ' VAL . 18.7 m -106.29 140.75 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -177.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -157.21 173.57 16.77 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.344 -170.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -151.98 141.17 21.35 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.86 0.864 . . . . 0.0 109.178 175.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -78.17 147.54 34.47 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.2 pt -124.39 154.1 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.329 0.652 . . . . 0.0 109.289 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.24 -34.43 1.79 Allowed Glycine 0 N--CA 1.471 0.989 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 174.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 m -117.9 99.55 6.99 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.56 1.144 . . . . 0.0 108.535 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.6 t -60.64 -35.3 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 122.977 0.511 . . . . 0.0 110.036 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.05 -40.44 95.78 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.065 0.946 . . . . 0.0 110.736 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.3 m -67.95 -42.87 80.29 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.565 176.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -55.14 -43.76 74.48 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.909 0.756 . . . . 0.0 111.394 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.47 -51.07 64.89 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.864 0.466 . . . . 0.0 110.73 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -34.42 73.52 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -171.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 29.9 p30 -74.27 -33.33 63.24 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 176.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.7 tp -62.89 -42.96 99.96 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.607 0.763 . . . . 0.0 110.859 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -60.34 -52.82 63.62 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.137 0.575 . . . . 0.0 110.566 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.8 m -61.97 -42.2 98.86 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 123.666 0.604 . . . . 0.0 110.738 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 73' ' ' ASN . 1.8 tm? -56.53 -47.82 78.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.84 1.256 . . . . 0.0 110.879 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.436 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 77.3 mt-30 -65.18 -36.83 85.43 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.143 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -63.85 -39.53 94.44 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.096 0.558 . . . . 0.0 110.814 176.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.97 -51.26 70.0 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.038 0.935 . . . . 0.0 111.169 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.8 mt -83.85 -2.57 56.69 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.001 -173.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.87 9.95 83.51 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 120.281 -0.177 . . . . 0.0 112.935 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.46 HG21 ' HA ' ' A' ' 88' ' ' ARG . 57.2 mt -73.59 118.61 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.733 1.213 . . . . 0.0 109.077 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -168.56 173.86 7.16 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.482 0.713 . . . . 0.0 111.193 -172.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.75 -122.11 25.39 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.589 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.46 -34.2 58.71 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.43 0.692 . . . . 0.0 110.245 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -74.33 -6.1 46.08 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.438 0.695 . . . . 0.0 112.455 -171.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.46 ' HA ' HG21 ' A' ' 83' ' ' ILE . 6.9 ptm180 -79.91 156.45 27.28 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.079 0.466 . . . . 0.0 111.274 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.5 t -98.99 114.81 65.84 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.246 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.92 160.74 33.64 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.164 2.576 . . . . 0.0 112.875 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.8 t -110.65 132.31 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.614 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.529 HG23 ' HD3' ' A' ' 35' ' ' ARG . 21.8 t -117.92 97.37 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -73.01 100.83 3.08 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.376 0.67 . . . . 0.0 109.883 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.675 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 46.8 mm . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.3 mtt . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.67 -2.0 63.2 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-O 119.523 -0.598 . . . . 0.0 113.729 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -65.83 -41.74 91.41 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.687 0.795 . . . . 0.0 110.797 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -90.34 83.8 5.97 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.804 0.811 . . . . 0.0 111.543 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -138.59 176.45 8.69 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.945 0.898 . . . . 0.0 110.251 174.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -66.34 96.22 0.34 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.617 0.722 . . . . 0.0 111.376 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -82.78 -42.39 18.0 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.72 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -87.49 66.01 8.85 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.012 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.0 m -152.54 144.42 23.67 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 125.311 1.444 . . . . 0.0 107.507 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -67.56 146.66 53.69 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 123.325 0.391 . . . . 0.0 110.524 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.9 ttt -62.03 98.8 0.11 Allowed 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 172.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.43 73.39 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 125.416 1.486 . . . . 0.0 110.783 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.406 ' HG2' ' CZ2' ' A' ' 61' ' ' TRP . 0.0 OUTLIER 58.49 -74.7 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.252 1.821 . . . . 0.0 111.618 -168.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.7 t -163.52 -51.04 0.03 OUTLIER 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.144 1.377 . . . . 0.0 108.48 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 59' ' ' TYR . . . 173.56 -117.49 0.65 Allowed Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.189 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -95.33 131.4 41.46 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.574 0.687 . . . . 0.0 109.936 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -77.01 126.18 30.55 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.92 0.888 . . . . 0.0 108.752 177.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.3 pt -126.55 166.86 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.785 1.234 . . . . 0.0 108.139 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 22' ' ' ASP . 9.8 t -96.4 157.84 15.71 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.541 ' O ' HG23 ' A' ' 24' ' ' VAL . 73.5 t-105 -53.91 -46.0 71.31 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.392 1.077 . . . . 0.0 110.993 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -61.04 -39.64 90.56 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.616 0.766 . . . . 0.0 112.037 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.417 ' H ' HG22 ' A' ' 19' ' ' THR . 24.4 t70 -66.55 -43.35 85.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.532 1.133 . . . . 0.0 110.415 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.434 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 12.5 t80 -52.46 -53.72 41.8 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.802 175.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 20' ' ' TRP . 62.3 t -58.65 -55.45 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 123.805 0.691 . . . . 0.0 111.22 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -71.78 -49.55 37.88 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.085 -0.962 . . . . 0.0 112.147 -169.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -90.07 -13.84 35.03 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.434 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 41.7 m-85 -127.81 -64.72 0.95 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 119.245 0.929 . . . . 0.0 113.131 -175.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.406 HD13 HG21 ' A' ' 89' ' ' VAL . 32.8 tp -58.47 -50.18 74.66 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.566 0.747 . . . . 0.0 112.775 -170.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.7 p -70.45 -18.37 63.0 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.15 0.58 . . . . 0.0 111.623 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -86.41 -7.59 58.32 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.435 0.694 . . . . 0.0 110.893 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.33 13.16 67.3 Favored Glycine 0 C--N 1.356 1.659 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 m -86.8 -0.47 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.435 0.617 . . . . 0.0 111.274 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.6 t -97.87 128.03 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.185 0.994 . . . . 0.0 109.062 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.521 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 23.9 t70 -86.94 -52.42 5.47 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.08 0.952 . . . . 0.0 109.75 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.489 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 17.5 ptp180 -156.48 163.66 39.16 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.512 -174.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.6 mt -118.75 104.4 10.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.825 0.85 . . . . 0.0 108.972 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.438 ' HG2' ' HB ' ' A' ' 92' ' ' VAL . 46.1 mt-10 -97.75 107.77 20.33 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.734 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.522 HG13 ' HA ' ' A' ' 41' ' ' LYS . 26.5 t -82.91 92.42 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -172.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.543 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 61.9 t -83.19 120.44 34.47 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 C-N-CA 122.797 0.439 . . . . 0.0 110.815 -169.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.569 ' HA ' ' HA ' ' A' ' 95' ' ' ALA . 3.8 m-20 54.53 21.45 3.35 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.811 1.644 . . . . 0.0 113.016 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.522 ' HA ' HG13 ' A' ' 38' ' ' VAL . 99.5 mttt 55.85 5.43 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.301 1.44 . . . . 0.0 114.472 -175.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -78.41 -41.32 33.37 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.02 0.914 . . . . 0.0 108.87 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -151.49 172.91 15.24 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.021 -172.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.437 HG23 HG23 ' A' ' 38' ' ' VAL . 79.4 t -122.38 131.26 73.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 124.248 1.019 . . . . 0.0 108.53 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -90.43 127.01 36.08 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.8 t -80.97 106.87 12.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 171.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.452 HG21 ' HE2' ' A' ' 59' ' ' TYR . 66.1 m -88.4 123.14 32.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -82.74 147.55 28.38 Favored 'General case' 0 C--O 1.247 0.939 0 O-C-N 123.609 0.568 . . . . 0.0 109.728 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.521 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 43.4 p -59.36 124.23 74.08 Favored Pre-proline 0 CA--C 1.556 1.174 0 O-C-N 124.327 1.017 . . . . 0.0 109.855 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.3 97.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 123.597 2.865 . . . . 0.0 113.563 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.9 -38.82 0.97 Allowed Glycine 0 C--N 1.344 0.993 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.724 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -67.58 -56.67 8.53 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.477 0.711 . . . . 0.0 111.1 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 65.5 p -132.06 135.52 26.68 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -71.82 -171.2 0.62 Allowed 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.636 2.224 . . . . 0.0 112.13 170.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.9 t -64.3 -41.83 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.1 -14.98 62.49 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.336 175.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.36 -12.73 59.1 Favored Glycine 0 C--N 1.351 1.376 0 C-N-CA 122.963 0.316 . . . . 0.0 112.815 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 66.99 94.15 0.07 Allowed 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.02 1.328 . . . . 0.0 111.049 172.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' HE2' HG21 ' A' ' 47' ' ' THR . 3.7 m-30 -65.21 157.33 29.12 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.128 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.1 m -110.2 164.68 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.343 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.406 ' CZ2' ' HG2' ' A' ' 13' ' ' ARG . 56.0 p-90 -157.35 165.67 35.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.176 0.59 . . . . 0.0 110.027 -173.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -149.2 142.01 24.64 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.467 0.707 . . . . 0.0 109.967 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -75.31 140.05 42.86 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.564 HD12 ' HA ' ' A' ' 67' ' ' VAL . 31.0 pt -115.18 -44.02 3.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.205 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.12 -74.74 0.36 Allowed Glycine 0 C--N 1.352 1.45 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 -171.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -80.33 97.47 7.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.456 1.102 . . . . 0.0 109.3 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.564 ' HA ' HD12 ' A' ' 64' ' ' ILE . 37.4 t -59.28 -37.44 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.821 0.849 . . . . 0.0 111.027 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 21.8 t70 -58.09 -49.87 75.43 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.497 1.119 . . . . 0.0 110.803 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.4 m -58.68 -46.08 88.03 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.917 0.887 . . . . 0.0 111.075 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -49.99 -50.81 45.85 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.16 0.984 . . . . 0.0 111.322 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 42.4 mt-10 -67.97 -45.83 73.09 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 124.251 0.97 . . . . 0.0 111.62 -173.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 68' ' ' ASP . 14.2 mtm180 -58.27 -46.05 86.73 Favored 'General case' 0 C--N 1.364 1.213 0 O-C-N 123.821 0.7 . . . . 0.0 109.845 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -65.48 -42.99 91.59 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.652 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.27 -50.59 69.57 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 123.946 0.778 . . . . 0.0 112.265 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -34.6 76.71 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.808 0.443 . . . . 0.0 111.675 -177.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.435 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 86.8 m -63.66 -52.02 62.57 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.352 0.596 . . . . 0.0 109.512 171.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.457 HD21 HG21 ' A' ' 24' ' ' VAL . 47.1 tp -52.99 -42.65 65.78 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.505 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -64.53 -45.7 86.03 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.915 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 76' ' ' THR . 10.1 pt20 -70.25 -26.84 64.02 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-N 117.763 0.256 . . . . 0.0 110.79 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 76' ' ' THR . 43.8 mt-10 -68.22 -50.23 55.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.013 0.925 . . . . 0.0 110.738 174.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.16 5.03 18.07 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.677 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.86 19.54 72.73 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-O 119.823 -0.432 . . . . 0.0 114.106 172.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.55 117.53 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.842 0.857 . . . . 0.0 109.612 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.65 -179.18 3.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.772 1.229 . . . . 0.0 108.568 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.17 -36.27 1.98 Allowed Glycine 0 N--CA 1.48 1.572 0 N-CA-C 116.246 1.258 . . . . 0.0 116.246 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.6 -37.03 60.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.504 0.722 . . . . 0.0 111.385 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -93.2 -5.63 49.56 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 118.85 -0.595 . . . . 0.0 111.966 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -58.85 124.51 20.06 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 118.046 0.385 . . . . 0.0 110.433 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.406 HG21 HD13 ' A' ' 28' ' ' LEU . 99.6 t -89.7 108.64 26.66 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.452 -172.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.489 ' HG2' ' HB3' ' A' ' 35' ' ' ARG . 19.4 Cg_endo -58.74 129.21 31.17 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.299 2.666 . . . . 0.0 112.591 -174.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.61 109.35 25.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.438 ' HB ' ' HG2' ' A' ' 37' ' ' GLU . 43.4 t -104.07 111.67 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -174.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -78.66 124.97 28.73 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 47.2 mt -124.71 137.59 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' A' ' 40' ' ' ASN . . . -161.04 90.86 0.85 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.796 0.438 . . . . 0.0 110.705 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -85.38 131.28 34.42 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 169.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.3 t -66.63 -19.31 65.74 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.728 0.811 . . . . 0.0 111.374 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -60.17 -35.8 76.15 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.751 1.22 . . . . 0.0 111.673 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.154 0 CA-C-O 119.305 -0.719 . . . . 0.0 111.35 178.781 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 120.802 0.334 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.48 78.57 0.5 Allowed Glycine 0 C--N 1.344 1.019 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -172.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -85.08 19.05 2.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.99 0.516 . . . . 0.0 111.574 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -75.34 -168.42 0.8 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.544 0.738 . . . . 0.0 109.848 168.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -66.71 89.15 0.15 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 170.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -110.87 94.36 4.95 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.852 0.834 . . . . 0.0 109.973 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -133.05 52.14 2.11 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -54.46 102.57 0.06 Allowed 'General case' 0 C--N 1.352 0.701 0 C-N-CA 124.033 0.933 . . . . 0.0 111.141 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 p -74.64 145.5 43.18 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.946 174.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -153.05 74.43 1.04 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.353 0.661 . . . . 0.0 110.399 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 70.1 mtm 56.67 -89.95 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.835 1.654 . . . . 0.0 112.328 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -137.01 141.67 42.51 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.799 0.84 . . . . 0.0 109.781 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -170.58 -64.03 0.02 OUTLIER 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.222 0.609 . . . . 0.0 110.273 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.3 m 64.31 -70.14 0.08 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.706 1.203 . . . . 0.0 109.522 -165.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 59' ' ' TYR . . . 167.85 -120.85 0.92 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 171.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.461 ' HB2' HG11 ' A' ' 60' ' ' VAL . 34.7 mmt180 -98.35 121.78 40.71 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.439 0.696 . . . . 0.0 110.715 176.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -79.76 109.62 14.35 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.2 pt -104.85 177.14 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 124.931 1.292 . . . . 0.0 108.9 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.5 p -92.02 163.14 14.09 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.527 ' O ' HG21 ' A' ' 24' ' ' VAL . 69.7 t-105 -58.89 -41.08 86.33 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.007 0.523 . . . . 0.0 109.657 171.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -52.16 -57.34 9.92 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.894 0.878 . . . . 0.0 111.733 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.33 -34.82 79.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.427 0.691 . . . . 0.0 111.157 -175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.402 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 45.2 t80 -54.56 -54.87 35.55 Favored 'General case' 0 C--N 1.344 0.334 0 O-C-N 123.991 0.807 . . . . 0.0 111.302 174.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.544 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 43.7 t -64.88 -50.64 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 O-C-N 123.43 0.456 . . . . 0.0 110.605 -174.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -66.44 -45.22 80.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.211 -172.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -95.71 -24.64 16.44 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -171.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.402 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 80.0 m-85 -122.13 -64.84 1.17 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 118.782 0.719 . . . . 0.0 112.591 -169.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.544 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 48.9 tp -55.54 -48.75 74.23 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.981 0.912 . . . . 0.0 112.045 -173.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 p -64.94 -22.95 67.08 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -89.49 -3.72 58.24 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.902 0.481 . . . . 0.0 110.439 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.37 19.14 61.78 Favored Glycine 0 C--N 1.355 1.599 0 N-CA-C 114.671 0.628 . . . . 0.0 114.671 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.5 m -79.06 0.16 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 117.415 0.608 . . . . 0.0 111.638 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.1 135.09 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.303 1.041 . . . . 0.0 108.941 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -81.64 -53.69 6.03 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.337 1.055 . . . . 0.0 108.887 174.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -168.15 164.19 13.35 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.944 -171.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.6 mt -116.96 105.18 12.05 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.061 0.945 . . . . 0.0 109.377 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -96.33 110.67 22.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.106 -174.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 41' ' ' LYS . 7.6 t -90.65 93.79 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -171.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.7 t -71.14 117.95 15.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 123.738 0.815 . . . . 0.0 110.919 -171.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 54.19 22.71 3.75 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.54 1.536 . . . . 0.0 113.03 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.547 ' HA ' HG11 ' A' ' 38' ' ' VAL . 8.5 mtpm? 53.7 17.15 1.15 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.852 1.261 . . . . 0.0 114.067 -172.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -91.28 -37.18 13.45 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.114 0.566 . . . . 0.0 110.434 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -152.8 163.78 39.07 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.75 0.82 . . . . 0.0 109.26 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.441 HG22 HG23 ' A' ' 38' ' ' VAL . 47.8 t -110.27 130.35 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.404 ' HG2' ' HB3' ' A' ' 61' ' ' TRP . 3.5 tmm_? -116.14 132.46 56.65 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.0 t -88.44 125.83 41.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.178 -170.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.9 m -95.14 129.77 42.12 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 167.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.471 ' HB2' HG21 ' A' ' 53' ' ' THR . 82.4 m-85 -87.03 144.7 26.78 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.828 0.451 . . . . 0.0 110.716 172.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 t -73.67 142.0 80.05 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.005 0.522 . . . . 0.0 110.195 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.54 121.0 9.25 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.428 2.752 . . . . 0.0 112.397 -173.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.59 -39.68 2.8 Favored Glycine 0 N--CA 1.471 0.999 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -95.83 1.98 53.47 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.699 0.8 . . . . 0.0 111.011 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.471 HG21 ' HB2' ' A' ' 48' ' ' PHE . 6.7 m -81.58 115.59 57.74 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.54 0.736 . . . . 0.0 109.955 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -48.02 120.73 5.12 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.605 2.87 . . . . 0.0 112.446 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.2 p -53.02 -32.58 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 124.967 1.307 . . . . 0.0 113.593 -166.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.7 -39.84 95.25 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.292 1.037 . . . . 0.0 110.66 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.41 16.78 6.92 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.203 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -78.49 103.06 8.18 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 122.964 0.505 . . . . 0.0 110.215 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.405 ' O ' ' HA3' ' A' ' 15' ' ' GLY . 87.1 m-85 -81.32 174.07 11.86 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 166.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 16' ' ' ARG . 25.2 m -122.81 170.26 13.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.404 ' HB3' ' HG2' ' A' ' 45' ' ' ARG . 8.9 p-90 -165.43 158.56 16.1 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.622 0.369 . . . . 0.0 110.624 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -145.0 151.03 37.94 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.316 0.579 . . . . 0.0 110.291 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -82.9 151.06 26.13 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.579 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 67' ' ' VAL . 26.0 pt -125.69 144.19 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.521 0.728 . . . . 0.0 110.425 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.99 -52.64 7.75 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m -131.72 135.7 47.05 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.717 0.807 . . . . 0.0 108.972 176.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.429 ' HA ' HD11 ' A' ' 64' ' ' ILE . 5.0 t -67.15 -37.27 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.01 0.924 . . . . 0.0 110.477 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 5.9 m-20 -67.0 -49.41 65.44 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.646 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.8 m -62.7 -36.01 81.57 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 122.576 0.351 . . . . 0.0 110.647 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -54.33 -57.52 10.92 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 123.81 0.844 . . . . 0.0 111.385 174.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -64.33 -33.13 75.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.438 0.462 . . . . 0.0 111.368 -175.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 5.3 mmp_? -60.69 -55.53 32.13 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.099 0.476 . . . . 0.0 110.412 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.401 HD21 ' N ' ' A' ' 73' ' ' ASN . 0.8 OUTLIER -66.6 -42.4 86.97 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.224 -173.057 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.5 tp -58.76 -56.02 27.58 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.111 0.964 . . . . 0.0 112.527 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -59.67 -42.06 92.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 123.447 0.467 . . . . 0.0 111.932 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.42 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 54.9 m -59.79 -53.08 62.11 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.3 tp -53.91 -46.48 71.46 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.813 1.645 . . . . 0.0 113.119 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -62.04 -48.34 80.68 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.998 0.519 . . . . 0.0 110.662 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -68.48 -22.95 64.53 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.42 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 76' ' ' THR . 61.1 mm-40 -71.56 -43.18 66.81 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.919 0.488 . . . . 0.0 110.135 169.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.0 mt -73.86 -15.58 61.15 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.921 0.888 . . . . 0.0 111.214 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.66 -6.79 80.04 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-O 119.601 -0.555 . . . . 0.0 112.923 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.439 HG21 ' HA ' ' A' ' 88' ' ' ARG . 77.8 mt -64.92 101.36 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.537 1.535 . . . . 0.0 110.271 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -144.31 167.84 21.49 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.523 1.129 . . . . 0.0 110.027 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.52 -122.89 23.96 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.506 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.97 -25.4 59.91 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.645 0.778 . . . . 0.0 111.307 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -75.61 -23.35 56.42 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.163 0.585 . . . . 0.0 110.407 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.439 ' HA ' HG21 ' A' ' 83' ' ' ILE . 15.0 ttm180 -57.88 137.48 56.64 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 124.103 0.961 . . . . 0.0 110.677 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.9 t -92.38 101.61 5.21 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.824 1.25 . . . . 0.0 109.723 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 88' ' ' ARG . 19.5 Cg_exo -68.15 153.69 74.17 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.994 2.463 . . . . 0.0 112.351 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.0 t -107.07 118.74 55.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.2 t -106.61 97.86 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -72.92 97.44 2.28 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.1 mt -87.2 140.11 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.82 82.82 1.86 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -78.79 83.69 4.91 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.017 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.5 m -135.09 134.51 40.37 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.987 0.915 . . . . 0.0 109.78 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.94 -26.46 65.08 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.682 0.793 . . . . 0.0 110.792 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.64 -1.089 . . . . 0.0 111.647 178.357 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 120.684 0.278 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.38 -18.14 3.11 Favored Glycine 0 C--N 1.345 1.064 0 C-N-CA 123.622 0.629 . . . . 0.0 112.407 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.455 ' HB3' ' O ' ' A' ' 6' ' ' HIS . 88.1 m-70 -87.31 77.05 9.03 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.76 0.824 . . . . 0.0 110.258 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -95.4 -36.94 11.16 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.35 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -73.25 -43.18 61.57 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.277 0.56 . . . . 0.0 110.546 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.455 ' O ' ' HB3' ' A' ' 3' ' ' HIS . 35.8 m170 -128.72 109.32 11.22 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -89.08 68.35 8.23 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 121.044 0.449 . . . . 0.0 110.749 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -102.57 21.54 15.13 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.71 0.767 . . . . 0.0 109.743 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.7 p -76.21 -41.67 48.61 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.646 1.179 . . . . 0.0 111.822 -175.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -79.07 -64.11 1.26 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.1 tpt 70.18 -19.95 0.2 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.87 1.268 . . . . 0.0 113.409 173.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 52.03 74.12 0.29 Allowed 'General case' 0 C--N 1.36 1.029 0 C-N-CA 124.788 1.235 . . . . 0.0 109.582 -166.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -85.53 31.33 0.59 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.262 1.025 . . . . 0.0 111.363 -170.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.8 t -55.11 93.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.726 1.611 . . . . 0.0 111.986 -170.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.46 80.01 0.21 Allowed Glycine 0 C--N 1.353 1.525 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.322 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.541 ' HB3' HG12 ' A' ' 60' ' ' VAL . 69.1 ttp85 -84.13 127.16 33.74 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -73.56 109.2 6.89 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 37.9 pt -97.35 173.64 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 166.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.4 p -110.49 169.72 8.56 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 166.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.408 ' O ' HG21 ' A' ' 24' ' ' VAL . 69.9 t-105 -53.33 -37.67 62.51 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.119 0.968 . . . . 0.0 111.695 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -58.07 -46.01 86.16 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 176.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.519 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 39.5 m-20 -66.44 -35.31 79.98 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.128 0.571 . . . . 0.0 111.036 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -59.77 -58.54 8.13 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.583 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.439 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 85.1 t -58.51 -57.11 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.179 0.592 . . . . 0.0 111.713 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -62.12 -56.23 20.94 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.031 0.832 . . . . 0.0 111.981 -173.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -84.49 -34.58 23.34 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.67 -168.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -114.36 -62.25 1.63 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -162.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.439 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 68.4 tp -59.42 -51.12 71.26 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.294 1.038 . . . . 0.0 111.172 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.9 t -59.38 -24.19 63.22 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.001 0.92 . . . . 0.0 113.024 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -98.66 -6.0 30.58 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.547 0.339 . . . . 0.0 111.504 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.06 31.38 58.76 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 114.477 0.551 . . . . 0.0 114.477 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.7 m -81.93 0.65 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.693 0.397 . . . . 0.0 110.882 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 24.9 t -98.65 128.48 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.514 1.126 . . . . 0.0 109.799 -173.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.584 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 31.0 t70 -77.81 -47.08 19.74 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.776 0.83 . . . . 0.0 109.692 177.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.442 ' HD2' HG23 ' A' ' 92' ' ' VAL . 31.7 ptt-85 -162.68 163.93 26.73 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.968 0.793 . . . . 0.0 111.243 -174.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.3 mt -117.8 104.66 11.17 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.583 1.153 . . . . 0.0 109.428 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -87.79 101.96 14.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.844 0.857 . . . . 0.0 109.767 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.459 HG23 HG23 ' A' ' 44' ' ' VAL . 35.6 t -88.32 91.3 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -175.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.9 t -92.91 119.69 41.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.825 -170.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 58.66 18.61 6.02 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.979 1.312 . . . . 0.0 112.56 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 54.84 21.09 3.4 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.87 1.268 . . . . 0.0 113.314 175.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -107.69 -28.51 9.67 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.283 1.033 . . . . 0.0 110.466 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -152.56 159.03 43.3 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.969 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.459 HG23 HG23 ' A' ' 38' ' ' VAL . 57.9 t -124.03 130.67 73.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 -98.14 124.79 42.86 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.492 ' HB ' HG22 ' A' ' 60' ' ' VAL . 55.9 t -82.67 107.72 14.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.1 m -93.62 128.61 39.86 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 57.2 m-85 -85.1 164.56 18.1 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.014 0.821 . . . . 0.0 109.519 176.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.584 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 11.5 t -68.29 138.4 91.81 Favored Pre-proline 0 CA--C 1.557 1.233 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -54.51 -41.51 76.45 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.66 2.906 . . . . 0.0 113.041 -170.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.14 -25.8 73.41 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.911 -177.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -77.33 -58.3 3.35 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.448 0.699 . . . . 0.0 110.326 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.8 m -65.88 120.43 69.02 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.09 0.556 . . . . 0.0 110.723 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -91.09 -162.54 0.11 Allowed 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 123.347 2.698 . . . . 0.0 112.476 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.6 m -66.2 -7.61 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.3 -24.49 67.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.354 1.061 . . . . 0.0 112.784 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.55 74.16 0.5 Allowed Glycine 0 C--N 1.353 1.501 0 O-C-N 123.41 0.444 . . . . 0.0 112.82 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -115.25 109.92 18.68 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.226 0.61 . . . . 0.0 111.077 -176.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -132.69 153.31 51.26 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.104 0.961 . . . . 0.0 109.572 164.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.541 HG12 ' HB3' ' A' ' 16' ' ' ARG . 27.8 m -129.18 178.75 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.329 0.652 . . . . 0.0 109.724 177.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -157.86 162.05 38.35 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.995 0.518 . . . . 0.0 110.245 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.416 ' HB3' HG13 ' A' ' 18' ' ' ILE . 47.4 p90 -145.73 153.75 41.31 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.326 0.65 . . . . 0.0 109.454 175.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -80.34 152.76 28.77 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.787 0.435 . . . . 0.0 110.748 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.8 pt -126.01 144.45 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.232 0.613 . . . . 0.0 109.445 172.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.05 -61.99 2.56 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.1 m -127.48 133.71 49.86 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.674 0.789 . . . . 0.0 109.024 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.4 t -57.87 -40.47 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.351 1.06 . . . . 0.0 111.506 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.09 -40.41 96.18 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.619 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.2 m -67.88 -45.08 75.5 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -51.04 -52.94 38.11 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.481 1.112 . . . . 0.0 112.495 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -71.32 -35.97 71.41 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.466 0.478 . . . . 0.0 110.838 -174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -66.97 -39.56 87.26 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.573 0.349 . . . . 0.0 110.589 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -66.79 -52.62 41.84 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.088 0.555 . . . . 0.0 110.173 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.4 tp -53.48 -55.08 28.32 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.205 1.002 . . . . 0.0 111.377 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 79' ' ' GLN . 68.6 mm-40 -61.84 -48.92 78.37 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.796 0.685 . . . . 0.0 112.725 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 58.1 m -64.53 -50.11 68.64 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.471 0.482 . . . . 0.0 110.116 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.8 tp -50.26 -46.29 54.89 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.229 1.411 . . . . 0.0 112.471 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -61.65 -46.75 88.45 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.842 0.457 . . . . 0.0 110.641 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 75.0 mt-30 -62.69 -34.76 77.79 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.255 0.622 . . . . 0.0 111.065 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.8 -39.31 57.1 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.81 0.844 . . . . 0.0 111.702 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.57 -21.34 61.16 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.601 0.361 . . . . 0.0 110.951 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.3 -5.65 57.51 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 120.075 -0.292 . . . . 0.0 113.019 -173.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.7 mt -70.08 121.53 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 124.478 1.111 . . . . 0.0 109.984 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -162.42 162.48 27.71 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.077 0.551 . . . . 0.0 111.107 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.97 -111.09 3.64 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.636 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.97 -23.75 58.33 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.902 0.881 . . . . 0.0 110.901 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.75 -26.71 29.46 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 ttm105 -63.32 123.38 18.55 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.5 t -72.69 119.57 75.94 Favored Pre-proline 0 CA--C 1.555 1.155 0 O-C-N 123.808 0.693 . . . . 0.0 110.247 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 31.9 Cg_exo -60.41 141.22 95.05 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.42 2.747 . . . . 0.0 112.523 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.6 t -111.69 114.94 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.442 HG23 ' HD2' ' A' ' 35' ' ' ARG . 60.8 t -109.15 98.33 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.212 1.005 . . . . 0.0 109.043 -173.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -71.7 114.86 10.23 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.939 0.496 . . . . 0.0 110.434 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 58.7 mt -107.86 127.3 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.86 89.78 3.2 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.358 0.663 . . . . 0.0 109.923 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -96.69 101.52 13.14 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.159 0.584 . . . . 0.0 109.456 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 54.1 p -152.63 91.99 1.62 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 117.798 0.272 . . . . 0.0 111.462 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.0 t70 66.87 -71.1 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.4 1.48 . . . . 0.0 111.797 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 CA-C-O 119.201 -0.777 . . . . 0.0 111.392 176.609 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.03 81.76 0.44 Allowed Glycine 0 CA--C 1.535 1.286 0 N-CA-C 112.318 -0.313 . . . . 0.0 112.318 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 50.99 -93.12 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.219 1.408 . . . . 0.0 111.628 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -171.73 103.77 0.19 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.38 1.072 . . . . 0.0 108.497 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -140.94 149.41 41.81 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.19 0.996 . . . . 0.0 108.32 173.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 69.03 142.81 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.615 1.166 . . . . 0.0 110.263 -173.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -63.4 132.13 50.47 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.152 0.501 . . . . 0.0 111.37 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -109.72 37.62 2.6 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.404 1.082 . . . . 0.0 108.56 174.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 t -74.9 83.5 2.2 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.159 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -104.3 80.0 1.66 Allowed 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 87.2 mmm -66.89 -49.12 66.62 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.288 -1.323 . . . . 0.0 110.188 -174.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -80.14 95.65 6.3 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -162.69 130.03 3.7 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.5 m -73.71 79.0 1.54 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.392 0.677 . . . . 0.0 110.345 -177.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.68 133.11 6.23 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.441 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.49 ' HB3' HG11 ' A' ' 60' ' ' VAL . 34.9 ttm180 -86.3 123.35 31.46 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -177.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -75.12 133.23 41.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.1 pt -128.67 168.82 21.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.755 1.222 . . . . 0.0 108.292 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.4 p -85.75 161.01 19.36 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.458 ' O ' HG23 ' A' ' 24' ' ' VAL . 61.2 t-105 -51.03 -48.98 61.36 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.933 0.893 . . . . 0.0 111.146 174.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -75.21 -24.13 57.71 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.515 0.509 . . . . 0.0 111.863 -175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -65.53 -42.81 91.57 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 172.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.419 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 17.7 t80 -56.44 -51.22 69.24 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.877 172.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 20' ' ' TRP . 60.8 t -58.11 -61.88 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.844 0.458 . . . . 0.0 111.035 -177.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.475 HD21 ' N ' ' A' ' 25' ' ' ASN . 0.7 OUTLIER -68.16 -46.17 71.49 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.427 0.691 . . . . 0.0 111.768 -166.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -84.77 -34.13 22.88 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.472 -172.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.504 ' HH ' HG12 ' A' ' 60' ' ' VAL . 88.0 m-85 -112.29 -66.57 1.07 Allowed 'General case' 0 C--O 1.248 0.977 0 O-C-N 121.849 -0.532 . . . . 0.0 111.825 -166.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.521 HD12 HG22 ' A' ' 89' ' ' VAL . 21.2 tp -64.57 -48.3 75.5 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -170.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 m -65.67 -21.2 66.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.627 0.771 . . . . 0.0 112.429 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -98.14 -1.02 43.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.858 0.863 . . . . 0.0 111.62 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.12 23.23 61.59 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 115.364 0.905 . . . . 0.0 115.364 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.413 HG22 ' HA ' ' A' ' 27' ' ' TYR . 17.6 m -88.36 11.62 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 117.476 0.638 . . . . 0.0 110.668 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.43 136.16 31.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 125.193 1.397 . . . . 0.0 108.938 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.514 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 25.8 t70 -87.55 -49.05 7.44 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.918 0.887 . . . . 0.0 109.014 172.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -164.2 172.42 13.67 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.523 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.2 mt -119.95 112.97 19.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.201 1.001 . . . . 0.0 110.222 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -99.6 104.49 16.27 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.913 0.885 . . . . 0.0 110.069 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.521 HG23 HG23 ' A' ' 44' ' ' VAL . 28.2 t -86.83 99.61 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -175.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.3 t -89.54 123.05 41.56 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 C-N-CA 123.942 0.897 . . . . 0.0 110.367 -169.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 54.12 18.45 1.76 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.569 1.548 . . . . 0.0 113.14 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.476 ' HB3' HG22 ' A' ' 67' ' ' VAL . 94.8 mttt 57.09 16.04 2.72 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.584 1.154 . . . . 0.0 113.496 -176.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -91.55 -32.87 15.38 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.334 0.654 . . . . 0.0 110.483 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -156.69 170.61 22.02 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.528 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.521 HG23 HG23 ' A' ' 38' ' ' VAL . 59.2 t -117.31 129.47 73.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.035 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -96.15 122.63 39.2 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.462 1.105 . . . . 0.0 108.08 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.513 ' HB ' HG22 ' A' ' 60' ' ' VAL . 46.3 t -84.72 112.13 21.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.7 m -90.08 132.61 35.32 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.596 ' HE2' ' HA ' ' A' ' 59' ' ' TYR . 53.1 m-85 -84.33 146.82 27.51 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.568 0.747 . . . . 0.0 110.286 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.514 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.7 OUTLIER -62.77 141.18 97.25 Favored Pre-proline 0 CA--C 1.565 1.533 0 C-N-CA 123.626 0.77 . . . . 0.0 110.154 175.172 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -48.84 123.79 10.25 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.89 3.06 . . . . 0.0 113.097 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.81 -21.13 43.32 Favored Glycine 0 N--CA 1.474 1.176 0 O-C-N 123.309 0.381 . . . . 0.0 112.846 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -107.57 -3.06 19.7 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.023 0.929 . . . . 0.0 110.564 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.8 m -71.02 131.36 87.3 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 123.929 0.891 . . . . 0.0 110.043 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -55.01 143.99 70.59 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.687 2.924 . . . . 0.0 112.919 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.9 -41.92 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.55 0.74 . . . . 0.0 111.442 -175.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -79.86 -41.36 26.46 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.98 0.912 . . . . 0.0 110.775 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.57 -140.22 11.69 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 110.039 -1.225 . . . . 0.0 110.039 -174.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 56.44 85.33 0.08 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.366 1.066 . . . . 0.0 110.617 -172.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.596 ' HA ' ' HE2' ' A' ' 48' ' ' PHE . 35.6 p90 -68.21 175.18 3.38 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.479 172.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.513 HG22 ' HB ' ' A' ' 46' ' ' VAL . 27.6 m -110.38 153.36 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 169.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 -160.3 166.25 29.83 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.615 0.766 . . . . 0.0 109.777 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -147.78 140.39 24.64 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.35 0.66 . . . . 0.0 109.939 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -84.58 126.92 33.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.323 0.649 . . . . 0.0 109.637 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' A' ' 67' ' ' VAL . 41.3 pt -104.61 -41.13 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 122.508 0.323 . . . . 0.0 111.754 -173.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.78 -80.43 0.12 Allowed Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 -171.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.3 m -71.4 95.45 1.35 Allowed 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.788 0.835 . . . . 0.0 109.901 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.555 ' HA ' HD12 ' A' ' 64' ' ' ILE . 58.5 t -61.49 -40.34 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.522 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 5.8 m-20 -58.57 -44.53 89.78 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.856 0.863 . . . . 0.0 110.478 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.0 m -66.67 -40.31 88.55 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.702 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -55.77 -46.09 77.98 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 123.258 0.623 . . . . 0.0 110.618 173.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 47.4 mt-10 -64.07 -44.95 90.84 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 124.244 0.965 . . . . 0.0 109.973 -176.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 4.5 mmp_? -59.15 -51.22 70.93 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 124.186 0.928 . . . . 0.0 111.262 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -65.6 -40.47 92.71 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.41 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.9 -50.25 72.94 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.672 0.789 . . . . 0.0 112.197 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -32.98 70.29 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -175.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.2 m -64.11 -44.9 90.84 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.189 0.596 . . . . 0.0 109.846 171.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 34.3 tp -63.05 -37.4 87.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.699 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -63.94 -38.43 91.04 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.347 0.659 . . . . 0.0 109.998 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -68.08 -36.73 80.3 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 175.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.07 -46.0 72.28 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.038 0.535 . . . . 0.0 111.383 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.0 mt -82.42 2.22 33.64 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.627 0.771 . . . . 0.0 112.259 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.47 14.6 79.39 Favored Glycine 0 C--N 1.358 1.787 0 O-C-N 123.311 0.382 . . . . 0.0 113.684 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 87.2 mt -82.56 111.66 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.282 1.433 . . . . 0.0 109.603 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.39 168.02 28.64 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.124 0.57 . . . . 0.0 111.605 -175.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.11 -126.41 23.08 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.492 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.81 -14.24 60.67 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.039 0.536 . . . . 0.0 110.487 177.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -79.64 -16.16 56.28 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.855 0.862 . . . . 0.0 111.699 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -51.1 129.89 24.94 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.067 0.947 . . . . 0.0 111.002 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.521 HG22 HD12 ' A' ' 28' ' ' LEU . 49.6 t -63.02 113.1 8.19 Favored Pre-proline 0 N--CA 1.474 0.727 0 O-C-N 124.484 1.115 . . . . 0.0 109.905 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.76 115.59 4.02 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.344 2.029 . . . . 0.0 111.137 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.2 t -108.45 121.05 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.4 t -116.57 119.68 62.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -174.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -90.07 113.66 25.42 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.59 128.06 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.27 106.98 5.61 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -64.28 -40.18 95.45 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.187 0.93 . . . . 0.0 109.478 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.1 t -169.34 162.66 10.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.286 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -84.85 -18.29 35.31 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.599 0.76 . . . . 0.0 109.407 172.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 177.401 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.1 114.89 5.04 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -62.21 87.51 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.15 0.98 . . . . 0.0 111.559 -174.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -131.19 3.86 4.36 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.602 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -121.81 124.67 44.71 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 65.29 -178.2 0.18 Allowed 'General case' 0 CA--C 1.554 1.102 0 O-C-N 124.622 1.202 . . . . 0.0 110.322 -173.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 71.28 -0.71 3.0 Favored 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 124.785 1.234 . . . . 0.0 111.585 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -63.54 -34.28 77.45 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.951 0.9 . . . . 0.0 109.413 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.485 ' HB3' ' HE3' ' A' ' 11' ' ' MET . 38.3 m -73.05 89.18 1.44 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.894 175.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -87.53 23.67 1.87 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.497 1.119 . . . . 0.0 110.527 174.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.485 ' HE3' ' HB3' ' A' ' 9' ' ' SER . 45.5 mtm -70.62 140.48 51.63 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 124.238 1.015 . . . . 0.0 111.055 -171.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -68.17 -34.99 77.33 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.792 171.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -73.38 153.36 40.5 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.459 172.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.1 m 79.98 -22.08 0.3 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.831 1.652 . . . . 0.0 112.117 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.59 164.28 43.2 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 163.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.423 ' HB3' HG12 ' A' ' 60' ' ' VAL . 20.9 tpp180 -90.77 119.35 30.93 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 117.839 0.82 . . . . 0.0 110.856 -174.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.63 110.15 13.49 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 27.4 pt -104.73 174.06 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.393 1.477 . . . . 0.0 109.959 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.6 p -91.3 168.74 11.36 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 169.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.544 ' O ' HG23 ' A' ' 24' ' ' VAL . 74.1 t-105 -57.07 -41.68 79.22 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.74 0.65 . . . . 0.0 109.473 168.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -55.66 -50.62 69.75 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.304 1.041 . . . . 0.0 112.409 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.493 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 65.1 m-20 -62.97 -38.95 93.14 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.856 0.462 . . . . 0.0 110.184 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.442 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 34.5 t80 -55.04 -50.51 68.9 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.663 1.227 . . . . 0.0 110.873 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 20' ' ' TRP . 47.1 t -58.12 -62.42 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 123.611 0.569 . . . . 0.0 110.895 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -65.87 -53.76 35.5 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.954 -168.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -84.73 -21.49 30.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.154 0.582 . . . . 0.0 111.86 -167.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.442 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 73.0 m-85 -122.75 -69.35 0.83 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -169.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.54 -56.54 20.79 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.834 0.853 . . . . 0.0 111.467 -173.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.6 m -60.38 -20.33 59.16 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.215 1.006 . . . . 0.0 112.891 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -94.05 -9.13 37.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.667 0.787 . . . . 0.0 111.617 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.27 21.5 68.37 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.723 0.64 . . . . 0.0 114.385 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 27' ' ' TYR . 10.4 m -80.74 -5.39 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 117.143 0.472 . . . . 0.0 110.984 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.8 t -93.75 130.07 43.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 123.321 0.648 . . . . 0.0 109.332 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 30.1 t70 -83.97 -51.96 6.71 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.495 1.118 . . . . 0.0 109.739 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.489 ' HD2' HG23 ' A' ' 92' ' ' VAL . 25.0 ptt180 -158.16 160.47 37.27 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.293 -174.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.8 mt -118.03 103.0 9.48 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.998 0.919 . . . . 0.0 109.027 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 43.4 mt-10 -87.55 108.65 19.15 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.415 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.532 HG13 ' HA ' ' A' ' 41' ' ' LYS . 43.0 t -84.83 92.82 3.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -177.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 96.0 t -81.73 109.81 16.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.101 -167.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 52.25 27.25 4.56 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 125.548 1.539 . . . . 0.0 112.945 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.532 ' HA ' HG13 ' A' ' 38' ' ' VAL . 35.3 mtmm 63.31 -4.44 0.3 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.077 1.351 . . . . 0.0 113.869 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -76.08 -38.88 56.48 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.386 1.074 . . . . 0.0 110.604 -171.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -153.44 179.98 8.29 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.574 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.461 HG23 HG23 ' A' ' 38' ' ' VAL . 98.3 t -127.64 131.44 70.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 123.97 0.908 . . . . 0.0 108.694 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -100.41 123.63 44.88 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -81.86 108.77 15.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.869 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.3 m -86.14 131.4 34.26 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -85.06 149.94 25.21 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.452 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 42.1 p -64.94 144.65 99.07 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 123.416 0.447 . . . . 0.0 110.391 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.99 104.5 0.12 Allowed 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.52 2.147 . . . . 0.0 111.379 171.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.44 -45.5 1.1 Allowed Glycine 0 N--CA 1.467 0.766 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -173.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -73.32 -32.81 64.8 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 169.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.2 p -66.16 115.57 24.79 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 123.902 0.881 . . . . 0.0 109.972 171.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -88.42 -164.43 0.18 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.838 2.358 . . . . 0.0 111.294 171.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.0 t -67.09 -32.43 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -83.38 65.39 8.32 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 167.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.2 59.33 3.18 Favored Glycine 0 C--N 1.348 1.23 0 C-N-CA 123.679 0.657 . . . . 0.0 113.235 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -90.37 142.98 27.18 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.084 0.954 . . . . 0.0 108.444 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -106.68 156.88 18.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.936 0.494 . . . . 0.0 110.619 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.423 HG12 ' HB3' ' A' ' 16' ' ' ARG . 20.0 m -107.23 164.41 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -162.69 162.81 27.07 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.785 0.326 . . . . 0.0 111.119 -172.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -145.06 146.69 31.97 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.727 0.811 . . . . 0.0 109.379 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -81.65 140.07 34.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.19 0.596 . . . . 0.0 109.591 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 65' ' ' GLY . 42.7 pt -117.12 -49.0 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.589 0.356 . . . . 0.0 111.434 -177.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.416 ' N ' HG13 ' A' ' 64' ' ' ILE . . . 67.67 -78.2 0.19 Allowed Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.949 -0.46 . . . . 0.0 111.949 -171.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.5 m -74.27 94.09 2.45 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.595 0.758 . . . . 0.0 109.663 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 64' ' ' ILE . 40.3 t -60.6 -36.66 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.805 1.242 . . . . 0.0 111.172 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -62.66 -39.13 92.95 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.553 0.741 . . . . 0.0 110.331 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.9 m -70.19 -41.44 73.69 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 123.503 0.502 . . . . 0.0 110.666 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -52.85 -53.39 49.51 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.19 0.596 . . . . 0.0 110.735 174.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -60.51 -52.41 65.32 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 124.509 1.13 . . . . 0.0 111.425 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.487 ' HE ' ' HA ' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -59.28 -46.39 88.67 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.508 1.123 . . . . 0.0 111.921 -174.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.407 HD21 ' N ' ' A' ' 73' ' ' ASN . 0.8 OUTLIER -67.47 -41.89 83.86 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.391 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.461 ' HG ' ' NE2' ' A' ' 78' ' ' GLN . 33.4 tp -59.55 -43.41 93.53 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 124.108 0.88 . . . . 0.0 111.465 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -60.27 -56.44 21.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.841 0.857 . . . . 0.0 111.059 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.1 m -63.22 -48.57 77.73 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.43 1.081 . . . . 0.0 110.303 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.418 HD22 HG21 ' A' ' 24' ' ' VAL . 42.9 tp -53.99 -53.06 58.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.77 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.461 ' NE2' ' HG ' ' A' ' 74' ' ' LEU . 45.0 mt-30 -66.8 -30.17 70.3 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.266 0.354 . . . . 0.0 111.266 -178.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -63.86 -38.68 92.0 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.615 0.366 . . . . 0.0 110.076 172.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -70.14 -43.92 69.94 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.221 0.608 . . . . 0.0 110.99 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 76.5 mt -71.22 -18.75 62.44 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.624 0.77 . . . . 0.0 111.578 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.02 8.1 76.29 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.282 0.364 . . . . 0.0 112.982 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.522 HG21 ' HA ' ' A' ' 88' ' ' ARG . 80.1 mt -82.52 97.08 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 125.343 1.457 . . . . 0.0 108.769 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -138.93 155.52 47.99 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.836 -0.54 . . . . 0.0 111.51 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.44 -99.85 0.11 Allowed Glycine 0 C--N 1.354 1.532 0 O-C-N 124.74 1.275 . . . . 0.0 113.893 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -75.59 -29.04 59.15 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.348 1.059 . . . . 0.0 111.427 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -87.82 -23.46 24.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.379 0.672 . . . . 0.0 111.277 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.522 ' HA ' HG21 ' A' ' 83' ' ' ILE . 43.0 ttm180 -61.48 119.54 8.78 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.401 0.68 . . . . 0.0 110.557 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 80.4 t -66.65 118.94 59.16 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.829 0.852 . . . . 0.0 111.225 -175.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 31.5 Cg_exo -60.58 146.87 96.26 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.294 2.662 . . . . 0.0 113.239 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.4 t -104.91 129.84 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.489 HG23 ' HD2' ' A' ' 35' ' ' ARG . 4.5 t -127.78 98.99 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.505 0.722 . . . . 0.0 109.394 -175.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -69.55 106.33 2.97 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 29.9 mm -113.66 116.33 52.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -175.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.08 14.01 17.2 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.882 0.473 . . . . 0.0 110.27 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 64.31 -78.89 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.555 1.942 . . . . 0.0 111.976 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.9 m 60.99 23.59 13.74 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.889 0.876 . . . . 0.0 110.421 -171.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.8 -42.09 77.79 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 125.084 1.354 . . . . 0.0 110.434 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.091 0 CA-C-O 118.65 -1.083 . . . . 0.0 110.523 179.154 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.3 mtp . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.69 144.25 46.68 Favored Glycine 0 C--N 1.34 0.756 0 O-C-N 123.418 0.449 . . . . 0.0 112.839 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -146.91 15.45 1.2 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.203 1.001 . . . . 0.0 110.041 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -99.41 4.55 46.27 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.138 0.975 . . . . 0.0 110.73 -175.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -84.9 16.64 3.25 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.915 0.886 . . . . 0.0 112.057 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -68.63 91.88 0.44 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -68.69 126.39 29.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.685 -168.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -85.1 -69.19 0.67 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 167.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.0 p 41.08 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 127.034 2.134 . . . . 0.0 113.249 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -124.23 110.34 14.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.776 0.83 . . . . 0.0 109.324 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.6 mtt -101.34 -5.17 25.76 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.079 0.952 . . . . 0.0 110.158 171.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.5 tttm 72.73 -70.29 0.16 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 126.075 1.75 . . . . 0.0 111.9 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -67.0 135.16 53.32 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.411 0.685 . . . . 0.0 112.026 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.1 m -79.64 -0.76 35.2 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.35 1.06 . . . . 0.0 111.726 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.06 142.55 46.44 Favored Glycine 0 C--N 1.356 1.67 0 O-C-N 123.302 0.376 . . . . 0.0 113.492 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.405 ' HB2' HG13 ' A' ' 60' ' ' VAL . 49.7 mtp180 -83.95 132.77 34.74 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.984 0.514 . . . . 0.0 110.961 -172.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -79.92 110.92 15.76 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 165.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.559 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 34.4 pt -96.13 174.39 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 123.99 0.916 . . . . 0.0 110.61 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.2 p -98.21 168.63 10.12 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 166.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.435 ' O ' HG23 ' A' ' 24' ' ' VAL . 61.7 t-105 -55.41 -37.22 67.34 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.685 0.794 . . . . 0.0 110.781 175.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -56.08 -48.66 75.67 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.518 0.727 . . . . 0.0 111.671 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.559 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 34.4 m-20 -65.53 -42.27 92.18 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.414 0.286 . . . . 0.0 110.791 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -50.35 -48.17 55.65 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.51 1.131 . . . . 0.0 111.116 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.438 HG21 HD23 ' A' ' 77' ' ' LEU . 90.7 t -71.97 -62.07 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 O-C-N 123.421 0.45 . . . . 0.0 110.82 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -69.87 -52.65 23.04 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.03 0.532 . . . . 0.0 111.737 -167.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -80.01 -19.48 47.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.912 0.485 . . . . 0.0 112.049 -171.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -126.12 -69.95 0.75 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -171.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.1 tp -63.79 -43.61 95.81 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -166.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.2 p -73.23 -11.38 60.49 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.904 0.481 . . . . 0.0 111.944 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -92.61 -9.22 41.81 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.252 0.621 . . . . 0.0 110.64 173.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.78 27.83 67.25 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 114.047 0.379 . . . . 0.0 114.047 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.7 m -86.87 6.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 116.972 0.386 . . . . 0.0 110.548 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.26 125.72 51.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.023 0.929 . . . . 0.0 108.964 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 28.5 t70 -77.34 -54.08 6.9 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.315 1.046 . . . . 0.0 108.196 172.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.442 ' HD2' HG23 ' A' ' 92' ' ' VAL . 43.0 ttp180 -154.9 153.19 30.72 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.024 -164.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.9 mt -113.32 119.82 39.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.88 1.272 . . . . 0.0 108.535 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -111.92 106.48 15.19 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.383 0.673 . . . . 0.0 110.312 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.412 HG23 HG23 ' A' ' 44' ' ' VAL . 44.9 t -81.61 98.48 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 54.7 t -94.96 122.41 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 122.862 0.465 . . . . 0.0 110.522 -171.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 60.11 15.24 5.01 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.245 1.418 . . . . 0.0 113.434 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.9 mttm 65.64 -3.02 0.76 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.534 1.533 . . . . 0.0 112.778 -175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -87.62 -32.51 19.24 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.11 0.964 . . . . 0.0 109.982 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -154.2 171.28 19.44 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.488 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.412 HG23 HG23 ' A' ' 38' ' ' VAL . 54.4 t -128.86 133.87 65.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -99.52 130.36 45.77 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.4 t -82.85 106.58 13.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 172.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.4 m -94.11 126.02 39.08 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.401 ' HE1' ' HA ' ' A' ' 59' ' ' TYR . 89.8 m-85 -81.84 152.38 26.92 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.875 0.734 . . . . 0.0 111.24 -175.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.543 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -64.64 138.54 97.49 Favored Pre-proline 0 CA--C 1.558 1.286 0 CA-C-O 117.802 -1.094 . . . . 0.0 109.061 173.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -36.88 -52.28 1.31 Allowed 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 124.871 3.714 . . . . 0.0 115.983 -173.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.09 -25.74 51.06 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 116.698 -0.228 . . . . 0.0 113.04 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -81.44 -6.27 58.76 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.827 0.851 . . . . 0.0 112.015 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.5 m -64.82 122.68 80.49 Favored Pre-proline 0 C--N 1.351 0.669 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.453 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -49.98 153.14 6.63 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.046 2.497 . . . . 0.0 112.396 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.11 -32.53 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 123.617 0.767 . . . . 0.0 110.918 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -87.89 -0.77 57.41 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.055 0.942 . . . . 0.0 111.747 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.71 -73.96 2.59 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 46.79 56.47 6.58 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.947 1.299 . . . . 0.0 113.45 170.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.401 ' HA ' ' HE1' ' A' ' 48' ' ' PHE . 92.3 m-85 -65.69 122.18 16.67 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.424 173.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.405 HG13 ' HB2' ' A' ' 16' ' ' ARG . 27.1 m -105.73 156.52 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.333 -172.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -150.91 158.41 44.11 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.848 0.459 . . . . 0.0 111.37 -173.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -140.32 139.24 35.4 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.397 0.679 . . . . 0.0 109.298 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -79.34 131.58 36.17 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.443 0.697 . . . . 0.0 110.323 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.7 pt -110.05 143.08 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.931 0.892 . . . . 0.0 109.298 173.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.11 -43.28 7.17 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.8 t -131.25 140.34 49.81 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.92 0.888 . . . . 0.0 109.282 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.429 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 62.0 t -60.11 -41.74 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 123.679 0.612 . . . . 0.0 110.226 172.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.22 -42.14 80.81 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.323 0.649 . . . . 0.0 111.631 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 m -66.12 -45.77 79.93 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.194 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -55.65 -48.42 75.04 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.836 0.454 . . . . 0.0 111.271 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 39.4 mm-40 -62.43 -52.9 61.69 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.342 0.657 . . . . 0.0 111.292 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -67.41 -38.3 84.42 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.659 0.783 . . . . 0.0 111.396 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -67.09 -35.86 80.72 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 122.658 0.383 . . . . 0.0 110.317 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.99 -32.25 71.68 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.071 0.548 . . . . 0.0 111.503 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 51.5 mm-40 -62.09 -51.78 66.54 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.153 0.501 . . . . 0.0 110.172 173.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.457 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 25.7 m -62.9 -47.95 81.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.242 -1.344 . . . . 0.0 110.395 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.438 HD23 HG21 ' A' ' 24' ' ' VAL . 49.6 tp -57.94 -57.92 10.7 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.405 1.082 . . . . 0.0 112.2 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 45.5 mt-30 -62.12 -39.92 94.17 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 123.715 0.634 . . . . 0.0 111.514 -174.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -66.46 -33.92 76.77 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 76' ' ' THR . 43.3 mm-40 -70.18 -39.98 74.93 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.795 0.438 . . . . 0.0 110.573 176.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.25 -12.43 60.86 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.602 0.761 . . . . 0.0 111.166 176.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.33 -8.09 79.71 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.944 -0.365 . . . . 0.0 112.829 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.415 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 70.7 mt -67.76 105.53 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.254 1.422 . . . . 0.0 109.172 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -151.46 159.59 44.12 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.561 0.344 . . . . 0.0 111.432 -174.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.3 -124.34 33.27 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.926 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -66.3 -22.52 66.29 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.306 1.043 . . . . 0.0 111.752 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -83.54 -5.18 59.09 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.232 0.613 . . . . 0.0 112.362 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -65.56 142.2 58.18 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 120.803 0.335 . . . . 0.0 111.325 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.8 t -82.84 122.99 78.44 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.92 0.888 . . . . 0.0 109.516 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.14 132.76 43.25 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.413 2.742 . . . . 0.0 113.786 -171.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.3 t -108.28 119.84 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.0 0.92 . . . . 0.0 108.877 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.442 HG23 ' HD2' ' A' ' 35' ' ' ARG . 41.7 t -129.37 121.94 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.018 0.927 . . . . 0.0 109.11 -173.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -84.98 116.68 23.52 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.037 0.535 . . . . 0.0 110.24 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 49.8 mm -114.36 128.34 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.104 0.961 . . . . 0.0 108.758 -176.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.87 86.91 3.17 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.85 99.22 0.8 Allowed 'General case' 0 C--N 1.352 0.694 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -146.18 46.15 1.24 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.566 1.146 . . . . 0.0 108.337 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.28 -41.97 94.46 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.56 0.744 . . . . 0.0 110.463 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.855 -0.97 . . . . 0.0 111.744 179.346 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.479 ' SD ' ' HB2' ' A' ' 4' ' ' HIS . 5.1 ppp? . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.59 -16.83 38.2 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-O 119.654 -0.526 . . . . 0.0 114.402 -169.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -68.28 -39.29 82.16 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.982 0.513 . . . . 0.0 111.427 -174.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.479 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 32.6 m170 -101.61 16.05 26.97 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.092 0.557 . . . . 0.0 110.826 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -85.21 71.53 10.86 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.574 0.702 . . . . 0.0 109.3 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -83.37 87.3 6.97 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.064 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -93.98 98.09 10.79 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.555 -174.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -164.86 -30.24 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.073 1.349 . . . . 0.0 108.21 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -156.36 149.87 24.64 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.417 -1.265 . . . . 0.0 108.394 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -142.99 46.59 1.55 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.427 1.091 . . . . 0.0 108.651 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.58 88.19 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.302 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HE3' HG22 ' A' ' 94' ' ' ILE . 63.6 mttm -123.57 108.63 12.83 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.025 1.33 . . . . 0.0 107.554 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -85.62 84.91 7.46 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.069 0.461 . . . . 0.0 109.833 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.7 m -78.5 87.66 4.48 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.98 -79.17 0.29 Allowed Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.483 -170.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 6.3 ptm180 -115.68 126.37 54.04 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.582 0.753 . . . . 0.0 111.081 -167.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.508 ' HG3' ' HA ' ' A' ' 62' ' ' PHE . 32.6 tt0 -85.35 128.1 34.58 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 pt -109.88 179.61 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 125.696 1.598 . . . . 0.0 109.621 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.8 p -89.93 154.15 20.07 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.074 0.95 . . . . 0.0 109.441 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.413 ' O ' HG23 ' A' ' 24' ' ' VAL . 54.4 t-105 -59.93 -43.37 94.96 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.513 0.725 . . . . 0.0 110.282 176.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -53.85 -48.67 69.75 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 123.952 0.783 . . . . 0.0 111.292 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' ' 26' ' ' ASN . 26.3 t70 -70.09 -34.96 73.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.778 0.431 . . . . 0.0 110.224 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.418 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 18.0 t80 -55.78 -46.12 78.01 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.945 0.498 . . . . 0.0 110.627 175.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 20' ' ' TRP . 79.9 t -61.98 -71.38 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 123.602 0.564 . . . . 0.0 110.783 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -73.66 -31.77 63.65 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.923 -161.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' A' ' 22' ' ' ASP . 54.9 t30 -90.99 -23.59 20.35 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.665 0.786 . . . . 0.0 111.902 -176.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.418 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 75.4 m-85 -124.62 -66.42 0.98 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -172.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.64 -49.83 76.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.718 0.807 . . . . 0.0 111.401 -174.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.0 m -64.5 -20.74 66.39 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.555 1.142 . . . . 0.0 112.161 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -97.1 0.14 48.04 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.507 0.723 . . . . 0.0 111.301 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.92 26.61 60.95 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 115.543 0.977 . . . . 0.0 115.543 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.8 m -90.7 3.9 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 122.898 0.479 . . . . 0.0 111.405 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.3 126.06 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.887 0.875 . . . . 0.0 108.926 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.498 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 30.9 t70 -84.1 -51.61 6.94 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.546 1.138 . . . . 0.0 109.967 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -154.07 161.61 41.79 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.583 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.05 101.83 9.37 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.9 0.88 . . . . 0.0 108.67 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -87.0 101.13 13.15 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.102 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.635 HG11 ' HA ' ' A' ' 41' ' ' LYS . 19.8 t -88.54 90.2 3.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -173.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.9 t -81.43 127.76 39.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.6 -173.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.618 ' HA ' ' HB3' ' A' ' 96' ' ' GLU . 1.2 t-20 59.95 19.51 8.55 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.8 2.04 . . . . 0.0 111.452 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.635 ' HA ' HG11 ' A' ' 38' ' ' VAL . 19.7 pttm 42.06 18.29 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 126.287 1.835 . . . . 0.0 115.251 -167.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.3 ttp-105 -98.93 -30.49 12.34 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.149 0.98 . . . . 0.0 109.102 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -147.62 152.12 37.36 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.02 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 59.0 t -110.97 128.07 67.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.541 1.137 . . . . 0.0 108.465 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -100.67 124.73 46.68 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.1 t -82.69 105.39 12.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.7 m -92.1 125.91 36.97 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.407 ' H ' ' HE1' ' A' ' 59' ' ' TYR . 67.4 m-85 -84.87 148.98 25.99 Favored 'General case' 0 C--O 1.241 0.607 0 O-C-N 123.723 0.64 . . . . 0.0 111.917 -176.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.498 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 10.0 p -60.68 129.02 89.39 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.779 172.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.27 118.77 5.38 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.106 2.537 . . . . 0.0 112.375 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.75 -25.06 25.36 Favored Glycine 0 N--CA 1.468 0.828 0 N-CA-C 112.363 -0.295 . . . . 0.0 112.363 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -117.49 28.72 8.28 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.9 0.88 . . . . 0.0 109.71 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.1 m -85.55 111.07 34.47 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.62 129.7 19.35 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.122 1.882 . . . . 0.0 111.566 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.14 -27.6 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 123.372 0.669 . . . . 0.0 109.833 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -72.47 -33.18 66.82 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.419 0.688 . . . . 0.0 110.454 172.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.27 -30.35 50.47 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.098 176.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 54.44 -100.31 0.1 Allowed 'General case' 0 C--N 1.362 1.109 0 C-N-CA 124.654 1.181 . . . . 0.0 109.545 -173.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.407 ' HE1' ' H ' ' A' ' 48' ' ' PHE . 34.6 m-85 -132.5 131.48 41.66 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.525 1.13 . . . . 0.0 108.357 157.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 16' ' ' ARG . 33.2 m -106.38 154.96 7.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -157.57 174.94 14.6 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.173 0.589 . . . . 0.0 110.11 -175.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.508 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 33.9 p90 -157.6 147.32 20.26 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.974 0.51 . . . . 0.0 110.253 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -91.09 130.16 37.01 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 67' ' ' VAL . 30.3 pt -102.93 -46.99 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.217 0.607 . . . . 0.0 111.334 -176.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.26 -83.24 0.43 Allowed Glycine 0 C--N 1.345 1.082 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -167.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.8 t -72.45 96.74 1.95 Allowed 'General case' 0 C--O 1.249 1.027 0 CA-C-O 121.778 0.799 . . . . 0.0 109.875 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.562 ' HA ' HD12 ' A' ' 64' ' ' ILE . 11.0 t -56.04 -39.33 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 113.952 -1.477 . . . . 0.0 110.999 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -58.26 -42.37 86.3 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.049 0.843 . . . . 0.0 111.02 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.0 m -64.67 -45.73 85.47 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 123.657 0.598 . . . . 0.0 110.159 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -52.66 -50.83 62.44 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.816 0.698 . . . . 0.0 111.266 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -63.58 -46.19 86.99 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.135 0.897 . . . . 0.0 110.774 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 mtp-105 -59.35 -49.47 77.71 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.765 0.826 . . . . 0.0 111.41 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -66.32 -43.6 85.72 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.435 0.694 . . . . 0.0 110.18 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.3 tp -56.13 -49.6 73.45 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.272 1.029 . . . . 0.0 110.736 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -66.62 -49.17 67.16 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.446 0.698 . . . . 0.0 111.649 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.4 m -60.17 -44.61 94.88 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.46 0.648 . . . . 0.0 109.926 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.9 tp -57.81 -53.38 58.81 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.757 175.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.402 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 22.9 mt-30 -64.89 -45.04 87.62 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.28 0.632 . . . . 0.0 111.018 -173.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.56 -38.2 83.79 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.312 0.645 . . . . 0.0 110.633 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.34 -41.12 90.05 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.2 1.0 . . . . 0.0 110.978 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.1 mt -87.29 0.77 54.9 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.487 0.715 . . . . 0.0 111.458 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.25 -4.32 63.37 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.595 -0.558 . . . . 0.0 113.809 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 68.4 mt -68.08 116.31 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.672 1.189 . . . . 0.0 109.47 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -161.1 148.26 15.16 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.082 0.553 . . . . 0.0 110.497 -173.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.07 -89.84 0.01 OUTLIER Glycine 0 C--N 1.349 1.263 0 O-C-N 124.923 1.389 . . . . 0.0 114.722 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.41 -44.31 83.36 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.29 1.036 . . . . 0.0 110.565 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -98.65 -1.46 40.72 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.445 0.698 . . . . 0.0 111.741 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -70.44 134.41 47.77 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 122.994 0.184 . . . . 0.0 110.939 -178.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.2 t -72.37 112.51 15.09 Favored Pre-proline 0 CA--C 1.561 1.391 0 O-C-N 124.165 0.916 . . . . 0.0 109.49 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.92 142.63 57.67 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.981 2.454 . . . . 0.0 113.117 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.4 t -105.75 118.2 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.461 1.104 . . . . 0.0 109.178 -175.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.7 t -119.93 98.96 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.583 0.753 . . . . 0.0 110.166 -171.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -75.3 109.59 8.95 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.153 0.581 . . . . 0.0 110.585 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.431 HG22 ' HE3' ' A' ' 12' ' ' LYS . 77.7 mt -115.45 155.42 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.983 0.913 . . . . 0.0 108.54 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 71.64 -7.58 1.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.597 1.559 . . . . 0.0 114.365 169.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.618 ' HB3' ' HA ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -109.44 -179.24 3.77 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 122.997 0.519 . . . . 0.0 111.783 -177.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.6 m -109.57 136.54 48.79 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.529 0.732 . . . . 0.0 109.155 173.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.34 -34.3 77.67 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.024 0.53 . . . . 0.0 111.24 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.372 0 CA-C-O 118.887 -0.952 . . . . 0.0 113.042 -179.322 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.553 0.216 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.06 -79.88 1.82 Allowed Glycine 0 C--N 1.348 1.204 0 CA-C-N 116.497 -0.32 . . . . 0.0 112.366 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -131.93 -173.76 3.23 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.717 0.807 . . . . 0.0 109.611 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -108.84 -14.87 14.51 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.23 0.612 . . . . 0.0 111.873 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -57.04 -31.82 65.56 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.295 1.038 . . . . 0.0 113.01 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -73.21 8.28 1.75 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -68.39 85.61 0.28 Allowed 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 122.662 1.22 . . . . 0.0 110.231 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -97.76 -10.88 24.08 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.084 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.9 m -73.11 97.31 2.35 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 168.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -73.17 -175.15 1.75 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.341 0.656 . . . . 0.0 110.207 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.4 mmt -78.41 36.78 0.26 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.65 -38.9 92.87 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 124.087 0.955 . . . . 0.0 109.703 172.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.2 tpp85 -70.67 86.98 0.67 Allowed 'General case' 0 C--N 1.361 1.08 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 168.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.1 t -114.88 -165.93 1.06 Allowed 'General case' 0 C--O 1.246 0.92 0 CA-C-N 113.861 -1.518 . . . . 0.0 107.278 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -166.99 165.2 38.4 Favored Glycine 0 CA--C 1.507 -0.451 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 174.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.595 ' HB3' HG13 ' A' ' 60' ' ' VAL . 20.0 ttt180 -87.56 125.03 34.1 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.9 109.33 8.27 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.7 pt -106.8 175.38 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.685 1.194 . . . . 0.0 108.762 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.0 p -97.2 167.92 10.75 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.492 ' O ' HG23 ' A' ' 24' ' ' VAL . 69.1 t-105 -57.5 -41.97 81.8 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 123.462 0.476 . . . . 0.0 110.04 169.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.623 ' HZ2' ' HB2' ' A' ' 21' ' ' LYS . 5.0 ttmp? -60.4 -49.39 77.76 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.71 0.404 . . . . 0.0 111.761 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.51 -38.79 90.73 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.298 0.639 . . . . 0.0 110.591 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.44 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 40.3 t80 -52.56 -53.46 46.11 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.968 172.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.558 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 69.1 t -60.33 -47.77 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.11 0.564 . . . . 0.0 110.769 -177.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.28 -55.91 11.96 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.521 -173.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -85.01 -27.88 26.12 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.44 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 87.1 m-85 -117.01 -68.86 0.89 Allowed 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -165.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.558 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 56.6 tp -59.91 -45.28 93.05 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.457 1.103 . . . . 0.0 113.149 -171.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 81.2 p -64.53 -21.29 66.64 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.066 0.546 . . . . 0.0 112.39 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -99.2 -9.05 24.21 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.794 0.837 . . . . 0.0 110.728 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.44 37.72 88.88 Favored Glycine 0 C--N 1.348 1.218 0 O-C-N 123.835 0.709 . . . . 0.0 114.836 -173.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.414 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 6.3 m -79.76 -3.46 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 174.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.407 ' HB ' HG22 ' A' ' 89' ' ' VAL . 16.6 t -99.54 128.08 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.911 0.884 . . . . 0.0 109.308 -175.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -86.72 -48.24 8.43 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.161 1.385 . . . . 0.0 110.312 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.507 ' HD3' HG23 ' A' ' 92' ' ' VAL . 19.2 ptp180 -158.49 149.39 20.48 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.857 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.532 ' HG ' HG12 ' A' ' 89' ' ' VAL . 31.4 mt -108.16 102.0 11.18 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -93.6 105.79 17.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.864 -172.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.517 HG23 HG23 ' A' ' 44' ' ' VAL . 48.3 t -81.06 102.12 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -176.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.3 t -90.23 114.71 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.263 0.625 . . . . 0.0 109.537 -173.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.3 m120 58.94 16.75 4.82 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.434 1.493 . . . . 0.0 113.688 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 90.6 mttt 60.35 8.58 1.65 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.447 1.099 . . . . 0.0 113.335 -171.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 -81.67 -39.51 24.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.924 0.889 . . . . 0.0 109.516 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -155.33 174.82 14.68 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.267 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.517 HG23 HG23 ' A' ' 38' ' ' VAL . 59.4 t -123.81 131.53 72.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -103.29 127.32 50.65 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.439 0.695 . . . . 0.0 109.439 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 80.2 t -84.08 110.16 18.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.621 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.5 m -90.44 141.62 28.56 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 170.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.433 ' HE2' ' HA ' ' A' ' 59' ' ' TYR . 63.3 m-85 -97.38 149.69 21.84 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 176.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.5 p -71.01 140.83 86.11 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.224 1.01 . . . . 0.0 111.419 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -63.91 73.85 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 123.271 2.647 . . . . 0.0 112.302 169.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.9 -40.09 0.43 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.336 -173.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 32' ' ' VAL . 90.2 mttt -123.64 87.36 2.73 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.4 m -135.21 133.25 20.54 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 124.391 1.076 . . . . 0.0 109.185 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -58.25 99.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.028 1.818 . . . . 0.0 110.018 165.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.77 -31.54 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.289 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -78.87 -31.4 45.5 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.668 0.787 . . . . 0.0 110.156 173.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.83 -171.26 45.84 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.619 -0.719 . . . . 0.0 114.205 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -133.32 -171.98 2.83 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.957 1.303 . . . . 0.0 109.446 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.433 ' HA ' ' HE2' ' A' ' 48' ' ' PHE . 11.6 m-85 -65.1 154.83 36.74 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.539 0.685 . . . . 0.0 111.046 176.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.595 HG13 ' HB3' ' A' ' 16' ' ' ARG . 33.8 m -131.39 170.12 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -167.04 160.1 13.76 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.141 0.576 . . . . 0.0 110.091 -174.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -144.1 140.17 29.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.998 0.519 . . . . 0.0 110.351 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -77.08 147.05 36.88 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.406 0.682 . . . . 0.0 110.27 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 67' ' ' VAL . 40.3 pt -131.03 139.4 51.18 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 C-N-CA 123.552 0.741 . . . . 0.0 109.992 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.34 -44.36 17.53 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 172.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.7 t -131.16 129.84 42.28 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.992 0.917 . . . . 0.0 110.285 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.405 ' HA ' HD12 ' A' ' 64' ' ' ILE . 15.6 t -64.41 -37.99 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.796 0.838 . . . . 0.0 110.691 171.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.587 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 31.3 t70 -62.23 -56.53 17.7 Favored 'General case' 0 C--O 1.216 -0.694 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.5 m -55.24 -45.42 76.03 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.943 0.497 . . . . 0.0 111.176 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -47.3 -56.15 7.36 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.411 1.084 . . . . 0.0 112.096 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 12.2 pt-20 -73.27 -28.77 62.31 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.814 -173.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 18.1 mmm-85 -59.98 -45.76 91.66 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 176.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -67.57 -38.37 84.0 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.705 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 tp -57.28 -56.73 18.03 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.697 0.623 . . . . 0.0 111.059 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 79' ' ' GLN . 32.0 mt-10 -59.92 -47.74 84.55 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.023 0.929 . . . . 0.0 112.693 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 51.5 m -61.56 -48.87 79.0 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.504 0.669 . . . . 0.0 110.144 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 35.6 tp -57.56 -38.94 75.63 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.251 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.745 ' HB3' HD12 ' A' ' 83' ' ' ILE . 25.0 mt-30 -63.81 -39.03 93.27 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.522 0.729 . . . . 0.0 110.434 175.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 76.7 mt-30 -67.97 -29.25 68.24 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.932 0.493 . . . . 0.0 110.697 176.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -71.24 -47.78 55.12 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.617 0.767 . . . . 0.0 110.546 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 87.6 mt -68.0 -18.72 64.8 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.183 0.993 . . . . 0.0 111.644 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.76 31.27 79.64 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.713 0.633 . . . . 0.0 112.342 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.745 HD12 ' HB3' ' A' ' 78' ' ' GLN . 1.2 pp -64.81 162.49 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 122.041 0.924 . . . . 0.0 113.186 -176.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -119.53 169.15 10.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 161.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.89 -25.69 1.0 Allowed Glycine 0 N--CA 1.481 1.687 0 N-CA-C 117.311 1.685 . . . . 0.0 117.311 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.02 -46.65 83.51 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.688 0.744 . . . . 0.0 111.522 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -101.34 -11.9 19.06 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.439 0.696 . . . . 0.0 111.225 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -84.0 140.89 31.59 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.213 1.005 . . . . 0.0 109.294 174.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.532 HG12 ' HG ' ' A' ' 36' ' ' LEU . 46.5 t -117.17 120.41 33.65 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 122.781 0.432 . . . . 0.0 111.467 -167.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.83 154.26 48.47 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.976 2.451 . . . . 0.0 112.592 172.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.4 t -106.94 125.38 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.519 0.727 . . . . 0.0 109.768 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.507 HG23 ' HD3' ' A' ' 35' ' ' ARG . 21.8 t -113.13 112.45 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -82.39 109.43 16.63 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.2 mt -118.89 132.9 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -175.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -107.46 117.38 33.93 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 172.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -87.36 145.51 26.29 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.2 p -84.17 87.93 7.19 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.309 0.644 . . . . 0.0 110.341 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -88.09 -35.94 17.21 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.034 0.934 . . . . 0.0 109.921 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.286 0 CA-C-O 118.58 -1.122 . . . . 0.0 111.667 178.837 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.45 174.01 16.09 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 123.074 0.368 . . . . 0.0 112.301 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -151.58 126.97 9.98 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.661 0.785 . . . . 0.0 109.17 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 85.3 t60 73.33 -51.47 0.7 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.573 1.549 . . . . 0.0 109.879 -169.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -129.52 165.14 22.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.135 0.974 . . . . 0.0 109.358 165.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -82.36 166.6 19.31 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.883 0.873 . . . . 0.0 111.935 -174.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.4 m80 60.13 -149.68 0.43 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.306 1.042 . . . . 0.0 109.27 -176.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 -66.16 111.59 3.49 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 162.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.3 m -66.58 91.98 0.2 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.518 0.727 . . . . 0.0 110.534 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -58.02 136.02 57.06 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.929 174.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 56.0 mtm -81.49 53.28 2.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.165 0.986 . . . . 0.0 110.872 -175.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.416 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -80.61 108.42 14.23 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 174.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -167.17 176.81 6.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.668 -167.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.8 m -86.3 -39.48 16.46 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 165.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.52 58.34 15.09 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.643 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -122.96 123.21 40.41 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -77.3 107.25 9.58 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 172.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 pt -95.48 170.2 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 123.737 0.815 . . . . 0.0 109.235 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.428 HG22 ' H ' ' A' ' 22' ' ' ASP . 9.0 t -85.43 149.85 25.12 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 172.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.535 ' O ' HG23 ' A' ' 24' ' ' VAL . 67.1 t-105 -52.09 -42.85 63.56 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.972 0.909 . . . . 0.0 111.192 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -61.3 -36.21 79.46 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 123.372 0.42 . . . . 0.0 111.725 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.428 ' H ' HG22 ' A' ' 19' ' ' THR . 31.7 t70 -70.35 -40.83 73.84 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -56.15 -42.33 76.81 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.673 175.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 20' ' ' TRP . 97.3 t -67.65 -66.3 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.402 0.681 . . . . 0.0 111.025 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -71.13 -44.81 64.82 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.443 0.464 . . . . 0.0 111.664 -166.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -80.13 -29.22 38.89 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.906 0.883 . . . . 0.0 111.786 -171.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -120.34 -66.19 1.08 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -169.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.34 -44.36 95.59 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.972 0.909 . . . . 0.0 111.526 -172.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.528 ' HG ' HD12 ' A' ' 81' ' ' LEU . 40.1 m -73.04 -16.23 61.49 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.351 1.06 . . . . 0.0 112.412 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -96.2 -3.77 43.69 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.136 0.575 . . . . 0.0 110.974 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.22 37.37 91.71 Favored Glycine 0 C--N 1.357 1.738 0 N-CA-C 114.776 0.671 . . . . 0.0 114.776 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.7 m -98.95 0.8 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.06 126.6 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.481 0.712 . . . . 0.0 110.272 -174.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -85.28 -47.21 10.28 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.343 1.057 . . . . 0.0 110.707 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.467 ' HG2' ' HB ' ' A' ' 47' ' ' THR . 10.2 ptp180 -157.07 160.29 38.76 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.873 0.469 . . . . 0.0 110.138 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.4 mt -117.77 103.29 9.85 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.74 0.816 . . . . 0.0 109.303 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -88.9 111.86 22.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.602 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.498 HG23 HG23 ' A' ' 44' ' ' VAL . 31.0 t -84.45 99.86 7.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.9 t -91.25 114.43 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 122.865 0.466 . . . . 0.0 110.033 -171.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 52.52 27.29 4.92 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.408 1.483 . . . . 0.0 112.886 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.411 ' HA ' HG11 ' A' ' 38' ' ' VAL . 98.0 mttt 61.71 -0.7 0.39 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.812 1.645 . . . . 0.0 114.31 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -81.74 -34.16 30.64 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.385 0.674 . . . . 0.0 110.6 -171.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -157.4 179.32 9.36 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.498 HG23 HG23 ' A' ' 38' ' ' VAL . 91.9 t -126.59 129.1 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 124.175 0.99 . . . . 0.0 109.072 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -101.37 128.75 47.41 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.9 t -88.84 109.84 20.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.726 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.467 ' HB ' ' HG2' ' A' ' 35' ' ' ARG . 87.1 m -88.31 134.37 33.83 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 172.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -103.6 154.5 19.43 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.198 0.599 . . . . 0.0 111.379 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.3 p -75.48 117.53 63.99 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.172 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.07 103.66 0.13 Allowed 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.214 2.61 . . . . 0.0 111.294 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.54 -50.71 0.81 Allowed Glycine 0 C--N 1.336 0.563 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -173.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.39 21.91 16.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.982 0.913 . . . . 0.0 110.488 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.8 m -73.13 119.72 77.17 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.98 139.44 84.79 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.584 2.19 . . . . 0.0 112.312 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.08 -44.54 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.571 0.748 . . . . 0.0 109.024 173.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.37 82.84 2.23 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.74 46.5 0.09 OUTLIER Glycine 0 C--N 1.344 1.021 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -62.52 -61.15 2.64 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.085 0.954 . . . . 0.0 112.306 -171.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -135.21 119.05 17.26 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -118.67 -179.6 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.626 0.371 . . . . 0.0 110.127 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -159.54 165.82 32.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.966 0.907 . . . . 0.0 109.167 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -152.56 152.16 31.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.624 0.37 . . . . 0.0 111.455 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -78.19 149.59 33.67 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.206 1.002 . . . . 0.0 110.145 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.2 pt -127.06 -26.79 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.063 0.545 . . . . 0.0 111.999 -174.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.52 -78.0 1.52 Allowed Glycine 0 C--N 1.344 0.991 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.2 t -107.4 132.05 53.6 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.181 0.992 . . . . 0.0 108.585 172.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.8 t -62.33 -32.37 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.357 0.663 . . . . 0.0 110.757 173.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.95 -38.2 90.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.689 0.796 . . . . 0.0 110.807 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.6 m -63.39 -51.38 66.08 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 122.905 0.482 . . . . 0.0 110.221 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -53.33 -58.22 7.86 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 124.102 0.876 . . . . 0.0 111.961 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 15.5 pt-20 -62.56 -47.78 82.37 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.962 0.789 . . . . 0.0 111.065 -172.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -64.15 -48.1 77.32 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 122.37 0.268 . . . . 0.0 110.873 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.87 -43.34 88.67 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.814 0.696 . . . . 0.0 110.24 -176.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.436 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 39.9 tp -57.7 -55.92 28.58 Favored 'General case' 0 C--O 1.215 -0.751 0 O-C-N 124.759 1.287 . . . . 0.0 111.651 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.587 ' HG2' ' NH2' ' A' ' 88' ' ' ARG . 44.8 mt-10 -66.43 -35.35 80.09 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.409 0.684 . . . . 0.0 112.156 -172.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.7 m -65.12 -48.04 75.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.188 0.595 . . . . 0.0 109.441 174.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.509 HD22 HG21 ' A' ' 24' ' ' VAL . 44.9 tp -57.17 -41.48 79.35 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.216 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.46 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 60.8 mt-30 -63.65 -46.31 86.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.682 0.793 . . . . 0.0 110.243 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -65.65 -31.04 71.84 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.46 0.704 . . . . 0.0 110.886 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -71.79 -52.64 16.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.559 1.143 . . . . 0.0 110.791 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.528 HD12 ' HG ' ' A' ' 29' ' ' SER . 72.3 mt -79.42 -10.16 59.75 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.403 0.681 . . . . 0.0 111.592 -173.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.88 10.17 59.03 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 114.301 0.48 . . . . 0.0 114.301 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 3.5 mp -80.13 90.32 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 168.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.99 143.14 50.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.656 -0.653 . . . . 0.0 111.925 -171.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.0 -100.3 0.17 Allowed Glycine 0 C--N 1.349 1.297 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.749 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -79.02 -27.88 43.28 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.946 0.899 . . . . 0.0 110.904 -176.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -76.46 -9.53 58.72 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.088 0.555 . . . . 0.0 111.557 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.587 ' NH2' ' HG2' ' A' ' 75' ' ' GLU . 70.2 mtp180 -69.15 151.55 46.23 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-O 121.551 0.691 . . . . 0.0 112.836 -175.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.5 t -91.87 108.77 32.37 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.056 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -57.36 125.57 19.27 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.972 2.448 . . . . 0.0 111.535 -175.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.77 107.79 20.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -176.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 t -105.52 98.03 6.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -71.14 107.77 4.34 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.9 mt -117.97 144.59 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.903 0.881 . . . . 0.0 109.814 -175.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 98' ' ' ASP . . . -109.56 102.92 11.73 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -72.24 -46.72 54.82 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.764 0.825 . . . . 0.0 111.112 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.4 p -144.89 21.45 1.61 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.992 0.517 . . . . 0.0 111.347 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 95' ' ' ALA . 17.3 t70 -74.1 -38.52 63.82 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.03 0.532 . . . . 0.0 110.211 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.286 0 CA-C-O 118.774 -1.014 . . . . 0.0 112.091 179.724 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.71 -154.86 53.42 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 116.275 -0.42 . . . . 0.0 113.423 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 74.91 -19.03 0.4 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.61 1.564 . . . . 0.0 113.081 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -77.44 100.3 5.95 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.583 0.753 . . . . 0.0 109.909 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -75.95 75.58 2.85 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.759 0.824 . . . . 0.0 110.295 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -93.96 126.03 38.93 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.695 0.798 . . . . 0.0 109.049 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -111.52 140.19 46.33 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -73.13 78.14 1.25 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.443 0.64 . . . . 0.0 109.742 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.8 m -140.02 -3.05 1.44 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.704 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -92.1 147.37 23.0 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.758 0.823 . . . . 0.0 108.849 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.3 mmt 66.53 -167.28 0.21 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.35 1.06 . . . . 0.0 110.286 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -83.1 120.52 25.87 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.508 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 6.3 ptm180 -75.71 85.09 2.72 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.75 0.786 . . . . 0.0 109.774 171.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 p -120.2 -79.38 0.6 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.41 98.63 1.73 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 171.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.508 ' HD2' ' HA ' ' A' ' 13' ' ' ARG . 4.1 mmp_? -108.33 116.83 32.7 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 117.092 0.446 . . . . 0.0 111.45 -173.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.07 108.52 7.85 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 36.0 pt -100.62 171.55 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.514 1.126 . . . . 0.0 109.227 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.6 p -100.11 178.43 4.79 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 166.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -59.05 -35.19 72.91 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.445 173.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -60.88 -46.55 90.18 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.388 0.675 . . . . 0.0 112.22 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.593 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 7.0 m-20 -62.23 -44.95 95.4 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.312 0.245 . . . . 0.0 110.368 174.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.432 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 37.3 t80 -55.15 -50.63 68.8 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 124.118 0.886 . . . . 0.0 110.81 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.8 t -64.04 -66.47 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.944 0.897 . . . . 0.0 111.583 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -71.46 -47.15 57.54 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.87 0.468 . . . . 0.0 112.186 -166.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -80.26 -22.37 41.76 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -172.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.432 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 53.7 m-85 -128.22 -61.57 1.09 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -169.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.0 tp -64.13 -44.67 91.51 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.085 0.954 . . . . 0.0 111.317 -168.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.477 ' HA ' HD13 ' A' ' 81' ' ' LEU . 91.0 p -62.91 -20.31 65.04 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.59 0.756 . . . . 0.0 112.791 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -97.4 -10.44 25.5 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.868 0.867 . . . . 0.0 110.747 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.32 31.89 80.89 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 114.652 0.621 . . . . 0.0 114.652 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.429 HG12 ' HD3' ' A' ' 52' ' ' LYS . 18.2 m -80.5 -0.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 117.125 0.462 . . . . 0.0 110.676 175.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 t -98.82 133.06 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -176.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.475 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 18.6 t70 -92.38 -55.03 3.56 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.519 1.128 . . . . 0.0 109.621 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -154.46 164.99 37.81 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.386 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.6 mt -120.51 108.84 14.57 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.689 0.795 . . . . 0.0 110.788 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 45' ' ' ARG . 49.3 mt-10 -88.21 102.64 15.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.741 0.816 . . . . 0.0 110.053 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 41' ' ' LYS . 21.8 t -97.3 91.03 2.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.1 t -79.58 118.25 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.079 -174.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 49.73 27.92 2.45 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.688 1.595 . . . . 0.0 113.425 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.547 ' HA ' HG11 ' A' ' 38' ' ' VAL . 10.6 mtmp? 53.74 15.52 0.81 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.116 1.366 . . . . 0.0 114.181 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -85.64 -47.02 10.22 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.964 0.906 . . . . 0.0 110.421 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.409 ' HE2' ' HE ' ' A' ' 45' ' ' ARG . 44.1 p90 -147.56 159.83 43.31 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.177 0.513 . . . . 0.0 109.852 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.479 HG23 HG23 ' A' ' 38' ' ' VAL . 57.4 t -121.53 131.9 71.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.345 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.409 ' HE ' ' HE2' ' A' ' 43' ' ' PHE . 89.3 mtt180 -99.32 124.82 44.74 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HB ' HG22 ' A' ' 60' ' ' VAL . 44.8 t -82.36 108.87 15.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 83.4 m -87.82 129.48 35.18 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -86.03 145.08 27.24 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.79 0.436 . . . . 0.0 110.409 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.4 t -86.66 145.21 38.71 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 123.297 0.639 . . . . 0.0 111.265 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.13 139.52 20.86 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 124.204 3.269 . . . . 0.0 114.631 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.0 -36.11 3.54 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.144 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.429 ' HD3' HG12 ' A' ' 32' ' ' VAL . 67.1 mttm -98.97 -18.85 17.6 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.383 0.673 . . . . 0.0 110.799 175.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 m -65.6 130.1 94.51 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 122.89 0.476 . . . . 0.0 111.376 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -72.91 96.78 0.87 Allowed 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 121.986 1.791 . . . . 0.0 108.908 163.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.95 -17.5 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.715 0.806 . . . . 0.0 112.007 -169.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -60.88 -28.52 68.94 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.985 0.914 . . . . 0.0 111.997 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.68 82.4 1.11 Allowed Glycine 0 C--N 1.339 0.713 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.67 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.42 94.17 3.38 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -104.28 127.51 51.92 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.078 0.951 . . . . 0.0 110.05 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 16' ' ' ARG . 33.0 m -109.17 144.16 18.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 173.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -154.73 163.13 40.7 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.83 0.452 . . . . 0.0 110.693 -173.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -150.19 150.76 32.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.708 0.403 . . . . 0.0 110.733 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -93.8 119.12 32.35 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.1 pt -84.31 116.77 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.069 0.548 . . . . 0.0 110.384 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.35 99.42 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.776 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.6 t -132.15 126.59 34.03 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.052 0.941 . . . . 0.0 108.731 172.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 41' ' ' LYS . 17.5 t -61.57 -36.3 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.363 0.665 . . . . 0.0 110.049 172.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -58.01 -43.9 86.92 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.125 0.97 . . . . 0.0 111.094 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.5 m -64.87 -46.53 81.45 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.537 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -51.39 -53.45 36.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.813 0.845 . . . . 0.0 111.834 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 44.7 mt-10 -67.9 -52.95 30.52 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.761 0.824 . . . . 0.0 111.845 -172.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -68.88 -36.06 77.63 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.588 0.555 . . . . 0.0 111.785 -173.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -70.89 -39.7 72.65 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 174.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 46.5 tp -56.51 -45.19 81.2 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.023 0.529 . . . . 0.0 111.34 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.5 -42.18 99.32 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.874 0.734 . . . . 0.0 111.187 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.1 m -60.31 -56.41 21.84 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 123.8 0.688 . . . . 0.0 110.398 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -51.73 -52.16 50.65 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 124.418 1.074 . . . . 0.0 112.067 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -60.17 -43.34 95.91 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 123.627 0.579 . . . . 0.0 111.383 -175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -62.75 -44.86 95.11 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.923 0.889 . . . . 0.0 111.122 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -70.1 -38.36 75.61 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.131 -176.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.477 HD13 ' HA ' ' A' ' 29' ' ' SER . 41.5 mt -77.77 -17.3 57.65 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.66 0.784 . . . . 0.0 110.515 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.7 6.54 88.99 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-O 119.887 -0.396 . . . . 0.0 113.853 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.527 HG23 ' HA ' ' A' ' 88' ' ' ARG . 75.7 mt -70.98 92.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.1 0.96 . . . . 0.0 109.479 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -136.33 152.82 51.07 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 124.133 0.973 . . . . 0.0 110.569 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.0 -93.91 0.07 OUTLIER Glycine 0 C--N 1.343 0.947 0 CA-C-N 114.594 -1.185 . . . . 0.0 115.406 172.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -77.46 -45.72 24.79 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.562 0.696 . . . . 0.0 109.517 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -79.86 -15.7 56.85 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.759 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.527 ' HA ' HG23 ' A' ' 83' ' ' ILE . 58.0 ttt180 -56.53 152.25 12.09 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.112 0.965 . . . . 0.0 111.991 -174.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 68.6 t -100.09 99.74 10.03 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 57.2 Cg_endo -70.48 149.07 61.71 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.919 2.413 . . . . 0.0 112.268 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.8 t -108.63 119.32 57.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.417 -174.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.7 t -104.84 96.27 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -74.64 98.52 3.43 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.497 HG21 ' HG2' ' A' ' 96' ' ' GLU . 64.3 mt -87.1 129.19 38.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.81 75.71 1.45 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -175.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.497 ' HG2' HG21 ' A' ' 94' ' ' ILE . 12.3 mm-40 -72.68 -46.75 52.19 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.053 -174.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.7 m 66.12 98.56 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.529 1.143 . . . . 0.0 110.914 -176.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.91 -41.12 71.65 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.005 0.922 . . . . 0.0 110.224 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.128 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.148 173.965 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 mtt . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.576 0.227 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.08 26.41 26.34 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 116.387 -0.37 . . . . 0.0 112.314 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -60.92 -39.24 88.62 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.144 0.578 . . . . 0.0 110.838 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -77.5 81.98 3.94 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 166.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -65.2 -65.62 0.65 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.233 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -145.12 115.62 7.63 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 171.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -66.98 151.6 47.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.876 0.47 . . . . 0.0 110.216 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.6 p80 48.23 31.15 2.48 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.061 1.345 . . . . 0.0 111.963 -175.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.2 p -51.38 151.8 2.83 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.091 0.956 . . . . 0.0 111.572 -175.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -45.19 132.46 7.35 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 124.562 1.164 . . . . 0.0 111.414 -171.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.483 ' HG3' ' HB2' ' A' ' 13' ' ' ARG . 13.7 tpt -43.09 105.61 0.05 Allowed 'General case' 0 C--N 1.354 0.798 0 O-C-N 125.278 1.611 . . . . 0.0 111.081 -177.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.515 ' HD3' HG13 ' A' ' 39' ' ' VAL . 24.1 ttpt -42.09 -56.2 2.93 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 125.237 1.415 . . . . 0.0 110.308 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.483 ' HB2' ' HG3' ' A' ' 11' ' ' MET . 3.2 tmt_? 59.08 -87.96 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.066 0 O-C-N 125.417 1.698 . . . . 0.0 108.489 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.7 p 175.82 -70.56 0.01 OUTLIER 'General case' 0 C--N 1.353 0.731 0 C-N-CA 124.458 1.103 . . . . 0.0 109.694 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.98 -154.02 19.51 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.351 -168.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -89.65 127.13 35.87 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.384 0.674 . . . . 0.0 109.366 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -74.26 128.98 36.92 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.4 pt -129.69 170.6 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.618 0.767 . . . . 0.0 109.649 -175.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.6 p -91.71 153.59 19.55 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.574 ' O ' HG22 ' A' ' 24' ' ' VAL . 68.9 t-105 -53.58 -46.46 70.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.302 0.641 . . . . 0.0 110.806 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -54.82 -50.73 67.86 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.815 0.846 . . . . 0.0 112.476 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.454 ' HA ' ' ND2' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -70.99 -33.83 70.79 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -176.627 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -54.23 -45.47 72.3 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.41 0.444 . . . . 0.0 110.49 172.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 20' ' ' TRP . 89.3 t -58.11 -64.09 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.017 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.454 ' ND2' ' HA ' ' A' ' 22' ' ' ASP . 9.3 p30 -75.21 -33.41 61.39 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.233 0.333 . . . . 0.0 111.815 -166.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -80.66 -41.29 24.04 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.868 0.467 . . . . 0.0 111.606 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -113.51 -65.3 1.2 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -163.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.8 tp -60.89 -45.52 94.26 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.886 0.741 . . . . 0.0 111.53 -174.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.485 ' HA ' HD13 ' A' ' 83' ' ' ILE . 22.7 t -72.39 -14.29 61.67 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.33 1.052 . . . . 0.0 111.863 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -101.83 -2.18 30.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.771 0.428 . . . . 0.0 111.12 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.93 22.41 34.49 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.8 m -77.78 -3.59 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 123.055 0.542 . . . . 0.0 111.468 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.9 t -93.63 129.91 43.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.267 1.027 . . . . 0.0 108.625 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -80.56 -47.32 14.36 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.537 0.735 . . . . 0.0 110.193 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.508 ' HG2' ' HB ' ' A' ' 47' ' ' THR . 6.6 ptp85 -159.4 157.92 31.18 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.092 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.5 mt -114.83 102.14 9.71 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.774 0.829 . . . . 0.0 108.964 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -89.79 108.61 19.8 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.136 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.505 HG23 HG23 ' A' ' 44' ' ' VAL . 40.6 t -88.45 94.59 4.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.515 HG13 ' HD3' ' A' ' 12' ' ' LYS . 19.9 t -90.94 127.06 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 O-C-N 123.233 0.333 . . . . 0.0 111.44 -169.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.4 m120 53.28 23.23 3.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.653 1.581 . . . . 0.0 113.632 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 61.28 6.6 1.41 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.986 1.314 . . . . 0.0 114.196 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.7 mtp-105 -91.22 -40.81 11.33 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.274 0.488 . . . . 0.0 110.436 -176.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.486 ' HZ ' ' HD2' ' A' ' 12' ' ' LYS . 41.2 p90 -151.99 174.04 14.13 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.15 -170.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.505 HG23 HG23 ' A' ' 38' ' ' VAL . 71.9 t -119.88 122.89 69.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -100.03 121.9 42.09 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.0 t -90.24 119.74 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.127 0.971 . . . . 0.0 110.327 -168.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.508 ' HB ' ' HG2' ' A' ' 35' ' ' ARG . 58.1 m -93.86 130.05 40.04 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -97.32 170.39 9.11 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.931 0.769 . . . . 0.0 111.079 176.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.6 p -83.23 141.94 43.4 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 123.301 0.64 . . . . 0.0 110.997 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -55.19 146.57 59.36 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.609 2.873 . . . . 0.0 112.976 174.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.15 -54.96 1.56 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 112.066 -0.414 . . . . 0.0 112.066 -178.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -70.27 -58.14 4.1 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.4 m -134.64 99.37 12.9 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -81.01 -160.73 0.13 Allowed 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 123.062 2.508 . . . . 0.0 112.834 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.11 -34.96 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.846 0.858 . . . . 0.0 111.175 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -68.62 -38.93 80.93 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.356 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.1 126.84 29.34 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 123.723 0.639 . . . . 0.0 112.761 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -64.88 136.89 57.37 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.709 0.804 . . . . 0.0 110.965 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -78.78 175.39 10.52 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.401 0.68 . . . . 0.0 110.719 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.8 169.87 20.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.078 170.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -158.25 158.42 34.43 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.533 0.733 . . . . 0.0 109.35 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -146.54 141.32 26.88 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.951 0.5 . . . . 0.0 109.722 177.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -83.15 128.57 34.61 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.874 0.47 . . . . 0.0 109.897 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 67' ' ' VAL . 22.5 pt -106.5 -29.29 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.342 0.657 . . . . 0.0 110.658 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.79 -71.85 1.6 Allowed Glycine 0 C--N 1.35 1.314 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.4 t -100.18 121.45 41.45 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.278 1.031 . . . . 0.0 110.127 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.478 ' HA ' HD12 ' A' ' 64' ' ' ILE . 39.5 t -66.56 -34.13 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.091 172.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 24.6 t70 -64.09 -37.11 86.26 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 63.2 m -65.89 -45.39 82.18 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.737 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -52.55 -41.56 63.64 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 123.778 0.674 . . . . 0.0 111.619 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.46 -51.25 53.63 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.488 0.492 . . . . 0.0 110.341 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 68' ' ' ASP . 95.5 mtt180 -55.94 -54.94 38.67 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.211 0.604 . . . . 0.0 111.771 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -71.42 -31.95 67.82 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.521 -175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.44 ' HG ' ' NE2' ' A' ' 78' ' ' GLN . 35.4 tp -62.84 -44.75 95.3 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.345 0.658 . . . . 0.0 111.858 172.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -63.32 -45.17 92.56 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.267 0.627 . . . . 0.0 112.065 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 14.8 m -63.57 -50.18 70.47 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.01 0.819 . . . . 0.0 109.361 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.429 HD22 HG23 ' A' ' 24' ' ' VAL . 45.3 tp -54.16 -51.24 64.95 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.298 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.44 ' NE2' ' HG ' ' A' ' 74' ' ' LEU . 46.0 mt-30 -64.72 -39.61 93.94 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.453 0.47 . . . . 0.0 111.232 -178.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 76' ' ' THR . 1.4 pt20 -68.04 -35.76 78.79 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 120.647 0.26 . . . . 0.0 110.549 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 76' ' ' THR . 30.9 mm-40 -74.24 -43.81 55.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.305 0.642 . . . . 0.0 111.047 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.6 mt -70.92 -8.65 54.51 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.74 0.816 . . . . 0.0 112.193 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.15 2.55 87.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.969 -0.351 . . . . 0.0 113.216 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 29' ' ' SER . 76.8 mt -73.03 101.73 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 124.844 1.258 . . . . 0.0 108.961 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -137.5 155.74 48.93 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.281 0.633 . . . . 0.0 111.257 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.23 -118.43 12.91 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 124.114 0.884 . . . . 0.0 113.719 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -20.75 66.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.385 1.074 . . . . 0.0 111.895 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -79.62 -24.77 41.7 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.666 0.386 . . . . 0.0 111.998 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -69.78 118.67 12.92 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.733 0.242 . . . . 0.0 110.773 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.09 126.42 92.4 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.272 0.629 . . . . 0.0 110.117 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.9 143.2 65.57 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.817 2.345 . . . . 0.0 112.575 -177.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.4 t -109.53 122.04 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.748 0.819 . . . . 0.0 109.322 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.453 HG23 ' HD3' ' A' ' 35' ' ' ARG . 23.0 t -114.31 101.77 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.932 0.893 . . . . 0.0 109.61 -174.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -75.62 104.49 6.19 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.088 0.555 . . . . 0.0 110.648 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 51.4 mm -106.62 129.9 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -154.71 65.91 0.67 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.527 0.679 . . . . 0.0 109.451 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.6 -173.17 2.08 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.012 -177.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.0 p -118.38 100.41 7.46 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.21 0.604 . . . . 0.0 109.992 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.52 -24.93 62.05 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.436 0.694 . . . . 0.0 110.9 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.781 -1.011 . . . . 0.0 112.086 179.727 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.433 ' HB3' ' HB3' ' A' ' 6' ' ' HIS . 51.6 mtm . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.73 -119.45 11.12 Favored Glycine 0 C--N 1.355 1.591 0 O-C-N 123.701 0.625 . . . . 0.0 111.877 178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -103.66 -11.62 17.55 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.66 0.784 . . . . 0.0 110.034 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -79.07 117.96 20.6 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.984 0.914 . . . . 0.0 109.732 -177.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 57.62 -93.3 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.299 1.439 . . . . 0.0 112.84 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 30.2 p80 44.73 23.59 0.08 Allowed 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.976 1.71 . . . . 0.0 113.969 -175.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -163.19 104.19 0.98 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.733 0.413 . . . . 0.0 110.082 -171.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -96.84 116.68 29.58 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -74.59 132.35 41.7 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.112 0.565 . . . . 0.0 110.084 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -87.81 -27.41 22.29 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.86 0.864 . . . . 0.0 109.537 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -63.92 137.85 58.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.815 0.846 . . . . 0.0 108.876 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.66 83.36 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.216 1.006 . . . . 0.0 111.283 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 58.01 86.94 0.07 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.183 1.393 . . . . 0.0 111.515 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.7 m -57.89 -29.28 64.94 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.27 0.628 . . . . 0.0 110.741 173.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.64 -176.26 38.97 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.699 170.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.554 ' HB3' HG13 ' A' ' 60' ' ' VAL . 63.7 ttt180 -85.56 121.19 27.9 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -73.53 130.72 40.67 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.9 pt -133.15 175.68 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.509 1.124 . . . . 0.0 109.218 -177.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.9 p -95.92 164.8 12.57 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.72 172.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.504 ' O ' HG23 ' A' ' 24' ' ' VAL . 72.6 t-105 -55.49 -44.42 76.5 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.013 0.925 . . . . 0.0 110.657 174.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -56.07 -47.26 78.3 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.732 0.813 . . . . 0.0 111.129 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.6 -42.02 92.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.05 0.54 . . . . 0.0 110.567 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -51.78 -51.02 59.46 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.665 0.603 . . . . 0.0 111.228 175.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 20' ' ' TRP . 59.9 t -63.75 -61.31 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.238 0.615 . . . . 0.0 111.5 -175.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -71.91 -40.87 68.53 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.034 -168.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -79.82 -43.48 22.32 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.377 0.671 . . . . 0.0 110.915 -175.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -114.08 -65.66 1.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -163.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.4 tp -55.08 -45.14 75.36 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.081 0.952 . . . . 0.0 112.146 -171.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.2 p -71.55 -9.18 57.81 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -95.96 -6.47 38.92 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 118.835 -0.603 . . . . 0.0 112.012 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.42 31.25 80.26 Favored Glycine 0 C--N 1.353 1.482 0 C-N-CA 121.433 -0.413 . . . . 0.0 113.687 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.8 -3.46 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.38 0.672 . . . . 0.0 111.728 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.04 130.78 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.497 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 24.8 t70 -88.26 -51.27 5.85 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.967 1.307 . . . . 0.0 110.124 -175.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -152.71 152.33 31.57 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.676 0.79 . . . . 0.0 110.208 -175.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.1 mt -112.0 101.97 10.23 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.43 1.092 . . . . 0.0 109.054 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 43.1 mt-10 -93.49 101.18 13.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.856 -172.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.56 HG23 HG23 ' A' ' 44' ' ' VAL . 49.0 t -81.08 104.94 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -176.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.5 t -95.24 115.48 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 123.055 0.542 . . . . 0.0 110.538 -174.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 53.31 24.04 3.59 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.157 1.783 . . . . 0.0 113.905 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt 67.49 0.77 2.29 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.447 1.499 . . . . 0.0 112.98 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -76.87 -45.26 28.93 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.109 0.963 . . . . 0.0 110.135 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -152.32 175.02 13.1 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.964 -173.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.56 HG23 HG23 ' A' ' 38' ' ' VAL . 86.8 t -124.58 130.57 73.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 125.109 1.364 . . . . 0.0 107.846 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.615 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 68.4 ttt180 -97.9 116.91 31.07 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.732 1.213 . . . . 0.0 108.48 -177.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.51 ' HB ' HG23 ' A' ' 60' ' ' VAL . 46.7 t -85.11 106.7 15.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.7 m -103.17 135.86 44.03 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -97.0 148.08 23.34 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.88 0.738 . . . . 0.0 111.96 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.497 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 57.7 p -62.32 133.1 94.32 Favored Pre-proline 0 C--N 1.349 0.557 0 C-N-CA 124.56 1.144 . . . . 0.0 111.26 -176.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.742 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 12.3 Cg_exo -73.64 35.93 0.38 Allowed 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 123.815 3.01 . . . . 0.0 113.385 171.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.78 -46.2 0.04 OUTLIER Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 -173.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.51 -67.71 0.76 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.8 t -139.13 75.38 34.6 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 123.603 0.761 . . . . 0.0 110.109 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.742 ' HB3' ' HA ' ' A' ' 50' ' ' PRO . 15.1 Cg_endo -62.09 -81.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.242 1.961 . . . . 0.0 112.618 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.9 t -81.45 -29.34 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.182 0.593 . . . . 0.0 109.814 -173.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -64.38 -23.22 67.21 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.391 0.676 . . . . 0.0 110.925 170.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.35 97.67 0.1 OUTLIER Glycine 0 C--N 1.352 1.468 0 O-C-N 123.86 0.725 . . . . 0.0 112.188 176.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -65.06 92.63 0.11 Allowed 'General case' 0 C--N 1.347 0.498 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -59.81 115.73 3.59 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.243 -172.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.554 HG13 ' HB3' ' A' ' 16' ' ' ARG . 10.6 m -119.53 170.04 9.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.505 -175.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -156.18 161.52 40.3 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.166 0.586 . . . . 0.0 109.532 176.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -147.26 145.15 29.31 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.92 154.53 31.57 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 67' ' ' VAL . 31.9 pt -128.82 -46.37 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 122.937 0.495 . . . . 0.0 110.441 174.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.45 -72.15 0.47 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -168.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.9 t -78.57 104.51 9.23 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 124.456 1.102 . . . . 0.0 110.638 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.478 ' HA ' HD12 ' A' ' 64' ' ' ILE . 26.4 t -66.95 -31.7 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.068 173.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.45 -42.91 98.63 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.238 0.615 . . . . 0.0 110.597 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 80.4 m -62.86 -48.47 78.87 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -51.73 -52.43 48.57 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 124.475 1.11 . . . . 0.0 112.046 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -66.24 -42.38 88.67 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.306 0.379 . . . . 0.0 111.301 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -66.18 -49.87 65.84 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.829 0.452 . . . . 0.0 112.064 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -71.14 -32.5 69.03 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 119.206 -0.426 . . . . 0.0 110.828 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.1 tp -59.78 -48.16 82.81 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.89 0.876 . . . . 0.0 111.135 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -65.0 -42.89 94.08 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.261 0.624 . . . . 0.0 112.139 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.7 m -59.77 -49.51 77.46 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 122.013 0.911 . . . . 0.0 109.693 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.9 tp -58.96 -42.73 90.58 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 112.914 -1.948 . . . . 0.0 112.614 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -65.77 -37.11 85.44 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.242 0.617 . . . . 0.0 111.051 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -69.85 -35.28 74.58 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.108 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.31 -52.54 22.04 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.565 1.146 . . . . 0.0 110.996 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.5 mt -73.02 -19.77 61.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.183 0.993 . . . . 0.0 111.222 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 7.39 70.38 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-O 119.723 -0.487 . . . . 0.0 113.2 -175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.3 mt -67.77 92.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.157 0.983 . . . . 0.0 109.033 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -137.97 148.12 44.91 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.716 0.807 . . . . 0.0 110.147 -171.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.78 -102.83 0.74 Allowed Glycine 0 C--N 1.351 1.365 0 O-C-N 124.508 1.13 . . . . 0.0 112.992 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.52 -30.42 57.17 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.746 0.818 . . . . 0.0 110.72 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -72.05 -21.09 61.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.082 0.553 . . . . 0.0 111.379 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -62.01 142.6 57.4 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.231 0.613 . . . . 0.0 111.751 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.4 t -107.55 106.37 58.26 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -58.6 143.86 97.99 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 124.047 3.164 . . . . 0.0 113.258 -175.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.7 t -98.87 119.4 46.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 54.2 t -110.95 121.39 63.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -87.51 127.2 35.24 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.8 mm -124.43 129.24 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.289 1.436 . . . . 0.0 107.791 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.56 145.23 47.54 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.028 0.531 . . . . 0.0 110.108 175.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -108.57 8.43 27.15 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.494 1.118 . . . . 0.0 110.141 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.4 m -83.74 10.0 10.46 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.853 0.861 . . . . 0.0 113.043 -168.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -153.05 -49.65 0.1 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.189 0.996 . . . . 0.0 108.705 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.516 179.557 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 110.887 -0.042 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.98 154.5 22.07 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 112.083 -0.407 . . . . 0.0 112.083 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -105.46 72.79 0.99 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -164.76 34.4 0.07 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.286 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -62.55 -38.38 89.82 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.771 0.828 . . . . 0.0 111.75 -176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -149.45 147.34 28.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.395 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -78.18 68.42 4.21 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.336 1.054 . . . . 0.0 109.556 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 40.88 -83.36 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 126.429 1.892 . . . . 0.0 113.962 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.2 t -145.57 -176.28 5.06 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.431 1.092 . . . . 0.0 109.047 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -161.32 93.89 0.96 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.974 0.51 . . . . 0.0 110.778 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.4 tpt -89.84 -34.6 16.06 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -68.44 163.73 22.64 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.943 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -68.94 81.85 0.31 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.177 1.391 . . . . 0.0 109.686 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.6 p -97.45 140.01 32.54 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.5 1.12 . . . . 0.0 109.396 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.98 151.61 22.3 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.261 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.521 ' HB3' HG13 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -87.28 119.7 27.8 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -177.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.94 107.2 6.02 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 48.2 pt -99.72 176.66 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.943 0.897 . . . . 0.0 109.967 173.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.3 p -104.78 171.6 7.24 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.383 171.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -57.78 -38.88 76.22 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.504 0.722 . . . . 0.0 110.381 171.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -55.45 -48.79 73.94 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.747 0.819 . . . . 0.0 111.211 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.554 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 50.8 m-20 -64.66 -45.15 87.96 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.77 0.428 . . . . 0.0 111.924 176.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -49.39 -57.35 7.09 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.121 0.888 . . . . 0.0 110.228 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.6 t -66.13 -56.41 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 123.89 0.744 . . . . 0.0 111.859 -174.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -76.32 -48.87 18.54 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -168.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -76.49 -39.62 52.62 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.265 0.626 . . . . 0.0 111.528 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -108.91 -65.54 1.13 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -165.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.4 tp -58.07 -44.45 87.51 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.88 0.872 . . . . 0.0 111.86 -173.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.1 t -57.47 -30.23 64.88 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.201 1.0 . . . . 0.0 112.455 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -91.81 0.97 57.46 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.979 0.912 . . . . 0.0 110.887 -176.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.46 25.41 62.93 Favored Glycine 0 C--N 1.351 1.409 0 N-CA-C 114.444 0.537 . . . . 0.0 114.444 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.9 m -85.91 -2.02 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 117.257 0.529 . . . . 0.0 110.617 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.5 t -93.77 122.22 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.908 0.883 . . . . 0.0 109.431 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.502 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 17.8 t70 -82.25 -52.44 6.94 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.208 1.003 . . . . 0.0 109.625 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -155.13 166.19 34.35 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.57 0.748 . . . . 0.0 110.687 -173.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.408 ' HG ' HG13 ' A' ' 89' ' ' VAL . 84.4 mt -119.15 107.25 13.24 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.949 0.9 . . . . 0.0 110.432 175.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -94.27 101.75 13.73 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.335 0.654 . . . . 0.0 110.257 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.477 HG11 ' HA ' ' A' ' 41' ' ' LYS . 23.4 t -82.58 89.91 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.412 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 95.4 t -73.94 116.77 16.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.289 1.035 . . . . 0.0 110.946 -169.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 95' ' ' ALA . 3.4 m-20 55.8 21.4 4.73 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.604 1.162 . . . . 0.0 112.397 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.477 ' HA ' HG11 ' A' ' 38' ' ' VAL . 91.7 mttt 61.98 2.18 0.75 Allowed 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.845 1.658 . . . . 0.0 114.143 -173.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -80.06 -39.96 28.67 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.87 0.868 . . . . 0.0 110.766 -173.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -153.56 166.54 32.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.042 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 53.0 t -120.16 130.91 73.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -175.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -91.01 127.93 36.63 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.489 ' HB ' HG22 ' A' ' 60' ' ' VAL . 44.9 t -83.42 105.45 13.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 165.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.9 m -94.59 130.18 41.14 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.402 ' HB2' ' HA ' ' A' ' 53' ' ' THR . 84.6 m-85 -87.76 156.88 19.21 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.018 0.824 . . . . 0.0 111.095 -175.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.502 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 64.4 p -63.04 141.5 97.7 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.361 174.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -51.31 -40.84 61.0 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.97 3.114 . . . . 0.0 114.871 -163.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.55 -17.48 73.25 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.518 -0.31 . . . . 0.0 113.497 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -105.98 0.58 25.85 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.515 0.726 . . . . 0.0 111.525 177.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.402 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 100.0 m -66.73 126.86 93.01 Favored Pre-proline 0 C--N 1.354 0.782 0 CA-C-O 118.974 -0.536 . . . . 0.0 110.401 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -63.39 89.04 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 121.845 1.696 . . . . 0.0 109.122 165.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.84 -9.58 9.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.778 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.285 -175.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -57.83 -23.72 54.06 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.208 1.003 . . . . 0.0 111.08 170.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 128.41 -33.29 3.18 Favored Glycine 0 C--N 1.357 1.739 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.859 170.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -84.14 100.44 11.14 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.283 0.633 . . . . 0.0 111.049 -166.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -75.65 175.48 8.58 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.225 165.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' A' ' 16' ' ' ARG . 35.7 m -110.94 152.69 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -153.64 156.57 38.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.85 0.46 . . . . 0.0 110.678 -174.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -139.8 139.94 36.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.322 0.649 . . . . 0.0 109.294 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -81.3 144.02 31.82 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.417 0.687 . . . . 0.0 110.045 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 67' ' ' VAL . 37.4 pt -120.46 140.18 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.519 0.728 . . . . 0.0 109.516 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.49 -46.13 26.77 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 177.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.8 m -132.09 138.44 48.13 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.694 0.798 . . . . 0.0 109.439 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.49 ' HA ' HD11 ' A' ' 64' ' ' ILE . 34.4 t -63.03 -41.4 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.287 0.635 . . . . 0.0 110.967 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.87 -39.69 92.76 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.939 0.495 . . . . 0.0 111.079 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.6 m -63.03 -45.86 90.31 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.864 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -53.46 -47.69 69.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.789 0.836 . . . . 0.0 111.291 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 52.1 mt-10 -63.35 -47.67 81.17 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.73 0.644 . . . . 0.0 110.901 -178.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.1 mtp-105 -61.24 -44.63 96.95 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.227 0.611 . . . . 0.0 111.082 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -63.65 -46.78 84.05 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.552 0.741 . . . . 0.0 110.741 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.23 -48.93 79.21 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.143 0.977 . . . . 0.0 111.655 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 23.0 mm-40 -61.96 -48.37 80.66 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.117 0.567 . . . . 0.0 110.956 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.446 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 96.1 m -57.24 -55.43 34.88 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.502 0.721 . . . . 0.0 110.35 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.4 tp -44.71 -51.24 9.46 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.18 1.792 . . . . 0.0 112.686 174.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -64.71 -41.59 95.88 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.014 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 13.9 mm100 -64.04 -38.65 91.85 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.485 0.314 . . . . 0.0 110.567 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 76' ' ' THR . 21.1 mm-40 -60.48 -39.81 89.0 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.83 0.852 . . . . 0.0 111.07 175.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.9 mt -84.1 -8.49 59.09 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.721 0.808 . . . . 0.0 112.097 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.45 6.25 89.36 Favored Glycine 0 C--N 1.353 1.474 0 C-N-CA 122.894 0.283 . . . . 0.0 113.392 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.509 HG23 ' HA ' ' A' ' 88' ' ' ARG . 69.5 mt -76.26 108.66 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 124.987 1.315 . . . . 0.0 109.555 177.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.25 177.29 10.38 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.62 0.768 . . . . 0.0 110.658 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.04 -125.15 29.6 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.662 0.601 . . . . 0.0 113.621 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -85.76 -8.12 58.34 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.354 0.662 . . . . 0.0 111.096 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.435 HD21 HG22 ' A' ' 83' ' ' ILE . 7.9 t30 -88.41 -12.94 41.77 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.339 0.655 . . . . 0.0 110.865 -178.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.509 ' HA ' HG23 ' A' ' 83' ' ' ILE . 12.1 ptp85 -63.69 147.52 51.4 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 117.507 0.14 . . . . 0.0 110.681 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.408 HG13 ' HG ' ' A' ' 36' ' ' LEU . 40.2 t -66.39 116.51 34.58 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -175.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 32.3 Cg_exo -59.56 117.34 4.07 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.576 2.851 . . . . 0.0 111.248 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.9 t -102.63 125.45 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.65 95.73 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -76.85 100.45 5.52 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.412 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 56.4 mt -95.05 142.9 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.833 0.853 . . . . 0.0 109.51 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 40' ' ' ASN . . . -144.73 79.43 1.6 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.745 0.818 . . . . 0.0 109.306 175.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -83.86 154.8 23.26 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.126 0.57 . . . . 0.0 111.201 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.9 t -73.53 -22.98 59.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.092 0.557 . . . . 0.0 110.034 174.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.0 t70 65.72 -75.61 0.05 OUTLIER 'General case' 0 C--N 1.355 0.83 0 C-N-CA 125.815 1.646 . . . . 0.0 111.053 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 172.41 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.733 0.301 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.18 -153.84 21.25 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -175.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -73.96 103.14 4.35 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.881 0.472 . . . . 0.0 110.332 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -75.08 134.6 41.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.777 0.831 . . . . 0.0 108.95 173.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -63.77 81.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.614 0.766 . . . . 0.0 111.833 -176.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.3 t60 169.37 128.8 0.02 OUTLIER 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.386 1.874 . . . . 0.0 107.267 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -76.15 127.01 32.05 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -61.87 129.54 41.42 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.499 1.12 . . . . 0.0 110.97 -178.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.6 m -75.03 97.83 3.49 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.533 0.733 . . . . 0.0 110.687 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -97.11 98.05 9.72 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 56.3 ttm -151.61 -59.54 0.16 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.813 0.339 . . . . 0.0 111.346 -170.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 57.2 tttp -88.01 77.22 8.46 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.495 0.718 . . . . 0.0 110.918 -172.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 27.7 ttt180 148.05 38.87 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.618 0 C-N-CA 127.828 2.451 . . . . 0.0 108.538 168.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 95.2 p 51.93 38.32 23.32 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.237 1.415 . . . . 0.0 112.135 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.93 -150.61 21.63 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.528 -174.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.501 ' HB2' HG13 ' A' ' 60' ' ' VAL . 18.9 mmm180 -100.94 135.52 42.25 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.488 0.715 . . . . 0.0 111.164 -173.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 42.8 tt0 -89.68 116.54 27.89 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 169.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.3 pt -105.92 -177.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.663 0.785 . . . . 0.0 109.679 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.0 p -97.55 165.71 11.85 Favored 'General case' 0 C--O 1.248 0.999 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 169.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.487 ' O ' HG22 ' A' ' 24' ' ' VAL . 73.6 t-105 -55.84 -40.81 73.36 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.58 0.55 . . . . 0.0 110.388 171.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -53.4 -53.78 46.35 Favored 'General case' 0 C--O 1.256 1.447 0 C-N-CA 124.017 0.927 . . . . 0.0 111.881 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -51.88 -54.42 29.44 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 124.318 1.011 . . . . 0.0 109.195 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -51.89 -45.32 64.11 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 124.983 1.427 . . . . 0.0 111.745 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 20' ' ' TRP . 72.4 t -55.56 -63.16 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 O-C-N 123.551 0.532 . . . . 0.0 111.31 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -67.37 -42.03 84.12 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.923 0.764 . . . . 0.0 112.757 -167.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.62 -21.45 18.8 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -173.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.44 ' HE2' HG22 ' A' ' 60' ' ' VAL . 22.8 m-85 -122.19 -67.47 0.96 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.778 0.717 . . . . 0.0 112.618 -169.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.4 tp -59.46 -48.2 82.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.612 0.765 . . . . 0.0 111.597 -173.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.3 p -64.86 -20.64 66.52 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -102.74 -2.48 28.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.949 0.5 . . . . 0.0 110.995 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.61 33.88 42.17 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 115.424 0.93 . . . . 0.0 115.424 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.7 m -81.87 -3.57 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 122.934 0.493 . . . . 0.0 111.297 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.42 135.76 30.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 123.972 0.909 . . . . 0.0 108.792 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.09 -49.51 7.73 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.801 0.84 . . . . 0.0 110.323 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -153.83 149.17 27.11 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.765 0.826 . . . . 0.0 111.095 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.411 ' HG ' HG11 ' A' ' 89' ' ' VAL . 54.5 mt -118.39 103.22 9.58 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.908 1.283 . . . . 0.0 108.01 178.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.606 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 37.8 mt-10 -99.15 109.59 22.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.066 -171.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.493 HG23 HG23 ' A' ' 44' ' ' VAL . 57.3 t -83.42 98.6 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.5 t -92.62 120.99 42.87 Favored 'Isoleucine or valine' 0 C--O 1.251 1.176 0 C-N-CA 123.204 0.602 . . . . 0.0 109.779 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 59.47 18.37 6.84 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.084 1.354 . . . . 0.0 113.437 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 60.4 6.69 1.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.686 1.194 . . . . 0.0 112.94 -173.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -87.71 -48.82 7.56 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.609 1.164 . . . . 0.0 110.215 -173.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -146.21 170.14 17.33 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.416 -172.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.493 HG23 HG23 ' A' ' 38' ' ' VAL . 95.6 t -121.26 123.54 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.86 0.864 . . . . 0.0 109.561 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.606 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 7.9 tpm_? -83.37 109.48 17.33 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.312 1.445 . . . . 0.0 107.458 177.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.06 107.44 16.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.4 m -107.79 127.73 53.96 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.475 ' H ' ' HE1' ' A' ' 59' ' ' TYR . 99.7 m-85 -100.61 169.55 8.97 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.269 1.028 . . . . 0.0 111.991 -171.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.1 p -87.83 132.29 40.7 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.17 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.19 -18.63 30.55 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.38 2.72 . . . . 0.0 114.479 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.96 -43.85 90.28 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.371 0.42 . . . . 0.0 112.661 176.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -85.36 -65.0 1.06 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.1 0.56 . . . . 0.0 110.146 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 38.5 p -80.43 138.78 51.59 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.236 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 53' ' ' THR . 5.2 Cg_exo -73.76 -151.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 123.29 2.66 . . . . 0.0 111.853 173.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.3 m -56.92 -23.06 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -173.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -143.3 -48.78 0.31 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.206 0.602 . . . . 0.0 109.687 170.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.95 -91.77 0.07 OUTLIER Glycine 0 C--N 1.353 1.525 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -171.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -163.32 84.26 0.49 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.154 0.982 . . . . 0.0 109.899 169.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.475 ' HE1' ' H ' ' A' ' 48' ' ' PHE . 60.2 m-85 -67.52 114.81 6.48 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 170.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.501 HG13 ' HB2' ' A' ' 16' ' ' ARG . 28.7 m -111.15 172.48 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.666 -174.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.4 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 42.8 p-90 -160.45 164.87 31.92 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.048 0.939 . . . . 0.0 108.948 178.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -152.53 143.65 23.13 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.551 0.34 . . . . 0.0 110.357 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -89.09 123.67 33.59 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' A' ' 67' ' ' VAL . 32.1 pt -95.44 -40.95 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.777 -171.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.94 -75.31 0.24 Allowed Glycine 0 C--N 1.35 1.307 0 O-C-N 123.424 0.452 . . . . 0.0 112.264 -172.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.1 m -82.06 99.22 9.05 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.484 ' HA ' HD12 ' A' ' 64' ' ' ILE . 60.3 t -54.7 -39.59 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.379 1.072 . . . . 0.0 110.887 171.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 18.9 t70 -54.34 -55.93 23.63 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 123.97 0.908 . . . . 0.0 110.73 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.4 m -59.82 -42.81 94.33 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 124.087 0.867 . . . . 0.0 111.506 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -50.84 -50.09 57.49 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 123.409 0.684 . . . . 0.0 111.488 172.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 47.0 mt-10 -68.58 -47.23 67.32 Favored 'General case' 0 C--O 1.217 -0.639 0 O-C-N 123.97 0.794 . . . . 0.0 111.243 -177.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 24.3 mmm180 -53.55 -48.6 68.98 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.454 0.701 . . . . 0.0 110.458 -178.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.21 -53.42 37.46 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.601 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.13 -53.31 58.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.69 0.796 . . . . 0.0 112.117 -174.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -61.64 -51.19 69.51 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.492 0.717 . . . . 0.0 112.028 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.419 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 94.1 m -63.11 -47.4 82.96 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.781 0.676 . . . . 0.0 110.619 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.457 HD22 HG13 ' A' ' 24' ' ' VAL . 35.4 tp -56.82 -45.61 82.16 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.73 1.212 . . . . 0.0 112.913 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -66.44 -34.83 78.83 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.385 0.428 . . . . 0.0 110.284 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -66.36 -38.35 87.39 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.632 0.373 . . . . 0.0 111.347 173.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 76' ' ' THR . 49.9 mt-10 -69.5 -36.99 76.99 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.909 0.884 . . . . 0.0 111.0 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.78 -19.38 59.03 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.017 0.927 . . . . 0.0 111.641 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.85 6.03 70.34 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.862 -0.41 . . . . 0.0 113.494 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.714 HG23 HD21 ' A' ' 87' ' ' ASN . 68.5 mt -71.27 109.98 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 124.511 1.124 . . . . 0.0 109.403 176.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -124.35 144.09 50.21 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.369 0.668 . . . . 0.0 111.507 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.83 -115.0 5.0 Favored Glycine 0 C--N 1.354 1.549 0 O-C-N 124.897 1.373 . . . . 0.0 114.831 169.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -64.61 -26.43 68.39 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.17 0.988 . . . . 0.0 112.067 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.714 HD21 HG23 ' A' ' 83' ' ' ILE . 6.6 t30 -79.71 -20.3 46.82 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.24 0.216 . . . . 0.0 110.988 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -64.86 139.59 58.78 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 174.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.411 HG11 ' HG ' ' A' ' 36' ' ' LEU . 35.3 t -75.9 114.84 40.87 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 124.03 0.831 . . . . 0.0 109.243 -177.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.87 140.3 94.58 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.465 2.777 . . . . 0.0 113.252 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.8 t -105.97 112.52 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.437 ' HB ' ' HG2' ' A' ' 37' ' ' GLU . 63.0 t -110.78 97.13 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 123.821 0.849 . . . . 0.0 109.656 -171.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -70.61 103.11 2.43 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.551 0.34 . . . . 0.0 110.276 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 63.1 mt -98.77 131.02 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.38 95.1 4.41 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -137.68 113.21 9.48 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.44 0.696 . . . . 0.0 110.448 -174.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.6 m -69.17 151.37 46.43 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.213 0.605 . . . . 0.0 110.774 173.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -75.86 88.36 2.87 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.976 0.51 . . . . 0.0 110.011 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.927 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.098 175.388 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.4 mtm . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.759 0.314 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.01 -86.67 0.74 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -171.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 58.65 25.95 13.92 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.836 1.254 . . . . 0.0 112.257 173.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -130.54 101.72 5.83 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -81.45 -79.12 0.17 Allowed 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -163.15 -23.38 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.491 0.716 . . . . 0.0 111.736 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -64.75 -33.96 77.2 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.655 0.782 . . . . 0.0 111.077 -172.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 26.4 m170 67.8 18.72 9.7 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.885 1.274 . . . . 0.0 112.072 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.8 p -74.46 84.83 2.0 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.572 0.701 . . . . 0.0 110.427 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -131.68 -156.09 0.73 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.114 0.965 . . . . 0.0 108.963 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.6 ttt -54.07 130.32 37.6 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.335 0.654 . . . . 0.0 111.53 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -129.06 33.83 4.53 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.278 1.031 . . . . 0.0 109.426 -177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 58.95 91.62 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.403 1.081 . . . . 0.0 110.533 -175.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.5 t -77.49 121.81 24.36 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -115.87 150.1 18.7 Favored Glycine 0 N--CA 1.471 0.986 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -140.51 128.12 21.56 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.391 0.676 . . . . 0.0 109.729 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.34 141.24 35.61 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.7 pt -137.38 -175.44 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.237 1.415 . . . . 0.0 108.14 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.4 p -105.44 165.36 11.18 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.63 0.372 . . . . 0.0 110.209 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.46 ' O ' HG23 ' A' ' 24' ' ' VAL . 70.8 t-105 -56.43 -37.54 70.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.61 0.764 . . . . 0.0 109.879 169.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.18 -46.04 83.18 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 123.799 0.84 . . . . 0.0 112.217 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -61.31 -46.13 91.59 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.684 0.393 . . . . 0.0 110.895 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -54.29 -55.55 27.14 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 124.184 0.927 . . . . 0.0 111.256 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 20' ' ' TRP . 94.2 t -57.19 -62.69 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.299 0.639 . . . . 0.0 111.73 -176.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -67.38 -54.39 20.87 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.573 -170.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -87.64 -14.79 39.06 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.441 0.696 . . . . 0.0 112.649 -165.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -124.8 -67.12 0.93 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 118.397 0.544 . . . . 0.0 112.003 -174.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.4 tp -60.68 -47.98 83.85 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.749 0.819 . . . . 0.0 111.733 -172.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.9 m -68.96 -16.67 63.8 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.615 0.766 . . . . 0.0 112.807 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -93.56 -5.49 48.83 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.011 0.524 . . . . 0.0 111.512 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.18 33.94 82.1 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 123.572 0.545 . . . . 0.0 114.142 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.455 HG12 ' HD3' ' A' ' 52' ' ' LYS . 18.5 m -93.23 1.66 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 122.551 0.34 . . . . 0.0 111.071 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 t -96.67 126.68 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 120.688 0.28 . . . . 0.0 110.278 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.582 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 23.4 t70 -88.45 -50.36 6.36 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.347 1.059 . . . . 0.0 109.43 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -155.01 162.72 41.0 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.794 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.4 mt -117.08 103.32 10.11 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.457 0.703 . . . . 0.0 109.648 174.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -87.39 100.74 12.96 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.511 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.2 t -93.1 92.64 3.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -172.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.408 HG23 ' HB ' ' A' ' 94' ' ' ILE . 60.7 t -83.6 132.23 31.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.566 -175.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 66.19 11.12 7.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.895 1.278 . . . . 0.0 112.392 172.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.464 ' HB3' HG22 ' A' ' 67' ' ' VAL . 62.0 mttm 58.47 6.14 0.53 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.478 1.111 . . . . 0.0 112.55 -168.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -94.52 -38.11 11.06 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.7 1.2 . . . . 0.0 110.234 -168.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -148.4 151.85 35.98 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.237 -176.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.91 126.43 68.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.257 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -101.84 123.22 45.41 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.464 ' HB ' HG22 ' A' ' 60' ' ' VAL . 46.5 t -83.78 111.2 19.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.526 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.0 m -91.91 135.48 33.9 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.544 ' HE1' ' HA ' ' A' ' 59' ' ' TYR . 75.9 m-85 -85.49 148.46 25.96 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.308 0.38 . . . . 0.0 110.159 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.582 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 27.5 p -65.15 135.0 96.06 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.13 0.572 . . . . 0.0 111.055 176.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.31 95.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 123.706 2.937 . . . . 0.0 112.63 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.06 -47.37 0.92 Allowed Glycine 0 C--N 1.344 1.024 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.455 ' HD3' HG12 ' A' ' 32' ' ' VAL . 92.3 mttt -82.74 -6.19 59.28 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.454 0.702 . . . . 0.0 110.159 171.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.506 HG21 ' HB2' ' A' ' 48' ' ' PHE . 9.2 p -60.66 109.21 1.86 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.882 0.873 . . . . 0.0 109.573 167.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.1 166.49 18.64 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.803 2.335 . . . . 0.0 112.995 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.0 m -64.86 -16.33 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.321 0.648 . . . . 0.0 112.161 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.66 -42.71 93.45 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.78 0.832 . . . . 0.0 110.714 175.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.88 -1.43 68.33 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.089 -176.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -77.38 163.08 26.73 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.53 0.732 . . . . 0.0 111.154 -176.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.544 ' HA ' ' HE1' ' A' ' 48' ' ' PHE . 97.5 m-85 -129.27 153.51 47.73 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.641 177.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.464 HG22 ' HB ' ' A' ' 46' ' ' VAL . 19.1 m -109.56 159.16 9.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.504 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -159.44 164.5 34.48 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.836 0.855 . . . . 0.0 108.975 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -148.73 141.11 24.19 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -88.35 132.5 34.4 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 67' ' ' VAL . 24.3 pt -104.36 139.8 24.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 123.788 0.835 . . . . 0.0 109.808 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.22 -41.94 44.75 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.824 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.4 t -132.17 132.17 42.93 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.937 0.895 . . . . 0.0 110.393 177.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 41' ' ' LYS . 38.6 t -63.6 -35.49 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.467 0.707 . . . . 0.0 110.745 172.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -57.81 -50.26 73.86 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.767 0.827 . . . . 0.0 110.724 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.1 m -61.69 -45.82 92.34 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 124.167 0.917 . . . . 0.0 111.027 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -54.0 -51.25 64.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.197 0.599 . . . . 0.0 111.023 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -64.77 -51.13 63.91 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.577 0.751 . . . . 0.0 112.451 -174.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -66.74 -36.4 82.37 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.116 0.26 . . . . 0.0 111.054 -175.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -69.25 -42.53 75.49 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.424 ' HG ' ' NE2' ' A' ' 78' ' ' GLN . 29.9 tp -59.76 -53.19 60.88 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 123.593 0.558 . . . . 0.0 111.232 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -62.96 -41.84 99.64 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.046 0.539 . . . . 0.0 111.807 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.6 m -66.97 -54.95 16.85 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.387 0.675 . . . . 0.0 111.05 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.8 tp -52.0 -41.17 61.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.142 1.377 . . . . 0.0 112.651 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.424 ' NE2' ' HG ' ' A' ' 74' ' ' LEU . 44.8 mt-30 -64.01 -42.95 96.97 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.4 0.28 . . . . 0.0 110.487 175.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.495 ' NE2' ' HB3' ' A' ' 84' ' ' GLU . 23.8 mm-40 -63.37 -32.13 73.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.756 0.423 . . . . 0.0 111.782 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -64.42 -38.32 90.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.12 0.568 . . . . 0.0 110.32 173.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.4 mt -78.36 -13.97 59.61 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.518 0.727 . . . . 0.0 111.324 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.35 21.35 58.7 Favored Glycine 0 C--N 1.355 1.606 0 C-N-CA 122.88 0.276 . . . . 0.0 113.126 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.1 mt -94.06 131.62 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 125.467 1.507 . . . . 0.0 110.179 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.495 ' HB3' ' NE2' ' A' ' 79' ' ' GLN . 9.5 pt-20 -166.63 160.83 15.4 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.026 0.93 . . . . 0.0 109.737 175.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.93 -92.65 0.01 OUTLIER Glycine 0 C--N 1.347 1.149 0 O-C-N 123.919 0.762 . . . . 0.0 114.688 173.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -69.8 -46.44 65.7 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.37 1.068 . . . . 0.0 110.638 -172.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -92.48 -4.9 52.91 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.374 -174.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -70.39 128.28 35.66 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.153 0.581 . . . . 0.0 109.87 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.84 113.67 13.03 Favored Pre-proline 0 CA--C 1.55 0.977 0 O-C-N 124.049 0.843 . . . . 0.0 111.081 -170.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 74.9 Cg_exo -54.48 122.67 11.96 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.482 2.788 . . . . 0.0 112.666 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.7 121.43 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.8 t -118.69 97.47 5.34 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -71.61 117.87 13.73 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.408 ' HB ' HG23 ' A' ' 39' ' ' VAL . 54.9 mt -108.76 142.48 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.05 142.31 27.88 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -156.69 156.32 33.21 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.0 m 58.05 29.55 17.94 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.739 0.78 . . . . 0.0 110.161 -175.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -88.44 99.23 12.12 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.463 -176.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.156 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.879 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.56 ' SD ' ' HB3' ' A' ' 97' ' ' SER . 21.9 ptt? . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -98.93 134.38 11.66 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 167.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -68.32 144.74 54.7 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.401 0.681 . . . . 0.0 109.377 173.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -60.74 94.6 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.716 0.806 . . . . 0.0 110.327 177.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -77.57 87.62 3.89 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.019 0.914 . . . . 0.0 110.422 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -68.13 -45.05 74.68 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 172.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -138.43 153.35 48.87 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.878 1.271 . . . . 0.0 108.396 170.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -80.23 75.14 7.04 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 172.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.7 p -62.53 -43.79 97.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.396 0.678 . . . . 0.0 111.111 -173.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -171.88 165.98 6.4 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.465 1.106 . . . . 0.0 108.696 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.1 ttt -52.18 141.62 18.39 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.53 0.732 . . . . 0.0 110.412 171.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.578 ' HB2' ' HZ3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -51.12 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.157 1.383 . . . . 0.0 112.179 178.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -151.1 71.74 1.03 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.867 1.267 . . . . 0.0 107.835 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.7 t -76.33 89.97 3.18 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.79 178.24 30.81 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.28 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.594 ' HB2' HG12 ' A' ' 60' ' ' VAL . 51.6 mmm-85 -81.15 114.18 19.81 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -75.24 108.21 7.85 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 50.0 pt -105.49 -178.13 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 124.936 1.295 . . . . 0.0 108.804 173.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.4 p -98.85 168.6 10.02 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 123.186 0.594 . . . . 0.0 109.506 167.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.476 ' O ' HG23 ' A' ' 24' ' ' VAL . 44.8 t-105 -53.74 -42.74 68.46 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.563 0.745 . . . . 0.0 110.336 171.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -60.33 -43.47 96.37 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.007 0.523 . . . . 0.0 112.34 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.516 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 63.1 m-20 -64.5 -35.12 79.91 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.51 0.324 . . . . 0.0 110.845 177.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 35.8 t80 -57.67 -51.93 67.51 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 123.905 0.753 . . . . 0.0 110.839 174.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 20' ' ' TRP . 90.4 t -54.75 -62.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.047 0.939 . . . . 0.0 112.136 -176.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -73.25 -49.27 28.7 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.06 -18.91 37.99 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -170.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.552 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 60.0 m-85 -128.12 -64.93 0.93 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.075 0.852 . . . . 0.0 112.994 -170.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -60.84 -46.25 91.32 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.312 0.645 . . . . 0.0 111.787 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.1 t -58.56 -27.77 64.9 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.581 1.152 . . . . 0.0 112.929 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -87.51 -17.63 31.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.957 0.503 . . . . 0.0 110.739 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.35 32.59 84.13 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 123.804 0.69 . . . . 0.0 113.897 -172.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.8 m -80.7 -0.88 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.3 t -100.5 132.16 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.694 0.798 . . . . 0.0 110.117 -170.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -83.28 -52.69 6.34 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.206 1.002 . . . . 0.0 109.967 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -154.67 156.81 37.11 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.657 0.783 . . . . 0.0 109.74 -175.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.3 mt -112.28 102.87 11.0 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -92.5 101.88 14.33 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.984 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 38.7 t -83.88 96.23 4.21 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -175.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.23 118.63 25.66 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.639 -173.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.502 HD22 ' HB3' ' A' ' 98' ' ' ASP . 2.6 t-20 58.74 18.38 5.93 Favored 'General case' 0 CA--C 1.559 1.298 0 O-C-N 124.944 1.402 . . . . 0.0 112.587 172.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm 58.66 2.23 0.22 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.388 1.475 . . . . 0.0 114.33 -171.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -82.05 -33.85 29.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.371 0.668 . . . . 0.0 109.803 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -154.36 163.81 39.58 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.767 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 57.9 t -111.74 129.28 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -103.84 128.07 51.31 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.88 106.98 17.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.397 -1.274 . . . . 0.0 107.656 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.4 m -96.71 125.53 41.23 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.451 ' HB2' HG21 ' A' ' 53' ' ' THR . 98.2 m-85 -94.44 170.38 9.53 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.027 0.829 . . . . 0.0 110.994 -173.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.6 p -82.49 145.25 50.98 Favored Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 168.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.06 -34.73 69.29 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.384 2.723 . . . . 0.0 113.621 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.57 -18.19 69.05 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.654 0.596 . . . . 0.0 113.834 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -118.17 17.01 14.06 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.519 0.728 . . . . 0.0 112.408 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.451 HG21 ' HB2' ' A' ' 48' ' ' PHE . 20.5 p -65.51 137.54 96.55 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.65 170.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.97 154.18 22.78 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 122.987 2.458 . . . . 0.0 111.358 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.5 p -56.18 -27.34 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 124.255 1.022 . . . . 0.0 112.73 -171.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.7 -13.63 61.53 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.016 0.927 . . . . 0.0 112.9 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.67 33.55 71.67 Favored Glycine 0 C--N 1.346 1.13 0 O-C-N 123.656 0.597 . . . . 0.0 112.254 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -123.29 -174.73 3.02 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.798 0.839 . . . . 0.0 110.669 -175.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -112.71 174.02 6.1 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.202 1.001 . . . . 0.0 109.491 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 16' ' ' ARG . 11.4 m -124.6 166.7 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -165.2 159.86 17.95 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.767 0.427 . . . . 0.0 111.079 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -147.76 142.29 26.48 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.4 0.68 . . . . 0.0 109.914 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -81.49 141.64 33.66 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 67' ' ' VAL . 33.3 pt -117.42 124.09 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.274 0.63 . . . . 0.0 110.361 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -71.6 -40.46 59.1 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.1 t -129.92 120.01 24.18 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.118 0.967 . . . . 0.0 108.73 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.499 ' HA ' HD13 ' A' ' 64' ' ' ILE . 97.5 t -56.04 -38.83 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.49 1.116 . . . . 0.0 110.774 172.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -60.66 -45.62 93.44 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.003 0.921 . . . . 0.0 110.805 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.1 m -59.57 -47.46 85.46 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.353 0.661 . . . . 0.0 110.747 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -53.65 -60.43 3.32 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.772 0.829 . . . . 0.0 111.862 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -42.01 80.19 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.24 0.616 . . . . 0.0 112.032 -169.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -62.9 -47.79 81.77 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.063 0.545 . . . . 0.0 110.851 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -65.92 -38.73 89.45 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.329 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.3 tp -58.04 -56.85 16.67 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.683 0.793 . . . . 0.0 111.974 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -35.17 79.55 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 123.452 0.47 . . . . 0.0 112.182 -174.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.1 m -62.26 -55.03 32.39 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.328 0.651 . . . . 0.0 110.116 172.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.468 HD22 HG13 ' A' ' 24' ' ' VAL . 52.5 tp -50.77 -45.09 58.88 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.644 1.578 . . . . 0.0 113.04 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -63.07 -41.32 99.41 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.046 0.539 . . . . 0.0 110.775 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -65.2 -35.83 82.28 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.129 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -71.33 -44.12 65.7 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.514 0.726 . . . . 0.0 111.458 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.7 mt -74.19 -7.27 52.08 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.753 0.821 . . . . 0.0 111.888 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.27 8.18 87.84 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.506 0.504 . . . . 0.0 112.537 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.9 mt -70.24 108.67 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.868 1.267 . . . . 0.0 108.057 175.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -141.59 162.73 34.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.627 0.771 . . . . 0.0 110.616 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.44 -120.67 23.75 Favored Glycine 0 C--N 1.344 1.009 0 O-C-N 124.577 1.173 . . . . 0.0 112.995 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.36 -39.99 85.03 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.69 1.196 . . . . 0.0 111.362 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -69.5 -19.75 63.73 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.353 0.661 . . . . 0.0 111.596 -168.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -68.35 148.29 50.92 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.911 0.386 . . . . 0.0 111.097 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.92 117.93 56.44 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.744 -173.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.16 150.63 72.07 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 123.215 2.61 . . . . 0.0 112.473 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.3 t -112.88 116.89 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.665 0.786 . . . . 0.0 108.957 -176.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.0 t -117.92 115.6 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.419 1.088 . . . . 0.0 108.56 -171.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -94.69 115.57 27.7 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.176 0.59 . . . . 0.0 110.902 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.06 146.51 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 175.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.13 19.15 4.42 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.852 0.861 . . . . 0.0 111.706 174.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 54.75 -88.71 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.815 1.246 . . . . 0.0 110.112 -166.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.56 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 26.6 t -174.92 11.01 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.272 1.829 . . . . 0.0 107.635 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.502 ' HB3' HD22 ' A' ' 40' ' ' ASN . 26.0 t70 -96.18 -18.56 20.0 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.983 1.313 . . . . 0.0 110.446 -167.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.921 0 CA-C-O 119.376 -0.68 . . . . 0.0 111.856 -177.72 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 tpt . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -90.52 -145.67 14.3 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.111 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -74.13 133.04 42.79 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.033 0.417 . . . . 0.0 110.1 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -143.94 166.59 24.52 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.696 0.798 . . . . 0.0 110.976 -178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -90.29 -19.4 24.13 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.719 0.808 . . . . 0.0 110.907 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.493 ' NE2' ' HA ' ' A' ' 9' ' ' SER . 14.9 t60 71.62 113.18 0.06 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.958 1.303 . . . . 0.0 110.251 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -126.57 133.53 51.05 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.772 0.829 . . . . 0.0 109.597 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 72.8 t60 46.71 46.9 15.05 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.197 1.399 . . . . 0.0 111.421 174.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.493 ' HA ' ' NE2' ' A' ' 6' ' ' HIS . 16.4 m 61.79 -86.23 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.965 1.306 . . . . 0.0 110.193 -172.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -170.26 -156.97 0.14 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.684 1.194 . . . . 0.0 107.896 177.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.1 ttt 76.69 137.35 0.06 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.356 1.062 . . . . 0.0 112.492 168.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.581 ' HB2' ' HZ3' ' A' ' 12' ' ' LYS . 10.0 mtmp? -118.3 -64.32 1.3 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 169.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.2 mtm105 -142.61 166.83 23.59 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.054 0.942 . . . . 0.0 109.467 177.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.7 p -70.04 81.59 0.49 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.421 0.629 . . . . 0.0 110.33 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.41 76.9 0.02 OUTLIER Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.373 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.595 ' HB2' HG13 ' A' ' 60' ' ' VAL . 18.8 mtm180 -90.68 123.05 33.98 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -177.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.67 109.83 6.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.684 0.394 . . . . 0.0 110.095 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 36.6 pt -104.16 170.89 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.023 0.929 . . . . 0.0 109.226 175.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 76.9 p -86.41 168.62 13.64 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 166.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.56 ' O ' HG22 ' A' ' 24' ' ' VAL . 69.2 t-105 -55.1 -40.78 70.81 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.626 0.579 . . . . 0.0 109.849 168.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -56.15 -47.97 77.18 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.552 0.741 . . . . 0.0 111.424 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.555 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 39.7 m-20 -65.11 -39.19 92.77 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.488 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 19.5 t80 -53.8 -48.92 69.37 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 124.208 0.943 . . . . 0.0 110.852 176.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 20' ' ' TRP . 61.2 t -67.4 -65.98 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 123.572 0.545 . . . . 0.0 111.231 -176.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -67.76 -46.67 71.4 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.637 -166.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -85.56 -18.53 33.13 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.964 0.506 . . . . 0.0 112.001 -172.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.488 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 47.8 m-85 -127.55 -67.99 0.8 Allowed 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 119.277 0.944 . . . . 0.0 112.946 -171.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.13 -47.99 83.27 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.736 0.815 . . . . 0.0 111.482 -172.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.4 m -63.79 -23.25 67.29 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.855 0.862 . . . . 0.0 113.13 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -101.99 4.47 39.95 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 119.361 -0.352 . . . . 0.0 111.533 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.63 28.24 56.14 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.1 m -81.31 -5.96 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.115 0.566 . . . . 0.0 111.01 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.83 136.4 26.09 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 C-N-CA 124.014 0.926 . . . . 0.0 108.923 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -86.86 -57.75 2.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.131 0.973 . . . . 0.0 108.978 174.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -153.31 159.93 42.6 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.716 -174.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.4 mt -113.87 102.17 9.96 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -94.8 103.68 15.58 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.446 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 18.4 t -87.79 101.7 11.76 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -174.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.5 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 94.9 t -75.59 116.8 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.615 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 21.4 p-10 37.85 37.17 0.12 Allowed 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 128.348 2.659 . . . . 0.0 115.913 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt 67.27 -1.83 1.4 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.918 1.287 . . . . 0.0 112.793 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -80.76 -37.37 30.5 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.063 0.945 . . . . 0.0 110.42 -175.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -159.07 158.93 33.97 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.11 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 61.8 t -109.38 129.42 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.533 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -94.02 126.01 38.98 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.424 ' HB ' HG21 ' A' ' 60' ' ' VAL . 33.5 t -84.21 105.1 13.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.2 m -103.95 130.98 51.61 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.432 ' HB2' HG21 ' A' ' 53' ' ' THR . 92.8 m-85 -96.43 163.8 12.9 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.17 0.918 . . . . 0.0 111.956 -170.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.1 p -62.84 151.74 84.39 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 124.084 0.953 . . . . 0.0 112.052 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -55.67 106.94 0.21 Allowed 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.388 2.725 . . . . 0.0 113.911 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.17 -4.16 44.63 Favored Glycine 0 N--CA 1.478 1.439 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.559 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -71.06 -36.64 72.36 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.774 0.83 . . . . 0.0 109.936 176.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.432 HG21 ' HB2' ' A' ' 48' ' ' PHE . 25.6 p -90.15 110.76 42.64 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 124.356 1.062 . . . . 0.0 112.032 -172.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.28 -162.74 0.19 Allowed 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.986 3.124 . . . . 0.0 112.992 173.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.66 -29.53 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 124.747 1.219 . . . . 0.0 112.975 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.4 -34.58 75.59 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.512 0.673 . . . . 0.0 111.161 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.02 -43.65 1.82 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.77 -175.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.489 ' NE2' HH12 ' A' ' 16' ' ' ARG . 16.7 mm100 61.9 -0.16 0.47 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.113 1.365 . . . . 0.0 114.583 174.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -62.55 127.63 32.22 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.595 HG13 ' HB2' ' A' ' 16' ' ' ARG . 29.5 m -124.67 156.51 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 124.127 0.892 . . . . 0.0 108.595 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -155.23 171.23 20.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.938 0.495 . . . . 0.0 110.556 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -150.54 143.66 24.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.83 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -79.97 134.45 36.25 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.182 0.593 . . . . 0.0 110.454 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.8 pt -120.24 175.66 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.148 0.579 . . . . 0.0 110.334 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.4 -50.69 0.08 OUTLIER Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.2 t -100.72 108.87 20.83 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.771 0.828 . . . . 0.0 109.631 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.0 t -57.88 -37.69 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.124 0.97 . . . . 0.0 110.402 170.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -53.59 -50.23 66.05 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.786 1.234 . . . . 0.0 110.574 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.6 m -66.83 -43.75 82.9 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 124.126 0.891 . . . . 0.0 111.275 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -53.52 -49.56 67.33 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.084 0.554 . . . . 0.0 110.948 172.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -65.61 -51.67 57.88 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.256 1.022 . . . . 0.0 112.847 -172.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.5 ptt85 -68.11 -38.24 82.05 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.57 0.544 . . . . 0.0 111.255 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -72.48 -39.14 67.93 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 40.5 tp -59.92 -54.42 46.3 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.822 0.849 . . . . 0.0 111.931 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.445 ' HB2' HH12 ' A' ' 88' ' ' ARG . 13.6 pt-20 -63.13 -40.03 96.41 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.301 0.64 . . . . 0.0 111.447 -175.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.7 m -66.86 -49.43 65.7 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.617 0.767 . . . . 0.0 109.736 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 43.0 tp -51.11 -48.81 61.62 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.526 1.13 . . . . 0.0 111.998 174.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -62.42 -46.41 88.68 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 123.67 0.606 . . . . 0.0 111.225 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -67.04 -30.15 70.14 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 123.043 0.214 . . . . 0.0 110.871 -177.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.64 -42.65 70.59 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.812 0.845 . . . . 0.0 110.842 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 94.4 mt -71.81 -12.16 61.16 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.645 0.778 . . . . 0.0 111.47 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.03 -0.61 76.24 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 123.288 0.368 . . . . 0.0 112.75 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 66.2 mt -74.46 92.28 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.75 152.2 48.05 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.82 0.448 . . . . 0.0 111.225 -172.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.92 -115.91 8.26 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 124.453 1.096 . . . . 0.0 113.02 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.16 -26.48 68.19 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.248 1.019 . . . . 0.0 111.595 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.45 -24.41 60.22 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.846 0.458 . . . . 0.0 111.881 -176.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.445 HH12 ' HB2' ' A' ' 75' ' ' GLU . 60.8 mtt180 -63.02 135.2 57.14 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 123.427 0.455 . . . . 0.0 110.802 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.56 118.87 74.81 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 123.733 0.813 . . . . 0.0 110.44 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.99 135.27 50.45 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 123.596 2.864 . . . . 0.0 113.262 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.2 116.38 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.531 0.733 . . . . 0.0 109.48 -176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.2 t -105.74 99.08 7.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -174.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -74.92 99.71 3.9 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.5 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 42.3 mm -84.75 135.31 25.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 98' ' ' ASP . . . -121.25 111.66 17.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.318 0.647 . . . . 0.0 110.499 -176.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' A' ' 40' ' ' ASN . 24.9 mm-40 -80.5 -70.83 0.5 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 51.0 m -99.68 -8.05 24.86 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.349 0.66 . . . . 0.0 110.844 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.631 ' HB2' ' HB1' ' A' ' 95' ' ' ALA . 2.3 m-20 -71.15 -28.53 64.33 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.799 0.839 . . . . 0.0 110.726 -178.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.178 0 CA-C-O 118.707 -1.052 . . . . 0.0 110.818 179.487 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 mtm . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.63 51.1 0.25 Allowed Glycine 0 C--N 1.342 0.907 0 C-N-CA 121.681 -0.295 . . . . 0.0 113.18 -174.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -74.15 -33.27 63.45 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -76.01 159.39 30.89 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.332 170.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -61.71 85.35 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.585 1.154 . . . . 0.0 111.034 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -150.35 71.47 1.06 Allowed 'General case' 0 C--O 1.245 0.865 0 C-N-CA 123.776 0.83 . . . . 0.0 109.298 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -168.37 142.49 3.29 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.987 173.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -139.02 115.7 10.68 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.2 p -83.1 125.2 31.23 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.473 0.709 . . . . 0.0 110.951 -173.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -166.46 -65.22 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.005 0.922 . . . . 0.0 109.69 177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.8 tpt 43.36 130.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 127.119 2.168 . . . . 0.0 115.258 -171.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.65 ' HZ3' ' HB3' ' A' ' 12' ' ' LYS . 9.2 mtpm? -117.56 77.62 1.15 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.49 0.716 . . . . 0.0 110.035 177.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -90.09 -48.81 6.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.573 171.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.1 t -165.75 65.02 0.11 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.99 -124.54 7.2 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -169.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.626 ' HB2' HG13 ' A' ' 60' ' ' VAL . 31.9 mmt180 -125.32 113.46 17.62 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 117.971 0.885 . . . . 0.0 109.968 175.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -78.52 133.21 37.41 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.267 0.556 . . . . 0.0 109.648 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 48.5 pt -132.13 -177.04 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 126.009 1.724 . . . . 0.0 108.27 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.8 p -102.98 169.91 8.28 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 167.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.491 ' O ' HG22 ' A' ' 24' ' ' VAL . 66.4 t-105 -53.18 -40.15 64.17 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.552 0.741 . . . . 0.0 110.486 170.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.6 tttp -56.48 -49.0 75.94 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.749 0.819 . . . . 0.0 111.632 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 30.5 m-20 -61.95 -40.66 96.3 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.625 0.37 . . . . 0.0 110.773 177.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.436 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 33.9 t80 -54.01 -53.0 59.0 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 124.413 1.07 . . . . 0.0 110.96 177.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 20' ' ' TRP . 63.8 t -57.23 -56.77 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 123.732 0.645 . . . . 0.0 111.074 -177.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -67.6 -58.95 3.78 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.739 0.816 . . . . 0.0 112.274 -170.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -85.44 -20.65 29.47 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.555 0.742 . . . . 0.0 112.084 -165.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.436 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 78.1 m-85 -120.66 -68.97 0.87 Allowed 'General case' 0 C--O 1.248 1.003 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -168.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.7 tp -60.21 -48.85 79.98 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.562 0.745 . . . . 0.0 111.894 -173.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.1 m -68.48 -17.05 64.1 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -96.6 1.38 51.18 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.267 0.485 . . . . 0.0 111.358 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.94 22.01 56.82 Favored Glycine 0 C--N 1.35 1.307 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.446 HG13 ' HD3' ' A' ' 52' ' ' LYS . 20.4 m -89.95 4.83 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.886 0.474 . . . . 0.0 111.334 -178.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.6 t -96.18 128.58 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.421 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 25.6 t70 -90.35 -50.09 6.16 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.885 0.874 . . . . 0.0 109.951 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -163.94 159.21 20.6 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.291 -177.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 46' ' ' VAL . 96.3 mt -120.72 102.55 8.47 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.987 0.915 . . . . 0.0 110.877 -173.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 49.4 mp0 -83.99 108.67 17.09 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.698 0.799 . . . . 0.0 110.092 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 41' ' ' LYS . 47.8 t -86.15 90.61 3.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.441 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 59.8 t -84.84 119.05 33.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.851 -170.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 56.89 22.38 7.06 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 125.404 1.482 . . . . 0.0 112.992 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.523 ' HA ' HG13 ' A' ' 38' ' ' VAL . 36.2 mtmm 58.58 8.28 0.86 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.526 1.13 . . . . 0.0 113.666 -173.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -88.59 -40.18 13.56 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.447 1.099 . . . . 0.0 110.851 -174.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -150.33 173.78 13.6 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.062 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.505 HG23 HG23 ' A' ' 38' ' ' VAL . 73.8 t -124.05 132.72 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.179 0.992 . . . . 0.0 109.676 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.688 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 40.9 ttm180 -96.39 113.09 24.64 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.521 1.128 . . . . 0.0 108.582 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' A' ' 36' ' ' LEU . 44.6 t -82.66 107.2 14.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.3 m -93.16 144.67 25.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.27 140.48 29.65 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.887 0.475 . . . . 0.0 112.02 177.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' A' ' 52' ' ' LYS . 32.1 p -62.06 128.1 90.32 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.121 0.968 . . . . 0.0 110.96 174.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.87 97.94 0.1 OUTLIER 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.112 2.541 . . . . 0.0 111.709 174.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.04 -39.09 1.54 Allowed Glycine 0 C--N 1.343 0.936 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 -175.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.446 ' HD3' HG13 ' A' ' 32' ' ' VAL . 61.0 mttp -106.28 5.23 29.55 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.588 0.755 . . . . 0.0 111.888 177.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.4 m -58.45 127.57 81.63 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.004 176.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.97 167.18 14.55 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.565 2.177 . . . . 0.0 112.389 -176.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.4 t -55.32 -43.7 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -84.43 86.82 7.23 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 168.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.9 59.73 4.47 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.039 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -110.55 129.88 55.69 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 171.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -61.87 152.85 30.64 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 123.573 0.546 . . . . 0.0 110.098 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.626 HG13 ' HB2' ' A' ' 16' ' ' ARG . 23.3 m -109.19 164.61 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -158.89 158.35 33.23 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 118.385 0.539 . . . . 0.0 111.202 -173.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -146.1 145.68 30.62 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.999 0.52 . . . . 0.0 110.245 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -85.35 121.81 28.62 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.973 0.909 . . . . 0.0 110.487 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 67' ' ' VAL . 36.2 pt -103.77 -51.51 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.283 0.633 . . . . 0.0 111.236 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.435 ' N ' HG13 ' A' ' 64' ' ' ILE . . . 71.03 -70.07 0.78 Allowed Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -165.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.6 m -81.55 96.27 7.39 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.108 0.963 . . . . 0.0 110.895 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.539 ' HA ' HD12 ' A' ' 64' ' ' ILE . 13.0 t -64.72 -34.06 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.626 0.77 . . . . 0.0 111.383 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -58.73 -45.35 89.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.063 0.545 . . . . 0.0 109.819 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.5 m -64.19 -46.23 84.87 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.014 0.926 . . . . 0.0 110.229 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -49.65 -54.53 18.0 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.197 0.999 . . . . 0.0 112.042 174.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -66.59 -43.5 84.72 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.125 0.891 . . . . 0.0 111.83 -174.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -63.98 -40.07 95.57 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.568 0.747 . . . . 0.0 111.041 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -64.17 -46.82 82.32 Favored 'General case' 0 C--O 1.216 -0.698 0 O-C-N 123.704 0.627 . . . . 0.0 109.678 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.7 tp -60.79 -41.81 96.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.935 0.894 . . . . 0.0 111.86 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -65.14 -51.53 60.69 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.211 0.605 . . . . 0.0 111.786 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 m -65.7 -37.28 86.01 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.618 0.767 . . . . 0.0 110.214 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.42 -44.02 95.82 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.494 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -66.25 -29.88 70.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.694 0.397 . . . . 0.0 110.516 176.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -66.88 -49.12 66.64 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.65 0.38 . . . . 0.0 111.397 175.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.46 -36.03 73.66 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.228 0.211 . . . . 0.0 111.239 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.531 ' HB2' HG12 ' A' ' 83' ' ' ILE . 92.0 mt -75.78 -20.06 58.52 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.144 0.578 . . . . 0.0 111.228 175.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.68 30.56 66.11 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 120.121 -0.266 . . . . 0.0 113.131 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 81' ' ' LEU . 17.6 mm -66.45 102.35 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.414 1.085 . . . . 0.0 109.279 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -72.6 166.99 21.64 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.63 -32.85 54.26 Favored Glycine 0 N--CA 1.48 1.613 0 O-C-N 124.179 0.924 . . . . 0.0 114.73 -171.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -67.28 -43.52 81.56 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.966 0.906 . . . . 0.0 110.408 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -81.19 -19.91 42.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.145 0.978 . . . . 0.0 111.593 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.5 mtt-85 -61.47 122.08 14.3 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.904 0.881 . . . . 0.0 110.567 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.5 t -77.91 117.95 69.06 Favored Pre-proline 0 CA--C 1.554 1.103 0 O-C-N 123.983 0.802 . . . . 0.0 110.47 -172.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 71.9 Cg_exo -54.84 136.98 74.19 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.841 3.027 . . . . 0.0 113.261 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.3 t -103.53 113.4 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 37' ' ' GLU . 60.3 t -100.89 149.36 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.927 1.291 . . . . 0.0 108.025 -177.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -114.2 131.5 56.44 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.441 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 38.4 mm -126.41 138.23 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.882 0.873 . . . . 0.0 109.244 -176.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.5 90.33 3.1 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -116.57 136.41 53.0 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.823 0.849 . . . . 0.0 110.657 -174.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 55.6 p -66.37 138.28 57.48 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.52 0.728 . . . . 0.0 110.038 175.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 71.22 9.1 6.56 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.672 1.189 . . . . 0.0 113.181 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.679 0 CA-C-O 119.158 -0.801 . . . . 0.0 113.3 178.481 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.11 100.43 0.4 Allowed Glycine 0 C--N 1.349 1.28 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 172.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -63.17 -67.43 0.42 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.743 0.817 . . . . 0.0 110.33 -174.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 29.0 p80 47.6 -65.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 127.393 2.277 . . . . 0.0 114.36 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -54.48 118.59 4.28 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.046 0.938 . . . . 0.0 110.698 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 65.18 53.67 1.31 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.994 1.318 . . . . 0.0 110.41 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -79.36 77.04 5.92 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.994 0.902 . . . . 0.0 110.321 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -69.03 -22.22 64.07 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.837 173.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.7 t -70.73 136.62 49.06 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.902 173.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -125.28 29.13 6.14 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.047 1.339 . . . . 0.0 108.091 171.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.7 ttp 76.23 -49.03 0.58 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 126.18 1.792 . . . . 0.0 112.993 172.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -73.86 84.14 1.69 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 173.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.8 ttp-105 -81.99 80.28 8.29 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.355 0.662 . . . . 0.0 109.805 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.9 t 65.46 -81.5 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 113.861 -1.518 . . . . 0.0 111.091 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -119.76 -151.84 8.91 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 174.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.621 ' HB2' HG11 ' A' ' 60' ' ' VAL . 59.2 mtm180 -96.92 114.03 25.62 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -78.81 129.72 34.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.4 pt -124.42 179.72 2.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 124.914 1.286 . . . . 0.0 108.921 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.8 p -106.32 170.1 8.12 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.66 0.784 . . . . 0.0 109.682 172.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.403 ' O ' HG21 ' A' ' 24' ' ' VAL . 71.1 t-105 -59.62 -39.87 85.71 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.527 0.731 . . . . 0.0 111.174 176.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -55.68 -52.38 64.05 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.585 0.754 . . . . 0.0 112.229 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -70.18 -32.38 70.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.935 0.494 . . . . 0.0 111.51 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.481 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 17.4 t80 -55.84 -56.11 24.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.635 0.774 . . . . 0.0 111.671 172.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.442 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 97.4 t -61.95 -58.33 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 123.595 0.56 . . . . 0.0 110.419 -176.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -65.47 -49.82 67.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.052 -168.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -87.46 -17.08 33.0 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -170.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.481 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 42.7 m-85 -128.6 -68.04 0.77 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -171.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.442 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 7.9 tt -59.06 -52.65 64.83 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.559 0.744 . . . . 0.0 111.903 -169.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 82.3 p -66.61 -22.57 66.12 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.554 0.742 . . . . 0.0 112.152 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -89.76 -5.42 56.98 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.342 0.657 . . . . 0.0 111.664 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.24 32.67 77.34 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.468 0.48 . . . . 0.0 113.991 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 m -101.93 11.44 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 122.855 0.462 . . . . 0.0 110.328 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.67 122.59 51.69 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 C-N-CA 124.207 1.003 . . . . 0.0 109.519 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 25.7 t70 -77.04 -45.89 25.62 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.732 0.813 . . . . 0.0 109.601 176.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -162.59 162.44 27.18 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.747 -167.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.421 ' HG ' HG11 ' A' ' 89' ' ' VAL . 95.4 mt -120.41 137.11 54.49 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.906 1.283 . . . . 0.0 108.375 170.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -120.13 110.49 16.7 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.213 0.605 . . . . 0.0 109.491 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.51 HG23 HG23 ' A' ' 44' ' ' VAL . 24.3 t -90.09 91.14 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -176.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.49 119.11 34.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -172.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 57.99 17.1 4.14 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.629 1.571 . . . . 0.0 113.855 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.1 mttp 61.69 2.81 0.76 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -172.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -80.04 -42.43 23.77 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.658 0.783 . . . . 0.0 109.856 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -151.38 170.41 19.63 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.334 -174.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.51 HG23 HG23 ' A' ' 38' ' ' VAL . 84.6 t -129.21 133.7 65.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -99.57 132.41 44.93 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.15 109.39 16.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 114.59 -1.186 . . . . 0.0 107.819 174.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.7 m -82.13 125.95 31.47 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 172.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 22.7 m-85 -84.21 133.42 34.59 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.369 0.668 . . . . 0.0 110.204 177.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -69.82 136.37 87.7 Favored Pre-proline 0 C--O 1.245 0.817 0 O-C-N 123.497 0.498 . . . . 0.0 109.95 175.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.91 134.46 53.54 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.54 2.16 . . . . 0.0 111.183 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.19 -47.34 3.65 Favored Glycine 0 N--CA 1.476 1.313 0 O-C-N 123.166 0.291 . . . . 0.0 112.958 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -58.99 -40.48 84.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.911 0.884 . . . . 0.0 110.868 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' A' ' 48' ' ' PHE . 30.7 m -135.65 137.59 26.17 Favored Pre-proline 0 C--O 1.246 0.903 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.83 130.92 37.01 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.028 1.819 . . . . 0.0 110.837 171.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.9 t -69.7 -16.34 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.698 0.799 . . . . 0.0 110.18 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -60.82 -36.27 78.65 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.599 1.159 . . . . 0.0 110.409 169.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.3 126.2 19.17 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.551 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -65.01 139.0 58.71 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.803 0.841 . . . . 0.0 111.017 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.441 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 17.8 m-85 -68.19 143.13 55.47 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.544 0.737 . . . . 0.0 110.732 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.621 HG11 ' HB2' ' A' ' 16' ' ' ARG . 34.9 m -107.7 161.33 6.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.506 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 45.5 p-90 -153.3 162.26 41.49 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.601 0.76 . . . . 0.0 109.276 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -147.75 144.38 28.21 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -79.57 136.22 36.8 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.459 HD12 ' HA ' ' A' ' 67' ' ' VAL . 43.1 pt -108.23 -42.22 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 110.658 -0.127 . . . . 0.0 110.658 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.81 -81.53 0.05 OUTLIER Glycine 0 C--N 1.35 1.306 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 -173.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.3 m -74.48 97.49 3.12 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.739 0.816 . . . . 0.0 109.134 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.459 ' HA ' HD12 ' A' ' 64' ' ' ILE . 25.2 t -59.81 -33.67 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.98 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -57.05 -40.77 77.42 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.944 0.898 . . . . 0.0 111.069 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.2 m -67.19 -46.01 75.19 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.129 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -52.64 -52.73 54.32 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.503 0.502 . . . . 0.0 111.213 177.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -59.63 -59.01 6.12 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.3 1.0 . . . . 0.0 112.767 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -67.2 -36.79 82.46 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.534 -171.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.82 -52.63 59.3 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 174.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 47.7 tp -52.78 -52.96 54.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.188 1.395 . . . . 0.0 112.722 -176.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -68.17 -45.55 73.16 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.449 -175.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.406 ' HA ' ' NE2' ' A' ' 79' ' ' GLN . 27.6 m -64.72 -45.14 87.78 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.4 tp -46.45 -48.52 18.93 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.883 1.673 . . . . 0.0 112.382 171.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -62.23 -43.25 99.24 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.3 0.64 . . . . 0.0 111.258 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.406 ' NE2' ' HA ' ' A' ' 76' ' ' THR . 17.7 mt-30 -65.25 -41.69 94.05 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.255 0.622 . . . . 0.0 111.142 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -68.47 -40.26 81.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.741 0.816 . . . . 0.0 111.25 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.58 -15.04 59.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.214 0.605 . . . . 0.0 112.52 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.96 13.57 68.94 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-O 120.269 -0.184 . . . . 0.0 113.41 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.4 mt -71.67 108.11 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.43 1.092 . . . . 0.0 109.2 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -137.98 151.47 47.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.929 0.891 . . . . 0.0 110.568 -172.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.22 -118.91 13.96 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 123.905 0.753 . . . . 0.0 113.65 174.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.69 -29.32 70.56 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.043 0.937 . . . . 0.0 111.734 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.84 -21.66 60.92 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.943 -171.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 37.6 mtp85 -66.55 150.01 49.63 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.175 0.59 . . . . 0.0 110.416 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.421 HG11 ' HG ' ' A' ' 36' ' ' LEU . 20.2 t -91.64 119.55 68.46 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.118 -168.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.4 123.86 13.59 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.066 2.51 . . . . 0.0 111.377 175.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.2 t -116.19 118.34 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.8 t -113.36 105.59 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.106 0.963 . . . . 0.0 109.567 -173.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -75.35 123.46 25.42 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.051 0.54 . . . . 0.0 109.814 175.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.8 mt -119.58 140.38 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.882 1.273 . . . . 0.0 108.084 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.01 85.96 2.44 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.031 0.443 . . . . 0.0 110.356 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -89.8 -175.91 4.78 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.642 172.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.4 t -152.37 80.16 1.24 Allowed 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.557 0.694 . . . . 0.0 109.275 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -89.22 98.37 11.73 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.611 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.936 0 CA-C-O 118.688 -1.062 . . . . 0.0 112.042 174.432 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 121.021 0.439 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.41 -72.94 0.07 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 175.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.1 t60 54.85 -86.78 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.054 1.342 . . . . 0.0 112.334 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -98.21 9.69 42.37 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.117 0.967 . . . . 0.0 110.611 -174.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -63.37 -24.1 67.7 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 122.87 0.468 . . . . 0.0 111.49 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -122.12 152.82 39.48 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.893 0.477 . . . . 0.0 110.018 168.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -72.77 144.59 47.52 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.264 0.626 . . . . 0.0 109.946 172.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -78.97 159.91 27.46 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.968 0.907 . . . . 0.0 111.114 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -78.93 147.4 33.03 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.136 0.574 . . . . 0.0 110.672 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 59.6 89.89 0.06 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.456 1.102 . . . . 0.0 110.769 -176.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.4 ttm -55.15 -44.14 74.85 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.51 1.124 . . . . 0.0 111.287 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -81.39 142.34 33.1 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.627 172.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -115.08 -1.24 13.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.983 0.913 . . . . 0.0 109.971 176.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 p -155.0 -172.32 4.15 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.158 0.983 . . . . 0.0 109.612 -174.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.56 -79.87 0.04 OUTLIER Glycine 0 C--N 1.349 1.282 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 20.4 tpp180 -135.35 128.63 32.04 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.833 0.853 . . . . 0.0 109.396 176.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -77.44 111.32 13.02 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 167.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.457 HD13 HG22 ' A' ' 46' ' ' VAL . 27.5 pt -93.77 166.78 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.555 1.142 . . . . 0.0 109.241 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.9 p -88.57 170.73 10.6 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -56.79 -40.86 76.67 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.097 0.559 . . . . 0.0 110.13 168.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -59.98 -49.17 78.74 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.663 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -66.61 -36.79 83.46 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.193 0.197 . . . . 0.0 111.183 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -54.65 -59.4 4.76 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.654 0.596 . . . . 0.0 110.736 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.424 HG13 HD13 ' A' ' 77' ' ' LEU . 47.5 t -60.17 -50.79 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 123.933 0.771 . . . . 0.0 111.255 -175.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -73.1 -56.97 4.38 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.793 -173.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -90.89 -10.99 40.53 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.9 -64.69 1.0 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 119.158 0.89 . . . . 0.0 111.737 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.9 tp -58.15 -41.81 84.55 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.551 1.14 . . . . 0.0 112.224 -176.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.8 t -66.55 -22.21 66.15 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.576 0.751 . . . . 0.0 112.751 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -87.09 -7.9 57.58 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.326 0.512 . . . . 0.0 110.949 175.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.66 12.95 60.25 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 114.259 0.464 . . . . 0.0 114.259 -175.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.14 -1.01 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 117.317 0.558 . . . . 0.0 111.084 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.55 126.44 45.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 C-N-CA 123.525 0.73 . . . . 0.0 109.155 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.472 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 16.5 t70 -86.03 -51.58 6.25 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.886 0.851 . . . . 0.0 109.095 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.529 ' HD3' HG23 ' A' ' 92' ' ' VAL . 16.2 ptp180 -160.13 164.42 32.99 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.05 -172.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.2 mt -117.17 101.93 8.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.685 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -92.96 107.61 19.36 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.495 0.718 . . . . 0.0 109.944 -171.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.556 HG23 HG23 ' A' ' 44' ' ' VAL . 41.0 t -91.89 91.61 3.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -175.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.675 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 49.1 t -79.08 114.22 19.52 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.666 -172.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 50.66 31.7 6.1 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.496 1.519 . . . . 0.0 113.217 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.449 ' HA ' HG13 ' A' ' 38' ' ' VAL . 61.3 mttm 66.8 -6.87 0.5 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 125.714 1.606 . . . . 0.0 112.801 -177.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.7 mmt-85 -64.94 -50.19 67.42 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 124.865 1.266 . . . . 0.0 110.904 -170.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -148.74 159.83 43.77 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.49 -175.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.556 HG23 HG23 ' A' ' 38' ' ' VAL . 65.5 t -101.14 123.06 53.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 171.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -101.6 129.29 47.68 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.54 ' HB ' HG22 ' A' ' 60' ' ' VAL . 68.8 t -85.13 110.24 19.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.5 m -82.97 134.74 35.04 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -82.99 128.17 34.23 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 171.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.472 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 5.1 t -72.79 146.56 88.14 Favored Pre-proline 0 CA--C 1.556 1.202 0 C-N-CA 123.109 0.564 . . . . 0.0 110.541 -176.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.02 116.1 2.97 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 123.399 2.732 . . . . 0.0 112.606 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.22 -17.2 24.39 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.061 -173.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -128.36 20.34 6.24 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.699 1.2 . . . . 0.0 110.798 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.5 m -91.51 120.92 68.09 Favored Pre-proline 0 C--O 1.244 0.798 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.3 155.04 70.75 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.698 2.266 . . . . 0.0 112.289 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.9 t -61.55 -40.39 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-O 121.588 0.709 . . . . 0.0 109.4 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -83.22 89.82 7.02 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.622 169.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.09 71.91 0.94 Allowed Glycine 0 C--N 1.346 1.118 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.854 176.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -101.69 101.11 11.57 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -76.53 136.23 39.3 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.512 0.725 . . . . 0.0 112.088 -166.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.54 HG22 ' HB ' ' A' ' 46' ' ' VAL . 18.7 m -106.29 140.75 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -177.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -157.21 173.57 16.77 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.344 -170.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -151.98 141.17 21.35 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.86 0.864 . . . . 0.0 109.178 175.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -78.17 147.54 34.47 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.2 pt -124.39 154.1 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.329 0.652 . . . . 0.0 109.289 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.24 -34.43 1.79 Allowed Glycine 0 N--CA 1.471 0.989 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 174.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 m -117.9 99.55 6.99 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.56 1.144 . . . . 0.0 108.535 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.6 t -60.64 -35.3 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 122.977 0.511 . . . . 0.0 110.036 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.05 -40.44 95.78 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.065 0.946 . . . . 0.0 110.736 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.3 m -67.95 -42.87 80.29 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.565 176.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -55.14 -43.76 74.48 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.909 0.756 . . . . 0.0 111.394 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.47 -51.07 64.89 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.864 0.466 . . . . 0.0 110.73 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -34.42 73.52 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -171.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 29.9 p30 -74.27 -33.33 63.24 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 176.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.7 tp -62.89 -42.96 99.96 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.607 0.763 . . . . 0.0 110.859 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -60.34 -52.82 63.62 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.137 0.575 . . . . 0.0 110.566 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.8 m -61.97 -42.2 98.86 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 123.666 0.604 . . . . 0.0 110.738 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 73' ' ' ASN . 1.8 tm? -56.53 -47.82 78.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.84 1.256 . . . . 0.0 110.879 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.436 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 77.3 mt-30 -65.18 -36.83 85.43 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.143 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -63.85 -39.53 94.44 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.096 0.558 . . . . 0.0 110.814 176.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.97 -51.26 70.0 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.038 0.935 . . . . 0.0 111.169 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.8 mt -83.85 -2.57 56.69 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.001 -173.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.87 9.95 83.51 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 120.281 -0.177 . . . . 0.0 112.935 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.46 HG21 ' HA ' ' A' ' 88' ' ' ARG . 57.2 mt -73.59 118.61 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.733 1.213 . . . . 0.0 109.077 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -168.56 173.86 7.16 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.482 0.713 . . . . 0.0 111.193 -172.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.75 -122.11 25.39 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.589 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.46 -34.2 58.71 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.43 0.692 . . . . 0.0 110.245 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -74.33 -6.1 46.08 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.438 0.695 . . . . 0.0 112.455 -171.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.46 ' HA ' HG21 ' A' ' 83' ' ' ILE . 6.9 ptm180 -79.91 156.45 27.28 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.079 0.466 . . . . 0.0 111.274 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.5 t -98.99 114.81 65.84 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.246 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.92 160.74 33.64 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.164 2.576 . . . . 0.0 112.875 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.8 t -110.65 132.31 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.614 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.529 HG23 ' HD3' ' A' ' 35' ' ' ARG . 21.8 t -117.92 97.37 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -73.01 100.83 3.08 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.376 0.67 . . . . 0.0 109.883 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.675 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 46.8 mm -78.55 122.67 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.11 67.4 0.79 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -140.74 107.27 5.31 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.248 -173.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.6 p -159.84 136.44 9.1 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.035 0.534 . . . . 0.0 110.738 -175.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -122.54 -47.04 2.12 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.529 0.732 . . . . 0.0 109.677 173.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 CA-C-O 119.049 -0.861 . . . . 0.0 111.64 177.324 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -77.01 126.18 30.55 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.92 0.888 . . . . 0.0 108.752 177.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.3 pt -126.55 166.86 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.785 1.234 . . . . 0.0 108.139 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 22' ' ' ASP . 9.8 t -96.4 157.84 15.71 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.543 ' O ' HG23 ' A' ' 24' ' ' VAL . 73.5 t-105 -53.91 -46.0 71.31 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.392 1.077 . . . . 0.0 110.993 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -61.04 -39.64 90.56 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.616 0.766 . . . . 0.0 112.037 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.498 ' H ' HG23 ' A' ' 19' ' ' THR . 24.4 t70 -66.55 -43.35 85.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.532 1.133 . . . . 0.0 110.415 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.444 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 12.5 t80 -52.46 -53.72 41.8 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.802 175.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.564 HG22 HD21 ' A' ' 77' ' ' LEU . 62.3 t -58.65 -55.45 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 123.805 0.691 . . . . 0.0 111.22 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -71.78 -49.55 37.88 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.085 -0.962 . . . . 0.0 112.147 -169.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -90.07 -13.84 35.03 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.444 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 41.7 m-85 -127.81 -64.72 0.95 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 119.245 0.929 . . . . 0.0 113.131 -175.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.428 HD11 HG21 ' A' ' 89' ' ' VAL . 32.8 tp -58.47 -50.18 74.66 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.566 0.747 . . . . 0.0 112.775 -170.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.7 p -70.45 -18.37 63.0 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.15 0.58 . . . . 0.0 111.623 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -86.41 -7.59 58.32 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.435 0.694 . . . . 0.0 110.893 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.33 13.16 67.3 Favored Glycine 0 C--N 1.356 1.659 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 m -86.8 -0.47 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.435 0.617 . . . . 0.0 111.274 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.6 t -97.87 128.03 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.185 0.994 . . . . 0.0 109.062 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 23.9 t70 -86.94 -52.42 5.47 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.08 0.952 . . . . 0.0 109.75 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.516 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 17.5 ptp180 -156.48 163.66 39.16 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.512 -174.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.6 mt -118.75 104.4 10.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.825 0.85 . . . . 0.0 108.972 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.44 ' HG2' ' HB ' ' A' ' 92' ' ' VAL . 46.1 mt-10 -97.75 107.77 20.33 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.734 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 41' ' ' LYS . 26.5 t -82.91 92.42 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -172.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.549 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 61.9 t -83.19 120.44 34.47 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 C-N-CA 122.797 0.439 . . . . 0.0 110.815 -169.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 54.53 21.45 3.35 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.811 1.644 . . . . 0.0 113.016 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HA ' HG12 ' A' ' 38' ' ' VAL . 99.5 mttt 55.85 5.43 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.301 1.44 . . . . 0.0 114.472 -175.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -78.41 -41.32 33.37 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.02 0.914 . . . . 0.0 108.87 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -151.49 172.91 15.24 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.021 -172.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.424 HG22 HG22 ' A' ' 38' ' ' VAL . 79.4 t -122.38 131.26 73.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 124.248 1.019 . . . . 0.0 108.53 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -90.43 127.01 36.08 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 60' ' ' VAL . 60.8 t -80.97 106.87 12.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 171.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.463 HG23 ' HE2' ' A' ' 59' ' ' TYR . 66.1 m -88.4 123.14 32.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -82.74 147.55 28.38 Favored 'General case' 0 C--O 1.247 0.939 0 O-C-N 123.609 0.568 . . . . 0.0 109.728 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 43.4 p . . . . . 0 CA--C 1.556 1.174 0 O-C-N 124.327 1.017 . . . . 0.0 109.855 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.463 ' HE2' HG23 ' A' ' 47' ' ' THR . 3.7 m-30 . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 121.252 0.549 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 46' ' ' VAL . 31.1 m -110.2 164.68 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.343 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -157.35 165.67 35.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.176 0.59 . . . . 0.0 110.027 -173.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -149.2 142.01 24.64 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.467 0.707 . . . . 0.0 109.967 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -75.31 140.05 42.86 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 67' ' ' VAL . 31.0 pt -115.18 -44.02 3.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.205 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.12 -74.74 0.36 Allowed Glycine 0 C--N 1.352 1.45 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 -171.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -80.33 97.47 7.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.456 1.102 . . . . 0.0 109.3 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.592 ' HA ' HD12 ' A' ' 64' ' ' ILE . 37.4 t -59.28 -37.44 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.821 0.849 . . . . 0.0 111.027 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 21.8 t70 -58.09 -49.87 75.43 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.497 1.119 . . . . 0.0 110.803 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.4 m -58.68 -46.08 88.03 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.917 0.887 . . . . 0.0 111.075 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -49.99 -50.81 45.85 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.16 0.984 . . . . 0.0 111.322 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 42.4 mt-10 -67.97 -45.83 73.09 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 124.251 0.97 . . . . 0.0 111.62 -173.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 68' ' ' ASP . 14.2 mtm180 -58.27 -46.05 86.73 Favored 'General case' 0 C--N 1.364 1.213 0 O-C-N 123.821 0.7 . . . . 0.0 109.845 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -65.48 -42.99 91.59 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.652 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.27 -50.59 69.57 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 123.946 0.778 . . . . 0.0 112.265 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -34.6 76.71 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.808 0.443 . . . . 0.0 111.675 -177.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.44 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 86.8 m -63.66 -52.02 62.57 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.352 0.596 . . . . 0.0 109.512 171.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.564 HD21 HG22 ' A' ' 24' ' ' VAL . 47.1 tp -52.99 -42.65 65.78 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.505 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -64.53 -45.7 86.03 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.915 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 76' ' ' THR . 10.1 pt20 -70.25 -26.84 64.02 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-N 117.763 0.256 . . . . 0.0 110.79 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 76' ' ' THR . 43.8 mt-10 -68.22 -50.23 55.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.013 0.925 . . . . 0.0 110.738 174.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.16 5.03 18.07 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.677 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.86 19.54 72.73 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-O 119.823 -0.432 . . . . 0.0 114.106 172.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.55 117.53 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.842 0.857 . . . . 0.0 109.612 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.65 -179.18 3.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.772 1.229 . . . . 0.0 108.568 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.17 -36.27 1.98 Allowed Glycine 0 N--CA 1.48 1.572 0 N-CA-C 116.246 1.258 . . . . 0.0 116.246 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.6 -37.03 60.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.504 0.722 . . . . 0.0 111.385 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -93.2 -5.63 49.56 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 118.85 -0.595 . . . . 0.0 111.966 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -58.85 124.51 20.06 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 118.046 0.385 . . . . 0.0 110.433 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.428 HG21 HD11 ' A' ' 28' ' ' LEU . 99.6 t -89.7 108.64 26.66 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.452 -172.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.516 ' HG2' ' HB3' ' A' ' 35' ' ' ARG . 19.4 Cg_endo -58.74 129.21 31.17 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.299 2.666 . . . . 0.0 112.591 -174.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.61 109.35 25.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.44 ' HB ' ' HG2' ' A' ' 37' ' ' GLU . 43.4 t -104.07 111.67 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -174.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -78.66 124.97 28.73 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 47.2 mt . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.469 ' HB2' HG12 ' A' ' 60' ' ' VAL . 34.7 mmt180 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 110.715 -0.106 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -79.76 109.62 14.35 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.2 pt -104.85 177.14 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 124.931 1.292 . . . . 0.0 108.9 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.5 p -92.02 163.14 14.09 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.554 ' O ' HG23 ' A' ' 24' ' ' VAL . 69.7 t-105 -58.89 -41.08 86.33 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.007 0.523 . . . . 0.0 109.657 171.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -52.16 -57.34 9.92 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.894 0.878 . . . . 0.0 111.733 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.33 -34.82 79.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.427 0.691 . . . . 0.0 111.157 -175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.404 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 45.2 t80 -54.56 -54.87 35.55 Favored 'General case' 0 C--N 1.344 0.334 0 O-C-N 123.991 0.807 . . . . 0.0 111.302 174.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.556 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 43.7 t -64.88 -50.64 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 O-C-N 123.43 0.456 . . . . 0.0 110.605 -174.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -66.44 -45.22 80.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.211 -172.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -95.71 -24.64 16.44 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -171.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.404 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 80.0 m-85 -122.13 -64.84 1.17 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 118.782 0.719 . . . . 0.0 112.591 -169.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 48.9 tp -55.54 -48.75 74.23 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.981 0.912 . . . . 0.0 112.045 -173.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 p -64.94 -22.95 67.08 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -89.49 -3.72 58.24 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.902 0.481 . . . . 0.0 110.439 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.37 19.14 61.78 Favored Glycine 0 C--N 1.355 1.599 0 N-CA-C 114.671 0.628 . . . . 0.0 114.671 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.5 m -79.06 0.16 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 117.415 0.608 . . . . 0.0 111.638 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.1 135.09 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.303 1.041 . . . . 0.0 108.941 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -81.64 -53.69 6.03 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.337 1.055 . . . . 0.0 108.887 174.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -168.15 164.19 13.35 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.944 -171.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.6 mt -116.96 105.18 12.05 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.061 0.945 . . . . 0.0 109.377 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -96.33 110.67 22.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.106 -174.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 41' ' ' LYS . 7.6 t -90.65 93.79 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -171.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.7 t -71.14 117.95 15.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 123.738 0.815 . . . . 0.0 110.919 -171.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 54.19 22.71 3.75 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.54 1.536 . . . . 0.0 113.03 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.633 ' HA ' HG12 ' A' ' 38' ' ' VAL . 8.5 mtpm? 53.7 17.15 1.15 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.852 1.261 . . . . 0.0 114.067 -172.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -91.28 -37.18 13.45 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.114 0.566 . . . . 0.0 110.434 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -152.8 163.78 39.07 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.75 0.82 . . . . 0.0 109.26 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.421 HG22 HG22 ' A' ' 38' ' ' VAL . 47.8 t -110.27 130.35 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.426 ' HG2' ' HB3' ' A' ' 61' ' ' TRP . 3.5 tmm_? -116.14 132.46 56.65 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.0 t -88.44 125.83 41.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.178 -170.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.9 m -95.14 129.77 42.12 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 167.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -87.03 144.7 26.78 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.828 0.451 . . . . 0.0 110.716 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 123.005 0.522 . . . . 0.0 110.195 -178.967 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 . . . . . 0 C--O 1.237 0.446 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.469 HG12 ' HB2' ' A' ' 16' ' ' ARG . 25.2 m -122.81 170.26 13.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.426 ' HB3' ' HG2' ' A' ' 45' ' ' ARG . 8.9 p-90 -165.43 158.56 16.1 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.622 0.369 . . . . 0.0 110.624 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -145.0 151.03 37.94 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.316 0.579 . . . . 0.0 110.291 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -82.9 151.06 26.13 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.579 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 67' ' ' VAL . 26.0 pt -125.69 144.19 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.521 0.728 . . . . 0.0 110.425 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.99 -52.64 7.75 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m -131.72 135.7 47.05 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.717 0.807 . . . . 0.0 108.972 176.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.44 ' HA ' HD12 ' A' ' 64' ' ' ILE . 5.0 t -67.15 -37.27 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.01 0.924 . . . . 0.0 110.477 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.533 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 5.9 m-20 -67.0 -49.41 65.44 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.646 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.8 m -62.7 -36.01 81.57 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 122.576 0.351 . . . . 0.0 110.647 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -54.33 -57.52 10.92 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 123.81 0.844 . . . . 0.0 111.385 174.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -64.33 -33.13 75.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.438 0.462 . . . . 0.0 111.368 -175.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 5.3 mmp_? -60.69 -55.53 32.13 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.099 0.476 . . . . 0.0 110.412 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -66.6 -42.4 86.97 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.224 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.5 tp -58.76 -56.02 27.58 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.111 0.964 . . . . 0.0 112.527 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -59.67 -42.06 92.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 123.447 0.467 . . . . 0.0 111.932 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.425 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 54.9 m -59.79 -53.08 62.11 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.3 tp -53.91 -46.48 71.46 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.813 1.645 . . . . 0.0 113.119 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -62.04 -48.34 80.68 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.998 0.519 . . . . 0.0 110.662 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -68.48 -22.95 64.53 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.42 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 76' ' ' THR . 61.1 mm-40 -71.56 -43.18 66.81 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.919 0.488 . . . . 0.0 110.135 169.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.0 mt -73.86 -15.58 61.15 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.921 0.888 . . . . 0.0 111.214 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.66 -6.79 80.04 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-O 119.601 -0.555 . . . . 0.0 112.923 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.418 HG22 ' HA ' ' A' ' 88' ' ' ARG . 77.8 mt -64.92 101.36 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.537 1.535 . . . . 0.0 110.271 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -144.31 167.84 21.49 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.523 1.129 . . . . 0.0 110.027 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.52 -122.89 23.96 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.506 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.97 -25.4 59.91 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.645 0.778 . . . . 0.0 111.307 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -75.61 -23.35 56.42 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.163 0.585 . . . . 0.0 110.407 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.423 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 15.0 ttm180 -57.88 137.48 56.64 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 124.103 0.961 . . . . 0.0 110.677 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.9 t -92.38 101.61 5.21 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.824 1.25 . . . . 0.0 109.723 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 88' ' ' ARG . 19.5 Cg_exo -68.15 153.69 74.17 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.994 2.463 . . . . 0.0 112.351 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.0 t -107.07 118.74 55.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.2 t -106.61 97.86 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -72.92 97.44 2.28 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.1 mt . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.221 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.578 ' HB3' HG12 ' A' ' 60' ' ' VAL . 69.1 ttp85 . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -73.56 109.2 6.89 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 37.9 pt -97.35 173.64 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 166.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.4 p -110.49 169.72 8.56 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 166.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.42 ' O ' HG23 ' A' ' 24' ' ' VAL . 69.9 t-105 -53.33 -37.67 62.51 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.119 0.968 . . . . 0.0 111.695 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -58.07 -46.01 86.16 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 176.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.541 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 39.5 m-20 -66.44 -35.31 79.98 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.128 0.571 . . . . 0.0 111.036 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.442 ' CZ ' HD11 ' A' ' 36' ' ' LEU . 31.7 t80 -59.77 -58.54 8.13 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.583 173.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.456 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 85.1 t -58.51 -57.11 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.179 0.592 . . . . 0.0 111.713 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -62.12 -56.23 20.94 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.031 0.832 . . . . 0.0 111.981 -173.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -84.49 -34.58 23.34 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.67 -168.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.404 ' HA ' HG22 ' A' ' 32' ' ' VAL . 21.2 m-85 -114.36 -62.25 1.63 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -162.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.456 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 68.4 tp -59.42 -51.12 71.26 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.294 1.038 . . . . 0.0 111.172 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.9 t -59.38 -24.19 63.22 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.001 0.92 . . . . 0.0 113.024 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -98.66 -6.0 30.58 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.547 0.339 . . . . 0.0 111.504 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.06 31.38 58.76 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 114.477 0.551 . . . . 0.0 114.477 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 27' ' ' TYR . 20.7 m -81.93 0.65 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.693 0.397 . . . . 0.0 110.882 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.9 t -98.65 128.48 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.514 1.126 . . . . 0.0 109.799 -173.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.555 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 31.0 t70 -77.81 -47.08 19.74 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.776 0.83 . . . . 0.0 109.692 177.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HD2' HG21 ' A' ' 92' ' ' VAL . 31.7 ptt-85 -162.68 163.93 26.73 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.968 0.793 . . . . 0.0 111.243 -174.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.442 HD11 ' CZ ' ' A' ' 23' ' ' PHE . 60.3 mt -117.8 104.66 11.17 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.583 1.153 . . . . 0.0 109.428 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -87.79 101.96 14.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.844 0.857 . . . . 0.0 109.767 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 44' ' ' VAL . 35.6 t -88.32 91.3 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -175.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.9 t -92.91 119.69 41.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.825 -170.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 58.66 18.61 6.02 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.979 1.312 . . . . 0.0 112.56 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 54.84 21.09 3.4 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.87 1.268 . . . . 0.0 113.314 175.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -107.69 -28.51 9.67 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.283 1.033 . . . . 0.0 110.466 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -152.56 159.03 43.3 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.969 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 38' ' ' VAL . 57.9 t -124.03 130.67 73.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 -98.14 124.79 42.86 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.499 ' HB ' HG23 ' A' ' 60' ' ' VAL . 55.9 t -82.67 107.72 14.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.1 m -93.62 128.61 39.86 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -85.1 164.56 18.1 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.014 0.821 . . . . 0.0 109.519 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.555 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 11.5 t . . . . . 0 CA--C 1.557 1.233 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.8 p90 . . . . . 0 C--O 1.244 0.769 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.578 HG12 ' HB3' ' A' ' 16' ' ' ARG . 27.8 m -129.18 178.75 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.329 0.652 . . . . 0.0 109.724 177.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -157.86 162.05 38.35 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.995 0.518 . . . . 0.0 110.245 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.431 ' HB3' HG13 ' A' ' 18' ' ' ILE . 47.4 p90 -145.73 153.75 41.31 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.326 0.65 . . . . 0.0 109.454 175.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -80.34 152.76 28.77 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.787 0.435 . . . . 0.0 110.748 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.8 pt -126.01 144.45 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.232 0.613 . . . . 0.0 109.445 172.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.05 -61.99 2.56 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.1 m -127.48 133.71 49.86 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.674 0.789 . . . . 0.0 109.024 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.4 t -57.87 -40.47 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.351 1.06 . . . . 0.0 111.506 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.09 -40.41 96.18 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.619 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.2 m -67.88 -45.08 75.5 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -51.04 -52.94 38.11 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.481 1.112 . . . . 0.0 112.495 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -71.32 -35.97 71.41 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.466 0.478 . . . . 0.0 110.838 -174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -66.97 -39.56 87.26 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.573 0.349 . . . . 0.0 110.589 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -66.79 -52.62 41.84 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.088 0.555 . . . . 0.0 110.173 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.4 tp -53.48 -55.08 28.32 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.205 1.002 . . . . 0.0 111.377 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 79' ' ' GLN . 68.6 mm-40 -61.84 -48.92 78.37 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.796 0.685 . . . . 0.0 112.725 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 58.1 m -64.53 -50.11 68.64 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.471 0.482 . . . . 0.0 110.116 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.8 tp -50.26 -46.29 54.89 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.229 1.411 . . . . 0.0 112.471 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -61.65 -46.75 88.45 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.842 0.457 . . . . 0.0 110.641 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 75.0 mt-30 -62.69 -34.76 77.79 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.255 0.622 . . . . 0.0 111.065 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.8 -39.31 57.1 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.81 0.844 . . . . 0.0 111.702 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.57 -21.34 61.16 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.601 0.361 . . . . 0.0 110.951 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.3 -5.65 57.51 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 120.075 -0.292 . . . . 0.0 113.019 -173.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.7 mt -70.08 121.53 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 124.478 1.111 . . . . 0.0 109.984 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -162.42 162.48 27.71 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.077 0.551 . . . . 0.0 111.107 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.97 -111.09 3.64 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.636 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.97 -23.75 58.33 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.902 0.881 . . . . 0.0 110.901 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -83.75 -26.71 29.46 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 ttm105 -63.32 123.38 18.55 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.5 t -72.69 119.57 75.94 Favored Pre-proline 0 CA--C 1.555 1.155 0 O-C-N 123.808 0.693 . . . . 0.0 110.247 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 31.9 Cg_exo -60.41 141.22 95.05 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.42 2.747 . . . . 0.0 112.523 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.6 t -111.69 114.94 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.446 HG21 ' HD2' ' A' ' 35' ' ' ARG . 60.8 t -109.15 98.33 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.212 1.005 . . . . 0.0 109.043 -173.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -71.7 114.86 10.23 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.939 0.496 . . . . 0.0 110.434 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 58.7 mt . . . . . 0 CA--C 1.543 0.702 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.373 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.483 ' HB3' HG12 ' A' ' 60' ' ' VAL . 34.9 ttm180 . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -75.12 133.23 41.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.1 pt -128.67 168.82 21.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.755 1.222 . . . . 0.0 108.292 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.4 p -85.75 161.01 19.36 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.478 ' O ' HG23 ' A' ' 24' ' ' VAL . 61.2 t-105 -51.03 -48.98 61.36 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.933 0.893 . . . . 0.0 111.146 174.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -75.21 -24.13 57.71 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.515 0.509 . . . . 0.0 111.863 -175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -65.53 -42.81 91.57 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 172.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 17.7 t80 -56.44 -51.22 69.24 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.877 172.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 20' ' ' TRP . 60.8 t -58.11 -61.88 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.844 0.458 . . . . 0.0 111.035 -177.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -68.16 -46.17 71.49 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.427 0.691 . . . . 0.0 111.768 -166.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.406 ' O ' ' HD2' ' A' ' 30' ' ' LYS . 62.8 m-20 -84.77 -34.13 22.88 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.472 -172.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.428 ' HA ' HG22 ' A' ' 32' ' ' VAL . 88.0 m-85 -112.29 -66.57 1.07 Allowed 'General case' 0 C--O 1.248 0.977 0 O-C-N 121.849 -0.532 . . . . 0.0 111.825 -166.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.571 HD11 HG21 ' A' ' 89' ' ' VAL . 21.2 tp -64.57 -48.3 75.5 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -170.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 m -65.67 -21.2 66.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.627 0.771 . . . . 0.0 112.429 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' A' ' 26' ' ' ASN . 55.2 mttp -98.14 -1.02 43.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.858 0.863 . . . . 0.0 111.62 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.12 23.23 61.59 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 115.364 0.905 . . . . 0.0 115.364 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 27' ' ' TYR . 17.6 m -88.36 11.62 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 117.476 0.638 . . . . 0.0 110.668 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.43 136.16 31.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 125.193 1.397 . . . . 0.0 108.938 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.511 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 25.8 t70 -87.55 -49.05 7.44 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.918 0.887 . . . . 0.0 109.014 172.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 6.4 ptp180 -164.2 172.42 13.67 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.523 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.2 mt -119.95 112.97 19.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.201 1.001 . . . . 0.0 110.222 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -99.6 104.49 16.27 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.913 0.885 . . . . 0.0 110.069 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.522 HG22 HG22 ' A' ' 44' ' ' VAL . 28.2 t -86.83 99.61 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -175.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.3 t -89.54 123.05 41.56 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 C-N-CA 123.942 0.897 . . . . 0.0 110.367 -169.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 54.12 18.45 1.76 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.569 1.548 . . . . 0.0 113.14 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HB3' HG21 ' A' ' 67' ' ' VAL . 94.8 mttt 57.09 16.04 2.72 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.584 1.154 . . . . 0.0 113.496 -176.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -91.55 -32.87 15.38 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.334 0.654 . . . . 0.0 110.483 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -156.69 170.61 22.02 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.528 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.522 HG22 HG22 ' A' ' 38' ' ' VAL . 59.2 t -117.31 129.47 73.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.035 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -96.15 122.63 39.2 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.462 1.105 . . . . 0.0 108.08 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 60' ' ' VAL . 46.3 t -84.72 112.13 21.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.4 HG22 ' HB3' ' A' ' 34' ' ' ASP . 86.7 m -90.08 132.61 35.32 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.61 ' HE2' ' HA ' ' A' ' 59' ' ' TYR . 53.1 m-85 -84.33 146.82 27.51 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.568 0.747 . . . . 0.0 110.286 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.511 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.7 OUTLIER . . . . . 0 CA--C 1.565 1.533 0 C-N-CA 123.626 0.77 . . . . 0.0 110.154 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.61 ' HA ' ' HE2' ' A' ' 48' ' ' PHE . 35.6 p90 . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 120.59 0.233 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.52 HG23 ' HB ' ' A' ' 46' ' ' VAL . 27.6 m -110.38 153.36 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 169.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 -160.3 166.25 29.83 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.615 0.766 . . . . 0.0 109.777 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -147.78 140.39 24.64 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.35 0.66 . . . . 0.0 109.939 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -84.58 126.92 33.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.323 0.649 . . . . 0.0 109.637 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.586 HD12 ' HA ' ' A' ' 67' ' ' VAL . 41.3 pt -104.61 -41.13 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 122.508 0.323 . . . . 0.0 111.754 -173.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.78 -80.43 0.12 Allowed Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 -171.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.3 m -71.4 95.45 1.35 Allowed 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.788 0.835 . . . . 0.0 109.901 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.586 ' HA ' HD12 ' A' ' 64' ' ' ILE . 58.5 t -61.49 -40.34 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.522 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 5.8 m-20 -58.57 -44.53 89.78 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.856 0.863 . . . . 0.0 110.478 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.0 m -66.67 -40.31 88.55 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.702 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -55.77 -46.09 77.98 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 123.258 0.623 . . . . 0.0 110.618 173.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 47.4 mt-10 -64.07 -44.95 90.84 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 124.244 0.965 . . . . 0.0 109.973 -176.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 4.5 mmp_? -59.15 -51.22 70.93 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 124.186 0.928 . . . . 0.0 111.262 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -65.6 -40.47 92.71 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.41 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.9 -50.25 72.94 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.672 0.789 . . . . 0.0 112.197 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -32.98 70.29 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -175.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.2 m -64.11 -44.9 90.84 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.189 0.596 . . . . 0.0 109.846 171.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.449 HD21 HG22 ' A' ' 24' ' ' VAL . 34.3 tp -63.05 -37.4 87.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.699 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -63.94 -38.43 91.04 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.347 0.659 . . . . 0.0 109.998 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -68.08 -36.73 80.3 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 175.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.07 -46.0 72.28 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.038 0.535 . . . . 0.0 111.383 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.0 mt -82.42 2.22 33.64 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.627 0.771 . . . . 0.0 112.259 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.47 14.6 79.39 Favored Glycine 0 C--N 1.358 1.787 0 O-C-N 123.311 0.382 . . . . 0.0 113.684 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 87.2 mt -82.56 111.66 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.282 1.433 . . . . 0.0 109.603 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.39 168.02 28.64 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.124 0.57 . . . . 0.0 111.605 -175.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.11 -126.41 23.08 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.492 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.81 -14.24 60.67 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.039 0.536 . . . . 0.0 110.487 177.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -79.64 -16.16 56.28 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.855 0.862 . . . . 0.0 111.699 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -51.1 129.89 24.94 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.067 0.947 . . . . 0.0 111.002 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.571 HG21 HD11 ' A' ' 28' ' ' LEU . 49.6 t -63.02 113.1 8.19 Favored Pre-proline 0 N--CA 1.474 0.727 0 O-C-N 124.484 1.115 . . . . 0.0 109.905 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.4 ' HG2' ' HB3' ' A' ' 35' ' ' ARG . 54.4 Cg_endo -68.76 115.59 4.02 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.344 2.029 . . . . 0.0 111.137 -177.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.2 t -108.45 121.05 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.4 t -116.57 119.68 62.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -174.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -90.07 113.66 25.42 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 176.591 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HB3' HG12 ' A' ' 60' ' ' VAL . 20.9 tpp180 . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 120.422 0.153 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.63 110.15 13.49 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 27.4 pt -104.73 174.06 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.393 1.477 . . . . 0.0 109.959 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.6 p -91.3 168.74 11.36 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 169.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.564 ' O ' HG23 ' A' ' 24' ' ' VAL . 74.1 t-105 -57.07 -41.68 79.22 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.74 0.65 . . . . 0.0 109.473 168.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -55.66 -50.62 69.75 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.304 1.041 . . . . 0.0 112.409 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.499 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 65.1 m-20 -62.97 -38.95 93.14 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.856 0.462 . . . . 0.0 110.184 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.44 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 34.5 t80 -55.04 -50.51 68.9 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.663 1.227 . . . . 0.0 110.873 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 20' ' ' TRP . 47.1 t -58.12 -62.42 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 123.611 0.569 . . . . 0.0 110.895 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -65.87 -53.76 35.5 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.954 -168.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -84.73 -21.49 30.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.154 0.582 . . . . 0.0 111.86 -167.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.44 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 73.0 m-85 -122.75 -69.35 0.83 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -169.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.54 -56.54 20.79 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.834 0.853 . . . . 0.0 111.467 -173.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.6 m -60.38 -20.33 59.16 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.215 1.006 . . . . 0.0 112.891 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -94.05 -9.13 37.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.667 0.787 . . . . 0.0 111.617 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.27 21.5 68.37 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.723 0.64 . . . . 0.0 114.385 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.429 HG22 ' HA ' ' A' ' 27' ' ' TYR . 10.4 m -80.74 -5.39 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 117.143 0.472 . . . . 0.0 110.984 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.8 t -93.75 130.07 43.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 123.321 0.648 . . . . 0.0 109.332 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.459 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 30.1 t70 -83.97 -51.96 6.71 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.495 1.118 . . . . 0.0 109.739 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.497 ' HD2' HG21 ' A' ' 92' ' ' VAL . 25.0 ptt180 -158.16 160.47 37.27 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.293 -174.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.8 mt -118.03 103.0 9.48 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.998 0.919 . . . . 0.0 109.027 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 43.4 mt-10 -87.55 108.65 19.15 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.415 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 41' ' ' LYS . 43.0 t -84.83 92.82 3.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -177.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 96.0 t -81.73 109.81 16.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.101 -167.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 52.25 27.25 4.56 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 125.548 1.539 . . . . 0.0 112.945 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.552 ' HA ' HG12 ' A' ' 38' ' ' VAL . 35.3 mtmm 63.31 -4.44 0.3 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.077 1.351 . . . . 0.0 113.869 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -76.08 -38.88 56.48 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.386 1.074 . . . . 0.0 110.604 -171.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -153.44 179.98 8.29 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.574 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 38' ' ' VAL . 98.3 t -127.64 131.44 70.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 123.97 0.908 . . . . 0.0 108.694 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -100.41 123.63 44.88 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -81.86 108.77 15.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.869 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.3 m -86.14 131.4 34.26 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -85.06 149.94 25.21 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.459 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 42.1 p . . . . . 0 CA--C 1.548 0.87 0 O-C-N 123.416 0.447 . . . . 0.0 110.391 175.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 121.085 0.469 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 16' ' ' ARG . 20.0 m -107.23 164.41 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -162.69 162.81 27.07 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.785 0.326 . . . . 0.0 111.119 -172.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -145.06 146.69 31.97 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.727 0.811 . . . . 0.0 109.379 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -81.65 140.07 34.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.19 0.596 . . . . 0.0 109.591 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 65' ' ' GLY . 42.7 pt -117.12 -49.0 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.589 0.356 . . . . 0.0 111.434 -177.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.439 ' N ' HG13 ' A' ' 64' ' ' ILE . . . 67.67 -78.2 0.19 Allowed Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.949 -0.46 . . . . 0.0 111.949 -171.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.5 m -74.27 94.09 2.45 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.595 0.758 . . . . 0.0 109.663 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.428 ' HA ' HD12 ' A' ' 64' ' ' ILE . 40.3 t -60.6 -36.66 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.805 1.242 . . . . 0.0 111.172 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -62.66 -39.13 92.95 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.553 0.741 . . . . 0.0 110.331 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.9 m -70.19 -41.44 73.69 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 123.503 0.502 . . . . 0.0 110.666 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -52.85 -53.39 49.51 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.19 0.596 . . . . 0.0 110.735 174.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -60.51 -52.41 65.32 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 124.509 1.13 . . . . 0.0 111.425 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.506 ' HA ' ' HE ' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -59.28 -46.39 88.67 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.508 1.123 . . . . 0.0 111.921 -174.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -67.47 -41.89 83.86 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.391 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.459 ' HG ' ' NE2' ' A' ' 78' ' ' GLN . 33.4 tp -59.55 -43.41 93.53 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 124.108 0.88 . . . . 0.0 111.465 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -60.27 -56.44 21.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.841 0.857 . . . . 0.0 111.059 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.1 m -63.22 -48.57 77.73 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.43 1.081 . . . . 0.0 110.303 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.545 HD21 HG22 ' A' ' 24' ' ' VAL . 42.9 tp -53.99 -53.06 58.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.77 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.459 ' NE2' ' HG ' ' A' ' 74' ' ' LEU . 45.0 mt-30 -66.8 -30.17 70.3 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.266 0.354 . . . . 0.0 111.266 -178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -63.86 -38.68 92.0 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.615 0.366 . . . . 0.0 110.076 172.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -70.14 -43.92 69.94 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.221 0.608 . . . . 0.0 110.99 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 76.5 mt -71.22 -18.75 62.44 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.624 0.77 . . . . 0.0 111.578 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.02 8.1 76.29 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.282 0.364 . . . . 0.0 112.982 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.516 HG22 ' HA ' ' A' ' 88' ' ' ARG . 80.1 mt -82.52 97.08 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 125.343 1.457 . . . . 0.0 108.769 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -138.93 155.52 47.99 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.836 -0.54 . . . . 0.0 111.51 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.44 -99.85 0.11 Allowed Glycine 0 C--N 1.354 1.532 0 O-C-N 124.74 1.275 . . . . 0.0 113.893 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -75.59 -29.04 59.15 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.348 1.059 . . . . 0.0 111.427 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -87.82 -23.46 24.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.379 0.672 . . . . 0.0 111.277 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.516 ' HA ' HG22 ' A' ' 83' ' ' ILE . 43.0 ttm180 -61.48 119.54 8.78 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.401 0.68 . . . . 0.0 110.557 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 80.4 t -66.65 118.94 59.16 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.829 0.852 . . . . 0.0 111.225 -175.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.44 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 31.5 Cg_exo -60.58 146.87 96.26 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.294 2.662 . . . . 0.0 113.239 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.4 t -104.91 129.84 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.497 HG21 ' HD2' ' A' ' 35' ' ' ARG . 4.5 t -127.78 98.99 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.505 0.722 . . . . 0.0 109.394 -175.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -69.55 106.33 2.97 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 29.9 mm . . . . . 0 C--O 1.22 -0.457 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -175.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.436 ' HB2' HG12 ' A' ' 60' ' ' VAL . 49.7 mtp180 . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 120.342 0.115 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -79.92 110.92 15.76 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 165.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 34.4 pt -96.13 174.39 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 123.99 0.916 . . . . 0.0 110.61 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.2 p -98.21 168.63 10.12 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 166.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.472 ' CZ2' HD22 ' A' ' 77' ' ' LEU . 61.7 t-105 -55.41 -37.22 67.34 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.685 0.794 . . . . 0.0 110.781 175.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -56.08 -48.66 75.67 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.518 0.727 . . . . 0.0 111.671 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.57 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 34.4 m-20 -65.53 -42.27 92.18 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.414 0.286 . . . . 0.0 110.791 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.4 ' HE1' HD21 ' A' ' 36' ' ' LEU . 13.9 t80 -50.35 -48.17 55.65 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.51 1.131 . . . . 0.0 111.116 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.531 HG22 HD21 ' A' ' 77' ' ' LEU . 90.7 t -71.97 -62.07 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 O-C-N 123.421 0.45 . . . . 0.0 110.82 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -69.87 -52.65 23.04 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.03 0.532 . . . . 0.0 111.737 -167.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -80.01 -19.48 47.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.912 0.485 . . . . 0.0 112.049 -171.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -126.12 -69.95 0.75 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -171.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.403 HD11 HG21 ' A' ' 89' ' ' VAL . 22.1 tp -63.79 -43.61 95.81 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -166.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.2 p -73.23 -11.38 60.49 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.904 0.481 . . . . 0.0 111.944 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -92.61 -9.22 41.81 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.252 0.621 . . . . 0.0 110.64 173.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.78 27.83 67.25 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 114.047 0.379 . . . . 0.0 114.047 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.7 m -86.87 6.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 116.972 0.386 . . . . 0.0 110.548 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.26 125.72 51.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.023 0.929 . . . . 0.0 108.964 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.515 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 28.5 t70 -77.34 -54.08 6.9 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.315 1.046 . . . . 0.0 108.196 172.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.432 ' HD2' HG21 ' A' ' 92' ' ' VAL . 43.0 ttp180 -154.9 153.19 30.72 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.024 -164.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.4 HD21 ' HE1' ' A' ' 23' ' ' PHE . 97.9 mt -113.32 119.82 39.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.88 1.272 . . . . 0.0 108.535 175.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -111.92 106.48 15.19 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.383 0.673 . . . . 0.0 110.312 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.408 HG22 HG22 ' A' ' 44' ' ' VAL . 44.9 t -81.61 98.48 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 54.7 t -94.96 122.41 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 122.862 0.465 . . . . 0.0 110.522 -171.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 60.11 15.24 5.01 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.245 1.418 . . . . 0.0 113.434 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.9 mttm 65.64 -3.02 0.76 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.534 1.533 . . . . 0.0 112.778 -175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -87.62 -32.51 19.24 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.11 0.964 . . . . 0.0 109.982 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -154.2 171.28 19.44 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.488 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.408 HG22 HG22 ' A' ' 38' ' ' VAL . 54.4 t -128.86 133.87 65.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -99.52 130.36 45.77 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.4 t -82.85 106.58 13.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 172.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.4 m -94.11 126.02 39.08 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -81.84 152.38 26.92 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.875 0.734 . . . . 0.0 111.24 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.515 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.2 OUTLIER . . . . . 0 CA--C 1.558 1.286 0 CA-C-O 117.802 -1.094 . . . . 0.0 109.061 173.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 C--O 1.238 0.486 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 16' ' ' ARG . 27.1 m -105.73 156.52 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.333 -172.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -150.91 158.41 44.11 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.848 0.459 . . . . 0.0 111.37 -173.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -140.32 139.24 35.4 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.397 0.679 . . . . 0.0 109.298 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -79.34 131.58 36.17 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.443 0.697 . . . . 0.0 110.323 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.7 pt -110.05 143.08 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.931 0.892 . . . . 0.0 109.298 173.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.11 -43.28 7.17 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.8 t -131.25 140.34 49.81 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.92 0.888 . . . . 0.0 109.282 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 62.0 t -60.11 -41.74 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 123.679 0.612 . . . . 0.0 110.226 172.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.22 -42.14 80.81 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.323 0.649 . . . . 0.0 111.631 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 m -66.12 -45.77 79.93 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.194 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -55.65 -48.42 75.04 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.836 0.454 . . . . 0.0 111.271 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 39.4 mm-40 -62.43 -52.9 61.69 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.342 0.657 . . . . 0.0 111.292 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -67.41 -38.3 84.42 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.659 0.783 . . . . 0.0 111.396 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -67.09 -35.86 80.72 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 122.658 0.383 . . . . 0.0 110.317 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.99 -32.25 71.68 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.071 0.548 . . . . 0.0 111.503 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 51.5 mm-40 -62.09 -51.78 66.54 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.153 0.501 . . . . 0.0 110.172 173.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.461 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 25.7 m -62.9 -47.95 81.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.242 -1.344 . . . . 0.0 110.395 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.531 HD21 HG22 ' A' ' 24' ' ' VAL . 49.6 tp -57.94 -57.92 10.7 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.405 1.082 . . . . 0.0 112.2 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 45.5 mt-30 -62.12 -39.92 94.17 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 123.715 0.634 . . . . 0.0 111.514 -174.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -66.46 -33.92 76.77 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 76' ' ' THR . 43.3 mm-40 -70.18 -39.98 74.93 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.795 0.438 . . . . 0.0 110.573 176.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.25 -12.43 60.86 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.602 0.761 . . . . 0.0 111.166 176.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.33 -8.09 79.71 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.944 -0.365 . . . . 0.0 112.829 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 70.7 mt -67.76 105.53 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.254 1.422 . . . . 0.0 109.172 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -151.46 159.59 44.12 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.561 0.344 . . . . 0.0 111.432 -174.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.3 -124.34 33.27 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.926 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -66.3 -22.52 66.29 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.306 1.043 . . . . 0.0 111.752 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -83.54 -5.18 59.09 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.232 0.613 . . . . 0.0 112.362 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -65.56 142.2 58.18 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 120.803 0.335 . . . . 0.0 111.325 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.403 HG21 HD11 ' A' ' 28' ' ' LEU . 59.8 t -82.84 122.99 78.44 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.92 0.888 . . . . 0.0 109.516 -175.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.14 132.76 43.25 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.413 2.742 . . . . 0.0 113.786 -171.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.3 t -108.28 119.84 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.0 0.92 . . . . 0.0 108.877 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.432 HG21 ' HD2' ' A' ' 35' ' ' ARG . 41.7 t -129.37 121.94 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.018 0.927 . . . . 0.0 109.11 -173.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -84.98 116.68 23.52 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.037 0.535 . . . . 0.0 110.24 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 49.8 mm . . . . . 0 N--CA 1.472 0.663 0 C-N-CA 124.104 0.961 . . . . 0.0 108.758 -176.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 6.3 ptm180 . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.944 0.402 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.507 ' HG3' ' HA ' ' A' ' 62' ' ' PHE . 32.6 tt0 -85.35 128.1 34.58 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 pt -109.88 179.61 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 125.696 1.598 . . . . 0.0 109.621 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.8 p -89.93 154.15 20.07 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.074 0.95 . . . . 0.0 109.441 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.426 ' O ' HG23 ' A' ' 24' ' ' VAL . 54.4 t-105 -59.93 -43.37 94.96 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.513 0.725 . . . . 0.0 110.282 176.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -53.85 -48.67 69.75 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 123.952 0.783 . . . . 0.0 111.292 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' A' ' 26' ' ' ASN . 26.3 t70 -70.09 -34.96 73.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.778 0.431 . . . . 0.0 110.224 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.415 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 18.0 t80 -55.78 -46.12 78.01 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.945 0.498 . . . . 0.0 110.627 175.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 20' ' ' TRP . 79.9 t -61.98 -71.38 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 123.602 0.564 . . . . 0.0 110.783 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -73.66 -31.77 63.65 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.923 -161.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 22' ' ' ASP . 54.9 t30 -90.99 -23.59 20.35 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.665 0.786 . . . . 0.0 111.902 -176.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.415 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 75.4 m-85 -124.62 -66.42 0.98 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -172.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.64 -49.83 76.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.718 0.807 . . . . 0.0 111.401 -174.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.0 m -64.5 -20.74 66.39 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.555 1.142 . . . . 0.0 112.161 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -97.1 0.14 48.04 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.507 0.723 . . . . 0.0 111.301 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.92 26.61 60.95 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 115.543 0.977 . . . . 0.0 115.543 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.8 m -90.7 3.9 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 122.898 0.479 . . . . 0.0 111.405 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.3 126.06 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.887 0.875 . . . . 0.0 108.926 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.486 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 30.9 t70 -84.1 -51.61 6.94 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.546 1.138 . . . . 0.0 109.967 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -154.07 161.61 41.79 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.583 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.05 101.83 9.37 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.9 0.88 . . . . 0.0 108.67 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -87.0 101.13 13.15 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.102 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.709 HG12 ' HA ' ' A' ' 41' ' ' LYS . 19.8 t -88.54 90.2 3.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -173.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.9 t -81.43 127.76 39.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.6 -173.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 59.95 19.51 8.55 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.8 2.04 . . . . 0.0 111.452 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.709 ' HA ' HG12 ' A' ' 38' ' ' VAL . 19.7 pttm 42.06 18.29 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 126.287 1.835 . . . . 0.0 115.251 -167.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.3 ttp-105 -98.93 -30.49 12.34 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.149 0.98 . . . . 0.0 109.102 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -147.62 152.12 37.36 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.02 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 59.0 t -110.97 128.07 67.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.541 1.137 . . . . 0.0 108.465 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -100.67 124.73 46.68 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.1 t -82.69 105.39 12.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.7 m -92.1 125.91 36.97 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -84.87 148.98 25.99 Favored 'General case' 0 C--O 1.241 0.607 0 O-C-N 123.723 0.64 . . . . 0.0 111.917 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.486 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 10.0 p . . . . . 0 CA--C 1.55 0.946 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.779 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 . . . . . 0 C--O 1.241 0.654 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 16' ' ' ARG . 33.2 m -106.38 154.96 7.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -157.57 174.94 14.6 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.173 0.589 . . . . 0.0 110.11 -175.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.507 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 33.9 p90 -157.6 147.32 20.26 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.974 0.51 . . . . 0.0 110.253 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -91.09 130.16 37.01 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 67' ' ' VAL . 30.3 pt -102.93 -46.99 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.217 0.607 . . . . 0.0 111.334 -176.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.26 -83.24 0.43 Allowed Glycine 0 C--N 1.345 1.082 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -167.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.8 t -72.45 96.74 1.95 Allowed 'General case' 0 C--O 1.249 1.027 0 CA-C-O 121.778 0.799 . . . . 0.0 109.875 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.598 ' HA ' HD12 ' A' ' 64' ' ' ILE . 11.0 t -56.04 -39.33 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 113.952 -1.477 . . . . 0.0 110.999 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -58.26 -42.37 86.3 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.049 0.843 . . . . 0.0 111.02 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.0 m -64.67 -45.73 85.47 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 123.657 0.598 . . . . 0.0 110.159 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -52.66 -50.83 62.44 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.816 0.698 . . . . 0.0 111.266 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -63.58 -46.19 86.99 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.135 0.897 . . . . 0.0 110.774 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 mtp-105 -59.35 -49.47 77.71 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.765 0.826 . . . . 0.0 111.41 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -66.32 -43.6 85.72 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.435 0.694 . . . . 0.0 110.18 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.3 tp -56.13 -49.6 73.45 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.272 1.029 . . . . 0.0 110.736 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -66.62 -49.17 67.16 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.446 0.698 . . . . 0.0 111.649 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.4 m -60.17 -44.61 94.88 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.46 0.648 . . . . 0.0 109.926 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.9 tp -57.81 -53.38 58.81 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.757 175.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.412 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 87.4 mt-30 -64.89 -45.04 87.62 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.28 0.632 . . . . 0.0 111.018 -173.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.56 -38.2 83.79 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.312 0.645 . . . . 0.0 110.633 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.34 -41.12 90.05 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.2 1.0 . . . . 0.0 110.978 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.1 mt -87.29 0.77 54.9 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.487 0.715 . . . . 0.0 111.458 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.25 -4.32 63.37 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.595 -0.558 . . . . 0.0 113.809 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 68.4 mt -68.08 116.31 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.672 1.189 . . . . 0.0 109.47 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -161.1 148.26 15.16 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.082 0.553 . . . . 0.0 110.497 -173.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.07 -89.84 0.01 OUTLIER Glycine 0 C--N 1.349 1.263 0 O-C-N 124.923 1.389 . . . . 0.0 114.722 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.41 -44.31 83.36 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.29 1.036 . . . . 0.0 110.565 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -98.65 -1.46 40.72 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.445 0.698 . . . . 0.0 111.741 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -70.44 134.41 47.77 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 122.994 0.184 . . . . 0.0 110.939 -178.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.2 t -72.37 112.51 15.09 Favored Pre-proline 0 CA--C 1.561 1.391 0 O-C-N 124.165 0.916 . . . . 0.0 109.49 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.92 142.63 57.67 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.981 2.454 . . . . 0.0 113.117 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.4 t -105.75 118.2 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.461 1.104 . . . . 0.0 109.178 -175.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.7 t -119.93 98.96 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.583 0.753 . . . . 0.0 110.166 -171.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -75.3 109.59 8.95 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.153 0.581 . . . . 0.0 110.585 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.7 mt . . . . . 0 N--CA 1.476 0.853 0 C-N-CA 123.983 0.913 . . . . 0.0 108.54 -178.36 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.667 ' HB3' HG12 ' A' ' 60' ' ' VAL . 20.0 ttt180 . . . . . 0 C--O 1.237 0.396 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.9 109.33 8.27 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.7 pt -106.8 175.38 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.685 1.194 . . . . 0.0 108.762 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.0 p -97.2 167.92 10.75 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.521 ' O ' HG23 ' A' ' 24' ' ' VAL . 69.1 t-105 -57.5 -41.97 81.8 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 123.462 0.476 . . . . 0.0 110.04 169.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -60.4 -49.39 77.76 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.71 0.404 . . . . 0.0 111.761 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.51 -38.79 90.73 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.298 0.639 . . . . 0.0 110.591 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.453 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 40.3 t80 -52.56 -53.46 46.11 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.968 172.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.579 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 69.1 t -60.33 -47.77 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.11 0.564 . . . . 0.0 110.769 -177.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.28 -55.91 11.96 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.521 -173.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -85.01 -27.88 26.12 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.453 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 87.1 m-85 -117.01 -68.86 0.89 Allowed 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -165.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.579 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 56.6 tp -59.91 -45.28 93.05 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.457 1.103 . . . . 0.0 113.149 -171.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 81.2 p -64.53 -21.29 66.64 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.066 0.546 . . . . 0.0 112.39 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -99.2 -9.05 24.21 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.794 0.837 . . . . 0.0 110.728 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.44 37.72 88.88 Favored Glycine 0 C--N 1.348 1.218 0 O-C-N 123.835 0.709 . . . . 0.0 114.836 -173.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 m -79.76 -3.46 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.453 ' HB ' HG21 ' A' ' 89' ' ' VAL . 16.6 t -99.54 128.08 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.911 0.884 . . . . 0.0 109.308 -175.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -86.72 -48.24 8.43 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.161 1.385 . . . . 0.0 110.312 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.513 ' HD3' HG21 ' A' ' 92' ' ' VAL . 19.2 ptp180 -158.49 149.39 20.48 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.857 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.563 ' HG ' HG11 ' A' ' 89' ' ' VAL . 31.4 mt -108.16 102.0 11.18 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.45 ' HB3' HD12 ' A' ' 94' ' ' ILE . 52.1 mt-10 -93.6 105.79 17.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.864 -172.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.528 HG22 HG22 ' A' ' 44' ' ' VAL . 48.3 t -81.06 102.12 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -176.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.3 t -90.23 114.71 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.263 0.625 . . . . 0.0 109.537 -173.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.3 m120 58.94 16.75 4.82 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.434 1.493 . . . . 0.0 113.688 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 90.6 mttt 60.35 8.58 1.65 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.447 1.099 . . . . 0.0 113.335 -171.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 -81.67 -39.51 24.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.924 0.889 . . . . 0.0 109.516 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -155.33 174.82 14.68 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.267 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.528 HG22 HG22 ' A' ' 38' ' ' VAL . 59.4 t -123.81 131.53 72.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -103.29 127.32 50.65 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.439 0.695 . . . . 0.0 109.439 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 80.2 t -84.08 110.16 18.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.621 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.5 m -90.44 141.62 28.56 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 170.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.429 ' HE2' ' HA ' ' A' ' 59' ' ' TYR . 63.3 m-85 -97.38 149.69 21.84 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 176.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 CA--C 1.548 0.87 0 C-N-CA 124.224 1.01 . . . . 0.0 111.419 179.916 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.429 ' HA ' ' HE2' ' A' ' 48' ' ' PHE . 11.6 m-85 . . . . . 0 N--CA 1.469 0.485 0 CA-C-O 121.539 0.685 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.667 HG12 ' HB3' ' A' ' 16' ' ' ARG . 33.8 m -131.39 170.12 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -167.04 160.1 13.76 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.141 0.576 . . . . 0.0 110.091 -174.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -144.1 140.17 29.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.998 0.519 . . . . 0.0 110.351 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -77.08 147.05 36.88 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.406 0.682 . . . . 0.0 110.27 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 67' ' ' VAL . 40.3 pt -131.03 139.4 51.18 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 C-N-CA 123.552 0.741 . . . . 0.0 109.992 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.34 -44.36 17.53 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 172.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.7 t -131.16 129.84 42.28 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.992 0.917 . . . . 0.0 110.285 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.444 ' HA ' HD12 ' A' ' 64' ' ' ILE . 15.6 t -64.41 -37.99 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.796 0.838 . . . . 0.0 110.691 171.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.598 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 31.3 t70 -62.23 -56.53 17.7 Favored 'General case' 0 C--O 1.216 -0.694 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.5 m -55.24 -45.42 76.03 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.943 0.497 . . . . 0.0 111.176 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -47.3 -56.15 7.36 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.411 1.084 . . . . 0.0 112.096 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 12.2 pt-20 -73.27 -28.77 62.31 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.814 -173.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 18.1 mmm-85 -59.98 -45.76 91.66 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 176.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -67.57 -38.37 84.0 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.705 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 tp -57.28 -56.73 18.03 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.697 0.623 . . . . 0.0 111.059 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 79' ' ' GLN . 32.0 mt-10 -59.92 -47.74 84.55 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.023 0.929 . . . . 0.0 112.693 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 51.5 m -61.56 -48.87 79.0 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.504 0.669 . . . . 0.0 110.144 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 35.6 tp -57.56 -38.94 75.63 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.251 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.742 ' HB3' HD11 ' A' ' 83' ' ' ILE . 25.0 mt-30 -63.81 -39.03 93.27 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.522 0.729 . . . . 0.0 110.434 175.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 76.7 mt-30 -67.97 -29.25 68.24 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.932 0.493 . . . . 0.0 110.697 176.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -71.24 -47.78 55.12 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.617 0.767 . . . . 0.0 110.546 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 87.6 mt -68.0 -18.72 64.8 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.183 0.993 . . . . 0.0 111.644 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.76 31.27 79.64 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.713 0.633 . . . . 0.0 112.342 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.742 HD11 ' HB3' ' A' ' 78' ' ' GLN . 1.2 pp -64.81 162.49 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 122.041 0.924 . . . . 0.0 113.186 -176.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -119.53 169.15 10.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 161.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.89 -25.69 1.0 Allowed Glycine 0 N--CA 1.481 1.687 0 N-CA-C 117.311 1.685 . . . . 0.0 117.311 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.02 -46.65 83.51 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.688 0.744 . . . . 0.0 111.522 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -101.34 -11.9 19.06 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.439 0.696 . . . . 0.0 111.225 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.425 ' HB2' HD13 ' A' ' 83' ' ' ILE . 9.3 ttp180 -84.0 140.89 31.59 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.213 1.005 . . . . 0.0 109.294 174.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.563 HG11 ' HG ' ' A' ' 36' ' ' LEU . 46.5 t -117.17 120.41 33.65 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 122.781 0.432 . . . . 0.0 111.467 -167.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.83 154.26 48.47 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.976 2.451 . . . . 0.0 112.592 172.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.4 t -106.94 125.38 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.519 0.727 . . . . 0.0 109.768 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.513 HG21 ' HD3' ' A' ' 35' ' ' ARG . 21.8 t -113.13 112.45 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -82.39 109.43 16.63 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.45 HD12 ' HB3' ' A' ' 37' ' ' GLU . 50.2 mt . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 . . . . . 0 C--O 1.239 0.534 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -77.3 107.25 9.58 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 172.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 pt -95.48 170.2 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 123.737 0.815 . . . . 0.0 109.235 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.503 HG23 ' H ' ' A' ' 22' ' ' ASP . 9.0 t -85.43 149.85 25.12 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 172.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.537 ' O ' HG23 ' A' ' 24' ' ' VAL . 67.1 t-105 -52.09 -42.85 63.56 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.972 0.909 . . . . 0.0 111.192 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -61.3 -36.21 79.46 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 123.372 0.42 . . . . 0.0 111.725 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.503 ' H ' HG23 ' A' ' 19' ' ' THR . 31.7 t70 -70.35 -40.83 73.84 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.455 ' HZ ' HD11 ' A' ' 36' ' ' LEU . 40.2 t80 -56.15 -42.33 76.81 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.673 175.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.584 HG22 HD21 ' A' ' 77' ' ' LEU . 97.3 t -67.65 -66.3 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.402 0.681 . . . . 0.0 111.025 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -71.13 -44.81 64.82 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.443 0.464 . . . . 0.0 111.664 -166.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -80.13 -29.22 38.89 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.906 0.883 . . . . 0.0 111.786 -171.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -120.34 -66.19 1.08 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -169.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.34 -44.36 95.59 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.972 0.909 . . . . 0.0 111.526 -172.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.1 m -73.04 -16.23 61.49 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.351 1.06 . . . . 0.0 112.412 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -96.2 -3.77 43.69 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.136 0.575 . . . . 0.0 110.974 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.22 37.37 91.71 Favored Glycine 0 C--N 1.357 1.738 0 N-CA-C 114.776 0.671 . . . . 0.0 114.776 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.7 m -98.95 0.8 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.06 126.6 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.481 0.712 . . . . 0.0 110.272 -174.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -85.28 -47.21 10.28 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.343 1.057 . . . . 0.0 110.707 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.461 ' HG2' ' HB ' ' A' ' 47' ' ' THR . 10.2 ptp180 -157.07 160.29 38.76 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.873 0.469 . . . . 0.0 110.138 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.455 HD11 ' HZ ' ' A' ' 23' ' ' PHE . 92.4 mt -117.77 103.29 9.85 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.74 0.816 . . . . 0.0 109.303 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -88.9 111.86 22.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.602 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 44' ' ' VAL . 31.0 t -84.45 99.86 7.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.9 t -91.25 114.43 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 122.865 0.466 . . . . 0.0 110.033 -171.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 52.52 27.29 4.92 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.408 1.483 . . . . 0.0 112.886 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HA ' HG12 ' A' ' 38' ' ' VAL . 98.0 mttt 61.71 -0.7 0.39 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.812 1.645 . . . . 0.0 114.31 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -81.74 -34.16 30.64 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.385 0.674 . . . . 0.0 110.6 -171.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -157.4 179.32 9.36 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 38' ' ' VAL . 91.9 t -126.59 129.1 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 124.175 0.99 . . . . 0.0 109.072 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -101.37 128.75 47.41 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.9 t -88.84 109.84 20.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.726 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.461 ' HB ' ' HG2' ' A' ' 35' ' ' ARG . 87.1 m -88.31 134.37 33.83 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 172.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -103.6 154.5 19.43 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.198 0.599 . . . . 0.0 111.379 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 CA--C 1.549 0.917 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.172 -179.392 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -118.67 -179.6 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.626 0.371 . . . . 0.0 110.127 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -159.54 165.82 32.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.966 0.907 . . . . 0.0 109.167 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -152.56 152.16 31.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.624 0.37 . . . . 0.0 111.455 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -78.19 149.59 33.67 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.206 1.002 . . . . 0.0 110.145 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.2 pt -127.06 -26.79 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.063 0.545 . . . . 0.0 111.999 -174.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.52 -78.0 1.52 Allowed Glycine 0 C--N 1.344 0.991 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.2 t -107.4 132.05 53.6 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.181 0.992 . . . . 0.0 108.585 172.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.8 t -62.33 -32.37 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.357 0.663 . . . . 0.0 110.757 173.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.95 -38.2 90.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.689 0.796 . . . . 0.0 110.807 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.6 m -63.39 -51.38 66.08 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 122.905 0.482 . . . . 0.0 110.221 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -53.33 -58.22 7.86 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 124.102 0.876 . . . . 0.0 111.961 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 15.5 pt-20 -62.56 -47.78 82.37 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.962 0.789 . . . . 0.0 111.065 -172.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -64.15 -48.1 77.32 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 122.37 0.268 . . . . 0.0 110.873 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -65.87 -43.34 88.67 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.814 0.696 . . . . 0.0 110.24 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.438 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 39.9 tp -57.7 -55.92 28.58 Favored 'General case' 0 C--O 1.215 -0.751 0 O-C-N 124.759 1.287 . . . . 0.0 111.651 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.591 ' HG2' ' NH2' ' A' ' 88' ' ' ARG . 44.8 mt-10 -66.43 -35.35 80.09 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.409 0.684 . . . . 0.0 112.156 -172.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.7 m -65.12 -48.04 75.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.188 0.595 . . . . 0.0 109.441 174.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.584 HD21 HG22 ' A' ' 24' ' ' VAL . 44.9 tp -57.17 -41.48 79.35 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.216 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 60.8 mt-30 -63.65 -46.31 86.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.682 0.793 . . . . 0.0 110.243 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -65.65 -31.04 71.84 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.46 0.704 . . . . 0.0 110.886 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -71.79 -52.64 16.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.559 1.143 . . . . 0.0 110.791 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 72.3 mt -79.42 -10.16 59.75 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.403 0.681 . . . . 0.0 111.592 -173.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.88 10.17 59.03 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 114.301 0.48 . . . . 0.0 114.301 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.471 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 3.5 mp -80.13 90.32 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 168.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.99 143.14 50.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.656 -0.653 . . . . 0.0 111.925 -171.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.0 -100.3 0.17 Allowed Glycine 0 C--N 1.349 1.297 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.749 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -79.02 -27.88 43.28 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.946 0.899 . . . . 0.0 110.904 -176.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -76.46 -9.53 58.72 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.088 0.555 . . . . 0.0 111.557 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.591 ' NH2' ' HG2' ' A' ' 75' ' ' GLU . 70.2 mtp180 -69.15 151.55 46.23 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-O 121.551 0.691 . . . . 0.0 112.836 -175.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.5 t -91.87 108.77 32.37 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.056 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -57.36 125.57 19.27 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.972 2.448 . . . . 0.0 111.535 -175.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.77 107.79 20.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -176.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 t -105.52 98.03 6.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -71.14 107.77 4.34 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.9 mt . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 123.903 0.881 . . . . 0.0 109.814 -175.254 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.485 ' HB2' HG12 ' A' ' 60' ' ' VAL . 4.1 mmp_? . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 111.45 0.167 . . . . 0.0 111.45 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.07 108.52 7.85 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.618 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 36.0 pt -100.62 171.55 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.514 1.126 . . . . 0.0 109.227 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.6 p -100.11 178.43 4.79 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 166.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -59.05 -35.19 72.91 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.445 173.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -60.88 -46.55 90.18 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.388 0.675 . . . . 0.0 112.22 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.618 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 7.0 m-20 -62.23 -44.95 95.4 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.312 0.245 . . . . 0.0 110.368 174.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 37.3 t80 -55.15 -50.63 68.8 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 124.118 0.886 . . . . 0.0 110.81 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.414 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 45.8 t -64.04 -66.47 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.944 0.897 . . . . 0.0 111.583 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -71.46 -47.15 57.54 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.87 0.468 . . . . 0.0 112.186 -166.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -80.26 -22.37 41.76 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -172.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.433 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 53.7 m-85 -128.22 -61.57 1.09 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -169.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.414 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 58.0 tp -64.13 -44.67 91.51 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.085 0.954 . . . . 0.0 111.317 -168.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.486 ' HA ' HD13 ' A' ' 81' ' ' LEU . 91.0 p -62.91 -20.31 65.04 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.59 0.756 . . . . 0.0 112.791 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -97.4 -10.44 25.5 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.868 0.867 . . . . 0.0 110.747 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.32 31.89 80.89 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 114.652 0.621 . . . . 0.0 114.652 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.2 m -80.5 -0.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 117.125 0.462 . . . . 0.0 110.676 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 t -98.82 133.06 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -176.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.488 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 18.6 t70 -92.38 -55.03 3.56 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.519 1.128 . . . . 0.0 109.621 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -154.46 164.99 37.81 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.386 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.403 HD11 ' CZ ' ' A' ' 23' ' ' PHE . 91.6 mt -120.51 108.84 14.57 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.689 0.795 . . . . 0.0 110.788 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -88.21 102.64 15.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.741 0.816 . . . . 0.0 110.053 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 41' ' ' LYS . 21.8 t -97.3 91.03 2.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.1 t -79.58 118.25 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.079 -174.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 49.73 27.92 2.45 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.688 1.595 . . . . 0.0 113.425 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.566 ' HA ' HG12 ' A' ' 38' ' ' VAL . 10.6 mtmp? 53.74 15.52 0.81 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.116 1.366 . . . . 0.0 114.181 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -85.64 -47.02 10.22 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.964 0.906 . . . . 0.0 110.421 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.457 ' HE2' ' HE ' ' A' ' 45' ' ' ARG . 44.1 p90 -147.56 159.83 43.31 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.177 0.513 . . . . 0.0 109.852 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.476 HG22 HG22 ' A' ' 38' ' ' VAL . 57.4 t -121.53 131.9 71.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.345 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.457 ' HE ' ' HE2' ' A' ' 43' ' ' PHE . 89.3 mtt180 -99.32 124.82 44.74 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.413 ' HB ' HG23 ' A' ' 60' ' ' VAL . 44.8 t -82.36 108.87 15.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 83.4 m -87.82 129.48 35.18 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -86.03 145.08 27.24 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.79 0.436 . . . . 0.0 110.409 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.4 t . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 123.297 0.639 . . . . 0.0 111.265 179.874 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 121.126 0.489 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 16' ' ' ARG . 33.0 m -109.17 144.16 18.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 173.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -154.73 163.13 40.7 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.83 0.452 . . . . 0.0 110.693 -173.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -150.19 150.76 32.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.708 0.403 . . . . 0.0 110.733 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -93.8 119.12 32.35 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.1 pt -84.31 116.77 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.069 0.548 . . . . 0.0 110.384 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.35 99.42 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.776 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.6 t -132.15 126.59 34.03 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.052 0.941 . . . . 0.0 108.731 172.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.54 HG21 ' HB3' ' A' ' 41' ' ' LYS . 17.5 t -61.57 -36.3 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.363 0.665 . . . . 0.0 110.049 172.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -58.01 -43.9 86.92 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.125 0.97 . . . . 0.0 111.094 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.5 m -64.87 -46.53 81.45 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.537 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -51.39 -53.45 36.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.813 0.845 . . . . 0.0 111.834 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 44.7 mt-10 -67.9 -52.95 30.52 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.761 0.824 . . . . 0.0 111.845 -172.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -68.88 -36.06 77.63 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.588 0.555 . . . . 0.0 111.785 -173.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -70.89 -39.7 72.65 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 174.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 46.5 tp -56.51 -45.19 81.2 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.023 0.529 . . . . 0.0 111.34 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.5 -42.18 99.32 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.874 0.734 . . . . 0.0 111.187 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.1 m -60.31 -56.41 21.84 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 123.8 0.688 . . . . 0.0 110.398 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 77' ' ' LEU . 2.7 mm? -51.73 -52.16 50.65 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 124.418 1.074 . . . . 0.0 112.067 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -60.17 -43.34 95.91 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 123.627 0.579 . . . . 0.0 111.383 -175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -62.75 -44.86 95.11 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.923 0.889 . . . . 0.0 111.122 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -70.1 -38.36 75.61 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.131 -176.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 29' ' ' SER . 41.5 mt -77.77 -17.3 57.65 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.66 0.784 . . . . 0.0 110.515 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.7 6.54 88.99 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-O 119.887 -0.396 . . . . 0.0 113.853 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.539 HG22 ' HA ' ' A' ' 88' ' ' ARG . 75.7 mt -70.98 92.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.1 0.96 . . . . 0.0 109.479 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -136.33 152.82 51.07 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 124.133 0.973 . . . . 0.0 110.569 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.402 ' N ' ' HB2' ' A' ' 88' ' ' ARG . . . 61.0 -93.91 0.07 OUTLIER Glycine 0 C--N 1.343 0.947 0 CA-C-N 114.594 -1.185 . . . . 0.0 115.406 172.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -77.46 -45.72 24.79 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.562 0.696 . . . . 0.0 109.517 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -79.86 -15.7 56.85 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.759 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.539 ' HA ' HG22 ' A' ' 83' ' ' ILE . 58.0 ttt180 -56.53 152.25 12.09 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.112 0.965 . . . . 0.0 111.991 -174.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 68.6 t -100.09 99.74 10.03 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 57.2 Cg_endo -70.48 149.07 61.71 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.919 2.413 . . . . 0.0 112.268 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.8 t -108.63 119.32 57.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.417 -174.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.7 t -104.84 96.27 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -74.64 98.52 3.43 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.3 mt . . . . . 0 C--N 1.324 -0.535 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -178.747 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -74.26 128.98 36.92 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.4 pt -129.69 170.6 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.618 0.767 . . . . 0.0 109.649 -175.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.6 p -91.71 153.59 19.55 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.588 ' O ' HG23 ' A' ' 24' ' ' VAL . 68.9 t-105 -53.58 -46.46 70.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.302 0.641 . . . . 0.0 110.806 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -54.82 -50.73 67.86 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.815 0.846 . . . . 0.0 112.476 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -33.83 70.79 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -176.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -54.23 -45.47 72.3 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.41 0.444 . . . . 0.0 110.49 172.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 20' ' ' TRP . 89.3 t -58.11 -64.09 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.017 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -75.21 -33.41 61.39 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.233 0.333 . . . . 0.0 111.815 -166.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -80.66 -41.29 24.04 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.868 0.467 . . . . 0.0 111.606 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -113.51 -65.3 1.2 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -163.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.8 tp -60.89 -45.52 94.26 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.886 0.741 . . . . 0.0 111.53 -174.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.5 ' HA ' HD11 ' A' ' 83' ' ' ILE . 22.7 t -72.39 -14.29 61.67 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.33 1.052 . . . . 0.0 111.863 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -101.83 -2.18 30.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.771 0.428 . . . . 0.0 111.12 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.93 22.41 34.49 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.8 m -77.78 -3.59 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 123.055 0.542 . . . . 0.0 111.468 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.9 t -93.63 129.91 43.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.267 1.027 . . . . 0.0 108.625 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -80.56 -47.32 14.36 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.537 0.735 . . . . 0.0 110.193 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.485 ' HG2' ' HB ' ' A' ' 47' ' ' THR . 6.6 ptp85 -159.4 157.92 31.18 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.092 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.5 mt -114.83 102.14 9.71 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.774 0.829 . . . . 0.0 108.964 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -89.79 108.61 19.8 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.136 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.523 HG22 HG22 ' A' ' 44' ' ' VAL . 40.6 t -88.45 94.59 4.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.9 t -90.94 127.06 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 O-C-N 123.233 0.333 . . . . 0.0 111.44 -169.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 53.28 23.23 3.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.653 1.581 . . . . 0.0 113.632 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 61.28 6.6 1.41 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.986 1.314 . . . . 0.0 114.196 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.7 mtp-105 -91.22 -40.81 11.33 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.274 0.488 . . . . 0.0 110.436 -176.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -151.99 174.04 14.13 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.15 -170.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.523 HG22 HG22 ' A' ' 38' ' ' VAL . 71.9 t -119.88 122.89 69.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -100.03 121.9 42.09 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.0 t -90.24 119.74 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.127 0.971 . . . . 0.0 110.327 -168.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.485 ' HB ' ' HG2' ' A' ' 35' ' ' ARG . 58.1 m -93.86 130.05 40.04 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -97.32 170.39 9.11 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.931 0.769 . . . . 0.0 111.079 176.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 CA--C 1.553 1.093 0 C-N-CA 123.301 0.64 . . . . 0.0 110.997 176.369 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 121.001 0.429 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.8 169.87 20.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.078 170.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -158.25 158.42 34.43 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.533 0.733 . . . . 0.0 109.35 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -146.54 141.32 26.88 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.951 0.5 . . . . 0.0 109.722 177.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -83.15 128.57 34.61 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.874 0.47 . . . . 0.0 109.897 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 67' ' ' VAL . 22.5 pt -106.5 -29.29 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.342 0.657 . . . . 0.0 110.658 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.79 -71.85 1.6 Allowed Glycine 0 C--N 1.35 1.314 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.4 t -100.18 121.45 41.45 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.278 1.031 . . . . 0.0 110.127 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.506 ' HA ' HD12 ' A' ' 64' ' ' ILE . 39.5 t -66.56 -34.13 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.091 172.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.433 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 24.6 t70 -64.09 -37.11 86.26 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 63.2 m -65.89 -45.39 82.18 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.737 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -52.55 -41.56 63.64 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 123.778 0.674 . . . . 0.0 111.619 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.46 -51.25 53.63 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.488 0.492 . . . . 0.0 110.341 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 68' ' ' ASP . 95.5 mtt180 -55.94 -54.94 38.67 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.211 0.604 . . . . 0.0 111.771 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -71.42 -31.95 67.82 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.521 -175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.84 -44.75 95.3 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.345 0.658 . . . . 0.0 111.858 172.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -63.32 -45.17 92.56 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.267 0.627 . . . . 0.0 112.065 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.473 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 14.8 m -63.57 -50.18 70.47 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.01 0.819 . . . . 0.0 109.361 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.51 HD21 HG22 ' A' ' 24' ' ' VAL . 45.3 tp -54.16 -51.24 64.95 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.298 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -64.72 -39.61 93.94 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.453 0.47 . . . . 0.0 111.232 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 76' ' ' THR . 14.8 pt20 -68.04 -35.76 78.79 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 120.647 0.26 . . . . 0.0 110.549 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 76' ' ' THR . 30.9 mm-40 -74.24 -43.81 55.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.305 0.642 . . . . 0.0 111.047 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.6 mt -70.92 -8.65 54.51 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.74 0.816 . . . . 0.0 112.193 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.15 2.55 87.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.969 -0.351 . . . . 0.0 113.216 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 29' ' ' SER . 76.8 mt -73.03 101.73 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 124.844 1.258 . . . . 0.0 108.961 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -137.5 155.74 48.93 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.281 0.633 . . . . 0.0 111.257 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.23 -118.43 12.91 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 124.114 0.884 . . . . 0.0 113.719 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -20.75 66.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.385 1.074 . . . . 0.0 111.895 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -79.62 -24.77 41.7 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.666 0.386 . . . . 0.0 111.998 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -69.78 118.67 12.92 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.733 0.242 . . . . 0.0 110.773 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.09 126.42 92.4 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.272 0.629 . . . . 0.0 110.117 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.9 143.2 65.57 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.817 2.345 . . . . 0.0 112.575 -177.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.4 t -109.53 122.04 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.748 0.819 . . . . 0.0 109.322 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.471 HG21 ' HD3' ' A' ' 35' ' ' ARG . 23.0 t -114.31 101.77 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.932 0.893 . . . . 0.0 109.61 -174.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -75.62 104.49 6.19 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.088 0.555 . . . . 0.0 110.648 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 51.4 mm . . . . . 0 N--CA 1.469 0.476 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.505 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.566 ' HB3' HG12 ' A' ' 60' ' ' VAL . 63.7 ttt180 . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -73.53 130.72 40.67 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.9 pt -133.15 175.68 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.509 1.124 . . . . 0.0 109.218 -177.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.9 p -95.92 164.8 12.57 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.72 172.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.518 ' O ' HG23 ' A' ' 24' ' ' VAL . 72.6 t-105 -55.49 -44.42 76.5 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.013 0.925 . . . . 0.0 110.657 174.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -56.07 -47.26 78.3 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.732 0.813 . . . . 0.0 111.129 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.6 -42.02 92.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.05 0.54 . . . . 0.0 110.567 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -51.78 -51.02 59.46 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.665 0.603 . . . . 0.0 111.228 175.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 20' ' ' TRP . 59.9 t -63.75 -61.31 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.238 0.615 . . . . 0.0 111.5 -175.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -71.91 -40.87 68.53 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.034 -168.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -79.82 -43.48 22.32 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.377 0.671 . . . . 0.0 110.915 -175.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -114.08 -65.66 1.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -163.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.4 tp -55.08 -45.14 75.36 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.081 0.952 . . . . 0.0 112.146 -171.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.415 ' HA ' HD11 ' A' ' 83' ' ' ILE . 74.2 p -71.55 -9.18 57.81 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -95.96 -6.47 38.92 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 118.835 -0.603 . . . . 0.0 112.012 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.42 31.25 80.26 Favored Glycine 0 C--N 1.353 1.482 0 C-N-CA 121.433 -0.413 . . . . 0.0 113.687 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.8 -3.46 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.38 0.672 . . . . 0.0 111.728 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.04 130.78 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.492 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 24.8 t70 -88.26 -51.27 5.85 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.967 1.307 . . . . 0.0 110.124 -175.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -152.71 152.33 31.57 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.676 0.79 . . . . 0.0 110.208 -175.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.1 mt -112.0 101.97 10.23 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.43 1.092 . . . . 0.0 109.054 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 43.1 mt-10 -93.49 101.18 13.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.856 -172.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.583 HG22 HG22 ' A' ' 44' ' ' VAL . 49.0 t -81.08 104.94 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -176.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.5 t -95.24 115.48 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 123.055 0.542 . . . . 0.0 110.538 -174.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 53.31 24.04 3.59 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.157 1.783 . . . . 0.0 113.905 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt 67.49 0.77 2.29 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.447 1.499 . . . . 0.0 112.98 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -76.87 -45.26 28.93 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.109 0.963 . . . . 0.0 110.135 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -152.32 175.02 13.1 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.964 -173.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.583 HG22 HG22 ' A' ' 38' ' ' VAL . 86.8 t -124.58 130.57 73.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 125.109 1.364 . . . . 0.0 107.846 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.625 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 68.4 ttt180 -97.9 116.91 31.07 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.732 1.213 . . . . 0.0 108.48 -177.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.514 ' HB ' HG23 ' A' ' 60' ' ' VAL . 46.7 t -85.11 106.7 15.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.7 m -103.17 135.86 44.03 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -97.0 148.08 23.34 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.88 0.738 . . . . 0.0 111.96 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.492 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 57.7 p . . . . . 0 C--N 1.349 0.557 0 C-N-CA 124.56 1.144 . . . . 0.0 111.26 -176.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 121.034 0.445 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.566 HG12 ' HB3' ' A' ' 16' ' ' ARG . 10.6 m -119.53 170.04 9.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.505 -175.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -156.18 161.52 40.3 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.166 0.586 . . . . 0.0 109.532 176.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -147.26 145.15 29.31 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.92 154.53 31.57 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 67' ' ' VAL . 31.9 pt -128.82 -46.37 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 122.937 0.495 . . . . 0.0 110.441 174.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.45 -72.15 0.47 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -168.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.9 t -78.57 104.51 9.23 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 124.456 1.102 . . . . 0.0 110.638 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.485 ' HA ' HD12 ' A' ' 64' ' ' ILE . 26.4 t -66.95 -31.7 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.068 173.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.45 -42.91 98.63 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.238 0.615 . . . . 0.0 110.597 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 80.4 m -62.86 -48.47 78.87 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -51.73 -52.43 48.57 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 124.475 1.11 . . . . 0.0 112.046 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -66.24 -42.38 88.67 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.306 0.379 . . . . 0.0 111.301 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -66.18 -49.87 65.84 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.829 0.452 . . . . 0.0 112.064 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -71.14 -32.5 69.03 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 119.206 -0.426 . . . . 0.0 110.828 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.1 tp -59.78 -48.16 82.81 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.89 0.876 . . . . 0.0 111.135 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -65.0 -42.89 94.08 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.261 0.624 . . . . 0.0 112.139 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.7 m -59.77 -49.51 77.46 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 122.013 0.911 . . . . 0.0 109.693 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.407 HD21 HG22 ' A' ' 24' ' ' VAL . 32.9 tp -58.96 -42.73 90.58 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 112.914 -1.948 . . . . 0.0 112.614 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -65.77 -37.11 85.44 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.242 0.617 . . . . 0.0 111.051 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -69.85 -35.28 74.58 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.108 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.31 -52.54 22.04 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.565 1.146 . . . . 0.0 110.996 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.5 mt -73.02 -19.77 61.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.183 0.993 . . . . 0.0 111.222 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 7.39 70.38 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-O 119.723 -0.487 . . . . 0.0 113.2 -175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.415 HD11 ' HA ' ' A' ' 29' ' ' SER . 71.3 mt -67.77 92.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.157 0.983 . . . . 0.0 109.033 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -137.97 148.12 44.91 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.716 0.807 . . . . 0.0 110.147 -171.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.78 -102.83 0.74 Allowed Glycine 0 C--N 1.351 1.365 0 O-C-N 124.508 1.13 . . . . 0.0 112.992 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.52 -30.42 57.17 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.746 0.818 . . . . 0.0 110.72 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -72.05 -21.09 61.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.082 0.553 . . . . 0.0 111.379 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -62.01 142.6 57.4 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.231 0.613 . . . . 0.0 111.751 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.4 t -107.55 106.37 58.26 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -58.6 143.86 97.99 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 124.047 3.164 . . . . 0.0 113.258 -175.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.7 t -98.87 119.4 46.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 54.2 t -110.95 121.39 63.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -87.51 127.2 35.24 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.8 mm . . . . . 0 N--CA 1.474 0.753 0 C-N-CA 125.289 1.436 . . . . 0.0 107.791 -175.903 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.53 ' HB3' HG12 ' A' ' 60' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.94 107.2 6.02 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 48.2 pt -99.72 176.66 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.943 0.897 . . . . 0.0 109.967 173.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.3 p -104.78 171.6 7.24 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.383 171.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -57.78 -38.88 76.22 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.504 0.722 . . . . 0.0 110.381 171.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -55.45 -48.79 73.94 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.747 0.819 . . . . 0.0 111.211 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.576 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 50.8 m-20 -64.66 -45.15 87.96 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.77 0.428 . . . . 0.0 111.924 176.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.433 ' CZ ' HD11 ' A' ' 36' ' ' LEU . 10.1 t80 -49.39 -57.35 7.09 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.121 0.888 . . . . 0.0 110.228 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.409 HG22 HD21 ' A' ' 77' ' ' LEU . 96.6 t -66.13 -56.41 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 123.89 0.744 . . . . 0.0 111.859 -174.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -76.32 -48.87 18.54 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -168.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -76.49 -39.62 52.62 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.265 0.626 . . . . 0.0 111.528 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -108.91 -65.54 1.13 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -165.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.4 tp -58.07 -44.45 87.51 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.88 0.872 . . . . 0.0 111.86 -173.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.1 t -57.47 -30.23 64.88 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.201 1.0 . . . . 0.0 112.455 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -91.81 0.97 57.46 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.979 0.912 . . . . 0.0 110.887 -176.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.46 25.41 62.93 Favored Glycine 0 C--N 1.351 1.409 0 N-CA-C 114.444 0.537 . . . . 0.0 114.444 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.9 m -85.91 -2.02 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 117.257 0.529 . . . . 0.0 110.617 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.5 t -93.77 122.22 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.908 0.883 . . . . 0.0 109.431 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 17.8 t70 -82.25 -52.44 6.94 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.208 1.003 . . . . 0.0 109.625 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -155.13 166.19 34.35 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.57 0.748 . . . . 0.0 110.687 -173.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.433 HD11 ' CZ ' ' A' ' 23' ' ' PHE . 84.4 mt -119.15 107.25 13.24 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.949 0.9 . . . . 0.0 110.432 175.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 40.4 mt-10 -94.27 101.75 13.73 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.335 0.654 . . . . 0.0 110.257 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 41' ' ' LYS . 23.4 t -82.58 89.91 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.42 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 95.4 t -73.94 116.77 16.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.289 1.035 . . . . 0.0 110.946 -169.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 55.8 21.4 4.73 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.604 1.162 . . . . 0.0 112.397 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.516 ' HA ' HG12 ' A' ' 38' ' ' VAL . 91.7 mttt 61.98 2.18 0.75 Allowed 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.845 1.658 . . . . 0.0 114.143 -173.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -80.06 -39.96 28.67 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.87 0.868 . . . . 0.0 110.766 -173.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -153.56 166.54 32.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.042 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 53.0 t -120.16 130.91 73.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -175.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.41 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 34.4 ttm180 -91.01 127.93 36.63 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 175.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.511 ' HB ' HG23 ' A' ' 60' ' ' VAL . 44.9 t -83.42 105.45 13.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 165.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.9 m -94.59 130.18 41.14 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -87.76 156.88 19.21 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.018 0.824 . . . . 0.0 111.095 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.479 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 64.4 p . . . . . 0 CA--C 1.553 1.088 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.361 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.53 HG12 ' HB3' ' A' ' 16' ' ' ARG . 35.7 m -110.94 152.69 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -153.64 156.57 38.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.85 0.46 . . . . 0.0 110.678 -174.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -139.8 139.94 36.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.322 0.649 . . . . 0.0 109.294 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -81.3 144.02 31.82 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.417 0.687 . . . . 0.0 110.045 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 67' ' ' VAL . 37.4 pt -120.46 140.18 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.519 0.728 . . . . 0.0 109.516 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.49 -46.13 26.77 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 177.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.8 m -132.09 138.44 48.13 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.694 0.798 . . . . 0.0 109.439 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.505 ' HA ' HD12 ' A' ' 64' ' ' ILE . 34.4 t -63.03 -41.4 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.287 0.635 . . . . 0.0 110.967 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.87 -39.69 92.76 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.939 0.495 . . . . 0.0 111.079 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.6 m -63.03 -45.86 90.31 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.864 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -53.46 -47.69 69.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.789 0.836 . . . . 0.0 111.291 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 52.1 mt-10 -63.35 -47.67 81.17 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.73 0.644 . . . . 0.0 110.901 -178.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.1 mtp-105 -61.24 -44.63 96.95 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.227 0.611 . . . . 0.0 111.082 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -63.65 -46.78 84.05 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.552 0.741 . . . . 0.0 110.741 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.23 -48.93 79.21 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.143 0.977 . . . . 0.0 111.655 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 23.0 mm-40 -61.96 -48.37 80.66 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.117 0.567 . . . . 0.0 110.956 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 96.1 m -57.24 -55.43 34.88 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.502 0.721 . . . . 0.0 110.35 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.409 HD21 HG22 ' A' ' 24' ' ' VAL . 66.4 tp -44.71 -51.24 9.46 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.18 1.792 . . . . 0.0 112.686 174.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -64.71 -41.59 95.88 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.014 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 13.9 mm100 -64.04 -38.65 91.85 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.485 0.314 . . . . 0.0 110.567 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 76' ' ' THR . 21.1 mm-40 -60.48 -39.81 89.0 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.83 0.852 . . . . 0.0 111.07 175.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.9 mt -84.1 -8.49 59.09 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.721 0.808 . . . . 0.0 112.097 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.45 6.25 89.36 Favored Glycine 0 C--N 1.353 1.474 0 C-N-CA 122.894 0.283 . . . . 0.0 113.392 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.527 HG22 ' HA ' ' A' ' 88' ' ' ARG . 69.5 mt -76.26 108.66 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 124.987 1.315 . . . . 0.0 109.555 177.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.25 177.29 10.38 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.62 0.768 . . . . 0.0 110.658 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.04 -125.15 29.6 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.662 0.601 . . . . 0.0 113.621 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -85.76 -8.12 58.34 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.354 0.662 . . . . 0.0 111.096 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -88.41 -12.94 41.77 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.339 0.655 . . . . 0.0 110.865 -178.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.527 ' HA ' HG22 ' A' ' 83' ' ' ILE . 12.1 ptp85 -63.69 147.52 51.4 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 117.507 0.14 . . . . 0.0 110.681 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.402 HG11 ' HG ' ' A' ' 36' ' ' LEU . 40.2 t -66.39 116.51 34.58 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -175.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 32.3 Cg_exo -59.56 117.34 4.07 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.576 2.851 . . . . 0.0 111.248 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.9 t -102.63 125.45 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.65 95.73 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -76.85 100.45 5.52 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 56.4 mt . . . . . 0 CA--C 1.546 0.817 0 C-N-CA 123.833 0.853 . . . . 0.0 109.51 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.519 ' HB2' HG12 ' A' ' 60' ' ' VAL . 18.9 mmm180 . . . . . 0 N--CA 1.478 0.945 0 CA-C-O 120.576 0.227 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -89.68 116.54 27.89 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 169.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.3 pt -105.92 -177.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.663 0.785 . . . . 0.0 109.679 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.0 p -97.55 165.71 11.85 Favored 'General case' 0 C--O 1.248 0.999 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 169.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.496 ' O ' HG23 ' A' ' 24' ' ' VAL . 73.6 t-105 -55.84 -40.81 73.36 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.58 0.55 . . . . 0.0 110.388 171.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -53.4 -53.78 46.35 Favored 'General case' 0 C--O 1.256 1.447 0 C-N-CA 124.017 0.927 . . . . 0.0 111.881 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -51.88 -54.42 29.44 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 124.318 1.011 . . . . 0.0 109.195 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -51.89 -45.32 64.11 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 124.983 1.427 . . . . 0.0 111.745 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 20' ' ' TRP . 72.4 t -55.56 -63.16 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 O-C-N 123.551 0.532 . . . . 0.0 111.31 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -67.37 -42.03 84.12 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.923 0.764 . . . . 0.0 112.757 -167.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -94.62 -21.45 18.8 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -173.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.453 ' HE2' HG21 ' A' ' 60' ' ' VAL . 22.8 m-85 -122.19 -67.47 0.96 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.778 0.717 . . . . 0.0 112.618 -169.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.4 tp -59.46 -48.2 82.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.612 0.765 . . . . 0.0 111.597 -173.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.3 p -64.86 -20.64 66.52 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -102.74 -2.48 28.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.949 0.5 . . . . 0.0 110.995 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.61 33.88 42.17 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 115.424 0.93 . . . . 0.0 115.424 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.7 m -81.87 -3.57 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 122.934 0.493 . . . . 0.0 111.297 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.42 135.76 30.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 123.972 0.909 . . . . 0.0 108.792 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.09 -49.51 7.73 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.801 0.84 . . . . 0.0 110.323 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -153.83 149.17 27.11 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.765 0.826 . . . . 0.0 111.095 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.5 mt -118.39 103.22 9.58 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.908 1.283 . . . . 0.0 108.01 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.606 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 37.8 mt-10 -99.15 109.59 22.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.066 -171.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 44' ' ' VAL . 57.3 t -83.42 98.6 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.5 t -92.62 120.99 42.87 Favored 'Isoleucine or valine' 0 C--O 1.251 1.176 0 C-N-CA 123.204 0.602 . . . . 0.0 109.779 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 59.47 18.37 6.84 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.084 1.354 . . . . 0.0 113.437 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 60.4 6.69 1.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.686 1.194 . . . . 0.0 112.94 -173.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -87.71 -48.82 7.56 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.609 1.164 . . . . 0.0 110.215 -173.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -146.21 170.14 17.33 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.416 -172.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 38' ' ' VAL . 95.6 t -121.26 123.54 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.86 0.864 . . . . 0.0 109.561 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.606 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 7.9 tpm_? -83.37 109.48 17.33 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.312 1.445 . . . . 0.0 107.458 177.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.06 107.44 16.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.4 m -107.79 127.73 53.96 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.504 ' H ' ' HE1' ' A' ' 59' ' ' TYR . 99.7 m-85 -100.61 169.55 8.97 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.269 1.028 . . . . 0.0 111.991 -171.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.1 p . . . . . 0 CA--C 1.552 1.038 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.17 179.581 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.504 ' HE1' ' H ' ' A' ' 48' ' ' PHE . 60.2 m-85 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.519 HG12 ' HB2' ' A' ' 16' ' ' ARG . 28.7 m -111.15 172.48 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.666 -174.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -160.45 164.87 31.92 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.048 0.939 . . . . 0.0 108.948 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -152.53 143.65 23.13 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.551 0.34 . . . . 0.0 110.357 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -89.09 123.67 33.59 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 67' ' ' VAL . 32.1 pt -95.44 -40.95 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.777 -171.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.94 -75.31 0.24 Allowed Glycine 0 C--N 1.35 1.307 0 O-C-N 123.424 0.452 . . . . 0.0 112.264 -172.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.1 m -82.06 99.22 9.05 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.498 ' HA ' HD12 ' A' ' 64' ' ' ILE . 60.3 t -54.7 -39.59 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.379 1.072 . . . . 0.0 110.887 171.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 18.9 t70 -54.34 -55.93 23.63 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 123.97 0.908 . . . . 0.0 110.73 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.4 m -59.82 -42.81 94.33 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 124.087 0.867 . . . . 0.0 111.506 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -50.84 -50.09 57.49 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 123.409 0.684 . . . . 0.0 111.488 172.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 47.0 mt-10 -68.58 -47.23 67.32 Favored 'General case' 0 C--O 1.217 -0.639 0 O-C-N 123.97 0.794 . . . . 0.0 111.243 -177.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 24.3 mmm180 -53.55 -48.6 68.98 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.454 0.701 . . . . 0.0 110.458 -178.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.21 -53.42 37.46 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.601 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.13 -53.31 58.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.69 0.796 . . . . 0.0 112.117 -174.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -61.64 -51.19 69.51 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.492 0.717 . . . . 0.0 112.028 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.414 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 94.1 m -63.11 -47.4 82.96 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.781 0.676 . . . . 0.0 110.619 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.475 HD21 HG13 ' A' ' 24' ' ' VAL . 35.4 tp -56.82 -45.61 82.16 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.73 1.212 . . . . 0.0 112.913 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -66.44 -34.83 78.83 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.385 0.428 . . . . 0.0 110.284 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -66.36 -38.35 87.39 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.632 0.373 . . . . 0.0 111.347 173.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 76' ' ' THR . 49.9 mt-10 -69.5 -36.99 76.99 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.909 0.884 . . . . 0.0 111.0 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.78 -19.38 59.03 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.017 0.927 . . . . 0.0 111.641 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.85 6.03 70.34 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.862 -0.41 . . . . 0.0 113.494 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.5 mt -71.27 109.98 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 124.511 1.124 . . . . 0.0 109.403 176.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -124.35 144.09 50.21 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.369 0.668 . . . . 0.0 111.507 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.83 -115.0 5.0 Favored Glycine 0 C--N 1.354 1.549 0 O-C-N 124.897 1.373 . . . . 0.0 114.831 169.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -64.61 -26.43 68.39 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.17 0.988 . . . . 0.0 112.067 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -79.71 -20.3 46.82 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.24 0.216 . . . . 0.0 110.988 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -64.86 139.59 58.78 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 174.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 t -75.9 114.84 40.87 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 124.03 0.831 . . . . 0.0 109.243 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.87 140.3 94.58 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.465 2.777 . . . . 0.0 113.252 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.8 t -105.97 112.52 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.432 ' HB ' ' HG2' ' A' ' 37' ' ' GLU . 63.0 t -110.78 97.13 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 123.821 0.849 . . . . 0.0 109.656 -171.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -70.61 103.11 2.43 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.551 0.34 . . . . 0.0 110.276 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 63.1 mt . . . . . 0 CA--C 1.537 0.452 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.819 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.34 141.24 35.61 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.7 pt -137.38 -175.44 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.237 1.415 . . . . 0.0 108.14 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.4 p -105.44 165.36 11.18 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.63 0.372 . . . . 0.0 110.209 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.468 ' O ' HG23 ' A' ' 24' ' ' VAL . 70.8 t-105 -56.43 -37.54 70.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.61 0.764 . . . . 0.0 109.879 169.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.18 -46.04 83.18 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 123.799 0.84 . . . . 0.0 112.217 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -61.31 -46.13 91.59 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.684 0.393 . . . . 0.0 110.895 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.401 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 35.6 t80 -54.29 -55.55 27.14 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 124.184 0.927 . . . . 0.0 111.256 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 20' ' ' TRP . 94.2 t -57.19 -62.69 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.299 0.639 . . . . 0.0 111.73 -176.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -67.38 -54.39 20.87 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.573 -170.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -87.64 -14.79 39.06 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.441 0.696 . . . . 0.0 112.649 -165.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.401 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 91.1 m-85 -124.8 -67.12 0.93 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 118.397 0.544 . . . . 0.0 112.003 -174.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.4 tp -60.68 -47.98 83.85 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.749 0.819 . . . . 0.0 111.733 -172.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.9 m -68.96 -16.67 63.8 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.615 0.766 . . . . 0.0 112.807 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -93.56 -5.49 48.83 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.011 0.524 . . . . 0.0 111.512 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.18 33.94 82.1 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 123.572 0.545 . . . . 0.0 114.142 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 18.5 m -93.23 1.66 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 122.551 0.34 . . . . 0.0 111.071 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 t -96.67 126.68 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 120.688 0.28 . . . . 0.0 110.278 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 23.4 t70 -88.45 -50.36 6.36 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.347 1.059 . . . . 0.0 109.43 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -155.01 162.72 41.0 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.794 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.4 mt -117.08 103.32 10.11 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.457 0.703 . . . . 0.0 109.648 174.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -87.39 100.74 12.96 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.511 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.2 t -93.1 92.64 3.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -172.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.421 HG22 ' HB ' ' A' ' 94' ' ' ILE . 60.7 t -83.6 132.23 31.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.566 -175.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 66.19 11.12 7.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.895 1.278 . . . . 0.0 112.392 172.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.481 ' HB3' HG21 ' A' ' 67' ' ' VAL . 62.0 mttm 58.47 6.14 0.53 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.478 1.111 . . . . 0.0 112.55 -168.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -94.52 -38.11 11.06 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.7 1.2 . . . . 0.0 110.234 -168.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -148.4 151.85 35.98 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.237 -176.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.91 126.43 68.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.257 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -101.84 123.22 45.41 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.452 ' HB ' HG23 ' A' ' 60' ' ' VAL . 46.5 t -83.78 111.2 19.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.526 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.0 m -91.91 135.48 33.9 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.54 ' HE1' ' HA ' ' A' ' 59' ' ' TYR . 75.9 m-85 -85.49 148.46 25.96 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.308 0.38 . . . . 0.0 110.159 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.594 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 27.5 p . . . . . 0 CA--C 1.549 0.933 0 C-N-CA 123.13 0.572 . . . . 0.0 111.055 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.54 ' HA ' ' HE1' ' A' ' 48' ' ' PHE . 97.5 m-85 . . . . . 0 C--O 1.238 0.498 0 CA-C-O 121.181 0.515 . . . . 0.0 109.641 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.452 HG23 ' HB ' ' A' ' 46' ' ' VAL . 19.1 m -109.56 159.16 9.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.504 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -159.44 164.5 34.48 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.836 0.855 . . . . 0.0 108.975 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -148.73 141.11 24.19 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -88.35 132.5 34.4 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 67' ' ' VAL . 24.3 pt -104.36 139.8 24.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 123.788 0.835 . . . . 0.0 109.808 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.22 -41.94 44.75 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.824 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.4 t -132.17 132.17 42.93 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.937 0.895 . . . . 0.0 110.393 177.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.481 HG21 ' HB3' ' A' ' 41' ' ' LYS . 38.6 t -63.6 -35.49 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.467 0.707 . . . . 0.0 110.745 172.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -57.81 -50.26 73.86 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.767 0.827 . . . . 0.0 110.724 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.1 m -61.69 -45.82 92.34 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 124.167 0.917 . . . . 0.0 111.027 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -54.0 -51.25 64.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.197 0.599 . . . . 0.0 111.023 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -64.77 -51.13 63.91 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.577 0.751 . . . . 0.0 112.451 -174.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -66.74 -36.4 82.37 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.116 0.26 . . . . 0.0 111.054 -175.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -69.25 -42.53 75.49 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.426 ' HG ' ' NE2' ' A' ' 78' ' ' GLN . 29.9 tp -59.76 -53.19 60.88 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 123.593 0.558 . . . . 0.0 111.232 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -62.96 -41.84 99.64 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.046 0.539 . . . . 0.0 111.807 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.6 m -66.97 -54.95 16.85 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.387 0.675 . . . . 0.0 111.05 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.8 tp -52.0 -41.17 61.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.142 1.377 . . . . 0.0 112.651 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.426 ' NE2' ' HG ' ' A' ' 74' ' ' LEU . 44.8 mt-30 -64.01 -42.95 96.97 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.4 0.28 . . . . 0.0 110.487 175.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -63.37 -32.13 73.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.756 0.423 . . . . 0.0 111.782 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -64.42 -38.32 90.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.12 0.568 . . . . 0.0 110.32 173.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.4 mt -78.36 -13.97 59.61 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.518 0.727 . . . . 0.0 111.324 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.35 21.35 58.7 Favored Glycine 0 C--N 1.355 1.606 0 C-N-CA 122.88 0.276 . . . . 0.0 113.126 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.1 mt -94.06 131.62 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 125.467 1.507 . . . . 0.0 110.179 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -166.63 160.83 15.4 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.026 0.93 . . . . 0.0 109.737 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.93 -92.65 0.01 OUTLIER Glycine 0 C--N 1.347 1.149 0 O-C-N 123.919 0.762 . . . . 0.0 114.688 173.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -69.8 -46.44 65.7 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.37 1.068 . . . . 0.0 110.638 -172.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -92.48 -4.9 52.91 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.374 -174.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -70.39 128.28 35.66 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.153 0.581 . . . . 0.0 109.87 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.84 113.67 13.03 Favored Pre-proline 0 CA--C 1.55 0.977 0 O-C-N 124.049 0.843 . . . . 0.0 111.081 -170.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 74.9 Cg_exo -54.48 122.67 11.96 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.482 2.788 . . . . 0.0 112.666 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.7 121.43 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.8 t -118.69 97.47 5.34 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -71.61 117.87 13.73 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.421 ' HB ' HG22 ' A' ' 39' ' ' VAL . 54.9 mt . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.644 ' HB2' HG12 ' A' ' 60' ' ' VAL . 51.6 mmm-85 . . . . . 0 C--O 1.236 0.372 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -75.24 108.21 7.85 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 50.0 pt -105.49 -178.13 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 124.936 1.295 . . . . 0.0 108.804 173.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.4 p -98.85 168.6 10.02 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 123.186 0.594 . . . . 0.0 109.506 167.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.492 ' O ' HG23 ' A' ' 24' ' ' VAL . 44.8 t-105 -53.74 -42.74 68.46 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.563 0.745 . . . . 0.0 110.336 171.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -60.33 -43.47 96.37 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.007 0.523 . . . . 0.0 112.34 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.533 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 63.1 m-20 -64.5 -35.12 79.91 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.51 0.324 . . . . 0.0 110.845 177.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.561 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 35.8 t80 -57.67 -51.93 67.51 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 123.905 0.753 . . . . 0.0 110.839 174.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.527 HG13 HD21 ' A' ' 77' ' ' LEU . 90.4 t -54.75 -62.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.047 0.939 . . . . 0.0 112.136 -176.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -73.25 -49.27 28.7 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -83.06 -18.91 37.99 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -170.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.561 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 60.0 m-85 -128.12 -64.93 0.93 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.075 0.852 . . . . 0.0 112.994 -170.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -60.84 -46.25 91.32 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.312 0.645 . . . . 0.0 111.787 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.1 t -58.56 -27.77 64.9 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.581 1.152 . . . . 0.0 112.929 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -87.51 -17.63 31.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.957 0.503 . . . . 0.0 110.739 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.35 32.59 84.13 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 123.804 0.69 . . . . 0.0 113.897 -172.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.8 m -80.7 -0.88 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.3 t -100.5 132.16 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.694 0.798 . . . . 0.0 110.117 -170.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -83.28 -52.69 6.34 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.206 1.002 . . . . 0.0 109.967 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.417 HH21 HG21 ' A' ' 92' ' ' VAL . 1.1 ptm180 -154.67 156.81 37.11 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.657 0.783 . . . . 0.0 109.74 -175.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.3 mt -112.28 102.87 11.0 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -92.5 101.88 14.33 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.984 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 38.7 t -83.88 96.23 4.21 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -175.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.23 118.63 25.66 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.639 -173.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 58.74 18.38 5.93 Favored 'General case' 0 CA--C 1.559 1.298 0 O-C-N 124.944 1.402 . . . . 0.0 112.587 172.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.411 ' HA ' HG12 ' A' ' 38' ' ' VAL . 33.4 mtmm 58.66 2.23 0.22 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.388 1.475 . . . . 0.0 114.33 -171.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -82.05 -33.85 29.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.371 0.668 . . . . 0.0 109.803 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -154.36 163.81 39.58 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.767 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 57.9 t -111.74 129.28 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -103.84 128.07 51.31 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.88 106.98 17.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.397 -1.274 . . . . 0.0 107.656 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.4 m -96.71 125.53 41.23 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -94.44 170.38 9.53 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.027 0.829 . . . . 0.0 110.994 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.6 p . . . . . 0 CA--C 1.552 1.026 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 168.813 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 . . . . . 0 C--O 1.239 0.55 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.644 HG12 ' HB2' ' A' ' 16' ' ' ARG . 11.4 m -124.6 166.7 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -165.2 159.86 17.95 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.767 0.427 . . . . 0.0 111.079 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -147.76 142.29 26.48 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.4 0.68 . . . . 0.0 109.914 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -81.49 141.64 33.66 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 67' ' ' VAL . 33.3 pt -117.42 124.09 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.274 0.63 . . . . 0.0 110.361 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -71.6 -40.46 59.1 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.1 t -129.92 120.01 24.18 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.118 0.967 . . . . 0.0 108.73 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.502 ' HA ' HD12 ' A' ' 64' ' ' ILE . 97.5 t -56.04 -38.83 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.49 1.116 . . . . 0.0 110.774 172.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -60.66 -45.62 93.44 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.003 0.921 . . . . 0.0 110.805 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.1 m -59.57 -47.46 85.46 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.353 0.661 . . . . 0.0 110.747 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -53.65 -60.43 3.32 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.772 0.829 . . . . 0.0 111.862 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -42.01 80.19 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.24 0.616 . . . . 0.0 112.032 -169.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -62.9 -47.79 81.77 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.063 0.545 . . . . 0.0 110.851 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -65.92 -38.73 89.45 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.329 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.3 tp -58.04 -56.85 16.67 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.683 0.793 . . . . 0.0 111.974 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -35.17 79.55 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 123.452 0.47 . . . . 0.0 112.182 -174.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.1 m -62.26 -55.03 32.39 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.328 0.651 . . . . 0.0 110.116 172.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.527 HD21 HG13 ' A' ' 24' ' ' VAL . 52.5 tp -50.77 -45.09 58.88 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.644 1.578 . . . . 0.0 113.04 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -63.07 -41.32 99.41 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.046 0.539 . . . . 0.0 110.775 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -65.2 -35.83 82.28 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.129 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -71.33 -44.12 65.7 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.514 0.726 . . . . 0.0 111.458 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.7 mt -74.19 -7.27 52.08 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.753 0.821 . . . . 0.0 111.888 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.27 8.18 87.84 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.506 0.504 . . . . 0.0 112.537 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.9 mt -70.24 108.67 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.868 1.267 . . . . 0.0 108.057 175.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -141.59 162.73 34.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.627 0.771 . . . . 0.0 110.616 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.44 -120.67 23.75 Favored Glycine 0 C--N 1.344 1.009 0 O-C-N 124.577 1.173 . . . . 0.0 112.995 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.36 -39.99 85.03 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.69 1.196 . . . . 0.0 111.362 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -69.5 -19.75 63.73 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.353 0.661 . . . . 0.0 111.596 -168.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -68.35 148.29 50.92 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.911 0.386 . . . . 0.0 111.097 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.92 117.93 56.44 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.744 -173.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.16 150.63 72.07 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 123.215 2.61 . . . . 0.0 112.473 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.3 t -112.88 116.89 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.665 0.786 . . . . 0.0 108.957 -176.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.417 HG21 HH21 ' A' ' 35' ' ' ARG . 47.0 t -117.92 115.6 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.419 1.088 . . . . 0.0 108.56 -171.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -94.69 115.57 27.7 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.176 0.59 . . . . 0.0 110.902 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 175.121 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.606 ' HB2' HG12 ' A' ' 60' ' ' VAL . 18.8 mtm180 . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.67 109.83 6.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.684 0.394 . . . . 0.0 110.095 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 36.6 pt -104.16 170.89 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.023 0.929 . . . . 0.0 109.226 175.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 76.9 p -86.41 168.62 13.64 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 166.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.571 ' O ' HG23 ' A' ' 24' ' ' VAL . 69.2 t-105 -55.1 -40.78 70.81 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.626 0.579 . . . . 0.0 109.849 168.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -56.15 -47.97 77.18 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.552 0.741 . . . . 0.0 111.424 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.569 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 39.7 m-20 -65.11 -39.19 92.77 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.495 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 19.5 t80 -53.8 -48.92 69.37 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 124.208 0.943 . . . . 0.0 110.852 176.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 20' ' ' TRP . 61.2 t -67.4 -65.98 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 123.572 0.545 . . . . 0.0 111.231 -176.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -67.76 -46.67 71.4 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.637 -166.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -85.56 -18.53 33.13 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.964 0.506 . . . . 0.0 112.001 -172.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.495 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 47.8 m-85 -127.55 -67.99 0.8 Allowed 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 119.277 0.944 . . . . 0.0 112.946 -171.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.13 -47.99 83.27 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.736 0.815 . . . . 0.0 111.482 -172.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.4 m -63.79 -23.25 67.29 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.855 0.862 . . . . 0.0 113.13 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -101.99 4.47 39.95 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 119.361 -0.352 . . . . 0.0 111.533 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.63 28.24 56.14 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.1 m -81.31 -5.96 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.115 0.566 . . . . 0.0 111.01 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.83 136.4 26.09 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 C-N-CA 124.014 0.926 . . . . 0.0 108.923 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -86.86 -57.75 2.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.131 0.973 . . . . 0.0 108.978 174.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -153.31 159.93 42.6 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.716 -174.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.4 mt -113.87 102.17 9.96 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -94.8 103.68 15.58 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.446 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 18.4 t -87.79 101.7 11.76 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -174.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.487 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 94.9 t -75.59 116.8 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 37.85 37.17 0.12 Allowed 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 128.348 2.659 . . . . 0.0 115.913 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt 67.27 -1.83 1.4 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.918 1.287 . . . . 0.0 112.793 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -80.76 -37.37 30.5 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.063 0.945 . . . . 0.0 110.42 -175.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -159.07 158.93 33.97 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.11 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 61.8 t -109.38 129.42 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.533 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -94.02 126.01 38.98 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.443 ' HB ' HG23 ' A' ' 60' ' ' VAL . 33.5 t -84.21 105.1 13.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.2 m -103.95 130.98 51.61 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -96.43 163.8 12.9 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.17 0.918 . . . . 0.0 111.956 -170.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.1 p . . . . . 0 CA--C 1.561 1.372 0 C-N-CA 124.084 0.953 . . . . 0.0 112.052 -178.317 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 . . . . . 0 N--CA 1.466 0.333 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.606 HG12 ' HB2' ' A' ' 16' ' ' ARG . 29.5 m -124.67 156.51 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 124.127 0.892 . . . . 0.0 108.595 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -155.23 171.23 20.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.938 0.495 . . . . 0.0 110.556 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -150.54 143.66 24.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.83 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -79.97 134.45 36.25 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.182 0.593 . . . . 0.0 110.454 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.8 pt -120.24 175.66 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.148 0.579 . . . . 0.0 110.334 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.4 -50.69 0.08 OUTLIER Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.2 t -100.72 108.87 20.83 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.771 0.828 . . . . 0.0 109.631 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.0 t -57.88 -37.69 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.124 0.97 . . . . 0.0 110.402 170.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -53.59 -50.23 66.05 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.786 1.234 . . . . 0.0 110.574 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.6 m -66.83 -43.75 82.9 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 124.126 0.891 . . . . 0.0 111.275 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -53.52 -49.56 67.33 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.084 0.554 . . . . 0.0 110.948 172.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -65.61 -51.67 57.88 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.256 1.022 . . . . 0.0 112.847 -172.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.5 ptt85 -68.11 -38.24 82.05 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.57 0.544 . . . . 0.0 111.255 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -72.48 -39.14 67.93 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 40.5 tp -59.92 -54.42 46.3 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.822 0.849 . . . . 0.0 111.931 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.46 ' HB2' HH12 ' A' ' 88' ' ' ARG . 13.6 pt-20 -63.13 -40.03 96.41 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.301 0.64 . . . . 0.0 111.447 -175.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.7 m -66.86 -49.43 65.7 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.617 0.767 . . . . 0.0 109.736 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.45 HD21 HG22 ' A' ' 24' ' ' VAL . 43.0 tp -51.11 -48.81 61.62 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.526 1.13 . . . . 0.0 111.998 174.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -62.42 -46.41 88.68 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 123.67 0.606 . . . . 0.0 111.225 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -67.04 -30.15 70.14 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 123.043 0.214 . . . . 0.0 110.871 -177.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.64 -42.65 70.59 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.812 0.845 . . . . 0.0 110.842 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 94.4 mt -71.81 -12.16 61.16 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.645 0.778 . . . . 0.0 111.47 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.03 -0.61 76.24 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 123.288 0.368 . . . . 0.0 112.75 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 66.2 mt -74.46 92.28 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.75 152.2 48.05 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.82 0.448 . . . . 0.0 111.225 -172.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.92 -115.91 8.26 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 124.453 1.096 . . . . 0.0 113.02 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.16 -26.48 68.19 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.248 1.019 . . . . 0.0 111.595 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.45 -24.41 60.22 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.846 0.458 . . . . 0.0 111.881 -176.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.46 HH12 ' HB2' ' A' ' 75' ' ' GLU . 60.8 mtt180 -63.02 135.2 57.14 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 123.427 0.455 . . . . 0.0 110.802 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.56 118.87 74.81 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 123.733 0.813 . . . . 0.0 110.44 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.99 135.27 50.45 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 123.596 2.864 . . . . 0.0 113.262 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.2 116.38 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.531 0.733 . . . . 0.0 109.48 -176.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.2 t -105.74 99.08 7.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -174.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -74.92 99.71 3.9 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 42.3 mm . . . . . 0 C--N 1.323 -0.554 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.65 ' HB2' HG12 ' A' ' 60' ' ' VAL . 31.9 mmt180 . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -78.52 133.21 37.41 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.267 0.556 . . . . 0.0 109.648 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 48.5 pt -132.13 -177.04 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 126.009 1.724 . . . . 0.0 108.27 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.8 p -102.98 169.91 8.28 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 167.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.502 ' O ' HG23 ' A' ' 24' ' ' VAL . 66.4 t-105 -53.18 -40.15 64.17 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.552 0.741 . . . . 0.0 110.486 170.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.6 tttp -56.48 -49.0 75.94 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.749 0.819 . . . . 0.0 111.632 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.515 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 30.5 m-20 -61.95 -40.66 96.3 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.625 0.37 . . . . 0.0 110.773 177.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.426 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 33.9 t80 -54.01 -53.0 59.0 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 124.413 1.07 . . . . 0.0 110.96 177.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 20' ' ' TRP . 63.8 t -57.23 -56.77 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 123.732 0.645 . . . . 0.0 111.074 -177.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -67.6 -58.95 3.78 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.739 0.816 . . . . 0.0 112.274 -170.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -85.44 -20.65 29.47 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.555 0.742 . . . . 0.0 112.084 -165.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.426 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 78.1 m-85 -120.66 -68.97 0.87 Allowed 'General case' 0 C--O 1.248 1.003 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -168.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.7 tp -60.21 -48.85 79.98 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.562 0.745 . . . . 0.0 111.894 -173.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.1 m -68.48 -17.05 64.1 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -96.6 1.38 51.18 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.267 0.485 . . . . 0.0 111.358 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.94 22.01 56.82 Favored Glycine 0 C--N 1.35 1.307 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 m -89.95 4.83 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.886 0.474 . . . . 0.0 111.334 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.6 t -96.18 128.58 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.432 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 25.6 t70 -90.35 -50.09 6.16 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.885 0.874 . . . . 0.0 109.951 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -163.94 159.21 20.6 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.291 -177.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 46' ' ' VAL . 96.3 mt -120.72 102.55 8.47 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.987 0.915 . . . . 0.0 110.877 -173.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.698 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 49.4 mp0 -83.99 108.67 17.09 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.698 0.799 . . . . 0.0 110.092 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 41' ' ' LYS . 47.8 t -86.15 90.61 3.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.446 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 59.8 t -84.84 119.05 33.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.851 -170.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 56.89 22.38 7.06 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 125.404 1.482 . . . . 0.0 112.992 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.525 ' HA ' HG12 ' A' ' 38' ' ' VAL . 36.2 mtmm 58.58 8.28 0.86 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.526 1.13 . . . . 0.0 113.666 -173.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -88.59 -40.18 13.56 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.447 1.099 . . . . 0.0 110.851 -174.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -150.33 173.78 13.6 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.062 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 38' ' ' VAL . 73.8 t -124.05 132.72 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.179 0.992 . . . . 0.0 109.676 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.698 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 40.9 ttm180 -96.39 113.09 24.64 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.521 1.128 . . . . 0.0 108.582 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.422 ' HA ' HD23 ' A' ' 36' ' ' LEU . 44.6 t -82.66 107.2 14.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.3 m -93.16 144.67 25.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.27 140.48 29.65 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.887 0.475 . . . . 0.0 112.02 177.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 CA--C 1.55 0.978 0 C-N-CA 124.121 0.968 . . . . 0.0 110.96 174.566 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.5 p90 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 121.152 0.501 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.65 HG12 ' HB2' ' A' ' 16' ' ' ARG . 23.3 m -109.19 164.61 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -158.89 158.35 33.23 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 118.385 0.539 . . . . 0.0 111.202 -173.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -146.1 145.68 30.62 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.999 0.52 . . . . 0.0 110.245 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -85.35 121.81 28.62 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.973 0.909 . . . . 0.0 110.487 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 67' ' ' VAL . 36.2 pt -103.77 -51.51 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.283 0.633 . . . . 0.0 111.236 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.457 ' N ' HG13 ' A' ' 64' ' ' ILE . . . 71.03 -70.07 0.78 Allowed Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -165.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.6 m -81.55 96.27 7.39 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.108 0.963 . . . . 0.0 110.895 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.567 ' HA ' HD12 ' A' ' 64' ' ' ILE . 13.0 t -64.72 -34.06 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.626 0.77 . . . . 0.0 111.383 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -58.73 -45.35 89.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.063 0.545 . . . . 0.0 109.819 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.5 m -64.19 -46.23 84.87 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.014 0.926 . . . . 0.0 110.229 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -49.65 -54.53 18.0 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.197 0.999 . . . . 0.0 112.042 174.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -66.59 -43.5 84.72 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.125 0.891 . . . . 0.0 111.83 -174.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -63.98 -40.07 95.57 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.568 0.747 . . . . 0.0 111.041 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -64.17 -46.82 82.32 Favored 'General case' 0 C--O 1.216 -0.698 0 O-C-N 123.704 0.627 . . . . 0.0 109.678 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.7 tp -60.79 -41.81 96.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.935 0.894 . . . . 0.0 111.86 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -65.14 -51.53 60.69 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.211 0.605 . . . . 0.0 111.786 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 m -65.7 -37.28 86.01 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.618 0.767 . . . . 0.0 110.214 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.42 -44.02 95.82 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.494 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -66.25 -29.88 70.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.694 0.397 . . . . 0.0 110.516 176.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -66.88 -49.12 66.64 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.65 0.38 . . . . 0.0 111.397 175.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.46 -36.03 73.66 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.228 0.211 . . . . 0.0 111.239 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.557 ' HB2' HG12 ' A' ' 83' ' ' ILE . 92.0 mt -75.78 -20.06 58.52 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.144 0.578 . . . . 0.0 111.228 175.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.68 30.56 66.11 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 120.121 -0.266 . . . . 0.0 113.131 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.557 HG12 ' HB2' ' A' ' 81' ' ' LEU . 17.6 mm -66.45 102.35 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.414 1.085 . . . . 0.0 109.279 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -72.6 166.99 21.64 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.63 -32.85 54.26 Favored Glycine 0 N--CA 1.48 1.613 0 O-C-N 124.179 0.924 . . . . 0.0 114.73 -171.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -67.28 -43.52 81.56 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.966 0.906 . . . . 0.0 110.408 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -81.19 -19.91 42.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.145 0.978 . . . . 0.0 111.593 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.5 mtt-85 -61.47 122.08 14.3 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.904 0.881 . . . . 0.0 110.567 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.5 t -77.91 117.95 69.06 Favored Pre-proline 0 CA--C 1.554 1.103 0 O-C-N 123.983 0.802 . . . . 0.0 110.47 -172.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.432 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 71.9 Cg_exo -54.84 136.98 74.19 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.841 3.027 . . . . 0.0 113.261 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.3 t -103.53 113.4 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' A' ' 37' ' ' GLU . 60.3 t -100.89 149.36 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.927 1.291 . . . . 0.0 108.025 -177.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -114.2 131.5 56.44 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 38.4 mm . . . . . 0 N--CA 1.473 0.72 0 C-N-CA 123.882 0.873 . . . . 0.0 109.244 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.651 ' HB2' HG12 ' A' ' 60' ' ' VAL . 59.2 mtm180 . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -78.81 129.72 34.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.4 pt -124.42 179.72 2.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 124.914 1.286 . . . . 0.0 108.921 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.8 p -106.32 170.1 8.12 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.66 0.784 . . . . 0.0 109.682 172.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.422 ' O ' HG23 ' A' ' 24' ' ' VAL . 71.1 t-105 -59.62 -39.87 85.71 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.527 0.731 . . . . 0.0 111.174 176.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -55.68 -52.38 64.05 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.585 0.754 . . . . 0.0 112.229 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -70.18 -32.38 70.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.935 0.494 . . . . 0.0 111.51 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.495 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 17.4 t80 -55.84 -56.11 24.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.635 0.774 . . . . 0.0 111.671 172.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.44 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 97.4 t -61.95 -58.33 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 123.595 0.56 . . . . 0.0 110.419 -176.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -65.47 -49.82 67.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.052 -168.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -87.46 -17.08 33.0 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -170.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.495 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 42.7 m-85 -128.6 -68.04 0.77 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -171.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 7.9 tt -59.06 -52.65 64.83 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.559 0.744 . . . . 0.0 111.903 -169.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 82.3 p -66.61 -22.57 66.12 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.554 0.742 . . . . 0.0 112.152 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -89.76 -5.42 56.98 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.342 0.657 . . . . 0.0 111.664 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.24 32.67 77.34 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.468 0.48 . . . . 0.0 113.991 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 m -101.93 11.44 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 122.855 0.462 . . . . 0.0 110.328 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.67 122.59 51.69 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 C-N-CA 124.207 1.003 . . . . 0.0 109.519 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 25.7 t70 -77.04 -45.89 25.62 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.732 0.813 . . . . 0.0 109.601 176.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -162.59 162.44 27.18 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.747 -167.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.426 ' HG ' HG11 ' A' ' 89' ' ' VAL . 95.4 mt -120.41 137.11 54.49 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.906 1.283 . . . . 0.0 108.375 170.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -120.13 110.49 16.7 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.213 0.605 . . . . 0.0 109.491 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 44' ' ' VAL . 24.3 t -90.09 91.14 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -176.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.49 119.11 34.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -172.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 57.99 17.1 4.14 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.629 1.571 . . . . 0.0 113.855 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.1 mttp 61.69 2.81 0.76 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -172.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -80.04 -42.43 23.77 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.658 0.783 . . . . 0.0 109.856 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -151.38 170.41 19.63 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.334 -174.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 38' ' ' VAL . 84.6 t -129.21 133.7 65.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -99.57 132.41 44.93 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.15 109.39 16.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 114.59 -1.186 . . . . 0.0 107.819 174.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.7 m -82.13 125.95 31.47 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 172.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.439 ' CE2' ' HA ' ' A' ' 59' ' ' TYR . 22.7 m-85 -84.21 133.42 34.59 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.369 0.668 . . . . 0.0 110.204 177.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.817 0 O-C-N 123.497 0.498 . . . . 0.0 109.95 175.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.439 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 17.8 m-85 . . . . . 0 C--O 1.237 0.425 0 CA-C-O 121.184 0.516 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.651 HG12 ' HB2' ' A' ' 16' ' ' ARG . 34.9 m -107.7 161.33 6.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.506 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 45.5 p-90 -153.3 162.26 41.49 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.601 0.76 . . . . 0.0 109.276 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -147.75 144.38 28.21 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -79.57 136.22 36.8 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 67' ' ' VAL . 43.1 pt -108.23 -42.22 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 110.658 -0.127 . . . . 0.0 110.658 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.81 -81.53 0.05 OUTLIER Glycine 0 C--N 1.35 1.306 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 -173.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.3 m -74.48 97.49 3.12 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.739 0.816 . . . . 0.0 109.134 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.467 ' HA ' HD12 ' A' ' 64' ' ' ILE . 25.2 t -59.81 -33.67 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.98 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -57.05 -40.77 77.42 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.944 0.898 . . . . 0.0 111.069 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.2 m -67.19 -46.01 75.19 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.129 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -52.64 -52.73 54.32 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.503 0.502 . . . . 0.0 111.213 177.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -59.63 -59.01 6.12 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.3 1.0 . . . . 0.0 112.767 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -67.2 -36.79 82.46 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.534 -171.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -63.82 -52.63 59.3 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 174.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 47.7 tp -52.78 -52.96 54.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.188 1.395 . . . . 0.0 112.722 -176.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -68.17 -45.55 73.16 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.449 -175.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.6 m -64.72 -45.14 87.78 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.4 tp -46.45 -48.52 18.93 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.883 1.673 . . . . 0.0 112.382 171.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -62.23 -43.25 99.24 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.3 0.64 . . . . 0.0 111.258 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -65.25 -41.69 94.05 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.255 0.622 . . . . 0.0 111.142 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -68.47 -40.26 81.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.741 0.816 . . . . 0.0 111.25 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.58 -15.04 59.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.214 0.605 . . . . 0.0 112.52 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.96 13.57 68.94 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-O 120.269 -0.184 . . . . 0.0 113.41 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.4 mt -71.67 108.11 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.43 1.092 . . . . 0.0 109.2 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -137.98 151.47 47.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.929 0.891 . . . . 0.0 110.568 -172.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.22 -118.91 13.96 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 123.905 0.753 . . . . 0.0 113.65 174.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.69 -29.32 70.56 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.043 0.937 . . . . 0.0 111.734 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.84 -21.66 60.92 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.943 -171.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 88' ' ' ARG . 37.6 mtp85 -66.55 150.01 49.63 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.175 0.59 . . . . 0.0 110.416 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.426 HG11 ' HG ' ' A' ' 36' ' ' LEU . 20.2 t -91.64 119.55 68.46 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.118 -168.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.4 123.86 13.59 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.066 2.51 . . . . 0.0 111.377 175.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.2 t -116.19 118.34 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.8 t -113.36 105.59 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.106 0.963 . . . . 0.0 109.567 -173.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -75.35 123.46 25.42 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.051 0.54 . . . . 0.0 109.814 175.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.8 mt . . . . . 0 CA--C 1.54 0.573 0 C-N-CA 124.882 1.273 . . . . 0.0 108.084 -178.978 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 20.4 tpp180 . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -77.44 111.32 13.02 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 167.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.465 HD11 HG21 ' A' ' 46' ' ' VAL . 27.5 pt -93.77 166.78 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.555 1.142 . . . . 0.0 109.241 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.9 p -88.57 170.73 10.6 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -56.79 -40.86 76.67 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.097 0.559 . . . . 0.0 110.13 168.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -59.98 -49.17 78.74 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.663 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -66.61 -36.79 83.46 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.193 0.197 . . . . 0.0 111.183 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -54.65 -59.4 4.76 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.654 0.596 . . . . 0.0 110.736 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.486 HG13 HD11 ' A' ' 77' ' ' LEU . 47.5 t -60.17 -50.79 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 123.933 0.771 . . . . 0.0 111.255 -175.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -73.1 -56.97 4.38 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.793 -173.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -90.89 -10.99 40.53 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.9 -64.69 1.0 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 119.158 0.89 . . . . 0.0 111.737 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 41.9 tp -58.15 -41.81 84.55 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.551 1.14 . . . . 0.0 112.224 -176.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.8 t -66.55 -22.21 66.15 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.576 0.751 . . . . 0.0 112.751 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -87.09 -7.9 57.58 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.326 0.512 . . . . 0.0 110.949 175.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.66 12.95 60.25 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 114.259 0.464 . . . . 0.0 114.259 -175.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.14 -1.01 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 117.317 0.558 . . . . 0.0 111.084 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.55 126.44 45.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 C-N-CA 123.525 0.73 . . . . 0.0 109.155 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.443 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 16.5 t70 -86.03 -51.58 6.25 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.886 0.851 . . . . 0.0 109.095 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.534 ' HD3' HG21 ' A' ' 92' ' ' VAL . 16.2 ptp180 -160.13 164.42 32.99 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.05 -172.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.2 mt -117.17 101.93 8.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.685 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -92.96 107.61 19.36 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.495 0.718 . . . . 0.0 109.944 -171.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 44' ' ' VAL . 41.0 t -91.89 91.61 3.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -175.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.688 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 49.1 t -79.08 114.22 19.52 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.666 -172.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 50.66 31.7 6.1 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.496 1.519 . . . . 0.0 113.217 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HA ' HG12 ' A' ' 38' ' ' VAL . 61.3 mttm 66.8 -6.87 0.5 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 125.714 1.606 . . . . 0.0 112.801 -177.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.7 mmt-85 -64.94 -50.19 67.42 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 124.865 1.266 . . . . 0.0 110.904 -170.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -148.74 159.83 43.77 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.49 -175.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 38' ' ' VAL . 65.5 t -101.14 123.06 53.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 171.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -101.6 129.29 47.68 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.542 ' HB ' HG23 ' A' ' 60' ' ' VAL . 68.8 t -85.13 110.24 19.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.5 m -82.97 134.74 35.04 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -82.99 128.17 34.23 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 171.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.443 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 5.1 t . . . . . 0 CA--C 1.556 1.202 0 C-N-CA 123.109 0.564 . . . . 0.0 110.541 -176.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 121.362 0.601 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.542 HG23 ' HB ' ' A' ' 46' ' ' VAL . 18.7 m -106.29 140.75 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -177.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -157.21 173.57 16.77 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.344 -170.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 23.7 p90 -151.98 141.17 21.35 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.86 0.864 . . . . 0.0 109.178 175.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -78.17 147.54 34.47 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.2 pt -124.39 154.1 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.329 0.652 . . . . 0.0 109.289 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.24 -34.43 1.79 Allowed Glycine 0 N--CA 1.471 0.989 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 174.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 m -117.9 99.55 6.99 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.56 1.144 . . . . 0.0 108.535 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.6 t -60.64 -35.3 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 122.977 0.511 . . . . 0.0 110.036 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.05 -40.44 95.78 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.065 0.946 . . . . 0.0 110.736 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.3 m -67.95 -42.87 80.29 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.565 176.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -55.14 -43.76 74.48 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.909 0.756 . . . . 0.0 111.394 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.47 -51.07 64.89 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.864 0.466 . . . . 0.0 110.73 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -34.42 73.52 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -171.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 29.9 p30 -74.27 -33.33 63.24 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 176.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.7 tp -62.89 -42.96 99.96 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.607 0.763 . . . . 0.0 110.859 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -60.34 -52.82 63.62 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.137 0.575 . . . . 0.0 110.566 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.8 m -61.97 -42.2 98.86 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 123.666 0.604 . . . . 0.0 110.738 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 73' ' ' ASN . 1.8 tm? -56.53 -47.82 78.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.84 1.256 . . . . 0.0 110.879 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.439 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 77.3 mt-30 -65.18 -36.83 85.43 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.143 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -63.85 -39.53 94.44 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.096 0.558 . . . . 0.0 110.814 176.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.97 -51.26 70.0 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.038 0.935 . . . . 0.0 111.169 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.8 mt -83.85 -2.57 56.69 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.001 -173.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.87 9.95 83.51 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 120.281 -0.177 . . . . 0.0 112.935 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.478 HG22 ' HA ' ' A' ' 88' ' ' ARG . 57.2 mt -73.59 118.61 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.733 1.213 . . . . 0.0 109.077 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -168.56 173.86 7.16 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.482 0.713 . . . . 0.0 111.193 -172.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.75 -122.11 25.39 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.589 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.46 -34.2 58.71 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.43 0.692 . . . . 0.0 110.245 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -74.33 -6.1 46.08 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.438 0.695 . . . . 0.0 112.455 -171.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.478 ' HA ' HG22 ' A' ' 83' ' ' ILE . 6.9 ptm180 -79.91 156.45 27.28 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.079 0.466 . . . . 0.0 111.274 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.5 t -98.99 114.81 65.84 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.246 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.92 160.74 33.64 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.164 2.576 . . . . 0.0 112.875 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.8 t -110.65 132.31 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.614 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.534 HG21 ' HD3' ' A' ' 35' ' ' ARG . 21.8 t -117.92 97.37 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -73.01 100.83 3.08 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.376 0.67 . . . . 0.0 109.883 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.688 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 46.8 mm . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.3 mtt . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.67 -2.0 63.2 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-O 119.523 -0.598 . . . . 0.0 113.729 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -65.83 -41.74 91.41 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.687 0.795 . . . . 0.0 110.797 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -90.34 83.8 5.97 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.804 0.811 . . . . 0.0 111.543 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -138.59 176.45 8.69 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.945 0.898 . . . . 0.0 110.251 174.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -66.34 96.22 0.34 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.617 0.722 . . . . 0.0 111.376 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -82.78 -42.39 18.0 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.72 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -87.49 66.01 8.85 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.012 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.0 m -152.54 144.42 23.67 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 125.311 1.444 . . . . 0.0 107.507 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -67.56 146.66 53.69 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 123.325 0.391 . . . . 0.0 110.524 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.9 ttt -62.03 98.8 0.11 Allowed 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 172.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.43 73.39 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 125.416 1.486 . . . . 0.0 110.783 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.415 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER 58.49 -74.7 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.252 1.821 . . . . 0.0 111.618 -168.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.7 t -163.52 -51.04 0.03 OUTLIER 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.144 1.377 . . . . 0.0 108.48 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 59' ' ' TYR . . . 173.56 -117.49 0.65 Allowed Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.189 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -95.33 131.4 41.46 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.574 0.687 . . . . 0.0 109.936 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -77.01 126.18 30.55 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.92 0.888 . . . . 0.0 108.752 177.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.3 pt -126.55 166.86 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.785 1.234 . . . . 0.0 108.139 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 22' ' ' ASP . 9.8 t -96.4 157.84 15.71 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.543 ' O ' HG23 ' A' ' 24' ' ' VAL . 73.5 t-105 -53.91 -46.0 71.31 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.392 1.077 . . . . 0.0 110.993 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -61.04 -39.64 90.56 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.616 0.766 . . . . 0.0 112.037 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.498 ' H ' HG23 ' A' ' 19' ' ' THR . 24.4 t70 -66.55 -43.35 85.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.532 1.133 . . . . 0.0 110.415 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.444 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 12.5 t80 -52.46 -53.72 41.8 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.802 175.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.564 HG22 HD21 ' A' ' 77' ' ' LEU . 62.3 t -58.65 -55.45 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 123.805 0.691 . . . . 0.0 111.22 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -71.78 -49.55 37.88 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.085 -0.962 . . . . 0.0 112.147 -169.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -90.07 -13.84 35.03 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.444 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 41.7 m-85 -127.81 -64.72 0.95 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 119.245 0.929 . . . . 0.0 113.131 -175.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.428 HD11 HG21 ' A' ' 89' ' ' VAL . 32.8 tp -58.47 -50.18 74.66 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.566 0.747 . . . . 0.0 112.775 -170.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.7 p -70.45 -18.37 63.0 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.15 0.58 . . . . 0.0 111.623 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -86.41 -7.59 58.32 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.435 0.694 . . . . 0.0 110.893 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.33 13.16 67.3 Favored Glycine 0 C--N 1.356 1.659 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 m -86.8 -0.47 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.435 0.617 . . . . 0.0 111.274 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.6 t -97.87 128.03 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.185 0.994 . . . . 0.0 109.062 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 23.9 t70 -86.94 -52.42 5.47 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.08 0.952 . . . . 0.0 109.75 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.516 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 17.5 ptp180 -156.48 163.66 39.16 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.512 -174.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.6 mt -118.75 104.4 10.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.825 0.85 . . . . 0.0 108.972 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.44 ' HG2' ' HB ' ' A' ' 92' ' ' VAL . 46.1 mt-10 -97.75 107.77 20.33 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.734 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 41' ' ' LYS . 26.5 t -82.91 92.42 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -172.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.549 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 61.9 t -83.19 120.44 34.47 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 C-N-CA 122.797 0.439 . . . . 0.0 110.815 -169.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 95' ' ' ALA . 3.8 m-20 54.53 21.45 3.35 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.811 1.644 . . . . 0.0 113.016 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HA ' HG12 ' A' ' 38' ' ' VAL . 99.5 mttt 55.85 5.43 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.301 1.44 . . . . 0.0 114.472 -175.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -78.41 -41.32 33.37 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.02 0.914 . . . . 0.0 108.87 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -151.49 172.91 15.24 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.021 -172.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.424 HG22 HG22 ' A' ' 38' ' ' VAL . 79.4 t -122.38 131.26 73.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 124.248 1.019 . . . . 0.0 108.53 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -90.43 127.01 36.08 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 60' ' ' VAL . 60.8 t -80.97 106.87 12.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 171.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.463 HG23 ' HE2' ' A' ' 59' ' ' TYR . 66.1 m -88.4 123.14 32.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -82.74 147.55 28.38 Favored 'General case' 0 C--O 1.247 0.939 0 O-C-N 123.609 0.568 . . . . 0.0 109.728 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 43.4 p -59.36 124.23 74.08 Favored Pre-proline 0 CA--C 1.556 1.174 0 O-C-N 124.327 1.017 . . . . 0.0 109.855 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.3 97.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 123.597 2.865 . . . . 0.0 113.563 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.9 -38.82 0.97 Allowed Glycine 0 C--N 1.344 0.993 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.724 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -67.58 -56.67 8.53 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.477 0.711 . . . . 0.0 111.1 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 65.5 p -132.06 135.52 26.68 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -71.82 -171.2 0.62 Allowed 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.636 2.224 . . . . 0.0 112.13 170.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.9 t -64.3 -41.83 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.1 -14.98 62.49 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.336 175.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.36 -12.73 59.1 Favored Glycine 0 C--N 1.351 1.376 0 C-N-CA 122.963 0.316 . . . . 0.0 112.815 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 66.99 94.15 0.07 Allowed 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.02 1.328 . . . . 0.0 111.049 172.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.463 ' HE2' HG23 ' A' ' 47' ' ' THR . 3.7 m-30 -65.21 157.33 29.12 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.128 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 46' ' ' VAL . 31.1 m -110.2 164.68 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.343 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.412 ' CZ2' ' HG2' ' A' ' 13' ' ' ARG . 56.0 p-90 -157.35 165.67 35.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.176 0.59 . . . . 0.0 110.027 -173.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -149.2 142.01 24.64 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.467 0.707 . . . . 0.0 109.967 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -75.31 140.05 42.86 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 67' ' ' VAL . 31.0 pt -115.18 -44.02 3.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.205 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.12 -74.74 0.36 Allowed Glycine 0 C--N 1.352 1.45 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 -171.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -80.33 97.47 7.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.456 1.102 . . . . 0.0 109.3 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.592 ' HA ' HD12 ' A' ' 64' ' ' ILE . 37.4 t -59.28 -37.44 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.821 0.849 . . . . 0.0 111.027 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 21.8 t70 -58.09 -49.87 75.43 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.497 1.119 . . . . 0.0 110.803 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.4 m -58.68 -46.08 88.03 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.917 0.887 . . . . 0.0 111.075 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -49.99 -50.81 45.85 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.16 0.984 . . . . 0.0 111.322 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 42.4 mt-10 -67.97 -45.83 73.09 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 124.251 0.97 . . . . 0.0 111.62 -173.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 68' ' ' ASP . 14.2 mtm180 -58.27 -46.05 86.73 Favored 'General case' 0 C--N 1.364 1.213 0 O-C-N 123.821 0.7 . . . . 0.0 109.845 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -65.48 -42.99 91.59 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.652 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.27 -50.59 69.57 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 123.946 0.778 . . . . 0.0 112.265 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -34.6 76.71 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.808 0.443 . . . . 0.0 111.675 -177.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.44 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 86.8 m -63.66 -52.02 62.57 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.352 0.596 . . . . 0.0 109.512 171.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.564 HD21 HG22 ' A' ' 24' ' ' VAL . 47.1 tp -52.99 -42.65 65.78 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.505 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -64.53 -45.7 86.03 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.915 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 76' ' ' THR . 10.1 pt20 -70.25 -26.84 64.02 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-N 117.763 0.256 . . . . 0.0 110.79 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 76' ' ' THR . 43.8 mt-10 -68.22 -50.23 55.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.013 0.925 . . . . 0.0 110.738 174.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.16 5.03 18.07 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.677 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.86 19.54 72.73 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-O 119.823 -0.432 . . . . 0.0 114.106 172.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.55 117.53 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.842 0.857 . . . . 0.0 109.612 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.65 -179.18 3.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.772 1.229 . . . . 0.0 108.568 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.17 -36.27 1.98 Allowed Glycine 0 N--CA 1.48 1.572 0 N-CA-C 116.246 1.258 . . . . 0.0 116.246 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.6 -37.03 60.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.504 0.722 . . . . 0.0 111.385 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -93.2 -5.63 49.56 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 118.85 -0.595 . . . . 0.0 111.966 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -58.85 124.51 20.06 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 118.046 0.385 . . . . 0.0 110.433 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.428 HG21 HD11 ' A' ' 28' ' ' LEU . 99.6 t -89.7 108.64 26.66 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.452 -172.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.516 ' HG2' ' HB3' ' A' ' 35' ' ' ARG . 19.4 Cg_endo -58.74 129.21 31.17 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.299 2.666 . . . . 0.0 112.591 -174.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.61 109.35 25.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.44 ' HB ' ' HG2' ' A' ' 37' ' ' GLU . 43.4 t -104.07 111.67 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -174.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -78.66 124.97 28.73 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 47.2 mt -124.71 137.59 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 40' ' ' ASN . . . -161.04 90.86 0.85 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.796 0.438 . . . . 0.0 110.705 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -85.38 131.28 34.42 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 169.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.3 t -66.63 -19.31 65.74 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.728 0.811 . . . . 0.0 111.374 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -60.17 -35.8 76.15 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.751 1.22 . . . . 0.0 111.673 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.154 0 CA-C-O 119.305 -0.719 . . . . 0.0 111.35 178.781 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 120.802 0.334 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.48 78.57 0.5 Allowed Glycine 0 C--N 1.344 1.019 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -172.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -85.08 19.05 2.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.99 0.516 . . . . 0.0 111.574 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -75.34 -168.42 0.8 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.544 0.738 . . . . 0.0 109.848 168.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -66.71 89.15 0.15 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 170.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.7 p-80 -110.87 94.36 4.95 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.852 0.834 . . . . 0.0 109.973 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -133.05 52.14 2.11 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -54.46 102.57 0.06 Allowed 'General case' 0 C--N 1.352 0.701 0 C-N-CA 124.033 0.933 . . . . 0.0 111.141 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 p -74.64 145.5 43.18 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.946 174.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -153.05 74.43 1.04 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.353 0.661 . . . . 0.0 110.399 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 70.1 mtm 56.67 -89.95 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.835 1.654 . . . . 0.0 112.328 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -137.01 141.67 42.51 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.799 0.84 . . . . 0.0 109.781 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -170.58 -64.03 0.02 OUTLIER 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.222 0.609 . . . . 0.0 110.273 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.3 m 64.31 -70.14 0.08 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.706 1.203 . . . . 0.0 109.522 -165.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 59' ' ' TYR . . . 167.85 -120.85 0.92 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 171.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.469 ' HB2' HG12 ' A' ' 60' ' ' VAL . 34.7 mmt180 -98.35 121.78 40.71 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.439 0.696 . . . . 0.0 110.715 176.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -79.76 109.62 14.35 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.2 pt -104.85 177.14 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 124.931 1.292 . . . . 0.0 108.9 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.5 p -92.02 163.14 14.09 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.554 ' O ' HG23 ' A' ' 24' ' ' VAL . 69.7 t-105 -58.89 -41.08 86.33 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.007 0.523 . . . . 0.0 109.657 171.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -52.16 -57.34 9.92 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.894 0.878 . . . . 0.0 111.733 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.33 -34.82 79.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.427 0.691 . . . . 0.0 111.157 -175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.404 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 45.2 t80 -54.56 -54.87 35.55 Favored 'General case' 0 C--N 1.344 0.334 0 O-C-N 123.991 0.807 . . . . 0.0 111.302 174.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.556 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 43.7 t -64.88 -50.64 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 O-C-N 123.43 0.456 . . . . 0.0 110.605 -174.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -66.44 -45.22 80.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.211 -172.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -95.71 -24.64 16.44 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -171.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.404 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 80.0 m-85 -122.13 -64.84 1.17 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 118.782 0.719 . . . . 0.0 112.591 -169.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 48.9 tp -55.54 -48.75 74.23 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.981 0.912 . . . . 0.0 112.045 -173.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 p -64.94 -22.95 67.08 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -89.49 -3.72 58.24 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.902 0.481 . . . . 0.0 110.439 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.37 19.14 61.78 Favored Glycine 0 C--N 1.355 1.599 0 N-CA-C 114.671 0.628 . . . . 0.0 114.671 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.5 m -79.06 0.16 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 117.415 0.608 . . . . 0.0 111.638 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.1 135.09 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.303 1.041 . . . . 0.0 108.941 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -81.64 -53.69 6.03 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.337 1.055 . . . . 0.0 108.887 174.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -168.15 164.19 13.35 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.944 -171.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.6 mt -116.96 105.18 12.05 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.061 0.945 . . . . 0.0 109.377 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -96.33 110.67 22.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.106 -174.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 41' ' ' LYS . 7.6 t -90.65 93.79 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -171.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.7 t -71.14 117.95 15.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 123.738 0.815 . . . . 0.0 110.919 -171.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 54.19 22.71 3.75 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.54 1.536 . . . . 0.0 113.03 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.633 ' HA ' HG12 ' A' ' 38' ' ' VAL . 8.5 mtpm? 53.7 17.15 1.15 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.852 1.261 . . . . 0.0 114.067 -172.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -91.28 -37.18 13.45 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.114 0.566 . . . . 0.0 110.434 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -152.8 163.78 39.07 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.75 0.82 . . . . 0.0 109.26 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.421 HG22 HG22 ' A' ' 38' ' ' VAL . 47.8 t -110.27 130.35 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.426 ' HG2' ' HB3' ' A' ' 61' ' ' TRP . 3.5 tmm_? -116.14 132.46 56.65 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.0 t -88.44 125.83 41.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.178 -170.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.9 m -95.14 129.77 42.12 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 167.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.481 ' HB2' HG23 ' A' ' 53' ' ' THR . 82.4 m-85 -87.03 144.7 26.78 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.828 0.451 . . . . 0.0 110.716 172.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 t -73.67 142.0 80.05 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.005 0.522 . . . . 0.0 110.195 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.54 121.0 9.25 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.428 2.752 . . . . 0.0 112.397 -173.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.59 -39.68 2.8 Favored Glycine 0 N--CA 1.471 0.999 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -95.83 1.98 53.47 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.699 0.8 . . . . 0.0 111.011 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.481 HG23 ' HB2' ' A' ' 48' ' ' PHE . 6.7 m -81.58 115.59 57.74 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.54 0.736 . . . . 0.0 109.955 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -48.02 120.73 5.12 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.605 2.87 . . . . 0.0 112.446 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.2 p -53.02 -32.58 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 124.967 1.307 . . . . 0.0 113.593 -166.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.7 -39.84 95.25 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.292 1.037 . . . . 0.0 110.66 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.41 16.78 6.92 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.203 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -78.49 103.06 8.18 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 122.964 0.505 . . . . 0.0 110.215 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.405 ' O ' ' HA3' ' A' ' 15' ' ' GLY . 87.1 m-85 -81.32 174.07 11.86 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 166.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.469 HG12 ' HB2' ' A' ' 16' ' ' ARG . 25.2 m -122.81 170.26 13.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.426 ' HB3' ' HG2' ' A' ' 45' ' ' ARG . 8.9 p-90 -165.43 158.56 16.1 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.622 0.369 . . . . 0.0 110.624 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -145.0 151.03 37.94 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.316 0.579 . . . . 0.0 110.291 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -82.9 151.06 26.13 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.579 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 67' ' ' VAL . 26.0 pt -125.69 144.19 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.521 0.728 . . . . 0.0 110.425 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.99 -52.64 7.75 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m -131.72 135.7 47.05 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.717 0.807 . . . . 0.0 108.972 176.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.44 ' HA ' HD12 ' A' ' 64' ' ' ILE . 5.0 t -67.15 -37.27 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.01 0.924 . . . . 0.0 110.477 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.533 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 5.9 m-20 -67.0 -49.41 65.44 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.646 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.8 m -62.7 -36.01 81.57 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 122.576 0.351 . . . . 0.0 110.647 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -54.33 -57.52 10.92 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 123.81 0.844 . . . . 0.0 111.385 174.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -64.33 -33.13 75.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.438 0.462 . . . . 0.0 111.368 -175.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 5.3 mmp_? -60.69 -55.53 32.13 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.099 0.476 . . . . 0.0 110.412 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -66.6 -42.4 86.97 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.224 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.5 tp -58.76 -56.02 27.58 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.111 0.964 . . . . 0.0 112.527 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -59.67 -42.06 92.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 123.447 0.467 . . . . 0.0 111.932 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.425 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 54.9 m -59.79 -53.08 62.11 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.3 tp -53.91 -46.48 71.46 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.813 1.645 . . . . 0.0 113.119 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -62.04 -48.34 80.68 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.998 0.519 . . . . 0.0 110.662 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -68.48 -22.95 64.53 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.42 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 76' ' ' THR . 61.1 mm-40 -71.56 -43.18 66.81 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.919 0.488 . . . . 0.0 110.135 169.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.0 mt -73.86 -15.58 61.15 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.921 0.888 . . . . 0.0 111.214 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.66 -6.79 80.04 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-O 119.601 -0.555 . . . . 0.0 112.923 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.418 HG22 ' HA ' ' A' ' 88' ' ' ARG . 77.8 mt -64.92 101.36 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.537 1.535 . . . . 0.0 110.271 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -144.31 167.84 21.49 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.523 1.129 . . . . 0.0 110.027 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.52 -122.89 23.96 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.506 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.97 -25.4 59.91 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.645 0.778 . . . . 0.0 111.307 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -75.61 -23.35 56.42 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.163 0.585 . . . . 0.0 110.407 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.423 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 15.0 ttm180 -57.88 137.48 56.64 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 124.103 0.961 . . . . 0.0 110.677 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.9 t -92.38 101.61 5.21 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.824 1.25 . . . . 0.0 109.723 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 88' ' ' ARG . 19.5 Cg_exo -68.15 153.69 74.17 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.994 2.463 . . . . 0.0 112.351 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.0 t -107.07 118.74 55.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.2 t -106.61 97.86 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -72.92 97.44 2.28 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.1 mt -87.2 140.11 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.82 82.82 1.86 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -78.79 83.69 4.91 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.017 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.5 m -135.09 134.51 40.37 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.987 0.915 . . . . 0.0 109.78 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.94 -26.46 65.08 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.682 0.793 . . . . 0.0 110.792 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.64 -1.089 . . . . 0.0 111.647 178.357 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 120.684 0.278 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.38 -18.14 3.11 Favored Glycine 0 C--N 1.345 1.064 0 C-N-CA 123.622 0.629 . . . . 0.0 112.407 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.461 ' HB3' ' O ' ' A' ' 6' ' ' HIS . 88.1 m-70 -87.31 77.05 9.03 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.76 0.824 . . . . 0.0 110.258 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -95.4 -36.94 11.16 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.35 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -73.25 -43.18 61.57 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.277 0.56 . . . . 0.0 110.546 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.461 ' O ' ' HB3' ' A' ' 3' ' ' HIS . 35.8 m170 -128.72 109.32 11.22 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -89.08 68.35 8.23 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 121.044 0.449 . . . . 0.0 110.749 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -102.57 21.54 15.13 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.71 0.767 . . . . 0.0 109.743 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.7 p -76.21 -41.67 48.61 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.646 1.179 . . . . 0.0 111.822 -175.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -79.07 -64.11 1.26 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.1 tpt 70.18 -19.95 0.2 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.87 1.268 . . . . 0.0 113.409 173.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 52.03 74.12 0.29 Allowed 'General case' 0 C--N 1.36 1.029 0 C-N-CA 124.788 1.235 . . . . 0.0 109.582 -166.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -85.53 31.33 0.59 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.262 1.025 . . . . 0.0 111.363 -170.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.8 t -55.11 93.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.726 1.611 . . . . 0.0 111.986 -170.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.46 80.01 0.21 Allowed Glycine 0 C--N 1.353 1.525 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.322 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.578 ' HB3' HG12 ' A' ' 60' ' ' VAL . 69.1 ttp85 -84.13 127.16 33.74 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -73.56 109.2 6.89 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 37.9 pt -97.35 173.64 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 166.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.4 p -110.49 169.72 8.56 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 166.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.42 ' O ' HG23 ' A' ' 24' ' ' VAL . 69.9 t-105 -53.33 -37.67 62.51 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.119 0.968 . . . . 0.0 111.695 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -58.07 -46.01 86.16 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 176.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.541 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 39.5 m-20 -66.44 -35.31 79.98 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.128 0.571 . . . . 0.0 111.036 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.442 ' CZ ' HD11 ' A' ' 36' ' ' LEU . 31.7 t80 -59.77 -58.54 8.13 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.583 173.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.456 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 85.1 t -58.51 -57.11 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.179 0.592 . . . . 0.0 111.713 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -62.12 -56.23 20.94 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.031 0.832 . . . . 0.0 111.981 -173.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -84.49 -34.58 23.34 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.67 -168.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.404 ' HA ' HG22 ' A' ' 32' ' ' VAL . 21.2 m-85 -114.36 -62.25 1.63 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -162.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.456 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 68.4 tp -59.42 -51.12 71.26 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.294 1.038 . . . . 0.0 111.172 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.9 t -59.38 -24.19 63.22 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.001 0.92 . . . . 0.0 113.024 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -98.66 -6.0 30.58 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.547 0.339 . . . . 0.0 111.504 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.06 31.38 58.76 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 114.477 0.551 . . . . 0.0 114.477 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 27' ' ' TYR . 20.7 m -81.93 0.65 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.693 0.397 . . . . 0.0 110.882 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.9 t -98.65 128.48 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.514 1.126 . . . . 0.0 109.799 -173.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.555 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 31.0 t70 -77.81 -47.08 19.74 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.776 0.83 . . . . 0.0 109.692 177.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HD2' HG21 ' A' ' 92' ' ' VAL . 31.7 ptt-85 -162.68 163.93 26.73 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.968 0.793 . . . . 0.0 111.243 -174.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.442 HD11 ' CZ ' ' A' ' 23' ' ' PHE . 60.3 mt -117.8 104.66 11.17 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.583 1.153 . . . . 0.0 109.428 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -87.79 101.96 14.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.844 0.857 . . . . 0.0 109.767 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 44' ' ' VAL . 35.6 t -88.32 91.3 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -175.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.9 t -92.91 119.69 41.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.825 -170.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 58.66 18.61 6.02 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.979 1.312 . . . . 0.0 112.56 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 54.84 21.09 3.4 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.87 1.268 . . . . 0.0 113.314 175.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -107.69 -28.51 9.67 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.283 1.033 . . . . 0.0 110.466 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -152.56 159.03 43.3 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.969 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 38' ' ' VAL . 57.9 t -124.03 130.67 73.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 -98.14 124.79 42.86 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.499 ' HB ' HG23 ' A' ' 60' ' ' VAL . 55.9 t -82.67 107.72 14.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.1 m -93.62 128.61 39.86 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -85.1 164.56 18.1 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.014 0.821 . . . . 0.0 109.519 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.555 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 11.5 t -68.29 138.4 91.81 Favored Pre-proline 0 CA--C 1.557 1.233 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -54.51 -41.51 76.45 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.66 2.906 . . . . 0.0 113.041 -170.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.14 -25.8 73.41 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.911 -177.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -77.33 -58.3 3.35 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.448 0.699 . . . . 0.0 110.326 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.8 m -65.88 120.43 69.02 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.09 0.556 . . . . 0.0 110.723 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -91.09 -162.54 0.11 Allowed 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 123.347 2.698 . . . . 0.0 112.476 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.6 m -66.2 -7.61 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.3 -24.49 67.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.354 1.061 . . . . 0.0 112.784 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.55 74.16 0.5 Allowed Glycine 0 C--N 1.353 1.501 0 O-C-N 123.41 0.444 . . . . 0.0 112.82 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -115.25 109.92 18.68 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.226 0.61 . . . . 0.0 111.077 -176.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -132.69 153.31 51.26 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.104 0.961 . . . . 0.0 109.572 164.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.578 HG12 ' HB3' ' A' ' 16' ' ' ARG . 27.8 m -129.18 178.75 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.329 0.652 . . . . 0.0 109.724 177.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -157.86 162.05 38.35 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.995 0.518 . . . . 0.0 110.245 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.431 ' HB3' HG13 ' A' ' 18' ' ' ILE . 47.4 p90 -145.73 153.75 41.31 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.326 0.65 . . . . 0.0 109.454 175.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -80.34 152.76 28.77 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.787 0.435 . . . . 0.0 110.748 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.8 pt -126.01 144.45 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.232 0.613 . . . . 0.0 109.445 172.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.05 -61.99 2.56 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.1 m -127.48 133.71 49.86 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.674 0.789 . . . . 0.0 109.024 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.4 t -57.87 -40.47 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.351 1.06 . . . . 0.0 111.506 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.09 -40.41 96.18 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.619 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.2 m -67.88 -45.08 75.5 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -51.04 -52.94 38.11 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.481 1.112 . . . . 0.0 112.495 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -71.32 -35.97 71.41 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.466 0.478 . . . . 0.0 110.838 -174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -66.97 -39.56 87.26 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.573 0.349 . . . . 0.0 110.589 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -66.79 -52.62 41.84 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.088 0.555 . . . . 0.0 110.173 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.4 tp -53.48 -55.08 28.32 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.205 1.002 . . . . 0.0 111.377 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 79' ' ' GLN . 68.6 mm-40 -61.84 -48.92 78.37 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.796 0.685 . . . . 0.0 112.725 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 58.1 m -64.53 -50.11 68.64 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.471 0.482 . . . . 0.0 110.116 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.8 tp -50.26 -46.29 54.89 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.229 1.411 . . . . 0.0 112.471 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -61.65 -46.75 88.45 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.842 0.457 . . . . 0.0 110.641 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 75.0 mt-30 -62.69 -34.76 77.79 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.255 0.622 . . . . 0.0 111.065 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.8 -39.31 57.1 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.81 0.844 . . . . 0.0 111.702 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.57 -21.34 61.16 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.601 0.361 . . . . 0.0 110.951 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.3 -5.65 57.51 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 120.075 -0.292 . . . . 0.0 113.019 -173.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.7 mt -70.08 121.53 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 124.478 1.111 . . . . 0.0 109.984 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -162.42 162.48 27.71 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.077 0.551 . . . . 0.0 111.107 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.97 -111.09 3.64 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.636 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.97 -23.75 58.33 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.902 0.881 . . . . 0.0 110.901 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -83.75 -26.71 29.46 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 ttm105 -63.32 123.38 18.55 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.5 t -72.69 119.57 75.94 Favored Pre-proline 0 CA--C 1.555 1.155 0 O-C-N 123.808 0.693 . . . . 0.0 110.247 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 31.9 Cg_exo -60.41 141.22 95.05 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.42 2.747 . . . . 0.0 112.523 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.6 t -111.69 114.94 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.446 HG21 ' HD2' ' A' ' 35' ' ' ARG . 60.8 t -109.15 98.33 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.212 1.005 . . . . 0.0 109.043 -173.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -71.7 114.86 10.23 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.939 0.496 . . . . 0.0 110.434 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.407 HG22 ' HG2' ' A' ' 96' ' ' GLU . 58.7 mt -107.86 127.3 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.86 89.78 3.2 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.358 0.663 . . . . 0.0 109.923 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.407 ' HG2' HG22 ' A' ' 94' ' ' ILE . 26.9 mm-40 -96.69 101.52 13.14 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.159 0.584 . . . . 0.0 109.456 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 54.1 p -152.63 91.99 1.62 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 117.798 0.272 . . . . 0.0 111.462 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.0 t70 66.87 -71.1 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.4 1.48 . . . . 0.0 111.797 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 CA-C-O 119.201 -0.777 . . . . 0.0 111.392 176.609 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.03 81.76 0.44 Allowed Glycine 0 CA--C 1.535 1.286 0 N-CA-C 112.318 -0.313 . . . . 0.0 112.318 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 50.99 -93.12 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.219 1.408 . . . . 0.0 111.628 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -171.73 103.77 0.19 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.38 1.072 . . . . 0.0 108.497 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -140.94 149.41 41.81 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.19 0.996 . . . . 0.0 108.32 173.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 69.03 142.81 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.615 1.166 . . . . 0.0 110.263 -173.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -63.4 132.13 50.47 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.152 0.501 . . . . 0.0 111.37 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -109.72 37.62 2.6 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.404 1.082 . . . . 0.0 108.56 174.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 t -74.9 83.5 2.2 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.159 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -104.3 80.0 1.66 Allowed 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 87.2 mmm -66.89 -49.12 66.62 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.288 -1.323 . . . . 0.0 110.188 -174.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -80.14 95.65 6.3 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -162.69 130.03 3.7 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.5 m -73.71 79.0 1.54 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.392 0.677 . . . . 0.0 110.345 -177.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.68 133.11 6.23 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.441 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.483 ' HB3' HG12 ' A' ' 60' ' ' VAL . 34.9 ttm180 -86.3 123.35 31.46 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -177.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -75.12 133.23 41.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.1 pt -128.67 168.82 21.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.755 1.222 . . . . 0.0 108.292 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.4 p -85.75 161.01 19.36 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.478 ' O ' HG23 ' A' ' 24' ' ' VAL . 61.2 t-105 -51.03 -48.98 61.36 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.933 0.893 . . . . 0.0 111.146 174.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -75.21 -24.13 57.71 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.515 0.509 . . . . 0.0 111.863 -175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -65.53 -42.81 91.57 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 172.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 17.7 t80 -56.44 -51.22 69.24 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.877 172.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 20' ' ' TRP . 60.8 t -58.11 -61.88 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.844 0.458 . . . . 0.0 111.035 -177.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -68.16 -46.17 71.49 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.427 0.691 . . . . 0.0 111.768 -166.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.406 ' O ' ' HD2' ' A' ' 30' ' ' LYS . 62.8 m-20 -84.77 -34.13 22.88 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.472 -172.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.428 ' HA ' HG22 ' A' ' 32' ' ' VAL . 88.0 m-85 -112.29 -66.57 1.07 Allowed 'General case' 0 C--O 1.248 0.977 0 O-C-N 121.849 -0.532 . . . . 0.0 111.825 -166.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.571 HD11 HG21 ' A' ' 89' ' ' VAL . 21.2 tp -64.57 -48.3 75.5 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -170.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 m -65.67 -21.2 66.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.627 0.771 . . . . 0.0 112.429 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' A' ' 26' ' ' ASN . 55.2 mttp -98.14 -1.02 43.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.858 0.863 . . . . 0.0 111.62 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.12 23.23 61.59 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 115.364 0.905 . . . . 0.0 115.364 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 27' ' ' TYR . 17.6 m -88.36 11.62 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 117.476 0.638 . . . . 0.0 110.668 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.43 136.16 31.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 125.193 1.397 . . . . 0.0 108.938 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.511 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 25.8 t70 -87.55 -49.05 7.44 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.918 0.887 . . . . 0.0 109.014 172.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 6.4 ptp180 -164.2 172.42 13.67 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.523 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.2 mt -119.95 112.97 19.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.201 1.001 . . . . 0.0 110.222 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -99.6 104.49 16.27 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.913 0.885 . . . . 0.0 110.069 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.522 HG22 HG22 ' A' ' 44' ' ' VAL . 28.2 t -86.83 99.61 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -175.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.3 t -89.54 123.05 41.56 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 C-N-CA 123.942 0.897 . . . . 0.0 110.367 -169.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 54.12 18.45 1.76 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.569 1.548 . . . . 0.0 113.14 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HB3' HG21 ' A' ' 67' ' ' VAL . 94.8 mttt 57.09 16.04 2.72 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.584 1.154 . . . . 0.0 113.496 -176.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -91.55 -32.87 15.38 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.334 0.654 . . . . 0.0 110.483 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -156.69 170.61 22.02 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.528 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.522 HG22 HG22 ' A' ' 38' ' ' VAL . 59.2 t -117.31 129.47 73.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.035 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -96.15 122.63 39.2 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.462 1.105 . . . . 0.0 108.08 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 60' ' ' VAL . 46.3 t -84.72 112.13 21.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.4 HG22 ' HB3' ' A' ' 34' ' ' ASP . 86.7 m -90.08 132.61 35.32 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.61 ' HE2' ' HA ' ' A' ' 59' ' ' TYR . 53.1 m-85 -84.33 146.82 27.51 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.568 0.747 . . . . 0.0 110.286 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.511 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.7 OUTLIER -62.77 141.18 97.25 Favored Pre-proline 0 CA--C 1.565 1.533 0 C-N-CA 123.626 0.77 . . . . 0.0 110.154 175.172 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -48.84 123.79 10.25 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.89 3.06 . . . . 0.0 113.097 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.81 -21.13 43.32 Favored Glycine 0 N--CA 1.474 1.176 0 O-C-N 123.309 0.381 . . . . 0.0 112.846 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -107.57 -3.06 19.7 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.023 0.929 . . . . 0.0 110.564 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.8 m -71.02 131.36 87.3 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 123.929 0.891 . . . . 0.0 110.043 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -55.01 143.99 70.59 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.687 2.924 . . . . 0.0 112.919 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.9 -41.92 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.55 0.74 . . . . 0.0 111.442 -175.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -79.86 -41.36 26.46 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.98 0.912 . . . . 0.0 110.775 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.57 -140.22 11.69 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 110.039 -1.225 . . . . 0.0 110.039 -174.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 56.44 85.33 0.08 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.366 1.066 . . . . 0.0 110.617 -172.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.61 ' HA ' ' HE2' ' A' ' 48' ' ' PHE . 35.6 p90 -68.21 175.18 3.38 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.479 172.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.52 HG23 ' HB ' ' A' ' 46' ' ' VAL . 27.6 m -110.38 153.36 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 169.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 -160.3 166.25 29.83 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.615 0.766 . . . . 0.0 109.777 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -147.78 140.39 24.64 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.35 0.66 . . . . 0.0 109.939 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -84.58 126.92 33.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.323 0.649 . . . . 0.0 109.637 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.586 HD12 ' HA ' ' A' ' 67' ' ' VAL . 41.3 pt -104.61 -41.13 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 122.508 0.323 . . . . 0.0 111.754 -173.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.78 -80.43 0.12 Allowed Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 -171.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.3 m -71.4 95.45 1.35 Allowed 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.788 0.835 . . . . 0.0 109.901 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.586 ' HA ' HD12 ' A' ' 64' ' ' ILE . 58.5 t -61.49 -40.34 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.522 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 5.8 m-20 -58.57 -44.53 89.78 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.856 0.863 . . . . 0.0 110.478 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.0 m -66.67 -40.31 88.55 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.702 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -55.77 -46.09 77.98 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 123.258 0.623 . . . . 0.0 110.618 173.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 47.4 mt-10 -64.07 -44.95 90.84 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 124.244 0.965 . . . . 0.0 109.973 -176.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 4.5 mmp_? -59.15 -51.22 70.93 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 124.186 0.928 . . . . 0.0 111.262 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -65.6 -40.47 92.71 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.41 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.9 -50.25 72.94 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.672 0.789 . . . . 0.0 112.197 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -32.98 70.29 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -175.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.2 m -64.11 -44.9 90.84 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.189 0.596 . . . . 0.0 109.846 171.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.449 HD21 HG22 ' A' ' 24' ' ' VAL . 34.3 tp -63.05 -37.4 87.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.699 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -63.94 -38.43 91.04 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.347 0.659 . . . . 0.0 109.998 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -68.08 -36.73 80.3 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 175.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.07 -46.0 72.28 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.038 0.535 . . . . 0.0 111.383 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.0 mt -82.42 2.22 33.64 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.627 0.771 . . . . 0.0 112.259 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.47 14.6 79.39 Favored Glycine 0 C--N 1.358 1.787 0 O-C-N 123.311 0.382 . . . . 0.0 113.684 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 87.2 mt -82.56 111.66 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.282 1.433 . . . . 0.0 109.603 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.39 168.02 28.64 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.124 0.57 . . . . 0.0 111.605 -175.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.11 -126.41 23.08 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.492 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.81 -14.24 60.67 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.039 0.536 . . . . 0.0 110.487 177.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -79.64 -16.16 56.28 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.855 0.862 . . . . 0.0 111.699 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -51.1 129.89 24.94 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.067 0.947 . . . . 0.0 111.002 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.571 HG21 HD11 ' A' ' 28' ' ' LEU . 49.6 t -63.02 113.1 8.19 Favored Pre-proline 0 N--CA 1.474 0.727 0 O-C-N 124.484 1.115 . . . . 0.0 109.905 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.4 ' HG2' ' HB3' ' A' ' 35' ' ' ARG . 54.4 Cg_endo -68.76 115.59 4.02 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.344 2.029 . . . . 0.0 111.137 -177.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.2 t -108.45 121.05 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.4 t -116.57 119.68 62.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -174.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -90.07 113.66 25.42 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.59 128.06 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.27 106.98 5.61 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -64.28 -40.18 95.45 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.187 0.93 . . . . 0.0 109.478 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.1 t -169.34 162.66 10.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.286 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -84.85 -18.29 35.31 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.599 0.76 . . . . 0.0 109.407 172.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 177.401 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.1 114.89 5.04 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -62.21 87.51 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.15 0.98 . . . . 0.0 111.559 -174.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -131.19 3.86 4.36 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.602 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -121.81 124.67 44.71 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 65.29 -178.2 0.18 Allowed 'General case' 0 CA--C 1.554 1.102 0 O-C-N 124.622 1.202 . . . . 0.0 110.322 -173.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 71.28 -0.71 3.0 Favored 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 124.785 1.234 . . . . 0.0 111.585 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -63.54 -34.28 77.45 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.951 0.9 . . . . 0.0 109.413 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.3 m -73.05 89.18 1.44 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.894 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -87.53 23.67 1.87 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.497 1.119 . . . . 0.0 110.527 174.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.5 mtm -70.62 140.48 51.63 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 124.238 1.015 . . . . 0.0 111.055 -171.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -68.17 -34.99 77.33 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.792 171.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -73.38 153.36 40.5 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.459 172.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.1 m 79.98 -22.08 0.3 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.831 1.652 . . . . 0.0 112.117 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.59 164.28 43.2 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 163.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HB3' HG12 ' A' ' 60' ' ' VAL . 20.9 tpp180 -90.77 119.35 30.93 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 117.839 0.82 . . . . 0.0 110.856 -174.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.63 110.15 13.49 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 27.4 pt -104.73 174.06 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.393 1.477 . . . . 0.0 109.959 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.6 p -91.3 168.74 11.36 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 169.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.564 ' O ' HG23 ' A' ' 24' ' ' VAL . 74.1 t-105 -57.07 -41.68 79.22 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.74 0.65 . . . . 0.0 109.473 168.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -55.66 -50.62 69.75 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.304 1.041 . . . . 0.0 112.409 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.499 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 65.1 m-20 -62.97 -38.95 93.14 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.856 0.462 . . . . 0.0 110.184 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.44 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 34.5 t80 -55.04 -50.51 68.9 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.663 1.227 . . . . 0.0 110.873 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 20' ' ' TRP . 47.1 t -58.12 -62.42 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 123.611 0.569 . . . . 0.0 110.895 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -65.87 -53.76 35.5 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.954 -168.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -84.73 -21.49 30.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.154 0.582 . . . . 0.0 111.86 -167.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.44 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 73.0 m-85 -122.75 -69.35 0.83 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -169.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.54 -56.54 20.79 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.834 0.853 . . . . 0.0 111.467 -173.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.6 m -60.38 -20.33 59.16 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.215 1.006 . . . . 0.0 112.891 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -94.05 -9.13 37.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.667 0.787 . . . . 0.0 111.617 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.27 21.5 68.37 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.723 0.64 . . . . 0.0 114.385 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.429 HG22 ' HA ' ' A' ' 27' ' ' TYR . 10.4 m -80.74 -5.39 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 117.143 0.472 . . . . 0.0 110.984 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.8 t -93.75 130.07 43.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 123.321 0.648 . . . . 0.0 109.332 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.459 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 30.1 t70 -83.97 -51.96 6.71 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.495 1.118 . . . . 0.0 109.739 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.497 ' HD2' HG21 ' A' ' 92' ' ' VAL . 25.0 ptt180 -158.16 160.47 37.27 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.293 -174.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.8 mt -118.03 103.0 9.48 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.998 0.919 . . . . 0.0 109.027 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 43.4 mt-10 -87.55 108.65 19.15 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.415 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 41' ' ' LYS . 43.0 t -84.83 92.82 3.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -177.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 96.0 t -81.73 109.81 16.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.101 -167.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.2 m120 52.25 27.25 4.56 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 125.548 1.539 . . . . 0.0 112.945 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.552 ' HA ' HG12 ' A' ' 38' ' ' VAL . 35.3 mtmm 63.31 -4.44 0.3 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.077 1.351 . . . . 0.0 113.869 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -76.08 -38.88 56.48 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.386 1.074 . . . . 0.0 110.604 -171.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -153.44 179.98 8.29 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.574 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 38' ' ' VAL . 98.3 t -127.64 131.44 70.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 123.97 0.908 . . . . 0.0 108.694 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -100.41 123.63 44.88 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -81.86 108.77 15.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.869 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.3 m -86.14 131.4 34.26 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -85.06 149.94 25.21 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.459 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 42.1 p -64.94 144.65 99.07 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 123.416 0.447 . . . . 0.0 110.391 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.99 104.5 0.12 Allowed 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.52 2.147 . . . . 0.0 111.379 171.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.44 -45.5 1.1 Allowed Glycine 0 N--CA 1.467 0.766 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -173.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.417 ' HE2' HG12 ' A' ' 32' ' ' VAL . 44.6 mmtm -73.32 -32.81 64.8 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 169.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.2 p -66.16 115.57 24.79 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 123.902 0.881 . . . . 0.0 109.972 171.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -88.42 -164.43 0.18 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.838 2.358 . . . . 0.0 111.294 171.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.0 t -67.09 -32.43 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -83.38 65.39 8.32 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 167.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.2 59.33 3.18 Favored Glycine 0 C--N 1.348 1.23 0 C-N-CA 123.679 0.657 . . . . 0.0 113.235 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -90.37 142.98 27.18 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.084 0.954 . . . . 0.0 108.444 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -106.68 156.88 18.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.936 0.494 . . . . 0.0 110.619 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 16' ' ' ARG . 20.0 m -107.23 164.41 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -162.69 162.81 27.07 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.785 0.326 . . . . 0.0 111.119 -172.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -145.06 146.69 31.97 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.727 0.811 . . . . 0.0 109.379 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -81.65 140.07 34.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.19 0.596 . . . . 0.0 109.591 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 65' ' ' GLY . 42.7 pt -117.12 -49.0 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.589 0.356 . . . . 0.0 111.434 -177.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.439 ' N ' HG13 ' A' ' 64' ' ' ILE . . . 67.67 -78.2 0.19 Allowed Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.949 -0.46 . . . . 0.0 111.949 -171.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.5 m -74.27 94.09 2.45 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.595 0.758 . . . . 0.0 109.663 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.428 ' HA ' HD12 ' A' ' 64' ' ' ILE . 40.3 t -60.6 -36.66 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.805 1.242 . . . . 0.0 111.172 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -62.66 -39.13 92.95 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.553 0.741 . . . . 0.0 110.331 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.9 m -70.19 -41.44 73.69 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 123.503 0.502 . . . . 0.0 110.666 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -52.85 -53.39 49.51 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.19 0.596 . . . . 0.0 110.735 174.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -60.51 -52.41 65.32 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 124.509 1.13 . . . . 0.0 111.425 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.506 ' HA ' ' HE ' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -59.28 -46.39 88.67 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.508 1.123 . . . . 0.0 111.921 -174.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -67.47 -41.89 83.86 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.391 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.459 ' HG ' ' NE2' ' A' ' 78' ' ' GLN . 33.4 tp -59.55 -43.41 93.53 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 124.108 0.88 . . . . 0.0 111.465 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -60.27 -56.44 21.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.841 0.857 . . . . 0.0 111.059 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.1 m -63.22 -48.57 77.73 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.43 1.081 . . . . 0.0 110.303 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.545 HD21 HG22 ' A' ' 24' ' ' VAL . 42.9 tp -53.99 -53.06 58.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.77 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.459 ' NE2' ' HG ' ' A' ' 74' ' ' LEU . 45.0 mt-30 -66.8 -30.17 70.3 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.266 0.354 . . . . 0.0 111.266 -178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -63.86 -38.68 92.0 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.615 0.366 . . . . 0.0 110.076 172.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -70.14 -43.92 69.94 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.221 0.608 . . . . 0.0 110.99 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 76.5 mt -71.22 -18.75 62.44 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.624 0.77 . . . . 0.0 111.578 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.02 8.1 76.29 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.282 0.364 . . . . 0.0 112.982 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.516 HG22 ' HA ' ' A' ' 88' ' ' ARG . 80.1 mt -82.52 97.08 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 125.343 1.457 . . . . 0.0 108.769 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -138.93 155.52 47.99 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.836 -0.54 . . . . 0.0 111.51 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.44 -99.85 0.11 Allowed Glycine 0 C--N 1.354 1.532 0 O-C-N 124.74 1.275 . . . . 0.0 113.893 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -75.59 -29.04 59.15 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.348 1.059 . . . . 0.0 111.427 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -87.82 -23.46 24.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.379 0.672 . . . . 0.0 111.277 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.516 ' HA ' HG22 ' A' ' 83' ' ' ILE . 43.0 ttm180 -61.48 119.54 8.78 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.401 0.68 . . . . 0.0 110.557 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 80.4 t -66.65 118.94 59.16 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.829 0.852 . . . . 0.0 111.225 -175.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.44 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 31.5 Cg_exo -60.58 146.87 96.26 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.294 2.662 . . . . 0.0 113.239 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.4 t -104.91 129.84 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.497 HG21 ' HD2' ' A' ' 35' ' ' ARG . 4.5 t -127.78 98.99 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.505 0.722 . . . . 0.0 109.394 -175.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -69.55 106.33 2.97 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 29.9 mm -113.66 116.33 52.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -175.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.08 14.01 17.2 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.882 0.473 . . . . 0.0 110.27 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 64.31 -78.89 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.555 1.942 . . . . 0.0 111.976 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.9 m 60.99 23.59 13.74 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.889 0.876 . . . . 0.0 110.421 -171.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.8 -42.09 77.79 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 125.084 1.354 . . . . 0.0 110.434 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.091 0 CA-C-O 118.65 -1.083 . . . . 0.0 110.523 179.154 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.3 mtp . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.69 144.25 46.68 Favored Glycine 0 C--N 1.34 0.756 0 O-C-N 123.418 0.449 . . . . 0.0 112.839 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -146.91 15.45 1.2 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.203 1.001 . . . . 0.0 110.041 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -99.41 4.55 46.27 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.138 0.975 . . . . 0.0 110.73 -175.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -84.9 16.64 3.25 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.915 0.886 . . . . 0.0 112.057 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -68.63 91.88 0.44 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -68.69 126.39 29.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.685 -168.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -85.1 -69.19 0.67 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 167.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.0 p 41.08 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 127.034 2.134 . . . . 0.0 113.249 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -124.23 110.34 14.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.776 0.83 . . . . 0.0 109.324 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.6 mtt -101.34 -5.17 25.76 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.079 0.952 . . . . 0.0 110.158 171.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.5 tttm 72.73 -70.29 0.16 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 126.075 1.75 . . . . 0.0 111.9 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -67.0 135.16 53.32 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.411 0.685 . . . . 0.0 112.026 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.1 m -79.64 -0.76 35.2 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.35 1.06 . . . . 0.0 111.726 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.06 142.55 46.44 Favored Glycine 0 C--N 1.356 1.67 0 O-C-N 123.302 0.376 . . . . 0.0 113.492 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.436 ' HB2' HG12 ' A' ' 60' ' ' VAL . 49.7 mtp180 -83.95 132.77 34.74 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.984 0.514 . . . . 0.0 110.961 -172.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -79.92 110.92 15.76 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 165.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 34.4 pt -96.13 174.39 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 123.99 0.916 . . . . 0.0 110.61 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.2 p -98.21 168.63 10.12 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 166.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.472 ' CZ2' HD22 ' A' ' 77' ' ' LEU . 61.7 t-105 -55.41 -37.22 67.34 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.685 0.794 . . . . 0.0 110.781 175.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -56.08 -48.66 75.67 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.518 0.727 . . . . 0.0 111.671 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.57 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 34.4 m-20 -65.53 -42.27 92.18 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.414 0.286 . . . . 0.0 110.791 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.4 ' HE1' HD21 ' A' ' 36' ' ' LEU . 13.9 t80 -50.35 -48.17 55.65 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.51 1.131 . . . . 0.0 111.116 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.531 HG22 HD21 ' A' ' 77' ' ' LEU . 90.7 t -71.97 -62.07 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 O-C-N 123.421 0.45 . . . . 0.0 110.82 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -69.87 -52.65 23.04 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.03 0.532 . . . . 0.0 111.737 -167.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -80.01 -19.48 47.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.912 0.485 . . . . 0.0 112.049 -171.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -126.12 -69.95 0.75 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -171.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.403 HD11 HG21 ' A' ' 89' ' ' VAL . 22.1 tp -63.79 -43.61 95.81 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -166.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.2 p -73.23 -11.38 60.49 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.904 0.481 . . . . 0.0 111.944 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -92.61 -9.22 41.81 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.252 0.621 . . . . 0.0 110.64 173.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.78 27.83 67.25 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 114.047 0.379 . . . . 0.0 114.047 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.7 m -86.87 6.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 116.972 0.386 . . . . 0.0 110.548 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.26 125.72 51.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.023 0.929 . . . . 0.0 108.964 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.515 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 28.5 t70 -77.34 -54.08 6.9 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.315 1.046 . . . . 0.0 108.196 172.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.432 ' HD2' HG21 ' A' ' 92' ' ' VAL . 43.0 ttp180 -154.9 153.19 30.72 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.024 -164.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.4 HD21 ' HE1' ' A' ' 23' ' ' PHE . 97.9 mt -113.32 119.82 39.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.88 1.272 . . . . 0.0 108.535 175.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -111.92 106.48 15.19 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.383 0.673 . . . . 0.0 110.312 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.408 HG22 HG22 ' A' ' 44' ' ' VAL . 44.9 t -81.61 98.48 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 54.7 t -94.96 122.41 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 122.862 0.465 . . . . 0.0 110.522 -171.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 60.11 15.24 5.01 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.245 1.418 . . . . 0.0 113.434 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.9 mttm 65.64 -3.02 0.76 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.534 1.533 . . . . 0.0 112.778 -175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -87.62 -32.51 19.24 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.11 0.964 . . . . 0.0 109.982 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -154.2 171.28 19.44 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.488 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.408 HG22 HG22 ' A' ' 38' ' ' VAL . 54.4 t -128.86 133.87 65.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -99.52 130.36 45.77 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.4 t -82.85 106.58 13.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 172.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.4 m -94.11 126.02 39.08 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -81.84 152.38 26.92 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.875 0.734 . . . . 0.0 111.24 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.515 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -64.64 138.54 97.49 Favored Pre-proline 0 CA--C 1.558 1.286 0 CA-C-O 117.802 -1.094 . . . . 0.0 109.061 173.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -36.88 -52.28 1.31 Allowed 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 124.871 3.714 . . . . 0.0 115.983 -173.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.09 -25.74 51.06 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 116.698 -0.228 . . . . 0.0 113.04 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -81.44 -6.27 58.76 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.827 0.851 . . . . 0.0 112.015 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.5 m -64.82 122.68 80.49 Favored Pre-proline 0 C--N 1.351 0.669 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.453 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -49.98 153.14 6.63 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.046 2.497 . . . . 0.0 112.396 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.11 -32.53 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 123.617 0.767 . . . . 0.0 110.918 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -87.89 -0.77 57.41 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.055 0.942 . . . . 0.0 111.747 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.71 -73.96 2.59 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 46.79 56.47 6.58 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.947 1.299 . . . . 0.0 113.45 170.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -65.69 122.18 16.67 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.424 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 16' ' ' ARG . 27.1 m -105.73 156.52 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.333 -172.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -150.91 158.41 44.11 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.848 0.459 . . . . 0.0 111.37 -173.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -140.32 139.24 35.4 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.397 0.679 . . . . 0.0 109.298 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -79.34 131.58 36.17 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.443 0.697 . . . . 0.0 110.323 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.7 pt -110.05 143.08 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.931 0.892 . . . . 0.0 109.298 173.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.11 -43.28 7.17 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.8 t -131.25 140.34 49.81 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.92 0.888 . . . . 0.0 109.282 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 62.0 t -60.11 -41.74 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 123.679 0.612 . . . . 0.0 110.226 172.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.22 -42.14 80.81 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.323 0.649 . . . . 0.0 111.631 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 m -66.12 -45.77 79.93 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.194 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -55.65 -48.42 75.04 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.836 0.454 . . . . 0.0 111.271 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 39.4 mm-40 -62.43 -52.9 61.69 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.342 0.657 . . . . 0.0 111.292 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -67.41 -38.3 84.42 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.659 0.783 . . . . 0.0 111.396 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -67.09 -35.86 80.72 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 122.658 0.383 . . . . 0.0 110.317 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.99 -32.25 71.68 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.071 0.548 . . . . 0.0 111.503 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 51.5 mm-40 -62.09 -51.78 66.54 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.153 0.501 . . . . 0.0 110.172 173.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.461 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 25.7 m -62.9 -47.95 81.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.242 -1.344 . . . . 0.0 110.395 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.531 HD21 HG22 ' A' ' 24' ' ' VAL . 49.6 tp -57.94 -57.92 10.7 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.405 1.082 . . . . 0.0 112.2 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 45.5 mt-30 -62.12 -39.92 94.17 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 123.715 0.634 . . . . 0.0 111.514 -174.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -66.46 -33.92 76.77 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 76' ' ' THR . 43.3 mm-40 -70.18 -39.98 74.93 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.795 0.438 . . . . 0.0 110.573 176.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.25 -12.43 60.86 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.602 0.761 . . . . 0.0 111.166 176.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.33 -8.09 79.71 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.944 -0.365 . . . . 0.0 112.829 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 70.7 mt -67.76 105.53 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.254 1.422 . . . . 0.0 109.172 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -151.46 159.59 44.12 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.561 0.344 . . . . 0.0 111.432 -174.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.3 -124.34 33.27 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.926 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -66.3 -22.52 66.29 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.306 1.043 . . . . 0.0 111.752 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -83.54 -5.18 59.09 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.232 0.613 . . . . 0.0 112.362 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -65.56 142.2 58.18 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 120.803 0.335 . . . . 0.0 111.325 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.403 HG21 HD11 ' A' ' 28' ' ' LEU . 59.8 t -82.84 122.99 78.44 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.92 0.888 . . . . 0.0 109.516 -175.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.14 132.76 43.25 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.413 2.742 . . . . 0.0 113.786 -171.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.3 t -108.28 119.84 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.0 0.92 . . . . 0.0 108.877 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.432 HG21 ' HD2' ' A' ' 35' ' ' ARG . 41.7 t -129.37 121.94 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.018 0.927 . . . . 0.0 109.11 -173.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -84.98 116.68 23.52 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.037 0.535 . . . . 0.0 110.24 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 49.8 mm -114.36 128.34 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.104 0.961 . . . . 0.0 108.758 -176.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.87 86.91 3.17 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.85 99.22 0.8 Allowed 'General case' 0 C--N 1.352 0.694 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -146.18 46.15 1.24 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.566 1.146 . . . . 0.0 108.337 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.28 -41.97 94.46 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.56 0.744 . . . . 0.0 110.463 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.855 -0.97 . . . . 0.0 111.744 179.346 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.476 ' SD ' ' HB2' ' A' ' 4' ' ' HIS . 5.1 ppp? . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.59 -16.83 38.2 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-O 119.654 -0.526 . . . . 0.0 114.402 -169.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -68.28 -39.29 82.16 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.982 0.513 . . . . 0.0 111.427 -174.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.476 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 32.6 m170 -101.61 16.05 26.97 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.092 0.557 . . . . 0.0 110.826 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -85.21 71.53 10.86 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.574 0.702 . . . . 0.0 109.3 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -83.37 87.3 6.97 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.064 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -93.98 98.09 10.79 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.555 -174.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -164.86 -30.24 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.073 1.349 . . . . 0.0 108.21 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -156.36 149.87 24.64 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.417 -1.265 . . . . 0.0 108.394 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -142.99 46.59 1.55 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.427 1.091 . . . . 0.0 108.651 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.58 88.19 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.302 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.457 ' HE3' HG21 ' A' ' 94' ' ' ILE . 63.6 mttm -123.57 108.63 12.83 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.025 1.33 . . . . 0.0 107.554 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -85.62 84.91 7.46 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.069 0.461 . . . . 0.0 109.833 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.7 m -78.5 87.66 4.48 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.98 -79.17 0.29 Allowed Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.483 -170.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 6.3 ptm180 -115.68 126.37 54.04 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.582 0.753 . . . . 0.0 111.081 -167.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.507 ' HG3' ' HA ' ' A' ' 62' ' ' PHE . 32.6 tt0 -85.35 128.1 34.58 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 pt -109.88 179.61 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 125.696 1.598 . . . . 0.0 109.621 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.8 p -89.93 154.15 20.07 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.074 0.95 . . . . 0.0 109.441 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.426 ' O ' HG23 ' A' ' 24' ' ' VAL . 54.4 t-105 -59.93 -43.37 94.96 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.513 0.725 . . . . 0.0 110.282 176.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -53.85 -48.67 69.75 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 123.952 0.783 . . . . 0.0 111.292 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' A' ' 26' ' ' ASN . 26.3 t70 -70.09 -34.96 73.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.778 0.431 . . . . 0.0 110.224 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.415 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 18.0 t80 -55.78 -46.12 78.01 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.945 0.498 . . . . 0.0 110.627 175.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 20' ' ' TRP . 79.9 t -61.98 -71.38 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 123.602 0.564 . . . . 0.0 110.783 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -73.66 -31.77 63.65 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.923 -161.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 22' ' ' ASP . 54.9 t30 -90.99 -23.59 20.35 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.665 0.786 . . . . 0.0 111.902 -176.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.415 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 75.4 m-85 -124.62 -66.42 0.98 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -172.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.64 -49.83 76.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.718 0.807 . . . . 0.0 111.401 -174.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.0 m -64.5 -20.74 66.39 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.555 1.142 . . . . 0.0 112.161 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -97.1 0.14 48.04 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.507 0.723 . . . . 0.0 111.301 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.92 26.61 60.95 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 115.543 0.977 . . . . 0.0 115.543 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.8 m -90.7 3.9 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 122.898 0.479 . . . . 0.0 111.405 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.3 126.06 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.887 0.875 . . . . 0.0 108.926 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.486 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 30.9 t70 -84.1 -51.61 6.94 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.546 1.138 . . . . 0.0 109.967 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -154.07 161.61 41.79 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.583 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.05 101.83 9.37 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.9 0.88 . . . . 0.0 108.67 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -87.0 101.13 13.15 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.102 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.709 HG12 ' HA ' ' A' ' 41' ' ' LYS . 19.8 t -88.54 90.2 3.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -173.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.9 t -81.43 127.76 39.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.6 -173.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.613 ' HA ' ' HB3' ' A' ' 96' ' ' GLU . 1.2 t-20 59.95 19.51 8.55 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.8 2.04 . . . . 0.0 111.452 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.709 ' HA ' HG12 ' A' ' 38' ' ' VAL . 19.7 pttm 42.06 18.29 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 126.287 1.835 . . . . 0.0 115.251 -167.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.3 ttp-105 -98.93 -30.49 12.34 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.149 0.98 . . . . 0.0 109.102 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -147.62 152.12 37.36 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.02 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 59.0 t -110.97 128.07 67.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.541 1.137 . . . . 0.0 108.465 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -100.67 124.73 46.68 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.1 t -82.69 105.39 12.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.7 m -92.1 125.91 36.97 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -84.87 148.98 25.99 Favored 'General case' 0 C--O 1.241 0.607 0 O-C-N 123.723 0.64 . . . . 0.0 111.917 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.486 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 10.0 p -60.68 129.02 89.39 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.779 172.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.27 118.77 5.38 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.106 2.537 . . . . 0.0 112.375 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.75 -25.06 25.36 Favored Glycine 0 N--CA 1.468 0.828 0 N-CA-C 112.363 -0.295 . . . . 0.0 112.363 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.418 ' HE3' ' OG1' ' A' ' 49' ' ' THR . 52.7 mtmt -117.49 28.72 8.28 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.9 0.88 . . . . 0.0 109.71 175.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.1 m -85.55 111.07 34.47 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.62 129.7 19.35 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.122 1.882 . . . . 0.0 111.566 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.14 -27.6 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 123.372 0.669 . . . . 0.0 109.833 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -72.47 -33.18 66.82 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.419 0.688 . . . . 0.0 110.454 172.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.27 -30.35 50.47 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.098 176.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 54.44 -100.31 0.1 Allowed 'General case' 0 C--N 1.362 1.109 0 C-N-CA 124.654 1.181 . . . . 0.0 109.545 -173.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -132.5 131.48 41.66 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.525 1.13 . . . . 0.0 108.357 157.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 16' ' ' ARG . 33.2 m -106.38 154.96 7.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -157.57 174.94 14.6 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.173 0.589 . . . . 0.0 110.11 -175.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.507 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 33.9 p90 -157.6 147.32 20.26 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.974 0.51 . . . . 0.0 110.253 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -91.09 130.16 37.01 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 67' ' ' VAL . 30.3 pt -102.93 -46.99 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.217 0.607 . . . . 0.0 111.334 -176.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.26 -83.24 0.43 Allowed Glycine 0 C--N 1.345 1.082 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -167.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.8 t -72.45 96.74 1.95 Allowed 'General case' 0 C--O 1.249 1.027 0 CA-C-O 121.778 0.799 . . . . 0.0 109.875 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.598 ' HA ' HD12 ' A' ' 64' ' ' ILE . 11.0 t -56.04 -39.33 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 113.952 -1.477 . . . . 0.0 110.999 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -58.26 -42.37 86.3 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.049 0.843 . . . . 0.0 111.02 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.0 m -64.67 -45.73 85.47 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 123.657 0.598 . . . . 0.0 110.159 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -52.66 -50.83 62.44 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.816 0.698 . . . . 0.0 111.266 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -63.58 -46.19 86.99 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.135 0.897 . . . . 0.0 110.774 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 mtp-105 -59.35 -49.47 77.71 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.765 0.826 . . . . 0.0 111.41 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -66.32 -43.6 85.72 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.435 0.694 . . . . 0.0 110.18 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.3 tp -56.13 -49.6 73.45 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.272 1.029 . . . . 0.0 110.736 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -66.62 -49.17 67.16 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.446 0.698 . . . . 0.0 111.649 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.4 m -60.17 -44.61 94.88 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.46 0.648 . . . . 0.0 109.926 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.9 tp -57.81 -53.38 58.81 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.757 175.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.412 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 87.4 mt-30 -64.89 -45.04 87.62 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.28 0.632 . . . . 0.0 111.018 -173.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.56 -38.2 83.79 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.312 0.645 . . . . 0.0 110.633 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.34 -41.12 90.05 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.2 1.0 . . . . 0.0 110.978 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.1 mt -87.29 0.77 54.9 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.487 0.715 . . . . 0.0 111.458 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.25 -4.32 63.37 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.595 -0.558 . . . . 0.0 113.809 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 68.4 mt -68.08 116.31 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.672 1.189 . . . . 0.0 109.47 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -161.1 148.26 15.16 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.082 0.553 . . . . 0.0 110.497 -173.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.07 -89.84 0.01 OUTLIER Glycine 0 C--N 1.349 1.263 0 O-C-N 124.923 1.389 . . . . 0.0 114.722 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.41 -44.31 83.36 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.29 1.036 . . . . 0.0 110.565 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -98.65 -1.46 40.72 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.445 0.698 . . . . 0.0 111.741 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -70.44 134.41 47.77 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 122.994 0.184 . . . . 0.0 110.939 -178.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.2 t -72.37 112.51 15.09 Favored Pre-proline 0 CA--C 1.561 1.391 0 O-C-N 124.165 0.916 . . . . 0.0 109.49 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.92 142.63 57.67 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.981 2.454 . . . . 0.0 113.117 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.4 t -105.75 118.2 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.461 1.104 . . . . 0.0 109.178 -175.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.7 t -119.93 98.96 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.583 0.753 . . . . 0.0 110.166 -171.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -75.3 109.59 8.95 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.153 0.581 . . . . 0.0 110.585 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.457 HG21 ' HE3' ' A' ' 12' ' ' LYS . 77.7 mt -115.45 155.42 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.983 0.913 . . . . 0.0 108.54 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 71.64 -7.58 1.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.597 1.559 . . . . 0.0 114.365 169.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.613 ' HB3' ' HA ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -109.44 -179.24 3.77 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 122.997 0.519 . . . . 0.0 111.783 -177.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.6 m -109.57 136.54 48.79 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.529 0.732 . . . . 0.0 109.155 173.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.34 -34.3 77.67 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.024 0.53 . . . . 0.0 111.24 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.372 0 CA-C-O 118.887 -0.952 . . . . 0.0 113.042 -179.322 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.553 0.216 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.06 -79.88 1.82 Allowed Glycine 0 C--N 1.348 1.204 0 CA-C-N 116.497 -0.32 . . . . 0.0 112.366 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -131.93 -173.76 3.23 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.717 0.807 . . . . 0.0 109.611 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -108.84 -14.87 14.51 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.23 0.612 . . . . 0.0 111.873 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -57.04 -31.82 65.56 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.295 1.038 . . . . 0.0 113.01 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -73.21 8.28 1.75 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -68.39 85.61 0.28 Allowed 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 122.662 1.22 . . . . 0.0 110.231 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -97.76 -10.88 24.08 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.084 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.9 m -73.11 97.31 2.35 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 168.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -73.17 -175.15 1.75 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.341 0.656 . . . . 0.0 110.207 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.4 mmt -78.41 36.78 0.26 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.65 -38.9 92.87 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 124.087 0.955 . . . . 0.0 109.703 172.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.2 tpp85 -70.67 86.98 0.67 Allowed 'General case' 0 C--N 1.361 1.08 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 168.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.1 t -114.88 -165.93 1.06 Allowed 'General case' 0 C--O 1.246 0.92 0 CA-C-N 113.861 -1.518 . . . . 0.0 107.278 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -166.99 165.2 38.4 Favored Glycine 0 CA--C 1.507 -0.451 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 174.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.667 ' HB3' HG12 ' A' ' 60' ' ' VAL . 20.0 ttt180 -87.56 125.03 34.1 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.9 109.33 8.27 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.7 pt -106.8 175.38 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.685 1.194 . . . . 0.0 108.762 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.0 p -97.2 167.92 10.75 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.521 ' O ' HG23 ' A' ' 24' ' ' VAL . 69.1 t-105 -57.5 -41.97 81.8 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 123.462 0.476 . . . . 0.0 110.04 169.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -60.4 -49.39 77.76 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.71 0.404 . . . . 0.0 111.761 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.51 -38.79 90.73 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.298 0.639 . . . . 0.0 110.591 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.453 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 40.3 t80 -52.56 -53.46 46.11 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.968 172.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.579 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 69.1 t -60.33 -47.77 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.11 0.564 . . . . 0.0 110.769 -177.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.28 -55.91 11.96 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.521 -173.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -85.01 -27.88 26.12 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.453 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 87.1 m-85 -117.01 -68.86 0.89 Allowed 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -165.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.579 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 56.6 tp -59.91 -45.28 93.05 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.457 1.103 . . . . 0.0 113.149 -171.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 81.2 p -64.53 -21.29 66.64 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.066 0.546 . . . . 0.0 112.39 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -99.2 -9.05 24.21 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.794 0.837 . . . . 0.0 110.728 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.44 37.72 88.88 Favored Glycine 0 C--N 1.348 1.218 0 O-C-N 123.835 0.709 . . . . 0.0 114.836 -173.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.427 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 6.3 m -79.76 -3.46 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 174.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.453 ' HB ' HG21 ' A' ' 89' ' ' VAL . 16.6 t -99.54 128.08 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.911 0.884 . . . . 0.0 109.308 -175.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -86.72 -48.24 8.43 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.161 1.385 . . . . 0.0 110.312 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.513 ' HD3' HG21 ' A' ' 92' ' ' VAL . 19.2 ptp180 -158.49 149.39 20.48 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.857 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.563 ' HG ' HG11 ' A' ' 89' ' ' VAL . 31.4 mt -108.16 102.0 11.18 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.45 ' HB3' HD12 ' A' ' 94' ' ' ILE . 52.1 mt-10 -93.6 105.79 17.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.864 -172.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.528 HG22 HG22 ' A' ' 44' ' ' VAL . 48.3 t -81.06 102.12 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -176.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.3 t -90.23 114.71 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.263 0.625 . . . . 0.0 109.537 -173.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.3 m120 58.94 16.75 4.82 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.434 1.493 . . . . 0.0 113.688 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 90.6 mttt 60.35 8.58 1.65 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.447 1.099 . . . . 0.0 113.335 -171.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 -81.67 -39.51 24.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.924 0.889 . . . . 0.0 109.516 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -155.33 174.82 14.68 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.267 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.528 HG22 HG22 ' A' ' 38' ' ' VAL . 59.4 t -123.81 131.53 72.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -103.29 127.32 50.65 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.439 0.695 . . . . 0.0 109.439 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 80.2 t -84.08 110.16 18.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.621 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.5 m -90.44 141.62 28.56 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 170.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.429 ' HE2' ' HA ' ' A' ' 59' ' ' TYR . 63.3 m-85 -97.38 149.69 21.84 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 176.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.5 p -71.01 140.83 86.11 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.224 1.01 . . . . 0.0 111.419 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -63.91 73.85 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 123.271 2.647 . . . . 0.0 112.302 169.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.9 -40.09 0.43 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.336 -173.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.427 ' HB2' ' HA ' ' A' ' 32' ' ' VAL . 90.2 mttt -123.64 87.36 2.73 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.4 m -135.21 133.25 20.54 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 124.391 1.076 . . . . 0.0 109.185 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -58.25 99.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.028 1.818 . . . . 0.0 110.018 165.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.77 -31.54 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.289 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -78.87 -31.4 45.5 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.668 0.787 . . . . 0.0 110.156 173.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.83 -171.26 45.84 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.619 -0.719 . . . . 0.0 114.205 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -133.32 -171.98 2.83 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.957 1.303 . . . . 0.0 109.446 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.429 ' HA ' ' HE2' ' A' ' 48' ' ' PHE . 11.6 m-85 -65.1 154.83 36.74 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.539 0.685 . . . . 0.0 111.046 176.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.667 HG12 ' HB3' ' A' ' 16' ' ' ARG . 33.8 m -131.39 170.12 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -167.04 160.1 13.76 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.141 0.576 . . . . 0.0 110.091 -174.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -144.1 140.17 29.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.998 0.519 . . . . 0.0 110.351 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -77.08 147.05 36.88 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.406 0.682 . . . . 0.0 110.27 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 67' ' ' VAL . 40.3 pt -131.03 139.4 51.18 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 C-N-CA 123.552 0.741 . . . . 0.0 109.992 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.34 -44.36 17.53 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 172.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.7 t -131.16 129.84 42.28 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.992 0.917 . . . . 0.0 110.285 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.444 ' HA ' HD12 ' A' ' 64' ' ' ILE . 15.6 t -64.41 -37.99 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.796 0.838 . . . . 0.0 110.691 171.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.598 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 31.3 t70 -62.23 -56.53 17.7 Favored 'General case' 0 C--O 1.216 -0.694 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.5 m -55.24 -45.42 76.03 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.943 0.497 . . . . 0.0 111.176 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -47.3 -56.15 7.36 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.411 1.084 . . . . 0.0 112.096 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 12.2 pt-20 -73.27 -28.77 62.31 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.814 -173.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 18.1 mmm-85 -59.98 -45.76 91.66 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 176.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -67.57 -38.37 84.0 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.705 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 tp -57.28 -56.73 18.03 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.697 0.623 . . . . 0.0 111.059 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 79' ' ' GLN . 32.0 mt-10 -59.92 -47.74 84.55 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.023 0.929 . . . . 0.0 112.693 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 51.5 m -61.56 -48.87 79.0 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.504 0.669 . . . . 0.0 110.144 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 35.6 tp -57.56 -38.94 75.63 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.251 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.742 ' HB3' HD11 ' A' ' 83' ' ' ILE . 25.0 mt-30 -63.81 -39.03 93.27 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.522 0.729 . . . . 0.0 110.434 175.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 76.7 mt-30 -67.97 -29.25 68.24 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.932 0.493 . . . . 0.0 110.697 176.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -71.24 -47.78 55.12 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.617 0.767 . . . . 0.0 110.546 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 87.6 mt -68.0 -18.72 64.8 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.183 0.993 . . . . 0.0 111.644 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.76 31.27 79.64 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.713 0.633 . . . . 0.0 112.342 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.742 HD11 ' HB3' ' A' ' 78' ' ' GLN . 1.2 pp -64.81 162.49 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 122.041 0.924 . . . . 0.0 113.186 -176.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -119.53 169.15 10.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 161.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.89 -25.69 1.0 Allowed Glycine 0 N--CA 1.481 1.687 0 N-CA-C 117.311 1.685 . . . . 0.0 117.311 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.02 -46.65 83.51 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.688 0.744 . . . . 0.0 111.522 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -101.34 -11.9 19.06 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.439 0.696 . . . . 0.0 111.225 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.425 ' HB2' HD13 ' A' ' 83' ' ' ILE . 9.3 ttp180 -84.0 140.89 31.59 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.213 1.005 . . . . 0.0 109.294 174.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.563 HG11 ' HG ' ' A' ' 36' ' ' LEU . 46.5 t -117.17 120.41 33.65 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 122.781 0.432 . . . . 0.0 111.467 -167.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.83 154.26 48.47 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.976 2.451 . . . . 0.0 112.592 172.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.4 t -106.94 125.38 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.519 0.727 . . . . 0.0 109.768 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.513 HG21 ' HD3' ' A' ' 35' ' ' ARG . 21.8 t -113.13 112.45 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -82.39 109.43 16.63 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.45 HD12 ' HB3' ' A' ' 37' ' ' GLU . 50.2 mt -118.89 132.9 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -175.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -107.46 117.38 33.93 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 172.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -87.36 145.51 26.29 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.2 p -84.17 87.93 7.19 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.309 0.644 . . . . 0.0 110.341 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -88.09 -35.94 17.21 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.034 0.934 . . . . 0.0 109.921 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.286 0 CA-C-O 118.58 -1.122 . . . . 0.0 111.667 178.837 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.45 174.01 16.09 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 123.074 0.368 . . . . 0.0 112.301 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -151.58 126.97 9.98 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.661 0.785 . . . . 0.0 109.17 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 85.3 t60 73.33 -51.47 0.7 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.573 1.549 . . . . 0.0 109.879 -169.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -129.52 165.14 22.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.135 0.974 . . . . 0.0 109.358 165.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -82.36 166.6 19.31 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.883 0.873 . . . . 0.0 111.935 -174.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.4 m80 60.13 -149.68 0.43 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.306 1.042 . . . . 0.0 109.27 -176.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 -66.16 111.59 3.49 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 162.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.3 m -66.58 91.98 0.2 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.518 0.727 . . . . 0.0 110.534 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -58.02 136.02 57.06 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.929 174.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 56.0 mtm -81.49 53.28 2.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.165 0.986 . . . . 0.0 110.872 -175.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -80.61 108.42 14.23 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 174.508 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -167.17 176.81 6.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.668 -167.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.8 m -86.3 -39.48 16.46 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 165.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.52 58.34 15.09 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.643 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -122.96 123.21 40.41 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -77.3 107.25 9.58 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 172.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 pt -95.48 170.2 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 123.737 0.815 . . . . 0.0 109.235 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.503 HG23 ' H ' ' A' ' 22' ' ' ASP . 9.0 t -85.43 149.85 25.12 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 172.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.537 ' O ' HG23 ' A' ' 24' ' ' VAL . 67.1 t-105 -52.09 -42.85 63.56 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.972 0.909 . . . . 0.0 111.192 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -61.3 -36.21 79.46 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 123.372 0.42 . . . . 0.0 111.725 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.503 ' H ' HG23 ' A' ' 19' ' ' THR . 31.7 t70 -70.35 -40.83 73.84 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.455 ' HZ ' HD11 ' A' ' 36' ' ' LEU . 40.2 t80 -56.15 -42.33 76.81 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.673 175.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.584 HG22 HD21 ' A' ' 77' ' ' LEU . 97.3 t -67.65 -66.3 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.402 0.681 . . . . 0.0 111.025 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -71.13 -44.81 64.82 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.443 0.464 . . . . 0.0 111.664 -166.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -80.13 -29.22 38.89 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.906 0.883 . . . . 0.0 111.786 -171.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -120.34 -66.19 1.08 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -169.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.34 -44.36 95.59 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.972 0.909 . . . . 0.0 111.526 -172.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.1 m -73.04 -16.23 61.49 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.351 1.06 . . . . 0.0 112.412 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -96.2 -3.77 43.69 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.136 0.575 . . . . 0.0 110.974 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.22 37.37 91.71 Favored Glycine 0 C--N 1.357 1.738 0 N-CA-C 114.776 0.671 . . . . 0.0 114.776 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.7 m -98.95 0.8 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.06 126.6 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.481 0.712 . . . . 0.0 110.272 -174.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -85.28 -47.21 10.28 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.343 1.057 . . . . 0.0 110.707 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.461 ' HG2' ' HB ' ' A' ' 47' ' ' THR . 10.2 ptp180 -157.07 160.29 38.76 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.873 0.469 . . . . 0.0 110.138 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.455 HD11 ' HZ ' ' A' ' 23' ' ' PHE . 92.4 mt -117.77 103.29 9.85 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.74 0.816 . . . . 0.0 109.303 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -88.9 111.86 22.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.602 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 44' ' ' VAL . 31.0 t -84.45 99.86 7.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.9 t -91.25 114.43 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 122.865 0.466 . . . . 0.0 110.033 -171.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 52.52 27.29 4.92 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.408 1.483 . . . . 0.0 112.886 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HA ' HG12 ' A' ' 38' ' ' VAL . 98.0 mttt 61.71 -0.7 0.39 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.812 1.645 . . . . 0.0 114.31 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -81.74 -34.16 30.64 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.385 0.674 . . . . 0.0 110.6 -171.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -157.4 179.32 9.36 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 38' ' ' VAL . 91.9 t -126.59 129.1 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 124.175 0.99 . . . . 0.0 109.072 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -101.37 128.75 47.41 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.9 t -88.84 109.84 20.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.726 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.461 ' HB ' ' HG2' ' A' ' 35' ' ' ARG . 87.1 m -88.31 134.37 33.83 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 172.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -103.6 154.5 19.43 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.198 0.599 . . . . 0.0 111.379 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.3 p -75.48 117.53 63.99 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.172 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.07 103.66 0.13 Allowed 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.214 2.61 . . . . 0.0 111.294 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.54 -50.71 0.81 Allowed Glycine 0 C--N 1.336 0.563 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -173.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.39 21.91 16.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.982 0.913 . . . . 0.0 110.488 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.8 m -73.13 119.72 77.17 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.98 139.44 84.79 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.584 2.19 . . . . 0.0 112.312 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.08 -44.54 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.571 0.748 . . . . 0.0 109.024 173.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.37 82.84 2.23 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.74 46.5 0.09 OUTLIER Glycine 0 C--N 1.344 1.021 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -62.52 -61.15 2.64 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.085 0.954 . . . . 0.0 112.306 -171.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -135.21 119.05 17.26 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -118.67 -179.6 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.626 0.371 . . . . 0.0 110.127 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -159.54 165.82 32.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.966 0.907 . . . . 0.0 109.167 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -152.56 152.16 31.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.624 0.37 . . . . 0.0 111.455 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -78.19 149.59 33.67 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.206 1.002 . . . . 0.0 110.145 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.2 pt -127.06 -26.79 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.063 0.545 . . . . 0.0 111.999 -174.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.52 -78.0 1.52 Allowed Glycine 0 C--N 1.344 0.991 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.2 t -107.4 132.05 53.6 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.181 0.992 . . . . 0.0 108.585 172.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.8 t -62.33 -32.37 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.357 0.663 . . . . 0.0 110.757 173.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.95 -38.2 90.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.689 0.796 . . . . 0.0 110.807 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.6 m -63.39 -51.38 66.08 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 122.905 0.482 . . . . 0.0 110.221 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -53.33 -58.22 7.86 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 124.102 0.876 . . . . 0.0 111.961 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 15.5 pt-20 -62.56 -47.78 82.37 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.962 0.789 . . . . 0.0 111.065 -172.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -64.15 -48.1 77.32 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 122.37 0.268 . . . . 0.0 110.873 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -65.87 -43.34 88.67 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.814 0.696 . . . . 0.0 110.24 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.438 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 39.9 tp -57.7 -55.92 28.58 Favored 'General case' 0 C--O 1.215 -0.751 0 O-C-N 124.759 1.287 . . . . 0.0 111.651 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.591 ' HG2' ' NH2' ' A' ' 88' ' ' ARG . 44.8 mt-10 -66.43 -35.35 80.09 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.409 0.684 . . . . 0.0 112.156 -172.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.7 m -65.12 -48.04 75.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.188 0.595 . . . . 0.0 109.441 174.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.584 HD21 HG22 ' A' ' 24' ' ' VAL . 44.9 tp -57.17 -41.48 79.35 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.216 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 60.8 mt-30 -63.65 -46.31 86.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.682 0.793 . . . . 0.0 110.243 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -65.65 -31.04 71.84 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.46 0.704 . . . . 0.0 110.886 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -71.79 -52.64 16.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.559 1.143 . . . . 0.0 110.791 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 72.3 mt -79.42 -10.16 59.75 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.403 0.681 . . . . 0.0 111.592 -173.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.88 10.17 59.03 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 114.301 0.48 . . . . 0.0 114.301 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.471 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 3.5 mp -80.13 90.32 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 168.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.99 143.14 50.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.656 -0.653 . . . . 0.0 111.925 -171.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.0 -100.3 0.17 Allowed Glycine 0 C--N 1.349 1.297 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.749 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -79.02 -27.88 43.28 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.946 0.899 . . . . 0.0 110.904 -176.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -76.46 -9.53 58.72 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.088 0.555 . . . . 0.0 111.557 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.591 ' NH2' ' HG2' ' A' ' 75' ' ' GLU . 70.2 mtp180 -69.15 151.55 46.23 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-O 121.551 0.691 . . . . 0.0 112.836 -175.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.5 t -91.87 108.77 32.37 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.056 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -57.36 125.57 19.27 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.972 2.448 . . . . 0.0 111.535 -175.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.77 107.79 20.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -176.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 t -105.52 98.03 6.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -71.14 107.77 4.34 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.9 mt -117.97 144.59 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.903 0.881 . . . . 0.0 109.814 -175.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.563 ' HB1' ' HB3' ' A' ' 98' ' ' ASP . . . -109.56 102.92 11.73 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -72.24 -46.72 54.82 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.764 0.825 . . . . 0.0 111.112 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.4 p -144.89 21.45 1.61 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.992 0.517 . . . . 0.0 111.347 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.563 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . 17.3 t70 -74.1 -38.52 63.82 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.03 0.532 . . . . 0.0 110.211 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.286 0 CA-C-O 118.774 -1.014 . . . . 0.0 112.091 179.724 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.71 -154.86 53.42 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 116.275 -0.42 . . . . 0.0 113.423 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 74.91 -19.03 0.4 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.61 1.564 . . . . 0.0 113.081 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -77.44 100.3 5.95 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.583 0.753 . . . . 0.0 109.909 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -75.95 75.58 2.85 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.759 0.824 . . . . 0.0 110.295 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -93.96 126.03 38.93 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.695 0.798 . . . . 0.0 109.049 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -111.52 140.19 46.33 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -73.13 78.14 1.25 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.443 0.64 . . . . 0.0 109.742 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.8 m -140.02 -3.05 1.44 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.704 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -92.1 147.37 23.0 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.758 0.823 . . . . 0.0 108.849 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.3 mmt 66.53 -167.28 0.21 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.35 1.06 . . . . 0.0 110.286 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -83.1 120.52 25.87 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.494 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 6.3 ptm180 -75.71 85.09 2.72 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.75 0.786 . . . . 0.0 109.774 171.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 p -120.2 -79.38 0.6 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.41 98.63 1.73 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 171.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.494 ' HD2' ' HA ' ' A' ' 13' ' ' ARG . 4.1 mmp_? -108.33 116.83 32.7 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 117.092 0.446 . . . . 0.0 111.45 -173.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.07 108.52 7.85 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.618 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 36.0 pt -100.62 171.55 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.514 1.126 . . . . 0.0 109.227 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.6 p -100.11 178.43 4.79 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 166.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -59.05 -35.19 72.91 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.445 173.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -60.88 -46.55 90.18 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.388 0.675 . . . . 0.0 112.22 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.618 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 7.0 m-20 -62.23 -44.95 95.4 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.312 0.245 . . . . 0.0 110.368 174.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 37.3 t80 -55.15 -50.63 68.8 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 124.118 0.886 . . . . 0.0 110.81 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.414 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 45.8 t -64.04 -66.47 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.944 0.897 . . . . 0.0 111.583 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -71.46 -47.15 57.54 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.87 0.468 . . . . 0.0 112.186 -166.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -80.26 -22.37 41.76 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -172.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.433 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 53.7 m-85 -128.22 -61.57 1.09 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -169.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.414 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 58.0 tp -64.13 -44.67 91.51 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.085 0.954 . . . . 0.0 111.317 -168.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.486 ' HA ' HD13 ' A' ' 81' ' ' LEU . 91.0 p -62.91 -20.31 65.04 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.59 0.756 . . . . 0.0 112.791 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -97.4 -10.44 25.5 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.868 0.867 . . . . 0.0 110.747 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.32 31.89 80.89 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 114.652 0.621 . . . . 0.0 114.652 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.44 HG12 ' HD3' ' A' ' 52' ' ' LYS . 18.2 m -80.5 -0.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 117.125 0.462 . . . . 0.0 110.676 175.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 t -98.82 133.06 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -176.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.488 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 18.6 t70 -92.38 -55.03 3.56 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.519 1.128 . . . . 0.0 109.621 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -154.46 164.99 37.81 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.386 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.403 HD11 ' CZ ' ' A' ' 23' ' ' PHE . 91.6 mt -120.51 108.84 14.57 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.689 0.795 . . . . 0.0 110.788 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -88.21 102.64 15.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.741 0.816 . . . . 0.0 110.053 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 41' ' ' LYS . 21.8 t -97.3 91.03 2.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.1 t -79.58 118.25 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.079 -174.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 49.73 27.92 2.45 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.688 1.595 . . . . 0.0 113.425 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.566 ' HA ' HG12 ' A' ' 38' ' ' VAL . 10.6 mtmp? 53.74 15.52 0.81 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.116 1.366 . . . . 0.0 114.181 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -85.64 -47.02 10.22 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.964 0.906 . . . . 0.0 110.421 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.457 ' HE2' ' HE ' ' A' ' 45' ' ' ARG . 44.1 p90 -147.56 159.83 43.31 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.177 0.513 . . . . 0.0 109.852 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.476 HG22 HG22 ' A' ' 38' ' ' VAL . 57.4 t -121.53 131.9 71.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.345 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.457 ' HE ' ' HE2' ' A' ' 43' ' ' PHE . 89.3 mtt180 -99.32 124.82 44.74 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.413 ' HB ' HG23 ' A' ' 60' ' ' VAL . 44.8 t -82.36 108.87 15.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 83.4 m -87.82 129.48 35.18 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -86.03 145.08 27.24 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.79 0.436 . . . . 0.0 110.409 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.4 t -86.66 145.21 38.71 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 123.297 0.639 . . . . 0.0 111.265 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.13 139.52 20.86 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 124.204 3.269 . . . . 0.0 114.631 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.0 -36.11 3.54 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.144 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HD3' HG12 ' A' ' 32' ' ' VAL . 67.1 mttm -98.97 -18.85 17.6 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.383 0.673 . . . . 0.0 110.799 175.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 m -65.6 130.1 94.51 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 122.89 0.476 . . . . 0.0 111.376 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -72.91 96.78 0.87 Allowed 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 121.986 1.791 . . . . 0.0 108.908 163.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.95 -17.5 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.715 0.806 . . . . 0.0 112.007 -169.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -60.88 -28.52 68.94 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.985 0.914 . . . . 0.0 111.997 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.68 82.4 1.11 Allowed Glycine 0 C--N 1.339 0.713 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.67 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.42 94.17 3.38 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -104.28 127.51 51.92 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.078 0.951 . . . . 0.0 110.05 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 16' ' ' ARG . 33.0 m -109.17 144.16 18.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 173.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -154.73 163.13 40.7 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.83 0.452 . . . . 0.0 110.693 -173.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -150.19 150.76 32.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.708 0.403 . . . . 0.0 110.733 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -93.8 119.12 32.35 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.1 pt -84.31 116.77 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.069 0.548 . . . . 0.0 110.384 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.35 99.42 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.776 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.6 t -132.15 126.59 34.03 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.052 0.941 . . . . 0.0 108.731 172.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.54 HG21 ' HB3' ' A' ' 41' ' ' LYS . 17.5 t -61.57 -36.3 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.363 0.665 . . . . 0.0 110.049 172.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -58.01 -43.9 86.92 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.125 0.97 . . . . 0.0 111.094 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.5 m -64.87 -46.53 81.45 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.537 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -51.39 -53.45 36.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.813 0.845 . . . . 0.0 111.834 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 44.7 mt-10 -67.9 -52.95 30.52 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.761 0.824 . . . . 0.0 111.845 -172.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -68.88 -36.06 77.63 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.588 0.555 . . . . 0.0 111.785 -173.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -70.89 -39.7 72.65 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 174.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 46.5 tp -56.51 -45.19 81.2 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.023 0.529 . . . . 0.0 111.34 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.5 -42.18 99.32 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.874 0.734 . . . . 0.0 111.187 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.1 m -60.31 -56.41 21.84 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 123.8 0.688 . . . . 0.0 110.398 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 77' ' ' LEU . 2.7 mm? -51.73 -52.16 50.65 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 124.418 1.074 . . . . 0.0 112.067 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -60.17 -43.34 95.91 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 123.627 0.579 . . . . 0.0 111.383 -175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -62.75 -44.86 95.11 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.923 0.889 . . . . 0.0 111.122 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -70.1 -38.36 75.61 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.131 -176.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 29' ' ' SER . 41.5 mt -77.77 -17.3 57.65 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.66 0.784 . . . . 0.0 110.515 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.7 6.54 88.99 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-O 119.887 -0.396 . . . . 0.0 113.853 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.539 HG22 ' HA ' ' A' ' 88' ' ' ARG . 75.7 mt -70.98 92.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.1 0.96 . . . . 0.0 109.479 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -136.33 152.82 51.07 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 124.133 0.973 . . . . 0.0 110.569 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.402 ' N ' ' HB2' ' A' ' 88' ' ' ARG . . . 61.0 -93.91 0.07 OUTLIER Glycine 0 C--N 1.343 0.947 0 CA-C-N 114.594 -1.185 . . . . 0.0 115.406 172.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -77.46 -45.72 24.79 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.562 0.696 . . . . 0.0 109.517 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -79.86 -15.7 56.85 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.759 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.539 ' HA ' HG22 ' A' ' 83' ' ' ILE . 58.0 ttt180 -56.53 152.25 12.09 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.112 0.965 . . . . 0.0 111.991 -174.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 68.6 t -100.09 99.74 10.03 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 57.2 Cg_endo -70.48 149.07 61.71 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.919 2.413 . . . . 0.0 112.268 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.8 t -108.63 119.32 57.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.417 -174.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.7 t -104.84 96.27 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -74.64 98.52 3.43 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.508 HG22 ' HG2' ' A' ' 96' ' ' GLU . 64.3 mt -87.1 129.19 38.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.81 75.71 1.45 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -175.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.508 ' HG2' HG22 ' A' ' 94' ' ' ILE . 12.3 mm-40 -72.68 -46.75 52.19 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.053 -174.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.7 m 66.12 98.56 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.529 1.143 . . . . 0.0 110.914 -176.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.91 -41.12 71.65 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.005 0.922 . . . . 0.0 110.224 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.128 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.148 173.965 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 mtt . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.576 0.227 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.08 26.41 26.34 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 116.387 -0.37 . . . . 0.0 112.314 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -60.92 -39.24 88.62 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.144 0.578 . . . . 0.0 110.838 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -77.5 81.98 3.94 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 166.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -65.2 -65.62 0.65 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.233 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -145.12 115.62 7.63 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 171.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -66.98 151.6 47.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.876 0.47 . . . . 0.0 110.216 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.6 p80 48.23 31.15 2.48 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.061 1.345 . . . . 0.0 111.963 -175.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.2 p -51.38 151.8 2.83 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.091 0.956 . . . . 0.0 111.572 -175.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -45.19 132.46 7.35 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 124.562 1.164 . . . . 0.0 111.414 -171.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.485 ' HG3' ' HB2' ' A' ' 13' ' ' ARG . 13.7 tpt -43.09 105.61 0.05 Allowed 'General case' 0 C--N 1.354 0.798 0 O-C-N 125.278 1.611 . . . . 0.0 111.081 -177.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.537 ' HD3' HG11 ' A' ' 39' ' ' VAL . 24.1 ttpt -42.09 -56.2 2.93 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 125.237 1.415 . . . . 0.0 110.308 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.485 ' HB2' ' HG3' ' A' ' 11' ' ' MET . 3.2 tmt_? 59.08 -87.96 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.066 0 O-C-N 125.417 1.698 . . . . 0.0 108.489 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.7 p 175.82 -70.56 0.01 OUTLIER 'General case' 0 C--N 1.353 0.731 0 C-N-CA 124.458 1.103 . . . . 0.0 109.694 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.98 -154.02 19.51 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.351 -168.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -89.65 127.13 35.87 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.384 0.674 . . . . 0.0 109.366 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -74.26 128.98 36.92 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.4 pt -129.69 170.6 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.618 0.767 . . . . 0.0 109.649 -175.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.6 p -91.71 153.59 19.55 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.588 ' O ' HG23 ' A' ' 24' ' ' VAL . 68.9 t-105 -53.58 -46.46 70.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.302 0.641 . . . . 0.0 110.806 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -54.82 -50.73 67.86 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.815 0.846 . . . . 0.0 112.476 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -33.83 70.79 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -176.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -54.23 -45.47 72.3 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.41 0.444 . . . . 0.0 110.49 172.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 20' ' ' TRP . 89.3 t -58.11 -64.09 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.017 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -75.21 -33.41 61.39 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.233 0.333 . . . . 0.0 111.815 -166.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -80.66 -41.29 24.04 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.868 0.467 . . . . 0.0 111.606 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -113.51 -65.3 1.2 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -163.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.8 tp -60.89 -45.52 94.26 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.886 0.741 . . . . 0.0 111.53 -174.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.5 ' HA ' HD11 ' A' ' 83' ' ' ILE . 22.7 t -72.39 -14.29 61.67 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.33 1.052 . . . . 0.0 111.863 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -101.83 -2.18 30.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.771 0.428 . . . . 0.0 111.12 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.93 22.41 34.49 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.8 m -77.78 -3.59 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 123.055 0.542 . . . . 0.0 111.468 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.9 t -93.63 129.91 43.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.267 1.027 . . . . 0.0 108.625 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -80.56 -47.32 14.36 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.537 0.735 . . . . 0.0 110.193 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.485 ' HG2' ' HB ' ' A' ' 47' ' ' THR . 6.6 ptp85 -159.4 157.92 31.18 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.092 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.5 mt -114.83 102.14 9.71 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.774 0.829 . . . . 0.0 108.964 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -89.79 108.61 19.8 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.136 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.523 HG22 HG22 ' A' ' 44' ' ' VAL . 40.6 t -88.45 94.59 4.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.537 HG11 ' HD3' ' A' ' 12' ' ' LYS . 19.9 t -90.94 127.06 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 O-C-N 123.233 0.333 . . . . 0.0 111.44 -169.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 53.28 23.23 3.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.653 1.581 . . . . 0.0 113.632 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 61.28 6.6 1.41 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.986 1.314 . . . . 0.0 114.196 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.7 mtp-105 -91.22 -40.81 11.33 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.274 0.488 . . . . 0.0 110.436 -176.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.486 ' HZ ' ' HD2' ' A' ' 12' ' ' LYS . 41.2 p90 -151.99 174.04 14.13 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.15 -170.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.523 HG22 HG22 ' A' ' 38' ' ' VAL . 71.9 t -119.88 122.89 69.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -100.03 121.9 42.09 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.0 t -90.24 119.74 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.127 0.971 . . . . 0.0 110.327 -168.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.485 ' HB ' ' HG2' ' A' ' 35' ' ' ARG . 58.1 m -93.86 130.05 40.04 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -97.32 170.39 9.11 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.931 0.769 . . . . 0.0 111.079 176.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.6 p -83.23 141.94 43.4 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 123.301 0.64 . . . . 0.0 110.997 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -55.19 146.57 59.36 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.609 2.873 . . . . 0.0 112.976 174.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.15 -54.96 1.56 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 112.066 -0.414 . . . . 0.0 112.066 -178.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -70.27 -58.14 4.1 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.4 m -134.64 99.37 12.9 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -81.01 -160.73 0.13 Allowed 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 123.062 2.508 . . . . 0.0 112.834 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.11 -34.96 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.846 0.858 . . . . 0.0 111.175 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -68.62 -38.93 80.93 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.356 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.1 126.84 29.34 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 123.723 0.639 . . . . 0.0 112.761 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -64.88 136.89 57.37 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.709 0.804 . . . . 0.0 110.965 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -78.78 175.39 10.52 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.401 0.68 . . . . 0.0 110.719 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.8 169.87 20.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.078 170.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -158.25 158.42 34.43 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.533 0.733 . . . . 0.0 109.35 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -146.54 141.32 26.88 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.951 0.5 . . . . 0.0 109.722 177.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -83.15 128.57 34.61 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.874 0.47 . . . . 0.0 109.897 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 67' ' ' VAL . 22.5 pt -106.5 -29.29 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.342 0.657 . . . . 0.0 110.658 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.79 -71.85 1.6 Allowed Glycine 0 C--N 1.35 1.314 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.4 t -100.18 121.45 41.45 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.278 1.031 . . . . 0.0 110.127 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.506 ' HA ' HD12 ' A' ' 64' ' ' ILE . 39.5 t -66.56 -34.13 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.091 172.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.433 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 24.6 t70 -64.09 -37.11 86.26 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 63.2 m -65.89 -45.39 82.18 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.737 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -52.55 -41.56 63.64 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 123.778 0.674 . . . . 0.0 111.619 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.46 -51.25 53.63 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.488 0.492 . . . . 0.0 110.341 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 68' ' ' ASP . 95.5 mtt180 -55.94 -54.94 38.67 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.211 0.604 . . . . 0.0 111.771 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -71.42 -31.95 67.82 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.521 -175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.84 -44.75 95.3 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.345 0.658 . . . . 0.0 111.858 172.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -63.32 -45.17 92.56 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.267 0.627 . . . . 0.0 112.065 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.473 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 14.8 m -63.57 -50.18 70.47 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.01 0.819 . . . . 0.0 109.361 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.51 HD21 HG22 ' A' ' 24' ' ' VAL . 45.3 tp -54.16 -51.24 64.95 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.298 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -64.72 -39.61 93.94 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.453 0.47 . . . . 0.0 111.232 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 76' ' ' THR . 14.8 pt20 -68.04 -35.76 78.79 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 120.647 0.26 . . . . 0.0 110.549 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 76' ' ' THR . 30.9 mm-40 -74.24 -43.81 55.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.305 0.642 . . . . 0.0 111.047 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.6 mt -70.92 -8.65 54.51 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.74 0.816 . . . . 0.0 112.193 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.15 2.55 87.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.969 -0.351 . . . . 0.0 113.216 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 29' ' ' SER . 76.8 mt -73.03 101.73 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 124.844 1.258 . . . . 0.0 108.961 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -137.5 155.74 48.93 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.281 0.633 . . . . 0.0 111.257 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.23 -118.43 12.91 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 124.114 0.884 . . . . 0.0 113.719 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -20.75 66.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.385 1.074 . . . . 0.0 111.895 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -79.62 -24.77 41.7 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.666 0.386 . . . . 0.0 111.998 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -69.78 118.67 12.92 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.733 0.242 . . . . 0.0 110.773 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.09 126.42 92.4 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.272 0.629 . . . . 0.0 110.117 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.9 143.2 65.57 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.817 2.345 . . . . 0.0 112.575 -177.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.4 t -109.53 122.04 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.748 0.819 . . . . 0.0 109.322 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.471 HG21 ' HD3' ' A' ' 35' ' ' ARG . 23.0 t -114.31 101.77 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.932 0.893 . . . . 0.0 109.61 -174.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -75.62 104.49 6.19 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.088 0.555 . . . . 0.0 110.648 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 51.4 mm -106.62 129.9 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -154.71 65.91 0.67 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.527 0.679 . . . . 0.0 109.451 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.6 -173.17 2.08 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.012 -177.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.0 p -118.38 100.41 7.46 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.21 0.604 . . . . 0.0 109.992 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.52 -24.93 62.05 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.436 0.694 . . . . 0.0 110.9 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.781 -1.011 . . . . 0.0 112.086 179.727 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.452 ' HB3' ' HB3' ' A' ' 6' ' ' HIS . 51.6 mtm . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.73 -119.45 11.12 Favored Glycine 0 C--N 1.355 1.591 0 O-C-N 123.701 0.625 . . . . 0.0 111.877 178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -103.66 -11.62 17.55 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.66 0.784 . . . . 0.0 110.034 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -79.07 117.96 20.6 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.984 0.914 . . . . 0.0 109.732 -177.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 57.62 -93.3 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.299 1.439 . . . . 0.0 112.84 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 30.2 p80 44.73 23.59 0.08 Allowed 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.976 1.71 . . . . 0.0 113.969 -175.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -163.19 104.19 0.98 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.733 0.413 . . . . 0.0 110.082 -171.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -96.84 116.68 29.58 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -74.59 132.35 41.7 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.112 0.565 . . . . 0.0 110.084 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -87.81 -27.41 22.29 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.86 0.864 . . . . 0.0 109.537 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -63.92 137.85 58.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.815 0.846 . . . . 0.0 108.876 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.66 83.36 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.216 1.006 . . . . 0.0 111.283 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 58.01 86.94 0.07 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.183 1.393 . . . . 0.0 111.515 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.7 m -57.89 -29.28 64.94 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.27 0.628 . . . . 0.0 110.741 173.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.64 -176.26 38.97 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.699 170.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.566 ' HB3' HG12 ' A' ' 60' ' ' VAL . 63.7 ttt180 -85.56 121.19 27.9 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -73.53 130.72 40.67 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.9 pt -133.15 175.68 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.509 1.124 . . . . 0.0 109.218 -177.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.9 p -95.92 164.8 12.57 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.72 172.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.518 ' O ' HG23 ' A' ' 24' ' ' VAL . 72.6 t-105 -55.49 -44.42 76.5 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.013 0.925 . . . . 0.0 110.657 174.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -56.07 -47.26 78.3 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.732 0.813 . . . . 0.0 111.129 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.6 -42.02 92.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.05 0.54 . . . . 0.0 110.567 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -51.78 -51.02 59.46 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.665 0.603 . . . . 0.0 111.228 175.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 20' ' ' TRP . 59.9 t -63.75 -61.31 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.238 0.615 . . . . 0.0 111.5 -175.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -71.91 -40.87 68.53 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.034 -168.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -79.82 -43.48 22.32 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.377 0.671 . . . . 0.0 110.915 -175.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -114.08 -65.66 1.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -163.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.4 tp -55.08 -45.14 75.36 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.081 0.952 . . . . 0.0 112.146 -171.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.415 ' HA ' HD11 ' A' ' 83' ' ' ILE . 74.2 p -71.55 -9.18 57.81 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -95.96 -6.47 38.92 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 118.835 -0.603 . . . . 0.0 112.012 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.42 31.25 80.26 Favored Glycine 0 C--N 1.353 1.482 0 C-N-CA 121.433 -0.413 . . . . 0.0 113.687 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.8 -3.46 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.38 0.672 . . . . 0.0 111.728 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.04 130.78 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.492 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 24.8 t70 -88.26 -51.27 5.85 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.967 1.307 . . . . 0.0 110.124 -175.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -152.71 152.33 31.57 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.676 0.79 . . . . 0.0 110.208 -175.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.1 mt -112.0 101.97 10.23 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.43 1.092 . . . . 0.0 109.054 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 43.1 mt-10 -93.49 101.18 13.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.856 -172.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.583 HG22 HG22 ' A' ' 44' ' ' VAL . 49.0 t -81.08 104.94 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -176.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.5 t -95.24 115.48 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 123.055 0.542 . . . . 0.0 110.538 -174.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 53.31 24.04 3.59 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.157 1.783 . . . . 0.0 113.905 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt 67.49 0.77 2.29 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.447 1.499 . . . . 0.0 112.98 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -76.87 -45.26 28.93 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.109 0.963 . . . . 0.0 110.135 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -152.32 175.02 13.1 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.964 -173.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.583 HG22 HG22 ' A' ' 38' ' ' VAL . 86.8 t -124.58 130.57 73.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 125.109 1.364 . . . . 0.0 107.846 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.625 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 68.4 ttt180 -97.9 116.91 31.07 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.732 1.213 . . . . 0.0 108.48 -177.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.514 ' HB ' HG23 ' A' ' 60' ' ' VAL . 46.7 t -85.11 106.7 15.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.7 m -103.17 135.86 44.03 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -97.0 148.08 23.34 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.88 0.738 . . . . 0.0 111.96 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.492 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 57.7 p -62.32 133.1 94.32 Favored Pre-proline 0 C--N 1.349 0.557 0 C-N-CA 124.56 1.144 . . . . 0.0 111.26 -176.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.725 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 12.3 Cg_exo -73.64 35.93 0.38 Allowed 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 123.815 3.01 . . . . 0.0 113.385 171.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.78 -46.2 0.04 OUTLIER Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 -173.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.51 -67.71 0.76 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.8 t -139.13 75.38 34.6 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 123.603 0.761 . . . . 0.0 110.109 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.725 ' HB3' ' HA ' ' A' ' 50' ' ' PRO . 15.1 Cg_endo -62.09 -81.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.242 1.961 . . . . 0.0 112.618 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.9 t -81.45 -29.34 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.182 0.593 . . . . 0.0 109.814 -173.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -64.38 -23.22 67.21 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.391 0.676 . . . . 0.0 110.925 170.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.35 97.67 0.1 OUTLIER Glycine 0 C--N 1.352 1.468 0 O-C-N 123.86 0.725 . . . . 0.0 112.188 176.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -65.06 92.63 0.11 Allowed 'General case' 0 C--N 1.347 0.498 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -59.81 115.73 3.59 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.243 -172.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.566 HG12 ' HB3' ' A' ' 16' ' ' ARG . 10.6 m -119.53 170.04 9.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.505 -175.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -156.18 161.52 40.3 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.166 0.586 . . . . 0.0 109.532 176.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -147.26 145.15 29.31 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.92 154.53 31.57 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 67' ' ' VAL . 31.9 pt -128.82 -46.37 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 122.937 0.495 . . . . 0.0 110.441 174.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.45 -72.15 0.47 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -168.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.9 t -78.57 104.51 9.23 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 124.456 1.102 . . . . 0.0 110.638 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.485 ' HA ' HD12 ' A' ' 64' ' ' ILE . 26.4 t -66.95 -31.7 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.068 173.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.45 -42.91 98.63 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.238 0.615 . . . . 0.0 110.597 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 80.4 m -62.86 -48.47 78.87 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -51.73 -52.43 48.57 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 124.475 1.11 . . . . 0.0 112.046 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -66.24 -42.38 88.67 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.306 0.379 . . . . 0.0 111.301 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -66.18 -49.87 65.84 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.829 0.452 . . . . 0.0 112.064 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -71.14 -32.5 69.03 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 119.206 -0.426 . . . . 0.0 110.828 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.1 tp -59.78 -48.16 82.81 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.89 0.876 . . . . 0.0 111.135 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -65.0 -42.89 94.08 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.261 0.624 . . . . 0.0 112.139 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.7 m -59.77 -49.51 77.46 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 122.013 0.911 . . . . 0.0 109.693 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.407 HD21 HG22 ' A' ' 24' ' ' VAL . 32.9 tp -58.96 -42.73 90.58 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 112.914 -1.948 . . . . 0.0 112.614 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -65.77 -37.11 85.44 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.242 0.617 . . . . 0.0 111.051 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -69.85 -35.28 74.58 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.108 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.31 -52.54 22.04 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.565 1.146 . . . . 0.0 110.996 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.5 mt -73.02 -19.77 61.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.183 0.993 . . . . 0.0 111.222 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 7.39 70.38 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-O 119.723 -0.487 . . . . 0.0 113.2 -175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.415 HD11 ' HA ' ' A' ' 29' ' ' SER . 71.3 mt -67.77 92.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.157 0.983 . . . . 0.0 109.033 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -137.97 148.12 44.91 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.716 0.807 . . . . 0.0 110.147 -171.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.78 -102.83 0.74 Allowed Glycine 0 C--N 1.351 1.365 0 O-C-N 124.508 1.13 . . . . 0.0 112.992 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.52 -30.42 57.17 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.746 0.818 . . . . 0.0 110.72 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -72.05 -21.09 61.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.082 0.553 . . . . 0.0 111.379 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -62.01 142.6 57.4 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.231 0.613 . . . . 0.0 111.751 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.4 t -107.55 106.37 58.26 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -58.6 143.86 97.99 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 124.047 3.164 . . . . 0.0 113.258 -175.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.7 t -98.87 119.4 46.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 54.2 t -110.95 121.39 63.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -87.51 127.2 35.24 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.8 mm -124.43 129.24 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.289 1.436 . . . . 0.0 107.791 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.56 145.23 47.54 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.028 0.531 . . . . 0.0 110.108 175.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -108.57 8.43 27.15 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.494 1.118 . . . . 0.0 110.141 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.4 m -83.74 10.0 10.46 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.853 0.861 . . . . 0.0 113.043 -168.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -153.05 -49.65 0.1 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.189 0.996 . . . . 0.0 108.705 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.516 179.557 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 110.887 -0.042 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.98 154.5 22.07 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 112.083 -0.407 . . . . 0.0 112.083 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -105.46 72.79 0.99 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -164.76 34.4 0.07 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.286 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -62.55 -38.38 89.82 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.771 0.828 . . . . 0.0 111.75 -176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -149.45 147.34 28.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.395 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -78.18 68.42 4.21 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.336 1.054 . . . . 0.0 109.556 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 40.88 -83.36 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 126.429 1.892 . . . . 0.0 113.962 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.2 t -145.57 -176.28 5.06 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.431 1.092 . . . . 0.0 109.047 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -161.32 93.89 0.96 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.974 0.51 . . . . 0.0 110.778 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.4 tpt -89.84 -34.6 16.06 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -68.44 163.73 22.64 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.943 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -68.94 81.85 0.31 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.177 1.391 . . . . 0.0 109.686 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.6 p -97.45 140.01 32.54 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.5 1.12 . . . . 0.0 109.396 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.98 151.61 22.3 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.261 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.53 ' HB3' HG12 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -87.28 119.7 27.8 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -177.334 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.94 107.2 6.02 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 48.2 pt -99.72 176.66 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.943 0.897 . . . . 0.0 109.967 173.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.3 p -104.78 171.6 7.24 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.383 171.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -57.78 -38.88 76.22 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.504 0.722 . . . . 0.0 110.381 171.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -55.45 -48.79 73.94 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.747 0.819 . . . . 0.0 111.211 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.576 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 50.8 m-20 -64.66 -45.15 87.96 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.77 0.428 . . . . 0.0 111.924 176.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.433 ' CZ ' HD11 ' A' ' 36' ' ' LEU . 10.1 t80 -49.39 -57.35 7.09 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.121 0.888 . . . . 0.0 110.228 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.409 HG22 HD21 ' A' ' 77' ' ' LEU . 96.6 t -66.13 -56.41 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 123.89 0.744 . . . . 0.0 111.859 -174.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -76.32 -48.87 18.54 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -168.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -76.49 -39.62 52.62 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.265 0.626 . . . . 0.0 111.528 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -108.91 -65.54 1.13 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -165.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.4 tp -58.07 -44.45 87.51 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.88 0.872 . . . . 0.0 111.86 -173.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.1 t -57.47 -30.23 64.88 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.201 1.0 . . . . 0.0 112.455 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -91.81 0.97 57.46 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.979 0.912 . . . . 0.0 110.887 -176.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.46 25.41 62.93 Favored Glycine 0 C--N 1.351 1.409 0 N-CA-C 114.444 0.537 . . . . 0.0 114.444 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.413 HG12 ' HD3' ' A' ' 52' ' ' LYS . 18.9 m -85.91 -2.02 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 117.257 0.529 . . . . 0.0 110.617 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.5 t -93.77 122.22 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.908 0.883 . . . . 0.0 109.431 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 17.8 t70 -82.25 -52.44 6.94 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.208 1.003 . . . . 0.0 109.625 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -155.13 166.19 34.35 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.57 0.748 . . . . 0.0 110.687 -173.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.433 HD11 ' CZ ' ' A' ' 23' ' ' PHE . 84.4 mt -119.15 107.25 13.24 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.949 0.9 . . . . 0.0 110.432 175.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 40.4 mt-10 -94.27 101.75 13.73 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.335 0.654 . . . . 0.0 110.257 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 41' ' ' LYS . 23.4 t -82.58 89.91 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.42 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 95.4 t -73.94 116.77 16.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.289 1.035 . . . . 0.0 110.946 -169.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 95' ' ' ALA . 3.4 m-20 55.8 21.4 4.73 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.604 1.162 . . . . 0.0 112.397 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.516 ' HA ' HG12 ' A' ' 38' ' ' VAL . 91.7 mttt 61.98 2.18 0.75 Allowed 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.845 1.658 . . . . 0.0 114.143 -173.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -80.06 -39.96 28.67 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.87 0.868 . . . . 0.0 110.766 -173.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -153.56 166.54 32.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.042 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 53.0 t -120.16 130.91 73.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -175.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.41 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 34.4 ttm180 -91.01 127.93 36.63 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 175.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.511 ' HB ' HG23 ' A' ' 60' ' ' VAL . 44.9 t -83.42 105.45 13.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 165.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.9 m -94.59 130.18 41.14 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 53' ' ' THR . 84.6 m-85 -87.76 156.88 19.21 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.018 0.824 . . . . 0.0 111.095 -175.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.479 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 64.4 p -63.04 141.5 97.7 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.361 174.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -51.31 -40.84 61.0 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.97 3.114 . . . . 0.0 114.871 -163.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.55 -17.48 73.25 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.518 -0.31 . . . . 0.0 113.497 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HD3' HG12 ' A' ' 32' ' ' VAL . 65.0 mttm -105.98 0.58 25.85 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.515 0.726 . . . . 0.0 111.525 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.412 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 100.0 m -66.73 126.86 93.01 Favored Pre-proline 0 C--N 1.354 0.782 0 CA-C-O 118.974 -0.536 . . . . 0.0 110.401 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -63.39 89.04 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 121.845 1.696 . . . . 0.0 109.122 165.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.84 -9.58 9.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.778 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.285 -175.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -57.83 -23.72 54.06 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.208 1.003 . . . . 0.0 111.08 170.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 128.41 -33.29 3.18 Favored Glycine 0 C--N 1.357 1.739 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.859 170.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -84.14 100.44 11.14 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.283 0.633 . . . . 0.0 111.049 -166.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -75.65 175.48 8.58 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.225 165.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.53 HG12 ' HB3' ' A' ' 16' ' ' ARG . 35.7 m -110.94 152.69 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -153.64 156.57 38.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.85 0.46 . . . . 0.0 110.678 -174.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -139.8 139.94 36.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.322 0.649 . . . . 0.0 109.294 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -81.3 144.02 31.82 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.417 0.687 . . . . 0.0 110.045 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 67' ' ' VAL . 37.4 pt -120.46 140.18 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.519 0.728 . . . . 0.0 109.516 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.49 -46.13 26.77 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 177.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.8 m -132.09 138.44 48.13 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.694 0.798 . . . . 0.0 109.439 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.505 ' HA ' HD12 ' A' ' 64' ' ' ILE . 34.4 t -63.03 -41.4 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.287 0.635 . . . . 0.0 110.967 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.87 -39.69 92.76 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.939 0.495 . . . . 0.0 111.079 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.6 m -63.03 -45.86 90.31 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.864 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -53.46 -47.69 69.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.789 0.836 . . . . 0.0 111.291 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 52.1 mt-10 -63.35 -47.67 81.17 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.73 0.644 . . . . 0.0 110.901 -178.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.1 mtp-105 -61.24 -44.63 96.95 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.227 0.611 . . . . 0.0 111.082 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -63.65 -46.78 84.05 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.552 0.741 . . . . 0.0 110.741 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.23 -48.93 79.21 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.143 0.977 . . . . 0.0 111.655 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 23.0 mm-40 -61.96 -48.37 80.66 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.117 0.567 . . . . 0.0 110.956 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 96.1 m -57.24 -55.43 34.88 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.502 0.721 . . . . 0.0 110.35 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.409 HD21 HG22 ' A' ' 24' ' ' VAL . 66.4 tp -44.71 -51.24 9.46 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.18 1.792 . . . . 0.0 112.686 174.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -64.71 -41.59 95.88 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.014 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 13.9 mm100 -64.04 -38.65 91.85 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.485 0.314 . . . . 0.0 110.567 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 76' ' ' THR . 21.1 mm-40 -60.48 -39.81 89.0 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.83 0.852 . . . . 0.0 111.07 175.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.9 mt -84.1 -8.49 59.09 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.721 0.808 . . . . 0.0 112.097 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.45 6.25 89.36 Favored Glycine 0 C--N 1.353 1.474 0 C-N-CA 122.894 0.283 . . . . 0.0 113.392 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.527 HG22 ' HA ' ' A' ' 88' ' ' ARG . 69.5 mt -76.26 108.66 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 124.987 1.315 . . . . 0.0 109.555 177.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.25 177.29 10.38 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.62 0.768 . . . . 0.0 110.658 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.04 -125.15 29.6 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.662 0.601 . . . . 0.0 113.621 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -85.76 -8.12 58.34 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.354 0.662 . . . . 0.0 111.096 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -88.41 -12.94 41.77 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.339 0.655 . . . . 0.0 110.865 -178.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.527 ' HA ' HG22 ' A' ' 83' ' ' ILE . 12.1 ptp85 -63.69 147.52 51.4 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 117.507 0.14 . . . . 0.0 110.681 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.402 HG11 ' HG ' ' A' ' 36' ' ' LEU . 40.2 t -66.39 116.51 34.58 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -175.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 32.3 Cg_exo -59.56 117.34 4.07 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.576 2.851 . . . . 0.0 111.248 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.9 t -102.63 125.45 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.65 95.73 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -76.85 100.45 5.52 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 56.4 mt -95.05 142.9 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.833 0.853 . . . . 0.0 109.51 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 40' ' ' ASN . . . -144.73 79.43 1.6 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.745 0.818 . . . . 0.0 109.306 175.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -83.86 154.8 23.26 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.126 0.57 . . . . 0.0 111.201 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.9 t -73.53 -22.98 59.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.092 0.557 . . . . 0.0 110.034 174.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.0 t70 65.72 -75.61 0.05 OUTLIER 'General case' 0 C--N 1.355 0.83 0 C-N-CA 125.815 1.646 . . . . 0.0 111.053 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 172.41 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.733 0.301 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.18 -153.84 21.25 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -175.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -73.96 103.14 4.35 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.881 0.472 . . . . 0.0 110.332 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -75.08 134.6 41.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.777 0.831 . . . . 0.0 108.95 173.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -63.77 81.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.614 0.766 . . . . 0.0 111.833 -176.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.3 t60 169.37 128.8 0.02 OUTLIER 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.386 1.874 . . . . 0.0 107.267 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -76.15 127.01 32.05 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -61.87 129.54 41.42 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.499 1.12 . . . . 0.0 110.97 -178.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.6 m -75.03 97.83 3.49 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.533 0.733 . . . . 0.0 110.687 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -97.11 98.05 9.72 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 56.3 ttm -151.61 -59.54 0.16 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.813 0.339 . . . . 0.0 111.346 -170.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 57.2 tttp -88.01 77.22 8.46 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.495 0.718 . . . . 0.0 110.918 -172.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 27.7 ttt180 148.05 38.87 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.618 0 C-N-CA 127.828 2.451 . . . . 0.0 108.538 168.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 95.2 p 51.93 38.32 23.32 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.237 1.415 . . . . 0.0 112.135 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.93 -150.61 21.63 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.528 -174.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.519 ' HB2' HG12 ' A' ' 60' ' ' VAL . 18.9 mmm180 -100.94 135.52 42.25 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.488 0.715 . . . . 0.0 111.164 -173.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -89.68 116.54 27.89 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 169.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.3 pt -105.92 -177.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.663 0.785 . . . . 0.0 109.679 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.0 p -97.55 165.71 11.85 Favored 'General case' 0 C--O 1.248 0.999 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 169.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.496 ' O ' HG23 ' A' ' 24' ' ' VAL . 73.6 t-105 -55.84 -40.81 73.36 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.58 0.55 . . . . 0.0 110.388 171.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -53.4 -53.78 46.35 Favored 'General case' 0 C--O 1.256 1.447 0 C-N-CA 124.017 0.927 . . . . 0.0 111.881 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -51.88 -54.42 29.44 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 124.318 1.011 . . . . 0.0 109.195 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -51.89 -45.32 64.11 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 124.983 1.427 . . . . 0.0 111.745 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 20' ' ' TRP . 72.4 t -55.56 -63.16 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 O-C-N 123.551 0.532 . . . . 0.0 111.31 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -67.37 -42.03 84.12 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.923 0.764 . . . . 0.0 112.757 -167.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -94.62 -21.45 18.8 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -173.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.453 ' HE2' HG21 ' A' ' 60' ' ' VAL . 22.8 m-85 -122.19 -67.47 0.96 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.778 0.717 . . . . 0.0 112.618 -169.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.4 tp -59.46 -48.2 82.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.612 0.765 . . . . 0.0 111.597 -173.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.3 p -64.86 -20.64 66.52 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -102.74 -2.48 28.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.949 0.5 . . . . 0.0 110.995 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.61 33.88 42.17 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 115.424 0.93 . . . . 0.0 115.424 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.7 m -81.87 -3.57 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 122.934 0.493 . . . . 0.0 111.297 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.42 135.76 30.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 123.972 0.909 . . . . 0.0 108.792 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.09 -49.51 7.73 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.801 0.84 . . . . 0.0 110.323 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -153.83 149.17 27.11 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.765 0.826 . . . . 0.0 111.095 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.5 mt -118.39 103.22 9.58 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.908 1.283 . . . . 0.0 108.01 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.606 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 37.8 mt-10 -99.15 109.59 22.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.066 -171.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 44' ' ' VAL . 57.3 t -83.42 98.6 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.5 t -92.62 120.99 42.87 Favored 'Isoleucine or valine' 0 C--O 1.251 1.176 0 C-N-CA 123.204 0.602 . . . . 0.0 109.779 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 59.47 18.37 6.84 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.084 1.354 . . . . 0.0 113.437 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 60.4 6.69 1.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.686 1.194 . . . . 0.0 112.94 -173.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -87.71 -48.82 7.56 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.609 1.164 . . . . 0.0 110.215 -173.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -146.21 170.14 17.33 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.416 -172.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 38' ' ' VAL . 95.6 t -121.26 123.54 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.86 0.864 . . . . 0.0 109.561 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.606 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 7.9 tpm_? -83.37 109.48 17.33 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.312 1.445 . . . . 0.0 107.458 177.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.06 107.44 16.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.4 m -107.79 127.73 53.96 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.504 ' H ' ' HE1' ' A' ' 59' ' ' TYR . 99.7 m-85 -100.61 169.55 8.97 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.269 1.028 . . . . 0.0 111.991 -171.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.1 p -87.83 132.29 40.7 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.17 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.19 -18.63 30.55 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.38 2.72 . . . . 0.0 114.479 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.96 -43.85 90.28 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.371 0.42 . . . . 0.0 112.661 176.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -85.36 -65.0 1.06 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.1 0.56 . . . . 0.0 110.146 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 38.5 p -80.43 138.78 51.59 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.236 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 53' ' ' THR . 5.2 Cg_exo -73.76 -151.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 123.29 2.66 . . . . 0.0 111.853 173.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.3 m -56.92 -23.06 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -173.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -143.3 -48.78 0.31 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.206 0.602 . . . . 0.0 109.687 170.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.95 -91.77 0.07 OUTLIER Glycine 0 C--N 1.353 1.525 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -171.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -163.32 84.26 0.49 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.154 0.982 . . . . 0.0 109.899 169.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.504 ' HE1' ' H ' ' A' ' 48' ' ' PHE . 60.2 m-85 -67.52 114.81 6.48 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 170.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.519 HG12 ' HB2' ' A' ' 16' ' ' ARG . 28.7 m -111.15 172.48 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.666 -174.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -160.45 164.87 31.92 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.048 0.939 . . . . 0.0 108.948 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -152.53 143.65 23.13 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.551 0.34 . . . . 0.0 110.357 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -89.09 123.67 33.59 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 67' ' ' VAL . 32.1 pt -95.44 -40.95 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.777 -171.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.94 -75.31 0.24 Allowed Glycine 0 C--N 1.35 1.307 0 O-C-N 123.424 0.452 . . . . 0.0 112.264 -172.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.1 m -82.06 99.22 9.05 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.498 ' HA ' HD12 ' A' ' 64' ' ' ILE . 60.3 t -54.7 -39.59 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.379 1.072 . . . . 0.0 110.887 171.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 18.9 t70 -54.34 -55.93 23.63 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 123.97 0.908 . . . . 0.0 110.73 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.4 m -59.82 -42.81 94.33 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 124.087 0.867 . . . . 0.0 111.506 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -50.84 -50.09 57.49 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 123.409 0.684 . . . . 0.0 111.488 172.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 47.0 mt-10 -68.58 -47.23 67.32 Favored 'General case' 0 C--O 1.217 -0.639 0 O-C-N 123.97 0.794 . . . . 0.0 111.243 -177.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 24.3 mmm180 -53.55 -48.6 68.98 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.454 0.701 . . . . 0.0 110.458 -178.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.21 -53.42 37.46 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.601 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.13 -53.31 58.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.69 0.796 . . . . 0.0 112.117 -174.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -61.64 -51.19 69.51 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.492 0.717 . . . . 0.0 112.028 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.414 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 94.1 m -63.11 -47.4 82.96 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.781 0.676 . . . . 0.0 110.619 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.475 HD21 HG13 ' A' ' 24' ' ' VAL . 35.4 tp -56.82 -45.61 82.16 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.73 1.212 . . . . 0.0 112.913 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -66.44 -34.83 78.83 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.385 0.428 . . . . 0.0 110.284 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -66.36 -38.35 87.39 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.632 0.373 . . . . 0.0 111.347 173.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 76' ' ' THR . 49.9 mt-10 -69.5 -36.99 76.99 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.909 0.884 . . . . 0.0 111.0 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.78 -19.38 59.03 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.017 0.927 . . . . 0.0 111.641 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.85 6.03 70.34 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.862 -0.41 . . . . 0.0 113.494 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.5 mt -71.27 109.98 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 124.511 1.124 . . . . 0.0 109.403 176.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -124.35 144.09 50.21 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.369 0.668 . . . . 0.0 111.507 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.83 -115.0 5.0 Favored Glycine 0 C--N 1.354 1.549 0 O-C-N 124.897 1.373 . . . . 0.0 114.831 169.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -64.61 -26.43 68.39 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.17 0.988 . . . . 0.0 112.067 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -79.71 -20.3 46.82 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.24 0.216 . . . . 0.0 110.988 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -64.86 139.59 58.78 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 174.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 t -75.9 114.84 40.87 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 124.03 0.831 . . . . 0.0 109.243 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.87 140.3 94.58 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.465 2.777 . . . . 0.0 113.252 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.8 t -105.97 112.52 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.432 ' HB ' ' HG2' ' A' ' 37' ' ' GLU . 63.0 t -110.78 97.13 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 123.821 0.849 . . . . 0.0 109.656 -171.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -70.61 103.11 2.43 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.551 0.34 . . . . 0.0 110.276 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 63.1 mt -98.77 131.02 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.38 95.1 4.41 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -137.68 113.21 9.48 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.44 0.696 . . . . 0.0 110.448 -174.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.6 m -69.17 151.37 46.43 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.213 0.605 . . . . 0.0 110.774 173.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -75.86 88.36 2.87 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.976 0.51 . . . . 0.0 110.011 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.927 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.098 175.388 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.4 mtm . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.759 0.314 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.01 -86.67 0.74 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -171.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 58.65 25.95 13.92 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.836 1.254 . . . . 0.0 112.257 173.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -130.54 101.72 5.83 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -81.45 -79.12 0.17 Allowed 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -163.15 -23.38 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.491 0.716 . . . . 0.0 111.736 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -64.75 -33.96 77.2 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.655 0.782 . . . . 0.0 111.077 -172.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 26.4 m170 67.8 18.72 9.7 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.885 1.274 . . . . 0.0 112.072 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.8 p -74.46 84.83 2.0 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.572 0.701 . . . . 0.0 110.427 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -131.68 -156.09 0.73 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.114 0.965 . . . . 0.0 108.963 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.6 ttt -54.07 130.32 37.6 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.335 0.654 . . . . 0.0 111.53 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -129.06 33.83 4.53 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.278 1.031 . . . . 0.0 109.426 -177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 58.95 91.62 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.403 1.081 . . . . 0.0 110.533 -175.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.5 t -77.49 121.81 24.36 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -115.87 150.1 18.7 Favored Glycine 0 N--CA 1.471 0.986 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -140.51 128.12 21.56 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.391 0.676 . . . . 0.0 109.729 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.34 141.24 35.61 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.7 pt -137.38 -175.44 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.237 1.415 . . . . 0.0 108.14 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.4 p -105.44 165.36 11.18 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.63 0.372 . . . . 0.0 110.209 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.468 ' O ' HG23 ' A' ' 24' ' ' VAL . 70.8 t-105 -56.43 -37.54 70.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.61 0.764 . . . . 0.0 109.879 169.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.18 -46.04 83.18 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 123.799 0.84 . . . . 0.0 112.217 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -61.31 -46.13 91.59 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.684 0.393 . . . . 0.0 110.895 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.401 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 35.6 t80 -54.29 -55.55 27.14 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 124.184 0.927 . . . . 0.0 111.256 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 20' ' ' TRP . 94.2 t -57.19 -62.69 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.299 0.639 . . . . 0.0 111.73 -176.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -67.38 -54.39 20.87 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.573 -170.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -87.64 -14.79 39.06 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.441 0.696 . . . . 0.0 112.649 -165.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.401 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 91.1 m-85 -124.8 -67.12 0.93 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 118.397 0.544 . . . . 0.0 112.003 -174.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.4 tp -60.68 -47.98 83.85 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.749 0.819 . . . . 0.0 111.733 -172.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.9 m -68.96 -16.67 63.8 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.615 0.766 . . . . 0.0 112.807 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -93.56 -5.49 48.83 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.011 0.524 . . . . 0.0 111.512 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.18 33.94 82.1 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 123.572 0.545 . . . . 0.0 114.142 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.469 HG12 ' HD3' ' A' ' 52' ' ' LYS . 18.5 m -93.23 1.66 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 122.551 0.34 . . . . 0.0 111.071 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 t -96.67 126.68 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 120.688 0.28 . . . . 0.0 110.278 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 23.4 t70 -88.45 -50.36 6.36 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.347 1.059 . . . . 0.0 109.43 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -155.01 162.72 41.0 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.794 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.4 mt -117.08 103.32 10.11 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.457 0.703 . . . . 0.0 109.648 174.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -87.39 100.74 12.96 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.511 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.2 t -93.1 92.64 3.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -172.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.421 HG22 ' HB ' ' A' ' 94' ' ' ILE . 60.7 t -83.6 132.23 31.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.566 -175.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 66.19 11.12 7.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.895 1.278 . . . . 0.0 112.392 172.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.481 ' HB3' HG21 ' A' ' 67' ' ' VAL . 62.0 mttm 58.47 6.14 0.53 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.478 1.111 . . . . 0.0 112.55 -168.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -94.52 -38.11 11.06 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.7 1.2 . . . . 0.0 110.234 -168.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -148.4 151.85 35.98 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.237 -176.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.91 126.43 68.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.257 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -101.84 123.22 45.41 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.452 ' HB ' HG23 ' A' ' 60' ' ' VAL . 46.5 t -83.78 111.2 19.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.526 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.0 m -91.91 135.48 33.9 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.54 ' HE1' ' HA ' ' A' ' 59' ' ' TYR . 75.9 m-85 -85.49 148.46 25.96 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.308 0.38 . . . . 0.0 110.159 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.594 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 27.5 p -65.15 135.0 96.06 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.13 0.572 . . . . 0.0 111.055 176.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.31 95.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 123.706 2.937 . . . . 0.0 112.63 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.06 -47.37 0.92 Allowed Glycine 0 C--N 1.344 1.024 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.469 ' HD3' HG12 ' A' ' 32' ' ' VAL . 92.3 mttt -82.74 -6.19 59.28 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.454 0.702 . . . . 0.0 110.159 171.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.516 HG22 ' HB2' ' A' ' 48' ' ' PHE . 9.2 p -60.66 109.21 1.86 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.882 0.873 . . . . 0.0 109.573 167.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.1 166.49 18.64 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.803 2.335 . . . . 0.0 112.995 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.0 m -64.86 -16.33 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.321 0.648 . . . . 0.0 112.161 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.66 -42.71 93.45 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.78 0.832 . . . . 0.0 110.714 175.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.88 -1.43 68.33 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.089 -176.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -77.38 163.08 26.73 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.53 0.732 . . . . 0.0 111.154 -176.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.54 ' HA ' ' HE1' ' A' ' 48' ' ' PHE . 97.5 m-85 -129.27 153.51 47.73 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.641 177.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.452 HG23 ' HB ' ' A' ' 46' ' ' VAL . 19.1 m -109.56 159.16 9.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.504 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -159.44 164.5 34.48 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.836 0.855 . . . . 0.0 108.975 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -148.73 141.11 24.19 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -88.35 132.5 34.4 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 67' ' ' VAL . 24.3 pt -104.36 139.8 24.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 123.788 0.835 . . . . 0.0 109.808 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.22 -41.94 44.75 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.824 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.4 t -132.17 132.17 42.93 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.937 0.895 . . . . 0.0 110.393 177.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.481 HG21 ' HB3' ' A' ' 41' ' ' LYS . 38.6 t -63.6 -35.49 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.467 0.707 . . . . 0.0 110.745 172.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -57.81 -50.26 73.86 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.767 0.827 . . . . 0.0 110.724 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.1 m -61.69 -45.82 92.34 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 124.167 0.917 . . . . 0.0 111.027 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -54.0 -51.25 64.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.197 0.599 . . . . 0.0 111.023 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -64.77 -51.13 63.91 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.577 0.751 . . . . 0.0 112.451 -174.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -66.74 -36.4 82.37 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.116 0.26 . . . . 0.0 111.054 -175.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -69.25 -42.53 75.49 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.426 ' HG ' ' NE2' ' A' ' 78' ' ' GLN . 29.9 tp -59.76 -53.19 60.88 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 123.593 0.558 . . . . 0.0 111.232 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -62.96 -41.84 99.64 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.046 0.539 . . . . 0.0 111.807 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.6 m -66.97 -54.95 16.85 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.387 0.675 . . . . 0.0 111.05 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.8 tp -52.0 -41.17 61.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.142 1.377 . . . . 0.0 112.651 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.426 ' NE2' ' HG ' ' A' ' 74' ' ' LEU . 44.8 mt-30 -64.01 -42.95 96.97 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.4 0.28 . . . . 0.0 110.487 175.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -63.37 -32.13 73.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.756 0.423 . . . . 0.0 111.782 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -64.42 -38.32 90.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.12 0.568 . . . . 0.0 110.32 173.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.4 mt -78.36 -13.97 59.61 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.518 0.727 . . . . 0.0 111.324 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.35 21.35 58.7 Favored Glycine 0 C--N 1.355 1.606 0 C-N-CA 122.88 0.276 . . . . 0.0 113.126 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.1 mt -94.06 131.62 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 125.467 1.507 . . . . 0.0 110.179 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -166.63 160.83 15.4 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.026 0.93 . . . . 0.0 109.737 175.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.93 -92.65 0.01 OUTLIER Glycine 0 C--N 1.347 1.149 0 O-C-N 123.919 0.762 . . . . 0.0 114.688 173.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -69.8 -46.44 65.7 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.37 1.068 . . . . 0.0 110.638 -172.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -92.48 -4.9 52.91 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.374 -174.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -70.39 128.28 35.66 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.153 0.581 . . . . 0.0 109.87 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.84 113.67 13.03 Favored Pre-proline 0 CA--C 1.55 0.977 0 O-C-N 124.049 0.843 . . . . 0.0 111.081 -170.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 74.9 Cg_exo -54.48 122.67 11.96 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.482 2.788 . . . . 0.0 112.666 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.7 121.43 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.8 t -118.69 97.47 5.34 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -71.61 117.87 13.73 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.421 ' HB ' HG22 ' A' ' 39' ' ' VAL . 54.9 mt -108.76 142.48 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.05 142.31 27.88 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -156.69 156.32 33.21 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.0 m 58.05 29.55 17.94 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.739 0.78 . . . . 0.0 110.161 -175.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -88.44 99.23 12.12 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.463 -176.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.156 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.879 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.571 ' SD ' ' HB3' ' A' ' 97' ' ' SER . 21.9 ptt? . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -98.93 134.38 11.66 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 167.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -68.32 144.74 54.7 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.401 0.681 . . . . 0.0 109.377 173.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -60.74 94.6 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.716 0.806 . . . . 0.0 110.327 177.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -77.57 87.62 3.89 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.019 0.914 . . . . 0.0 110.422 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -68.13 -45.05 74.68 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 172.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -138.43 153.35 48.87 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.878 1.271 . . . . 0.0 108.396 170.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -80.23 75.14 7.04 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 172.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.7 p -62.53 -43.79 97.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.396 0.678 . . . . 0.0 111.111 -173.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -171.88 165.98 6.4 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.465 1.106 . . . . 0.0 108.696 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.1 ttt -52.18 141.62 18.39 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.53 0.732 . . . . 0.0 110.412 171.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.12 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.157 1.383 . . . . 0.0 112.179 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -151.1 71.74 1.03 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.867 1.267 . . . . 0.0 107.835 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.7 t -76.33 89.97 3.18 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.79 178.24 30.81 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.28 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.644 ' HB2' HG12 ' A' ' 60' ' ' VAL . 51.6 mmm-85 -81.15 114.18 19.81 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -75.24 108.21 7.85 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 50.0 pt -105.49 -178.13 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 124.936 1.295 . . . . 0.0 108.804 173.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.4 p -98.85 168.6 10.02 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 123.186 0.594 . . . . 0.0 109.506 167.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.492 ' O ' HG23 ' A' ' 24' ' ' VAL . 44.8 t-105 -53.74 -42.74 68.46 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.563 0.745 . . . . 0.0 110.336 171.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -60.33 -43.47 96.37 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.007 0.523 . . . . 0.0 112.34 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.533 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 63.1 m-20 -64.5 -35.12 79.91 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.51 0.324 . . . . 0.0 110.845 177.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.561 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 35.8 t80 -57.67 -51.93 67.51 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 123.905 0.753 . . . . 0.0 110.839 174.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.527 HG13 HD21 ' A' ' 77' ' ' LEU . 90.4 t -54.75 -62.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.047 0.939 . . . . 0.0 112.136 -176.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -73.25 -49.27 28.7 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -83.06 -18.91 37.99 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -170.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.561 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 60.0 m-85 -128.12 -64.93 0.93 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.075 0.852 . . . . 0.0 112.994 -170.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -60.84 -46.25 91.32 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.312 0.645 . . . . 0.0 111.787 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.1 t -58.56 -27.77 64.9 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.581 1.152 . . . . 0.0 112.929 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -87.51 -17.63 31.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.957 0.503 . . . . 0.0 110.739 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.35 32.59 84.13 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 123.804 0.69 . . . . 0.0 113.897 -172.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.8 m -80.7 -0.88 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.3 t -100.5 132.16 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.694 0.798 . . . . 0.0 110.117 -170.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -83.28 -52.69 6.34 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.206 1.002 . . . . 0.0 109.967 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.417 HH21 HG21 ' A' ' 92' ' ' VAL . 1.1 ptm180 -154.67 156.81 37.11 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.657 0.783 . . . . 0.0 109.74 -175.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.3 mt -112.28 102.87 11.0 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -92.5 101.88 14.33 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.984 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 38.7 t -83.88 96.23 4.21 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -175.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.23 118.63 25.66 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.639 -173.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.525 HD21 ' HB3' ' A' ' 98' ' ' ASP . 2.6 t-20 58.74 18.38 5.93 Favored 'General case' 0 CA--C 1.559 1.298 0 O-C-N 124.944 1.402 . . . . 0.0 112.587 172.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.411 ' HA ' HG12 ' A' ' 38' ' ' VAL . 33.4 mtmm 58.66 2.23 0.22 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.388 1.475 . . . . 0.0 114.33 -171.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -82.05 -33.85 29.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.371 0.668 . . . . 0.0 109.803 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -154.36 163.81 39.58 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.767 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 57.9 t -111.74 129.28 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -103.84 128.07 51.31 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.88 106.98 17.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.397 -1.274 . . . . 0.0 107.656 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.4 m -96.71 125.53 41.23 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.442 ' HB2' HG22 ' A' ' 53' ' ' THR . 98.2 m-85 -94.44 170.38 9.53 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.027 0.829 . . . . 0.0 110.994 -173.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.6 p -82.49 145.25 50.98 Favored Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 168.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.06 -34.73 69.29 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.384 2.723 . . . . 0.0 113.621 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.57 -18.19 69.05 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.654 0.596 . . . . 0.0 113.834 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -118.17 17.01 14.06 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.519 0.728 . . . . 0.0 112.408 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.442 HG22 ' HB2' ' A' ' 48' ' ' PHE . 20.5 p -65.51 137.54 96.55 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.65 170.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.97 154.18 22.78 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 122.987 2.458 . . . . 0.0 111.358 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.5 p -56.18 -27.34 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 124.255 1.022 . . . . 0.0 112.73 -171.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.7 -13.63 61.53 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.016 0.927 . . . . 0.0 112.9 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.67 33.55 71.67 Favored Glycine 0 C--N 1.346 1.13 0 O-C-N 123.656 0.597 . . . . 0.0 112.254 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -123.29 -174.73 3.02 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.798 0.839 . . . . 0.0 110.669 -175.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -112.71 174.02 6.1 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.202 1.001 . . . . 0.0 109.491 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.644 HG12 ' HB2' ' A' ' 16' ' ' ARG . 11.4 m -124.6 166.7 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -165.2 159.86 17.95 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.767 0.427 . . . . 0.0 111.079 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -147.76 142.29 26.48 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.4 0.68 . . . . 0.0 109.914 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -81.49 141.64 33.66 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 67' ' ' VAL . 33.3 pt -117.42 124.09 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.274 0.63 . . . . 0.0 110.361 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -71.6 -40.46 59.1 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.1 t -129.92 120.01 24.18 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.118 0.967 . . . . 0.0 108.73 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.502 ' HA ' HD12 ' A' ' 64' ' ' ILE . 97.5 t -56.04 -38.83 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.49 1.116 . . . . 0.0 110.774 172.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -60.66 -45.62 93.44 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.003 0.921 . . . . 0.0 110.805 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.1 m -59.57 -47.46 85.46 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.353 0.661 . . . . 0.0 110.747 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -53.65 -60.43 3.32 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.772 0.829 . . . . 0.0 111.862 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -42.01 80.19 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.24 0.616 . . . . 0.0 112.032 -169.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -62.9 -47.79 81.77 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.063 0.545 . . . . 0.0 110.851 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -65.92 -38.73 89.45 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.329 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.3 tp -58.04 -56.85 16.67 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.683 0.793 . . . . 0.0 111.974 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -35.17 79.55 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 123.452 0.47 . . . . 0.0 112.182 -174.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.1 m -62.26 -55.03 32.39 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.328 0.651 . . . . 0.0 110.116 172.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.527 HD21 HG13 ' A' ' 24' ' ' VAL . 52.5 tp -50.77 -45.09 58.88 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.644 1.578 . . . . 0.0 113.04 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -63.07 -41.32 99.41 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.046 0.539 . . . . 0.0 110.775 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -65.2 -35.83 82.28 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.129 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -71.33 -44.12 65.7 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.514 0.726 . . . . 0.0 111.458 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.7 mt -74.19 -7.27 52.08 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.753 0.821 . . . . 0.0 111.888 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.27 8.18 87.84 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.506 0.504 . . . . 0.0 112.537 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.9 mt -70.24 108.67 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.868 1.267 . . . . 0.0 108.057 175.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -141.59 162.73 34.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.627 0.771 . . . . 0.0 110.616 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.44 -120.67 23.75 Favored Glycine 0 C--N 1.344 1.009 0 O-C-N 124.577 1.173 . . . . 0.0 112.995 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.36 -39.99 85.03 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.69 1.196 . . . . 0.0 111.362 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -69.5 -19.75 63.73 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.353 0.661 . . . . 0.0 111.596 -168.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -68.35 148.29 50.92 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.911 0.386 . . . . 0.0 111.097 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.92 117.93 56.44 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.744 -173.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.16 150.63 72.07 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 123.215 2.61 . . . . 0.0 112.473 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.3 t -112.88 116.89 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.665 0.786 . . . . 0.0 108.957 -176.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.417 HG21 HH21 ' A' ' 35' ' ' ARG . 47.0 t -117.92 115.6 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.419 1.088 . . . . 0.0 108.56 -171.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -94.69 115.57 27.7 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.176 0.59 . . . . 0.0 110.902 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.06 146.51 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 175.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.13 19.15 4.42 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.852 0.861 . . . . 0.0 111.706 174.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 54.75 -88.71 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.815 1.246 . . . . 0.0 110.112 -166.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.571 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 26.6 t -174.92 11.01 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.272 1.829 . . . . 0.0 107.635 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.525 ' HB3' HD21 ' A' ' 40' ' ' ASN . 26.0 t70 -96.18 -18.56 20.0 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.983 1.313 . . . . 0.0 110.446 -167.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.921 0 CA-C-O 119.376 -0.68 . . . . 0.0 111.856 -177.72 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 tpt . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -90.52 -145.67 14.3 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.111 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -74.13 133.04 42.79 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.033 0.417 . . . . 0.0 110.1 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -143.94 166.59 24.52 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.696 0.798 . . . . 0.0 110.976 -178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -90.29 -19.4 24.13 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.719 0.808 . . . . 0.0 110.907 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.482 ' NE2' ' HA ' ' A' ' 9' ' ' SER . 14.9 t60 71.62 113.18 0.06 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.958 1.303 . . . . 0.0 110.251 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -126.57 133.53 51.05 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.772 0.829 . . . . 0.0 109.597 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 72.8 t60 46.71 46.9 15.05 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.197 1.399 . . . . 0.0 111.421 174.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.482 ' HA ' ' NE2' ' A' ' 6' ' ' HIS . 16.4 m 61.79 -86.23 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.965 1.306 . . . . 0.0 110.193 -172.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -170.26 -156.97 0.14 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.684 1.194 . . . . 0.0 107.896 177.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.1 ttt 76.69 137.35 0.06 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.356 1.062 . . . . 0.0 112.492 168.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -118.3 -64.32 1.3 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 169.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.2 mtm105 -142.61 166.83 23.59 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.054 0.942 . . . . 0.0 109.467 177.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.7 p -70.04 81.59 0.49 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.421 0.629 . . . . 0.0 110.33 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.41 76.9 0.02 OUTLIER Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.373 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.606 ' HB2' HG12 ' A' ' 60' ' ' VAL . 18.8 mtm180 -90.68 123.05 33.98 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -177.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.67 109.83 6.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.684 0.394 . . . . 0.0 110.095 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 36.6 pt -104.16 170.89 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.023 0.929 . . . . 0.0 109.226 175.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 76.9 p -86.41 168.62 13.64 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 166.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.571 ' O ' HG23 ' A' ' 24' ' ' VAL . 69.2 t-105 -55.1 -40.78 70.81 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.626 0.579 . . . . 0.0 109.849 168.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -56.15 -47.97 77.18 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.552 0.741 . . . . 0.0 111.424 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.569 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 39.7 m-20 -65.11 -39.19 92.77 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.495 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 19.5 t80 -53.8 -48.92 69.37 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 124.208 0.943 . . . . 0.0 110.852 176.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 20' ' ' TRP . 61.2 t -67.4 -65.98 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 123.572 0.545 . . . . 0.0 111.231 -176.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -67.76 -46.67 71.4 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.637 -166.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -85.56 -18.53 33.13 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.964 0.506 . . . . 0.0 112.001 -172.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.495 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 47.8 m-85 -127.55 -67.99 0.8 Allowed 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 119.277 0.944 . . . . 0.0 112.946 -171.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.13 -47.99 83.27 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.736 0.815 . . . . 0.0 111.482 -172.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.4 m -63.79 -23.25 67.29 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.855 0.862 . . . . 0.0 113.13 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -101.99 4.47 39.95 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 119.361 -0.352 . . . . 0.0 111.533 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.63 28.24 56.14 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.1 m -81.31 -5.96 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.115 0.566 . . . . 0.0 111.01 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.83 136.4 26.09 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 C-N-CA 124.014 0.926 . . . . 0.0 108.923 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -86.86 -57.75 2.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.131 0.973 . . . . 0.0 108.978 174.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -153.31 159.93 42.6 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.716 -174.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.4 mt -113.87 102.17 9.96 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -94.8 103.68 15.58 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.446 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 18.4 t -87.79 101.7 11.76 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -174.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.487 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 94.9 t -75.59 116.8 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.618 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 21.4 p-10 37.85 37.17 0.12 Allowed 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 128.348 2.659 . . . . 0.0 115.913 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt 67.27 -1.83 1.4 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.918 1.287 . . . . 0.0 112.793 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -80.76 -37.37 30.5 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.063 0.945 . . . . 0.0 110.42 -175.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -159.07 158.93 33.97 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.11 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 61.8 t -109.38 129.42 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.533 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -94.02 126.01 38.98 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.443 ' HB ' HG23 ' A' ' 60' ' ' VAL . 33.5 t -84.21 105.1 13.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.2 m -103.95 130.98 51.61 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.446 ' HB2' HG23 ' A' ' 53' ' ' THR . 92.8 m-85 -96.43 163.8 12.9 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.17 0.918 . . . . 0.0 111.956 -170.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.1 p -62.84 151.74 84.39 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 124.084 0.953 . . . . 0.0 112.052 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -55.67 106.94 0.21 Allowed 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.388 2.725 . . . . 0.0 113.911 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.17 -4.16 44.63 Favored Glycine 0 N--CA 1.478 1.439 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.559 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -71.06 -36.64 72.36 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.774 0.83 . . . . 0.0 109.936 176.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.446 HG23 ' HB2' ' A' ' 48' ' ' PHE . 25.6 p -90.15 110.76 42.64 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 124.356 1.062 . . . . 0.0 112.032 -172.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HD2' ' HG3' ' A' ' 58' ' ' GLN . 98.6 Cg_endo -78.28 -162.74 0.19 Allowed 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.986 3.124 . . . . 0.0 112.992 173.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.66 -29.53 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 124.747 1.219 . . . . 0.0 112.975 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.4 -34.58 75.59 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.512 0.673 . . . . 0.0 111.161 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.02 -43.65 1.82 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.77 -175.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.421 ' HG3' ' HD2' ' A' ' 54' ' ' PRO . 89.9 mm-40 61.9 -0.16 0.47 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.113 1.365 . . . . 0.0 114.583 174.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -62.55 127.63 32.22 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.606 HG12 ' HB2' ' A' ' 16' ' ' ARG . 29.5 m -124.67 156.51 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 124.127 0.892 . . . . 0.0 108.595 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -155.23 171.23 20.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.938 0.495 . . . . 0.0 110.556 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -150.54 143.66 24.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.83 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -79.97 134.45 36.25 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.182 0.593 . . . . 0.0 110.454 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.8 pt -120.24 175.66 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.148 0.579 . . . . 0.0 110.334 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.4 -50.69 0.08 OUTLIER Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.2 t -100.72 108.87 20.83 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.771 0.828 . . . . 0.0 109.631 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.0 t -57.88 -37.69 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.124 0.97 . . . . 0.0 110.402 170.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -53.59 -50.23 66.05 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.786 1.234 . . . . 0.0 110.574 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.6 m -66.83 -43.75 82.9 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 124.126 0.891 . . . . 0.0 111.275 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -53.52 -49.56 67.33 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.084 0.554 . . . . 0.0 110.948 172.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -65.61 -51.67 57.88 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.256 1.022 . . . . 0.0 112.847 -172.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.5 ptt85 -68.11 -38.24 82.05 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.57 0.544 . . . . 0.0 111.255 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -72.48 -39.14 67.93 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 40.5 tp -59.92 -54.42 46.3 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.822 0.849 . . . . 0.0 111.931 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.46 ' HB2' HH12 ' A' ' 88' ' ' ARG . 13.6 pt-20 -63.13 -40.03 96.41 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.301 0.64 . . . . 0.0 111.447 -175.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.7 m -66.86 -49.43 65.7 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.617 0.767 . . . . 0.0 109.736 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.45 HD21 HG22 ' A' ' 24' ' ' VAL . 43.0 tp -51.11 -48.81 61.62 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.526 1.13 . . . . 0.0 111.998 174.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -62.42 -46.41 88.68 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 123.67 0.606 . . . . 0.0 111.225 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -67.04 -30.15 70.14 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 123.043 0.214 . . . . 0.0 110.871 -177.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.64 -42.65 70.59 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.812 0.845 . . . . 0.0 110.842 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 94.4 mt -71.81 -12.16 61.16 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.645 0.778 . . . . 0.0 111.47 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.03 -0.61 76.24 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 123.288 0.368 . . . . 0.0 112.75 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 66.2 mt -74.46 92.28 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.75 152.2 48.05 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.82 0.448 . . . . 0.0 111.225 -172.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.92 -115.91 8.26 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 124.453 1.096 . . . . 0.0 113.02 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.16 -26.48 68.19 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.248 1.019 . . . . 0.0 111.595 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.45 -24.41 60.22 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.846 0.458 . . . . 0.0 111.881 -176.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.46 HH12 ' HB2' ' A' ' 75' ' ' GLU . 60.8 mtt180 -63.02 135.2 57.14 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 123.427 0.455 . . . . 0.0 110.802 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.56 118.87 74.81 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 123.733 0.813 . . . . 0.0 110.44 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.99 135.27 50.45 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 123.596 2.864 . . . . 0.0 113.262 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.2 116.38 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.531 0.733 . . . . 0.0 109.48 -176.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.2 t -105.74 99.08 7.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -174.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -74.92 99.71 3.9 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 42.3 mm -84.75 135.31 25.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.646 ' HB1' ' HB2' ' A' ' 98' ' ' ASP . . . -121.25 111.66 17.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.318 0.647 . . . . 0.0 110.499 -176.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.618 ' HG2' ' HB3' ' A' ' 40' ' ' ASN . 24.9 mm-40 -80.5 -70.83 0.5 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 51.0 m -99.68 -8.05 24.86 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.349 0.66 . . . . 0.0 110.844 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.646 ' HB2' ' HB1' ' A' ' 95' ' ' ALA . 2.3 m-20 -71.15 -28.53 64.33 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.799 0.839 . . . . 0.0 110.726 -178.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.178 0 CA-C-O 118.707 -1.052 . . . . 0.0 110.818 179.487 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 mtm . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.63 51.1 0.25 Allowed Glycine 0 C--N 1.342 0.907 0 C-N-CA 121.681 -0.295 . . . . 0.0 113.18 -174.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -74.15 -33.27 63.45 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -76.01 159.39 30.89 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.332 170.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -61.71 85.35 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.585 1.154 . . . . 0.0 111.034 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -150.35 71.47 1.06 Allowed 'General case' 0 C--O 1.245 0.865 0 C-N-CA 123.776 0.83 . . . . 0.0 109.298 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -168.37 142.49 3.29 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.987 173.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -139.02 115.7 10.68 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.2 p -83.1 125.2 31.23 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.473 0.709 . . . . 0.0 110.951 -173.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -166.46 -65.22 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.005 0.922 . . . . 0.0 109.69 177.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.8 tpt 43.36 130.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 127.119 2.168 . . . . 0.0 115.258 -171.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -117.56 77.62 1.15 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.49 0.716 . . . . 0.0 110.035 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -90.09 -48.81 6.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.573 171.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.1 t -165.75 65.02 0.11 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.99 -124.54 7.2 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -169.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.65 ' HB2' HG12 ' A' ' 60' ' ' VAL . 31.9 mmt180 -125.32 113.46 17.62 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 117.971 0.885 . . . . 0.0 109.968 175.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -78.52 133.21 37.41 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.267 0.556 . . . . 0.0 109.648 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 48.5 pt -132.13 -177.04 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 126.009 1.724 . . . . 0.0 108.27 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.8 p -102.98 169.91 8.28 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 167.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.502 ' O ' HG23 ' A' ' 24' ' ' VAL . 66.4 t-105 -53.18 -40.15 64.17 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.552 0.741 . . . . 0.0 110.486 170.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.6 tttp -56.48 -49.0 75.94 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.749 0.819 . . . . 0.0 111.632 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.515 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 30.5 m-20 -61.95 -40.66 96.3 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.625 0.37 . . . . 0.0 110.773 177.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.426 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 33.9 t80 -54.01 -53.0 59.0 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 124.413 1.07 . . . . 0.0 110.96 177.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 20' ' ' TRP . 63.8 t -57.23 -56.77 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 123.732 0.645 . . . . 0.0 111.074 -177.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -67.6 -58.95 3.78 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.739 0.816 . . . . 0.0 112.274 -170.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -85.44 -20.65 29.47 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.555 0.742 . . . . 0.0 112.084 -165.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.426 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 78.1 m-85 -120.66 -68.97 0.87 Allowed 'General case' 0 C--O 1.248 1.003 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -168.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.7 tp -60.21 -48.85 79.98 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.562 0.745 . . . . 0.0 111.894 -173.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.1 m -68.48 -17.05 64.1 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -96.6 1.38 51.18 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.267 0.485 . . . . 0.0 111.358 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.94 22.01 56.82 Favored Glycine 0 C--N 1.35 1.307 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.456 HG12 ' HD3' ' A' ' 52' ' ' LYS . 20.4 m -89.95 4.83 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.886 0.474 . . . . 0.0 111.334 -178.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.6 t -96.18 128.58 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.432 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 25.6 t70 -90.35 -50.09 6.16 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.885 0.874 . . . . 0.0 109.951 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -163.94 159.21 20.6 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.291 -177.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 46' ' ' VAL . 96.3 mt -120.72 102.55 8.47 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.987 0.915 . . . . 0.0 110.877 -173.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.698 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 49.4 mp0 -83.99 108.67 17.09 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.698 0.799 . . . . 0.0 110.092 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 41' ' ' LYS . 47.8 t -86.15 90.61 3.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.446 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 59.8 t -84.84 119.05 33.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.851 -170.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 56.89 22.38 7.06 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 125.404 1.482 . . . . 0.0 112.992 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.525 ' HA ' HG12 ' A' ' 38' ' ' VAL . 36.2 mtmm 58.58 8.28 0.86 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.526 1.13 . . . . 0.0 113.666 -173.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -88.59 -40.18 13.56 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.447 1.099 . . . . 0.0 110.851 -174.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -150.33 173.78 13.6 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.062 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 38' ' ' VAL . 73.8 t -124.05 132.72 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.179 0.992 . . . . 0.0 109.676 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.698 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 40.9 ttm180 -96.39 113.09 24.64 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.521 1.128 . . . . 0.0 108.582 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.422 ' HA ' HD23 ' A' ' 36' ' ' LEU . 44.6 t -82.66 107.2 14.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.3 m -93.16 144.67 25.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.27 140.48 29.65 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.887 0.475 . . . . 0.0 112.02 177.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' A' ' 52' ' ' LYS . 32.1 p -62.06 128.1 90.32 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.121 0.968 . . . . 0.0 110.96 174.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.87 97.94 0.1 OUTLIER 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.112 2.541 . . . . 0.0 111.709 174.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.04 -39.09 1.54 Allowed Glycine 0 C--N 1.343 0.936 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 -175.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.456 ' HD3' HG12 ' A' ' 32' ' ' VAL . 61.0 mttp -106.28 5.23 29.55 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.588 0.755 . . . . 0.0 111.888 177.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.4 m -58.45 127.57 81.63 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.004 176.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.97 167.18 14.55 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.565 2.177 . . . . 0.0 112.389 -176.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.4 t -55.32 -43.7 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -84.43 86.82 7.23 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 168.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.9 59.73 4.47 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.039 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -110.55 129.88 55.69 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 171.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -61.87 152.85 30.64 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 123.573 0.546 . . . . 0.0 110.098 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.65 HG12 ' HB2' ' A' ' 16' ' ' ARG . 23.3 m -109.19 164.61 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -158.89 158.35 33.23 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 118.385 0.539 . . . . 0.0 111.202 -173.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -146.1 145.68 30.62 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.999 0.52 . . . . 0.0 110.245 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -85.35 121.81 28.62 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.973 0.909 . . . . 0.0 110.487 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 67' ' ' VAL . 36.2 pt -103.77 -51.51 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.283 0.633 . . . . 0.0 111.236 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.457 ' N ' HG13 ' A' ' 64' ' ' ILE . . . 71.03 -70.07 0.78 Allowed Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -165.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.6 m -81.55 96.27 7.39 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.108 0.963 . . . . 0.0 110.895 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.567 ' HA ' HD12 ' A' ' 64' ' ' ILE . 13.0 t -64.72 -34.06 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.626 0.77 . . . . 0.0 111.383 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -58.73 -45.35 89.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.063 0.545 . . . . 0.0 109.819 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.5 m -64.19 -46.23 84.87 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.014 0.926 . . . . 0.0 110.229 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -49.65 -54.53 18.0 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.197 0.999 . . . . 0.0 112.042 174.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -66.59 -43.5 84.72 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.125 0.891 . . . . 0.0 111.83 -174.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -63.98 -40.07 95.57 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.568 0.747 . . . . 0.0 111.041 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -64.17 -46.82 82.32 Favored 'General case' 0 C--O 1.216 -0.698 0 O-C-N 123.704 0.627 . . . . 0.0 109.678 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.7 tp -60.79 -41.81 96.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.935 0.894 . . . . 0.0 111.86 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -65.14 -51.53 60.69 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.211 0.605 . . . . 0.0 111.786 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 m -65.7 -37.28 86.01 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.618 0.767 . . . . 0.0 110.214 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.42 -44.02 95.82 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.494 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -66.25 -29.88 70.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.694 0.397 . . . . 0.0 110.516 176.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -66.88 -49.12 66.64 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.65 0.38 . . . . 0.0 111.397 175.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.46 -36.03 73.66 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.228 0.211 . . . . 0.0 111.239 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.557 ' HB2' HG12 ' A' ' 83' ' ' ILE . 92.0 mt -75.78 -20.06 58.52 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.144 0.578 . . . . 0.0 111.228 175.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.68 30.56 66.11 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 120.121 -0.266 . . . . 0.0 113.131 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.557 HG12 ' HB2' ' A' ' 81' ' ' LEU . 17.6 mm -66.45 102.35 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.414 1.085 . . . . 0.0 109.279 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -72.6 166.99 21.64 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.63 -32.85 54.26 Favored Glycine 0 N--CA 1.48 1.613 0 O-C-N 124.179 0.924 . . . . 0.0 114.73 -171.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -67.28 -43.52 81.56 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.966 0.906 . . . . 0.0 110.408 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -81.19 -19.91 42.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.145 0.978 . . . . 0.0 111.593 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.5 mtt-85 -61.47 122.08 14.3 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.904 0.881 . . . . 0.0 110.567 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.5 t -77.91 117.95 69.06 Favored Pre-proline 0 CA--C 1.554 1.103 0 O-C-N 123.983 0.802 . . . . 0.0 110.47 -172.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.432 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 71.9 Cg_exo -54.84 136.98 74.19 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.841 3.027 . . . . 0.0 113.261 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.3 t -103.53 113.4 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' A' ' 37' ' ' GLU . 60.3 t -100.89 149.36 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.927 1.291 . . . . 0.0 108.025 -177.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -114.2 131.5 56.44 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 38.4 mm -126.41 138.23 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.882 0.873 . . . . 0.0 109.244 -176.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.5 90.33 3.1 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -116.57 136.41 53.0 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.823 0.849 . . . . 0.0 110.657 -174.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 55.6 p -66.37 138.28 57.48 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.52 0.728 . . . . 0.0 110.038 175.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 71.22 9.1 6.56 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.672 1.189 . . . . 0.0 113.181 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.679 0 CA-C-O 119.158 -0.801 . . . . 0.0 113.3 178.481 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.11 100.43 0.4 Allowed Glycine 0 C--N 1.349 1.28 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 172.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -63.17 -67.43 0.42 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.743 0.817 . . . . 0.0 110.33 -174.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 29.0 p80 47.6 -65.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 127.393 2.277 . . . . 0.0 114.36 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -54.48 118.59 4.28 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.046 0.938 . . . . 0.0 110.698 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 65.18 53.67 1.31 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.994 1.318 . . . . 0.0 110.41 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -79.36 77.04 5.92 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.994 0.902 . . . . 0.0 110.321 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -69.03 -22.22 64.07 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.837 173.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.7 t -70.73 136.62 49.06 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.902 173.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -125.28 29.13 6.14 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.047 1.339 . . . . 0.0 108.091 171.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.7 ttp 76.23 -49.03 0.58 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 126.18 1.792 . . . . 0.0 112.993 172.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -73.86 84.14 1.69 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 173.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.8 ttp-105 -81.99 80.28 8.29 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.355 0.662 . . . . 0.0 109.805 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.9 t 65.46 -81.5 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 113.861 -1.518 . . . . 0.0 111.091 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -119.76 -151.84 8.91 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 174.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.651 ' HB2' HG12 ' A' ' 60' ' ' VAL . 59.2 mtm180 -96.92 114.03 25.62 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -78.81 129.72 34.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.4 pt -124.42 179.72 2.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 124.914 1.286 . . . . 0.0 108.921 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.8 p -106.32 170.1 8.12 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.66 0.784 . . . . 0.0 109.682 172.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.422 ' O ' HG23 ' A' ' 24' ' ' VAL . 71.1 t-105 -59.62 -39.87 85.71 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.527 0.731 . . . . 0.0 111.174 176.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -55.68 -52.38 64.05 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.585 0.754 . . . . 0.0 112.229 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -70.18 -32.38 70.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.935 0.494 . . . . 0.0 111.51 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.495 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 17.4 t80 -55.84 -56.11 24.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.635 0.774 . . . . 0.0 111.671 172.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.44 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 97.4 t -61.95 -58.33 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 123.595 0.56 . . . . 0.0 110.419 -176.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -65.47 -49.82 67.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.052 -168.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -87.46 -17.08 33.0 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -170.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.495 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 42.7 m-85 -128.6 -68.04 0.77 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -171.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 7.9 tt -59.06 -52.65 64.83 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.559 0.744 . . . . 0.0 111.903 -169.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 82.3 p -66.61 -22.57 66.12 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.554 0.742 . . . . 0.0 112.152 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -89.76 -5.42 56.98 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.342 0.657 . . . . 0.0 111.664 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.24 32.67 77.34 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.468 0.48 . . . . 0.0 113.991 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 m -101.93 11.44 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 122.855 0.462 . . . . 0.0 110.328 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.67 122.59 51.69 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 C-N-CA 124.207 1.003 . . . . 0.0 109.519 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 25.7 t70 -77.04 -45.89 25.62 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.732 0.813 . . . . 0.0 109.601 176.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -162.59 162.44 27.18 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.747 -167.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.426 ' HG ' HG11 ' A' ' 89' ' ' VAL . 95.4 mt -120.41 137.11 54.49 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.906 1.283 . . . . 0.0 108.375 170.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -120.13 110.49 16.7 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.213 0.605 . . . . 0.0 109.491 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 44' ' ' VAL . 24.3 t -90.09 91.14 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -176.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.49 119.11 34.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -172.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 57.99 17.1 4.14 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.629 1.571 . . . . 0.0 113.855 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.1 mttp 61.69 2.81 0.76 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -172.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -80.04 -42.43 23.77 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.658 0.783 . . . . 0.0 109.856 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -151.38 170.41 19.63 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.334 -174.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 38' ' ' VAL . 84.6 t -129.21 133.7 65.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -99.57 132.41 44.93 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.15 109.39 16.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 114.59 -1.186 . . . . 0.0 107.819 174.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.7 m -82.13 125.95 31.47 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 172.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.546 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 22.7 m-85 -84.21 133.42 34.59 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.369 0.668 . . . . 0.0 110.204 177.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -69.82 136.37 87.7 Favored Pre-proline 0 C--O 1.245 0.817 0 O-C-N 123.497 0.498 . . . . 0.0 109.95 175.784 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.91 134.46 53.54 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.54 2.16 . . . . 0.0 111.183 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.19 -47.34 3.65 Favored Glycine 0 N--CA 1.476 1.313 0 O-C-N 123.166 0.291 . . . . 0.0 112.958 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -58.99 -40.48 84.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.911 0.884 . . . . 0.0 110.868 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 48' ' ' PHE . 30.7 m -135.65 137.59 26.17 Favored Pre-proline 0 C--O 1.246 0.903 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.83 130.92 37.01 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.028 1.819 . . . . 0.0 110.837 171.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.9 t -69.7 -16.34 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.698 0.799 . . . . 0.0 110.18 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -60.82 -36.27 78.65 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.599 1.159 . . . . 0.0 110.409 169.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.3 126.2 19.17 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.551 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -65.01 139.0 58.71 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.803 0.841 . . . . 0.0 111.017 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.439 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 17.8 m-85 -68.19 143.13 55.47 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.544 0.737 . . . . 0.0 110.732 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.651 HG12 ' HB2' ' A' ' 16' ' ' ARG . 34.9 m -107.7 161.33 6.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.506 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 45.5 p-90 -153.3 162.26 41.49 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.601 0.76 . . . . 0.0 109.276 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -147.75 144.38 28.21 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -79.57 136.22 36.8 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 67' ' ' VAL . 43.1 pt -108.23 -42.22 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 110.658 -0.127 . . . . 0.0 110.658 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.81 -81.53 0.05 OUTLIER Glycine 0 C--N 1.35 1.306 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 -173.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.3 m -74.48 97.49 3.12 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.739 0.816 . . . . 0.0 109.134 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.467 ' HA ' HD12 ' A' ' 64' ' ' ILE . 25.2 t -59.81 -33.67 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.98 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -57.05 -40.77 77.42 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.944 0.898 . . . . 0.0 111.069 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.2 m -67.19 -46.01 75.19 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.129 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -52.64 -52.73 54.32 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.503 0.502 . . . . 0.0 111.213 177.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -59.63 -59.01 6.12 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.3 1.0 . . . . 0.0 112.767 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -67.2 -36.79 82.46 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.534 -171.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -63.82 -52.63 59.3 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 174.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 47.7 tp -52.78 -52.96 54.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.188 1.395 . . . . 0.0 112.722 -176.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -68.17 -45.55 73.16 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.449 -175.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.6 m -64.72 -45.14 87.78 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.4 tp -46.45 -48.52 18.93 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.883 1.673 . . . . 0.0 112.382 171.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -62.23 -43.25 99.24 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.3 0.64 . . . . 0.0 111.258 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -65.25 -41.69 94.05 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.255 0.622 . . . . 0.0 111.142 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -68.47 -40.26 81.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.741 0.816 . . . . 0.0 111.25 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.58 -15.04 59.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.214 0.605 . . . . 0.0 112.52 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.96 13.57 68.94 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-O 120.269 -0.184 . . . . 0.0 113.41 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.4 mt -71.67 108.11 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.43 1.092 . . . . 0.0 109.2 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -137.98 151.47 47.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.929 0.891 . . . . 0.0 110.568 -172.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.22 -118.91 13.96 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 123.905 0.753 . . . . 0.0 113.65 174.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.69 -29.32 70.56 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.043 0.937 . . . . 0.0 111.734 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.84 -21.66 60.92 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.943 -171.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 88' ' ' ARG . 37.6 mtp85 -66.55 150.01 49.63 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.175 0.59 . . . . 0.0 110.416 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.426 HG11 ' HG ' ' A' ' 36' ' ' LEU . 20.2 t -91.64 119.55 68.46 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.118 -168.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.4 123.86 13.59 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.066 2.51 . . . . 0.0 111.377 175.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.2 t -116.19 118.34 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.8 t -113.36 105.59 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.106 0.963 . . . . 0.0 109.567 -173.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -75.35 123.46 25.42 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.051 0.54 . . . . 0.0 109.814 175.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.8 mt -119.58 140.38 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.882 1.273 . . . . 0.0 108.084 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.01 85.96 2.44 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.031 0.443 . . . . 0.0 110.356 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -89.8 -175.91 4.78 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.642 172.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.4 t -152.37 80.16 1.24 Allowed 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.557 0.694 . . . . 0.0 109.275 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -89.22 98.37 11.73 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.611 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.936 0 CA-C-O 118.688 -1.062 . . . . 0.0 112.042 174.432 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 121.021 0.439 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.41 -72.94 0.07 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 175.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.1 t60 54.85 -86.78 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.054 1.342 . . . . 0.0 112.334 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -98.21 9.69 42.37 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.117 0.967 . . . . 0.0 110.611 -174.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -63.37 -24.1 67.7 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 122.87 0.468 . . . . 0.0 111.49 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -122.12 152.82 39.48 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.893 0.477 . . . . 0.0 110.018 168.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -72.77 144.59 47.52 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.264 0.626 . . . . 0.0 109.946 172.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -78.97 159.91 27.46 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.968 0.907 . . . . 0.0 111.114 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -78.93 147.4 33.03 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.136 0.574 . . . . 0.0 110.672 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 59.6 89.89 0.06 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.456 1.102 . . . . 0.0 110.769 -176.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.4 ttm -55.15 -44.14 74.85 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.51 1.124 . . . . 0.0 111.287 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -81.39 142.34 33.1 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.627 172.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -115.08 -1.24 13.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.983 0.913 . . . . 0.0 109.971 176.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 p -155.0 -172.32 4.15 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.158 0.983 . . . . 0.0 109.612 -174.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.56 -79.87 0.04 OUTLIER Glycine 0 C--N 1.349 1.282 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 20.4 tpp180 -135.35 128.63 32.04 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.833 0.853 . . . . 0.0 109.396 176.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -77.44 111.32 13.02 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 167.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.465 HD11 HG21 ' A' ' 46' ' ' VAL . 27.5 pt -93.77 166.78 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.555 1.142 . . . . 0.0 109.241 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.9 p -88.57 170.73 10.6 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -56.79 -40.86 76.67 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.097 0.559 . . . . 0.0 110.13 168.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -59.98 -49.17 78.74 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.663 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -66.61 -36.79 83.46 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.193 0.197 . . . . 0.0 111.183 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -54.65 -59.4 4.76 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.654 0.596 . . . . 0.0 110.736 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.486 HG13 HD11 ' A' ' 77' ' ' LEU . 47.5 t -60.17 -50.79 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 123.933 0.771 . . . . 0.0 111.255 -175.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -73.1 -56.97 4.38 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.793 -173.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -90.89 -10.99 40.53 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.9 -64.69 1.0 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 119.158 0.89 . . . . 0.0 111.737 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 41.9 tp -58.15 -41.81 84.55 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.551 1.14 . . . . 0.0 112.224 -176.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.8 t -66.55 -22.21 66.15 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.576 0.751 . . . . 0.0 112.751 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -87.09 -7.9 57.58 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.326 0.512 . . . . 0.0 110.949 175.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.66 12.95 60.25 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 114.259 0.464 . . . . 0.0 114.259 -175.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.14 -1.01 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 117.317 0.558 . . . . 0.0 111.084 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.55 126.44 45.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 C-N-CA 123.525 0.73 . . . . 0.0 109.155 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.443 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 16.5 t70 -86.03 -51.58 6.25 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.886 0.851 . . . . 0.0 109.095 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.534 ' HD3' HG21 ' A' ' 92' ' ' VAL . 16.2 ptp180 -160.13 164.42 32.99 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.05 -172.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.2 mt -117.17 101.93 8.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.685 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -92.96 107.61 19.36 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.495 0.718 . . . . 0.0 109.944 -171.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 44' ' ' VAL . 41.0 t -91.89 91.61 3.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -175.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.688 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 49.1 t -79.08 114.22 19.52 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.666 -172.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 50.66 31.7 6.1 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.496 1.519 . . . . 0.0 113.217 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HA ' HG12 ' A' ' 38' ' ' VAL . 61.3 mttm 66.8 -6.87 0.5 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 125.714 1.606 . . . . 0.0 112.801 -177.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.7 mmt-85 -64.94 -50.19 67.42 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 124.865 1.266 . . . . 0.0 110.904 -170.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -148.74 159.83 43.77 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.49 -175.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 38' ' ' VAL . 65.5 t -101.14 123.06 53.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 171.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -101.6 129.29 47.68 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.542 ' HB ' HG23 ' A' ' 60' ' ' VAL . 68.8 t -85.13 110.24 19.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.5 m -82.97 134.74 35.04 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -82.99 128.17 34.23 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 171.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.443 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 5.1 t -72.79 146.56 88.14 Favored Pre-proline 0 CA--C 1.556 1.202 0 C-N-CA 123.109 0.564 . . . . 0.0 110.541 -176.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.02 116.1 2.97 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 123.399 2.732 . . . . 0.0 112.606 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.22 -17.2 24.39 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.061 -173.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -128.36 20.34 6.24 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.699 1.2 . . . . 0.0 110.798 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.5 m -91.51 120.92 68.09 Favored Pre-proline 0 C--O 1.244 0.798 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.3 155.04 70.75 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.698 2.266 . . . . 0.0 112.289 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.9 t -61.55 -40.39 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-O 121.588 0.709 . . . . 0.0 109.4 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -83.22 89.82 7.02 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.622 169.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.09 71.91 0.94 Allowed Glycine 0 C--N 1.346 1.118 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.854 176.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -101.69 101.11 11.57 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -76.53 136.23 39.3 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.512 0.725 . . . . 0.0 112.088 -166.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.542 HG23 ' HB ' ' A' ' 46' ' ' VAL . 18.7 m -106.29 140.75 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -177.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -157.21 173.57 16.77 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.344 -170.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 23.7 p90 -151.98 141.17 21.35 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.86 0.864 . . . . 0.0 109.178 175.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -78.17 147.54 34.47 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.2 pt -124.39 154.1 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.329 0.652 . . . . 0.0 109.289 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.24 -34.43 1.79 Allowed Glycine 0 N--CA 1.471 0.989 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 174.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 m -117.9 99.55 6.99 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.56 1.144 . . . . 0.0 108.535 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.6 t -60.64 -35.3 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 122.977 0.511 . . . . 0.0 110.036 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.05 -40.44 95.78 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.065 0.946 . . . . 0.0 110.736 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.3 m -67.95 -42.87 80.29 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.565 176.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -55.14 -43.76 74.48 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.909 0.756 . . . . 0.0 111.394 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.47 -51.07 64.89 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.864 0.466 . . . . 0.0 110.73 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -34.42 73.52 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -171.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 29.9 p30 -74.27 -33.33 63.24 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 176.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.7 tp -62.89 -42.96 99.96 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.607 0.763 . . . . 0.0 110.859 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -60.34 -52.82 63.62 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.137 0.575 . . . . 0.0 110.566 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.8 m -61.97 -42.2 98.86 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 123.666 0.604 . . . . 0.0 110.738 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 73' ' ' ASN . 1.8 tm? -56.53 -47.82 78.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.84 1.256 . . . . 0.0 110.879 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.439 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 77.3 mt-30 -65.18 -36.83 85.43 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.143 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -63.85 -39.53 94.44 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.096 0.558 . . . . 0.0 110.814 176.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.97 -51.26 70.0 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.038 0.935 . . . . 0.0 111.169 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.8 mt -83.85 -2.57 56.69 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.001 -173.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.87 9.95 83.51 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 120.281 -0.177 . . . . 0.0 112.935 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.478 HG22 ' HA ' ' A' ' 88' ' ' ARG . 57.2 mt -73.59 118.61 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.733 1.213 . . . . 0.0 109.077 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -168.56 173.86 7.16 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.482 0.713 . . . . 0.0 111.193 -172.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.75 -122.11 25.39 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.589 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.46 -34.2 58.71 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.43 0.692 . . . . 0.0 110.245 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -74.33 -6.1 46.08 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.438 0.695 . . . . 0.0 112.455 -171.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.478 ' HA ' HG22 ' A' ' 83' ' ' ILE . 6.9 ptm180 -79.91 156.45 27.28 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.079 0.466 . . . . 0.0 111.274 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.5 t -98.99 114.81 65.84 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.246 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.92 160.74 33.64 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.164 2.576 . . . . 0.0 112.875 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.8 t -110.65 132.31 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.614 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.534 HG21 ' HD3' ' A' ' 35' ' ' ARG . 21.8 t -117.92 97.37 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -73.01 100.83 3.08 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.376 0.67 . . . . 0.0 109.883 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.688 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 46.8 mm -78.55 122.67 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.11 67.4 0.79 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -140.74 107.27 5.31 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.248 -173.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.6 p -159.84 136.44 9.1 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.035 0.534 . . . . 0.0 110.738 -175.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -122.54 -47.04 2.12 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.529 0.732 . . . . 0.0 109.677 173.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 CA-C-O 119.049 -0.861 . . . . 0.0 111.64 177.324 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -77.01 126.18 30.55 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.92 0.888 . . . . 0.0 108.752 177.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.3 pt -126.55 166.86 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.785 1.234 . . . . 0.0 108.139 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 22' ' ' ASP . 9.8 t -96.4 157.84 15.71 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.543 ' O ' HG23 ' A' ' 24' ' ' VAL . 73.5 t-105 -53.91 -46.0 71.31 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.392 1.077 . . . . 0.0 110.993 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -61.04 -39.64 90.56 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.616 0.766 . . . . 0.0 112.037 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.498 ' H ' HG23 ' A' ' 19' ' ' THR . 24.4 t70 -66.55 -43.35 85.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.532 1.133 . . . . 0.0 110.415 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.444 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 12.5 t80 -52.46 -53.72 41.8 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.802 175.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.564 HG22 HD21 ' A' ' 77' ' ' LEU . 62.3 t -58.65 -55.45 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 123.805 0.691 . . . . 0.0 111.22 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -71.78 -49.55 37.88 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.085 -0.962 . . . . 0.0 112.147 -169.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -90.07 -13.84 35.03 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.444 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 41.7 m-85 -127.81 -64.72 0.95 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 119.245 0.929 . . . . 0.0 113.131 -175.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.428 HD11 HG21 ' A' ' 89' ' ' VAL . 32.8 tp -58.47 -50.18 74.66 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.566 0.747 . . . . 0.0 112.775 -170.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.7 p -70.45 -18.37 63.0 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.15 0.58 . . . . 0.0 111.623 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -86.41 -7.59 58.32 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.435 0.694 . . . . 0.0 110.893 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.33 13.16 67.3 Favored Glycine 0 C--N 1.356 1.659 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 m -86.8 -0.47 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.435 0.617 . . . . 0.0 111.274 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.6 t -97.87 128.03 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.185 0.994 . . . . 0.0 109.062 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 23.9 t70 -86.94 -52.42 5.47 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.08 0.952 . . . . 0.0 109.75 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.516 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 17.5 ptp180 -156.48 163.66 39.16 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.512 -174.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.6 mt -118.75 104.4 10.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.825 0.85 . . . . 0.0 108.972 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.44 ' HG2' ' HB ' ' A' ' 92' ' ' VAL . 46.1 mt-10 -97.75 107.77 20.33 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.734 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 41' ' ' LYS . 26.5 t -82.91 92.42 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -172.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.549 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 61.9 t -83.19 120.44 34.47 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 C-N-CA 122.797 0.439 . . . . 0.0 110.815 -169.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 54.53 21.45 3.35 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.811 1.644 . . . . 0.0 113.016 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HA ' HG12 ' A' ' 38' ' ' VAL . 99.5 mttt 55.85 5.43 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.301 1.44 . . . . 0.0 114.472 -175.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -78.41 -41.32 33.37 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.02 0.914 . . . . 0.0 108.87 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -151.49 172.91 15.24 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.021 -172.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.424 HG22 HG22 ' A' ' 38' ' ' VAL . 79.4 t -122.38 131.26 73.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 124.248 1.019 . . . . 0.0 108.53 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -90.43 127.01 36.08 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 60' ' ' VAL . 60.8 t -80.97 106.87 12.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 171.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.463 HG23 ' HE2' ' A' ' 59' ' ' TYR . 66.1 m -88.4 123.14 32.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -82.74 147.55 28.38 Favored 'General case' 0 C--O 1.247 0.939 0 O-C-N 123.609 0.568 . . . . 0.0 109.728 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 43.4 p . . . . . 0 CA--C 1.556 1.174 0 O-C-N 124.327 1.017 . . . . 0.0 109.855 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.463 ' HE2' HG23 ' A' ' 47' ' ' THR . 3.7 m-30 . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 121.252 0.549 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 46' ' ' VAL . 31.1 m -110.2 164.68 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.343 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -157.35 165.67 35.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.176 0.59 . . . . 0.0 110.027 -173.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -149.2 142.01 24.64 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.467 0.707 . . . . 0.0 109.967 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -75.31 140.05 42.86 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 67' ' ' VAL . 31.0 pt -115.18 -44.02 3.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.205 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.12 -74.74 0.36 Allowed Glycine 0 C--N 1.352 1.45 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 -171.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -80.33 97.47 7.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.456 1.102 . . . . 0.0 109.3 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.592 ' HA ' HD12 ' A' ' 64' ' ' ILE . 37.4 t -59.28 -37.44 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.821 0.849 . . . . 0.0 111.027 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 21.8 t70 -58.09 -49.87 75.43 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.497 1.119 . . . . 0.0 110.803 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.4 m -58.68 -46.08 88.03 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.917 0.887 . . . . 0.0 111.075 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -49.99 -50.81 45.85 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.16 0.984 . . . . 0.0 111.322 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 42.4 mt-10 -67.97 -45.83 73.09 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 124.251 0.97 . . . . 0.0 111.62 -173.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 68' ' ' ASP . 14.2 mtm180 -58.27 -46.05 86.73 Favored 'General case' 0 C--N 1.364 1.213 0 O-C-N 123.821 0.7 . . . . 0.0 109.845 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -65.48 -42.99 91.59 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.652 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.27 -50.59 69.57 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 123.946 0.778 . . . . 0.0 112.265 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -34.6 76.71 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.808 0.443 . . . . 0.0 111.675 -177.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.44 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 86.8 m -63.66 -52.02 62.57 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.352 0.596 . . . . 0.0 109.512 171.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.564 HD21 HG22 ' A' ' 24' ' ' VAL . 47.1 tp -52.99 -42.65 65.78 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.505 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -64.53 -45.7 86.03 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.915 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 76' ' ' THR . 10.1 pt20 -70.25 -26.84 64.02 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-N 117.763 0.256 . . . . 0.0 110.79 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 76' ' ' THR . 43.8 mt-10 -68.22 -50.23 55.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.013 0.925 . . . . 0.0 110.738 174.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.16 5.03 18.07 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.677 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.86 19.54 72.73 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-O 119.823 -0.432 . . . . 0.0 114.106 172.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.55 117.53 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.842 0.857 . . . . 0.0 109.612 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.65 -179.18 3.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.772 1.229 . . . . 0.0 108.568 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.17 -36.27 1.98 Allowed Glycine 0 N--CA 1.48 1.572 0 N-CA-C 116.246 1.258 . . . . 0.0 116.246 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.6 -37.03 60.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.504 0.722 . . . . 0.0 111.385 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -93.2 -5.63 49.56 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 118.85 -0.595 . . . . 0.0 111.966 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -58.85 124.51 20.06 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 118.046 0.385 . . . . 0.0 110.433 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.428 HG21 HD11 ' A' ' 28' ' ' LEU . 99.6 t -89.7 108.64 26.66 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.452 -172.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.516 ' HG2' ' HB3' ' A' ' 35' ' ' ARG . 19.4 Cg_endo -58.74 129.21 31.17 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.299 2.666 . . . . 0.0 112.591 -174.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.61 109.35 25.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.44 ' HB ' ' HG2' ' A' ' 37' ' ' GLU . 43.4 t -104.07 111.67 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -174.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -78.66 124.97 28.73 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 47.2 mt . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.469 ' HB2' HG12 ' A' ' 60' ' ' VAL . 34.7 mmt180 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 110.715 -0.106 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -79.76 109.62 14.35 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.2 pt -104.85 177.14 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 124.931 1.292 . . . . 0.0 108.9 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.5 p -92.02 163.14 14.09 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.554 ' O ' HG23 ' A' ' 24' ' ' VAL . 69.7 t-105 -58.89 -41.08 86.33 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.007 0.523 . . . . 0.0 109.657 171.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -52.16 -57.34 9.92 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.894 0.878 . . . . 0.0 111.733 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.33 -34.82 79.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.427 0.691 . . . . 0.0 111.157 -175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.404 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 45.2 t80 -54.56 -54.87 35.55 Favored 'General case' 0 C--N 1.344 0.334 0 O-C-N 123.991 0.807 . . . . 0.0 111.302 174.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.556 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 43.7 t -64.88 -50.64 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 O-C-N 123.43 0.456 . . . . 0.0 110.605 -174.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -66.44 -45.22 80.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.211 -172.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -95.71 -24.64 16.44 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -171.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.404 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 80.0 m-85 -122.13 -64.84 1.17 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 118.782 0.719 . . . . 0.0 112.591 -169.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 48.9 tp -55.54 -48.75 74.23 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.981 0.912 . . . . 0.0 112.045 -173.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 p -64.94 -22.95 67.08 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -89.49 -3.72 58.24 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.902 0.481 . . . . 0.0 110.439 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.37 19.14 61.78 Favored Glycine 0 C--N 1.355 1.599 0 N-CA-C 114.671 0.628 . . . . 0.0 114.671 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.5 m -79.06 0.16 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 117.415 0.608 . . . . 0.0 111.638 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.1 135.09 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.303 1.041 . . . . 0.0 108.941 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -81.64 -53.69 6.03 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.337 1.055 . . . . 0.0 108.887 174.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -168.15 164.19 13.35 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.944 -171.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.6 mt -116.96 105.18 12.05 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.061 0.945 . . . . 0.0 109.377 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -96.33 110.67 22.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.106 -174.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 41' ' ' LYS . 7.6 t -90.65 93.79 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -171.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.7 t -71.14 117.95 15.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 123.738 0.815 . . . . 0.0 110.919 -171.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 54.19 22.71 3.75 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.54 1.536 . . . . 0.0 113.03 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.633 ' HA ' HG12 ' A' ' 38' ' ' VAL . 8.5 mtpm? 53.7 17.15 1.15 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.852 1.261 . . . . 0.0 114.067 -172.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -91.28 -37.18 13.45 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.114 0.566 . . . . 0.0 110.434 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -152.8 163.78 39.07 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.75 0.82 . . . . 0.0 109.26 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.421 HG22 HG22 ' A' ' 38' ' ' VAL . 47.8 t -110.27 130.35 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.426 ' HG2' ' HB3' ' A' ' 61' ' ' TRP . 3.5 tmm_? -116.14 132.46 56.65 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.0 t -88.44 125.83 41.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.178 -170.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.9 m -95.14 129.77 42.12 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 167.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -87.03 144.7 26.78 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.828 0.451 . . . . 0.0 110.716 172.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 123.005 0.522 . . . . 0.0 110.195 -178.967 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 . . . . . 0 C--O 1.237 0.446 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.469 HG12 ' HB2' ' A' ' 16' ' ' ARG . 25.2 m -122.81 170.26 13.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.426 ' HB3' ' HG2' ' A' ' 45' ' ' ARG . 8.9 p-90 -165.43 158.56 16.1 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.622 0.369 . . . . 0.0 110.624 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -145.0 151.03 37.94 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.316 0.579 . . . . 0.0 110.291 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -82.9 151.06 26.13 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.579 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 67' ' ' VAL . 26.0 pt -125.69 144.19 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.521 0.728 . . . . 0.0 110.425 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.99 -52.64 7.75 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m -131.72 135.7 47.05 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.717 0.807 . . . . 0.0 108.972 176.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.44 ' HA ' HD12 ' A' ' 64' ' ' ILE . 5.0 t -67.15 -37.27 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.01 0.924 . . . . 0.0 110.477 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.533 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 5.9 m-20 -67.0 -49.41 65.44 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.646 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.8 m -62.7 -36.01 81.57 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 122.576 0.351 . . . . 0.0 110.647 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -54.33 -57.52 10.92 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 123.81 0.844 . . . . 0.0 111.385 174.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -64.33 -33.13 75.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.438 0.462 . . . . 0.0 111.368 -175.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 5.3 mmp_? -60.69 -55.53 32.13 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.099 0.476 . . . . 0.0 110.412 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.412 HD22 ' N ' ' A' ' 73' ' ' ASN . 0.8 OUTLIER -66.6 -42.4 86.97 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.224 -173.057 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.5 tp -58.76 -56.02 27.58 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.111 0.964 . . . . 0.0 112.527 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -59.67 -42.06 92.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 123.447 0.467 . . . . 0.0 111.932 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.425 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 54.9 m -59.79 -53.08 62.11 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.3 tp -53.91 -46.48 71.46 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.813 1.645 . . . . 0.0 113.119 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -62.04 -48.34 80.68 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.998 0.519 . . . . 0.0 110.662 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -68.48 -22.95 64.53 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.42 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 76' ' ' THR . 61.1 mm-40 -71.56 -43.18 66.81 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.919 0.488 . . . . 0.0 110.135 169.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.0 mt -73.86 -15.58 61.15 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.921 0.888 . . . . 0.0 111.214 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.66 -6.79 80.04 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-O 119.601 -0.555 . . . . 0.0 112.923 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.418 HG22 ' HA ' ' A' ' 88' ' ' ARG . 77.8 mt -64.92 101.36 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.537 1.535 . . . . 0.0 110.271 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -144.31 167.84 21.49 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.523 1.129 . . . . 0.0 110.027 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.52 -122.89 23.96 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.506 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.97 -25.4 59.91 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.645 0.778 . . . . 0.0 111.307 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -75.61 -23.35 56.42 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.163 0.585 . . . . 0.0 110.407 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.423 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 15.0 ttm180 -57.88 137.48 56.64 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 124.103 0.961 . . . . 0.0 110.677 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.9 t -92.38 101.61 5.21 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.824 1.25 . . . . 0.0 109.723 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 88' ' ' ARG . 19.5 Cg_exo -68.15 153.69 74.17 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.994 2.463 . . . . 0.0 112.351 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.0 t -107.07 118.74 55.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.2 t -106.61 97.86 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -72.92 97.44 2.28 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.1 mt . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.221 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.578 ' HB3' HG12 ' A' ' 60' ' ' VAL . 69.1 ttp85 . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -73.56 109.2 6.89 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 37.9 pt -97.35 173.64 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 166.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.4 p -110.49 169.72 8.56 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 166.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.42 ' O ' HG23 ' A' ' 24' ' ' VAL . 69.9 t-105 -53.33 -37.67 62.51 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.119 0.968 . . . . 0.0 111.695 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -58.07 -46.01 86.16 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 176.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.541 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 39.5 m-20 -66.44 -35.31 79.98 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.128 0.571 . . . . 0.0 111.036 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.442 ' CZ ' HD11 ' A' ' 36' ' ' LEU . 31.7 t80 -59.77 -58.54 8.13 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.583 173.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.456 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 85.1 t -58.51 -57.11 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.179 0.592 . . . . 0.0 111.713 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -62.12 -56.23 20.94 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.031 0.832 . . . . 0.0 111.981 -173.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -84.49 -34.58 23.34 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.67 -168.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.404 ' HA ' HG22 ' A' ' 32' ' ' VAL . 21.2 m-85 -114.36 -62.25 1.63 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -162.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.456 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 68.4 tp -59.42 -51.12 71.26 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.294 1.038 . . . . 0.0 111.172 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.9 t -59.38 -24.19 63.22 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.001 0.92 . . . . 0.0 113.024 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -98.66 -6.0 30.58 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.547 0.339 . . . . 0.0 111.504 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.06 31.38 58.76 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 114.477 0.551 . . . . 0.0 114.477 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 27' ' ' TYR . 20.7 m -81.93 0.65 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.693 0.397 . . . . 0.0 110.882 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.9 t -98.65 128.48 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.514 1.126 . . . . 0.0 109.799 -173.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.555 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 31.0 t70 -77.81 -47.08 19.74 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.776 0.83 . . . . 0.0 109.692 177.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HD2' HG21 ' A' ' 92' ' ' VAL . 31.7 ptt-85 -162.68 163.93 26.73 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.968 0.793 . . . . 0.0 111.243 -174.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.442 HD11 ' CZ ' ' A' ' 23' ' ' PHE . 60.3 mt -117.8 104.66 11.17 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.583 1.153 . . . . 0.0 109.428 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -87.79 101.96 14.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.844 0.857 . . . . 0.0 109.767 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 44' ' ' VAL . 35.6 t -88.32 91.3 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -175.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.9 t -92.91 119.69 41.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.825 -170.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 58.66 18.61 6.02 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.979 1.312 . . . . 0.0 112.56 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 54.84 21.09 3.4 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.87 1.268 . . . . 0.0 113.314 175.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -107.69 -28.51 9.67 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.283 1.033 . . . . 0.0 110.466 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -152.56 159.03 43.3 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.969 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 38' ' ' VAL . 57.9 t -124.03 130.67 73.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 -98.14 124.79 42.86 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.499 ' HB ' HG23 ' A' ' 60' ' ' VAL . 55.9 t -82.67 107.72 14.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.1 m -93.62 128.61 39.86 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -85.1 164.56 18.1 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.014 0.821 . . . . 0.0 109.519 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.555 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 11.5 t . . . . . 0 CA--C 1.557 1.233 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.8 p90 . . . . . 0 C--O 1.244 0.769 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.578 HG12 ' HB3' ' A' ' 16' ' ' ARG . 27.8 m -129.18 178.75 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.329 0.652 . . . . 0.0 109.724 177.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -157.86 162.05 38.35 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.995 0.518 . . . . 0.0 110.245 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.431 ' HB3' HG13 ' A' ' 18' ' ' ILE . 47.4 p90 -145.73 153.75 41.31 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.326 0.65 . . . . 0.0 109.454 175.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -80.34 152.76 28.77 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.787 0.435 . . . . 0.0 110.748 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.8 pt -126.01 144.45 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.232 0.613 . . . . 0.0 109.445 172.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.05 -61.99 2.56 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.1 m -127.48 133.71 49.86 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.674 0.789 . . . . 0.0 109.024 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.4 t -57.87 -40.47 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.351 1.06 . . . . 0.0 111.506 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.09 -40.41 96.18 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.619 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.405 HG22 HD21 ' A' ' 73' ' ' ASN . 19.2 m -67.88 -45.08 75.5 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -51.04 -52.94 38.11 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.481 1.112 . . . . 0.0 112.495 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -71.32 -35.97 71.41 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.466 0.478 . . . . 0.0 110.838 -174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -66.97 -39.56 87.26 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.573 0.349 . . . . 0.0 110.589 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.405 HD21 HG22 ' A' ' 69' ' ' THR . 94.5 m-20 -66.79 -52.62 41.84 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.088 0.555 . . . . 0.0 110.173 177.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.4 tp -53.48 -55.08 28.32 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.205 1.002 . . . . 0.0 111.377 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 79' ' ' GLN . 68.6 mm-40 -61.84 -48.92 78.37 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.796 0.685 . . . . 0.0 112.725 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 58.1 m -64.53 -50.11 68.64 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.471 0.482 . . . . 0.0 110.116 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.8 tp -50.26 -46.29 54.89 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.229 1.411 . . . . 0.0 112.471 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -61.65 -46.75 88.45 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.842 0.457 . . . . 0.0 110.641 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 75.0 mt-30 -62.69 -34.76 77.79 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.255 0.622 . . . . 0.0 111.065 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.8 -39.31 57.1 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.81 0.844 . . . . 0.0 111.702 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.57 -21.34 61.16 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.601 0.361 . . . . 0.0 110.951 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.3 -5.65 57.51 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 120.075 -0.292 . . . . 0.0 113.019 -173.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.7 mt -70.08 121.53 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 124.478 1.111 . . . . 0.0 109.984 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -162.42 162.48 27.71 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.077 0.551 . . . . 0.0 111.107 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.97 -111.09 3.64 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.636 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.97 -23.75 58.33 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.902 0.881 . . . . 0.0 110.901 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.75 -26.71 29.46 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 ttm105 -63.32 123.38 18.55 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.5 t -72.69 119.57 75.94 Favored Pre-proline 0 CA--C 1.555 1.155 0 O-C-N 123.808 0.693 . . . . 0.0 110.247 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 31.9 Cg_exo -60.41 141.22 95.05 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.42 2.747 . . . . 0.0 112.523 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.6 t -111.69 114.94 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.446 HG21 ' HD2' ' A' ' 35' ' ' ARG . 60.8 t -109.15 98.33 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.212 1.005 . . . . 0.0 109.043 -173.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -71.7 114.86 10.23 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.939 0.496 . . . . 0.0 110.434 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 58.7 mt . . . . . 0 CA--C 1.543 0.702 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.373 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.483 ' HB3' HG12 ' A' ' 60' ' ' VAL . 34.9 ttm180 . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -75.12 133.23 41.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.1 pt -128.67 168.82 21.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.755 1.222 . . . . 0.0 108.292 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.4 p -85.75 161.01 19.36 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.478 ' O ' HG23 ' A' ' 24' ' ' VAL . 61.2 t-105 -51.03 -48.98 61.36 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.933 0.893 . . . . 0.0 111.146 174.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -75.21 -24.13 57.71 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.515 0.509 . . . . 0.0 111.863 -175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -65.53 -42.81 91.57 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 172.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 17.7 t80 -56.44 -51.22 69.24 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.877 172.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 20' ' ' TRP . 60.8 t -58.11 -61.88 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.844 0.458 . . . . 0.0 111.035 -177.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.498 ' N ' HD22 ' A' ' 25' ' ' ASN . 0.7 OUTLIER -68.16 -46.17 71.49 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.427 0.691 . . . . 0.0 111.768 -166.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.406 ' O ' ' HD2' ' A' ' 30' ' ' LYS . 62.8 m-20 -84.77 -34.13 22.88 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.472 -172.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.428 ' HA ' HG22 ' A' ' 32' ' ' VAL . 88.0 m-85 -112.29 -66.57 1.07 Allowed 'General case' 0 C--O 1.248 0.977 0 O-C-N 121.849 -0.532 . . . . 0.0 111.825 -166.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.571 HD11 HG21 ' A' ' 89' ' ' VAL . 21.2 tp -64.57 -48.3 75.5 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -170.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 m -65.67 -21.2 66.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.627 0.771 . . . . 0.0 112.429 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' A' ' 26' ' ' ASN . 55.2 mttp -98.14 -1.02 43.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.858 0.863 . . . . 0.0 111.62 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.12 23.23 61.59 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 115.364 0.905 . . . . 0.0 115.364 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 27' ' ' TYR . 17.6 m -88.36 11.62 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 117.476 0.638 . . . . 0.0 110.668 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.43 136.16 31.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 125.193 1.397 . . . . 0.0 108.938 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.511 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 25.8 t70 -87.55 -49.05 7.44 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.918 0.887 . . . . 0.0 109.014 172.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 6.4 ptp180 -164.2 172.42 13.67 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.523 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.2 mt -119.95 112.97 19.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.201 1.001 . . . . 0.0 110.222 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -99.6 104.49 16.27 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.913 0.885 . . . . 0.0 110.069 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.522 HG22 HG22 ' A' ' 44' ' ' VAL . 28.2 t -86.83 99.61 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -175.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.3 t -89.54 123.05 41.56 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 C-N-CA 123.942 0.897 . . . . 0.0 110.367 -169.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 54.12 18.45 1.76 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.569 1.548 . . . . 0.0 113.14 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HB3' HG21 ' A' ' 67' ' ' VAL . 94.8 mttt 57.09 16.04 2.72 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.584 1.154 . . . . 0.0 113.496 -176.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -91.55 -32.87 15.38 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.334 0.654 . . . . 0.0 110.483 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -156.69 170.61 22.02 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.528 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.522 HG22 HG22 ' A' ' 38' ' ' VAL . 59.2 t -117.31 129.47 73.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.035 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -96.15 122.63 39.2 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.462 1.105 . . . . 0.0 108.08 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 60' ' ' VAL . 46.3 t -84.72 112.13 21.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.4 HG22 ' HB3' ' A' ' 34' ' ' ASP . 86.7 m -90.08 132.61 35.32 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.61 ' HE2' ' HA ' ' A' ' 59' ' ' TYR . 53.1 m-85 -84.33 146.82 27.51 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.568 0.747 . . . . 0.0 110.286 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.511 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.7 OUTLIER . . . . . 0 CA--C 1.565 1.533 0 C-N-CA 123.626 0.77 . . . . 0.0 110.154 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.61 ' HA ' ' HE2' ' A' ' 48' ' ' PHE . 35.6 p90 . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 120.59 0.233 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.52 HG23 ' HB ' ' A' ' 46' ' ' VAL . 27.6 m -110.38 153.36 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 169.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 -160.3 166.25 29.83 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.615 0.766 . . . . 0.0 109.777 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -147.78 140.39 24.64 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.35 0.66 . . . . 0.0 109.939 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -84.58 126.92 33.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.323 0.649 . . . . 0.0 109.637 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.586 HD12 ' HA ' ' A' ' 67' ' ' VAL . 41.3 pt -104.61 -41.13 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 122.508 0.323 . . . . 0.0 111.754 -173.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.78 -80.43 0.12 Allowed Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 -171.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.3 m -71.4 95.45 1.35 Allowed 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.788 0.835 . . . . 0.0 109.901 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.586 ' HA ' HD12 ' A' ' 64' ' ' ILE . 58.5 t -61.49 -40.34 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.522 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 5.8 m-20 -58.57 -44.53 89.78 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.856 0.863 . . . . 0.0 110.478 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.0 m -66.67 -40.31 88.55 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.702 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -55.77 -46.09 77.98 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 123.258 0.623 . . . . 0.0 110.618 173.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 47.4 mt-10 -64.07 -44.95 90.84 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 124.244 0.965 . . . . 0.0 109.973 -176.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 4.5 mmp_? -59.15 -51.22 70.93 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 124.186 0.928 . . . . 0.0 111.262 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -65.6 -40.47 92.71 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.41 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.9 -50.25 72.94 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.672 0.789 . . . . 0.0 112.197 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -32.98 70.29 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -175.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.2 m -64.11 -44.9 90.84 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.189 0.596 . . . . 0.0 109.846 171.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.449 HD21 HG22 ' A' ' 24' ' ' VAL . 34.3 tp -63.05 -37.4 87.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.699 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -63.94 -38.43 91.04 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.347 0.659 . . . . 0.0 109.998 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -68.08 -36.73 80.3 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 175.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.07 -46.0 72.28 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.038 0.535 . . . . 0.0 111.383 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.0 mt -82.42 2.22 33.64 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.627 0.771 . . . . 0.0 112.259 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.47 14.6 79.39 Favored Glycine 0 C--N 1.358 1.787 0 O-C-N 123.311 0.382 . . . . 0.0 113.684 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 87.2 mt -82.56 111.66 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.282 1.433 . . . . 0.0 109.603 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.39 168.02 28.64 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.124 0.57 . . . . 0.0 111.605 -175.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.11 -126.41 23.08 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.492 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.81 -14.24 60.67 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.039 0.536 . . . . 0.0 110.487 177.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -79.64 -16.16 56.28 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.855 0.862 . . . . 0.0 111.699 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -51.1 129.89 24.94 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.067 0.947 . . . . 0.0 111.002 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.571 HG21 HD11 ' A' ' 28' ' ' LEU . 49.6 t -63.02 113.1 8.19 Favored Pre-proline 0 N--CA 1.474 0.727 0 O-C-N 124.484 1.115 . . . . 0.0 109.905 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.4 ' HG2' ' HB3' ' A' ' 35' ' ' ARG . 54.4 Cg_endo -68.76 115.59 4.02 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.344 2.029 . . . . 0.0 111.137 -177.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.2 t -108.45 121.05 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.4 t -116.57 119.68 62.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -174.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -90.07 113.66 25.42 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 176.591 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HB3' HG12 ' A' ' 60' ' ' VAL . 20.9 tpp180 . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 120.422 0.153 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.63 110.15 13.49 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 27.4 pt -104.73 174.06 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.393 1.477 . . . . 0.0 109.959 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.6 p -91.3 168.74 11.36 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 169.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.564 ' O ' HG23 ' A' ' 24' ' ' VAL . 74.1 t-105 -57.07 -41.68 79.22 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.74 0.65 . . . . 0.0 109.473 168.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -55.66 -50.62 69.75 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.304 1.041 . . . . 0.0 112.409 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.499 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 65.1 m-20 -62.97 -38.95 93.14 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.856 0.462 . . . . 0.0 110.184 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.44 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 34.5 t80 -55.04 -50.51 68.9 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.663 1.227 . . . . 0.0 110.873 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 20' ' ' TRP . 47.1 t -58.12 -62.42 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 123.611 0.569 . . . . 0.0 110.895 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -65.87 -53.76 35.5 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.954 -168.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -84.73 -21.49 30.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.154 0.582 . . . . 0.0 111.86 -167.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.44 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 73.0 m-85 -122.75 -69.35 0.83 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -169.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.54 -56.54 20.79 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.834 0.853 . . . . 0.0 111.467 -173.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.6 m -60.38 -20.33 59.16 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.215 1.006 . . . . 0.0 112.891 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -94.05 -9.13 37.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.667 0.787 . . . . 0.0 111.617 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.27 21.5 68.37 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.723 0.64 . . . . 0.0 114.385 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.429 HG22 ' HA ' ' A' ' 27' ' ' TYR . 10.4 m -80.74 -5.39 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 117.143 0.472 . . . . 0.0 110.984 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.8 t -93.75 130.07 43.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 123.321 0.648 . . . . 0.0 109.332 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.459 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 30.1 t70 -83.97 -51.96 6.71 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.495 1.118 . . . . 0.0 109.739 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.497 ' HD2' HG21 ' A' ' 92' ' ' VAL . 25.0 ptt180 -158.16 160.47 37.27 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.293 -174.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.8 mt -118.03 103.0 9.48 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.998 0.919 . . . . 0.0 109.027 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 43.4 mt-10 -87.55 108.65 19.15 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.415 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 41' ' ' LYS . 43.0 t -84.83 92.82 3.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -177.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 96.0 t -81.73 109.81 16.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.101 -167.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 52.25 27.25 4.56 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 125.548 1.539 . . . . 0.0 112.945 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.552 ' HA ' HG12 ' A' ' 38' ' ' VAL . 35.3 mtmm 63.31 -4.44 0.3 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.077 1.351 . . . . 0.0 113.869 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -76.08 -38.88 56.48 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.386 1.074 . . . . 0.0 110.604 -171.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -153.44 179.98 8.29 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.574 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 38' ' ' VAL . 98.3 t -127.64 131.44 70.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 123.97 0.908 . . . . 0.0 108.694 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -100.41 123.63 44.88 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -81.86 108.77 15.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.869 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.3 m -86.14 131.4 34.26 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -85.06 149.94 25.21 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.459 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 42.1 p . . . . . 0 CA--C 1.548 0.87 0 O-C-N 123.416 0.447 . . . . 0.0 110.391 175.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 121.085 0.469 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 16' ' ' ARG . 20.0 m -107.23 164.41 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -162.69 162.81 27.07 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.785 0.326 . . . . 0.0 111.119 -172.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -145.06 146.69 31.97 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.727 0.811 . . . . 0.0 109.379 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -81.65 140.07 34.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.19 0.596 . . . . 0.0 109.591 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 65' ' ' GLY . 42.7 pt -117.12 -49.0 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.589 0.356 . . . . 0.0 111.434 -177.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.439 ' N ' HG13 ' A' ' 64' ' ' ILE . . . 67.67 -78.2 0.19 Allowed Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.949 -0.46 . . . . 0.0 111.949 -171.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.5 m -74.27 94.09 2.45 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.595 0.758 . . . . 0.0 109.663 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.428 ' HA ' HD12 ' A' ' 64' ' ' ILE . 40.3 t -60.6 -36.66 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.805 1.242 . . . . 0.0 111.172 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -62.66 -39.13 92.95 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.553 0.741 . . . . 0.0 110.331 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.9 m -70.19 -41.44 73.69 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 123.503 0.502 . . . . 0.0 110.666 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -52.85 -53.39 49.51 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.19 0.596 . . . . 0.0 110.735 174.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -60.51 -52.41 65.32 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 124.509 1.13 . . . . 0.0 111.425 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.506 ' HE ' ' HA ' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -59.28 -46.39 88.67 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.508 1.123 . . . . 0.0 111.921 -174.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.424 HD22 ' N ' ' A' ' 73' ' ' ASN . 0.8 OUTLIER -67.47 -41.89 83.86 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.391 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.459 ' HG ' ' NE2' ' A' ' 78' ' ' GLN . 33.4 tp -59.55 -43.41 93.53 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 124.108 0.88 . . . . 0.0 111.465 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -60.27 -56.44 21.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.841 0.857 . . . . 0.0 111.059 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.1 m -63.22 -48.57 77.73 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.43 1.081 . . . . 0.0 110.303 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.545 HD21 HG22 ' A' ' 24' ' ' VAL . 42.9 tp -53.99 -53.06 58.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.77 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.459 ' NE2' ' HG ' ' A' ' 74' ' ' LEU . 45.0 mt-30 -66.8 -30.17 70.3 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.266 0.354 . . . . 0.0 111.266 -178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -63.86 -38.68 92.0 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.615 0.366 . . . . 0.0 110.076 172.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -70.14 -43.92 69.94 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.221 0.608 . . . . 0.0 110.99 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 76.5 mt -71.22 -18.75 62.44 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.624 0.77 . . . . 0.0 111.578 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.02 8.1 76.29 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.282 0.364 . . . . 0.0 112.982 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.516 HG22 ' HA ' ' A' ' 88' ' ' ARG . 80.1 mt -82.52 97.08 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 125.343 1.457 . . . . 0.0 108.769 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -138.93 155.52 47.99 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.836 -0.54 . . . . 0.0 111.51 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.44 -99.85 0.11 Allowed Glycine 0 C--N 1.354 1.532 0 O-C-N 124.74 1.275 . . . . 0.0 113.893 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -75.59 -29.04 59.15 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.348 1.059 . . . . 0.0 111.427 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -87.82 -23.46 24.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.379 0.672 . . . . 0.0 111.277 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.516 ' HA ' HG22 ' A' ' 83' ' ' ILE . 43.0 ttm180 -61.48 119.54 8.78 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.401 0.68 . . . . 0.0 110.557 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 80.4 t -66.65 118.94 59.16 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.829 0.852 . . . . 0.0 111.225 -175.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.44 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 31.5 Cg_exo -60.58 146.87 96.26 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.294 2.662 . . . . 0.0 113.239 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.4 t -104.91 129.84 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.497 HG21 ' HD2' ' A' ' 35' ' ' ARG . 4.5 t -127.78 98.99 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.505 0.722 . . . . 0.0 109.394 -175.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -69.55 106.33 2.97 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 29.9 mm . . . . . 0 C--O 1.22 -0.457 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -175.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.436 ' HB2' HG12 ' A' ' 60' ' ' VAL . 49.7 mtp180 . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 120.342 0.115 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -79.92 110.92 15.76 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 165.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 34.4 pt -96.13 174.39 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 123.99 0.916 . . . . 0.0 110.61 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.2 p -98.21 168.63 10.12 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 166.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.472 ' CZ2' HD22 ' A' ' 77' ' ' LEU . 61.7 t-105 -55.41 -37.22 67.34 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.685 0.794 . . . . 0.0 110.781 175.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -56.08 -48.66 75.67 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.518 0.727 . . . . 0.0 111.671 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.57 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 34.4 m-20 -65.53 -42.27 92.18 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.414 0.286 . . . . 0.0 110.791 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.4 ' HE1' HD21 ' A' ' 36' ' ' LEU . 13.9 t80 -50.35 -48.17 55.65 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.51 1.131 . . . . 0.0 111.116 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.531 HG22 HD21 ' A' ' 77' ' ' LEU . 90.7 t -71.97 -62.07 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 O-C-N 123.421 0.45 . . . . 0.0 110.82 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -69.87 -52.65 23.04 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.03 0.532 . . . . 0.0 111.737 -167.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -80.01 -19.48 47.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.912 0.485 . . . . 0.0 112.049 -171.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -126.12 -69.95 0.75 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -171.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.403 HD11 HG21 ' A' ' 89' ' ' VAL . 22.1 tp -63.79 -43.61 95.81 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -166.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.2 p -73.23 -11.38 60.49 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.904 0.481 . . . . 0.0 111.944 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -92.61 -9.22 41.81 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.252 0.621 . . . . 0.0 110.64 173.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.78 27.83 67.25 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 114.047 0.379 . . . . 0.0 114.047 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.7 m -86.87 6.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 116.972 0.386 . . . . 0.0 110.548 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.26 125.72 51.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.023 0.929 . . . . 0.0 108.964 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.515 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 28.5 t70 -77.34 -54.08 6.9 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.315 1.046 . . . . 0.0 108.196 172.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.432 ' HD2' HG21 ' A' ' 92' ' ' VAL . 43.0 ttp180 -154.9 153.19 30.72 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.024 -164.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.4 HD21 ' HE1' ' A' ' 23' ' ' PHE . 97.9 mt -113.32 119.82 39.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.88 1.272 . . . . 0.0 108.535 175.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -111.92 106.48 15.19 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.383 0.673 . . . . 0.0 110.312 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.408 HG22 HG22 ' A' ' 44' ' ' VAL . 44.9 t -81.61 98.48 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 54.7 t -94.96 122.41 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 122.862 0.465 . . . . 0.0 110.522 -171.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 60.11 15.24 5.01 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.245 1.418 . . . . 0.0 113.434 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.9 mttm 65.64 -3.02 0.76 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.534 1.533 . . . . 0.0 112.778 -175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -87.62 -32.51 19.24 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.11 0.964 . . . . 0.0 109.982 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -154.2 171.28 19.44 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.488 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.408 HG22 HG22 ' A' ' 38' ' ' VAL . 54.4 t -128.86 133.87 65.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -99.52 130.36 45.77 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.4 t -82.85 106.58 13.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 172.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.4 m -94.11 126.02 39.08 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -81.84 152.38 26.92 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.875 0.734 . . . . 0.0 111.24 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.515 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.2 OUTLIER . . . . . 0 CA--C 1.558 1.286 0 CA-C-O 117.802 -1.094 . . . . 0.0 109.061 173.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 C--O 1.238 0.486 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 16' ' ' ARG . 27.1 m -105.73 156.52 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.333 -172.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -150.91 158.41 44.11 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.848 0.459 . . . . 0.0 111.37 -173.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -140.32 139.24 35.4 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.397 0.679 . . . . 0.0 109.298 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -79.34 131.58 36.17 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.443 0.697 . . . . 0.0 110.323 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.7 pt -110.05 143.08 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.931 0.892 . . . . 0.0 109.298 173.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.11 -43.28 7.17 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.8 t -131.25 140.34 49.81 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.92 0.888 . . . . 0.0 109.282 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 62.0 t -60.11 -41.74 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 123.679 0.612 . . . . 0.0 110.226 172.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.22 -42.14 80.81 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.323 0.649 . . . . 0.0 111.631 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 m -66.12 -45.77 79.93 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.194 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -55.65 -48.42 75.04 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.836 0.454 . . . . 0.0 111.271 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 39.4 mm-40 -62.43 -52.9 61.69 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.342 0.657 . . . . 0.0 111.292 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -67.41 -38.3 84.42 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.659 0.783 . . . . 0.0 111.396 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -67.09 -35.86 80.72 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 122.658 0.383 . . . . 0.0 110.317 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.99 -32.25 71.68 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.071 0.548 . . . . 0.0 111.503 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 51.5 mm-40 -62.09 -51.78 66.54 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.153 0.501 . . . . 0.0 110.172 173.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.461 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 25.7 m -62.9 -47.95 81.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.242 -1.344 . . . . 0.0 110.395 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.531 HD21 HG22 ' A' ' 24' ' ' VAL . 49.6 tp -57.94 -57.92 10.7 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.405 1.082 . . . . 0.0 112.2 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 45.5 mt-30 -62.12 -39.92 94.17 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 123.715 0.634 . . . . 0.0 111.514 -174.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -66.46 -33.92 76.77 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 76' ' ' THR . 43.3 mm-40 -70.18 -39.98 74.93 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.795 0.438 . . . . 0.0 110.573 176.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.25 -12.43 60.86 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.602 0.761 . . . . 0.0 111.166 176.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.33 -8.09 79.71 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.944 -0.365 . . . . 0.0 112.829 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 70.7 mt -67.76 105.53 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.254 1.422 . . . . 0.0 109.172 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -151.46 159.59 44.12 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.561 0.344 . . . . 0.0 111.432 -174.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.3 -124.34 33.27 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.926 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -66.3 -22.52 66.29 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.306 1.043 . . . . 0.0 111.752 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -83.54 -5.18 59.09 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.232 0.613 . . . . 0.0 112.362 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -65.56 142.2 58.18 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 120.803 0.335 . . . . 0.0 111.325 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.403 HG21 HD11 ' A' ' 28' ' ' LEU . 59.8 t -82.84 122.99 78.44 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.92 0.888 . . . . 0.0 109.516 -175.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.14 132.76 43.25 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.413 2.742 . . . . 0.0 113.786 -171.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.3 t -108.28 119.84 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.0 0.92 . . . . 0.0 108.877 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.432 HG21 ' HD2' ' A' ' 35' ' ' ARG . 41.7 t -129.37 121.94 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.018 0.927 . . . . 0.0 109.11 -173.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -84.98 116.68 23.52 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.037 0.535 . . . . 0.0 110.24 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 49.8 mm . . . . . 0 N--CA 1.472 0.663 0 C-N-CA 124.104 0.961 . . . . 0.0 108.758 -176.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 6.3 ptm180 . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.944 0.402 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.507 ' HG3' ' HA ' ' A' ' 62' ' ' PHE . 32.6 tt0 -85.35 128.1 34.58 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 pt -109.88 179.61 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 125.696 1.598 . . . . 0.0 109.621 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.8 p -89.93 154.15 20.07 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.074 0.95 . . . . 0.0 109.441 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.426 ' O ' HG23 ' A' ' 24' ' ' VAL . 54.4 t-105 -59.93 -43.37 94.96 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.513 0.725 . . . . 0.0 110.282 176.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -53.85 -48.67 69.75 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 123.952 0.783 . . . . 0.0 111.292 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' A' ' 26' ' ' ASN . 26.3 t70 -70.09 -34.96 73.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.778 0.431 . . . . 0.0 110.224 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.415 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 18.0 t80 -55.78 -46.12 78.01 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.945 0.498 . . . . 0.0 110.627 175.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 20' ' ' TRP . 79.9 t -61.98 -71.38 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 123.602 0.564 . . . . 0.0 110.783 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -73.66 -31.77 63.65 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.923 -161.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 22' ' ' ASP . 54.9 t30 -90.99 -23.59 20.35 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.665 0.786 . . . . 0.0 111.902 -176.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.415 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 75.4 m-85 -124.62 -66.42 0.98 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -172.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.64 -49.83 76.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.718 0.807 . . . . 0.0 111.401 -174.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.0 m -64.5 -20.74 66.39 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.555 1.142 . . . . 0.0 112.161 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -97.1 0.14 48.04 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.507 0.723 . . . . 0.0 111.301 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.92 26.61 60.95 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 115.543 0.977 . . . . 0.0 115.543 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.8 m -90.7 3.9 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 122.898 0.479 . . . . 0.0 111.405 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.3 126.06 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.887 0.875 . . . . 0.0 108.926 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.486 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 30.9 t70 -84.1 -51.61 6.94 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.546 1.138 . . . . 0.0 109.967 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -154.07 161.61 41.79 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.583 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.05 101.83 9.37 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.9 0.88 . . . . 0.0 108.67 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -87.0 101.13 13.15 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.102 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.709 HG12 ' HA ' ' A' ' 41' ' ' LYS . 19.8 t -88.54 90.2 3.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -173.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.9 t -81.43 127.76 39.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.6 -173.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 59.95 19.51 8.55 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.8 2.04 . . . . 0.0 111.452 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.709 ' HA ' HG12 ' A' ' 38' ' ' VAL . 19.7 pttm 42.06 18.29 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 126.287 1.835 . . . . 0.0 115.251 -167.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.3 ttp-105 -98.93 -30.49 12.34 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.149 0.98 . . . . 0.0 109.102 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -147.62 152.12 37.36 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.02 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 59.0 t -110.97 128.07 67.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.541 1.137 . . . . 0.0 108.465 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -100.67 124.73 46.68 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.1 t -82.69 105.39 12.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.7 m -92.1 125.91 36.97 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -84.87 148.98 25.99 Favored 'General case' 0 C--O 1.241 0.607 0 O-C-N 123.723 0.64 . . . . 0.0 111.917 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.486 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 10.0 p . . . . . 0 CA--C 1.55 0.946 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.779 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 . . . . . 0 C--O 1.241 0.654 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 16' ' ' ARG . 33.2 m -106.38 154.96 7.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -157.57 174.94 14.6 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.173 0.589 . . . . 0.0 110.11 -175.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.507 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 33.9 p90 -157.6 147.32 20.26 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.974 0.51 . . . . 0.0 110.253 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -91.09 130.16 37.01 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 67' ' ' VAL . 30.3 pt -102.93 -46.99 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.217 0.607 . . . . 0.0 111.334 -176.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.26 -83.24 0.43 Allowed Glycine 0 C--N 1.345 1.082 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -167.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.8 t -72.45 96.74 1.95 Allowed 'General case' 0 C--O 1.249 1.027 0 CA-C-O 121.778 0.799 . . . . 0.0 109.875 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.598 ' HA ' HD12 ' A' ' 64' ' ' ILE . 11.0 t -56.04 -39.33 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 113.952 -1.477 . . . . 0.0 110.999 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -58.26 -42.37 86.3 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.049 0.843 . . . . 0.0 111.02 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.0 m -64.67 -45.73 85.47 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 123.657 0.598 . . . . 0.0 110.159 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -52.66 -50.83 62.44 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.816 0.698 . . . . 0.0 111.266 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -63.58 -46.19 86.99 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.135 0.897 . . . . 0.0 110.774 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 mtp-105 -59.35 -49.47 77.71 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.765 0.826 . . . . 0.0 111.41 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -66.32 -43.6 85.72 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.435 0.694 . . . . 0.0 110.18 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.3 tp -56.13 -49.6 73.45 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.272 1.029 . . . . 0.0 110.736 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -66.62 -49.17 67.16 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.446 0.698 . . . . 0.0 111.649 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.4 m -60.17 -44.61 94.88 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.46 0.648 . . . . 0.0 109.926 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.9 tp -57.81 -53.38 58.81 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.757 175.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.412 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 22.9 mt-30 -64.89 -45.04 87.62 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.28 0.632 . . . . 0.0 111.018 -173.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.56 -38.2 83.79 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.312 0.645 . . . . 0.0 110.633 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.34 -41.12 90.05 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.2 1.0 . . . . 0.0 110.978 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.1 mt -87.29 0.77 54.9 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.487 0.715 . . . . 0.0 111.458 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.25 -4.32 63.37 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.595 -0.558 . . . . 0.0 113.809 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 68.4 mt -68.08 116.31 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.672 1.189 . . . . 0.0 109.47 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -161.1 148.26 15.16 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.082 0.553 . . . . 0.0 110.497 -173.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.07 -89.84 0.01 OUTLIER Glycine 0 C--N 1.349 1.263 0 O-C-N 124.923 1.389 . . . . 0.0 114.722 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.41 -44.31 83.36 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.29 1.036 . . . . 0.0 110.565 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -98.65 -1.46 40.72 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.445 0.698 . . . . 0.0 111.741 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -70.44 134.41 47.77 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 122.994 0.184 . . . . 0.0 110.939 -178.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.2 t -72.37 112.51 15.09 Favored Pre-proline 0 CA--C 1.561 1.391 0 O-C-N 124.165 0.916 . . . . 0.0 109.49 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.92 142.63 57.67 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.981 2.454 . . . . 0.0 113.117 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.4 t -105.75 118.2 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.461 1.104 . . . . 0.0 109.178 -175.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.7 t -119.93 98.96 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.583 0.753 . . . . 0.0 110.166 -171.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -75.3 109.59 8.95 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.153 0.581 . . . . 0.0 110.585 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.7 mt . . . . . 0 N--CA 1.476 0.853 0 C-N-CA 123.983 0.913 . . . . 0.0 108.54 -178.36 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.667 ' HB3' HG12 ' A' ' 60' ' ' VAL . 20.0 ttt180 . . . . . 0 C--O 1.237 0.396 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.9 109.33 8.27 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.7 pt -106.8 175.38 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.685 1.194 . . . . 0.0 108.762 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.0 p -97.2 167.92 10.75 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.521 ' O ' HG23 ' A' ' 24' ' ' VAL . 69.1 t-105 -57.5 -41.97 81.8 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 123.462 0.476 . . . . 0.0 110.04 169.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -60.4 -49.39 77.76 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.71 0.404 . . . . 0.0 111.761 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.51 -38.79 90.73 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.298 0.639 . . . . 0.0 110.591 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.453 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 40.3 t80 -52.56 -53.46 46.11 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.968 172.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.579 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 69.1 t -60.33 -47.77 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.11 0.564 . . . . 0.0 110.769 -177.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.28 -55.91 11.96 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.521 -173.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -85.01 -27.88 26.12 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.453 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 87.1 m-85 -117.01 -68.86 0.89 Allowed 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -165.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.579 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 56.6 tp -59.91 -45.28 93.05 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.457 1.103 . . . . 0.0 113.149 -171.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 81.2 p -64.53 -21.29 66.64 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.066 0.546 . . . . 0.0 112.39 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -99.2 -9.05 24.21 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.794 0.837 . . . . 0.0 110.728 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.44 37.72 88.88 Favored Glycine 0 C--N 1.348 1.218 0 O-C-N 123.835 0.709 . . . . 0.0 114.836 -173.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 m -79.76 -3.46 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.453 ' HB ' HG21 ' A' ' 89' ' ' VAL . 16.6 t -99.54 128.08 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.911 0.884 . . . . 0.0 109.308 -175.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -86.72 -48.24 8.43 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.161 1.385 . . . . 0.0 110.312 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.513 ' HD3' HG21 ' A' ' 92' ' ' VAL . 19.2 ptp180 -158.49 149.39 20.48 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.857 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.563 ' HG ' HG11 ' A' ' 89' ' ' VAL . 31.4 mt -108.16 102.0 11.18 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.45 ' HB3' HD12 ' A' ' 94' ' ' ILE . 52.1 mt-10 -93.6 105.79 17.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.864 -172.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.528 HG22 HG22 ' A' ' 44' ' ' VAL . 48.3 t -81.06 102.12 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -176.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.3 t -90.23 114.71 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.263 0.625 . . . . 0.0 109.537 -173.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.3 m120 58.94 16.75 4.82 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.434 1.493 . . . . 0.0 113.688 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 90.6 mttt 60.35 8.58 1.65 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.447 1.099 . . . . 0.0 113.335 -171.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 -81.67 -39.51 24.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.924 0.889 . . . . 0.0 109.516 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -155.33 174.82 14.68 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.267 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.528 HG22 HG22 ' A' ' 38' ' ' VAL . 59.4 t -123.81 131.53 72.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -103.29 127.32 50.65 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.439 0.695 . . . . 0.0 109.439 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 80.2 t -84.08 110.16 18.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.621 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.5 m -90.44 141.62 28.56 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 170.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.429 ' HE2' ' HA ' ' A' ' 59' ' ' TYR . 63.3 m-85 -97.38 149.69 21.84 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 176.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 CA--C 1.548 0.87 0 C-N-CA 124.224 1.01 . . . . 0.0 111.419 179.916 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.429 ' HA ' ' HE2' ' A' ' 48' ' ' PHE . 11.6 m-85 . . . . . 0 N--CA 1.469 0.485 0 CA-C-O 121.539 0.685 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.667 HG12 ' HB3' ' A' ' 16' ' ' ARG . 33.8 m -131.39 170.12 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -167.04 160.1 13.76 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.141 0.576 . . . . 0.0 110.091 -174.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -144.1 140.17 29.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.998 0.519 . . . . 0.0 110.351 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -77.08 147.05 36.88 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.406 0.682 . . . . 0.0 110.27 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 67' ' ' VAL . 40.3 pt -131.03 139.4 51.18 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 C-N-CA 123.552 0.741 . . . . 0.0 109.992 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.34 -44.36 17.53 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 172.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.7 t -131.16 129.84 42.28 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.992 0.917 . . . . 0.0 110.285 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.444 ' HA ' HD12 ' A' ' 64' ' ' ILE . 15.6 t -64.41 -37.99 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.796 0.838 . . . . 0.0 110.691 171.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.598 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 31.3 t70 -62.23 -56.53 17.7 Favored 'General case' 0 C--O 1.216 -0.694 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.5 m -55.24 -45.42 76.03 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.943 0.497 . . . . 0.0 111.176 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -47.3 -56.15 7.36 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.411 1.084 . . . . 0.0 112.096 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 12.2 pt-20 -73.27 -28.77 62.31 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.814 -173.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 18.1 mmm-85 -59.98 -45.76 91.66 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 176.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -67.57 -38.37 84.0 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.705 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 tp -57.28 -56.73 18.03 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.697 0.623 . . . . 0.0 111.059 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 79' ' ' GLN . 32.0 mt-10 -59.92 -47.74 84.55 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.023 0.929 . . . . 0.0 112.693 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 51.5 m -61.56 -48.87 79.0 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.504 0.669 . . . . 0.0 110.144 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 35.6 tp -57.56 -38.94 75.63 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.251 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.742 ' HB3' HD11 ' A' ' 83' ' ' ILE . 25.0 mt-30 -63.81 -39.03 93.27 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.522 0.729 . . . . 0.0 110.434 175.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 76.7 mt-30 -67.97 -29.25 68.24 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.932 0.493 . . . . 0.0 110.697 176.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -71.24 -47.78 55.12 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.617 0.767 . . . . 0.0 110.546 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 87.6 mt -68.0 -18.72 64.8 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.183 0.993 . . . . 0.0 111.644 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.76 31.27 79.64 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.713 0.633 . . . . 0.0 112.342 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.742 HD11 ' HB3' ' A' ' 78' ' ' GLN . 1.2 pp -64.81 162.49 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 122.041 0.924 . . . . 0.0 113.186 -176.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -119.53 169.15 10.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 161.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.89 -25.69 1.0 Allowed Glycine 0 N--CA 1.481 1.687 0 N-CA-C 117.311 1.685 . . . . 0.0 117.311 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.02 -46.65 83.51 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.688 0.744 . . . . 0.0 111.522 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -101.34 -11.9 19.06 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.439 0.696 . . . . 0.0 111.225 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.425 ' HB2' HD13 ' A' ' 83' ' ' ILE . 9.3 ttp180 -84.0 140.89 31.59 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.213 1.005 . . . . 0.0 109.294 174.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.563 HG11 ' HG ' ' A' ' 36' ' ' LEU . 46.5 t -117.17 120.41 33.65 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 122.781 0.432 . . . . 0.0 111.467 -167.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.83 154.26 48.47 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.976 2.451 . . . . 0.0 112.592 172.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.4 t -106.94 125.38 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.519 0.727 . . . . 0.0 109.768 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.513 HG21 ' HD3' ' A' ' 35' ' ' ARG . 21.8 t -113.13 112.45 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -82.39 109.43 16.63 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.45 HD12 ' HB3' ' A' ' 37' ' ' GLU . 50.2 mt . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 . . . . . 0 C--O 1.239 0.534 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -77.3 107.25 9.58 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 172.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 pt -95.48 170.2 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 123.737 0.815 . . . . 0.0 109.235 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.503 HG23 ' H ' ' A' ' 22' ' ' ASP . 9.0 t -85.43 149.85 25.12 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 172.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.537 ' O ' HG23 ' A' ' 24' ' ' VAL . 67.1 t-105 -52.09 -42.85 63.56 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.972 0.909 . . . . 0.0 111.192 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -61.3 -36.21 79.46 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 123.372 0.42 . . . . 0.0 111.725 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.503 ' H ' HG23 ' A' ' 19' ' ' THR . 31.7 t70 -70.35 -40.83 73.84 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.455 ' HZ ' HD11 ' A' ' 36' ' ' LEU . 40.2 t80 -56.15 -42.33 76.81 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.673 175.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.584 HG22 HD21 ' A' ' 77' ' ' LEU . 97.3 t -67.65 -66.3 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.402 0.681 . . . . 0.0 111.025 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -71.13 -44.81 64.82 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.443 0.464 . . . . 0.0 111.664 -166.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -80.13 -29.22 38.89 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.906 0.883 . . . . 0.0 111.786 -171.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -120.34 -66.19 1.08 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -169.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.34 -44.36 95.59 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.972 0.909 . . . . 0.0 111.526 -172.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.1 m -73.04 -16.23 61.49 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.351 1.06 . . . . 0.0 112.412 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -96.2 -3.77 43.69 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.136 0.575 . . . . 0.0 110.974 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.22 37.37 91.71 Favored Glycine 0 C--N 1.357 1.738 0 N-CA-C 114.776 0.671 . . . . 0.0 114.776 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.7 m -98.95 0.8 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.06 126.6 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.481 0.712 . . . . 0.0 110.272 -174.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -85.28 -47.21 10.28 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.343 1.057 . . . . 0.0 110.707 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.461 ' HG2' ' HB ' ' A' ' 47' ' ' THR . 10.2 ptp180 -157.07 160.29 38.76 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.873 0.469 . . . . 0.0 110.138 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.455 HD11 ' HZ ' ' A' ' 23' ' ' PHE . 92.4 mt -117.77 103.29 9.85 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.74 0.816 . . . . 0.0 109.303 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -88.9 111.86 22.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.602 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 44' ' ' VAL . 31.0 t -84.45 99.86 7.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.9 t -91.25 114.43 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 122.865 0.466 . . . . 0.0 110.033 -171.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 52.52 27.29 4.92 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.408 1.483 . . . . 0.0 112.886 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HA ' HG12 ' A' ' 38' ' ' VAL . 98.0 mttt 61.71 -0.7 0.39 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.812 1.645 . . . . 0.0 114.31 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -81.74 -34.16 30.64 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.385 0.674 . . . . 0.0 110.6 -171.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -157.4 179.32 9.36 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 38' ' ' VAL . 91.9 t -126.59 129.1 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 124.175 0.99 . . . . 0.0 109.072 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -101.37 128.75 47.41 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.9 t -88.84 109.84 20.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.726 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.461 ' HB ' ' HG2' ' A' ' 35' ' ' ARG . 87.1 m -88.31 134.37 33.83 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 172.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -103.6 154.5 19.43 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.198 0.599 . . . . 0.0 111.379 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 CA--C 1.549 0.917 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.172 -179.392 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -118.67 -179.6 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.626 0.371 . . . . 0.0 110.127 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -159.54 165.82 32.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.966 0.907 . . . . 0.0 109.167 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -152.56 152.16 31.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.624 0.37 . . . . 0.0 111.455 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -78.19 149.59 33.67 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.206 1.002 . . . . 0.0 110.145 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.2 pt -127.06 -26.79 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.063 0.545 . . . . 0.0 111.999 -174.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.52 -78.0 1.52 Allowed Glycine 0 C--N 1.344 0.991 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.2 t -107.4 132.05 53.6 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.181 0.992 . . . . 0.0 108.585 172.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.8 t -62.33 -32.37 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.357 0.663 . . . . 0.0 110.757 173.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.95 -38.2 90.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.689 0.796 . . . . 0.0 110.807 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.6 m -63.39 -51.38 66.08 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 122.905 0.482 . . . . 0.0 110.221 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -53.33 -58.22 7.86 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 124.102 0.876 . . . . 0.0 111.961 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 15.5 pt-20 -62.56 -47.78 82.37 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.962 0.789 . . . . 0.0 111.065 -172.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -64.15 -48.1 77.32 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 122.37 0.268 . . . . 0.0 110.873 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.414 HD22 ' N ' ' A' ' 73' ' ' ASN . 0.8 OUTLIER -65.87 -43.34 88.67 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.814 0.696 . . . . 0.0 110.24 -176.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.438 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 39.9 tp -57.7 -55.92 28.58 Favored 'General case' 0 C--O 1.215 -0.751 0 O-C-N 124.759 1.287 . . . . 0.0 111.651 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.591 ' HG2' ' NH2' ' A' ' 88' ' ' ARG . 44.8 mt-10 -66.43 -35.35 80.09 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.409 0.684 . . . . 0.0 112.156 -172.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.7 m -65.12 -48.04 75.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.188 0.595 . . . . 0.0 109.441 174.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.584 HD21 HG22 ' A' ' 24' ' ' VAL . 44.9 tp -57.17 -41.48 79.35 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.216 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 60.8 mt-30 -63.65 -46.31 86.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.682 0.793 . . . . 0.0 110.243 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -65.65 -31.04 71.84 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.46 0.704 . . . . 0.0 110.886 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -71.79 -52.64 16.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.559 1.143 . . . . 0.0 110.791 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 72.3 mt -79.42 -10.16 59.75 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.403 0.681 . . . . 0.0 111.592 -173.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.88 10.17 59.03 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 114.301 0.48 . . . . 0.0 114.301 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.471 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 3.5 mp -80.13 90.32 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 168.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.99 143.14 50.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.656 -0.653 . . . . 0.0 111.925 -171.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.0 -100.3 0.17 Allowed Glycine 0 C--N 1.349 1.297 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.749 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -79.02 -27.88 43.28 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.946 0.899 . . . . 0.0 110.904 -176.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -76.46 -9.53 58.72 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.088 0.555 . . . . 0.0 111.557 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.591 ' NH2' ' HG2' ' A' ' 75' ' ' GLU . 70.2 mtp180 -69.15 151.55 46.23 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-O 121.551 0.691 . . . . 0.0 112.836 -175.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.5 t -91.87 108.77 32.37 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.056 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -57.36 125.57 19.27 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.972 2.448 . . . . 0.0 111.535 -175.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.77 107.79 20.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -176.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 t -105.52 98.03 6.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -71.14 107.77 4.34 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.9 mt . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 123.903 0.881 . . . . 0.0 109.814 -175.254 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.485 ' HB2' HG12 ' A' ' 60' ' ' VAL . 4.1 mmp_? . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 111.45 0.167 . . . . 0.0 111.45 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.07 108.52 7.85 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.618 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 36.0 pt -100.62 171.55 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.514 1.126 . . . . 0.0 109.227 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.6 p -100.11 178.43 4.79 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 166.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -59.05 -35.19 72.91 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.445 173.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -60.88 -46.55 90.18 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.388 0.675 . . . . 0.0 112.22 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.618 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 7.0 m-20 -62.23 -44.95 95.4 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.312 0.245 . . . . 0.0 110.368 174.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 37.3 t80 -55.15 -50.63 68.8 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 124.118 0.886 . . . . 0.0 110.81 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.414 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 45.8 t -64.04 -66.47 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.944 0.897 . . . . 0.0 111.583 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -71.46 -47.15 57.54 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.87 0.468 . . . . 0.0 112.186 -166.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -80.26 -22.37 41.76 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -172.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.433 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 53.7 m-85 -128.22 -61.57 1.09 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -169.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.414 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 58.0 tp -64.13 -44.67 91.51 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.085 0.954 . . . . 0.0 111.317 -168.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.486 ' HA ' HD13 ' A' ' 81' ' ' LEU . 91.0 p -62.91 -20.31 65.04 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.59 0.756 . . . . 0.0 112.791 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -97.4 -10.44 25.5 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.868 0.867 . . . . 0.0 110.747 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.32 31.89 80.89 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 114.652 0.621 . . . . 0.0 114.652 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.2 m -80.5 -0.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 117.125 0.462 . . . . 0.0 110.676 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 t -98.82 133.06 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -176.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.488 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 18.6 t70 -92.38 -55.03 3.56 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.519 1.128 . . . . 0.0 109.621 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -154.46 164.99 37.81 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.386 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.403 HD11 ' CZ ' ' A' ' 23' ' ' PHE . 91.6 mt -120.51 108.84 14.57 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.689 0.795 . . . . 0.0 110.788 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -88.21 102.64 15.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.741 0.816 . . . . 0.0 110.053 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 41' ' ' LYS . 21.8 t -97.3 91.03 2.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.1 t -79.58 118.25 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.079 -174.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 49.73 27.92 2.45 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.688 1.595 . . . . 0.0 113.425 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.566 ' HA ' HG12 ' A' ' 38' ' ' VAL . 10.6 mtmp? 53.74 15.52 0.81 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.116 1.366 . . . . 0.0 114.181 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -85.64 -47.02 10.22 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.964 0.906 . . . . 0.0 110.421 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.457 ' HE2' ' HE ' ' A' ' 45' ' ' ARG . 44.1 p90 -147.56 159.83 43.31 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.177 0.513 . . . . 0.0 109.852 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.476 HG22 HG22 ' A' ' 38' ' ' VAL . 57.4 t -121.53 131.9 71.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.345 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.457 ' HE ' ' HE2' ' A' ' 43' ' ' PHE . 89.3 mtt180 -99.32 124.82 44.74 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.413 ' HB ' HG23 ' A' ' 60' ' ' VAL . 44.8 t -82.36 108.87 15.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 83.4 m -87.82 129.48 35.18 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -86.03 145.08 27.24 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.79 0.436 . . . . 0.0 110.409 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.4 t . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 123.297 0.639 . . . . 0.0 111.265 179.874 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 121.126 0.489 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 16' ' ' ARG . 33.0 m -109.17 144.16 18.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 173.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -154.73 163.13 40.7 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.83 0.452 . . . . 0.0 110.693 -173.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -150.19 150.76 32.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.708 0.403 . . . . 0.0 110.733 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -93.8 119.12 32.35 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.1 pt -84.31 116.77 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.069 0.548 . . . . 0.0 110.384 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.35 99.42 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.776 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.6 t -132.15 126.59 34.03 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.052 0.941 . . . . 0.0 108.731 172.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.54 HG21 ' HB3' ' A' ' 41' ' ' LYS . 17.5 t -61.57 -36.3 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.363 0.665 . . . . 0.0 110.049 172.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -58.01 -43.9 86.92 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.125 0.97 . . . . 0.0 111.094 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.5 m -64.87 -46.53 81.45 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.537 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -51.39 -53.45 36.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.813 0.845 . . . . 0.0 111.834 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 44.7 mt-10 -67.9 -52.95 30.52 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.761 0.824 . . . . 0.0 111.845 -172.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -68.88 -36.06 77.63 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.588 0.555 . . . . 0.0 111.785 -173.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -70.89 -39.7 72.65 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 174.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 46.5 tp -56.51 -45.19 81.2 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.023 0.529 . . . . 0.0 111.34 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.5 -42.18 99.32 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.874 0.734 . . . . 0.0 111.187 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.1 m -60.31 -56.41 21.84 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 123.8 0.688 . . . . 0.0 110.398 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 77' ' ' LEU . 2.7 mm? -51.73 -52.16 50.65 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 124.418 1.074 . . . . 0.0 112.067 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -60.17 -43.34 95.91 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 123.627 0.579 . . . . 0.0 111.383 -175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -62.75 -44.86 95.11 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.923 0.889 . . . . 0.0 111.122 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -70.1 -38.36 75.61 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.131 -176.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 29' ' ' SER . 41.5 mt -77.77 -17.3 57.65 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.66 0.784 . . . . 0.0 110.515 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.7 6.54 88.99 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-O 119.887 -0.396 . . . . 0.0 113.853 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.539 HG22 ' HA ' ' A' ' 88' ' ' ARG . 75.7 mt -70.98 92.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.1 0.96 . . . . 0.0 109.479 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -136.33 152.82 51.07 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 124.133 0.973 . . . . 0.0 110.569 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.402 ' N ' ' HB2' ' A' ' 88' ' ' ARG . . . 61.0 -93.91 0.07 OUTLIER Glycine 0 C--N 1.343 0.947 0 CA-C-N 114.594 -1.185 . . . . 0.0 115.406 172.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -77.46 -45.72 24.79 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.562 0.696 . . . . 0.0 109.517 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -79.86 -15.7 56.85 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.759 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.539 ' HA ' HG22 ' A' ' 83' ' ' ILE . 58.0 ttt180 -56.53 152.25 12.09 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.112 0.965 . . . . 0.0 111.991 -174.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 68.6 t -100.09 99.74 10.03 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 57.2 Cg_endo -70.48 149.07 61.71 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.919 2.413 . . . . 0.0 112.268 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.8 t -108.63 119.32 57.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.417 -174.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.7 t -104.84 96.27 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -74.64 98.52 3.43 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.3 mt . . . . . 0 C--N 1.324 -0.535 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -178.747 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -74.26 128.98 36.92 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.4 pt -129.69 170.6 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.618 0.767 . . . . 0.0 109.649 -175.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.6 p -91.71 153.59 19.55 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.588 ' O ' HG23 ' A' ' 24' ' ' VAL . 68.9 t-105 -53.58 -46.46 70.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.302 0.641 . . . . 0.0 110.806 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -54.82 -50.73 67.86 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.815 0.846 . . . . 0.0 112.476 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.46 ' HA ' HD21 ' A' ' 25' ' ' ASN . 0.0 OUTLIER -70.99 -33.83 70.79 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -176.627 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -54.23 -45.47 72.3 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.41 0.444 . . . . 0.0 110.49 172.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 20' ' ' TRP . 89.3 t -58.11 -64.09 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.017 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.46 HD21 ' HA ' ' A' ' 22' ' ' ASP . 9.3 p30 -75.21 -33.41 61.39 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.233 0.333 . . . . 0.0 111.815 -166.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -80.66 -41.29 24.04 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.868 0.467 . . . . 0.0 111.606 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -113.51 -65.3 1.2 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -163.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.8 tp -60.89 -45.52 94.26 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.886 0.741 . . . . 0.0 111.53 -174.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.5 ' HA ' HD11 ' A' ' 83' ' ' ILE . 22.7 t -72.39 -14.29 61.67 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.33 1.052 . . . . 0.0 111.863 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -101.83 -2.18 30.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.771 0.428 . . . . 0.0 111.12 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.93 22.41 34.49 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.8 m -77.78 -3.59 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 123.055 0.542 . . . . 0.0 111.468 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.9 t -93.63 129.91 43.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.267 1.027 . . . . 0.0 108.625 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -80.56 -47.32 14.36 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.537 0.735 . . . . 0.0 110.193 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.485 ' HG2' ' HB ' ' A' ' 47' ' ' THR . 6.6 ptp85 -159.4 157.92 31.18 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.092 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.5 mt -114.83 102.14 9.71 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.774 0.829 . . . . 0.0 108.964 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -89.79 108.61 19.8 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.136 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.523 HG22 HG22 ' A' ' 44' ' ' VAL . 40.6 t -88.45 94.59 4.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.9 t -90.94 127.06 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 O-C-N 123.233 0.333 . . . . 0.0 111.44 -169.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.4 m120 53.28 23.23 3.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.653 1.581 . . . . 0.0 113.632 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 61.28 6.6 1.41 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.986 1.314 . . . . 0.0 114.196 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.7 mtp-105 -91.22 -40.81 11.33 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.274 0.488 . . . . 0.0 110.436 -176.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -151.99 174.04 14.13 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.15 -170.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.523 HG22 HG22 ' A' ' 38' ' ' VAL . 71.9 t -119.88 122.89 69.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -100.03 121.9 42.09 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.0 t -90.24 119.74 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.127 0.971 . . . . 0.0 110.327 -168.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.485 ' HB ' ' HG2' ' A' ' 35' ' ' ARG . 58.1 m -93.86 130.05 40.04 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -97.32 170.39 9.11 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.931 0.769 . . . . 0.0 111.079 176.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 CA--C 1.553 1.093 0 C-N-CA 123.301 0.64 . . . . 0.0 110.997 176.369 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 121.001 0.429 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.8 169.87 20.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.078 170.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -158.25 158.42 34.43 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.533 0.733 . . . . 0.0 109.35 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -146.54 141.32 26.88 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.951 0.5 . . . . 0.0 109.722 177.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -83.15 128.57 34.61 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.874 0.47 . . . . 0.0 109.897 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 67' ' ' VAL . 22.5 pt -106.5 -29.29 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.342 0.657 . . . . 0.0 110.658 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.79 -71.85 1.6 Allowed Glycine 0 C--N 1.35 1.314 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.4 t -100.18 121.45 41.45 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.278 1.031 . . . . 0.0 110.127 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.506 ' HA ' HD12 ' A' ' 64' ' ' ILE . 39.5 t -66.56 -34.13 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.091 172.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.433 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 24.6 t70 -64.09 -37.11 86.26 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 63.2 m -65.89 -45.39 82.18 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.737 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -52.55 -41.56 63.64 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 123.778 0.674 . . . . 0.0 111.619 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.46 -51.25 53.63 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.488 0.492 . . . . 0.0 110.341 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 68' ' ' ASP . 95.5 mtt180 -55.94 -54.94 38.67 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.211 0.604 . . . . 0.0 111.771 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -71.42 -31.95 67.82 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.521 -175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.439 ' HG ' ' NE2' ' A' ' 78' ' ' GLN . 35.4 tp -62.84 -44.75 95.3 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.345 0.658 . . . . 0.0 111.858 172.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -63.32 -45.17 92.56 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.267 0.627 . . . . 0.0 112.065 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.473 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 14.8 m -63.57 -50.18 70.47 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.01 0.819 . . . . 0.0 109.361 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.51 HD21 HG22 ' A' ' 24' ' ' VAL . 45.3 tp -54.16 -51.24 64.95 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.298 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.439 ' NE2' ' HG ' ' A' ' 74' ' ' LEU . 46.0 mt-30 -64.72 -39.61 93.94 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.453 0.47 . . . . 0.0 111.232 -178.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 76' ' ' THR . 1.4 pt20 -68.04 -35.76 78.79 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 120.647 0.26 . . . . 0.0 110.549 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 76' ' ' THR . 30.9 mm-40 -74.24 -43.81 55.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.305 0.642 . . . . 0.0 111.047 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.6 mt -70.92 -8.65 54.51 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.74 0.816 . . . . 0.0 112.193 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.15 2.55 87.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.969 -0.351 . . . . 0.0 113.216 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 29' ' ' SER . 76.8 mt -73.03 101.73 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 124.844 1.258 . . . . 0.0 108.961 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -137.5 155.74 48.93 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.281 0.633 . . . . 0.0 111.257 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.23 -118.43 12.91 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 124.114 0.884 . . . . 0.0 113.719 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -20.75 66.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.385 1.074 . . . . 0.0 111.895 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -79.62 -24.77 41.7 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.666 0.386 . . . . 0.0 111.998 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -69.78 118.67 12.92 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.733 0.242 . . . . 0.0 110.773 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.09 126.42 92.4 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.272 0.629 . . . . 0.0 110.117 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.9 143.2 65.57 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.817 2.345 . . . . 0.0 112.575 -177.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.4 t -109.53 122.04 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.748 0.819 . . . . 0.0 109.322 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.471 HG21 ' HD3' ' A' ' 35' ' ' ARG . 23.0 t -114.31 101.77 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.932 0.893 . . . . 0.0 109.61 -174.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -75.62 104.49 6.19 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.088 0.555 . . . . 0.0 110.648 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 51.4 mm . . . . . 0 N--CA 1.469 0.476 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.505 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.566 ' HB3' HG12 ' A' ' 60' ' ' VAL . 63.7 ttt180 . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -73.53 130.72 40.67 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.9 pt -133.15 175.68 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.509 1.124 . . . . 0.0 109.218 -177.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.9 p -95.92 164.8 12.57 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.72 172.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.518 ' O ' HG23 ' A' ' 24' ' ' VAL . 72.6 t-105 -55.49 -44.42 76.5 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.013 0.925 . . . . 0.0 110.657 174.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -56.07 -47.26 78.3 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.732 0.813 . . . . 0.0 111.129 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.6 -42.02 92.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.05 0.54 . . . . 0.0 110.567 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -51.78 -51.02 59.46 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.665 0.603 . . . . 0.0 111.228 175.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 20' ' ' TRP . 59.9 t -63.75 -61.31 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.238 0.615 . . . . 0.0 111.5 -175.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -71.91 -40.87 68.53 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.034 -168.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -79.82 -43.48 22.32 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.377 0.671 . . . . 0.0 110.915 -175.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -114.08 -65.66 1.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -163.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.4 tp -55.08 -45.14 75.36 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.081 0.952 . . . . 0.0 112.146 -171.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.415 ' HA ' HD11 ' A' ' 83' ' ' ILE . 74.2 p -71.55 -9.18 57.81 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -95.96 -6.47 38.92 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 118.835 -0.603 . . . . 0.0 112.012 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.42 31.25 80.26 Favored Glycine 0 C--N 1.353 1.482 0 C-N-CA 121.433 -0.413 . . . . 0.0 113.687 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.8 -3.46 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.38 0.672 . . . . 0.0 111.728 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.04 130.78 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.492 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 24.8 t70 -88.26 -51.27 5.85 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.967 1.307 . . . . 0.0 110.124 -175.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -152.71 152.33 31.57 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.676 0.79 . . . . 0.0 110.208 -175.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.1 mt -112.0 101.97 10.23 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.43 1.092 . . . . 0.0 109.054 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 43.1 mt-10 -93.49 101.18 13.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.856 -172.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.583 HG22 HG22 ' A' ' 44' ' ' VAL . 49.0 t -81.08 104.94 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -176.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.5 t -95.24 115.48 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 123.055 0.542 . . . . 0.0 110.538 -174.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 53.31 24.04 3.59 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.157 1.783 . . . . 0.0 113.905 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt 67.49 0.77 2.29 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.447 1.499 . . . . 0.0 112.98 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -76.87 -45.26 28.93 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.109 0.963 . . . . 0.0 110.135 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -152.32 175.02 13.1 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.964 -173.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.583 HG22 HG22 ' A' ' 38' ' ' VAL . 86.8 t -124.58 130.57 73.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 125.109 1.364 . . . . 0.0 107.846 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.625 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 68.4 ttt180 -97.9 116.91 31.07 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.732 1.213 . . . . 0.0 108.48 -177.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.514 ' HB ' HG23 ' A' ' 60' ' ' VAL . 46.7 t -85.11 106.7 15.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.7 m -103.17 135.86 44.03 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -97.0 148.08 23.34 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.88 0.738 . . . . 0.0 111.96 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.492 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 57.7 p . . . . . 0 C--N 1.349 0.557 0 C-N-CA 124.56 1.144 . . . . 0.0 111.26 -176.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 121.034 0.445 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.566 HG12 ' HB3' ' A' ' 16' ' ' ARG . 10.6 m -119.53 170.04 9.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.505 -175.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -156.18 161.52 40.3 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.166 0.586 . . . . 0.0 109.532 176.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -147.26 145.15 29.31 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.92 154.53 31.57 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 67' ' ' VAL . 31.9 pt -128.82 -46.37 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 122.937 0.495 . . . . 0.0 110.441 174.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.45 -72.15 0.47 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -168.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.9 t -78.57 104.51 9.23 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 124.456 1.102 . . . . 0.0 110.638 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.485 ' HA ' HD12 ' A' ' 64' ' ' ILE . 26.4 t -66.95 -31.7 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.068 173.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.45 -42.91 98.63 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.238 0.615 . . . . 0.0 110.597 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 80.4 m -62.86 -48.47 78.87 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -51.73 -52.43 48.57 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 124.475 1.11 . . . . 0.0 112.046 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -66.24 -42.38 88.67 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.306 0.379 . . . . 0.0 111.301 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -66.18 -49.87 65.84 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.829 0.452 . . . . 0.0 112.064 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -71.14 -32.5 69.03 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 119.206 -0.426 . . . . 0.0 110.828 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.1 tp -59.78 -48.16 82.81 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.89 0.876 . . . . 0.0 111.135 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -65.0 -42.89 94.08 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.261 0.624 . . . . 0.0 112.139 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.7 m -59.77 -49.51 77.46 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 122.013 0.911 . . . . 0.0 109.693 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.407 HD21 HG22 ' A' ' 24' ' ' VAL . 32.9 tp -58.96 -42.73 90.58 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 112.914 -1.948 . . . . 0.0 112.614 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -65.77 -37.11 85.44 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.242 0.617 . . . . 0.0 111.051 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -69.85 -35.28 74.58 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.108 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.31 -52.54 22.04 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.565 1.146 . . . . 0.0 110.996 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.5 mt -73.02 -19.77 61.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.183 0.993 . . . . 0.0 111.222 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 7.39 70.38 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-O 119.723 -0.487 . . . . 0.0 113.2 -175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.415 HD11 ' HA ' ' A' ' 29' ' ' SER . 71.3 mt -67.77 92.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.157 0.983 . . . . 0.0 109.033 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -137.97 148.12 44.91 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.716 0.807 . . . . 0.0 110.147 -171.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.78 -102.83 0.74 Allowed Glycine 0 C--N 1.351 1.365 0 O-C-N 124.508 1.13 . . . . 0.0 112.992 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.52 -30.42 57.17 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.746 0.818 . . . . 0.0 110.72 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -72.05 -21.09 61.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.082 0.553 . . . . 0.0 111.379 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -62.01 142.6 57.4 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.231 0.613 . . . . 0.0 111.751 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.4 t -107.55 106.37 58.26 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -58.6 143.86 97.99 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 124.047 3.164 . . . . 0.0 113.258 -175.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.7 t -98.87 119.4 46.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 54.2 t -110.95 121.39 63.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -87.51 127.2 35.24 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.8 mm . . . . . 0 N--CA 1.474 0.753 0 C-N-CA 125.289 1.436 . . . . 0.0 107.791 -175.903 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.53 ' HB3' HG12 ' A' ' 60' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.94 107.2 6.02 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 48.2 pt -99.72 176.66 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.943 0.897 . . . . 0.0 109.967 173.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.3 p -104.78 171.6 7.24 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.383 171.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -57.78 -38.88 76.22 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.504 0.722 . . . . 0.0 110.381 171.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -55.45 -48.79 73.94 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.747 0.819 . . . . 0.0 111.211 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.576 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 50.8 m-20 -64.66 -45.15 87.96 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.77 0.428 . . . . 0.0 111.924 176.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.433 ' CZ ' HD11 ' A' ' 36' ' ' LEU . 10.1 t80 -49.39 -57.35 7.09 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.121 0.888 . . . . 0.0 110.228 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.409 HG22 HD21 ' A' ' 77' ' ' LEU . 96.6 t -66.13 -56.41 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 123.89 0.744 . . . . 0.0 111.859 -174.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -76.32 -48.87 18.54 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -168.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -76.49 -39.62 52.62 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.265 0.626 . . . . 0.0 111.528 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -108.91 -65.54 1.13 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -165.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.4 tp -58.07 -44.45 87.51 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.88 0.872 . . . . 0.0 111.86 -173.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.1 t -57.47 -30.23 64.88 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.201 1.0 . . . . 0.0 112.455 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -91.81 0.97 57.46 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.979 0.912 . . . . 0.0 110.887 -176.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.46 25.41 62.93 Favored Glycine 0 C--N 1.351 1.409 0 N-CA-C 114.444 0.537 . . . . 0.0 114.444 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.9 m -85.91 -2.02 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 117.257 0.529 . . . . 0.0 110.617 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.5 t -93.77 122.22 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.908 0.883 . . . . 0.0 109.431 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 17.8 t70 -82.25 -52.44 6.94 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.208 1.003 . . . . 0.0 109.625 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -155.13 166.19 34.35 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.57 0.748 . . . . 0.0 110.687 -173.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.433 HD11 ' CZ ' ' A' ' 23' ' ' PHE . 84.4 mt -119.15 107.25 13.24 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.949 0.9 . . . . 0.0 110.432 175.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 40.4 mt-10 -94.27 101.75 13.73 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.335 0.654 . . . . 0.0 110.257 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 41' ' ' LYS . 23.4 t -82.58 89.91 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.42 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 95.4 t -73.94 116.77 16.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.289 1.035 . . . . 0.0 110.946 -169.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 55.8 21.4 4.73 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.604 1.162 . . . . 0.0 112.397 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.516 ' HA ' HG12 ' A' ' 38' ' ' VAL . 91.7 mttt 61.98 2.18 0.75 Allowed 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.845 1.658 . . . . 0.0 114.143 -173.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -80.06 -39.96 28.67 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.87 0.868 . . . . 0.0 110.766 -173.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -153.56 166.54 32.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.042 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 53.0 t -120.16 130.91 73.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -175.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.41 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 34.4 ttm180 -91.01 127.93 36.63 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 175.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.511 ' HB ' HG23 ' A' ' 60' ' ' VAL . 44.9 t -83.42 105.45 13.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 165.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.9 m -94.59 130.18 41.14 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -87.76 156.88 19.21 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.018 0.824 . . . . 0.0 111.095 -175.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.479 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 64.4 p . . . . . 0 CA--C 1.553 1.088 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.361 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.53 HG12 ' HB3' ' A' ' 16' ' ' ARG . 35.7 m -110.94 152.69 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -153.64 156.57 38.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.85 0.46 . . . . 0.0 110.678 -174.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -139.8 139.94 36.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.322 0.649 . . . . 0.0 109.294 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -81.3 144.02 31.82 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.417 0.687 . . . . 0.0 110.045 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 67' ' ' VAL . 37.4 pt -120.46 140.18 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.519 0.728 . . . . 0.0 109.516 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.49 -46.13 26.77 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 177.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.8 m -132.09 138.44 48.13 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.694 0.798 . . . . 0.0 109.439 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.505 ' HA ' HD12 ' A' ' 64' ' ' ILE . 34.4 t -63.03 -41.4 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.287 0.635 . . . . 0.0 110.967 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.87 -39.69 92.76 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.939 0.495 . . . . 0.0 111.079 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.6 m -63.03 -45.86 90.31 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.864 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -53.46 -47.69 69.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.789 0.836 . . . . 0.0 111.291 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 52.1 mt-10 -63.35 -47.67 81.17 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.73 0.644 . . . . 0.0 110.901 -178.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.1 mtp-105 -61.24 -44.63 96.95 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.227 0.611 . . . . 0.0 111.082 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -63.65 -46.78 84.05 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.552 0.741 . . . . 0.0 110.741 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.23 -48.93 79.21 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.143 0.977 . . . . 0.0 111.655 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 23.0 mm-40 -61.96 -48.37 80.66 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.117 0.567 . . . . 0.0 110.956 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 96.1 m -57.24 -55.43 34.88 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.502 0.721 . . . . 0.0 110.35 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.409 HD21 HG22 ' A' ' 24' ' ' VAL . 66.4 tp -44.71 -51.24 9.46 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.18 1.792 . . . . 0.0 112.686 174.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -64.71 -41.59 95.88 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.014 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 13.9 mm100 -64.04 -38.65 91.85 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.485 0.314 . . . . 0.0 110.567 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 76' ' ' THR . 21.1 mm-40 -60.48 -39.81 89.0 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.83 0.852 . . . . 0.0 111.07 175.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.9 mt -84.1 -8.49 59.09 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.721 0.808 . . . . 0.0 112.097 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.45 6.25 89.36 Favored Glycine 0 C--N 1.353 1.474 0 C-N-CA 122.894 0.283 . . . . 0.0 113.392 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.527 HG22 ' HA ' ' A' ' 88' ' ' ARG . 69.5 mt -76.26 108.66 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 124.987 1.315 . . . . 0.0 109.555 177.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.25 177.29 10.38 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.62 0.768 . . . . 0.0 110.658 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.04 -125.15 29.6 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.662 0.601 . . . . 0.0 113.621 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -85.76 -8.12 58.34 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.354 0.662 . . . . 0.0 111.096 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.497 HD22 HG23 ' A' ' 83' ' ' ILE . 7.9 t30 -88.41 -12.94 41.77 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.339 0.655 . . . . 0.0 110.865 -178.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.527 ' HA ' HG22 ' A' ' 83' ' ' ILE . 12.1 ptp85 -63.69 147.52 51.4 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 117.507 0.14 . . . . 0.0 110.681 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.402 HG11 ' HG ' ' A' ' 36' ' ' LEU . 40.2 t -66.39 116.51 34.58 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -175.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 32.3 Cg_exo -59.56 117.34 4.07 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.576 2.851 . . . . 0.0 111.248 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.9 t -102.63 125.45 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.65 95.73 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -76.85 100.45 5.52 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 56.4 mt . . . . . 0 CA--C 1.546 0.817 0 C-N-CA 123.833 0.853 . . . . 0.0 109.51 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.519 ' HB2' HG12 ' A' ' 60' ' ' VAL . 18.9 mmm180 . . . . . 0 N--CA 1.478 0.945 0 CA-C-O 120.576 0.227 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -89.68 116.54 27.89 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 169.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.3 pt -105.92 -177.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.663 0.785 . . . . 0.0 109.679 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.0 p -97.55 165.71 11.85 Favored 'General case' 0 C--O 1.248 0.999 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 169.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.496 ' O ' HG23 ' A' ' 24' ' ' VAL . 73.6 t-105 -55.84 -40.81 73.36 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.58 0.55 . . . . 0.0 110.388 171.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -53.4 -53.78 46.35 Favored 'General case' 0 C--O 1.256 1.447 0 C-N-CA 124.017 0.927 . . . . 0.0 111.881 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -51.88 -54.42 29.44 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 124.318 1.011 . . . . 0.0 109.195 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -51.89 -45.32 64.11 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 124.983 1.427 . . . . 0.0 111.745 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 20' ' ' TRP . 72.4 t -55.56 -63.16 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 O-C-N 123.551 0.532 . . . . 0.0 111.31 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -67.37 -42.03 84.12 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.923 0.764 . . . . 0.0 112.757 -167.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.424 HD22 ' N ' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -94.62 -21.45 18.8 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -173.571 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.453 ' HE2' HG21 ' A' ' 60' ' ' VAL . 22.8 m-85 -122.19 -67.47 0.96 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.778 0.717 . . . . 0.0 112.618 -169.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.4 tp -59.46 -48.2 82.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.612 0.765 . . . . 0.0 111.597 -173.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.3 p -64.86 -20.64 66.52 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -102.74 -2.48 28.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.949 0.5 . . . . 0.0 110.995 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.61 33.88 42.17 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 115.424 0.93 . . . . 0.0 115.424 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.7 m -81.87 -3.57 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 122.934 0.493 . . . . 0.0 111.297 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.42 135.76 30.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 123.972 0.909 . . . . 0.0 108.792 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.09 -49.51 7.73 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.801 0.84 . . . . 0.0 110.323 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -153.83 149.17 27.11 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.765 0.826 . . . . 0.0 111.095 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.5 mt -118.39 103.22 9.58 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.908 1.283 . . . . 0.0 108.01 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.606 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 37.8 mt-10 -99.15 109.59 22.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.066 -171.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 44' ' ' VAL . 57.3 t -83.42 98.6 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.5 t -92.62 120.99 42.87 Favored 'Isoleucine or valine' 0 C--O 1.251 1.176 0 C-N-CA 123.204 0.602 . . . . 0.0 109.779 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 59.47 18.37 6.84 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.084 1.354 . . . . 0.0 113.437 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 60.4 6.69 1.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.686 1.194 . . . . 0.0 112.94 -173.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -87.71 -48.82 7.56 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.609 1.164 . . . . 0.0 110.215 -173.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -146.21 170.14 17.33 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.416 -172.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 38' ' ' VAL . 95.6 t -121.26 123.54 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.86 0.864 . . . . 0.0 109.561 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.606 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 7.9 tpm_? -83.37 109.48 17.33 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.312 1.445 . . . . 0.0 107.458 177.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.06 107.44 16.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.4 m -107.79 127.73 53.96 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.504 ' H ' ' HE1' ' A' ' 59' ' ' TYR . 99.7 m-85 -100.61 169.55 8.97 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.269 1.028 . . . . 0.0 111.991 -171.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.1 p . . . . . 0 CA--C 1.552 1.038 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.17 179.581 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.504 ' HE1' ' H ' ' A' ' 48' ' ' PHE . 60.2 m-85 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.519 HG12 ' HB2' ' A' ' 16' ' ' ARG . 28.7 m -111.15 172.48 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.666 -174.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -160.45 164.87 31.92 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.048 0.939 . . . . 0.0 108.948 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -152.53 143.65 23.13 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.551 0.34 . . . . 0.0 110.357 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -89.09 123.67 33.59 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 67' ' ' VAL . 32.1 pt -95.44 -40.95 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.777 -171.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.94 -75.31 0.24 Allowed Glycine 0 C--N 1.35 1.307 0 O-C-N 123.424 0.452 . . . . 0.0 112.264 -172.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.1 m -82.06 99.22 9.05 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.498 ' HA ' HD12 ' A' ' 64' ' ' ILE . 60.3 t -54.7 -39.59 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.379 1.072 . . . . 0.0 110.887 171.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 18.9 t70 -54.34 -55.93 23.63 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 123.97 0.908 . . . . 0.0 110.73 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.4 m -59.82 -42.81 94.33 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 124.087 0.867 . . . . 0.0 111.506 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -50.84 -50.09 57.49 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 123.409 0.684 . . . . 0.0 111.488 172.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 47.0 mt-10 -68.58 -47.23 67.32 Favored 'General case' 0 C--O 1.217 -0.639 0 O-C-N 123.97 0.794 . . . . 0.0 111.243 -177.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 24.3 mmm180 -53.55 -48.6 68.98 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.454 0.701 . . . . 0.0 110.458 -178.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.21 -53.42 37.46 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.601 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.13 -53.31 58.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.69 0.796 . . . . 0.0 112.117 -174.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -61.64 -51.19 69.51 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.492 0.717 . . . . 0.0 112.028 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.414 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 94.1 m -63.11 -47.4 82.96 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.781 0.676 . . . . 0.0 110.619 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.475 HD21 HG13 ' A' ' 24' ' ' VAL . 35.4 tp -56.82 -45.61 82.16 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.73 1.212 . . . . 0.0 112.913 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -66.44 -34.83 78.83 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.385 0.428 . . . . 0.0 110.284 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -66.36 -38.35 87.39 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.632 0.373 . . . . 0.0 111.347 173.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 76' ' ' THR . 49.9 mt-10 -69.5 -36.99 76.99 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.909 0.884 . . . . 0.0 111.0 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.78 -19.38 59.03 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.017 0.927 . . . . 0.0 111.641 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.85 6.03 70.34 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.862 -0.41 . . . . 0.0 113.494 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.776 HG23 HD22 ' A' ' 87' ' ' ASN . 68.5 mt -71.27 109.98 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 124.511 1.124 . . . . 0.0 109.403 176.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -124.35 144.09 50.21 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.369 0.668 . . . . 0.0 111.507 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.83 -115.0 5.0 Favored Glycine 0 C--N 1.354 1.549 0 O-C-N 124.897 1.373 . . . . 0.0 114.831 169.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -64.61 -26.43 68.39 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.17 0.988 . . . . 0.0 112.067 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.776 HD22 HG23 ' A' ' 83' ' ' ILE . 6.6 t30 -79.71 -20.3 46.82 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.24 0.216 . . . . 0.0 110.988 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -64.86 139.59 58.78 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 174.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 t -75.9 114.84 40.87 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 124.03 0.831 . . . . 0.0 109.243 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.87 140.3 94.58 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.465 2.777 . . . . 0.0 113.252 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.8 t -105.97 112.52 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.432 ' HB ' ' HG2' ' A' ' 37' ' ' GLU . 63.0 t -110.78 97.13 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 123.821 0.849 . . . . 0.0 109.656 -171.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -70.61 103.11 2.43 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.551 0.34 . . . . 0.0 110.276 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 63.1 mt . . . . . 0 CA--C 1.537 0.452 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.819 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.34 141.24 35.61 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.7 pt -137.38 -175.44 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.237 1.415 . . . . 0.0 108.14 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.4 p -105.44 165.36 11.18 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.63 0.372 . . . . 0.0 110.209 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.468 ' O ' HG23 ' A' ' 24' ' ' VAL . 70.8 t-105 -56.43 -37.54 70.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.61 0.764 . . . . 0.0 109.879 169.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.18 -46.04 83.18 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 123.799 0.84 . . . . 0.0 112.217 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -61.31 -46.13 91.59 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.684 0.393 . . . . 0.0 110.895 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.401 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 35.6 t80 -54.29 -55.55 27.14 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 124.184 0.927 . . . . 0.0 111.256 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 20' ' ' TRP . 94.2 t -57.19 -62.69 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.299 0.639 . . . . 0.0 111.73 -176.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -67.38 -54.39 20.87 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.573 -170.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -87.64 -14.79 39.06 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.441 0.696 . . . . 0.0 112.649 -165.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.401 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 91.1 m-85 -124.8 -67.12 0.93 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 118.397 0.544 . . . . 0.0 112.003 -174.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.4 tp -60.68 -47.98 83.85 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.749 0.819 . . . . 0.0 111.733 -172.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.9 m -68.96 -16.67 63.8 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.615 0.766 . . . . 0.0 112.807 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -93.56 -5.49 48.83 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.011 0.524 . . . . 0.0 111.512 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.18 33.94 82.1 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 123.572 0.545 . . . . 0.0 114.142 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 18.5 m -93.23 1.66 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 122.551 0.34 . . . . 0.0 111.071 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 t -96.67 126.68 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 120.688 0.28 . . . . 0.0 110.278 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 23.4 t70 -88.45 -50.36 6.36 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.347 1.059 . . . . 0.0 109.43 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -155.01 162.72 41.0 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.794 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.4 mt -117.08 103.32 10.11 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.457 0.703 . . . . 0.0 109.648 174.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -87.39 100.74 12.96 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.511 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.2 t -93.1 92.64 3.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -172.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.421 HG22 ' HB ' ' A' ' 94' ' ' ILE . 60.7 t -83.6 132.23 31.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.566 -175.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 66.19 11.12 7.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.895 1.278 . . . . 0.0 112.392 172.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.481 ' HB3' HG21 ' A' ' 67' ' ' VAL . 62.0 mttm 58.47 6.14 0.53 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.478 1.111 . . . . 0.0 112.55 -168.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -94.52 -38.11 11.06 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.7 1.2 . . . . 0.0 110.234 -168.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -148.4 151.85 35.98 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.237 -176.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.91 126.43 68.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.257 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -101.84 123.22 45.41 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.452 ' HB ' HG23 ' A' ' 60' ' ' VAL . 46.5 t -83.78 111.2 19.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.526 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.0 m -91.91 135.48 33.9 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.54 ' HE1' ' HA ' ' A' ' 59' ' ' TYR . 75.9 m-85 -85.49 148.46 25.96 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.308 0.38 . . . . 0.0 110.159 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.594 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 27.5 p . . . . . 0 CA--C 1.549 0.933 0 C-N-CA 123.13 0.572 . . . . 0.0 111.055 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.54 ' HA ' ' HE1' ' A' ' 48' ' ' PHE . 97.5 m-85 . . . . . 0 C--O 1.238 0.498 0 CA-C-O 121.181 0.515 . . . . 0.0 109.641 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.452 HG23 ' HB ' ' A' ' 46' ' ' VAL . 19.1 m -109.56 159.16 9.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.504 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -159.44 164.5 34.48 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.836 0.855 . . . . 0.0 108.975 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -148.73 141.11 24.19 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -88.35 132.5 34.4 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 67' ' ' VAL . 24.3 pt -104.36 139.8 24.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 123.788 0.835 . . . . 0.0 109.808 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.22 -41.94 44.75 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.824 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.4 t -132.17 132.17 42.93 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.937 0.895 . . . . 0.0 110.393 177.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.481 HG21 ' HB3' ' A' ' 41' ' ' LYS . 38.6 t -63.6 -35.49 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.467 0.707 . . . . 0.0 110.745 172.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -57.81 -50.26 73.86 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.767 0.827 . . . . 0.0 110.724 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.1 m -61.69 -45.82 92.34 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 124.167 0.917 . . . . 0.0 111.027 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -54.0 -51.25 64.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.197 0.599 . . . . 0.0 111.023 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -64.77 -51.13 63.91 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.577 0.751 . . . . 0.0 112.451 -174.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -66.74 -36.4 82.37 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.116 0.26 . . . . 0.0 111.054 -175.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -69.25 -42.53 75.49 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.426 ' HG ' ' NE2' ' A' ' 78' ' ' GLN . 29.9 tp -59.76 -53.19 60.88 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 123.593 0.558 . . . . 0.0 111.232 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -62.96 -41.84 99.64 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.046 0.539 . . . . 0.0 111.807 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.6 m -66.97 -54.95 16.85 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.387 0.675 . . . . 0.0 111.05 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.8 tp -52.0 -41.17 61.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.142 1.377 . . . . 0.0 112.651 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.426 ' NE2' ' HG ' ' A' ' 74' ' ' LEU . 44.8 mt-30 -64.01 -42.95 96.97 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.4 0.28 . . . . 0.0 110.487 175.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' A' ' 84' ' ' GLU . 23.8 mm-40 -63.37 -32.13 73.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.756 0.423 . . . . 0.0 111.782 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -64.42 -38.32 90.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.12 0.568 . . . . 0.0 110.32 173.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.4 mt -78.36 -13.97 59.61 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.518 0.727 . . . . 0.0 111.324 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.35 21.35 58.7 Favored Glycine 0 C--N 1.355 1.606 0 C-N-CA 122.88 0.276 . . . . 0.0 113.126 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.1 mt -94.06 131.62 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 125.467 1.507 . . . . 0.0 110.179 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.497 ' HB3' ' NE2' ' A' ' 79' ' ' GLN . 9.5 pt-20 -166.63 160.83 15.4 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.026 0.93 . . . . 0.0 109.737 175.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.93 -92.65 0.01 OUTLIER Glycine 0 C--N 1.347 1.149 0 O-C-N 123.919 0.762 . . . . 0.0 114.688 173.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -69.8 -46.44 65.7 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.37 1.068 . . . . 0.0 110.638 -172.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -92.48 -4.9 52.91 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.374 -174.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -70.39 128.28 35.66 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.153 0.581 . . . . 0.0 109.87 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.84 113.67 13.03 Favored Pre-proline 0 CA--C 1.55 0.977 0 O-C-N 124.049 0.843 . . . . 0.0 111.081 -170.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 74.9 Cg_exo -54.48 122.67 11.96 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.482 2.788 . . . . 0.0 112.666 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.7 121.43 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.8 t -118.69 97.47 5.34 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -71.61 117.87 13.73 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.421 ' HB ' HG22 ' A' ' 39' ' ' VAL . 54.9 mt . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.644 ' HB2' HG12 ' A' ' 60' ' ' VAL . 51.6 mmm-85 . . . . . 0 C--O 1.236 0.372 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -75.24 108.21 7.85 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 50.0 pt -105.49 -178.13 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 124.936 1.295 . . . . 0.0 108.804 173.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.4 p -98.85 168.6 10.02 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 123.186 0.594 . . . . 0.0 109.506 167.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.492 ' O ' HG23 ' A' ' 24' ' ' VAL . 44.8 t-105 -53.74 -42.74 68.46 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.563 0.745 . . . . 0.0 110.336 171.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -60.33 -43.47 96.37 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.007 0.523 . . . . 0.0 112.34 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.533 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 63.1 m-20 -64.5 -35.12 79.91 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.51 0.324 . . . . 0.0 110.845 177.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.561 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 35.8 t80 -57.67 -51.93 67.51 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 123.905 0.753 . . . . 0.0 110.839 174.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.527 HG13 HD21 ' A' ' 77' ' ' LEU . 90.4 t -54.75 -62.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.047 0.939 . . . . 0.0 112.136 -176.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -73.25 -49.27 28.7 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.06 -18.91 37.99 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -170.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.561 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 60.0 m-85 -128.12 -64.93 0.93 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.075 0.852 . . . . 0.0 112.994 -170.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -60.84 -46.25 91.32 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.312 0.645 . . . . 0.0 111.787 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.1 t -58.56 -27.77 64.9 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.581 1.152 . . . . 0.0 112.929 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -87.51 -17.63 31.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.957 0.503 . . . . 0.0 110.739 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.35 32.59 84.13 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 123.804 0.69 . . . . 0.0 113.897 -172.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.8 m -80.7 -0.88 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.3 t -100.5 132.16 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.694 0.798 . . . . 0.0 110.117 -170.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -83.28 -52.69 6.34 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.206 1.002 . . . . 0.0 109.967 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.417 HH21 HG21 ' A' ' 92' ' ' VAL . 1.1 ptm180 -154.67 156.81 37.11 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.657 0.783 . . . . 0.0 109.74 -175.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.3 mt -112.28 102.87 11.0 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -92.5 101.88 14.33 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.984 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 38.7 t -83.88 96.23 4.21 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -175.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.23 118.63 25.66 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.639 -173.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 58.74 18.38 5.93 Favored 'General case' 0 CA--C 1.559 1.298 0 O-C-N 124.944 1.402 . . . . 0.0 112.587 172.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.411 ' HA ' HG12 ' A' ' 38' ' ' VAL . 33.4 mtmm 58.66 2.23 0.22 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.388 1.475 . . . . 0.0 114.33 -171.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -82.05 -33.85 29.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.371 0.668 . . . . 0.0 109.803 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -154.36 163.81 39.58 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.767 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 57.9 t -111.74 129.28 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -103.84 128.07 51.31 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.88 106.98 17.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.397 -1.274 . . . . 0.0 107.656 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.4 m -96.71 125.53 41.23 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -94.44 170.38 9.53 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.027 0.829 . . . . 0.0 110.994 -173.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.6 p . . . . . 0 CA--C 1.552 1.026 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 168.813 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 . . . . . 0 C--O 1.239 0.55 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.644 HG12 ' HB2' ' A' ' 16' ' ' ARG . 11.4 m -124.6 166.7 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -165.2 159.86 17.95 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.767 0.427 . . . . 0.0 111.079 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -147.76 142.29 26.48 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.4 0.68 . . . . 0.0 109.914 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -81.49 141.64 33.66 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 67' ' ' VAL . 33.3 pt -117.42 124.09 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.274 0.63 . . . . 0.0 110.361 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -71.6 -40.46 59.1 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.1 t -129.92 120.01 24.18 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.118 0.967 . . . . 0.0 108.73 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.502 ' HA ' HD12 ' A' ' 64' ' ' ILE . 97.5 t -56.04 -38.83 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.49 1.116 . . . . 0.0 110.774 172.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -60.66 -45.62 93.44 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.003 0.921 . . . . 0.0 110.805 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.1 m -59.57 -47.46 85.46 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.353 0.661 . . . . 0.0 110.747 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -53.65 -60.43 3.32 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.772 0.829 . . . . 0.0 111.862 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -42.01 80.19 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.24 0.616 . . . . 0.0 112.032 -169.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -62.9 -47.79 81.77 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.063 0.545 . . . . 0.0 110.851 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -65.92 -38.73 89.45 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.329 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.3 tp -58.04 -56.85 16.67 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.683 0.793 . . . . 0.0 111.974 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -35.17 79.55 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 123.452 0.47 . . . . 0.0 112.182 -174.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.1 m -62.26 -55.03 32.39 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.328 0.651 . . . . 0.0 110.116 172.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.527 HD21 HG13 ' A' ' 24' ' ' VAL . 52.5 tp -50.77 -45.09 58.88 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.644 1.578 . . . . 0.0 113.04 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -63.07 -41.32 99.41 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.046 0.539 . . . . 0.0 110.775 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -65.2 -35.83 82.28 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.129 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -71.33 -44.12 65.7 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.514 0.726 . . . . 0.0 111.458 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.7 mt -74.19 -7.27 52.08 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.753 0.821 . . . . 0.0 111.888 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.27 8.18 87.84 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.506 0.504 . . . . 0.0 112.537 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.9 mt -70.24 108.67 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.868 1.267 . . . . 0.0 108.057 175.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -141.59 162.73 34.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.627 0.771 . . . . 0.0 110.616 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.44 -120.67 23.75 Favored Glycine 0 C--N 1.344 1.009 0 O-C-N 124.577 1.173 . . . . 0.0 112.995 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.36 -39.99 85.03 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.69 1.196 . . . . 0.0 111.362 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -69.5 -19.75 63.73 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.353 0.661 . . . . 0.0 111.596 -168.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -68.35 148.29 50.92 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.911 0.386 . . . . 0.0 111.097 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.92 117.93 56.44 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.744 -173.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.16 150.63 72.07 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 123.215 2.61 . . . . 0.0 112.473 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.3 t -112.88 116.89 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.665 0.786 . . . . 0.0 108.957 -176.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.417 HG21 HH21 ' A' ' 35' ' ' ARG . 47.0 t -117.92 115.6 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.419 1.088 . . . . 0.0 108.56 -171.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -94.69 115.57 27.7 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.176 0.59 . . . . 0.0 110.902 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 175.121 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.606 ' HB2' HG12 ' A' ' 60' ' ' VAL . 18.8 mtm180 . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.67 109.83 6.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.684 0.394 . . . . 0.0 110.095 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 36.6 pt -104.16 170.89 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.023 0.929 . . . . 0.0 109.226 175.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 76.9 p -86.41 168.62 13.64 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 166.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.571 ' O ' HG23 ' A' ' 24' ' ' VAL . 69.2 t-105 -55.1 -40.78 70.81 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.626 0.579 . . . . 0.0 109.849 168.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -56.15 -47.97 77.18 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.552 0.741 . . . . 0.0 111.424 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.569 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 39.7 m-20 -65.11 -39.19 92.77 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.495 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 19.5 t80 -53.8 -48.92 69.37 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 124.208 0.943 . . . . 0.0 110.852 176.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 20' ' ' TRP . 61.2 t -67.4 -65.98 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 123.572 0.545 . . . . 0.0 111.231 -176.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -67.76 -46.67 71.4 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.637 -166.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -85.56 -18.53 33.13 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.964 0.506 . . . . 0.0 112.001 -172.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.495 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 47.8 m-85 -127.55 -67.99 0.8 Allowed 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 119.277 0.944 . . . . 0.0 112.946 -171.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.13 -47.99 83.27 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.736 0.815 . . . . 0.0 111.482 -172.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.4 m -63.79 -23.25 67.29 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.855 0.862 . . . . 0.0 113.13 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -101.99 4.47 39.95 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 119.361 -0.352 . . . . 0.0 111.533 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.63 28.24 56.14 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.1 m -81.31 -5.96 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.115 0.566 . . . . 0.0 111.01 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.83 136.4 26.09 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 C-N-CA 124.014 0.926 . . . . 0.0 108.923 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -86.86 -57.75 2.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.131 0.973 . . . . 0.0 108.978 174.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -153.31 159.93 42.6 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.716 -174.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.4 mt -113.87 102.17 9.96 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -94.8 103.68 15.58 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.446 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 18.4 t -87.79 101.7 11.76 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -174.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.487 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 94.9 t -75.59 116.8 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 37.85 37.17 0.12 Allowed 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 128.348 2.659 . . . . 0.0 115.913 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt 67.27 -1.83 1.4 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.918 1.287 . . . . 0.0 112.793 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -80.76 -37.37 30.5 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.063 0.945 . . . . 0.0 110.42 -175.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -159.07 158.93 33.97 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.11 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 61.8 t -109.38 129.42 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.533 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -94.02 126.01 38.98 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.443 ' HB ' HG23 ' A' ' 60' ' ' VAL . 33.5 t -84.21 105.1 13.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.2 m -103.95 130.98 51.61 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -96.43 163.8 12.9 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.17 0.918 . . . . 0.0 111.956 -170.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.1 p . . . . . 0 CA--C 1.561 1.372 0 C-N-CA 124.084 0.953 . . . . 0.0 112.052 -178.317 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 . . . . . 0 N--CA 1.466 0.333 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.606 HG12 ' HB2' ' A' ' 16' ' ' ARG . 29.5 m -124.67 156.51 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 124.127 0.892 . . . . 0.0 108.595 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -155.23 171.23 20.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.938 0.495 . . . . 0.0 110.556 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -150.54 143.66 24.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.83 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -79.97 134.45 36.25 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.182 0.593 . . . . 0.0 110.454 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.8 pt -120.24 175.66 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.148 0.579 . . . . 0.0 110.334 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.4 -50.69 0.08 OUTLIER Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.2 t -100.72 108.87 20.83 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.771 0.828 . . . . 0.0 109.631 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.0 t -57.88 -37.69 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.124 0.97 . . . . 0.0 110.402 170.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -53.59 -50.23 66.05 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.786 1.234 . . . . 0.0 110.574 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.6 m -66.83 -43.75 82.9 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 124.126 0.891 . . . . 0.0 111.275 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -53.52 -49.56 67.33 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.084 0.554 . . . . 0.0 110.948 172.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -65.61 -51.67 57.88 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.256 1.022 . . . . 0.0 112.847 -172.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.5 ptt85 -68.11 -38.24 82.05 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.57 0.544 . . . . 0.0 111.255 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -72.48 -39.14 67.93 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 40.5 tp -59.92 -54.42 46.3 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.822 0.849 . . . . 0.0 111.931 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.46 ' HB2' HH12 ' A' ' 88' ' ' ARG . 13.6 pt-20 -63.13 -40.03 96.41 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.301 0.64 . . . . 0.0 111.447 -175.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.7 m -66.86 -49.43 65.7 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.617 0.767 . . . . 0.0 109.736 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.45 HD21 HG22 ' A' ' 24' ' ' VAL . 43.0 tp -51.11 -48.81 61.62 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.526 1.13 . . . . 0.0 111.998 174.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -62.42 -46.41 88.68 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 123.67 0.606 . . . . 0.0 111.225 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -67.04 -30.15 70.14 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 123.043 0.214 . . . . 0.0 110.871 -177.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.64 -42.65 70.59 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.812 0.845 . . . . 0.0 110.842 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 94.4 mt -71.81 -12.16 61.16 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.645 0.778 . . . . 0.0 111.47 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.03 -0.61 76.24 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 123.288 0.368 . . . . 0.0 112.75 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 66.2 mt -74.46 92.28 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.75 152.2 48.05 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.82 0.448 . . . . 0.0 111.225 -172.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.92 -115.91 8.26 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 124.453 1.096 . . . . 0.0 113.02 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.16 -26.48 68.19 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.248 1.019 . . . . 0.0 111.595 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.45 -24.41 60.22 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.846 0.458 . . . . 0.0 111.881 -176.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.46 HH12 ' HB2' ' A' ' 75' ' ' GLU . 60.8 mtt180 -63.02 135.2 57.14 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 123.427 0.455 . . . . 0.0 110.802 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.56 118.87 74.81 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 123.733 0.813 . . . . 0.0 110.44 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.99 135.27 50.45 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 123.596 2.864 . . . . 0.0 113.262 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.2 116.38 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.531 0.733 . . . . 0.0 109.48 -176.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.2 t -105.74 99.08 7.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -174.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -74.92 99.71 3.9 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 42.3 mm . . . . . 0 C--N 1.323 -0.554 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.65 ' HB2' HG12 ' A' ' 60' ' ' VAL . 31.9 mmt180 . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -78.52 133.21 37.41 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.267 0.556 . . . . 0.0 109.648 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 48.5 pt -132.13 -177.04 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 126.009 1.724 . . . . 0.0 108.27 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.8 p -102.98 169.91 8.28 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 167.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.502 ' O ' HG23 ' A' ' 24' ' ' VAL . 66.4 t-105 -53.18 -40.15 64.17 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.552 0.741 . . . . 0.0 110.486 170.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.6 tttp -56.48 -49.0 75.94 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.749 0.819 . . . . 0.0 111.632 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.515 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 30.5 m-20 -61.95 -40.66 96.3 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.625 0.37 . . . . 0.0 110.773 177.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.426 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 33.9 t80 -54.01 -53.0 59.0 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 124.413 1.07 . . . . 0.0 110.96 177.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 20' ' ' TRP . 63.8 t -57.23 -56.77 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 123.732 0.645 . . . . 0.0 111.074 -177.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -67.6 -58.95 3.78 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.739 0.816 . . . . 0.0 112.274 -170.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -85.44 -20.65 29.47 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.555 0.742 . . . . 0.0 112.084 -165.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.426 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 78.1 m-85 -120.66 -68.97 0.87 Allowed 'General case' 0 C--O 1.248 1.003 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -168.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.7 tp -60.21 -48.85 79.98 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.562 0.745 . . . . 0.0 111.894 -173.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.1 m -68.48 -17.05 64.1 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -96.6 1.38 51.18 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.267 0.485 . . . . 0.0 111.358 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.94 22.01 56.82 Favored Glycine 0 C--N 1.35 1.307 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 m -89.95 4.83 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.886 0.474 . . . . 0.0 111.334 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.6 t -96.18 128.58 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.432 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 25.6 t70 -90.35 -50.09 6.16 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.885 0.874 . . . . 0.0 109.951 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -163.94 159.21 20.6 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.291 -177.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 46' ' ' VAL . 96.3 mt -120.72 102.55 8.47 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.987 0.915 . . . . 0.0 110.877 -173.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.698 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 49.4 mp0 -83.99 108.67 17.09 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.698 0.799 . . . . 0.0 110.092 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 41' ' ' LYS . 47.8 t -86.15 90.61 3.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.446 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 59.8 t -84.84 119.05 33.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.851 -170.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 56.89 22.38 7.06 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 125.404 1.482 . . . . 0.0 112.992 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.525 ' HA ' HG12 ' A' ' 38' ' ' VAL . 36.2 mtmm 58.58 8.28 0.86 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.526 1.13 . . . . 0.0 113.666 -173.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -88.59 -40.18 13.56 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.447 1.099 . . . . 0.0 110.851 -174.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -150.33 173.78 13.6 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.062 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 38' ' ' VAL . 73.8 t -124.05 132.72 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.179 0.992 . . . . 0.0 109.676 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.698 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 40.9 ttm180 -96.39 113.09 24.64 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.521 1.128 . . . . 0.0 108.582 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.422 ' HA ' HD23 ' A' ' 36' ' ' LEU . 44.6 t -82.66 107.2 14.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.3 m -93.16 144.67 25.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.27 140.48 29.65 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.887 0.475 . . . . 0.0 112.02 177.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 CA--C 1.55 0.978 0 C-N-CA 124.121 0.968 . . . . 0.0 110.96 174.566 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.5 p90 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 121.152 0.501 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.65 HG12 ' HB2' ' A' ' 16' ' ' ARG . 23.3 m -109.19 164.61 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -158.89 158.35 33.23 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 118.385 0.539 . . . . 0.0 111.202 -173.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -146.1 145.68 30.62 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.999 0.52 . . . . 0.0 110.245 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -85.35 121.81 28.62 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.973 0.909 . . . . 0.0 110.487 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 67' ' ' VAL . 36.2 pt -103.77 -51.51 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.283 0.633 . . . . 0.0 111.236 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.457 ' N ' HG13 ' A' ' 64' ' ' ILE . . . 71.03 -70.07 0.78 Allowed Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -165.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.6 m -81.55 96.27 7.39 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.108 0.963 . . . . 0.0 110.895 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.567 ' HA ' HD12 ' A' ' 64' ' ' ILE . 13.0 t -64.72 -34.06 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.626 0.77 . . . . 0.0 111.383 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -58.73 -45.35 89.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.063 0.545 . . . . 0.0 109.819 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.5 m -64.19 -46.23 84.87 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.014 0.926 . . . . 0.0 110.229 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -49.65 -54.53 18.0 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.197 0.999 . . . . 0.0 112.042 174.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -66.59 -43.5 84.72 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.125 0.891 . . . . 0.0 111.83 -174.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -63.98 -40.07 95.57 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.568 0.747 . . . . 0.0 111.041 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -64.17 -46.82 82.32 Favored 'General case' 0 C--O 1.216 -0.698 0 O-C-N 123.704 0.627 . . . . 0.0 109.678 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.7 tp -60.79 -41.81 96.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.935 0.894 . . . . 0.0 111.86 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -65.14 -51.53 60.69 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.211 0.605 . . . . 0.0 111.786 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 m -65.7 -37.28 86.01 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.618 0.767 . . . . 0.0 110.214 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.42 -44.02 95.82 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.494 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -66.25 -29.88 70.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.694 0.397 . . . . 0.0 110.516 176.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -66.88 -49.12 66.64 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.65 0.38 . . . . 0.0 111.397 175.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.46 -36.03 73.66 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.228 0.211 . . . . 0.0 111.239 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.557 ' HB2' HG12 ' A' ' 83' ' ' ILE . 92.0 mt -75.78 -20.06 58.52 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.144 0.578 . . . . 0.0 111.228 175.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.68 30.56 66.11 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 120.121 -0.266 . . . . 0.0 113.131 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.557 HG12 ' HB2' ' A' ' 81' ' ' LEU . 17.6 mm -66.45 102.35 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.414 1.085 . . . . 0.0 109.279 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -72.6 166.99 21.64 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.63 -32.85 54.26 Favored Glycine 0 N--CA 1.48 1.613 0 O-C-N 124.179 0.924 . . . . 0.0 114.73 -171.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -67.28 -43.52 81.56 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.966 0.906 . . . . 0.0 110.408 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -81.19 -19.91 42.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.145 0.978 . . . . 0.0 111.593 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.5 mtt-85 -61.47 122.08 14.3 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.904 0.881 . . . . 0.0 110.567 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.5 t -77.91 117.95 69.06 Favored Pre-proline 0 CA--C 1.554 1.103 0 O-C-N 123.983 0.802 . . . . 0.0 110.47 -172.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.432 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 71.9 Cg_exo -54.84 136.98 74.19 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.841 3.027 . . . . 0.0 113.261 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.3 t -103.53 113.4 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' A' ' 37' ' ' GLU . 60.3 t -100.89 149.36 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.927 1.291 . . . . 0.0 108.025 -177.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -114.2 131.5 56.44 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 38.4 mm . . . . . 0 N--CA 1.473 0.72 0 C-N-CA 123.882 0.873 . . . . 0.0 109.244 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.651 ' HB2' HG12 ' A' ' 60' ' ' VAL . 59.2 mtm180 . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -78.81 129.72 34.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.4 pt -124.42 179.72 2.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 124.914 1.286 . . . . 0.0 108.921 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.8 p -106.32 170.1 8.12 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.66 0.784 . . . . 0.0 109.682 172.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.422 ' O ' HG23 ' A' ' 24' ' ' VAL . 71.1 t-105 -59.62 -39.87 85.71 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.527 0.731 . . . . 0.0 111.174 176.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -55.68 -52.38 64.05 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.585 0.754 . . . . 0.0 112.229 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -70.18 -32.38 70.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.935 0.494 . . . . 0.0 111.51 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.495 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 17.4 t80 -55.84 -56.11 24.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.635 0.774 . . . . 0.0 111.671 172.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.44 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 97.4 t -61.95 -58.33 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 123.595 0.56 . . . . 0.0 110.419 -176.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -65.47 -49.82 67.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.052 -168.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -87.46 -17.08 33.0 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -170.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.495 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 42.7 m-85 -128.6 -68.04 0.77 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -171.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 7.9 tt -59.06 -52.65 64.83 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.559 0.744 . . . . 0.0 111.903 -169.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 82.3 p -66.61 -22.57 66.12 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.554 0.742 . . . . 0.0 112.152 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -89.76 -5.42 56.98 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.342 0.657 . . . . 0.0 111.664 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.24 32.67 77.34 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.468 0.48 . . . . 0.0 113.991 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 m -101.93 11.44 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 122.855 0.462 . . . . 0.0 110.328 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.67 122.59 51.69 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 C-N-CA 124.207 1.003 . . . . 0.0 109.519 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 25.7 t70 -77.04 -45.89 25.62 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.732 0.813 . . . . 0.0 109.601 176.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -162.59 162.44 27.18 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.747 -167.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.426 ' HG ' HG11 ' A' ' 89' ' ' VAL . 95.4 mt -120.41 137.11 54.49 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.906 1.283 . . . . 0.0 108.375 170.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -120.13 110.49 16.7 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.213 0.605 . . . . 0.0 109.491 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 44' ' ' VAL . 24.3 t -90.09 91.14 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -176.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.49 119.11 34.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -172.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 57.99 17.1 4.14 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.629 1.571 . . . . 0.0 113.855 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.1 mttp 61.69 2.81 0.76 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -172.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -80.04 -42.43 23.77 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.658 0.783 . . . . 0.0 109.856 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -151.38 170.41 19.63 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.334 -174.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 38' ' ' VAL . 84.6 t -129.21 133.7 65.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -99.57 132.41 44.93 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.15 109.39 16.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 114.59 -1.186 . . . . 0.0 107.819 174.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.7 m -82.13 125.95 31.47 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 172.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.439 ' CE2' ' HA ' ' A' ' 59' ' ' TYR . 22.7 m-85 -84.21 133.42 34.59 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.369 0.668 . . . . 0.0 110.204 177.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.817 0 O-C-N 123.497 0.498 . . . . 0.0 109.95 175.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.439 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 17.8 m-85 . . . . . 0 C--O 1.237 0.425 0 CA-C-O 121.184 0.516 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.651 HG12 ' HB2' ' A' ' 16' ' ' ARG . 34.9 m -107.7 161.33 6.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.506 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 45.5 p-90 -153.3 162.26 41.49 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.601 0.76 . . . . 0.0 109.276 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -147.75 144.38 28.21 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -79.57 136.22 36.8 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 67' ' ' VAL . 43.1 pt -108.23 -42.22 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 110.658 -0.127 . . . . 0.0 110.658 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.81 -81.53 0.05 OUTLIER Glycine 0 C--N 1.35 1.306 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 -173.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.3 m -74.48 97.49 3.12 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.739 0.816 . . . . 0.0 109.134 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.467 ' HA ' HD12 ' A' ' 64' ' ' ILE . 25.2 t -59.81 -33.67 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.98 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -57.05 -40.77 77.42 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.944 0.898 . . . . 0.0 111.069 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.2 m -67.19 -46.01 75.19 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.129 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -52.64 -52.73 54.32 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.503 0.502 . . . . 0.0 111.213 177.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -59.63 -59.01 6.12 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.3 1.0 . . . . 0.0 112.767 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -67.2 -36.79 82.46 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.534 -171.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.82 -52.63 59.3 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 174.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 47.7 tp -52.78 -52.96 54.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.188 1.395 . . . . 0.0 112.722 -176.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -68.17 -45.55 73.16 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.449 -175.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.41 ' HA ' ' NE2' ' A' ' 79' ' ' GLN . 27.6 m -64.72 -45.14 87.78 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.4 tp -46.45 -48.52 18.93 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.883 1.673 . . . . 0.0 112.382 171.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -62.23 -43.25 99.24 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.3 0.64 . . . . 0.0 111.258 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.41 ' NE2' ' HA ' ' A' ' 76' ' ' THR . 17.7 mt-30 -65.25 -41.69 94.05 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.255 0.622 . . . . 0.0 111.142 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -68.47 -40.26 81.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.741 0.816 . . . . 0.0 111.25 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.58 -15.04 59.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.214 0.605 . . . . 0.0 112.52 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.96 13.57 68.94 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-O 120.269 -0.184 . . . . 0.0 113.41 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.4 mt -71.67 108.11 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.43 1.092 . . . . 0.0 109.2 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -137.98 151.47 47.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.929 0.891 . . . . 0.0 110.568 -172.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.22 -118.91 13.96 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 123.905 0.753 . . . . 0.0 113.65 174.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.69 -29.32 70.56 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.043 0.937 . . . . 0.0 111.734 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.84 -21.66 60.92 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.943 -171.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 88' ' ' ARG . 37.6 mtp85 -66.55 150.01 49.63 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.175 0.59 . . . . 0.0 110.416 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.426 HG11 ' HG ' ' A' ' 36' ' ' LEU . 20.2 t -91.64 119.55 68.46 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.118 -168.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.4 123.86 13.59 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.066 2.51 . . . . 0.0 111.377 175.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.2 t -116.19 118.34 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.8 t -113.36 105.59 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.106 0.963 . . . . 0.0 109.567 -173.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -75.35 123.46 25.42 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.051 0.54 . . . . 0.0 109.814 175.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.8 mt . . . . . 0 CA--C 1.54 0.573 0 C-N-CA 124.882 1.273 . . . . 0.0 108.084 -178.978 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 20.4 tpp180 . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -77.44 111.32 13.02 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 167.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.465 HD11 HG21 ' A' ' 46' ' ' VAL . 27.5 pt -93.77 166.78 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.555 1.142 . . . . 0.0 109.241 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.9 p -88.57 170.73 10.6 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -56.79 -40.86 76.67 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.097 0.559 . . . . 0.0 110.13 168.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -59.98 -49.17 78.74 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.663 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.425 ' HA ' HD22 ' A' ' 26' ' ' ASN . 59.0 m-20 -66.61 -36.79 83.46 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.193 0.197 . . . . 0.0 111.183 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -54.65 -59.4 4.76 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.654 0.596 . . . . 0.0 110.736 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.486 HG13 HD11 ' A' ' 77' ' ' LEU . 47.5 t -60.17 -50.79 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 123.933 0.771 . . . . 0.0 111.255 -175.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -73.1 -56.97 4.38 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.793 -173.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.425 HD22 ' HA ' ' A' ' 22' ' ' ASP . 23.7 m-80 -90.89 -10.99 40.53 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -166.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.9 -64.69 1.0 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 119.158 0.89 . . . . 0.0 111.737 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 41.9 tp -58.15 -41.81 84.55 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.551 1.14 . . . . 0.0 112.224 -176.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.8 t -66.55 -22.21 66.15 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.576 0.751 . . . . 0.0 112.751 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -87.09 -7.9 57.58 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.326 0.512 . . . . 0.0 110.949 175.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.66 12.95 60.25 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 114.259 0.464 . . . . 0.0 114.259 -175.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.14 -1.01 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 117.317 0.558 . . . . 0.0 111.084 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.55 126.44 45.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 C-N-CA 123.525 0.73 . . . . 0.0 109.155 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.443 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 16.5 t70 -86.03 -51.58 6.25 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.886 0.851 . . . . 0.0 109.095 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.534 ' HD3' HG21 ' A' ' 92' ' ' VAL . 16.2 ptp180 -160.13 164.42 32.99 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.05 -172.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.2 mt -117.17 101.93 8.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.685 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -92.96 107.61 19.36 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.495 0.718 . . . . 0.0 109.944 -171.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 44' ' ' VAL . 41.0 t -91.89 91.61 3.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -175.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.688 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 49.1 t -79.08 114.22 19.52 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.666 -172.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 50.66 31.7 6.1 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.496 1.519 . . . . 0.0 113.217 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HA ' HG12 ' A' ' 38' ' ' VAL . 61.3 mttm 66.8 -6.87 0.5 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 125.714 1.606 . . . . 0.0 112.801 -177.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.7 mmt-85 -64.94 -50.19 67.42 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 124.865 1.266 . . . . 0.0 110.904 -170.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -148.74 159.83 43.77 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.49 -175.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 38' ' ' VAL . 65.5 t -101.14 123.06 53.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 171.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -101.6 129.29 47.68 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.542 ' HB ' HG23 ' A' ' 60' ' ' VAL . 68.8 t -85.13 110.24 19.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.5 m -82.97 134.74 35.04 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -82.99 128.17 34.23 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 171.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.443 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 5.1 t . . . . . 0 CA--C 1.556 1.202 0 C-N-CA 123.109 0.564 . . . . 0.0 110.541 -176.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 121.362 0.601 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.542 HG23 ' HB ' ' A' ' 46' ' ' VAL . 18.7 m -106.29 140.75 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -177.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -157.21 173.57 16.77 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.344 -170.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 23.7 p90 -151.98 141.17 21.35 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.86 0.864 . . . . 0.0 109.178 175.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -78.17 147.54 34.47 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.2 pt -124.39 154.1 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.329 0.652 . . . . 0.0 109.289 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.24 -34.43 1.79 Allowed Glycine 0 N--CA 1.471 0.989 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 174.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 m -117.9 99.55 6.99 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.56 1.144 . . . . 0.0 108.535 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.6 t -60.64 -35.3 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 122.977 0.511 . . . . 0.0 110.036 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.05 -40.44 95.78 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.065 0.946 . . . . 0.0 110.736 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.3 m -67.95 -42.87 80.29 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.565 176.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -55.14 -43.76 74.48 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.909 0.756 . . . . 0.0 111.394 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.47 -51.07 64.89 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.864 0.466 . . . . 0.0 110.73 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -34.42 73.52 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -171.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 29.9 p30 -74.27 -33.33 63.24 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 176.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.7 tp -62.89 -42.96 99.96 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.607 0.763 . . . . 0.0 110.859 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -60.34 -52.82 63.62 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.137 0.575 . . . . 0.0 110.566 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.8 m -61.97 -42.2 98.86 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 123.666 0.604 . . . . 0.0 110.738 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 73' ' ' ASN . 1.8 tm? -56.53 -47.82 78.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.84 1.256 . . . . 0.0 110.879 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.439 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 77.3 mt-30 -65.18 -36.83 85.43 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.143 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -63.85 -39.53 94.44 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.096 0.558 . . . . 0.0 110.814 176.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.97 -51.26 70.0 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.038 0.935 . . . . 0.0 111.169 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.8 mt -83.85 -2.57 56.69 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.001 -173.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.87 9.95 83.51 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 120.281 -0.177 . . . . 0.0 112.935 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.478 HG22 ' HA ' ' A' ' 88' ' ' ARG . 57.2 mt -73.59 118.61 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.733 1.213 . . . . 0.0 109.077 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -168.56 173.86 7.16 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.482 0.713 . . . . 0.0 111.193 -172.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.75 -122.11 25.39 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.589 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.46 -34.2 58.71 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.43 0.692 . . . . 0.0 110.245 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -74.33 -6.1 46.08 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.438 0.695 . . . . 0.0 112.455 -171.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.478 ' HA ' HG22 ' A' ' 83' ' ' ILE . 6.9 ptm180 -79.91 156.45 27.28 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.079 0.466 . . . . 0.0 111.274 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.5 t -98.99 114.81 65.84 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.246 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.92 160.74 33.64 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.164 2.576 . . . . 0.0 112.875 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.8 t -110.65 132.31 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.614 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.534 HG21 ' HD3' ' A' ' 35' ' ' ARG . 21.8 t -117.92 97.37 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -73.01 100.83 3.08 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.376 0.67 . . . . 0.0 109.883 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.688 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 46.8 mm . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.3 mtt . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.67 -2.0 63.2 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-O 119.523 -0.598 . . . . 0.0 113.729 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -65.83 -41.74 91.41 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.687 0.795 . . . . 0.0 110.797 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -90.34 83.8 5.97 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.804 0.811 . . . . 0.0 111.543 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -138.59 176.45 8.69 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.945 0.898 . . . . 0.0 110.251 174.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -66.34 96.22 0.34 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.617 0.722 . . . . 0.0 111.376 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -82.78 -42.39 18.0 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.72 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -87.49 66.01 8.85 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.012 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.0 m -152.54 144.42 23.67 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 125.311 1.444 . . . . 0.0 107.507 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -67.56 146.66 53.69 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 123.325 0.391 . . . . 0.0 110.524 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.9 ttt -62.03 98.8 0.11 Allowed 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 172.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.43 73.39 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 125.416 1.486 . . . . 0.0 110.783 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.415 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER 58.49 -74.7 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.252 1.821 . . . . 0.0 111.618 -168.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.7 t -163.52 -51.04 0.03 OUTLIER 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.144 1.377 . . . . 0.0 108.48 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 59' ' ' TYR . . . 173.56 -117.49 0.65 Allowed Glycine 0 C--N 1.343 0.932 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.189 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 41.0 ttp-105 -95.33 131.4 41.46 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.574 0.687 . . . . 0.0 109.936 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -77.01 126.18 30.55 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.92 0.888 . . . . 0.0 108.752 177.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.3 pt -126.55 166.86 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.785 1.234 . . . . 0.0 108.139 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 22' ' ' ASP . 9.8 t -96.4 157.84 15.71 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 174.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.543 ' O ' HG23 ' A' ' 24' ' ' VAL . 73.5 t-105 -53.91 -46.0 71.31 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.392 1.077 . . . . 0.0 110.993 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -61.04 -39.64 90.56 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.616 0.766 . . . . 0.0 112.037 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.498 ' H ' HG23 ' A' ' 19' ' ' THR . 24.4 t70 -66.55 -43.35 85.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.532 1.133 . . . . 0.0 110.415 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.444 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 12.5 t80 -52.46 -53.72 41.8 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.802 175.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.564 HG22 HD21 ' A' ' 77' ' ' LEU . 62.3 t -58.65 -55.45 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 123.805 0.691 . . . . 0.0 111.22 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -71.78 -49.55 37.88 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.085 -0.962 . . . . 0.0 112.147 -169.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -90.07 -13.84 35.03 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.444 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 41.7 m-85 -127.81 -64.72 0.95 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 119.245 0.929 . . . . 0.0 113.131 -175.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.428 HD11 HG21 ' A' ' 89' ' ' VAL . 32.8 tp -58.47 -50.18 74.66 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.566 0.747 . . . . 0.0 112.775 -170.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.7 p -70.45 -18.37 63.0 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.15 0.58 . . . . 0.0 111.623 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -86.41 -7.59 58.32 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.435 0.694 . . . . 0.0 110.893 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.33 13.16 67.3 Favored Glycine 0 C--N 1.356 1.659 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 m -86.8 -0.47 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.435 0.617 . . . . 0.0 111.274 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.6 t -97.87 128.03 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.185 0.994 . . . . 0.0 109.062 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 23.9 t70 -86.94 -52.42 5.47 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.08 0.952 . . . . 0.0 109.75 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.516 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 17.5 ptp180 -156.48 163.66 39.16 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.512 -174.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.6 mt -118.75 104.4 10.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.825 0.85 . . . . 0.0 108.972 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.44 ' HG2' ' HB ' ' A' ' 92' ' ' VAL . 46.1 mt-10 -97.75 107.77 20.33 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.734 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 41' ' ' LYS . 26.5 t -82.91 92.42 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -172.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.549 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 61.9 t -83.19 120.44 34.47 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 C-N-CA 122.797 0.439 . . . . 0.0 110.815 -169.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 95' ' ' ALA . 3.8 m-20 54.53 21.45 3.35 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.811 1.644 . . . . 0.0 113.016 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HA ' HG12 ' A' ' 38' ' ' VAL . 99.5 mttt 55.85 5.43 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.301 1.44 . . . . 0.0 114.472 -175.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -78.41 -41.32 33.37 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.02 0.914 . . . . 0.0 108.87 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -151.49 172.91 15.24 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.021 -172.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.424 HG22 HG22 ' A' ' 38' ' ' VAL . 79.4 t -122.38 131.26 73.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 124.248 1.019 . . . . 0.0 108.53 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -90.43 127.01 36.08 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 60' ' ' VAL . 60.8 t -80.97 106.87 12.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 171.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.463 HG23 ' HE2' ' A' ' 59' ' ' TYR . 66.1 m -88.4 123.14 32.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -82.74 147.55 28.38 Favored 'General case' 0 C--O 1.247 0.939 0 O-C-N 123.609 0.568 . . . . 0.0 109.728 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 43.4 p -59.36 124.23 74.08 Favored Pre-proline 0 CA--C 1.556 1.174 0 O-C-N 124.327 1.017 . . . . 0.0 109.855 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.3 97.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 123.597 2.865 . . . . 0.0 113.563 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.9 -38.82 0.97 Allowed Glycine 0 C--N 1.344 0.993 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.724 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -67.58 -56.67 8.53 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.477 0.711 . . . . 0.0 111.1 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 65.5 p -132.06 135.52 26.68 Favored Pre-proline 0 N--CA 1.477 0.92 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -71.82 -171.2 0.62 Allowed 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.636 2.224 . . . . 0.0 112.13 170.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.9 t -64.3 -41.83 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.1 -14.98 62.49 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.336 175.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.36 -12.73 59.1 Favored Glycine 0 C--N 1.351 1.376 0 C-N-CA 122.963 0.316 . . . . 0.0 112.815 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 66.99 94.15 0.07 Allowed 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.02 1.328 . . . . 0.0 111.049 172.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.463 ' HE2' HG23 ' A' ' 47' ' ' THR . 3.7 m-30 -65.21 157.33 29.12 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.128 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 46' ' ' VAL . 31.1 m -110.2 164.68 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.343 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.412 ' CZ2' ' HG2' ' A' ' 13' ' ' ARG . 56.0 p-90 -157.35 165.67 35.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.176 0.59 . . . . 0.0 110.027 -173.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -149.2 142.01 24.64 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.467 0.707 . . . . 0.0 109.967 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -75.31 140.05 42.86 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 67' ' ' VAL . 31.0 pt -115.18 -44.02 3.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.205 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.12 -74.74 0.36 Allowed Glycine 0 C--N 1.352 1.45 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 -171.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -80.33 97.47 7.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.456 1.102 . . . . 0.0 109.3 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.592 ' HA ' HD12 ' A' ' 64' ' ' ILE . 37.4 t -59.28 -37.44 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 123.821 0.849 . . . . 0.0 111.027 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 21.8 t70 -58.09 -49.87 75.43 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.497 1.119 . . . . 0.0 110.803 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.4 m -58.68 -46.08 88.03 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 123.917 0.887 . . . . 0.0 111.075 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -49.99 -50.81 45.85 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.16 0.984 . . . . 0.0 111.322 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 42.4 mt-10 -67.97 -45.83 73.09 Favored 'General case' 0 C--N 1.347 0.457 0 O-C-N 124.251 0.97 . . . . 0.0 111.62 -173.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 68' ' ' ASP . 14.2 mtm180 -58.27 -46.05 86.73 Favored 'General case' 0 C--N 1.364 1.213 0 O-C-N 123.821 0.7 . . . . 0.0 109.845 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -65.48 -42.99 91.59 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.652 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.27 -50.59 69.57 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 123.946 0.778 . . . . 0.0 112.265 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -34.6 76.71 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 122.808 0.443 . . . . 0.0 111.675 -177.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.44 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 86.8 m -63.66 -52.02 62.57 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.352 0.596 . . . . 0.0 109.512 171.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.564 HD21 HG22 ' A' ' 24' ' ' VAL . 47.1 tp -52.99 -42.65 65.78 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.505 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -64.53 -45.7 86.03 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.915 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 76' ' ' THR . 10.1 pt20 -70.25 -26.84 64.02 Favored 'General case' 0 CA--C 1.56 1.365 0 CA-C-N 117.763 0.256 . . . . 0.0 110.79 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 76' ' ' THR . 43.8 mt-10 -68.22 -50.23 55.47 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.013 0.925 . . . . 0.0 110.738 174.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.16 5.03 18.07 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.677 -176.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.86 19.54 72.73 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-O 119.823 -0.432 . . . . 0.0 114.106 172.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.55 117.53 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 123.842 0.857 . . . . 0.0 109.612 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -102.65 -179.18 3.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.772 1.229 . . . . 0.0 108.568 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.17 -36.27 1.98 Allowed Glycine 0 N--CA 1.48 1.572 0 N-CA-C 116.246 1.258 . . . . 0.0 116.246 -174.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.6 -37.03 60.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.504 0.722 . . . . 0.0 111.385 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -93.2 -5.63 49.56 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 118.85 -0.595 . . . . 0.0 111.966 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -58.85 124.51 20.06 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 118.046 0.385 . . . . 0.0 110.433 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.428 HG21 HD11 ' A' ' 28' ' ' LEU . 99.6 t -89.7 108.64 26.66 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.452 -172.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.516 ' HG2' ' HB3' ' A' ' 35' ' ' ARG . 19.4 Cg_endo -58.74 129.21 31.17 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.299 2.666 . . . . 0.0 112.591 -174.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.61 109.35 25.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.44 ' HB ' ' HG2' ' A' ' 37' ' ' GLU . 43.4 t -104.07 111.67 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -174.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -78.66 124.97 28.73 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 47.2 mt -124.71 137.59 56.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 40' ' ' ASN . . . -161.04 90.86 0.85 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.796 0.438 . . . . 0.0 110.705 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -85.38 131.28 34.42 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 169.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.3 t -66.63 -19.31 65.74 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.728 0.811 . . . . 0.0 111.374 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -60.17 -35.8 76.15 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.751 1.22 . . . . 0.0 111.673 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.154 0 CA-C-O 119.305 -0.719 . . . . 0.0 111.35 178.781 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 120.802 0.334 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.48 78.57 0.5 Allowed Glycine 0 C--N 1.344 1.019 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 -172.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -85.08 19.05 2.29 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.99 0.516 . . . . 0.0 111.574 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -75.34 -168.42 0.8 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.544 0.738 . . . . 0.0 109.848 168.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -66.71 89.15 0.15 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 170.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -110.87 94.36 4.95 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.852 0.834 . . . . 0.0 109.973 -176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -133.05 52.14 2.11 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -54.46 102.57 0.06 Allowed 'General case' 0 C--N 1.352 0.701 0 C-N-CA 124.033 0.933 . . . . 0.0 111.141 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 p -74.64 145.5 43.18 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.946 174.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -153.05 74.43 1.04 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.353 0.661 . . . . 0.0 110.399 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 70.1 mtm 56.67 -89.95 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.835 1.654 . . . . 0.0 112.328 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -137.01 141.67 42.51 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.799 0.84 . . . . 0.0 109.781 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -170.58 -64.03 0.02 OUTLIER 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.222 0.609 . . . . 0.0 110.273 174.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.3 m 64.31 -70.14 0.08 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.706 1.203 . . . . 0.0 109.522 -165.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 59' ' ' TYR . . . 167.85 -120.85 0.92 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 171.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.469 ' HB2' HG12 ' A' ' 60' ' ' VAL . 34.7 mmt180 -98.35 121.78 40.71 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.439 0.696 . . . . 0.0 110.715 176.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -79.76 109.62 14.35 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.2 pt -104.85 177.14 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 124.931 1.292 . . . . 0.0 108.9 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.5 p -92.02 163.14 14.09 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.554 ' O ' HG23 ' A' ' 24' ' ' VAL . 69.7 t-105 -58.89 -41.08 86.33 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.007 0.523 . . . . 0.0 109.657 171.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -52.16 -57.34 9.92 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.894 0.878 . . . . 0.0 111.733 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.33 -34.82 79.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.427 0.691 . . . . 0.0 111.157 -175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.404 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 45.2 t80 -54.56 -54.87 35.55 Favored 'General case' 0 C--N 1.344 0.334 0 O-C-N 123.991 0.807 . . . . 0.0 111.302 174.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.556 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 43.7 t -64.88 -50.64 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 O-C-N 123.43 0.456 . . . . 0.0 110.605 -174.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -66.44 -45.22 80.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.211 -172.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -95.71 -24.64 16.44 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -171.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.404 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 80.0 m-85 -122.13 -64.84 1.17 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 118.782 0.719 . . . . 0.0 112.591 -169.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 48.9 tp -55.54 -48.75 74.23 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.981 0.912 . . . . 0.0 112.045 -173.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 p -64.94 -22.95 67.08 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -89.49 -3.72 58.24 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.902 0.481 . . . . 0.0 110.439 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.37 19.14 61.78 Favored Glycine 0 C--N 1.355 1.599 0 N-CA-C 114.671 0.628 . . . . 0.0 114.671 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.5 m -79.06 0.16 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 117.415 0.608 . . . . 0.0 111.638 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.1 135.09 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.303 1.041 . . . . 0.0 108.941 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -81.64 -53.69 6.03 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.337 1.055 . . . . 0.0 108.887 174.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 32.4 ptt-85 -168.15 164.19 13.35 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.944 -171.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.6 mt -116.96 105.18 12.05 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.061 0.945 . . . . 0.0 109.377 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -96.33 110.67 22.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.106 -174.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 41' ' ' LYS . 7.6 t -90.65 93.79 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -171.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.7 t -71.14 117.95 15.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 123.738 0.815 . . . . 0.0 110.919 -171.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 54.19 22.71 3.75 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.54 1.536 . . . . 0.0 113.03 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.633 ' HA ' HG12 ' A' ' 38' ' ' VAL . 8.5 mtpm? 53.7 17.15 1.15 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.852 1.261 . . . . 0.0 114.067 -172.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -91.28 -37.18 13.45 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.114 0.566 . . . . 0.0 110.434 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -152.8 163.78 39.07 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.75 0.82 . . . . 0.0 109.26 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.421 HG22 HG22 ' A' ' 38' ' ' VAL . 47.8 t -110.27 130.35 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.426 ' HG2' ' HB3' ' A' ' 61' ' ' TRP . 3.5 tmm_? -116.14 132.46 56.65 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.0 t -88.44 125.83 41.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.178 -170.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.9 m -95.14 129.77 42.12 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 167.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.481 ' HB2' HG23 ' A' ' 53' ' ' THR . 82.4 m-85 -87.03 144.7 26.78 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.828 0.451 . . . . 0.0 110.716 172.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 t -73.67 142.0 80.05 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.005 0.522 . . . . 0.0 110.195 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.54 121.0 9.25 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 123.428 2.752 . . . . 0.0 112.397 -173.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.59 -39.68 2.8 Favored Glycine 0 N--CA 1.471 0.999 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -95.83 1.98 53.47 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.699 0.8 . . . . 0.0 111.011 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.481 HG23 ' HB2' ' A' ' 48' ' ' PHE . 6.7 m -81.58 115.59 57.74 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.54 0.736 . . . . 0.0 109.955 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -48.02 120.73 5.12 Favored 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.605 2.87 . . . . 0.0 112.446 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.2 p -53.02 -32.58 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 124.967 1.307 . . . . 0.0 113.593 -166.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.7 -39.84 95.25 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.292 1.037 . . . . 0.0 110.66 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.41 16.78 6.92 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 115.421 -0.808 . . . . 0.0 112.203 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -78.49 103.06 8.18 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 122.964 0.505 . . . . 0.0 110.215 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.405 ' O ' ' HA3' ' A' ' 15' ' ' GLY . 87.1 m-85 -81.32 174.07 11.86 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 166.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.469 HG12 ' HB2' ' A' ' 16' ' ' ARG . 25.2 m -122.81 170.26 13.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 168.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.426 ' HB3' ' HG2' ' A' ' 45' ' ' ARG . 8.9 p-90 -165.43 158.56 16.1 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.622 0.369 . . . . 0.0 110.624 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -145.0 151.03 37.94 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.316 0.579 . . . . 0.0 110.291 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -82.9 151.06 26.13 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.579 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 67' ' ' VAL . 26.0 pt -125.69 144.19 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.521 0.728 . . . . 0.0 110.425 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.99 -52.64 7.75 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m -131.72 135.7 47.05 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.717 0.807 . . . . 0.0 108.972 176.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.44 ' HA ' HD12 ' A' ' 64' ' ' ILE . 5.0 t -67.15 -37.27 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.01 0.924 . . . . 0.0 110.477 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.533 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 5.9 m-20 -67.0 -49.41 65.44 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.646 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.8 m -62.7 -36.01 81.57 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 122.576 0.351 . . . . 0.0 110.647 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -54.33 -57.52 10.92 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 123.81 0.844 . . . . 0.0 111.385 174.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -64.33 -33.13 75.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.438 0.462 . . . . 0.0 111.368 -175.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 5.3 mmp_? -60.69 -55.53 32.13 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.099 0.476 . . . . 0.0 110.412 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.412 HD22 ' N ' ' A' ' 73' ' ' ASN . 0.8 OUTLIER -66.6 -42.4 86.97 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.224 -173.057 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 65.5 tp -58.76 -56.02 27.58 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.111 0.964 . . . . 0.0 112.527 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -59.67 -42.06 92.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 123.447 0.467 . . . . 0.0 111.932 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.425 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 54.9 m -59.79 -53.08 62.11 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 51.3 tp -53.91 -46.48 71.46 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.813 1.645 . . . . 0.0 113.119 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -62.04 -48.34 80.68 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.998 0.519 . . . . 0.0 110.662 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -68.48 -22.95 64.53 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.42 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 76' ' ' THR . 61.1 mm-40 -71.56 -43.18 66.81 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.919 0.488 . . . . 0.0 110.135 169.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.0 mt -73.86 -15.58 61.15 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.921 0.888 . . . . 0.0 111.214 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.66 -6.79 80.04 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-O 119.601 -0.555 . . . . 0.0 112.923 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.418 HG22 ' HA ' ' A' ' 88' ' ' ARG . 77.8 mt -64.92 101.36 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.537 1.535 . . . . 0.0 110.271 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -144.31 167.84 21.49 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.523 1.129 . . . . 0.0 110.027 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.52 -122.89 23.96 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.506 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -73.97 -25.4 59.91 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.645 0.778 . . . . 0.0 111.307 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -75.61 -23.35 56.42 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.163 0.585 . . . . 0.0 110.407 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.423 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 15.0 ttm180 -57.88 137.48 56.64 Favored 'General case' 0 C--N 1.35 0.594 0 C-N-CA 124.103 0.961 . . . . 0.0 110.677 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.9 t -92.38 101.61 5.21 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.824 1.25 . . . . 0.0 109.723 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 88' ' ' ARG . 19.5 Cg_exo -68.15 153.69 74.17 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.994 2.463 . . . . 0.0 112.351 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.0 t -107.07 118.74 55.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.2 t -106.61 97.86 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -72.92 97.44 2.28 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.1 mt -87.2 140.11 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -140.82 82.82 1.86 Allowed 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -78.79 83.69 4.91 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.017 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.5 m -135.09 134.51 40.37 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.987 0.915 . . . . 0.0 109.78 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.94 -26.46 65.08 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.682 0.793 . . . . 0.0 110.792 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.64 -1.089 . . . . 0.0 111.647 178.357 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 120.684 0.278 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.38 -18.14 3.11 Favored Glycine 0 C--N 1.345 1.064 0 C-N-CA 123.622 0.629 . . . . 0.0 112.407 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.461 ' HB3' ' O ' ' A' ' 6' ' ' HIS . 88.1 m-70 -87.31 77.05 9.03 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.76 0.824 . . . . 0.0 110.258 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -95.4 -36.94 11.16 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.35 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -73.25 -43.18 61.57 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.277 0.56 . . . . 0.0 110.546 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.461 ' O ' ' HB3' ' A' ' 3' ' ' HIS . 35.8 m170 -128.72 109.32 11.22 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 176.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -89.08 68.35 8.23 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 121.044 0.449 . . . . 0.0 110.749 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -102.57 21.54 15.13 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.71 0.767 . . . . 0.0 109.743 172.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.7 p -76.21 -41.67 48.61 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.646 1.179 . . . . 0.0 111.822 -175.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -79.07 -64.11 1.26 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.1 tpt 70.18 -19.95 0.2 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.87 1.268 . . . . 0.0 113.409 173.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 52.03 74.12 0.29 Allowed 'General case' 0 C--N 1.36 1.029 0 C-N-CA 124.788 1.235 . . . . 0.0 109.582 -166.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -85.53 31.33 0.59 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.262 1.025 . . . . 0.0 111.363 -170.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.8 t -55.11 93.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.726 1.611 . . . . 0.0 111.986 -170.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.46 80.01 0.21 Allowed Glycine 0 C--N 1.353 1.525 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.322 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.578 ' HB3' HG12 ' A' ' 60' ' ' VAL . 69.1 ttp85 -84.13 127.16 33.74 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -73.56 109.2 6.89 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 37.9 pt -97.35 173.64 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 166.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.4 p -110.49 169.72 8.56 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 166.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.42 ' O ' HG23 ' A' ' 24' ' ' VAL . 69.9 t-105 -53.33 -37.67 62.51 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.119 0.968 . . . . 0.0 111.695 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -58.07 -46.01 86.16 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 176.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.541 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 39.5 m-20 -66.44 -35.31 79.98 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.128 0.571 . . . . 0.0 111.036 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.442 ' CZ ' HD11 ' A' ' 36' ' ' LEU . 31.7 t80 -59.77 -58.54 8.13 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.583 173.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.456 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 85.1 t -58.51 -57.11 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.179 0.592 . . . . 0.0 111.713 -175.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -62.12 -56.23 20.94 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.031 0.832 . . . . 0.0 111.981 -173.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -84.49 -34.58 23.34 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.67 -168.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.404 ' HA ' HG22 ' A' ' 32' ' ' VAL . 21.2 m-85 -114.36 -62.25 1.63 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -162.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.456 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 68.4 tp -59.42 -51.12 71.26 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.294 1.038 . . . . 0.0 111.172 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.9 t -59.38 -24.19 63.22 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.001 0.92 . . . . 0.0 113.024 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -98.66 -6.0 30.58 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.547 0.339 . . . . 0.0 111.504 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.06 31.38 58.76 Favored Glycine 0 N--CA 1.476 1.351 0 N-CA-C 114.477 0.551 . . . . 0.0 114.477 -176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 27' ' ' TYR . 20.7 m -81.93 0.65 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.693 0.397 . . . . 0.0 110.882 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.9 t -98.65 128.48 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.514 1.126 . . . . 0.0 109.799 -173.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.555 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 31.0 t70 -77.81 -47.08 19.74 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.776 0.83 . . . . 0.0 109.692 177.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HD2' HG21 ' A' ' 92' ' ' VAL . 31.7 ptt-85 -162.68 163.93 26.73 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.968 0.793 . . . . 0.0 111.243 -174.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.442 HD11 ' CZ ' ' A' ' 23' ' ' PHE . 60.3 mt -117.8 104.66 11.17 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.583 1.153 . . . . 0.0 109.428 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -87.79 101.96 14.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.844 0.857 . . . . 0.0 109.767 -174.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 44' ' ' VAL . 35.6 t -88.32 91.3 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -175.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.9 t -92.91 119.69 41.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.825 -170.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 58.66 18.61 6.02 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.979 1.312 . . . . 0.0 112.56 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 54.84 21.09 3.4 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.87 1.268 . . . . 0.0 113.314 175.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -107.69 -28.51 9.67 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.283 1.033 . . . . 0.0 110.466 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -152.56 159.03 43.3 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.969 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 38' ' ' VAL . 57.9 t -124.03 130.67 73.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 -98.14 124.79 42.86 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.499 ' HB ' HG23 ' A' ' 60' ' ' VAL . 55.9 t -82.67 107.72 14.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.1 m -93.62 128.61 39.86 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -85.1 164.56 18.1 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.014 0.821 . . . . 0.0 109.519 176.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.555 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 11.5 t -68.29 138.4 91.81 Favored Pre-proline 0 CA--C 1.557 1.233 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -54.51 -41.51 76.45 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 123.66 2.906 . . . . 0.0 113.041 -170.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.14 -25.8 73.41 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.911 -177.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -77.33 -58.3 3.35 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.448 0.699 . . . . 0.0 110.326 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.8 m -65.88 120.43 69.02 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.09 0.556 . . . . 0.0 110.723 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -91.09 -162.54 0.11 Allowed 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 123.347 2.698 . . . . 0.0 112.476 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.6 m -66.2 -7.61 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.3 -24.49 67.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.354 1.061 . . . . 0.0 112.784 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.55 74.16 0.5 Allowed Glycine 0 C--N 1.353 1.501 0 O-C-N 123.41 0.444 . . . . 0.0 112.82 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -115.25 109.92 18.68 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.226 0.61 . . . . 0.0 111.077 -176.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -132.69 153.31 51.26 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.104 0.961 . . . . 0.0 109.572 164.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.578 HG12 ' HB3' ' A' ' 16' ' ' ARG . 27.8 m -129.18 178.75 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.329 0.652 . . . . 0.0 109.724 177.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -157.86 162.05 38.35 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.995 0.518 . . . . 0.0 110.245 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.431 ' HB3' HG13 ' A' ' 18' ' ' ILE . 47.4 p90 -145.73 153.75 41.31 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.326 0.65 . . . . 0.0 109.454 175.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -80.34 152.76 28.77 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.787 0.435 . . . . 0.0 110.748 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 31.8 pt -126.01 144.45 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.232 0.613 . . . . 0.0 109.445 172.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.05 -61.99 2.56 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.1 m -127.48 133.71 49.86 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.674 0.789 . . . . 0.0 109.024 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.4 t -57.87 -40.47 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.351 1.06 . . . . 0.0 111.506 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.09 -40.41 96.18 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.619 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.405 HG22 HD21 ' A' ' 73' ' ' ASN . 19.2 m -67.88 -45.08 75.5 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 176.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -51.04 -52.94 38.11 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.481 1.112 . . . . 0.0 112.495 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -71.32 -35.97 71.41 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.466 0.478 . . . . 0.0 110.838 -174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -66.97 -39.56 87.26 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.573 0.349 . . . . 0.0 110.589 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.405 HD21 HG22 ' A' ' 69' ' ' THR . 94.5 m-20 -66.79 -52.62 41.84 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.088 0.555 . . . . 0.0 110.173 177.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.4 tp -53.48 -55.08 28.32 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.205 1.002 . . . . 0.0 111.377 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 79' ' ' GLN . 68.6 mm-40 -61.84 -48.92 78.37 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.796 0.685 . . . . 0.0 112.725 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 58.1 m -64.53 -50.11 68.64 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.471 0.482 . . . . 0.0 110.116 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.8 tp -50.26 -46.29 54.89 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.229 1.411 . . . . 0.0 112.471 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -61.65 -46.75 88.45 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.842 0.457 . . . . 0.0 110.641 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 75.0 mt-30 -62.69 -34.76 77.79 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.255 0.622 . . . . 0.0 111.065 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.8 -39.31 57.1 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.81 0.844 . . . . 0.0 111.702 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.57 -21.34 61.16 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.601 0.361 . . . . 0.0 110.951 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.3 -5.65 57.51 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 120.075 -0.292 . . . . 0.0 113.019 -173.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.7 mt -70.08 121.53 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 124.478 1.111 . . . . 0.0 109.984 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -162.42 162.48 27.71 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.077 0.551 . . . . 0.0 111.107 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.97 -111.09 3.64 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.314 -0.857 . . . . 0.0 113.636 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.97 -23.75 58.33 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.902 0.881 . . . . 0.0 110.901 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.75 -26.71 29.46 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.3 ttm105 -63.32 123.38 18.55 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.5 t -72.69 119.57 75.94 Favored Pre-proline 0 CA--C 1.555 1.155 0 O-C-N 123.808 0.693 . . . . 0.0 110.247 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 31.9 Cg_exo -60.41 141.22 95.05 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.42 2.747 . . . . 0.0 112.523 176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.6 t -111.69 114.94 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.446 HG21 ' HD2' ' A' ' 35' ' ' ARG . 60.8 t -109.15 98.33 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.212 1.005 . . . . 0.0 109.043 -173.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -71.7 114.86 10.23 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.939 0.496 . . . . 0.0 110.434 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.407 HG22 ' HG2' ' A' ' 96' ' ' GLU . 58.7 mt -107.86 127.3 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -118.86 89.78 3.2 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.358 0.663 . . . . 0.0 109.923 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.407 ' HG2' HG22 ' A' ' 94' ' ' ILE . 26.9 mm-40 -96.69 101.52 13.14 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.159 0.584 . . . . 0.0 109.456 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 54.1 p -152.63 91.99 1.62 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 117.798 0.272 . . . . 0.0 111.462 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.0 t70 66.87 -71.1 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.4 1.48 . . . . 0.0 111.797 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.413 0 CA-C-O 119.201 -0.777 . . . . 0.0 111.392 176.609 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.03 81.76 0.44 Allowed Glycine 0 CA--C 1.535 1.286 0 N-CA-C 112.318 -0.313 . . . . 0.0 112.318 177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 50.99 -93.12 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.219 1.408 . . . . 0.0 111.628 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -171.73 103.77 0.19 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.38 1.072 . . . . 0.0 108.497 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -140.94 149.41 41.81 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.19 0.996 . . . . 0.0 108.32 173.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 69.03 142.81 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.615 1.166 . . . . 0.0 110.263 -173.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -63.4 132.13 50.47 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.152 0.501 . . . . 0.0 111.37 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -109.72 37.62 2.6 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.404 1.082 . . . . 0.0 108.56 174.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.7 t -74.9 83.5 2.2 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.159 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -104.3 80.0 1.66 Allowed 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 87.2 mmm -66.89 -49.12 66.62 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 114.288 -1.323 . . . . 0.0 110.188 -174.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -80.14 95.65 6.3 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -162.69 130.03 3.7 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.5 m -73.71 79.0 1.54 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.392 0.677 . . . . 0.0 110.345 -177.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.68 133.11 6.23 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.441 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.483 ' HB3' HG12 ' A' ' 60' ' ' VAL . 34.9 ttm180 -86.3 123.35 31.46 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -177.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -75.12 133.23 41.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.1 pt -128.67 168.82 21.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.755 1.222 . . . . 0.0 108.292 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.4 p -85.75 161.01 19.36 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.478 ' O ' HG23 ' A' ' 24' ' ' VAL . 61.2 t-105 -51.03 -48.98 61.36 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.933 0.893 . . . . 0.0 111.146 174.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -75.21 -24.13 57.71 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.515 0.509 . . . . 0.0 111.863 -175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -65.53 -42.81 91.57 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 172.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 17.7 t80 -56.44 -51.22 69.24 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.877 172.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 20' ' ' TRP . 60.8 t -58.11 -61.88 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.844 0.458 . . . . 0.0 111.035 -177.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.498 ' N ' HD22 ' A' ' 25' ' ' ASN . 0.7 OUTLIER -68.16 -46.17 71.49 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.427 0.691 . . . . 0.0 111.768 -166.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.406 ' O ' ' HD2' ' A' ' 30' ' ' LYS . 62.8 m-20 -84.77 -34.13 22.88 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.472 -172.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.428 ' HA ' HG22 ' A' ' 32' ' ' VAL . 88.0 m-85 -112.29 -66.57 1.07 Allowed 'General case' 0 C--O 1.248 0.977 0 O-C-N 121.849 -0.532 . . . . 0.0 111.825 -166.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.571 HD11 HG21 ' A' ' 89' ' ' VAL . 21.2 tp -64.57 -48.3 75.5 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -170.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 m -65.67 -21.2 66.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.627 0.771 . . . . 0.0 112.429 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' A' ' 26' ' ' ASN . 55.2 mttp -98.14 -1.02 43.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.858 0.863 . . . . 0.0 111.62 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.12 23.23 61.59 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 115.364 0.905 . . . . 0.0 115.364 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 27' ' ' TYR . 17.6 m -88.36 11.62 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 117.476 0.638 . . . . 0.0 110.668 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.43 136.16 31.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 125.193 1.397 . . . . 0.0 108.938 173.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.511 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 25.8 t70 -87.55 -49.05 7.44 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.918 0.887 . . . . 0.0 109.014 172.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 6.4 ptp180 -164.2 172.42 13.67 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.523 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 78.2 mt -119.95 112.97 19.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.201 1.001 . . . . 0.0 110.222 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -99.6 104.49 16.27 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.913 0.885 . . . . 0.0 110.069 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.522 HG22 HG22 ' A' ' 44' ' ' VAL . 28.2 t -86.83 99.61 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -175.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.3 t -89.54 123.05 41.56 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 C-N-CA 123.942 0.897 . . . . 0.0 110.367 -169.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 54.12 18.45 1.76 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 125.569 1.548 . . . . 0.0 113.14 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HB3' HG21 ' A' ' 67' ' ' VAL . 94.8 mttt 57.09 16.04 2.72 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.584 1.154 . . . . 0.0 113.496 -176.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -91.55 -32.87 15.38 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.334 0.654 . . . . 0.0 110.483 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -156.69 170.61 22.02 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.528 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.522 HG22 HG22 ' A' ' 38' ' ' VAL . 59.2 t -117.31 129.47 73.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.035 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -96.15 122.63 39.2 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.462 1.105 . . . . 0.0 108.08 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 60' ' ' VAL . 46.3 t -84.72 112.13 21.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.4 HG22 ' HB3' ' A' ' 34' ' ' ASP . 86.7 m -90.08 132.61 35.32 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 175.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.61 ' HE2' ' HA ' ' A' ' 59' ' ' TYR . 53.1 m-85 -84.33 146.82 27.51 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.568 0.747 . . . . 0.0 110.286 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.511 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.7 OUTLIER -62.77 141.18 97.25 Favored Pre-proline 0 CA--C 1.565 1.533 0 C-N-CA 123.626 0.77 . . . . 0.0 110.154 175.172 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -48.84 123.79 10.25 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.89 3.06 . . . . 0.0 113.097 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.81 -21.13 43.32 Favored Glycine 0 N--CA 1.474 1.176 0 O-C-N 123.309 0.381 . . . . 0.0 112.846 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -107.57 -3.06 19.7 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.023 0.929 . . . . 0.0 110.564 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.8 m -71.02 131.36 87.3 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 123.929 0.891 . . . . 0.0 110.043 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -55.01 143.99 70.59 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.687 2.924 . . . . 0.0 112.919 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.9 -41.92 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.55 0.74 . . . . 0.0 111.442 -175.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -79.86 -41.36 26.46 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.98 0.912 . . . . 0.0 110.775 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.57 -140.22 11.69 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 110.039 -1.225 . . . . 0.0 110.039 -174.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 56.44 85.33 0.08 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.366 1.066 . . . . 0.0 110.617 -172.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.61 ' HA ' ' HE2' ' A' ' 48' ' ' PHE . 35.6 p90 -68.21 175.18 3.38 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.479 172.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.52 HG23 ' HB ' ' A' ' 46' ' ' VAL . 27.6 m -110.38 153.36 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 169.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 -160.3 166.25 29.83 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.615 0.766 . . . . 0.0 109.777 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -147.78 140.39 24.64 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.35 0.66 . . . . 0.0 109.939 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -84.58 126.92 33.76 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.323 0.649 . . . . 0.0 109.637 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.586 HD12 ' HA ' ' A' ' 67' ' ' VAL . 41.3 pt -104.61 -41.13 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 122.508 0.323 . . . . 0.0 111.754 -173.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.78 -80.43 0.12 Allowed Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 -171.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.3 m -71.4 95.45 1.35 Allowed 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.788 0.835 . . . . 0.0 109.901 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.586 ' HA ' HD12 ' A' ' 64' ' ' ILE . 58.5 t -61.49 -40.34 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.522 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 5.8 m-20 -58.57 -44.53 89.78 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.856 0.863 . . . . 0.0 110.478 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.0 m -66.67 -40.31 88.55 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.702 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -55.77 -46.09 77.98 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 123.258 0.623 . . . . 0.0 110.618 173.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 47.4 mt-10 -64.07 -44.95 90.84 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 124.244 0.965 . . . . 0.0 109.973 -176.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 4.5 mmp_? -59.15 -51.22 70.93 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 124.186 0.928 . . . . 0.0 111.262 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -65.6 -40.47 92.71 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.41 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.9 -50.25 72.94 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.672 0.789 . . . . 0.0 112.197 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -32.98 70.29 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -175.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.2 m -64.11 -44.9 90.84 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.189 0.596 . . . . 0.0 109.846 171.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.449 HD21 HG22 ' A' ' 24' ' ' VAL . 34.3 tp -63.05 -37.4 87.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.699 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -63.94 -38.43 91.04 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.347 0.659 . . . . 0.0 109.998 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -68.08 -36.73 80.3 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 175.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -68.07 -46.0 72.28 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.038 0.535 . . . . 0.0 111.383 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.0 mt -82.42 2.22 33.64 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.627 0.771 . . . . 0.0 112.259 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.47 14.6 79.39 Favored Glycine 0 C--N 1.358 1.787 0 O-C-N 123.311 0.382 . . . . 0.0 113.684 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 87.2 mt -82.56 111.66 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 125.282 1.433 . . . . 0.0 109.603 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -156.39 168.02 28.64 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.124 0.57 . . . . 0.0 111.605 -175.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.11 -126.41 23.08 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.492 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.81 -14.24 60.67 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.039 0.536 . . . . 0.0 110.487 177.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -79.64 -16.16 56.28 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.855 0.862 . . . . 0.0 111.699 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -51.1 129.89 24.94 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.067 0.947 . . . . 0.0 111.002 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.571 HG21 HD11 ' A' ' 28' ' ' LEU . 49.6 t -63.02 113.1 8.19 Favored Pre-proline 0 N--CA 1.474 0.727 0 O-C-N 124.484 1.115 . . . . 0.0 109.905 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.4 ' HG2' ' HB3' ' A' ' 35' ' ' ARG . 54.4 Cg_endo -68.76 115.59 4.02 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.344 2.029 . . . . 0.0 111.137 -177.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.2 t -108.45 121.05 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.4 t -116.57 119.68 62.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -174.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -90.07 113.66 25.42 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.59 128.06 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.27 106.98 5.61 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -64.28 -40.18 95.45 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.187 0.93 . . . . 0.0 109.478 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.1 t -169.34 162.66 10.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.286 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -84.85 -18.29 35.31 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.599 0.76 . . . . 0.0 109.407 172.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 177.401 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.1 114.89 5.04 Favored Glycine 0 C--N 1.347 1.178 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -62.21 87.51 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.15 0.98 . . . . 0.0 111.559 -174.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -131.19 3.86 4.36 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.602 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -121.81 124.67 44.71 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.3 m-70 65.29 -178.2 0.18 Allowed 'General case' 0 CA--C 1.554 1.102 0 O-C-N 124.622 1.202 . . . . 0.0 110.322 -173.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 71.28 -0.71 3.0 Favored 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 124.785 1.234 . . . . 0.0 111.585 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -63.54 -34.28 77.45 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.951 0.9 . . . . 0.0 109.413 173.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.3 m -73.05 89.18 1.44 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.894 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -87.53 23.67 1.87 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.497 1.119 . . . . 0.0 110.527 174.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.5 mtm -70.62 140.48 51.63 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 124.238 1.015 . . . . 0.0 111.055 -171.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -68.17 -34.99 77.33 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.792 171.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -73.38 153.36 40.5 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.459 172.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.1 m 79.98 -22.08 0.3 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.831 1.652 . . . . 0.0 112.117 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.59 164.28 43.2 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 163.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HB3' HG12 ' A' ' 60' ' ' VAL . 20.9 tpp180 -90.77 119.35 30.93 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 117.839 0.82 . . . . 0.0 110.856 -174.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.63 110.15 13.49 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 27.4 pt -104.73 174.06 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.393 1.477 . . . . 0.0 109.959 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.6 p -91.3 168.74 11.36 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 169.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.564 ' O ' HG23 ' A' ' 24' ' ' VAL . 74.1 t-105 -57.07 -41.68 79.22 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.74 0.65 . . . . 0.0 109.473 168.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -55.66 -50.62 69.75 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.304 1.041 . . . . 0.0 112.409 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.499 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 65.1 m-20 -62.97 -38.95 93.14 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.856 0.462 . . . . 0.0 110.184 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.44 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 34.5 t80 -55.04 -50.51 68.9 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.663 1.227 . . . . 0.0 110.873 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 20' ' ' TRP . 47.1 t -58.12 -62.42 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 123.611 0.569 . . . . 0.0 110.895 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -65.87 -53.76 35.5 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.954 -168.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -84.73 -21.49 30.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.154 0.582 . . . . 0.0 111.86 -167.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.44 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 73.0 m-85 -122.75 -69.35 0.83 Allowed 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -169.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.54 -56.54 20.79 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.834 0.853 . . . . 0.0 111.467 -173.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.6 m -60.38 -20.33 59.16 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.215 1.006 . . . . 0.0 112.891 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -94.05 -9.13 37.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.667 0.787 . . . . 0.0 111.617 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.27 21.5 68.37 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.723 0.64 . . . . 0.0 114.385 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.429 HG22 ' HA ' ' A' ' 27' ' ' TYR . 10.4 m -80.74 -5.39 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 117.143 0.472 . . . . 0.0 110.984 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.8 t -93.75 130.07 43.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 123.321 0.648 . . . . 0.0 109.332 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.459 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 30.1 t70 -83.97 -51.96 6.71 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.495 1.118 . . . . 0.0 109.739 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.497 ' HD2' HG21 ' A' ' 92' ' ' VAL . 25.0 ptt180 -158.16 160.47 37.27 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.293 -174.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.8 mt -118.03 103.0 9.48 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.998 0.919 . . . . 0.0 109.027 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 43.4 mt-10 -87.55 108.65 19.15 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.415 -176.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 41' ' ' LYS . 43.0 t -84.83 92.82 3.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -177.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 96.0 t -81.73 109.81 16.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.887 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.101 -167.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 52.25 27.25 4.56 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 125.548 1.539 . . . . 0.0 112.945 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.552 ' HA ' HG12 ' A' ' 38' ' ' VAL . 35.3 mtmm 63.31 -4.44 0.3 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.077 1.351 . . . . 0.0 113.869 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -76.08 -38.88 56.48 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.386 1.074 . . . . 0.0 110.604 -171.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -153.44 179.98 8.29 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.574 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 38' ' ' VAL . 98.3 t -127.64 131.44 70.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 123.97 0.908 . . . . 0.0 108.694 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -100.41 123.63 44.88 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -81.86 108.77 15.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 114.474 -1.239 . . . . 0.0 107.869 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.3 m -86.14 131.4 34.26 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -85.06 149.94 25.21 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.459 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 42.1 p -64.94 144.65 99.07 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 123.416 0.447 . . . . 0.0 110.391 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.99 104.5 0.12 Allowed 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.52 2.147 . . . . 0.0 111.379 171.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.44 -45.5 1.1 Allowed Glycine 0 N--CA 1.467 0.766 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -173.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.417 ' HE2' HG12 ' A' ' 32' ' ' VAL . 44.6 mmtm -73.32 -32.81 64.8 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 169.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.2 p -66.16 115.57 24.79 Favored Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 123.902 0.881 . . . . 0.0 109.972 171.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -88.42 -164.43 0.18 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.838 2.358 . . . . 0.0 111.294 171.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.0 t -67.09 -32.43 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -83.38 65.39 8.32 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 167.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.2 59.33 3.18 Favored Glycine 0 C--N 1.348 1.23 0 C-N-CA 123.679 0.657 . . . . 0.0 113.235 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -90.37 142.98 27.18 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.084 0.954 . . . . 0.0 108.444 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -106.68 156.88 18.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.936 0.494 . . . . 0.0 110.619 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 16' ' ' ARG . 20.0 m -107.23 164.41 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -162.69 162.81 27.07 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.785 0.326 . . . . 0.0 111.119 -172.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -145.06 146.69 31.97 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.727 0.811 . . . . 0.0 109.379 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -81.65 140.07 34.6 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.19 0.596 . . . . 0.0 109.591 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.439 HG13 ' N ' ' A' ' 65' ' ' GLY . 42.7 pt -117.12 -49.0 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 122.589 0.356 . . . . 0.0 111.434 -177.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.439 ' N ' HG13 ' A' ' 64' ' ' ILE . . . 67.67 -78.2 0.19 Allowed Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.949 -0.46 . . . . 0.0 111.949 -171.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.5 m -74.27 94.09 2.45 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.595 0.758 . . . . 0.0 109.663 175.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.428 ' HA ' HD12 ' A' ' 64' ' ' ILE . 40.3 t -60.6 -36.66 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.805 1.242 . . . . 0.0 111.172 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -62.66 -39.13 92.95 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.553 0.741 . . . . 0.0 110.331 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.9 m -70.19 -41.44 73.69 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 123.503 0.502 . . . . 0.0 110.666 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -52.85 -53.39 49.51 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.19 0.596 . . . . 0.0 110.735 174.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -60.51 -52.41 65.32 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 124.509 1.13 . . . . 0.0 111.425 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.506 ' HE ' ' HA ' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -59.28 -46.39 88.67 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.508 1.123 . . . . 0.0 111.921 -174.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.424 HD22 ' N ' ' A' ' 73' ' ' ASN . 0.8 OUTLIER -67.47 -41.89 83.86 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.391 179.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.459 ' HG ' ' NE2' ' A' ' 78' ' ' GLN . 33.4 tp -59.55 -43.41 93.53 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 124.108 0.88 . . . . 0.0 111.465 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -60.27 -56.44 21.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.841 0.857 . . . . 0.0 111.059 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.1 m -63.22 -48.57 77.73 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.43 1.081 . . . . 0.0 110.303 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.545 HD21 HG22 ' A' ' 24' ' ' VAL . 42.9 tp -53.99 -53.06 58.14 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.77 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.459 ' NE2' ' HG ' ' A' ' 74' ' ' LEU . 45.0 mt-30 -66.8 -30.17 70.3 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.266 0.354 . . . . 0.0 111.266 -178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -63.86 -38.68 92.0 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.615 0.366 . . . . 0.0 110.076 172.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -70.14 -43.92 69.94 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.221 0.608 . . . . 0.0 110.99 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 76.5 mt -71.22 -18.75 62.44 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.624 0.77 . . . . 0.0 111.578 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.02 8.1 76.29 Favored Glycine 0 C--N 1.351 1.416 0 O-C-N 123.282 0.364 . . . . 0.0 112.982 -176.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.516 HG22 ' HA ' ' A' ' 88' ' ' ARG . 80.1 mt -82.52 97.08 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 125.343 1.457 . . . . 0.0 108.769 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -138.93 155.52 47.99 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.836 -0.54 . . . . 0.0 111.51 -173.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.44 -99.85 0.11 Allowed Glycine 0 C--N 1.354 1.532 0 O-C-N 124.74 1.275 . . . . 0.0 113.893 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -75.59 -29.04 59.15 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.348 1.059 . . . . 0.0 111.427 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -87.82 -23.46 24.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.379 0.672 . . . . 0.0 111.277 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.516 ' HA ' HG22 ' A' ' 83' ' ' ILE . 43.0 ttm180 -61.48 119.54 8.78 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.401 0.68 . . . . 0.0 110.557 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 80.4 t -66.65 118.94 59.16 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.829 0.852 . . . . 0.0 111.225 -175.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.44 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 31.5 Cg_exo -60.58 146.87 96.26 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.294 2.662 . . . . 0.0 113.239 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.4 t -104.91 129.84 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.497 HG21 ' HD2' ' A' ' 35' ' ' ARG . 4.5 t -127.78 98.99 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.505 0.722 . . . . 0.0 109.394 -175.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -69.55 106.33 2.97 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 29.9 mm -113.66 116.33 52.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -175.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.08 14.01 17.2 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.882 0.473 . . . . 0.0 110.27 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 64.31 -78.89 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.555 1.942 . . . . 0.0 111.976 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.9 m 60.99 23.59 13.74 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.889 0.876 . . . . 0.0 110.421 -171.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.8 -42.09 77.79 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 125.084 1.354 . . . . 0.0 110.434 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.091 0 CA-C-O 118.65 -1.083 . . . . 0.0 110.523 179.154 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.3 mtp . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.69 144.25 46.68 Favored Glycine 0 C--N 1.34 0.756 0 O-C-N 123.418 0.449 . . . . 0.0 112.839 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -146.91 15.45 1.2 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.203 1.001 . . . . 0.0 110.041 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -99.41 4.55 46.27 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.138 0.975 . . . . 0.0 110.73 -175.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -84.9 16.64 3.25 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.915 0.886 . . . . 0.0 112.057 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -68.63 91.88 0.44 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -68.69 126.39 29.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.685 -168.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -85.1 -69.19 0.67 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 167.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 63.0 p 41.08 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 127.034 2.134 . . . . 0.0 113.249 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -124.23 110.34 14.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.776 0.83 . . . . 0.0 109.324 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.6 mtt -101.34 -5.17 25.76 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.079 0.952 . . . . 0.0 110.158 171.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.5 tttm 72.73 -70.29 0.16 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 126.075 1.75 . . . . 0.0 111.9 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -67.0 135.16 53.32 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.411 0.685 . . . . 0.0 112.026 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.1 m -79.64 -0.76 35.2 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.35 1.06 . . . . 0.0 111.726 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.06 142.55 46.44 Favored Glycine 0 C--N 1.356 1.67 0 O-C-N 123.302 0.376 . . . . 0.0 113.492 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.436 ' HB2' HG12 ' A' ' 60' ' ' VAL . 49.7 mtp180 -83.95 132.77 34.74 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.984 0.514 . . . . 0.0 110.961 -172.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -79.92 110.92 15.76 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 165.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 34.4 pt -96.13 174.39 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 123.99 0.916 . . . . 0.0 110.61 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.2 p -98.21 168.63 10.12 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 166.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.472 ' CZ2' HD22 ' A' ' 77' ' ' LEU . 61.7 t-105 -55.41 -37.22 67.34 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.685 0.794 . . . . 0.0 110.781 175.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -56.08 -48.66 75.67 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.518 0.727 . . . . 0.0 111.671 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.57 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 34.4 m-20 -65.53 -42.27 92.18 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.414 0.286 . . . . 0.0 110.791 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.4 ' HE1' HD21 ' A' ' 36' ' ' LEU . 13.9 t80 -50.35 -48.17 55.65 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.51 1.131 . . . . 0.0 111.116 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.531 HG22 HD21 ' A' ' 77' ' ' LEU . 90.7 t -71.97 -62.07 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 O-C-N 123.421 0.45 . . . . 0.0 110.82 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -69.87 -52.65 23.04 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.03 0.532 . . . . 0.0 111.737 -167.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -80.01 -19.48 47.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.912 0.485 . . . . 0.0 112.049 -171.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -126.12 -69.95 0.75 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -171.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.403 HD11 HG21 ' A' ' 89' ' ' VAL . 22.1 tp -63.79 -43.61 95.81 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -166.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.2 p -73.23 -11.38 60.49 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.904 0.481 . . . . 0.0 111.944 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -92.61 -9.22 41.81 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.252 0.621 . . . . 0.0 110.64 173.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.78 27.83 67.25 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 114.047 0.379 . . . . 0.0 114.047 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.7 m -86.87 6.59 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 116.972 0.386 . . . . 0.0 110.548 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.26 125.72 51.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.023 0.929 . . . . 0.0 108.964 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.515 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 28.5 t70 -77.34 -54.08 6.9 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.315 1.046 . . . . 0.0 108.196 172.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.432 ' HD2' HG21 ' A' ' 92' ' ' VAL . 43.0 ttp180 -154.9 153.19 30.72 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.024 -164.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.4 HD21 ' HE1' ' A' ' 23' ' ' PHE . 97.9 mt -113.32 119.82 39.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.88 1.272 . . . . 0.0 108.535 175.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -111.92 106.48 15.19 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.383 0.673 . . . . 0.0 110.312 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.408 HG22 HG22 ' A' ' 44' ' ' VAL . 44.9 t -81.61 98.48 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 54.7 t -94.96 122.41 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 122.862 0.465 . . . . 0.0 110.522 -171.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 60.11 15.24 5.01 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.245 1.418 . . . . 0.0 113.434 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.9 mttm 65.64 -3.02 0.76 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.534 1.533 . . . . 0.0 112.778 -175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -87.62 -32.51 19.24 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.11 0.964 . . . . 0.0 109.982 -172.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -154.2 171.28 19.44 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.488 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.408 HG22 HG22 ' A' ' 38' ' ' VAL . 54.4 t -128.86 133.87 65.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -99.52 130.36 45.77 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.4 t -82.85 106.58 13.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 172.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.4 m -94.11 126.02 39.08 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -81.84 152.38 26.92 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.875 0.734 . . . . 0.0 111.24 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.515 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -64.64 138.54 97.49 Favored Pre-proline 0 CA--C 1.558 1.286 0 CA-C-O 117.802 -1.094 . . . . 0.0 109.061 173.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -36.88 -52.28 1.31 Allowed 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 124.871 3.714 . . . . 0.0 115.983 -173.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.09 -25.74 51.06 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 116.698 -0.228 . . . . 0.0 113.04 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -81.44 -6.27 58.76 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.827 0.851 . . . . 0.0 112.015 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.5 m -64.82 122.68 80.49 Favored Pre-proline 0 C--N 1.351 0.669 0 CA-C-O 118.466 -0.778 . . . . 0.0 109.453 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -49.98 153.14 6.63 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.046 2.497 . . . . 0.0 112.396 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.11 -32.53 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 123.617 0.767 . . . . 0.0 110.918 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -87.89 -0.77 57.41 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.055 0.942 . . . . 0.0 111.747 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.71 -73.96 2.59 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 46.79 56.47 6.58 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.947 1.299 . . . . 0.0 113.45 170.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -65.69 122.18 16.67 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.424 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 16' ' ' ARG . 27.1 m -105.73 156.52 6.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.333 -172.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -150.91 158.41 44.11 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.848 0.459 . . . . 0.0 111.37 -173.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -140.32 139.24 35.4 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.397 0.679 . . . . 0.0 109.298 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -79.34 131.58 36.17 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.443 0.697 . . . . 0.0 110.323 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.7 pt -110.05 143.08 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.931 0.892 . . . . 0.0 109.298 173.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -84.11 -43.28 7.17 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.8 t -131.25 140.34 49.81 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.92 0.888 . . . . 0.0 109.282 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 71' ' ' GLU . 62.0 t -60.11 -41.74 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 123.679 0.612 . . . . 0.0 110.226 172.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.22 -42.14 80.81 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.323 0.649 . . . . 0.0 111.631 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 m -66.12 -45.77 79.93 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.194 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -55.65 -48.42 75.04 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.836 0.454 . . . . 0.0 111.271 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 39.4 mm-40 -62.43 -52.9 61.69 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.342 0.657 . . . . 0.0 111.292 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -67.41 -38.3 84.42 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.659 0.783 . . . . 0.0 111.396 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -67.09 -35.86 80.72 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 122.658 0.383 . . . . 0.0 110.317 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.99 -32.25 71.68 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.071 0.548 . . . . 0.0 111.503 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 71' ' ' GLU . 51.5 mm-40 -62.09 -51.78 66.54 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.153 0.501 . . . . 0.0 110.172 173.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.461 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 25.7 m -62.9 -47.95 81.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.242 -1.344 . . . . 0.0 110.395 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.531 HD21 HG22 ' A' ' 24' ' ' VAL . 49.6 tp -57.94 -57.92 10.7 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.405 1.082 . . . . 0.0 112.2 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 45.5 mt-30 -62.12 -39.92 94.17 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 123.715 0.634 . . . . 0.0 111.514 -174.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -66.46 -33.92 76.77 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 76' ' ' THR . 43.3 mm-40 -70.18 -39.98 74.93 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.795 0.438 . . . . 0.0 110.573 176.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.25 -12.43 60.86 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.602 0.761 . . . . 0.0 111.166 176.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.33 -8.09 79.71 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.944 -0.365 . . . . 0.0 112.829 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 70.7 mt -67.76 105.53 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.254 1.422 . . . . 0.0 109.172 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -151.46 159.59 44.12 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.561 0.344 . . . . 0.0 111.432 -174.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.3 -124.34 33.27 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.926 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -66.3 -22.52 66.29 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.306 1.043 . . . . 0.0 111.752 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -83.54 -5.18 59.09 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.232 0.613 . . . . 0.0 112.362 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -65.56 142.2 58.18 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 120.803 0.335 . . . . 0.0 111.325 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.403 HG21 HD11 ' A' ' 28' ' ' LEU . 59.8 t -82.84 122.99 78.44 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.92 0.888 . . . . 0.0 109.516 -175.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.14 132.76 43.25 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.413 2.742 . . . . 0.0 113.786 -171.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.3 t -108.28 119.84 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.0 0.92 . . . . 0.0 108.877 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.432 HG21 ' HD2' ' A' ' 35' ' ' ARG . 41.7 t -129.37 121.94 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 124.018 0.927 . . . . 0.0 109.11 -173.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -84.98 116.68 23.52 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.037 0.535 . . . . 0.0 110.24 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 49.8 mm -114.36 128.34 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.104 0.961 . . . . 0.0 108.758 -176.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.87 86.91 3.17 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.85 99.22 0.8 Allowed 'General case' 0 C--N 1.352 0.694 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.8 m -146.18 46.15 1.24 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.566 1.146 . . . . 0.0 108.337 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.28 -41.97 94.46 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.56 0.744 . . . . 0.0 110.463 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.855 -0.97 . . . . 0.0 111.744 179.346 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.476 ' SD ' ' HB2' ' A' ' 4' ' ' HIS . 5.1 ppp? . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.59 -16.83 38.2 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-O 119.654 -0.526 . . . . 0.0 114.402 -169.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -68.28 -39.29 82.16 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.982 0.513 . . . . 0.0 111.427 -174.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.476 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 32.6 m170 -101.61 16.05 26.97 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.092 0.557 . . . . 0.0 110.826 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -85.21 71.53 10.86 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.574 0.702 . . . . 0.0 109.3 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -83.37 87.3 6.97 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.064 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -93.98 98.09 10.79 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.555 -174.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -164.86 -30.24 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.073 1.349 . . . . 0.0 108.21 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -156.36 149.87 24.64 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.417 -1.265 . . . . 0.0 108.394 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -142.99 46.59 1.55 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.427 1.091 . . . . 0.0 108.651 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 61.6 mtt -63.58 88.19 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.302 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.457 ' HE3' HG21 ' A' ' 94' ' ' ILE . 63.6 mttm -123.57 108.63 12.83 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.025 1.33 . . . . 0.0 107.554 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -85.62 84.91 7.46 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.069 0.461 . . . . 0.0 109.833 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.7 m -78.5 87.66 4.48 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.98 -79.17 0.29 Allowed Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.483 -170.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 6.3 ptm180 -115.68 126.37 54.04 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.582 0.753 . . . . 0.0 111.081 -167.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.507 ' HG3' ' HA ' ' A' ' 62' ' ' PHE . 32.6 tt0 -85.35 128.1 34.58 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 pt -109.88 179.61 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 125.696 1.598 . . . . 0.0 109.621 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.8 p -89.93 154.15 20.07 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.074 0.95 . . . . 0.0 109.441 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.426 ' O ' HG23 ' A' ' 24' ' ' VAL . 54.4 t-105 -59.93 -43.37 94.96 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.513 0.725 . . . . 0.0 110.282 176.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -53.85 -48.67 69.75 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 123.952 0.783 . . . . 0.0 111.292 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' A' ' 26' ' ' ASN . 26.3 t70 -70.09 -34.96 73.8 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.778 0.431 . . . . 0.0 110.224 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.415 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 18.0 t80 -55.78 -46.12 78.01 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.945 0.498 . . . . 0.0 110.627 175.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 20' ' ' TRP . 79.9 t -61.98 -71.38 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 123.602 0.564 . . . . 0.0 110.783 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -73.66 -31.77 63.65 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.923 -161.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 22' ' ' ASP . 54.9 t30 -90.99 -23.59 20.35 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.665 0.786 . . . . 0.0 111.902 -176.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.415 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 75.4 m-85 -124.62 -66.42 0.98 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -172.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 tt -59.64 -49.83 76.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.718 0.807 . . . . 0.0 111.401 -174.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.0 m -64.5 -20.74 66.39 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.555 1.142 . . . . 0.0 112.161 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -97.1 0.14 48.04 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.507 0.723 . . . . 0.0 111.301 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.92 26.61 60.95 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 115.543 0.977 . . . . 0.0 115.543 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.8 m -90.7 3.9 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 122.898 0.479 . . . . 0.0 111.405 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.3 126.06 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.887 0.875 . . . . 0.0 108.926 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.486 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 30.9 t70 -84.1 -51.61 6.94 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.546 1.138 . . . . 0.0 109.967 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -154.07 161.61 41.79 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.583 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.1 mt -115.05 101.83 9.37 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.9 0.88 . . . . 0.0 108.67 176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -87.0 101.13 13.15 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.102 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.709 HG12 ' HA ' ' A' ' 41' ' ' LYS . 19.8 t -88.54 90.2 3.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -173.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.9 t -81.43 127.76 39.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.6 -173.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.613 ' HA ' ' HB3' ' A' ' 96' ' ' GLU . 1.2 t-20 59.95 19.51 8.55 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.8 2.04 . . . . 0.0 111.452 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.709 ' HA ' HG12 ' A' ' 38' ' ' VAL . 19.7 pttm 42.06 18.29 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 126.287 1.835 . . . . 0.0 115.251 -167.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.3 ttp-105 -98.93 -30.49 12.34 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.149 0.98 . . . . 0.0 109.102 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -147.62 152.12 37.36 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.02 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 59.0 t -110.97 128.07 67.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.541 1.137 . . . . 0.0 108.465 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -100.67 124.73 46.68 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.1 t -82.69 105.39 12.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.7 m -92.1 125.91 36.97 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -84.87 148.98 25.99 Favored 'General case' 0 C--O 1.241 0.607 0 O-C-N 123.723 0.64 . . . . 0.0 111.917 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.486 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 10.0 p -60.68 129.02 89.39 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.779 172.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.27 118.77 5.38 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.106 2.537 . . . . 0.0 112.375 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.75 -25.06 25.36 Favored Glycine 0 N--CA 1.468 0.828 0 N-CA-C 112.363 -0.295 . . . . 0.0 112.363 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.418 ' HE3' ' OG1' ' A' ' 49' ' ' THR . 52.7 mtmt -117.49 28.72 8.28 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.9 0.88 . . . . 0.0 109.71 175.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.1 m -85.55 111.07 34.47 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 176.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.62 129.7 19.35 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.122 1.882 . . . . 0.0 111.566 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.14 -27.6 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 123.372 0.669 . . . . 0.0 109.833 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -72.47 -33.18 66.82 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.419 0.688 . . . . 0.0 110.454 172.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.27 -30.35 50.47 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.098 176.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 54.44 -100.31 0.1 Allowed 'General case' 0 C--N 1.362 1.109 0 C-N-CA 124.654 1.181 . . . . 0.0 109.545 -173.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -132.5 131.48 41.66 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.525 1.13 . . . . 0.0 108.357 157.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 16' ' ' ARG . 33.2 m -106.38 154.96 7.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -157.57 174.94 14.6 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.173 0.589 . . . . 0.0 110.11 -175.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.507 ' HA ' ' HG3' ' A' ' 17' ' ' GLU . 33.9 p90 -157.6 147.32 20.26 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.974 0.51 . . . . 0.0 110.253 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -91.09 130.16 37.01 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 67' ' ' VAL . 30.3 pt -102.93 -46.99 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.217 0.607 . . . . 0.0 111.334 -176.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.26 -83.24 0.43 Allowed Glycine 0 C--N 1.345 1.082 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -167.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.8 t -72.45 96.74 1.95 Allowed 'General case' 0 C--O 1.249 1.027 0 CA-C-O 121.778 0.799 . . . . 0.0 109.875 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.598 ' HA ' HD12 ' A' ' 64' ' ' ILE . 11.0 t -56.04 -39.33 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 113.952 -1.477 . . . . 0.0 110.999 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -58.26 -42.37 86.3 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.049 0.843 . . . . 0.0 111.02 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.0 m -64.67 -45.73 85.47 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 123.657 0.598 . . . . 0.0 110.159 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -52.66 -50.83 62.44 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.816 0.698 . . . . 0.0 111.266 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -63.58 -46.19 86.99 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.135 0.897 . . . . 0.0 110.774 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.0 mtp-105 -59.35 -49.47 77.71 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.765 0.826 . . . . 0.0 111.41 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -66.32 -43.6 85.72 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.435 0.694 . . . . 0.0 110.18 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.3 tp -56.13 -49.6 73.45 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.272 1.029 . . . . 0.0 110.736 178.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -66.62 -49.17 67.16 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.446 0.698 . . . . 0.0 111.649 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.4 m -60.17 -44.61 94.88 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.46 0.648 . . . . 0.0 109.926 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.9 tp -57.81 -53.38 58.81 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.757 175.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.412 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 22.9 mt-30 -64.89 -45.04 87.62 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.28 0.632 . . . . 0.0 111.018 -173.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.56 -38.2 83.79 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.312 0.645 . . . . 0.0 110.633 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.34 -41.12 90.05 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.2 1.0 . . . . 0.0 110.978 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.1 mt -87.29 0.77 54.9 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.487 0.715 . . . . 0.0 111.458 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.25 -4.32 63.37 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.595 -0.558 . . . . 0.0 113.809 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 68.4 mt -68.08 116.31 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.672 1.189 . . . . 0.0 109.47 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -161.1 148.26 15.16 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.082 0.553 . . . . 0.0 110.497 -173.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.07 -89.84 0.01 OUTLIER Glycine 0 C--N 1.349 1.263 0 O-C-N 124.923 1.389 . . . . 0.0 114.722 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.41 -44.31 83.36 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.29 1.036 . . . . 0.0 110.565 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -98.65 -1.46 40.72 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.445 0.698 . . . . 0.0 111.741 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -70.44 134.41 47.77 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 122.994 0.184 . . . . 0.0 110.939 -178.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.2 t -72.37 112.51 15.09 Favored Pre-proline 0 CA--C 1.561 1.391 0 O-C-N 124.165 0.916 . . . . 0.0 109.49 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.92 142.63 57.67 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.981 2.454 . . . . 0.0 113.117 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.4 t -105.75 118.2 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 124.461 1.104 . . . . 0.0 109.178 -175.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.7 t -119.93 98.96 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.583 0.753 . . . . 0.0 110.166 -171.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -75.3 109.59 8.95 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.153 0.581 . . . . 0.0 110.585 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.457 HG21 ' HE3' ' A' ' 12' ' ' LYS . 77.7 mt -115.45 155.42 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.983 0.913 . . . . 0.0 108.54 -178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 71.64 -7.58 1.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.597 1.559 . . . . 0.0 114.365 169.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.613 ' HB3' ' HA ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -109.44 -179.24 3.77 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 122.997 0.519 . . . . 0.0 111.783 -177.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.6 m -109.57 136.54 48.79 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 123.529 0.732 . . . . 0.0 109.155 173.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.34 -34.3 77.67 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.024 0.53 . . . . 0.0 111.24 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.372 0 CA-C-O 118.887 -0.952 . . . . 0.0 113.042 -179.322 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.553 0.216 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.06 -79.88 1.82 Allowed Glycine 0 C--N 1.348 1.204 0 CA-C-N 116.497 -0.32 . . . . 0.0 112.366 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -131.93 -173.76 3.23 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.717 0.807 . . . . 0.0 109.611 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -108.84 -14.87 14.51 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.23 0.612 . . . . 0.0 111.873 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -57.04 -31.82 65.56 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.295 1.038 . . . . 0.0 113.01 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -73.21 8.28 1.75 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -68.39 85.61 0.28 Allowed 'General case' 0 CA--C 1.552 1.057 0 CA-C-O 122.662 1.22 . . . . 0.0 110.231 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -97.76 -10.88 24.08 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.084 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.9 m -73.11 97.31 2.35 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 168.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -73.17 -175.15 1.75 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.341 0.656 . . . . 0.0 110.207 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.4 mmt -78.41 36.78 0.26 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.65 -38.9 92.87 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 124.087 0.955 . . . . 0.0 109.703 172.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.2 tpp85 -70.67 86.98 0.67 Allowed 'General case' 0 C--N 1.361 1.08 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 168.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.1 t -114.88 -165.93 1.06 Allowed 'General case' 0 C--O 1.246 0.92 0 CA-C-N 113.861 -1.518 . . . . 0.0 107.278 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -166.99 165.2 38.4 Favored Glycine 0 CA--C 1.507 -0.451 0 N-CA-C 111.604 -0.599 . . . . 0.0 111.604 174.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.667 ' HB3' HG12 ' A' ' 60' ' ' VAL . 20.0 ttt180 -87.56 125.03 34.1 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.9 109.33 8.27 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.7 pt -106.8 175.38 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.685 1.194 . . . . 0.0 108.762 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.0 p -97.2 167.92 10.75 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.521 ' O ' HG23 ' A' ' 24' ' ' VAL . 69.1 t-105 -57.5 -41.97 81.8 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 123.462 0.476 . . . . 0.0 110.04 169.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -60.4 -49.39 77.76 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.71 0.404 . . . . 0.0 111.761 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.51 -38.79 90.73 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.298 0.639 . . . . 0.0 110.591 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.453 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 40.3 t80 -52.56 -53.46 46.11 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.968 172.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.579 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 69.1 t -60.33 -47.77 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.11 0.564 . . . . 0.0 110.769 -177.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -67.28 -55.91 11.96 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.521 -173.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -85.01 -27.88 26.12 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.453 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 87.1 m-85 -117.01 -68.86 0.89 Allowed 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -165.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.579 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 56.6 tp -59.91 -45.28 93.05 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.457 1.103 . . . . 0.0 113.149 -171.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 81.2 p -64.53 -21.29 66.64 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.066 0.546 . . . . 0.0 112.39 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -99.2 -9.05 24.21 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.794 0.837 . . . . 0.0 110.728 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.44 37.72 88.88 Favored Glycine 0 C--N 1.348 1.218 0 O-C-N 123.835 0.709 . . . . 0.0 114.836 -173.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.427 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 6.3 m -79.76 -3.46 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 174.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.453 ' HB ' HG21 ' A' ' 89' ' ' VAL . 16.6 t -99.54 128.08 51.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.911 0.884 . . . . 0.0 109.308 -175.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -86.72 -48.24 8.43 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.161 1.385 . . . . 0.0 110.312 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.513 ' HD3' HG21 ' A' ' 92' ' ' VAL . 19.2 ptp180 -158.49 149.39 20.48 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.857 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.563 ' HG ' HG11 ' A' ' 89' ' ' VAL . 31.4 mt -108.16 102.0 11.18 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.45 ' HB3' HD12 ' A' ' 94' ' ' ILE . 52.1 mt-10 -93.6 105.79 17.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.864 -172.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.528 HG22 HG22 ' A' ' 44' ' ' VAL . 48.3 t -81.06 102.12 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -176.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.3 t -90.23 114.71 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.263 0.625 . . . . 0.0 109.537 -173.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.3 m120 58.94 16.75 4.82 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.434 1.493 . . . . 0.0 113.688 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 90.6 mttt 60.35 8.58 1.65 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.447 1.099 . . . . 0.0 113.335 -171.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 -81.67 -39.51 24.25 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.924 0.889 . . . . 0.0 109.516 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -155.33 174.82 14.68 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.267 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.528 HG22 HG22 ' A' ' 38' ' ' VAL . 59.4 t -123.81 131.53 72.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -103.29 127.32 50.65 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.439 0.695 . . . . 0.0 109.439 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 80.2 t -84.08 110.16 18.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.621 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.5 m -90.44 141.62 28.56 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 170.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.429 ' HE2' ' HA ' ' A' ' 59' ' ' TYR . 63.3 m-85 -97.38 149.69 21.84 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 176.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.5 p -71.01 140.83 86.11 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.224 1.01 . . . . 0.0 111.419 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -63.91 73.85 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 123.271 2.647 . . . . 0.0 112.302 169.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.9 -40.09 0.43 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.336 -173.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.427 ' HB2' ' HA ' ' A' ' 32' ' ' VAL . 90.2 mttt -123.64 87.36 2.73 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 90.4 m -135.21 133.25 20.54 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 124.391 1.076 . . . . 0.0 109.185 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -58.25 99.3 0.1 OUTLIER 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.028 1.818 . . . . 0.0 110.018 165.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.77 -31.54 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.289 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -78.87 -31.4 45.5 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.668 0.787 . . . . 0.0 110.156 173.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.83 -171.26 45.84 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 115.619 -0.719 . . . . 0.0 114.205 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -133.32 -171.98 2.83 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.957 1.303 . . . . 0.0 109.446 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.429 ' HA ' ' HE2' ' A' ' 48' ' ' PHE . 11.6 m-85 -65.1 154.83 36.74 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.539 0.685 . . . . 0.0 111.046 176.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.667 HG12 ' HB3' ' A' ' 16' ' ' ARG . 33.8 m -131.39 170.12 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -167.04 160.1 13.76 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.141 0.576 . . . . 0.0 110.091 -174.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -144.1 140.17 29.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.998 0.519 . . . . 0.0 110.351 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -77.08 147.05 36.88 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.406 0.682 . . . . 0.0 110.27 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 67' ' ' VAL . 40.3 pt -131.03 139.4 51.18 Favored 'Isoleucine or valine' 0 C--O 1.246 0.897 0 C-N-CA 123.552 0.741 . . . . 0.0 109.992 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.34 -44.36 17.53 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 172.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.7 t -131.16 129.84 42.28 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.992 0.917 . . . . 0.0 110.285 177.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.444 ' HA ' HD12 ' A' ' 64' ' ' ILE . 15.6 t -64.41 -37.99 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.796 0.838 . . . . 0.0 110.691 171.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.598 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 31.3 t70 -62.23 -56.53 17.7 Favored 'General case' 0 C--O 1.216 -0.694 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.5 m -55.24 -45.42 76.03 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.943 0.497 . . . . 0.0 111.176 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -47.3 -56.15 7.36 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.411 1.084 . . . . 0.0 112.096 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 12.2 pt-20 -73.27 -28.77 62.31 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 119.227 -0.416 . . . . 0.0 111.814 -173.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 18.1 mmm-85 -59.98 -45.76 91.66 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 176.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -67.57 -38.37 84.0 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.705 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 tp -57.28 -56.73 18.03 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.697 0.623 . . . . 0.0 111.059 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 79' ' ' GLN . 32.0 mt-10 -59.92 -47.74 84.55 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.023 0.929 . . . . 0.0 112.693 -176.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 51.5 m -61.56 -48.87 79.0 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.504 0.669 . . . . 0.0 110.144 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 35.6 tp -57.56 -38.94 75.63 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.251 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.742 ' HB3' HD11 ' A' ' 83' ' ' ILE . 25.0 mt-30 -63.81 -39.03 93.27 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.522 0.729 . . . . 0.0 110.434 175.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 76.7 mt-30 -67.97 -29.25 68.24 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.932 0.493 . . . . 0.0 110.697 176.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -71.24 -47.78 55.12 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.617 0.767 . . . . 0.0 110.546 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 87.6 mt -68.0 -18.72 64.8 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.183 0.993 . . . . 0.0 111.644 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.76 31.27 79.64 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.713 0.633 . . . . 0.0 112.342 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.742 HD11 ' HB3' ' A' ' 78' ' ' GLN . 1.2 pp -64.81 162.49 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 122.041 0.924 . . . . 0.0 113.186 -176.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -119.53 169.15 10.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 161.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.89 -25.69 1.0 Allowed Glycine 0 N--CA 1.481 1.687 0 N-CA-C 117.311 1.685 . . . . 0.0 117.311 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.02 -46.65 83.51 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.688 0.744 . . . . 0.0 111.522 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -101.34 -11.9 19.06 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.439 0.696 . . . . 0.0 111.225 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.425 ' HB2' HD13 ' A' ' 83' ' ' ILE . 9.3 ttp180 -84.0 140.89 31.59 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.213 1.005 . . . . 0.0 109.294 174.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.563 HG11 ' HG ' ' A' ' 36' ' ' LEU . 46.5 t -117.17 120.41 33.65 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 122.781 0.432 . . . . 0.0 111.467 -167.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.83 154.26 48.47 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.976 2.451 . . . . 0.0 112.592 172.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.4 t -106.94 125.38 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.519 0.727 . . . . 0.0 109.768 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.513 HG21 ' HD3' ' A' ' 35' ' ' ARG . 21.8 t -113.13 112.45 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -82.39 109.43 16.63 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.45 HD12 ' HB3' ' A' ' 37' ' ' GLU . 50.2 mt -118.89 132.9 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -175.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -107.46 117.38 33.93 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 172.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -87.36 145.51 26.29 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.2 p -84.17 87.93 7.19 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.309 0.644 . . . . 0.0 110.341 179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -88.09 -35.94 17.21 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.034 0.934 . . . . 0.0 109.921 173.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.286 0 CA-C-O 118.58 -1.122 . . . . 0.0 111.667 178.837 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.45 174.01 16.09 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 123.074 0.368 . . . . 0.0 112.301 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -151.58 126.97 9.98 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.661 0.785 . . . . 0.0 109.17 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 85.3 t60 73.33 -51.47 0.7 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.573 1.549 . . . . 0.0 109.879 -169.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 -129.52 165.14 22.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.135 0.974 . . . . 0.0 109.358 165.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -82.36 166.6 19.31 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.883 0.873 . . . . 0.0 111.935 -174.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.4 m80 60.13 -149.68 0.43 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.306 1.042 . . . . 0.0 109.27 -176.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 -66.16 111.59 3.49 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 162.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.3 m -66.58 91.98 0.2 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.518 0.727 . . . . 0.0 110.534 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -58.02 136.02 57.06 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.929 174.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 56.0 mtm -81.49 53.28 2.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.165 0.986 . . . . 0.0 110.872 -175.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.433 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -80.61 108.42 14.23 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 174.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -167.17 176.81 6.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.668 -167.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.8 m -86.3 -39.48 16.46 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 165.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.52 58.34 15.09 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.643 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -122.96 123.21 40.41 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -77.3 107.25 9.58 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 172.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 pt -95.48 170.2 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 123.737 0.815 . . . . 0.0 109.235 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.503 HG23 ' H ' ' A' ' 22' ' ' ASP . 9.0 t -85.43 149.85 25.12 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 172.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.537 ' O ' HG23 ' A' ' 24' ' ' VAL . 67.1 t-105 -52.09 -42.85 63.56 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.972 0.909 . . . . 0.0 111.192 178.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -61.3 -36.21 79.46 Favored 'General case' 0 C--N 1.355 0.832 0 O-C-N 123.372 0.42 . . . . 0.0 111.725 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.503 ' H ' HG23 ' A' ' 19' ' ' THR . 31.7 t70 -70.35 -40.83 73.84 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 177.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.455 ' HZ ' HD11 ' A' ' 36' ' ' LEU . 40.2 t80 -56.15 -42.33 76.81 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.673 175.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.584 HG22 HD21 ' A' ' 77' ' ' LEU . 97.3 t -67.65 -66.3 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.402 0.681 . . . . 0.0 111.025 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -71.13 -44.81 64.82 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.443 0.464 . . . . 0.0 111.664 -166.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -80.13 -29.22 38.89 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.906 0.883 . . . . 0.0 111.786 -171.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -120.34 -66.19 1.08 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -169.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.5 tp -60.34 -44.36 95.59 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.972 0.909 . . . . 0.0 111.526 -172.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.1 m -73.04 -16.23 61.49 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.351 1.06 . . . . 0.0 112.412 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -96.2 -3.77 43.69 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.136 0.575 . . . . 0.0 110.974 176.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.22 37.37 91.71 Favored Glycine 0 C--N 1.357 1.738 0 N-CA-C 114.776 0.671 . . . . 0.0 114.776 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.7 m -98.95 0.8 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.7 t -99.06 126.6 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.481 0.712 . . . . 0.0 110.272 -174.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -85.28 -47.21 10.28 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.343 1.057 . . . . 0.0 110.707 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.461 ' HG2' ' HB ' ' A' ' 47' ' ' THR . 10.2 ptp180 -157.07 160.29 38.76 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.873 0.469 . . . . 0.0 110.138 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.455 HD11 ' HZ ' ' A' ' 23' ' ' PHE . 92.4 mt -117.77 103.29 9.85 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.74 0.816 . . . . 0.0 109.303 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -88.9 111.86 22.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.602 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 44' ' ' VAL . 31.0 t -84.45 99.86 7.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 95.9 t -91.25 114.43 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 122.865 0.466 . . . . 0.0 110.033 -171.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 52.52 27.29 4.92 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.408 1.483 . . . . 0.0 112.886 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HA ' HG12 ' A' ' 38' ' ' VAL . 98.0 mttt 61.71 -0.7 0.39 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.812 1.645 . . . . 0.0 114.31 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -81.74 -34.16 30.64 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.385 0.674 . . . . 0.0 110.6 -171.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -157.4 179.32 9.36 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 38' ' ' VAL . 91.9 t -126.59 129.1 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 124.175 0.99 . . . . 0.0 109.072 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -101.37 128.75 47.41 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.9 t -88.84 109.84 20.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.726 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.461 ' HB ' ' HG2' ' A' ' 35' ' ' ARG . 87.1 m -88.31 134.37 33.83 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 172.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -103.6 154.5 19.43 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.198 0.599 . . . . 0.0 111.379 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.3 p -75.48 117.53 63.99 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.172 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.07 103.66 0.13 Allowed 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.214 2.61 . . . . 0.0 111.294 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.54 -50.71 0.81 Allowed Glycine 0 C--N 1.336 0.563 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -173.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.39 21.91 16.66 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.982 0.913 . . . . 0.0 110.488 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.8 m -73.13 119.72 77.17 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.98 139.44 84.79 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.584 2.19 . . . . 0.0 112.312 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.08 -44.54 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.571 0.748 . . . . 0.0 109.024 173.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.37 82.84 2.23 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 171.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.74 46.5 0.09 OUTLIER Glycine 0 C--N 1.344 1.021 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -62.52 -61.15 2.64 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.085 0.954 . . . . 0.0 112.306 -171.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -135.21 119.05 17.26 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.7 m -118.67 -179.6 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.626 0.371 . . . . 0.0 110.127 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -159.54 165.82 32.12 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.966 0.907 . . . . 0.0 109.167 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -152.56 152.16 31.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.624 0.37 . . . . 0.0 111.455 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -78.19 149.59 33.67 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.206 1.002 . . . . 0.0 110.145 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.2 pt -127.06 -26.79 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.063 0.545 . . . . 0.0 111.999 -174.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.52 -78.0 1.52 Allowed Glycine 0 C--N 1.344 0.991 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.2 t -107.4 132.05 53.6 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.181 0.992 . . . . 0.0 108.585 172.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.8 t -62.33 -32.37 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.357 0.663 . . . . 0.0 110.757 173.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.95 -38.2 90.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.689 0.796 . . . . 0.0 110.807 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.6 m -63.39 -51.38 66.08 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 122.905 0.482 . . . . 0.0 110.221 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -53.33 -58.22 7.86 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 124.102 0.876 . . . . 0.0 111.961 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 15.5 pt-20 -62.56 -47.78 82.37 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.962 0.789 . . . . 0.0 111.065 -172.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -64.15 -48.1 77.32 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 122.37 0.268 . . . . 0.0 110.873 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.414 HD22 ' N ' ' A' ' 73' ' ' ASN . 0.8 OUTLIER -65.87 -43.34 88.67 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.814 0.696 . . . . 0.0 110.24 -176.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.438 ' O ' ' HG3' ' A' ' 78' ' ' GLN . 39.9 tp -57.7 -55.92 28.58 Favored 'General case' 0 C--O 1.215 -0.751 0 O-C-N 124.759 1.287 . . . . 0.0 111.651 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.591 ' HG2' ' NH2' ' A' ' 88' ' ' ARG . 44.8 mt-10 -66.43 -35.35 80.09 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.409 0.684 . . . . 0.0 112.156 -172.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.7 m -65.12 -48.04 75.01 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.188 0.595 . . . . 0.0 109.441 174.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.584 HD21 HG22 ' A' ' 24' ' ' VAL . 44.9 tp -57.17 -41.48 79.35 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 113.763 -1.562 . . . . 0.0 112.216 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 60.8 mt-30 -63.65 -46.31 86.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.682 0.793 . . . . 0.0 110.243 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -65.65 -31.04 71.84 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.46 0.704 . . . . 0.0 110.886 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -71.79 -52.64 16.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.559 1.143 . . . . 0.0 110.791 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 72.3 mt -79.42 -10.16 59.75 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.403 0.681 . . . . 0.0 111.592 -173.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.88 10.17 59.03 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 114.301 0.48 . . . . 0.0 114.301 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.471 ' O ' ' HB3' ' A' ' 78' ' ' GLN . 3.5 mp -80.13 90.32 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 168.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.99 143.14 50.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.656 -0.653 . . . . 0.0 111.925 -171.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.0 -100.3 0.17 Allowed Glycine 0 C--N 1.349 1.297 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.749 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -79.02 -27.88 43.28 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.946 0.899 . . . . 0.0 110.904 -176.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -76.46 -9.53 58.72 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.088 0.555 . . . . 0.0 111.557 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.591 ' NH2' ' HG2' ' A' ' 75' ' ' GLU . 70.2 mtp180 -69.15 151.55 46.23 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-O 121.551 0.691 . . . . 0.0 112.836 -175.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.5 t -91.87 108.77 32.37 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.056 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -57.36 125.57 19.27 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.972 2.448 . . . . 0.0 111.535 -175.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.77 107.79 20.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -176.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.4 t -105.52 98.03 6.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -71.14 107.77 4.34 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 59.9 mt -117.97 144.59 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.903 0.881 . . . . 0.0 109.814 -175.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.563 ' HB1' ' HB3' ' A' ' 98' ' ' ASP . . . -109.56 102.92 11.73 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 169.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -72.24 -46.72 54.82 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.764 0.825 . . . . 0.0 111.112 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.4 p -144.89 21.45 1.61 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.992 0.517 . . . . 0.0 111.347 -175.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.563 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . 17.3 t70 -74.1 -38.52 63.82 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.03 0.532 . . . . 0.0 110.211 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.286 0 CA-C-O 118.774 -1.014 . . . . 0.0 112.091 179.724 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.71 -154.86 53.42 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-N 116.275 -0.42 . . . . 0.0 113.423 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 74.91 -19.03 0.4 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.61 1.564 . . . . 0.0 113.081 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -77.44 100.3 5.95 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.583 0.753 . . . . 0.0 109.909 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -75.95 75.58 2.85 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.759 0.824 . . . . 0.0 110.295 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -93.96 126.03 38.93 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.695 0.798 . . . . 0.0 109.049 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -111.52 140.19 46.33 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -73.13 78.14 1.25 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.443 0.64 . . . . 0.0 109.742 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.8 m -140.02 -3.05 1.44 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.704 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -92.1 147.37 23.0 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.758 0.823 . . . . 0.0 108.849 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.3 mmt 66.53 -167.28 0.21 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.35 1.06 . . . . 0.0 110.286 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -83.1 120.52 25.87 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.494 ' HA ' ' HD2' ' A' ' 16' ' ' ARG . 6.3 ptm180 -75.71 85.09 2.72 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.75 0.786 . . . . 0.0 109.774 171.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 p -120.2 -79.38 0.6 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.41 98.63 1.73 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 171.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.494 ' HD2' ' HA ' ' A' ' 13' ' ' ARG . 4.1 mmp_? -108.33 116.83 32.7 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 117.092 0.446 . . . . 0.0 111.45 -173.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -75.07 108.52 7.85 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.618 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 36.0 pt -100.62 171.55 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.514 1.126 . . . . 0.0 109.227 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.6 p -100.11 178.43 4.79 Favored 'General case' 0 C--O 1.245 0.829 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 166.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -59.05 -35.19 72.91 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.445 173.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -60.88 -46.55 90.18 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.388 0.675 . . . . 0.0 112.22 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.618 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 7.0 m-20 -62.23 -44.95 95.4 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.312 0.245 . . . . 0.0 110.368 174.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 37.3 t80 -55.15 -50.63 68.8 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 124.118 0.886 . . . . 0.0 110.81 -178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.414 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 45.8 t -64.04 -66.47 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.944 0.897 . . . . 0.0 111.583 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -71.46 -47.15 57.54 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.87 0.468 . . . . 0.0 112.186 -166.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -80.26 -22.37 41.76 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -172.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.433 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 53.7 m-85 -128.22 -61.57 1.09 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -169.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.414 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 58.0 tp -64.13 -44.67 91.51 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.085 0.954 . . . . 0.0 111.317 -168.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.486 ' HA ' HD13 ' A' ' 81' ' ' LEU . 91.0 p -62.91 -20.31 65.04 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.59 0.756 . . . . 0.0 112.791 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -97.4 -10.44 25.5 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.868 0.867 . . . . 0.0 110.747 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.32 31.89 80.89 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 114.652 0.621 . . . . 0.0 114.652 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.44 HG12 ' HD3' ' A' ' 52' ' ' LYS . 18.2 m -80.5 -0.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 CA-C-N 117.125 0.462 . . . . 0.0 110.676 175.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 t -98.82 133.06 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -176.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.488 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 18.6 t70 -92.38 -55.03 3.56 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.519 1.128 . . . . 0.0 109.621 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -154.46 164.99 37.81 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.386 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.403 HD11 ' CZ ' ' A' ' 23' ' ' PHE . 91.6 mt -120.51 108.84 14.57 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.689 0.795 . . . . 0.0 110.788 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -88.21 102.64 15.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.741 0.816 . . . . 0.0 110.053 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 41' ' ' LYS . 21.8 t -97.3 91.03 2.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -173.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 65.1 t -79.58 118.25 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.079 -174.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 49.73 27.92 2.45 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.688 1.595 . . . . 0.0 113.425 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.566 ' HA ' HG12 ' A' ' 38' ' ' VAL . 10.6 mtmp? 53.74 15.52 0.81 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.116 1.366 . . . . 0.0 114.181 -175.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -85.64 -47.02 10.22 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.964 0.906 . . . . 0.0 110.421 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.457 ' HE2' ' HE ' ' A' ' 45' ' ' ARG . 44.1 p90 -147.56 159.83 43.31 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.177 0.513 . . . . 0.0 109.852 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.476 HG22 HG22 ' A' ' 38' ' ' VAL . 57.4 t -121.53 131.9 71.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.345 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.457 ' HE ' ' HE2' ' A' ' 43' ' ' PHE . 89.3 mtt180 -99.32 124.82 44.74 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.413 ' HB ' HG23 ' A' ' 60' ' ' VAL . 44.8 t -82.36 108.87 15.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 83.4 m -87.82 129.48 35.18 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -86.03 145.08 27.24 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.79 0.436 . . . . 0.0 110.409 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.4 t -86.66 145.21 38.71 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 123.297 0.639 . . . . 0.0 111.265 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -48.13 139.52 20.86 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 124.204 3.269 . . . . 0.0 114.631 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.0 -36.11 3.54 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.144 -174.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.44 ' HD3' HG12 ' A' ' 32' ' ' VAL . 67.1 mttm -98.97 -18.85 17.6 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.383 0.673 . . . . 0.0 110.799 175.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 m -65.6 130.1 94.51 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 122.89 0.476 . . . . 0.0 111.376 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -72.91 96.78 0.87 Allowed 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 121.986 1.791 . . . . 0.0 108.908 163.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.95 -17.5 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.715 0.806 . . . . 0.0 112.007 -169.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -60.88 -28.52 68.94 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.985 0.914 . . . . 0.0 111.997 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.68 82.4 1.11 Allowed Glycine 0 C--N 1.339 0.713 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.67 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.42 94.17 3.38 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -104.28 127.51 51.92 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.078 0.951 . . . . 0.0 110.05 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' A' ' 16' ' ' ARG . 33.0 m -109.17 144.16 18.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 173.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -154.73 163.13 40.7 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.83 0.452 . . . . 0.0 110.693 -173.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -150.19 150.76 32.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.708 0.403 . . . . 0.0 110.733 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -93.8 119.12 32.35 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.1 pt -84.31 116.77 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.069 0.548 . . . . 0.0 110.384 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.35 99.42 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.776 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.6 t -132.15 126.59 34.03 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.052 0.941 . . . . 0.0 108.731 172.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.54 HG21 ' HB3' ' A' ' 41' ' ' LYS . 17.5 t -61.57 -36.3 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.363 0.665 . . . . 0.0 110.049 172.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -58.01 -43.9 86.92 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.125 0.97 . . . . 0.0 111.094 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.5 m -64.87 -46.53 81.45 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.537 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -51.39 -53.45 36.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.813 0.845 . . . . 0.0 111.834 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 44.7 mt-10 -67.9 -52.95 30.52 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.761 0.824 . . . . 0.0 111.845 -172.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -68.88 -36.06 77.63 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.588 0.555 . . . . 0.0 111.785 -173.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -70.89 -39.7 72.65 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 174.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 46.5 tp -56.51 -45.19 81.2 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.023 0.529 . . . . 0.0 111.34 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.5 -42.18 99.32 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.874 0.734 . . . . 0.0 111.187 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.1 m -60.31 -56.41 21.84 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 123.8 0.688 . . . . 0.0 110.398 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 77' ' ' LEU . 2.7 mm? -51.73 -52.16 50.65 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 124.418 1.074 . . . . 0.0 112.067 176.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -60.17 -43.34 95.91 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 123.627 0.579 . . . . 0.0 111.383 -175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -62.75 -44.86 95.11 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.923 0.889 . . . . 0.0 111.122 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -70.1 -38.36 75.61 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.131 -176.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 29' ' ' SER . 41.5 mt -77.77 -17.3 57.65 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.66 0.784 . . . . 0.0 110.515 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.7 6.54 88.99 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-O 119.887 -0.396 . . . . 0.0 113.853 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.539 HG22 ' HA ' ' A' ' 88' ' ' ARG . 75.7 mt -70.98 92.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.1 0.96 . . . . 0.0 109.479 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -136.33 152.82 51.07 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 124.133 0.973 . . . . 0.0 110.569 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.402 ' N ' ' HB2' ' A' ' 88' ' ' ARG . . . 61.0 -93.91 0.07 OUTLIER Glycine 0 C--N 1.343 0.947 0 CA-C-N 114.594 -1.185 . . . . 0.0 115.406 172.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -77.46 -45.72 24.79 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.562 0.696 . . . . 0.0 109.517 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -79.86 -15.7 56.85 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.759 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.539 ' HA ' HG22 ' A' ' 83' ' ' ILE . 58.0 ttt180 -56.53 152.25 12.09 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.112 0.965 . . . . 0.0 111.991 -174.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 68.6 t -100.09 99.74 10.03 Favored Pre-proline 0 CA--C 1.551 0.993 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 57.2 Cg_endo -70.48 149.07 61.71 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.919 2.413 . . . . 0.0 112.268 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.8 t -108.63 119.32 57.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.417 -174.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.7 t -104.84 96.27 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -74.64 98.52 3.43 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 175.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.508 HG22 ' HG2' ' A' ' 96' ' ' GLU . 64.3 mt -87.1 129.19 38.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.81 75.71 1.45 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -175.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.508 ' HG2' HG22 ' A' ' 94' ' ' ILE . 12.3 mm-40 -72.68 -46.75 52.19 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.053 -174.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.7 m 66.12 98.56 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.529 1.143 . . . . 0.0 110.914 -176.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.91 -41.12 71.65 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.005 0.922 . . . . 0.0 110.224 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.128 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.148 173.965 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 mtt . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.576 0.227 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.08 26.41 26.34 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 116.387 -0.37 . . . . 0.0 112.314 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -60.92 -39.24 88.62 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.144 0.578 . . . . 0.0 110.838 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -77.5 81.98 3.94 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 166.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -65.2 -65.62 0.65 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.233 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.5 m80 -145.12 115.62 7.63 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 171.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -66.98 151.6 47.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.876 0.47 . . . . 0.0 110.216 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.6 p80 48.23 31.15 2.48 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.061 1.345 . . . . 0.0 111.963 -175.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.2 p -51.38 151.8 2.83 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.091 0.956 . . . . 0.0 111.572 -175.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -45.19 132.46 7.35 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 124.562 1.164 . . . . 0.0 111.414 -171.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.485 ' HG3' ' HB2' ' A' ' 13' ' ' ARG . 13.7 tpt -43.09 105.61 0.05 Allowed 'General case' 0 C--N 1.354 0.798 0 O-C-N 125.278 1.611 . . . . 0.0 111.081 -177.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.537 ' HD3' HG11 ' A' ' 39' ' ' VAL . 24.1 ttpt -42.09 -56.2 2.93 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 125.237 1.415 . . . . 0.0 110.308 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.485 ' HB2' ' HG3' ' A' ' 11' ' ' MET . 3.2 tmt_? 59.08 -87.96 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.066 0 O-C-N 125.417 1.698 . . . . 0.0 108.489 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.7 p 175.82 -70.56 0.01 OUTLIER 'General case' 0 C--N 1.353 0.731 0 C-N-CA 124.458 1.103 . . . . 0.0 109.694 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.98 -154.02 19.51 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.351 -168.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -89.65 127.13 35.87 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.384 0.674 . . . . 0.0 109.366 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -74.26 128.98 36.92 Favored 'General case' 0 C--N 1.352 0.683 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 176.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.4 pt -129.69 170.6 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.618 0.767 . . . . 0.0 109.649 -175.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.6 p -91.71 153.59 19.55 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.588 ' O ' HG23 ' A' ' 24' ' ' VAL . 68.9 t-105 -53.58 -46.46 70.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.302 0.641 . . . . 0.0 110.806 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -54.82 -50.73 67.86 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.815 0.846 . . . . 0.0 112.476 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.46 ' HA ' HD21 ' A' ' 25' ' ' ASN . 0.0 OUTLIER -70.99 -33.83 70.79 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -176.627 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -54.23 -45.47 72.3 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 123.41 0.444 . . . . 0.0 110.49 172.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 20' ' ' TRP . 89.3 t -58.11 -64.09 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.017 -179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.46 HD21 ' HA ' ' A' ' 22' ' ' ASP . 9.3 p30 -75.21 -33.41 61.39 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.233 0.333 . . . . 0.0 111.815 -166.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -80.66 -41.29 24.04 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.868 0.467 . . . . 0.0 111.606 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -113.51 -65.3 1.2 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -163.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.8 tp -60.89 -45.52 94.26 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 123.886 0.741 . . . . 0.0 111.53 -174.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.5 ' HA ' HD11 ' A' ' 83' ' ' ILE . 22.7 t -72.39 -14.29 61.67 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.33 1.052 . . . . 0.0 111.863 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -101.83 -2.18 30.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.771 0.428 . . . . 0.0 111.12 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.93 22.41 34.49 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 115.252 0.861 . . . . 0.0 115.252 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.8 m -77.78 -3.59 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 123.055 0.542 . . . . 0.0 111.468 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.9 t -93.63 129.91 43.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.267 1.027 . . . . 0.0 108.625 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -80.56 -47.32 14.36 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.537 0.735 . . . . 0.0 110.193 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.485 ' HG2' ' HB ' ' A' ' 47' ' ' THR . 6.6 ptp85 -159.4 157.92 31.18 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.092 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 90.5 mt -114.83 102.14 9.71 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.774 0.829 . . . . 0.0 108.964 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -89.79 108.61 19.8 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.136 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.523 HG22 HG22 ' A' ' 44' ' ' VAL . 40.6 t -88.45 94.59 4.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.537 HG11 ' HD3' ' A' ' 12' ' ' LYS . 19.9 t -90.94 127.06 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 O-C-N 123.233 0.333 . . . . 0.0 111.44 -169.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.4 m120 53.28 23.23 3.09 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.653 1.581 . . . . 0.0 113.632 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 61.28 6.6 1.41 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.986 1.314 . . . . 0.0 114.196 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.7 mtp-105 -91.22 -40.81 11.33 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.274 0.488 . . . . 0.0 110.436 -176.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.486 ' HZ ' ' HD2' ' A' ' 12' ' ' LYS . 41.2 p90 -151.99 174.04 14.13 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.15 -170.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.523 HG22 HG22 ' A' ' 38' ' ' VAL . 71.9 t -119.88 122.89 69.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -100.03 121.9 42.09 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.0 t -90.24 119.74 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.127 0.971 . . . . 0.0 110.327 -168.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.485 ' HB ' ' HG2' ' A' ' 35' ' ' ARG . 58.1 m -93.86 130.05 40.04 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -97.32 170.39 9.11 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.931 0.769 . . . . 0.0 111.079 176.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.6 p -83.23 141.94 43.4 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 123.301 0.64 . . . . 0.0 110.997 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -55.19 146.57 59.36 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.609 2.873 . . . . 0.0 112.976 174.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.15 -54.96 1.56 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 112.066 -0.414 . . . . 0.0 112.066 -178.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -70.27 -58.14 4.1 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.4 m -134.64 99.37 12.9 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -81.01 -160.73 0.13 Allowed 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 123.062 2.508 . . . . 0.0 112.834 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.11 -34.96 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.846 0.858 . . . . 0.0 111.175 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -68.62 -38.93 80.93 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.356 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.1 126.84 29.34 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 123.723 0.639 . . . . 0.0 112.761 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -64.88 136.89 57.37 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.709 0.804 . . . . 0.0 110.965 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -78.78 175.39 10.52 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.401 0.68 . . . . 0.0 110.719 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.8 169.87 20.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.078 170.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -158.25 158.42 34.43 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.533 0.733 . . . . 0.0 109.35 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -146.54 141.32 26.88 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.951 0.5 . . . . 0.0 109.722 177.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -83.15 128.57 34.61 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.874 0.47 . . . . 0.0 109.897 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 67' ' ' VAL . 22.5 pt -106.5 -29.29 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.342 0.657 . . . . 0.0 110.658 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.79 -71.85 1.6 Allowed Glycine 0 C--N 1.35 1.314 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -174.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.4 t -100.18 121.45 41.45 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.278 1.031 . . . . 0.0 110.127 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.506 ' HA ' HD12 ' A' ' 64' ' ' ILE . 39.5 t -66.56 -34.13 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.091 172.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.433 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 24.6 t70 -64.09 -37.11 86.26 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 63.2 m -65.89 -45.39 82.18 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.737 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -52.55 -41.56 63.64 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 123.778 0.674 . . . . 0.0 111.619 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.46 -51.25 53.63 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.488 0.492 . . . . 0.0 110.341 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 68' ' ' ASP . 95.5 mtt180 -55.94 -54.94 38.67 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.211 0.604 . . . . 0.0 111.771 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -71.42 -31.95 67.82 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.521 -175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.439 ' HG ' ' NE2' ' A' ' 78' ' ' GLN . 35.4 tp -62.84 -44.75 95.3 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.345 0.658 . . . . 0.0 111.858 172.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -63.32 -45.17 92.56 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.267 0.627 . . . . 0.0 112.065 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.473 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 14.8 m -63.57 -50.18 70.47 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.01 0.819 . . . . 0.0 109.361 177.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.51 HD21 HG22 ' A' ' 24' ' ' VAL . 45.3 tp -54.16 -51.24 64.95 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.824 -1.08 . . . . 0.0 113.298 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.439 ' NE2' ' HG ' ' A' ' 74' ' ' LEU . 46.0 mt-30 -64.72 -39.61 93.94 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.453 0.47 . . . . 0.0 111.232 -178.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 76' ' ' THR . 1.4 pt20 -68.04 -35.76 78.79 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 120.647 0.26 . . . . 0.0 110.549 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 76' ' ' THR . 30.9 mm-40 -74.24 -43.81 55.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.305 0.642 . . . . 0.0 111.047 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.6 mt -70.92 -8.65 54.51 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.74 0.816 . . . . 0.0 112.193 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.15 2.55 87.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 119.969 -0.351 . . . . 0.0 113.216 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 29' ' ' SER . 76.8 mt -73.03 101.73 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 124.844 1.258 . . . . 0.0 108.961 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -137.5 155.74 48.93 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.281 0.633 . . . . 0.0 111.257 -178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.23 -118.43 12.91 Favored Glycine 0 C--N 1.349 1.269 0 O-C-N 124.114 0.884 . . . . 0.0 113.719 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -20.75 66.02 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.385 1.074 . . . . 0.0 111.895 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -79.62 -24.77 41.7 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.666 0.386 . . . . 0.0 111.998 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -69.78 118.67 12.92 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.733 0.242 . . . . 0.0 110.773 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.09 126.42 92.4 Favored Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 123.272 0.629 . . . . 0.0 110.117 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.9 143.2 65.57 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.817 2.345 . . . . 0.0 112.575 -177.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.4 t -109.53 122.04 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.748 0.819 . . . . 0.0 109.322 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.471 HG21 ' HD3' ' A' ' 35' ' ' ARG . 23.0 t -114.31 101.77 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.932 0.893 . . . . 0.0 109.61 -174.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -75.62 104.49 6.19 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.088 0.555 . . . . 0.0 110.648 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 51.4 mm -106.62 129.9 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -154.71 65.91 0.67 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.527 0.679 . . . . 0.0 109.451 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.6 -173.17 2.08 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.012 -177.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.0 p -118.38 100.41 7.46 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.21 0.604 . . . . 0.0 109.992 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.52 -24.93 62.05 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.436 0.694 . . . . 0.0 110.9 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.781 -1.011 . . . . 0.0 112.086 179.727 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.452 ' HB3' ' HB3' ' A' ' 6' ' ' HIS . 51.6 mtm . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.73 -119.45 11.12 Favored Glycine 0 C--N 1.355 1.591 0 O-C-N 123.701 0.625 . . . . 0.0 111.877 178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -103.66 -11.62 17.55 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.66 0.784 . . . . 0.0 110.034 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -79.07 117.96 20.6 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.984 0.914 . . . . 0.0 109.732 -177.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 57.62 -93.3 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.299 1.439 . . . . 0.0 112.84 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 30.2 p80 44.73 23.59 0.08 Allowed 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.976 1.71 . . . . 0.0 113.969 -175.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -163.19 104.19 0.98 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 122.733 0.413 . . . . 0.0 110.082 -171.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -96.84 116.68 29.58 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -74.59 132.35 41.7 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.112 0.565 . . . . 0.0 110.084 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -87.81 -27.41 22.29 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.86 0.864 . . . . 0.0 109.537 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -63.92 137.85 58.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.815 0.846 . . . . 0.0 108.876 175.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.66 83.36 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.216 1.006 . . . . 0.0 111.283 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 58.01 86.94 0.07 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.183 1.393 . . . . 0.0 111.515 -178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.7 m -57.89 -29.28 64.94 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.27 0.628 . . . . 0.0 110.741 173.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.64 -176.26 38.97 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.699 170.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.566 ' HB3' HG12 ' A' ' 60' ' ' VAL . 63.7 ttt180 -85.56 121.19 27.9 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -73.53 130.72 40.67 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.9 pt -133.15 175.68 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.509 1.124 . . . . 0.0 109.218 -177.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.9 p -95.92 164.8 12.57 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.72 172.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.518 ' O ' HG23 ' A' ' 24' ' ' VAL . 72.6 t-105 -55.49 -44.42 76.5 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.013 0.925 . . . . 0.0 110.657 174.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -56.07 -47.26 78.3 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.732 0.813 . . . . 0.0 111.129 -178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.6 -42.02 92.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.05 0.54 . . . . 0.0 110.567 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -51.78 -51.02 59.46 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.665 0.603 . . . . 0.0 111.228 175.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 20' ' ' TRP . 59.9 t -63.75 -61.31 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.238 0.615 . . . . 0.0 111.5 -175.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -71.91 -40.87 68.53 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.034 -168.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -79.82 -43.48 22.32 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.377 0.671 . . . . 0.0 110.915 -175.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -114.08 -65.66 1.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -163.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 42.4 tp -55.08 -45.14 75.36 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.081 0.952 . . . . 0.0 112.146 -171.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.415 ' HA ' HD11 ' A' ' 83' ' ' ILE . 74.2 p -71.55 -9.18 57.81 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -95.96 -6.47 38.92 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 118.835 -0.603 . . . . 0.0 112.012 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.42 31.25 80.26 Favored Glycine 0 C--N 1.353 1.482 0 C-N-CA 121.433 -0.413 . . . . 0.0 113.687 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.8 -3.46 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.38 0.672 . . . . 0.0 111.728 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.04 130.78 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.492 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 24.8 t70 -88.26 -51.27 5.85 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.967 1.307 . . . . 0.0 110.124 -175.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -152.71 152.33 31.57 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.676 0.79 . . . . 0.0 110.208 -175.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 86.1 mt -112.0 101.97 10.23 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.43 1.092 . . . . 0.0 109.054 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.625 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 43.1 mt-10 -93.49 101.18 13.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.856 -172.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.583 HG22 HG22 ' A' ' 44' ' ' VAL . 49.0 t -81.08 104.94 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -176.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.5 t -95.24 115.48 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 123.055 0.542 . . . . 0.0 110.538 -174.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 53.31 24.04 3.59 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.157 1.783 . . . . 0.0 113.905 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt 67.49 0.77 2.29 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.447 1.499 . . . . 0.0 112.98 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -76.87 -45.26 28.93 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.109 0.963 . . . . 0.0 110.135 -176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -152.32 175.02 13.1 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.964 -173.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.583 HG22 HG22 ' A' ' 38' ' ' VAL . 86.8 t -124.58 130.57 73.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 125.109 1.364 . . . . 0.0 107.846 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.625 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 68.4 ttt180 -97.9 116.91 31.07 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.732 1.213 . . . . 0.0 108.48 -177.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.514 ' HB ' HG23 ' A' ' 60' ' ' VAL . 46.7 t -85.11 106.7 15.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.7 m -103.17 135.86 44.03 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -97.0 148.08 23.34 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.88 0.738 . . . . 0.0 111.96 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.492 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 57.7 p -62.32 133.1 94.32 Favored Pre-proline 0 C--N 1.349 0.557 0 C-N-CA 124.56 1.144 . . . . 0.0 111.26 -176.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.725 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 12.3 Cg_exo -73.64 35.93 0.38 Allowed 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 123.815 3.01 . . . . 0.0 113.385 171.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.78 -46.2 0.04 OUTLIER Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 -173.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.51 -67.71 0.76 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 175.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.8 t -139.13 75.38 34.6 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 123.603 0.761 . . . . 0.0 110.109 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.725 ' HB3' ' HA ' ' A' ' 50' ' ' PRO . 15.1 Cg_endo -62.09 -81.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.242 1.961 . . . . 0.0 112.618 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.9 t -81.45 -29.34 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.182 0.593 . . . . 0.0 109.814 -173.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -64.38 -23.22 67.21 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.391 0.676 . . . . 0.0 110.925 170.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.35 97.67 0.1 OUTLIER Glycine 0 C--N 1.352 1.468 0 O-C-N 123.86 0.725 . . . . 0.0 112.188 176.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -65.06 92.63 0.11 Allowed 'General case' 0 C--N 1.347 0.498 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -59.81 115.73 3.59 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.243 -172.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.566 HG12 ' HB3' ' A' ' 16' ' ' ARG . 10.6 m -119.53 170.04 9.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.505 -175.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -156.18 161.52 40.3 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.166 0.586 . . . . 0.0 109.532 176.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -147.26 145.15 29.31 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.92 154.53 31.57 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 67' ' ' VAL . 31.9 pt -128.82 -46.37 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 122.937 0.495 . . . . 0.0 110.441 174.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.45 -72.15 0.47 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -168.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.9 t -78.57 104.51 9.23 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 124.456 1.102 . . . . 0.0 110.638 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.485 ' HA ' HD12 ' A' ' 64' ' ' ILE . 26.4 t -66.95 -31.7 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.068 173.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.45 -42.91 98.63 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.238 0.615 . . . . 0.0 110.597 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 80.4 m -62.86 -48.47 78.87 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -51.73 -52.43 48.57 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 124.475 1.11 . . . . 0.0 112.046 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -66.24 -42.38 88.67 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 123.306 0.379 . . . . 0.0 111.301 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -66.18 -49.87 65.84 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.829 0.452 . . . . 0.0 112.064 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -71.14 -32.5 69.03 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 119.206 -0.426 . . . . 0.0 110.828 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.1 tp -59.78 -48.16 82.81 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.89 0.876 . . . . 0.0 111.135 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -65.0 -42.89 94.08 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.261 0.624 . . . . 0.0 112.139 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.7 m -59.77 -49.51 77.46 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 122.013 0.911 . . . . 0.0 109.693 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.407 HD21 HG22 ' A' ' 24' ' ' VAL . 32.9 tp -58.96 -42.73 90.58 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 112.914 -1.948 . . . . 0.0 112.614 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -65.77 -37.11 85.44 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.242 0.617 . . . . 0.0 111.051 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -69.85 -35.28 74.58 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.108 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -70.31 -52.54 22.04 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.565 1.146 . . . . 0.0 110.996 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.5 mt -73.02 -19.77 61.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.183 0.993 . . . . 0.0 111.222 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.05 7.39 70.38 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-O 119.723 -0.487 . . . . 0.0 113.2 -175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.415 HD11 ' HA ' ' A' ' 29' ' ' SER . 71.3 mt -67.77 92.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.157 0.983 . . . . 0.0 109.033 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -137.97 148.12 44.91 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.716 0.807 . . . . 0.0 110.147 -171.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.78 -102.83 0.74 Allowed Glycine 0 C--N 1.351 1.365 0 O-C-N 124.508 1.13 . . . . 0.0 112.992 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.52 -30.42 57.17 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.746 0.818 . . . . 0.0 110.72 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -72.05 -21.09 61.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.082 0.553 . . . . 0.0 111.379 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -62.01 142.6 57.4 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.231 0.613 . . . . 0.0 111.751 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.4 t -107.55 106.37 58.26 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -58.6 143.86 97.99 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 124.047 3.164 . . . . 0.0 113.258 -175.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.7 t -98.87 119.4 46.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 54.2 t -110.95 121.39 63.54 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -87.51 127.2 35.24 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 44.8 mm -124.43 129.24 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.289 1.436 . . . . 0.0 107.791 -175.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.56 145.23 47.54 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.028 0.531 . . . . 0.0 110.108 175.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -108.57 8.43 27.15 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.494 1.118 . . . . 0.0 110.141 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.4 m -83.74 10.0 10.46 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.853 0.861 . . . . 0.0 113.043 -168.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -153.05 -49.65 0.1 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.189 0.996 . . . . 0.0 108.705 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.516 179.557 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 110.887 -0.042 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.98 154.5 22.07 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 112.083 -0.407 . . . . 0.0 112.083 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -105.46 72.79 0.99 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -164.76 34.4 0.07 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.286 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -62.55 -38.38 89.82 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.771 0.828 . . . . 0.0 111.75 -176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -149.45 147.34 28.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.395 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -78.18 68.42 4.21 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.336 1.054 . . . . 0.0 109.556 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 40.88 -83.36 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 126.429 1.892 . . . . 0.0 113.962 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.2 t -145.57 -176.28 5.06 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.431 1.092 . . . . 0.0 109.047 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.405 ' CD2' HE22 ' A' ' 58' ' ' GLN . 4.6 p-80 -161.32 93.89 0.96 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.974 0.51 . . . . 0.0 110.778 -176.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 16.4 tpt -89.84 -34.6 16.06 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 167.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -68.44 163.73 22.64 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.943 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -68.94 81.85 0.31 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.177 1.391 . . . . 0.0 109.686 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.6 p -97.45 140.01 32.54 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.5 1.12 . . . . 0.0 109.396 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.98 151.61 22.3 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.261 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.53 ' HB3' HG12 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -87.28 119.7 27.8 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -177.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.94 107.2 6.02 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 48.2 pt -99.72 176.66 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.943 0.897 . . . . 0.0 109.967 173.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.3 p -104.78 171.6 7.24 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.383 171.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -57.78 -38.88 76.22 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.504 0.722 . . . . 0.0 110.381 171.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -55.45 -48.79 73.94 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.747 0.819 . . . . 0.0 111.211 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.576 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 50.8 m-20 -64.66 -45.15 87.96 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.77 0.428 . . . . 0.0 111.924 176.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.433 ' CZ ' HD11 ' A' ' 36' ' ' LEU . 10.1 t80 -49.39 -57.35 7.09 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.121 0.888 . . . . 0.0 110.228 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.409 HG22 HD21 ' A' ' 77' ' ' LEU . 96.6 t -66.13 -56.41 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 123.89 0.744 . . . . 0.0 111.859 -174.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -76.32 -48.87 18.54 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -168.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -76.49 -39.62 52.62 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.265 0.626 . . . . 0.0 111.528 -176.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -108.91 -65.54 1.13 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -165.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.4 tp -58.07 -44.45 87.51 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.88 0.872 . . . . 0.0 111.86 -173.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.1 t -57.47 -30.23 64.88 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.201 1.0 . . . . 0.0 112.455 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -91.81 0.97 57.46 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.979 0.912 . . . . 0.0 110.887 -176.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.46 25.41 62.93 Favored Glycine 0 C--N 1.351 1.409 0 N-CA-C 114.444 0.537 . . . . 0.0 114.444 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.413 HG12 ' HD3' ' A' ' 52' ' ' LYS . 18.9 m -85.91 -2.02 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 117.257 0.529 . . . . 0.0 110.617 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.5 t -93.77 122.22 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.908 0.883 . . . . 0.0 109.431 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 17.8 t70 -82.25 -52.44 6.94 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.208 1.003 . . . . 0.0 109.625 175.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -155.13 166.19 34.35 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.57 0.748 . . . . 0.0 110.687 -173.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.433 HD11 ' CZ ' ' A' ' 23' ' ' PHE . 84.4 mt -119.15 107.25 13.24 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.949 0.9 . . . . 0.0 110.432 175.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 40.4 mt-10 -94.27 101.75 13.73 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.335 0.654 . . . . 0.0 110.257 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 41' ' ' LYS . 23.4 t -82.58 89.91 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -175.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.42 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 95.4 t -73.94 116.77 16.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.289 1.035 . . . . 0.0 110.946 -169.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 95' ' ' ALA . 3.4 m-20 55.8 21.4 4.73 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.604 1.162 . . . . 0.0 112.397 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.516 ' HA ' HG12 ' A' ' 38' ' ' VAL . 91.7 mttt 61.98 2.18 0.75 Allowed 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.845 1.658 . . . . 0.0 114.143 -173.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -80.06 -39.96 28.67 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.87 0.868 . . . . 0.0 110.766 -173.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -153.56 166.54 32.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.042 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 53.0 t -120.16 130.91 73.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -175.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.41 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 34.4 ttm180 -91.01 127.93 36.63 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 175.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.511 ' HB ' HG23 ' A' ' 60' ' ' VAL . 44.9 t -83.42 105.45 13.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 165.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.9 m -94.59 130.18 41.14 Favored 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 53' ' ' THR . 84.6 m-85 -87.76 156.88 19.21 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.018 0.824 . . . . 0.0 111.095 -175.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.479 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 64.4 p -63.04 141.5 97.7 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-O 118.329 -0.843 . . . . 0.0 109.361 174.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -51.31 -40.84 61.0 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.97 3.114 . . . . 0.0 114.871 -163.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.55 -17.48 73.25 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.518 -0.31 . . . . 0.0 113.497 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HD3' HG12 ' A' ' 32' ' ' VAL . 65.0 mttm -105.98 0.58 25.85 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.515 0.726 . . . . 0.0 111.525 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.412 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 100.0 m -66.73 126.86 93.01 Favored Pre-proline 0 C--N 1.354 0.782 0 CA-C-O 118.974 -0.536 . . . . 0.0 110.401 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -63.39 89.04 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 121.845 1.696 . . . . 0.0 109.122 165.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.6 m -66.84 -9.58 9.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.778 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.285 -175.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -57.83 -23.72 54.06 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.208 1.003 . . . . 0.0 111.08 170.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 128.41 -33.29 3.18 Favored Glycine 0 C--N 1.357 1.739 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.859 170.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.405 HE22 ' CD2' ' A' ' 10' ' ' HIS . 1.6 mp0 -84.14 100.44 11.14 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.283 0.633 . . . . 0.0 111.049 -166.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -75.65 175.48 8.58 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.225 165.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.53 HG12 ' HB3' ' A' ' 16' ' ' ARG . 35.7 m -110.94 152.69 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -153.64 156.57 38.16 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.85 0.46 . . . . 0.0 110.678 -174.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -139.8 139.94 36.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.322 0.649 . . . . 0.0 109.294 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -81.3 144.02 31.82 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.417 0.687 . . . . 0.0 110.045 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 67' ' ' VAL . 37.4 pt -120.46 140.18 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.519 0.728 . . . . 0.0 109.516 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.49 -46.13 26.77 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 177.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.8 m -132.09 138.44 48.13 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.694 0.798 . . . . 0.0 109.439 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.505 ' HA ' HD12 ' A' ' 64' ' ' ILE . 34.4 t -63.03 -41.4 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.287 0.635 . . . . 0.0 110.967 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.87 -39.69 92.76 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.939 0.495 . . . . 0.0 111.079 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.6 m -63.03 -45.86 90.31 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.864 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -53.46 -47.69 69.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.789 0.836 . . . . 0.0 111.291 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 52.1 mt-10 -63.35 -47.67 81.17 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.73 0.644 . . . . 0.0 110.901 -178.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.1 mtp-105 -61.24 -44.63 96.95 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.227 0.611 . . . . 0.0 111.082 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -63.65 -46.78 84.05 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.552 0.741 . . . . 0.0 110.741 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.23 -48.93 79.21 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.143 0.977 . . . . 0.0 111.655 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 23.0 mm-40 -61.96 -48.37 80.66 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.117 0.567 . . . . 0.0 110.956 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.451 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 96.1 m -57.24 -55.43 34.88 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.502 0.721 . . . . 0.0 110.35 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.409 HD21 HG22 ' A' ' 24' ' ' VAL . 66.4 tp -44.71 -51.24 9.46 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.18 1.792 . . . . 0.0 112.686 174.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -64.71 -41.59 95.88 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.014 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 13.9 mm100 -64.04 -38.65 91.85 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.485 0.314 . . . . 0.0 110.567 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 76' ' ' THR . 21.1 mm-40 -60.48 -39.81 89.0 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.83 0.852 . . . . 0.0 111.07 175.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.9 mt -84.1 -8.49 59.09 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.721 0.808 . . . . 0.0 112.097 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.45 6.25 89.36 Favored Glycine 0 C--N 1.353 1.474 0 C-N-CA 122.894 0.283 . . . . 0.0 113.392 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.527 HG22 ' HA ' ' A' ' 88' ' ' ARG . 69.5 mt -76.26 108.66 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 124.987 1.315 . . . . 0.0 109.555 177.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.25 177.29 10.38 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.62 0.768 . . . . 0.0 110.658 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.04 -125.15 29.6 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.662 0.601 . . . . 0.0 113.621 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -85.76 -8.12 58.34 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.354 0.662 . . . . 0.0 111.096 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.497 HD22 HG23 ' A' ' 83' ' ' ILE . 7.9 t30 -88.41 -12.94 41.77 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.339 0.655 . . . . 0.0 110.865 -178.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.527 ' HA ' HG22 ' A' ' 83' ' ' ILE . 12.1 ptp85 -63.69 147.52 51.4 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 117.507 0.14 . . . . 0.0 110.681 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.402 HG11 ' HG ' ' A' ' 36' ' ' LEU . 40.2 t -66.39 116.51 34.58 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -175.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 32.3 Cg_exo -59.56 117.34 4.07 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.576 2.851 . . . . 0.0 111.248 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 12.9 t -102.63 125.45 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.8 t -111.65 95.73 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -76.85 100.45 5.52 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 56.4 mt -95.05 142.9 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.833 0.853 . . . . 0.0 109.51 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 40' ' ' ASN . . . -144.73 79.43 1.6 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.745 0.818 . . . . 0.0 109.306 175.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -83.86 154.8 23.26 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.126 0.57 . . . . 0.0 111.201 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.9 t -73.53 -22.98 59.95 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.092 0.557 . . . . 0.0 110.034 174.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.0 t70 65.72 -75.61 0.05 OUTLIER 'General case' 0 C--N 1.355 0.83 0 C-N-CA 125.815 1.646 . . . . 0.0 111.053 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 172.41 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.733 0.301 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.18 -153.84 21.25 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -175.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -73.96 103.14 4.35 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.881 0.472 . . . . 0.0 110.332 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -75.08 134.6 41.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.777 0.831 . . . . 0.0 108.95 173.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -63.77 81.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.614 0.766 . . . . 0.0 111.833 -176.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.3 t60 169.37 128.8 0.02 OUTLIER 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.386 1.874 . . . . 0.0 107.267 -178.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -76.15 127.01 32.05 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -61.87 129.54 41.42 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.499 1.12 . . . . 0.0 110.97 -178.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.6 m -75.03 97.83 3.49 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.533 0.733 . . . . 0.0 110.687 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -97.11 98.05 9.72 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 174.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 56.3 ttm -151.61 -59.54 0.16 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.813 0.339 . . . . 0.0 111.346 -170.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 57.2 tttp -88.01 77.22 8.46 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.495 0.718 . . . . 0.0 110.918 -172.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 27.7 ttt180 148.05 38.87 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.618 0 C-N-CA 127.828 2.451 . . . . 0.0 108.538 168.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 95.2 p 51.93 38.32 23.32 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.237 1.415 . . . . 0.0 112.135 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.93 -150.61 21.63 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.528 -174.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.519 ' HB2' HG12 ' A' ' 60' ' ' VAL . 18.9 mmm180 -100.94 135.52 42.25 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.488 0.715 . . . . 0.0 111.164 -173.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -89.68 116.54 27.89 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 169.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.3 pt -105.92 -177.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.663 0.785 . . . . 0.0 109.679 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.0 p -97.55 165.71 11.85 Favored 'General case' 0 C--O 1.248 0.999 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 169.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.496 ' O ' HG23 ' A' ' 24' ' ' VAL . 73.6 t-105 -55.84 -40.81 73.36 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.58 0.55 . . . . 0.0 110.388 171.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -53.4 -53.78 46.35 Favored 'General case' 0 C--O 1.256 1.447 0 C-N-CA 124.017 0.927 . . . . 0.0 111.881 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -51.88 -54.42 29.44 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 124.318 1.011 . . . . 0.0 109.195 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -51.89 -45.32 64.11 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 124.983 1.427 . . . . 0.0 111.745 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 20' ' ' TRP . 72.4 t -55.56 -63.16 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 O-C-N 123.551 0.532 . . . . 0.0 111.31 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -67.37 -42.03 84.12 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.923 0.764 . . . . 0.0 112.757 -167.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.424 HD22 ' N ' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -94.62 -21.45 18.8 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -173.571 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.453 ' HE2' HG21 ' A' ' 60' ' ' VAL . 22.8 m-85 -122.19 -67.47 0.96 Allowed 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 118.778 0.717 . . . . 0.0 112.618 -169.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.4 tp -59.46 -48.2 82.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.612 0.765 . . . . 0.0 111.597 -173.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.3 p -64.86 -20.64 66.52 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -102.74 -2.48 28.05 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.949 0.5 . . . . 0.0 110.995 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.61 33.88 42.17 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 115.424 0.93 . . . . 0.0 115.424 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.7 m -81.87 -3.57 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 122.934 0.493 . . . . 0.0 111.297 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.42 135.76 30.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 C-N-CA 123.972 0.909 . . . . 0.0 108.792 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.09 -49.51 7.73 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.801 0.84 . . . . 0.0 110.323 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -153.83 149.17 27.11 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.765 0.826 . . . . 0.0 111.095 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.5 mt -118.39 103.22 9.58 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.908 1.283 . . . . 0.0 108.01 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.606 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 37.8 mt-10 -99.15 109.59 22.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.066 -171.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 44' ' ' VAL . 57.3 t -83.42 98.6 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.5 t -92.62 120.99 42.87 Favored 'Isoleucine or valine' 0 C--O 1.251 1.176 0 C-N-CA 123.204 0.602 . . . . 0.0 109.779 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 59.47 18.37 6.84 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.084 1.354 . . . . 0.0 113.437 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 60.4 6.69 1.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.686 1.194 . . . . 0.0 112.94 -173.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -87.71 -48.82 7.56 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.609 1.164 . . . . 0.0 110.215 -173.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -146.21 170.14 17.33 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.416 -172.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.498 HG22 HG22 ' A' ' 38' ' ' VAL . 95.6 t -121.26 123.54 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.86 0.864 . . . . 0.0 109.561 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.606 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 7.9 tpm_? -83.37 109.48 17.33 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.312 1.445 . . . . 0.0 107.458 177.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.06 107.44 16.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.4 m -107.79 127.73 53.96 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.504 ' H ' ' HE1' ' A' ' 59' ' ' TYR . 99.7 m-85 -100.61 169.55 8.97 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.269 1.028 . . . . 0.0 111.991 -171.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.1 p -87.83 132.29 40.7 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.17 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.19 -18.63 30.55 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.38 2.72 . . . . 0.0 114.479 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.96 -43.85 90.28 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.371 0.42 . . . . 0.0 112.661 176.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -85.36 -65.0 1.06 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.1 0.56 . . . . 0.0 110.146 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 38.5 p -80.43 138.78 51.59 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.236 -176.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 53' ' ' THR . 5.2 Cg_exo -73.76 -151.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 123.29 2.66 . . . . 0.0 111.853 173.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.3 m -56.92 -23.06 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -173.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -143.3 -48.78 0.31 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.206 0.602 . . . . 0.0 109.687 170.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.95 -91.77 0.07 OUTLIER Glycine 0 C--N 1.353 1.525 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -171.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -163.32 84.26 0.49 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.154 0.982 . . . . 0.0 109.899 169.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.504 ' HE1' ' H ' ' A' ' 48' ' ' PHE . 60.2 m-85 -67.52 114.81 6.48 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 170.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.519 HG12 ' HB2' ' A' ' 16' ' ' ARG . 28.7 m -111.15 172.48 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.666 -174.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -160.45 164.87 31.92 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.048 0.939 . . . . 0.0 108.948 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -152.53 143.65 23.13 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 122.551 0.34 . . . . 0.0 110.357 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -89.09 123.67 33.59 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 67' ' ' VAL . 32.1 pt -95.44 -40.95 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.777 -171.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.94 -75.31 0.24 Allowed Glycine 0 C--N 1.35 1.307 0 O-C-N 123.424 0.452 . . . . 0.0 112.264 -172.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.1 m -82.06 99.22 9.05 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.498 ' HA ' HD12 ' A' ' 64' ' ' ILE . 60.3 t -54.7 -39.59 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.379 1.072 . . . . 0.0 110.887 171.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 18.9 t70 -54.34 -55.93 23.63 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 123.97 0.908 . . . . 0.0 110.73 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.4 m -59.82 -42.81 94.33 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 124.087 0.867 . . . . 0.0 111.506 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -50.84 -50.09 57.49 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 123.409 0.684 . . . . 0.0 111.488 172.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 67' ' ' VAL . 47.0 mt-10 -68.58 -47.23 67.32 Favored 'General case' 0 C--O 1.217 -0.639 0 O-C-N 123.97 0.794 . . . . 0.0 111.243 -177.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 68' ' ' ASP . 24.3 mmm180 -53.55 -48.6 68.98 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.454 0.701 . . . . 0.0 110.458 -178.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.21 -53.42 37.46 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.601 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.13 -53.31 58.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.69 0.796 . . . . 0.0 112.117 -174.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -61.64 -51.19 69.51 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.492 0.717 . . . . 0.0 112.028 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.414 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 94.1 m -63.11 -47.4 82.96 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.781 0.676 . . . . 0.0 110.619 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.475 HD21 HG13 ' A' ' 24' ' ' VAL . 35.4 tp -56.82 -45.61 82.16 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.73 1.212 . . . . 0.0 112.913 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -66.44 -34.83 78.83 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.385 0.428 . . . . 0.0 110.284 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -66.36 -38.35 87.39 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.632 0.373 . . . . 0.0 111.347 173.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 76' ' ' THR . 49.9 mt-10 -69.5 -36.99 76.99 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.909 0.884 . . . . 0.0 111.0 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.78 -19.38 59.03 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.017 0.927 . . . . 0.0 111.641 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.85 6.03 70.34 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.862 -0.41 . . . . 0.0 113.494 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.776 HG23 HD22 ' A' ' 87' ' ' ASN . 68.5 mt -71.27 109.98 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 124.511 1.124 . . . . 0.0 109.403 176.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -124.35 144.09 50.21 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.369 0.668 . . . . 0.0 111.507 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.83 -115.0 5.0 Favored Glycine 0 C--N 1.354 1.549 0 O-C-N 124.897 1.373 . . . . 0.0 114.831 169.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -64.61 -26.43 68.39 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.17 0.988 . . . . 0.0 112.067 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.776 HD22 HG23 ' A' ' 83' ' ' ILE . 6.6 t30 -79.71 -20.3 46.82 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.24 0.216 . . . . 0.0 110.988 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -64.86 139.59 58.78 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 174.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 t -75.9 114.84 40.87 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 124.03 0.831 . . . . 0.0 109.243 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.87 140.3 94.58 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.465 2.777 . . . . 0.0 113.252 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.8 t -105.97 112.52 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.432 ' HB ' ' HG2' ' A' ' 37' ' ' GLU . 63.0 t -110.78 97.13 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 123.821 0.849 . . . . 0.0 109.656 -171.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -70.61 103.11 2.43 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.551 0.34 . . . . 0.0 110.276 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 63.1 mt -98.77 131.02 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.38 95.1 4.41 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 176.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -137.68 113.21 9.48 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.44 0.696 . . . . 0.0 110.448 -174.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.6 m -69.17 151.37 46.43 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.213 0.605 . . . . 0.0 110.774 173.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -75.86 88.36 2.87 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.976 0.51 . . . . 0.0 110.011 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.927 0 CA-C-O 119.046 -0.863 . . . . 0.0 112.098 175.388 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.4 mtm . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.759 0.314 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.01 -86.67 0.74 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 -171.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 58.65 25.95 13.92 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.836 1.254 . . . . 0.0 112.257 173.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -130.54 101.72 5.83 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -81.45 -79.12 0.17 Allowed 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -163.15 -23.38 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.491 0.716 . . . . 0.0 111.736 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -64.75 -33.96 77.2 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.655 0.782 . . . . 0.0 111.077 -172.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 26.4 m170 67.8 18.72 9.7 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.885 1.274 . . . . 0.0 112.072 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.8 p -74.46 84.83 2.0 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.572 0.701 . . . . 0.0 110.427 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -131.68 -156.09 0.73 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.114 0.965 . . . . 0.0 108.963 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.6 ttt -54.07 130.32 37.6 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.335 0.654 . . . . 0.0 111.53 -178.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -129.06 33.83 4.53 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.278 1.031 . . . . 0.0 109.426 -177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 58.95 91.62 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.403 1.081 . . . . 0.0 110.533 -175.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.5 t -77.49 121.81 24.36 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -115.87 150.1 18.7 Favored Glycine 0 N--CA 1.471 0.986 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -140.51 128.12 21.56 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.391 0.676 . . . . 0.0 109.729 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.34 141.24 35.61 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.7 pt -137.38 -175.44 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.237 1.415 . . . . 0.0 108.14 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.4 p -105.44 165.36 11.18 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.63 0.372 . . . . 0.0 110.209 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.468 ' O ' HG23 ' A' ' 24' ' ' VAL . 70.8 t-105 -56.43 -37.54 70.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.61 0.764 . . . . 0.0 109.879 169.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -57.18 -46.04 83.18 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 123.799 0.84 . . . . 0.0 112.217 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -61.31 -46.13 91.59 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.684 0.393 . . . . 0.0 110.895 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.401 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 35.6 t80 -54.29 -55.55 27.14 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 124.184 0.927 . . . . 0.0 111.256 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 20' ' ' TRP . 94.2 t -57.19 -62.69 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.299 0.639 . . . . 0.0 111.73 -176.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -67.38 -54.39 20.87 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.573 -170.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -87.64 -14.79 39.06 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.441 0.696 . . . . 0.0 112.649 -165.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.401 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 91.1 m-85 -124.8 -67.12 0.93 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 118.397 0.544 . . . . 0.0 112.003 -174.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.4 tp -60.68 -47.98 83.85 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.749 0.819 . . . . 0.0 111.733 -172.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.9 m -68.96 -16.67 63.8 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.615 0.766 . . . . 0.0 112.807 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -93.56 -5.49 48.83 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.011 0.524 . . . . 0.0 111.512 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.18 33.94 82.1 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 123.572 0.545 . . . . 0.0 114.142 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.469 HG12 ' HD3' ' A' ' 52' ' ' LYS . 18.5 m -93.23 1.66 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 122.551 0.34 . . . . 0.0 111.071 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 t -96.67 126.68 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 120.688 0.28 . . . . 0.0 110.278 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 23.4 t70 -88.45 -50.36 6.36 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.347 1.059 . . . . 0.0 109.43 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -155.01 162.72 41.0 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.794 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.4 mt -117.08 103.32 10.11 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.457 0.703 . . . . 0.0 109.648 174.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -87.39 100.74 12.96 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.511 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.2 t -93.1 92.64 3.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -172.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.421 HG22 ' HB ' ' A' ' 94' ' ' ILE . 60.7 t -83.6 132.23 31.95 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.566 -175.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 66.19 11.12 7.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.895 1.278 . . . . 0.0 112.392 172.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.481 ' HB3' HG21 ' A' ' 67' ' ' VAL . 62.0 mttm 58.47 6.14 0.53 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.478 1.111 . . . . 0.0 112.55 -168.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -94.52 -38.11 11.06 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.7 1.2 . . . . 0.0 110.234 -168.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -148.4 151.85 35.98 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.237 -176.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.91 126.43 68.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.257 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -101.84 123.22 45.41 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.452 ' HB ' HG23 ' A' ' 60' ' ' VAL . 46.5 t -83.78 111.2 19.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.526 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.0 m -91.91 135.48 33.9 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.54 ' HE1' ' HA ' ' A' ' 59' ' ' TYR . 75.9 m-85 -85.49 148.46 25.96 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 123.308 0.38 . . . . 0.0 110.159 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.594 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 27.5 p -65.15 135.0 96.06 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.13 0.572 . . . . 0.0 111.055 176.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.31 95.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 123.706 2.937 . . . . 0.0 112.63 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.06 -47.37 0.92 Allowed Glycine 0 C--N 1.344 1.024 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.469 ' HD3' HG12 ' A' ' 32' ' ' VAL . 92.3 mttt -82.74 -6.19 59.28 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.454 0.702 . . . . 0.0 110.159 171.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.516 HG22 ' HB2' ' A' ' 48' ' ' PHE . 9.2 p -60.66 109.21 1.86 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.882 0.873 . . . . 0.0 109.573 167.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -65.1 166.49 18.64 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.803 2.335 . . . . 0.0 112.995 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.0 m -64.86 -16.33 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.321 0.648 . . . . 0.0 112.161 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.66 -42.71 93.45 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.78 0.832 . . . . 0.0 110.714 175.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.88 -1.43 68.33 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.089 -176.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -77.38 163.08 26.73 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.53 0.732 . . . . 0.0 111.154 -176.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.54 ' HA ' ' HE1' ' A' ' 48' ' ' PHE . 97.5 m-85 -129.27 153.51 47.73 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.641 177.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.452 HG23 ' HB ' ' A' ' 46' ' ' VAL . 19.1 m -109.56 159.16 9.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.504 174.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -159.44 164.5 34.48 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 123.836 0.855 . . . . 0.0 108.975 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -148.73 141.11 24.19 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -88.35 132.5 34.4 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 67' ' ' VAL . 24.3 pt -104.36 139.8 24.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 123.788 0.835 . . . . 0.0 109.808 -177.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.22 -41.94 44.75 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.824 176.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.4 t -132.17 132.17 42.93 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.937 0.895 . . . . 0.0 110.393 177.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.481 HG21 ' HB3' ' A' ' 41' ' ' LYS . 38.6 t -63.6 -35.49 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.467 0.707 . . . . 0.0 110.745 172.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -57.81 -50.26 73.86 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.767 0.827 . . . . 0.0 110.724 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.1 m -61.69 -45.82 92.34 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 124.167 0.917 . . . . 0.0 111.027 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -54.0 -51.25 64.52 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.197 0.599 . . . . 0.0 111.023 175.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -64.77 -51.13 63.91 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.577 0.751 . . . . 0.0 112.451 -174.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -66.74 -36.4 82.37 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.116 0.26 . . . . 0.0 111.054 -175.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -69.25 -42.53 75.49 Favored 'General case' 0 C--O 1.218 -0.567 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.426 ' HG ' ' NE2' ' A' ' 78' ' ' GLN . 29.9 tp -59.76 -53.19 60.88 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 123.593 0.558 . . . . 0.0 111.232 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -62.96 -41.84 99.64 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.046 0.539 . . . . 0.0 111.807 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.6 m -66.97 -54.95 16.85 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.387 0.675 . . . . 0.0 111.05 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.8 tp -52.0 -41.17 61.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.142 1.377 . . . . 0.0 112.651 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.426 ' NE2' ' HG ' ' A' ' 74' ' ' LEU . 44.8 mt-30 -64.01 -42.95 96.97 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.4 0.28 . . . . 0.0 110.487 175.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' A' ' 84' ' ' GLU . 23.8 mm-40 -63.37 -32.13 73.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.756 0.423 . . . . 0.0 111.782 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -64.42 -38.32 90.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.12 0.568 . . . . 0.0 110.32 173.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.4 mt -78.36 -13.97 59.61 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.518 0.727 . . . . 0.0 111.324 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.35 21.35 58.7 Favored Glycine 0 C--N 1.355 1.606 0 C-N-CA 122.88 0.276 . . . . 0.0 113.126 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 79.1 mt -94.06 131.62 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 125.467 1.507 . . . . 0.0 110.179 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.497 ' HB3' ' NE2' ' A' ' 79' ' ' GLN . 9.5 pt-20 -166.63 160.83 15.4 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.026 0.93 . . . . 0.0 109.737 175.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.93 -92.65 0.01 OUTLIER Glycine 0 C--N 1.347 1.149 0 O-C-N 123.919 0.762 . . . . 0.0 114.688 173.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -69.8 -46.44 65.7 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.37 1.068 . . . . 0.0 110.638 -172.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -92.48 -4.9 52.91 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.374 -174.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -70.39 128.28 35.66 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.153 0.581 . . . . 0.0 109.87 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.84 113.67 13.03 Favored Pre-proline 0 CA--C 1.55 0.977 0 O-C-N 124.049 0.843 . . . . 0.0 111.081 -170.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 74.9 Cg_exo -54.48 122.67 11.96 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 123.482 2.788 . . . . 0.0 112.666 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 91.7 t -102.7 121.43 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.8 t -118.69 97.47 5.34 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -71.61 117.87 13.73 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.421 ' HB ' HG22 ' A' ' 39' ' ' VAL . 54.9 mt -108.76 142.48 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.05 142.31 27.88 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -156.69 156.32 33.21 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.0 m 58.05 29.55 17.94 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.739 0.78 . . . . 0.0 110.161 -175.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -88.44 99.23 12.12 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.463 -176.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.156 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.879 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.571 ' SD ' ' HB3' ' A' ' 97' ' ' SER . 21.9 ptt? . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -98.93 134.38 11.66 Favored Glycine 0 C--N 1.342 0.905 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 167.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -68.32 144.74 54.7 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.401 0.681 . . . . 0.0 109.377 173.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -60.74 94.6 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.716 0.806 . . . . 0.0 110.327 177.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -77.57 87.62 3.89 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.019 0.914 . . . . 0.0 110.422 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -68.13 -45.05 74.68 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 172.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -138.43 153.35 48.87 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.878 1.271 . . . . 0.0 108.396 170.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -80.23 75.14 7.04 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 172.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.7 p -62.53 -43.79 97.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.396 0.678 . . . . 0.0 111.111 -173.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -171.88 165.98 6.4 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.465 1.106 . . . . 0.0 108.696 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.1 ttt -52.18 141.62 18.39 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.53 0.732 . . . . 0.0 110.412 171.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.12 91.85 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.157 1.383 . . . . 0.0 112.179 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -151.1 71.74 1.03 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.867 1.267 . . . . 0.0 107.835 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.7 t -76.33 89.97 3.18 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.79 178.24 30.81 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.28 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.644 ' HB2' HG12 ' A' ' 60' ' ' VAL . 51.6 mmm-85 -81.15 114.18 19.81 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -75.24 108.21 7.85 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 50.0 pt -105.49 -178.13 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 124.936 1.295 . . . . 0.0 108.804 173.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.4 p -98.85 168.6 10.02 Favored 'General case' 0 C--O 1.247 0.952 0 C-N-CA 123.186 0.594 . . . . 0.0 109.506 167.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.492 ' O ' HG23 ' A' ' 24' ' ' VAL . 44.8 t-105 -53.74 -42.74 68.46 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.563 0.745 . . . . 0.0 110.336 171.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -60.33 -43.47 96.37 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.007 0.523 . . . . 0.0 112.34 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.533 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 63.1 m-20 -64.5 -35.12 79.91 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.51 0.324 . . . . 0.0 110.845 177.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.561 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 35.8 t80 -57.67 -51.93 67.51 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 123.905 0.753 . . . . 0.0 110.839 174.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.527 HG13 HD21 ' A' ' 77' ' ' LEU . 90.4 t -54.75 -62.98 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.047 0.939 . . . . 0.0 112.136 -176.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -73.25 -49.27 28.7 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.06 -18.91 37.99 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -170.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.561 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 60.0 m-85 -128.12 -64.93 0.93 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 119.075 0.852 . . . . 0.0 112.994 -170.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 tp -60.84 -46.25 91.32 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.312 0.645 . . . . 0.0 111.787 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.1 t -58.56 -27.77 64.9 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.581 1.152 . . . . 0.0 112.929 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -87.51 -17.63 31.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.957 0.503 . . . . 0.0 110.739 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.35 32.59 84.13 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 123.804 0.69 . . . . 0.0 113.897 -172.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.8 m -80.7 -0.88 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.3 t -100.5 132.16 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.694 0.798 . . . . 0.0 110.117 -170.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -83.28 -52.69 6.34 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.206 1.002 . . . . 0.0 109.967 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.417 HH21 HG21 ' A' ' 92' ' ' VAL . 1.1 ptm180 -154.67 156.81 37.11 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.657 0.783 . . . . 0.0 109.74 -175.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 77.3 mt -112.28 102.87 11.0 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -92.5 101.88 14.33 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.984 -178.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 38.7 t -83.88 96.23 4.21 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -175.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.23 118.63 25.66 Favored 'Isoleucine or valine' 0 C--O 1.247 0.944 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.639 -173.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.525 HD21 ' HB3' ' A' ' 98' ' ' ASP . 2.6 t-20 58.74 18.38 5.93 Favored 'General case' 0 CA--C 1.559 1.298 0 O-C-N 124.944 1.402 . . . . 0.0 112.587 172.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.411 ' HA ' HG12 ' A' ' 38' ' ' VAL . 33.4 mtmm 58.66 2.23 0.22 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.388 1.475 . . . . 0.0 114.33 -171.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -82.05 -33.85 29.73 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.371 0.668 . . . . 0.0 109.803 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -154.36 163.81 39.58 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.767 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 57.9 t -111.74 129.28 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -103.84 128.07 51.31 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.0 t -88.88 106.98 17.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.397 -1.274 . . . . 0.0 107.656 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.4 m -96.71 125.53 41.23 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.442 ' HB2' HG22 ' A' ' 53' ' ' THR . 98.2 m-85 -94.44 170.38 9.53 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.027 0.829 . . . . 0.0 110.994 -173.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.6 p -82.49 145.25 50.98 Favored Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 168.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.06 -34.73 69.29 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.384 2.723 . . . . 0.0 113.621 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.57 -18.19 69.05 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.654 0.596 . . . . 0.0 113.834 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -118.17 17.01 14.06 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.519 0.728 . . . . 0.0 112.408 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.442 HG22 ' HB2' ' A' ' 48' ' ' PHE . 20.5 p -65.51 137.54 96.55 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.65 170.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.97 154.18 22.78 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 122.987 2.458 . . . . 0.0 111.358 177.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.5 p -56.18 -27.34 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 124.255 1.022 . . . . 0.0 112.73 -171.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.7 -13.63 61.53 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.016 0.927 . . . . 0.0 112.9 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.67 33.55 71.67 Favored Glycine 0 C--N 1.346 1.13 0 O-C-N 123.656 0.597 . . . . 0.0 112.254 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -123.29 -174.73 3.02 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.798 0.839 . . . . 0.0 110.669 -175.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -112.71 174.02 6.1 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.202 1.001 . . . . 0.0 109.491 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.644 HG12 ' HB2' ' A' ' 16' ' ' ARG . 11.4 m -124.6 166.7 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -165.2 159.86 17.95 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.767 0.427 . . . . 0.0 111.079 -175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -147.76 142.29 26.48 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.4 0.68 . . . . 0.0 109.914 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -81.49 141.64 33.66 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 67' ' ' VAL . 33.3 pt -117.42 124.09 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.274 0.63 . . . . 0.0 110.361 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -71.6 -40.46 59.1 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.1 t -129.92 120.01 24.18 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.118 0.967 . . . . 0.0 108.73 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.502 ' HA ' HD12 ' A' ' 64' ' ' ILE . 97.5 t -56.04 -38.83 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.49 1.116 . . . . 0.0 110.774 172.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -60.66 -45.62 93.44 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.003 0.921 . . . . 0.0 110.805 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.1 m -59.57 -47.46 85.46 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.353 0.661 . . . . 0.0 110.747 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -53.65 -60.43 3.32 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.772 0.829 . . . . 0.0 111.862 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -42.01 80.19 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.24 0.616 . . . . 0.0 112.032 -169.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -62.9 -47.79 81.77 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.063 0.545 . . . . 0.0 110.851 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -65.92 -38.73 89.45 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.329 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 58.3 tp -58.04 -56.85 16.67 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.683 0.793 . . . . 0.0 111.974 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -35.17 79.55 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 123.452 0.47 . . . . 0.0 112.182 -174.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.1 m -62.26 -55.03 32.39 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.328 0.651 . . . . 0.0 110.116 172.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.527 HD21 HG13 ' A' ' 24' ' ' VAL . 52.5 tp -50.77 -45.09 58.88 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.644 1.578 . . . . 0.0 113.04 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -63.07 -41.32 99.41 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.046 0.539 . . . . 0.0 110.775 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -65.2 -35.83 82.28 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.129 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -71.33 -44.12 65.7 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.514 0.726 . . . . 0.0 111.458 178.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 80.7 mt -74.19 -7.27 52.08 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.753 0.821 . . . . 0.0 111.888 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.27 8.18 87.84 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.506 0.504 . . . . 0.0 112.537 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.9 mt -70.24 108.67 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.868 1.267 . . . . 0.0 108.057 175.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -141.59 162.73 34.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.627 0.771 . . . . 0.0 110.616 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.44 -120.67 23.75 Favored Glycine 0 C--N 1.344 1.009 0 O-C-N 124.577 1.173 . . . . 0.0 112.995 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.36 -39.99 85.03 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.69 1.196 . . . . 0.0 111.362 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -69.5 -19.75 63.73 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.353 0.661 . . . . 0.0 111.596 -168.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -68.35 148.29 50.92 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 120.911 0.386 . . . . 0.0 111.097 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.92 117.93 56.44 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.744 -173.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.16 150.63 72.07 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 123.215 2.61 . . . . 0.0 112.473 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.3 t -112.88 116.89 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.665 0.786 . . . . 0.0 108.957 -176.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.417 HG21 HH21 ' A' ' 35' ' ' ARG . 47.0 t -117.92 115.6 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 124.419 1.088 . . . . 0.0 108.56 -171.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -94.69 115.57 27.7 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.176 0.59 . . . . 0.0 110.902 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.06 146.51 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 175.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.13 19.15 4.42 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.852 0.861 . . . . 0.0 111.706 174.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 54.75 -88.71 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.815 1.246 . . . . 0.0 110.112 -166.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.571 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 26.6 t -174.92 11.01 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.272 1.829 . . . . 0.0 107.635 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.525 ' HB3' HD21 ' A' ' 40' ' ' ASN . 26.0 t70 -96.18 -18.56 20.0 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.983 1.313 . . . . 0.0 110.446 -167.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.921 0 CA-C-O 119.376 -0.68 . . . . 0.0 111.856 -177.72 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 tpt . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -90.52 -145.67 14.3 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.111 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -74.13 133.04 42.79 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.033 0.417 . . . . 0.0 110.1 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -143.94 166.59 24.52 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.696 0.798 . . . . 0.0 110.976 -178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -90.29 -19.4 24.13 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.719 0.808 . . . . 0.0 110.907 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.482 ' NE2' ' HA ' ' A' ' 9' ' ' SER . 14.9 t60 71.62 113.18 0.06 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.958 1.303 . . . . 0.0 110.251 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -126.57 133.53 51.05 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.772 0.829 . . . . 0.0 109.597 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 72.8 t60 46.71 46.9 15.05 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.197 1.399 . . . . 0.0 111.421 174.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.482 ' HA ' ' NE2' ' A' ' 6' ' ' HIS . 16.4 m 61.79 -86.23 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.965 1.306 . . . . 0.0 110.193 -172.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -170.26 -156.97 0.14 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.684 1.194 . . . . 0.0 107.896 177.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.1 ttt 76.69 137.35 0.06 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.356 1.062 . . . . 0.0 112.492 168.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -118.3 -64.32 1.3 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 169.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.2 mtm105 -142.61 166.83 23.59 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.054 0.942 . . . . 0.0 109.467 177.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.7 p -70.04 81.59 0.49 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.421 0.629 . . . . 0.0 110.33 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.41 76.9 0.02 OUTLIER Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.373 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.606 ' HB2' HG12 ' A' ' 60' ' ' VAL . 18.8 mtm180 -90.68 123.05 33.98 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -177.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -72.67 109.83 6.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.684 0.394 . . . . 0.0 110.095 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 36.6 pt -104.16 170.89 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.023 0.929 . . . . 0.0 109.226 175.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 76.9 p -86.41 168.62 13.64 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 166.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.571 ' O ' HG23 ' A' ' 24' ' ' VAL . 69.2 t-105 -55.1 -40.78 70.81 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.626 0.579 . . . . 0.0 109.849 168.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -56.15 -47.97 77.18 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.552 0.741 . . . . 0.0 111.424 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.569 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 39.7 m-20 -65.11 -39.19 92.77 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.495 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 19.5 t80 -53.8 -48.92 69.37 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 124.208 0.943 . . . . 0.0 110.852 176.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 20' ' ' TRP . 61.2 t -67.4 -65.98 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 123.572 0.545 . . . . 0.0 111.231 -176.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -67.76 -46.67 71.4 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.637 -166.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -85.56 -18.53 33.13 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.964 0.506 . . . . 0.0 112.001 -172.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.495 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 47.8 m-85 -127.55 -67.99 0.8 Allowed 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 119.277 0.944 . . . . 0.0 112.946 -171.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.13 -47.99 83.27 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.736 0.815 . . . . 0.0 111.482 -172.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.4 m -63.79 -23.25 67.29 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.855 0.862 . . . . 0.0 113.13 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -101.99 4.47 39.95 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 119.361 -0.352 . . . . 0.0 111.533 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.63 28.24 56.14 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 114.977 0.751 . . . . 0.0 114.977 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.1 m -81.31 -5.96 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.115 0.566 . . . . 0.0 111.01 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.83 136.4 26.09 Favored 'Isoleucine or valine' 0 C--N 1.346 0.425 0 C-N-CA 124.014 0.926 . . . . 0.0 108.923 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -86.86 -57.75 2.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.131 0.973 . . . . 0.0 108.978 174.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -153.31 159.93 42.6 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.716 -174.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.4 mt -113.87 102.17 9.96 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -94.8 103.68 15.58 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.446 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 18.4 t -87.79 101.7 11.76 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -174.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.487 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 94.9 t -75.59 116.8 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.618 ' HB3' ' HG2' ' A' ' 96' ' ' GLU . 21.4 p-10 37.85 37.17 0.12 Allowed 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 128.348 2.659 . . . . 0.0 115.913 177.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt 67.27 -1.83 1.4 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.918 1.287 . . . . 0.0 112.793 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -80.76 -37.37 30.5 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.063 0.945 . . . . 0.0 110.42 -175.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -159.07 158.93 33.97 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.11 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 61.8 t -109.38 129.42 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.533 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -94.02 126.01 38.98 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.443 ' HB ' HG23 ' A' ' 60' ' ' VAL . 33.5 t -84.21 105.1 13.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.2 m -103.95 130.98 51.61 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.446 ' HB2' HG23 ' A' ' 53' ' ' THR . 92.8 m-85 -96.43 163.8 12.9 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.17 0.918 . . . . 0.0 111.956 -170.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 35.1 p -62.84 151.74 84.39 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 124.084 0.953 . . . . 0.0 112.052 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -55.67 106.94 0.21 Allowed 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.388 2.725 . . . . 0.0 113.911 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.17 -4.16 44.63 Favored Glycine 0 N--CA 1.478 1.439 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.559 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -71.06 -36.64 72.36 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.774 0.83 . . . . 0.0 109.936 176.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.446 HG23 ' HB2' ' A' ' 48' ' ' PHE . 25.6 p -90.15 110.76 42.64 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 124.356 1.062 . . . . 0.0 112.032 -172.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' HD2' ' HG3' ' A' ' 58' ' ' GLN . 98.6 Cg_endo -78.28 -162.74 0.19 Allowed 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.986 3.124 . . . . 0.0 112.992 173.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.66 -29.53 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 124.747 1.219 . . . . 0.0 112.975 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.4 -34.58 75.59 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.512 0.673 . . . . 0.0 111.161 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.02 -43.65 1.82 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.77 -175.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.511 ' NE2' HH12 ' A' ' 16' ' ' ARG . 16.7 mm100 61.9 -0.16 0.47 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.113 1.365 . . . . 0.0 114.583 174.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -62.55 127.63 32.22 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.606 HG12 ' HB2' ' A' ' 16' ' ' ARG . 29.5 m -124.67 156.51 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 124.127 0.892 . . . . 0.0 108.595 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -155.23 171.23 20.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.938 0.495 . . . . 0.0 110.556 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -150.54 143.66 24.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.83 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -79.97 134.45 36.25 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.182 0.593 . . . . 0.0 110.454 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.8 pt -120.24 175.66 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.148 0.579 . . . . 0.0 110.334 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.4 -50.69 0.08 OUTLIER Glycine 0 C--N 1.333 0.401 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.2 t -100.72 108.87 20.83 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.771 0.828 . . . . 0.0 109.631 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.0 t -57.88 -37.69 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.124 0.97 . . . . 0.0 110.402 170.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -53.59 -50.23 66.05 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.786 1.234 . . . . 0.0 110.574 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.6 m -66.83 -43.75 82.9 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 124.126 0.891 . . . . 0.0 111.275 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -53.52 -49.56 67.33 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.084 0.554 . . . . 0.0 110.948 172.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -65.61 -51.67 57.88 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.256 1.022 . . . . 0.0 112.847 -172.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.5 ptt85 -68.11 -38.24 82.05 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.57 0.544 . . . . 0.0 111.255 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -72.48 -39.14 67.93 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 40.5 tp -59.92 -54.42 46.3 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.822 0.849 . . . . 0.0 111.931 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.46 ' HB2' HH12 ' A' ' 88' ' ' ARG . 13.6 pt-20 -63.13 -40.03 96.41 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.301 0.64 . . . . 0.0 111.447 -175.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.7 m -66.86 -49.43 65.7 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.617 0.767 . . . . 0.0 109.736 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.45 HD21 HG22 ' A' ' 24' ' ' VAL . 43.0 tp -51.11 -48.81 61.62 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.526 1.13 . . . . 0.0 111.998 174.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -62.42 -46.41 88.68 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 123.67 0.606 . . . . 0.0 111.225 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -67.04 -30.15 70.14 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 123.043 0.214 . . . . 0.0 110.871 -177.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.64 -42.65 70.59 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.812 0.845 . . . . 0.0 110.842 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 94.4 mt -71.81 -12.16 61.16 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.645 0.778 . . . . 0.0 111.47 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.03 -0.61 76.24 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 123.288 0.368 . . . . 0.0 112.75 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 66.2 mt -74.46 92.28 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.75 152.2 48.05 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.82 0.448 . . . . 0.0 111.225 -172.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.92 -115.91 8.26 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 124.453 1.096 . . . . 0.0 113.02 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.16 -26.48 68.19 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.248 1.019 . . . . 0.0 111.595 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.45 -24.41 60.22 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.846 0.458 . . . . 0.0 111.881 -176.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.46 HH12 ' HB2' ' A' ' 75' ' ' GLU . 60.8 mtt180 -63.02 135.2 57.14 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 123.427 0.455 . . . . 0.0 110.802 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.56 118.87 74.81 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 123.733 0.813 . . . . 0.0 110.44 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.99 135.27 50.45 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 123.596 2.864 . . . . 0.0 113.262 -175.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.1 t -107.2 116.38 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.531 0.733 . . . . 0.0 109.48 -176.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.2 t -105.74 99.08 7.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -174.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -74.92 99.71 3.9 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 42.3 mm -84.75 135.31 25.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.646 ' HB1' ' HB2' ' A' ' 98' ' ' ASP . . . -121.25 111.66 17.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.318 0.647 . . . . 0.0 110.499 -176.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.618 ' HG2' ' HB3' ' A' ' 40' ' ' ASN . 24.9 mm-40 -80.5 -70.83 0.5 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 51.0 m -99.68 -8.05 24.86 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.349 0.66 . . . . 0.0 110.844 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.646 ' HB2' ' HB1' ' A' ' 95' ' ' ALA . 2.3 m-20 -71.15 -28.53 64.33 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.799 0.839 . . . . 0.0 110.726 -178.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.178 0 CA-C-O 118.707 -1.052 . . . . 0.0 110.818 179.487 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 mtm . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.63 51.1 0.25 Allowed Glycine 0 C--N 1.342 0.907 0 C-N-CA 121.681 -0.295 . . . . 0.0 113.18 -174.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -74.15 -33.27 63.45 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -76.01 159.39 30.89 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.332 170.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -61.71 85.35 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.585 1.154 . . . . 0.0 111.034 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -150.35 71.47 1.06 Allowed 'General case' 0 C--O 1.245 0.865 0 C-N-CA 123.776 0.83 . . . . 0.0 109.298 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -168.37 142.49 3.29 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.987 173.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -139.02 115.7 10.68 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.2 p -83.1 125.2 31.23 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.473 0.709 . . . . 0.0 110.951 -173.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -166.46 -65.22 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.005 0.922 . . . . 0.0 109.69 177.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.8 tpt 43.36 130.02 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 127.119 2.168 . . . . 0.0 115.258 -171.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -117.56 77.62 1.15 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.49 0.716 . . . . 0.0 110.035 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -90.09 -48.81 6.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.573 171.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.1 t -165.75 65.02 0.11 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.99 -124.54 7.2 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -169.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.65 ' HB2' HG12 ' A' ' 60' ' ' VAL . 31.9 mmt180 -125.32 113.46 17.62 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 117.971 0.885 . . . . 0.0 109.968 175.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -78.52 133.21 37.41 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.267 0.556 . . . . 0.0 109.648 176.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 22' ' ' ASP . 48.5 pt -132.13 -177.04 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 126.009 1.724 . . . . 0.0 108.27 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.8 p -102.98 169.91 8.28 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 167.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.502 ' O ' HG23 ' A' ' 24' ' ' VAL . 66.4 t-105 -53.18 -40.15 64.17 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.552 0.741 . . . . 0.0 110.486 170.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.6 tttp -56.48 -49.0 75.94 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.749 0.819 . . . . 0.0 111.632 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.515 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 30.5 m-20 -61.95 -40.66 96.3 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.625 0.37 . . . . 0.0 110.773 177.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.426 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 33.9 t80 -54.01 -53.0 59.0 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 124.413 1.07 . . . . 0.0 110.96 177.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 20' ' ' TRP . 63.8 t -57.23 -56.77 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 123.732 0.645 . . . . 0.0 111.074 -177.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -67.6 -58.95 3.78 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.739 0.816 . . . . 0.0 112.274 -170.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -85.44 -20.65 29.47 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.555 0.742 . . . . 0.0 112.084 -165.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.426 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 78.1 m-85 -120.66 -68.97 0.87 Allowed 'General case' 0 C--O 1.248 1.003 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -168.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.7 tp -60.21 -48.85 79.98 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.562 0.745 . . . . 0.0 111.894 -173.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.1 m -68.48 -17.05 64.1 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -96.6 1.38 51.18 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.267 0.485 . . . . 0.0 111.358 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.94 22.01 56.82 Favored Glycine 0 C--N 1.35 1.307 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.456 HG12 ' HD3' ' A' ' 52' ' ' LYS . 20.4 m -89.95 4.83 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.886 0.474 . . . . 0.0 111.334 -178.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.6 t -96.18 128.58 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.432 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 25.6 t70 -90.35 -50.09 6.16 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.885 0.874 . . . . 0.0 109.951 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -163.94 159.21 20.6 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.291 -177.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 46' ' ' VAL . 96.3 mt -120.72 102.55 8.47 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.987 0.915 . . . . 0.0 110.877 -173.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.698 ' HB2' ' HB3' ' A' ' 45' ' ' ARG . 49.4 mp0 -83.99 108.67 17.09 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.698 0.799 . . . . 0.0 110.092 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 41' ' ' LYS . 47.8 t -86.15 90.61 3.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.446 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 59.8 t -84.84 119.05 33.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.851 -170.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 56.89 22.38 7.06 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 125.404 1.482 . . . . 0.0 112.992 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.525 ' HA ' HG12 ' A' ' 38' ' ' VAL . 36.2 mtmm 58.58 8.28 0.86 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.526 1.13 . . . . 0.0 113.666 -173.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -88.59 -40.18 13.56 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.447 1.099 . . . . 0.0 110.851 -174.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -150.33 173.78 13.6 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.062 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 38' ' ' VAL . 73.8 t -124.05 132.72 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.179 0.992 . . . . 0.0 109.676 -178.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.698 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 40.9 ttm180 -96.39 113.09 24.64 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.521 1.128 . . . . 0.0 108.582 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.422 ' HA ' HD23 ' A' ' 36' ' ' LEU . 44.6 t -82.66 107.2 14.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.3 m -93.16 144.67 25.06 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.27 140.48 29.65 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.887 0.475 . . . . 0.0 112.02 177.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' A' ' 52' ' ' LYS . 32.1 p -62.06 128.1 90.32 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 124.121 0.968 . . . . 0.0 110.96 174.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.87 97.94 0.1 OUTLIER 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.112 2.541 . . . . 0.0 111.709 174.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.04 -39.09 1.54 Allowed Glycine 0 C--N 1.343 0.936 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 -175.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.456 ' HD3' HG12 ' A' ' 32' ' ' VAL . 61.0 mttp -106.28 5.23 29.55 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.588 0.755 . . . . 0.0 111.888 177.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.4 m -58.45 127.57 81.63 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-O 118.981 -0.533 . . . . 0.0 110.004 176.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.97 167.18 14.55 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.565 2.177 . . . . 0.0 112.389 -176.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.4 t -55.32 -43.7 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -84.43 86.82 7.23 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 168.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.9 59.73 4.47 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.039 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -110.55 129.88 55.69 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 171.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -61.87 152.85 30.64 Favored 'General case' 0 C--O 1.25 1.102 0 O-C-N 123.573 0.546 . . . . 0.0 110.098 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.65 HG12 ' HB2' ' A' ' 16' ' ' ARG . 23.3 m -109.19 164.61 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 173.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -158.89 158.35 33.23 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 118.385 0.539 . . . . 0.0 111.202 -173.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -146.1 145.68 30.62 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.999 0.52 . . . . 0.0 110.245 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -85.35 121.81 28.62 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.973 0.909 . . . . 0.0 110.487 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 67' ' ' VAL . 36.2 pt -103.77 -51.51 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.283 0.633 . . . . 0.0 111.236 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.457 ' N ' HG13 ' A' ' 64' ' ' ILE . . . 71.03 -70.07 0.78 Allowed Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -165.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.6 m -81.55 96.27 7.39 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.108 0.963 . . . . 0.0 110.895 177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.567 ' HA ' HD12 ' A' ' 64' ' ' ILE . 13.0 t -64.72 -34.06 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 123.626 0.77 . . . . 0.0 111.383 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -58.73 -45.35 89.83 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.063 0.545 . . . . 0.0 109.819 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.5 m -64.19 -46.23 84.87 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.014 0.926 . . . . 0.0 110.229 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -49.65 -54.53 18.0 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.197 0.999 . . . . 0.0 112.042 174.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -66.59 -43.5 84.72 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.125 0.891 . . . . 0.0 111.83 -174.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -63.98 -40.07 95.57 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.568 0.747 . . . . 0.0 111.041 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -64.17 -46.82 82.32 Favored 'General case' 0 C--O 1.216 -0.698 0 O-C-N 123.704 0.627 . . . . 0.0 109.678 175.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 43.7 tp -60.79 -41.81 96.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.935 0.894 . . . . 0.0 111.86 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -65.14 -51.53 60.69 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.211 0.605 . . . . 0.0 111.786 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 m -65.7 -37.28 86.01 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.618 0.767 . . . . 0.0 110.214 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.42 -44.02 95.82 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.494 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -66.25 -29.88 70.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.694 0.397 . . . . 0.0 110.516 176.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -66.88 -49.12 66.64 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.65 0.38 . . . . 0.0 111.397 175.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.46 -36.03 73.66 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.228 0.211 . . . . 0.0 111.239 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.557 ' HB2' HG12 ' A' ' 83' ' ' ILE . 92.0 mt -75.78 -20.06 58.52 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.144 0.578 . . . . 0.0 111.228 175.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.68 30.56 66.11 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 120.121 -0.266 . . . . 0.0 113.131 -175.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.557 HG12 ' HB2' ' A' ' 81' ' ' LEU . 17.6 mm -66.45 102.35 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.414 1.085 . . . . 0.0 109.279 176.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -72.6 166.99 21.64 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.63 -32.85 54.26 Favored Glycine 0 N--CA 1.48 1.613 0 O-C-N 124.179 0.924 . . . . 0.0 114.73 -171.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -67.28 -43.52 81.56 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.966 0.906 . . . . 0.0 110.408 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -81.19 -19.91 42.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.145 0.978 . . . . 0.0 111.593 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 40.5 mtt-85 -61.47 122.08 14.3 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.904 0.881 . . . . 0.0 110.567 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.5 t -77.91 117.95 69.06 Favored Pre-proline 0 CA--C 1.554 1.103 0 O-C-N 123.983 0.802 . . . . 0.0 110.47 -172.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.432 ' HD2' ' O ' ' A' ' 34' ' ' ASP . 71.9 Cg_exo -54.84 136.98 74.19 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.841 3.027 . . . . 0.0 113.261 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.3 t -103.53 113.4 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' A' ' 37' ' ' GLU . 60.3 t -100.89 149.36 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.927 1.291 . . . . 0.0 108.025 -177.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -114.2 131.5 56.44 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 38.4 mm -126.41 138.23 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.882 0.873 . . . . 0.0 109.244 -176.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.5 90.33 3.1 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -116.57 136.41 53.0 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.823 0.849 . . . . 0.0 110.657 -174.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 55.6 p -66.37 138.28 57.48 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.52 0.728 . . . . 0.0 110.038 175.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 71.22 9.1 6.56 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.672 1.189 . . . . 0.0 113.181 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.679 0 CA-C-O 119.158 -0.801 . . . . 0.0 113.3 178.481 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.11 100.43 0.4 Allowed Glycine 0 C--N 1.349 1.28 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 172.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -63.17 -67.43 0.42 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.743 0.817 . . . . 0.0 110.33 -174.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 29.0 p80 47.6 -65.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 127.393 2.277 . . . . 0.0 114.36 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -54.48 118.59 4.28 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.046 0.938 . . . . 0.0 110.698 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 65.18 53.67 1.31 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.994 1.318 . . . . 0.0 110.41 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -79.36 77.04 5.92 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.994 0.902 . . . . 0.0 110.321 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -69.03 -22.22 64.07 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.837 173.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.7 t -70.73 136.62 49.06 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.902 173.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -125.28 29.13 6.14 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.047 1.339 . . . . 0.0 108.091 171.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.7 ttp 76.23 -49.03 0.58 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 126.18 1.792 . . . . 0.0 112.993 172.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -73.86 84.14 1.69 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 173.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 36.8 ttp-105 -81.99 80.28 8.29 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.355 0.662 . . . . 0.0 109.805 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.9 t 65.46 -81.5 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 113.861 -1.518 . . . . 0.0 111.091 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -119.76 -151.84 8.91 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 174.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.651 ' HB2' HG12 ' A' ' 60' ' ' VAL . 59.2 mtm180 -96.92 114.03 25.62 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 175.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -78.81 129.72 34.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.4 pt -124.42 179.72 2.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 124.914 1.286 . . . . 0.0 108.921 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.8 p -106.32 170.1 8.12 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.66 0.784 . . . . 0.0 109.682 172.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.422 ' O ' HG23 ' A' ' 24' ' ' VAL . 71.1 t-105 -59.62 -39.87 85.71 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.527 0.731 . . . . 0.0 111.174 176.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -55.68 -52.38 64.05 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.585 0.754 . . . . 0.0 112.229 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -70.18 -32.38 70.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.935 0.494 . . . . 0.0 111.51 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.495 ' HA ' ' HD2' ' A' ' 27' ' ' TYR . 17.4 t80 -55.84 -56.11 24.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.635 0.774 . . . . 0.0 111.671 172.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.44 ' HA ' ' HB3' ' A' ' 28' ' ' LEU . 97.4 t -61.95 -58.33 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 123.595 0.56 . . . . 0.0 110.419 -176.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -65.47 -49.82 67.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.052 -168.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -87.46 -17.08 33.0 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -170.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.495 ' HD2' ' HA ' ' A' ' 23' ' ' PHE . 42.7 m-85 -128.6 -68.04 0.77 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -171.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 7.9 tt -59.06 -52.65 64.83 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.559 0.744 . . . . 0.0 111.903 -169.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 82.3 p -66.61 -22.57 66.12 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.554 0.742 . . . . 0.0 112.152 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -89.76 -5.42 56.98 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.342 0.657 . . . . 0.0 111.664 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.24 32.67 77.34 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.468 0.48 . . . . 0.0 113.991 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 m -101.93 11.44 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 122.855 0.462 . . . . 0.0 110.328 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.67 122.59 51.69 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 C-N-CA 124.207 1.003 . . . . 0.0 109.519 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 25.7 t70 -77.04 -45.89 25.62 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.732 0.813 . . . . 0.0 109.601 176.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -162.59 162.44 27.18 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.747 -167.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.426 ' HG ' HG11 ' A' ' 89' ' ' VAL . 95.4 mt -120.41 137.11 54.49 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.906 1.283 . . . . 0.0 108.375 170.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -120.13 110.49 16.7 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.213 0.605 . . . . 0.0 109.491 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 44' ' ' VAL . 24.3 t -90.09 91.14 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -176.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.49 119.11 34.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -172.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 57.99 17.1 4.14 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.629 1.571 . . . . 0.0 113.855 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.1 mttp 61.69 2.81 0.76 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -172.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -80.04 -42.43 23.77 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 123.658 0.783 . . . . 0.0 109.856 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -151.38 170.41 19.63 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.334 -174.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 38' ' ' VAL . 84.6 t -129.21 133.7 65.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -99.57 132.41 44.93 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.15 109.39 16.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 114.59 -1.186 . . . . 0.0 107.819 174.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 16.7 m -82.13 125.95 31.47 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 172.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.546 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 22.7 m-85 -84.21 133.42 34.59 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.369 0.668 . . . . 0.0 110.204 177.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.507 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 0.3 OUTLIER -69.82 136.37 87.7 Favored Pre-proline 0 C--O 1.245 0.817 0 O-C-N 123.497 0.498 . . . . 0.0 109.95 175.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.91 134.46 53.54 Favored 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.54 2.16 . . . . 0.0 111.183 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.19 -47.34 3.65 Favored Glycine 0 N--CA 1.476 1.313 0 O-C-N 123.166 0.291 . . . . 0.0 112.958 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -58.99 -40.48 84.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.911 0.884 . . . . 0.0 110.868 174.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' A' ' 48' ' ' PHE . 30.7 m -135.65 137.59 26.17 Favored Pre-proline 0 C--O 1.246 0.903 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.83 130.92 37.01 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.028 1.819 . . . . 0.0 110.837 171.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.9 t -69.7 -16.34 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.698 0.799 . . . . 0.0 110.18 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -60.82 -36.27 78.65 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.599 1.159 . . . . 0.0 110.409 169.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.3 126.2 19.17 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.551 173.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -65.01 139.0 58.71 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.803 0.841 . . . . 0.0 111.017 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.439 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 17.8 m-85 -68.19 143.13 55.47 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.544 0.737 . . . . 0.0 110.732 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.651 HG12 ' HB2' ' A' ' 16' ' ' ARG . 34.9 m -107.7 161.33 6.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.506 -176.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 45.5 p-90 -153.3 162.26 41.49 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.601 0.76 . . . . 0.0 109.276 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -147.75 144.38 28.21 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -79.57 136.22 36.8 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 67' ' ' VAL . 43.1 pt -108.23 -42.22 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 110.658 -0.127 . . . . 0.0 110.658 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.81 -81.53 0.05 OUTLIER Glycine 0 C--N 1.35 1.306 0 N-CA-C 112.028 -0.429 . . . . 0.0 112.028 -173.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.3 m -74.48 97.49 3.12 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.739 0.816 . . . . 0.0 109.134 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.467 ' HA ' HD12 ' A' ' 64' ' ' ILE . 25.2 t -59.81 -33.67 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.98 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -57.05 -40.77 77.42 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.944 0.898 . . . . 0.0 111.069 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.2 m -67.19 -46.01 75.19 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.129 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -52.64 -52.73 54.32 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.503 0.502 . . . . 0.0 111.213 177.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -59.63 -59.01 6.12 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.3 1.0 . . . . 0.0 112.767 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 -67.2 -36.79 82.46 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.534 -171.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.82 -52.63 59.3 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 174.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 47.7 tp -52.78 -52.96 54.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.188 1.395 . . . . 0.0 112.722 -176.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -68.17 -45.55 73.16 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.449 -175.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.41 ' HA ' ' NE2' ' A' ' 79' ' ' GLN . 27.6 m -64.72 -45.14 87.78 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.4 tp -46.45 -48.52 18.93 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.883 1.673 . . . . 0.0 112.382 171.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -62.23 -43.25 99.24 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.3 0.64 . . . . 0.0 111.258 177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.41 ' NE2' ' HA ' ' A' ' 76' ' ' THR . 17.7 mt-30 -65.25 -41.69 94.05 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.255 0.622 . . . . 0.0 111.142 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -68.47 -40.26 81.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.741 0.816 . . . . 0.0 111.25 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.58 -15.04 59.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.214 0.605 . . . . 0.0 112.52 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.96 13.57 68.94 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-O 120.269 -0.184 . . . . 0.0 113.41 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.4 mt -71.67 108.11 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.43 1.092 . . . . 0.0 109.2 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -137.98 151.47 47.96 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.929 0.891 . . . . 0.0 110.568 -172.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.22 -118.91 13.96 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 123.905 0.753 . . . . 0.0 113.65 174.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.69 -29.32 70.56 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.043 0.937 . . . . 0.0 111.734 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.84 -21.66 60.92 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.943 -171.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 88' ' ' ARG . 37.6 mtp85 -66.55 150.01 49.63 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.175 0.59 . . . . 0.0 110.416 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.426 HG11 ' HG ' ' A' ' 36' ' ' LEU . 20.2 t -91.64 119.55 68.46 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.118 -168.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -61.4 123.86 13.59 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.066 2.51 . . . . 0.0 111.377 175.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.2 t -116.19 118.34 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 67.8 t -113.36 105.59 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 124.106 0.963 . . . . 0.0 109.567 -173.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -75.35 123.46 25.42 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.051 0.54 . . . . 0.0 109.814 175.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.8 mt -119.58 140.38 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.882 1.273 . . . . 0.0 108.084 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.01 85.96 2.44 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.031 0.443 . . . . 0.0 110.356 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -89.8 -175.91 4.78 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.642 172.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.4 t -152.37 80.16 1.24 Allowed 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.557 0.694 . . . . 0.0 109.275 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -89.22 98.37 11.73 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.611 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.936 0 CA-C-O 118.688 -1.062 . . . . 0.0 112.042 174.432 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 121.021 0.439 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.41 -72.94 0.07 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 175.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.1 t60 54.85 -86.78 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.054 1.342 . . . . 0.0 112.334 178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -98.21 9.69 42.37 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.117 0.967 . . . . 0.0 110.611 -174.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -63.37 -24.1 67.7 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 122.87 0.468 . . . . 0.0 111.49 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -122.12 152.82 39.48 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.893 0.477 . . . . 0.0 110.018 168.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -72.77 144.59 47.52 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.264 0.626 . . . . 0.0 109.946 172.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -78.97 159.91 27.46 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.968 0.907 . . . . 0.0 111.114 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -78.93 147.4 33.03 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.136 0.574 . . . . 0.0 110.672 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 59.6 89.89 0.06 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.456 1.102 . . . . 0.0 110.769 -176.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.4 ttm -55.15 -44.14 74.85 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.51 1.124 . . . . 0.0 111.287 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -81.39 142.34 33.1 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.627 172.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -115.08 -1.24 13.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.983 0.913 . . . . 0.0 109.971 176.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 p -155.0 -172.32 4.15 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.158 0.983 . . . . 0.0 109.612 -174.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.56 -79.87 0.04 OUTLIER Glycine 0 C--N 1.349 1.282 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 20.4 tpp180 -135.35 128.63 32.04 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.833 0.853 . . . . 0.0 109.396 176.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -77.44 111.32 13.02 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 167.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.465 HD11 HG21 ' A' ' 46' ' ' VAL . 27.5 pt -93.77 166.78 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.555 1.142 . . . . 0.0 109.241 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 75.9 p -88.57 170.73 10.6 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -56.79 -40.86 76.67 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.097 0.559 . . . . 0.0 110.13 168.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -59.98 -49.17 78.74 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.663 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.425 ' HA ' HD22 ' A' ' 26' ' ' ASN . 59.0 m-20 -66.61 -36.79 83.46 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.193 0.197 . . . . 0.0 111.183 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -54.65 -59.4 4.76 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.654 0.596 . . . . 0.0 110.736 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.486 HG13 HD11 ' A' ' 77' ' ' LEU . 47.5 t -60.17 -50.79 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 123.933 0.771 . . . . 0.0 111.255 -175.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -73.1 -56.97 4.38 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.793 -173.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.425 HD22 ' HA ' ' A' ' 22' ' ' ASP . 23.7 m-80 -90.89 -10.99 40.53 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -166.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -126.9 -64.69 1.0 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 119.158 0.89 . . . . 0.0 111.737 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 41.9 tp -58.15 -41.81 84.55 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.551 1.14 . . . . 0.0 112.224 -176.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.8 t -66.55 -22.21 66.15 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.576 0.751 . . . . 0.0 112.751 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -87.09 -7.9 57.58 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.326 0.512 . . . . 0.0 110.949 175.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.66 12.95 60.25 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 114.259 0.464 . . . . 0.0 114.259 -175.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.14 -1.01 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 117.317 0.558 . . . . 0.0 111.084 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.55 126.44 45.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 C-N-CA 123.525 0.73 . . . . 0.0 109.155 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.443 ' HB2' ' HA ' ' A' ' 49' ' ' THR . 16.5 t70 -86.03 -51.58 6.25 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.886 0.851 . . . . 0.0 109.095 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.534 ' HD3' HG21 ' A' ' 92' ' ' VAL . 16.2 ptp180 -160.13 164.42 32.99 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.05 -172.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 92.2 mt -117.17 101.93 8.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.685 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -92.96 107.61 19.36 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.495 0.718 . . . . 0.0 109.944 -171.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 44' ' ' VAL . 41.0 t -91.89 91.61 3.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -175.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.688 ' HA ' ' HB ' ' A' ' 94' ' ' ILE . 49.1 t -79.08 114.22 19.52 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.666 -172.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 50.66 31.7 6.1 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.496 1.519 . . . . 0.0 113.217 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HA ' HG12 ' A' ' 38' ' ' VAL . 61.3 mttm 66.8 -6.87 0.5 Allowed 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 125.714 1.606 . . . . 0.0 112.801 -177.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.7 mmt-85 -64.94 -50.19 67.42 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 124.865 1.266 . . . . 0.0 110.904 -170.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -148.74 159.83 43.77 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.49 -175.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 38' ' ' VAL . 65.5 t -101.14 123.06 53.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 171.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -101.6 129.29 47.68 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.542 ' HB ' HG23 ' A' ' 60' ' ' VAL . 68.8 t -85.13 110.24 19.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.5 m -82.97 134.74 35.04 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -82.99 128.17 34.23 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 171.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.443 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 5.1 t -72.79 146.56 88.14 Favored Pre-proline 0 CA--C 1.556 1.202 0 C-N-CA 123.109 0.564 . . . . 0.0 110.541 -176.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -57.02 116.1 2.97 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 123.399 2.732 . . . . 0.0 112.606 178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.22 -17.2 24.39 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.061 -173.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -128.36 20.34 6.24 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.699 1.2 . . . . 0.0 110.798 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.5 m -91.51 120.92 68.09 Favored Pre-proline 0 C--O 1.244 0.798 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.3 155.04 70.75 Favored 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.698 2.266 . . . . 0.0 112.289 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.9 t -61.55 -40.39 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-O 121.588 0.709 . . . . 0.0 109.4 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -83.22 89.82 7.02 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.622 169.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.09 71.91 0.94 Allowed Glycine 0 C--N 1.346 1.118 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.854 176.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -101.69 101.11 11.57 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -76.53 136.23 39.3 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.512 0.725 . . . . 0.0 112.088 -166.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.542 HG23 ' HB ' ' A' ' 46' ' ' VAL . 18.7 m -106.29 140.75 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -177.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -157.21 173.57 16.77 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.344 -170.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 23.7 p90 -151.98 141.17 21.35 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.86 0.864 . . . . 0.0 109.178 175.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -78.17 147.54 34.47 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.2 pt -124.39 154.1 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.329 0.652 . . . . 0.0 109.289 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.24 -34.43 1.79 Allowed Glycine 0 N--CA 1.471 0.989 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 174.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 m -117.9 99.55 6.99 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.56 1.144 . . . . 0.0 108.535 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.6 t -60.64 -35.3 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 122.977 0.511 . . . . 0.0 110.036 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.05 -40.44 95.78 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.065 0.946 . . . . 0.0 110.736 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.3 m -67.95 -42.87 80.29 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.565 176.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -55.14 -43.76 74.48 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.909 0.756 . . . . 0.0 111.394 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.47 -51.07 64.89 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.864 0.466 . . . . 0.0 110.73 -179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -34.42 73.52 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -171.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 29.9 p30 -74.27 -33.33 63.24 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 176.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.7 tp -62.89 -42.96 99.96 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.607 0.763 . . . . 0.0 110.859 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -60.34 -52.82 63.62 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.137 0.575 . . . . 0.0 110.566 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 57.8 m -61.97 -42.2 98.86 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 123.666 0.604 . . . . 0.0 110.738 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 73' ' ' ASN . 1.8 tm? -56.53 -47.82 78.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.84 1.256 . . . . 0.0 110.879 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.439 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 77.3 mt-30 -65.18 -36.83 85.43 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.143 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -63.85 -39.53 94.44 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.096 0.558 . . . . 0.0 110.814 176.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.97 -51.26 70.0 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.038 0.935 . . . . 0.0 111.169 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.8 mt -83.85 -2.57 56.69 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.001 -173.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.87 9.95 83.51 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 120.281 -0.177 . . . . 0.0 112.935 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.478 HG22 ' HA ' ' A' ' 88' ' ' ARG . 57.2 mt -73.59 118.61 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.733 1.213 . . . . 0.0 109.077 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -168.56 173.86 7.16 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.482 0.713 . . . . 0.0 111.193 -172.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.75 -122.11 25.39 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.589 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -76.46 -34.2 58.71 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.43 0.692 . . . . 0.0 110.245 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -74.33 -6.1 46.08 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.438 0.695 . . . . 0.0 112.455 -171.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.478 ' HA ' HG22 ' A' ' 83' ' ' ILE . 6.9 ptm180 -79.91 156.45 27.28 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.079 0.466 . . . . 0.0 111.274 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.5 t -98.99 114.81 65.84 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.246 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.92 160.74 33.64 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.164 2.576 . . . . 0.0 112.875 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.8 t -110.65 132.31 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.614 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.534 HG21 ' HD3' ' A' ' 35' ' ' ARG . 21.8 t -117.92 97.37 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -73.01 100.83 3.08 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.376 0.67 . . . . 0.0 109.883 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.688 ' HB ' ' HA ' ' A' ' 39' ' ' VAL . 46.8 mm -78.55 122.67 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -119.11 67.4 0.79 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -140.74 107.27 5.31 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.248 -173.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.6 p -159.84 136.44 9.1 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.035 0.534 . . . . 0.0 110.738 -175.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -122.54 -47.04 2.12 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.529 0.732 . . . . 0.0 109.677 173.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 CA-C-O 119.049 -0.861 . . . . 0.0 111.64 177.324 . . . . . . . . 0 0 . 1 stop_ save_